1	From	IN	O	from	_	0	SENT_1	[p1l96t893r158b914],
2	St.	NNP	ORGANIZATION	St.	nn	3	SENT_1	[p1l170t890r268b921],
3	Jude	NNP	ORGANIZATION	Jude	pobj	1	SENT_1	[p1l170t890r268b921],
4	Children	NNP	ORGANIZATION	Children	poss	7	SENT_1	[p1l278t890r407b914],
5	's	POS	ORGANIZATION	's	_	0	SENT_1	[p1l278t890r407b914],
6	Research	NNP	ORGANIZATION	Research	nn	7	SENT_1	[p1l420t890r532b914],
7	Hospital	NNP	ORGANIZATION	Hospital	dep	3	SENT_1	[p1l546t893r630b921, p1l93t928r123b952],
8	and	CC	O	and	_	0	SENT_1	[p1l138t928r184b952],
9	the	DT	O	the	det	10	SENT_1	[p1l198t928r238b952],
10	University	NNP	ORGANIZATION	University	pobj	1	SENT_1	[p1l254t930r382b959],
11	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l395t928r423b952],
12	Tennessee	NNP	ORGANIZATION	Tennessee	nn	13	SENT_1	[p1l432t930r566b952],
13	Colleges	NNP	ORGANIZATION	Colleges	prep_of	10	SENT_1	[p1l580t928r629b952, p1l95t965r158b997],
14	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l177t965r205b989],
15	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	13	SENT_1	[p1l220t965r342b997],
16	and	CC	O	and	_	0	SENT_1	[p1l358t965r402b989],
17	Medicine	NNP	O	Medicine	prep_of	13	SENT_1	[p1l421t965r539b993],
18	,	,	O	,	_	0	SENT_1	[p1l421t965r539b993],
19	Memphis	NNP	LOCATION	Memphis	conj_and	3	SENT_1	[p1l558t968r630b989, p1l95t1003r145b1034],
20	(	CD	NUMBER	(	num	19	SENT_1	[p1l161t1005r263b1034],
21	\	CD	NUMBER	\	num	23	SENT_1	[p1l161t1005r263b1034],
22	N.E.E.	NNP	O	N.E.E.	nn	23	SENT_1	[p1l161t1005r263b1034],
23	)	NN	O	)	dep	19	SENT_1	[p1l161t1005r263b1034],
24	;	:	O	;	_	0	SENT_1	[p1l161t1005r263b1034],
25	and	CC	O	and	_	0	SENT_1	[p1l277t1003r321b1027],
26	Washington	NNP	ORGANIZATION	Washington	nn	29	SENT_1	[p1l335t1003r487b1034],
27	University	NNP	ORGANIZATION	University	nn	29	SENT_1	[p1l503t1005r630b1034],
28	Medical	NNP	ORGANIZATION	Medical	nn	29	SENT_1	[p1l96t1041r194b1064],
29	School	NNP	ORGANIZATION	School	pobj	1	SENT_1	[p1l210t1041r304b1069],
30	,	,	O	,	_	0	SENT_1	[p1l210t1041r304b1069],
31	St.	NNP	LOCATION	St.	nn	32	SENT_1	[p1l320t1043r352b1064],
32	Louis	NNP	LOCATION	Louis	appos	29	SENT_1	[p1l369t1043r436b1064],
33	(	CD	NUMBER	(	num	34	SENT_1	[p1l454t1043r572b1072],
34	H.L.M.	NNP	O	H.L.M.	dep	32	SENT_1	[p1l454t1043r572b1072],
35	)	CD	NUMBER	)	num	34	SENT_1	[p1l454t1043r572b1072],
36	.	.	O	.	_	0	SENT_1	[p1l454t1043r572b1072],

1	Address	NN	O	address	nsubj	2	SENT_2	[p1l586t1041r629b1064, p1l94t1078r162b1102],
2	reprint	VB	O	reprint	_	0	SENT_2	[p1l177t1080r261b1109],
3	requests	NNS	O	request	dobj	2	SENT_2	[p1l274t1083r381b1109],
4	to	TO	O	to	_	0	SENT_2	[p1l392t1083r417b1102],
5	Dr.	NNP	O	Dr.	nn	6	SENT_2	[p1l431t1080r464b1102],
6	Evans	NNP	PERSON	Evans	prep_to	2	SENT_2	[p1l479t1080r550b1102],
7	at	IN	O	at	_	0	SENT_2	[p1l563t1083r586b1102],
8	St.	NNP	ORGANIZATION	St.	nn	10	SENT_2	[p1l598t1080r629b1102],
9	Jude	NNP	ORGANIZATION	Jude	nn	10	SENT_2	[p1l90t1116r150b1146],
10	Children	NNP	ORGANIZATION	Children	poss	13	SENT_2	[p1l159t1116r287b1140],
11	's	POS	ORGANIZATION	's	_	0	SENT_2	[p1l159t1116r287b1140],
12	Research	NNP	ORGANIZATION	Research	nn	13	SENT_2	[p1l299t1116r411b1140],
13	Hospital	NNP	ORGANIZATION	Hospital	prep_at	6	SENT_2	[p1l423t1116r537b1147],
14	,	,	O	,	_	0	SENT_2	[p1l423t1116r537b1147],
15	332	CD	NUMBER	332	num	18	SENT_2	[p1l547t1118r591b1139],
16	N.	NNP	LOCATION	N.	nn	18	SENT_2	[p1l602t1118r629b1139],
17	Lauderdale	NNP	LOCATION	Lauderdale	nn	18	SENT_2	[p1l96t1153r235b1177],
18	St.	NNP	LOCATION	St.	conj_or	6	SENT_2	[p1l261t1155r299b1181],
19	,	,	O	,	_	0	SENT_2	[p1l261t1155r299b1181],
20	Memphis	NNP	LOCATION	Memphis	conj_or	6	SENT_2	[p1l328t1153r455b1184],
21	,	,	O	,	_	0	SENT_2	[p1l328t1153r455b1184],
22	TN	NN	O	tn	prep_to	2	SENT_2	[p1l480t1156r518b1177],
23	381010318	CD	NUMBER	381010318	num	22	SENT_2	[p1l546t1155r630b1177, p1l94t1192r161b1219],
24	,	,	O	,	_	0	SENT_2	[p1l546t1155r630b1177, p1l94t1192r161b1219],
25	or	CC	O	or	_	0	SENT_2	[p1l172t1199r198b1215],
26	at	IN	O	at	prep_to	2	SENT_2	[p1l207t1195r229b1215],
27	wi	FW	O	wi	pobj	26	SENT_2	[p1l237t1191r579b1222],
28	|	FW	O	|	nn	30	SENT_2	[p1l237t1191r579b1222],
29	|	FW	O	|	nn	30	SENT_2	[p1l237t1191r579b1222],
30	iam.evans@stjude.org	NN	O	iam.evans@stjude.org	dep	6	SENT_2	[p1l237t1191r579b1222],
31	.	.	O	.	_	0	SENT_2	[p1l237t1191r579b1222],

1	The	DT	O	the	det	4	SENT_3	[p1l1001t81r1039b103],
2	NEW	NNP	O	NEW	nn	4	SENT_3	[p1l1052t83r1132b103],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_3	[p1l1146t83r1321b103],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_3	[p1l1335t83r1501b110],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_3	[p1l1514t81r1731b109],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_4	[p1l1169t235r1351b261],
2	ARTICLE	NN	O	article	dep	1	SENT_4	[p1l1366t235r1565b261],

1	DRUG	NN	O	drug	nn	2	SENT_5	[p1l1223t387r1326b410],
2	THERAPY	NN	O	therapy	_	0	SENT_5	[p1l1344t387r1514b410],

1	AlastairJ	NN	O	alastairj	_	0	SENT_6	[p1l1159t453r1304b484],
2	.	.	O	.	_	0	SENT_6	[p1l1159t453r1304b484],

1	J.	NNP	PERSON	J.	nn	2	SENT_7	[p1l1159t453r1304b484],
2	Wood	NNP	PERSON	Wood	_	0	SENT_7	[p1l1315t453r1398b481],
3	,	,	O	,	_	0	SENT_7	[p1l1315t453r1398b481],
4	M.D.	NNP	O	M.D.	nn	6	SENT_7	[p1l1412t455r1482b481],
5	,	,	O	,	_	0	SENT_7	[p1l1412t455r1482b481],
6	Editor	NNP	O	Editor	appos	2	SENT_7	[p1l1496t453r1577b477],

1	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	2	SENT_8	[p1l757t559r1343b629],
2	—	NNP	MISC	—	_	0	SENT_8	[p1l1359t590r1434b595],
3	Drug	NNP	MISC	Drug	nn	4	SENT_8	[p1l1448t563r1601b629],
4	Disposition	NNP	MISC	Disposition	dep	2	SENT_8	[p1l1615t559r1975b628],
5	,	,	O	,	_	0	SENT_8	[p1l1615t559r1975b628],

1	Drug	NN	O	drug	_	0	SENT_9	[p1l926t646r1078b712],
2	Targets	NNS	O	target	dep	1	SENT_9	[p1l1091t646r1324b712],
3	,	,	O	,	_	0	SENT_9	[p1l1091t646r1324b712],
4	and	CC	O	and	_	0	SENT_9	[p1l1345t642r1454b696],
5	Side	NN	O	side	nn	6	SENT_9	[p1l1473t642r1594b696],
6	Effects	NNS	O	effect	dep	1	SENT_9	[p1l1611t641r1809b696],

1	William	NNP	PERSON	William	nn	3	SENT_10	[p1l829t776r956b807],
2	E.	NNP	PERSON	E.	nn	3	SENT_10	[p1l974t779r999b807],
3	Evans	NNP	PERSON	Evans	_	0	SENT_10	[p1l1016t779r1121b813],
4	,	,	O	,	_	0	SENT_10	[p1l1016t779r1121b813],
5	Pharm	NNP	O	Pharm	appos	3	SENT_10	[p1l1138t776r1306b813],
6	.	.	O	.	_	0	SENT_10	[p1l1138t776r1306b813],

1	D.	NNP	O	D.	_	0	SENT_11	[p1l1138t776r1306b813],
2	,	,	O	,	_	0	SENT_11	[p1l1138t776r1306b813],
3	and	CC	O	and	_	0	SENT_11	[p1l1321t776r1381b807],
4	Howard	NNP	PERSON	Howard	nn	5	SENT_11	[p1l1398t776r1529b807],
5	L.	NNP	PERSON	L.	conj_and	1	SENT_11	[p1l1546t779r1570b807],
6	McLeod	NNP	PERSON	McLeod	nn	8	SENT_11	[p1l1587t776r1730b813],
7	,	,	O	,	_	0	SENT_11	[p1l1587t776r1730b813],
8	Pharm	NNP	ORGANIZATION	Pharm	dep	1	SENT_11	[p1l1747t776r1905b807],
9	.	.	O	.	_	0	SENT_11	[p1l1747t776r1905b807],

1	D.	NNP	O	D.	_	0	SENT_12	[p1l1747t776r1905b807],

1	T	NN	O	t	nsubj	4	SENT_13	[p1l748t892r770b914],
2	IS	VBZ	O	be	cop	4	SENT_13	[p1l783t892r813b914],
3	WELL	NNP	O	WELL	nn	4	SENT_13	[p1l824t892r920b914],
4	RECOGNIZED	NNP	O	RECOGNIZED	_	0	SENT_13	[p1l933t892r1170b914],
5	THAT	WDT	O	that	dobj	8	SENT_13	[p1l1181t892r1276b914],
6	DIFFERENT	JJ	O	different	amod	7	SENT_13	[p1l1288t892r1492b914],
7	PATIENTS	NNS	O	patient	nsubj	8	SENT_13	[p1l1504t892r1672b914],
8	RESPOND	VBP	O	respond	rcmod	4	SENT_13	[p1l1687t892r1855b914],
9	IN	IN	O	in	_	0	SENT_13	[p1l1869t892r1910b914],
10	DIFFERent	JJ	O	different	amod	11	SENT_13	[p1l1925t892r2067b914, p1l750t940r802b964],
11	ways	NNS	O	way	prep_in	8	SENT_13	[p1l816t944r895b973],
12	to	TO	O	to	_	0	SENT_13	[p1l913t940r944b964],
13	the	DT	O	the	det	15	SENT_13	[p1l961t934r1012b964],
14	same	JJ	O	same	amod	15	SENT_13	[p1l1029t944r1114b964],
15	medication	NN	O	medication	prep_to	8	SENT_13	[p1l1131t934r1324b964],
16	.	.	O	.	_	0	SENT_13	[p1l1131t934r1324b964],

1	These	DT	O	these	det	2	SENT_14	[p1l1342t934r1439b964],
2	differences	NNS	O	difference	nsubj	5	SENT_14	[p1l1457t933r1636b964],
3	are	VBP	O	be	cop	5	SENT_14	[p1l1654t944r1703b964],
4	often	RB	O	often	advmod	5	SENT_14	[p1l1721t933r1804b964],
5	greater	JJR	O	greater	_	0	SENT_14	[p1l1822t940r1937b973],
6	among	IN	O	among	_	0	SENT_14	[p1l1953t943r2069b973],
7	members	NNS	O	member	prep_among	5	SENT_14	[p1l750t984r903b1014],
8	of	IN	O	of	_	0	SENT_14	[p1l915t983r954b1014],
9	a	DT	O	a	det	10	SENT_14	[p1l957t994r974b1014],
10	population	NN	O	population	prep_of	7	SENT_14	[p1l983t984r1163b1023],
11	than	IN	O	than	mark	13	SENT_14	[p1l1174t984r1247b1014],
12	they	PRP	O	they	nsubj	13	SENT_14	[p1l1258t984r1326b1023],
13	are	VBP	O	be	ccomp	5	SENT_14	[p1l1334t994r1383b1014],
14	within	IN	O	within	_	0	SENT_14	[p1l1392t984r1499b1015],
15	the	DT	O	the	det	17	SENT_14	[p1l1509t984r1559b1014],
16	same	JJ	O	same	amod	17	SENT_14	[p1l1571t994r1655b1014],
17	person	NN	O	person	prep_within	13	SENT_14	[p1l1665t994r1778b1023],
18	at	IN	O	at	_	0	SENT_14	[p1l1788t990r1819b1014],
19	different	JJ	O	different	amod	20	SENT_14	[p1l1827t983r1970b1014],
20	times	NNS	O	time	prep_at	17	SENT_14	[p1l1978t984r2067b1014],
21	(	CD	NUMBER	(	nsubj	26	SENT_14	[p1l671t1036r717b1069],
22	or	CC	O	or	dep	23	SENT_14	[p1l671t1036r717b1069],
23	between	IN	O	between	dep	21	SENT_14	[p1l728t1034r864b1065],
24	monozygotic	JJ	O	monozygotic	amod	25	SENT_14	[p1l876t1034r1090b1073],
25	twins	NNS	O	twin	pobj	23	SENT_14	[p1l1102t1034r1230b1069],
26	)	VBP	O	)	rcmod	17	SENT_14	[p1l1102t1034r1230b1069],
27	.1	CD	NUMBER	.1	dobj	26	SENT_14	[p1l1102t1034r1230b1069],
28	The	DT	O	the	det	29	SENT_14	[p1l1241t1034r1303b1064],
29	existence	NN	O	existence	nsubj	40	SENT_14	[p1l1315t1034r1464b1064],
30	of	IN	O	of	_	0	SENT_14	[p1l1477t1033r1516b1064],
31	large	JJ	O	large	amod	33	SENT_14	[p1l1520t1034r1601b1073],
32	population	NN	O	population	nn	33	SENT_14	[p1l1612t1034r1792b1073],
33	differences	NNS	O	difference	prep_of	29	SENT_14	[p1l1804t1033r1983b1064],
34	with	IN	O	with	_	0	SENT_14	[p1l1994t1034r2067b1065],
35	small	JJ	O	small	amod	37	SENT_14	[p1l670t1084r758b1114],
36	intrapatient	JJ	O	intrapatient	amod	37	SENT_14	[p1l766t1084r960b1123],
37	variability	NN	O	variability	prep_with	33	SENT_14	[p1l965t1084r1127b1123],
38	is	VBZ	O	be	cop	40	SENT_14	[p1l1134t1084r1159b1114],
39	consistentwith	JJ	O	consistentwith	amod	40	SENT_14	[p1l1169t1084r1417b1115],
40	inheritance	NN	O	inheritance	rcmod	27	SENT_14	[p1l1426t1084r1611b1114],
41	as	IN	O	as	_	0	SENT_14	[p1l1620t1094r1653b1114],
42	a	DT	O	a	det	43	SENT_14	[p1l1662t1094r1679b1114],
43	determinant	NN	O	determinant	prep_as	40	SENT_14	[p1l1688t1084r1891b1114],
44	of	IN	O	of	_	0	SENT_14	[p1l1898t1083r1937b1114],
45	drug	NN	O	drug	nn	46	SENT_14	[p1l1939t1084r2016b1123],
46	response	NN	O	response	prep_of	43	SENT_14	[p1l2024t1094r2067b1114, p1l670t1144r794b1173],
47	;	:	O	;	_	0	SENT_14	[p1l2024t1094r2067b1114, p1l670t1144r794b1173],
48	it	PRP	O	it	nsubjpass	50	SENT_14	[p1l807t1134r831b1164],
49	is	VBZ	O	be	auxpass	50	SENT_14	[p1l841t1134r866b1164],
50	estimated	VBN	O	estimate	parataxis	5	SENT_14	[p1l879t1134r1038b1165],
51	that	IN	O	that	complm	54	SENT_14	[p1l1050t1134r1115b1164],
52	genetics	NNS	O	genetics	nsubj	54	SENT_14	[p1l1125t1134r1259b1173],
53	can	MD	O	can	aux	54	SENT_14	[p1l1272t1144r1328b1164],
54	account	VB	O	account	ccomp	50	SENT_14	[p1l1340t1140r1471b1165],
55	for	IN	O	for	_	0	SENT_14	[p1l1481t1134r1529b1165],
56	20	CD	NUMBER	20	number	58	SENT_14	[p1l1540t1136r1579b1165],
57	to	TO	O	to	dep	58	SENT_14	[p1l1592t1140r1622b1165],
58	95	CD	PERCENT	95	num	59	SENT_14	[p1l1635t1136r1673b1165],
59	percent	NN	PERCENT	percent	prep_for	54	SENT_14	[p1l1686t1140r1811b1173],
60	of	IN	O	of	_	0	SENT_14	[p1l1821t1134r1860b1165],
61	variability	NN	O	variability	prep_of	59	SENT_14	[p1l1864t1134r2026b1173],
62	in	IN	O	in	_	0	SENT_14	[p1l2036t1134r2068b1164],
63	drug	NN	O	drug	nn	64	SENT_14	[p1l669t1184r747b1223],
64	disposition	NN	O	disposition	prep_in	54	SENT_14	[p1l756t1184r939b1223],
65	and	CC	O	and	_	0	SENT_14	[p1l949t1184r1010b1215],
66	effects	NNS	O	effect	prep_in	54	SENT_14	[p1l1020t1184r1152b1215],
67	?	.	O	?	_	0	SENT_14	[p1l1020t1184r1152b1215],

1	Although	IN	O	although	mark	5	SENT_15	[p1l1161t1184r1316b1223],
2	many	JJ	O	many	amod	4	SENT_15	[p1l1326t1194r1417b1223],
3	nongenetic	JJ	O	nongenetic	amod	4	SENT_15	[p1l1425t1184r1609b1223],
4	factors	NNS	O	factor	nsubj	5	SENT_15	[p1l1618t1184r1729b1215],
5	inﬂuence	VBP	O	inﬂuence	advcl	31	SENT_15	[p1l1739t1184r1891b1215],
6	the	DT	O	the	det	7	SENT_15	[p1l1901t1184r1952b1214],
7	effects	NNS	O	effect	dobj	5	SENT_15	[p1l1962t1184r2067b1214],
8	of	IN	O	of	_	0	SENT_15	[p1l669t1234r708b1265],
9	medications	NNS	O	medication	prep_of	7	SENT_15	[p1l710t1234r918b1271],
10	,	,	O	,	_	0	SENT_15	[p1l710t1234r918b1271],
11	including	VBG	O	include	_	0	SENT_15	[p1l929t1234r1085b1273],
12	age	NN	O	age	prep_including	5	SENT_15	[p1l1092t1244r1156b1273],
13	,	,	O	,	_	0	SENT_15	[p1l1092t1244r1156b1273],
14	organ	NN	O	organ	nn	15	SENT_15	[p1l1168t1244r1262b1273],
15	function	NN	O	function	conj_and	12	SENT_15	[p1l1271t1234r1417b1271],
16	,	,	O	,	_	0	SENT_15	[p1l1271t1234r1417b1271],
17	concomitant	JJ	O	concomitant	amod	18	SENT_15	[p1l1428t1234r1636b1265],
18	therapy	NN	O	therapy	conj_and	12	SENT_15	[p1l1643t1234r1769b1273],
19	,	,	O	,	_	0	SENT_15	[p1l1643t1234r1769b1273],
20	drug	NN	O	drug	nn	21	SENT_15	[p1l1780t1234r1857b1273],
21	interactions	NNS	O	interaction	conj_and	12	SENT_15	[p1l1864t1234r2066b1271],
22	,	,	O	,	_	0	SENT_15	[p1l1864t1234r2066b1271],
23	and	CC	O	and	_	0	SENT_15	[p1l669t1283r729b1314],
24	the	DT	O	the	det	25	SENT_15	[p1l740t1283r790b1313],
25	nature	NN	O	nature	conj_and	12	SENT_15	[p1l801t1289r905b1314],
26	of	IN	O	of	_	0	SENT_15	[p1l916t1283r955b1314],
27	the	DT	O	the	det	28	SENT_15	[p1l958t1283r1008b1313],
28	disease	NN	O	disease	prep_of	25	SENT_15	[p1l1019t1283r1146b1320],
29	,	,	O	,	_	0	SENT_15	[p1l1019t1283r1146b1320],
30	there	EX	O	there	expl	31	SENT_15	[p1l1159t1283r1241b1313],
31	are	VBP	O	be	ccomp	74	SENT_15	[p1l1252t1293r1301b1313],
32	now	RB	DATE	now	advmod	31	SENT_15	[p1l1311t1293r1383b1314],
33	numerous	JJ	O	numerous	amod	34	SENT_15	[p1l1391t1293r1558b1314],
34	examples	NNS	O	example	nsubj	31	SENT_15	[p1l1569t1283r1722b1322],
35	of	IN	O	of	_	0	SENT_15	[p1l1733t1283r1772b1314],
36	cases	NNS	O	case	prep_of	34	SENT_15	[p1l1776t1293r1860b1313],
37	in	IN	O	in	_	0	SENT_15	[p1l1871t1283r1903b1313],
38	which	WDT	O	which	rel	45	SENT_15	[p1l1911t1283r2013b1314],
39	interindividual	JJ	O	interindividual	amod	40	SENT_15	[p1l2023t1283r2067b1313, p1l669t1332r871b1363],
40	differences	NNS	O	difference	nsubj	45	SENT_15	[p1l879t1332r1054b1363],
41	in	IN	O	in	_	0	SENT_15	[p1l1062t1332r1093b1362],
42	drug	NN	O	drug	nn	43	SENT_15	[p1l1101t1332r1177b1371],
43	response	NN	O	response	prep_in	40	SENT_15	[p1l1183t1342r1327b1371],
44	are	VBP	O	be	cop	45	SENT_15	[p1l1334t1342r1382b1362],
45	due	JJ	O	due	rcmod	36	SENT_15	[p1l1390t1332r1447b1363],
46	to	TO	O	to	_	0	SENT_15	[p1l1455t1338r1485b1363],
47	sequence	NN	O	sequence	nn	48	SENT_15	[p1l1494t1342r1641b1371],
48	variants	NNS	O	variant	prep_to	45	SENT_15	[p1l1647t1332r1773b1363],
49	in	IN	O	in	_	0	SENT_15	[p1l1780t1332r1812b1362],
50	genes	NNS	O	gene	prep_in	48	SENT_15	[p1l1819t1342r1910b1371],
51	encoding	VBG	O	encode	partmod	50	SENT_15	[p1l1919t1332r2069b1371],
52	drug-metabolizing	JJ	O	drug-metabolizing	amod	53	SENT_15	[p1l669t1381r977b1420],
53	enzymes	NNS	O	enzyme	dobj	51	SENT_15	[p1l985t1391r1134b1420],
54	,	,	O	,	_	0	SENT_15	[p1l985t1391r1134b1420],
55	drug	NN	O	drug	nn	56	SENT_15	[p1l1145t1381r1222b1420],
56	transporters	NNS	O	transporter	conj_or	53	SENT_15	[p1l1230t1387r1437b1420],
57	,	,	O	,	_	0	SENT_15	[p1l1230t1387r1437b1420],
58	or	CC	O	or	_	0	SENT_15	[p1l1448t1391r1483b1412],
59	drug	NN	O	drug	nn	61	SENT_15	[p1l1491t1381r1568b1420],
60	targets	NNS	O	target	nn	61	SENT_15	[p1l1576t1383r1737b1420],
61	.3	NN	NUMBER	.3	conj_or	53	SENT_15	[p1l1576t1383r1737b1420],
62	'	''	O	'	_	0	SENT_15	[p1l1576t1383r1737b1420],
63	5	CD	NUMBER	5	dobj	51	SENT_15	[p1l1576t1383r1737b1420],
64	Unlike	IN	O	unlike	_	0	SENT_15	[p1l1747t1381r1854b1412],
65	other	JJ	O	other	amod	66	SENT_15	[p1l1864t1381r1950b1412],
66	factors	NNS	O	factor	nsubj	67	SENT_15	[p1l1958t1381r2067b1412],
67	inﬂuencing	VBG	O	inﬂuencing	prepc_unlike	45	SENT_15	[p1l669t1430r856b1469],
68	drug	NN	O	drug	nn	69	SENT_15	[p1l865t1430r942b1469],
69	response	NN	O	response	dobj	67	SENT_15	[p1l950t1440r1104b1469],
70	,	,	O	,	_	0	SENT_15	[p1l950t1440r1104b1469],
71	inherited	VBN	O	inherit	amod	72	SENT_15	[p1l1116t1430r1262b1461],
72	determinants	NNS	O	determinant	nsubj	74	SENT_15	[p1l1272t1430r1487b1461],
73	generally	RB	O	generally	advmod	74	SENT_15	[p1l1497t1430r1646b1469],
74	remain	VBP	O	remain	_	0	SENT_15	[p1l1653t1430r1768b1460],
75	stable	JJ	O	stable	acomp	74	SENT_15	[p1l1778t1430r1873b1461],
76	throughout	IN	O	throughout	_	0	SENT_15	[p1l1883t1430r2070b1469],
77	a	DT	O	a	det	78	SENT_15	[p1l669t1489r686b1509],
78	person	NN	O	person	poss	80	SENT_15	[p1l694t1481r833b1518],
79	’s	POS	O	’s	_	0	SENT_15	[p1l694t1481r833b1518],
80	lifetime	NN	O	lifetime	prep_throughout	74	SENT_15	[p1l842t1479r975b1510],
81	.	.	O	.	_	0	SENT_15	[p1l842t1479r975b1510],

1	Clinical	JJ	O	clinical	amod	2	SENT_16	[p1l719t1528r841b1559],
2	observations	NNS	O	observation	nsubj	10	SENT_16	[p1l849t1528r1052b1559],
3	of	IN	O	of	_	0	SENT_16	[p1l1061t1528r1100b1559],
4	inherited	VBN	O	inherit	amod	5	SENT_16	[p1l1100t1528r1246b1559],
5	differences	NNS	O	difference	prep_of	2	SENT_16	[p1l1254t1528r1430b1559],
6	in	IN	O	in	_	0	SENT_16	[p1l1439t1528r1470b1558],
7	drug	NN	O	drug	nn	8	SENT_16	[p1l1478t1528r1554b1567],
8	effects	NNS	O	effect	prep_in	5	SENT_16	[p1l1561t1528r1664b1558],
9	were	VBD	O	be	cop	10	SENT_16	[p1l1671t1538r1748b1559],
10	ﬁrst	NN	O	ﬁrst	_	0	SENT_16	[p1l1756t1528r1822b1558],
11	documented	VBN	O	document	partmod	10	SENT_16	[p1l1828t1528r2029b1559],
12	in	IN	O	in	_	0	SENT_16	[p1l2037t1528r2068b1558],
13	the	DT	DATE	the	det	15	SENT_16	[p1l669t1577r719b1607],
14	1950s	CD	DATE	1950s	num	15	SENT_16	[p1l728t1579r875b1614],
15	,5	CD	NUMBER	,5	prep_in	11	SENT_16	[p1l728t1579r875b1614],
16	‘	CD	NUMBER	‘	number	17	SENT_16	[p1l728t1579r875b1614],
17	9	CD	NUMBER	9	dep	15	SENT_16	[p1l728t1579r875b1614],
18	giving	VBG	O	give	xcomp	11	SENT_16	[p1l882t1577r983b1616],
19	rise	NN	O	rise	iobj	18	SENT_16	[p1l989t1577r1047b1607],
20	to	TO	O	to	dep	28	SENT_16	[p1l1055t1583r1085b1608],
21	the	DT	O	the	det	22	SENT_16	[p1l1094t1577r1144b1607],
22	ﬁeld	NN	O	ﬁeld	pobj	20	SENT_16	[p1l1151t1577r1223b1608],
23	of	IN	O	of	_	0	SENT_16	[p1l1231t1577r1269b1608],
24	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	22	SENT_16	[p1l1269t1577r1577b1616],
25	,	,	O	,	_	0	SENT_16	[p1l1269t1577r1577b1616],
26	and	CC	O	and	_	0	SENT_16	[p1l1587t1577r1647b1608],
27	later	RB	O	later	dep	28	SENT_16	[p1l1654t1577r1727b1607],
28	pharmacogenomics	NNS	O	pharmacogenomic	dobj	18	SENT_16	[p1l1733t1577r2066b1616],
29	.	.	O	.	_	0	SENT_16	[p1l1733t1577r2066b1616],

1	Although	IN	O	although	mark	6	SENT_17	[p1l668t1626r822b1665],
2	the	DT	O	the	det	4	SENT_17	[p1l830t1626r880b1656],
3	two	CD	NUMBER	two	num	4	SENT_17	[p1l889t1633r948b1657],
4	terms	NNS	O	term	nsubj	6	SENT_17	[p1l957t1633r1048b1656],
5	are	VBP	O	be	cop	6	SENT_17	[p1l1058t1636r1106b1656],
6	synonymous	JJ	O	synonymous	advcl	13	SENT_17	[p1l1116t1636r1319b1665],
7	for	IN	O	for	_	0	SENT_17	[p1l1329t1626r1376b1657],
8	all	DT	O	all	det	10	SENT_17	[p1l1383t1626r1421b1656],
9	practical	JJ	O	practical	amod	10	SENT_17	[p1l1429t1626r1568b1665],
10	purposes	NNS	O	purpose	prep_for	6	SENT_17	[p1l1576t1636r1734b1665],
11	,	,	O	,	_	0	SENT_17	[p1l1576t1636r1734b1665],
12	pharmacogenomics	NNS	O	pharmacogenomic	nsubj	13	SENT_17	[p1l1744t1626r2067b1665],
13	uses	VBZ	O	use	_	0	SENT_17	[p1l669t1685r739b1706],
14	genome-wide	JJ	O	genome-wide	amod	15	SENT_17	[p1l751t1675r975b1714],
15	approaches	NNS	O	approach	nsubj	17	SENT_17	[p1l985t1675r1173b1714],
16	to	TO	O	to	aux	17	SENT_17	[p1l1185t1681r1216b1706],
17	elucidate	VB	O	elucidate	xcomp	13	SENT_17	[p1l1227t1675r1373b1706],
18	the	DT	O	the	det	20	SENT_17	[p1l1384t1675r1434b1705],
19	inherited	VBN	O	inherit	amod	20	SENT_17	[p1l1445t1675r1593b1706],
20	basis	NN	O	basis	dobj	17	SENT_17	[p1l1604t1675r1686b1706],
21	of	IN	O	of	_	0	SENT_17	[p1l1698t1675r1737b1706],
22	differences	NNS	O	difference	prep_of	20	SENT_17	[p1l1741t1675r1920b1706],
23	between	IN	O	between	_	0	SENT_17	[p1l1932t1675r2068b1706],
24	persons	NNS	O	person	prep_between	22	SENT_17	[p1l669t1734r798b1763],
25	in	IN	O	in	_	0	SENT_17	[p1l808t1724r839b1754],
26	the	DT	O	the	det	27	SENT_17	[p1l849t1724r899b1754],
27	response	NN	O	response	prep_in	24	SENT_17	[p1l909t1734r1056b1763],
28	to	TO	O	to	_	0	SENT_17	[p1l1066t1730r1096b1755],
29	drugs	NNS	O	drug	prep_to	27	SENT_17	[p1l1107t1724r1209b1763],
30	.	.	O	.	_	0	SENT_17	[p1l1107t1724r1209b1763],

1	More	JJR	O	more	mwe	2	SENT_18	[p1l718t1776r804b1804],
2	than	IN	O	than	quantmod	4	SENT_18	[p1l815t1773r888b1803],
3	1.4	CD	NUMBER	1.4	number	4	SENT_18	[p1l900t1775r950b1804],
4	million	CD	NUMBER	million	num	6	SENT_18	[p1l960t1773r1079b1804],
5	single-nucleotide	JJ	O	single-nucleotide	amod	6	SENT_18	[p1l1090t1773r1373b1812],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_18	[p1l1384t1773r1643b1812],
7	were	VBD	O	be	auxpass	8	SENT_18	[p1l1653t1783r1731b1804],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_18	[p1l1742t1773r1899b1804],
9	in	IN	O	in	_	0	SENT_18	[p1l1909t1773r1941b1803],
10	the	DT	O	the	det	12	SENT_18	[p1l1951t1773r2002b1803],
11	initial	JJ	O	initial	amod	12	SENT_18	[p1l2012t1773r2067b1803, p1l669t1822r719b1852],
12	sequencing	NN	O	sequencing	prep_in	8	SENT_18	[p1l728t1822r916b1861],
13	of	IN	O	of	_	0	SENT_18	[p1l924t1822r963b1853],
14	the	DT	O	the	det	18	SENT_18	[p1l964t1822r1015b1852],
15	human	JJ	O	human	amod	18	SENT_18	[p1l1023t1822r1139b1853],
16	genome	NN	O	genome	nn	18	SENT_18	[p1l1148t1824r1323b1861],
17	,1	CD	NUMBER	,1	num	18	SENT_18	[p1l1148t1824r1323b1861],
18	°	NN	O	°	prep_of	12	SENT_18	[p1l1148t1824r1323b1861],
19	with	IN	O	with	dep	8	SENT_18	[p1l1329t1822r1403b1853],
20	over	IN	O	over	_	0	SENT_18	[p1l1412t1832r1481b1853],
21	60,000	CD	NUMBER	60,000	prep_over	8	SENT_18	[p1l1488t1824r1600b1859],
22	of	IN	O	of	_	0	SENT_18	[p1l1609t1822r1648b1853],
23	them	PRP	O	they	prep_of	21	SENT_18	[p1l1650t1822r1734b1852],
24	in	IN	O	in	_	0	SENT_18	[p1l1742t1822r1774b1852],
25	the	DT	O	the	det	27	SENT_18	[p1l1782t1822r1832b1852],
26	coding	VBG	O	code	amod	27	SENT_18	[p1l1841t1822r1955b1861],
27	region	NN	O	region	prep_in	21	SENT_18	[p1l1962t1822r2068b1861],
28	of	IN	O	of	_	0	SENT_18	[p1l669t1871r708b1902],
29	genes	NNS	O	gene	prep_of	27	SENT_18	[p1l710t1881r812b1910],
30	.	.	O	.	_	0	SENT_18	[p1l710t1881r812b1910],

1	Some	DT	O	some	nsubjpass	9	SENT_19	[p1l824t1873r913b1902],
2	of	IN	O	of	_	0	SENT_19	[p1l922t1871r961b1902],
3	these	DT	O	these	det	5	SENT_19	[p1l963t1871r1047b1901],
4	single-nucleotide	JJ	O	single-nucleotide	amod	5	SENT_19	[p1l1056t1871r1336b1910],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_19	[p1l1344t1871r1601b1910],
6	have	VBP	O	have	aux	9	SENT_19	[p1l1611t1871r1683b1902],
7	already	RB	O	already	advmod	9	SENT_19	[p1l1692t1871r1808b1910],
8	been	VBN	O	be	auxpass	9	SENT_19	[p1l1815t1871r1892b1902],
9	associated	VBN	O	associate	dep	64	SENT_19	[p1l1900t1871r2068b1902],
10	with	IN	O	with	_	0	SENT_19	[p1l667t1920r741b1951],
11	substantial	JJ	O	substantial	amod	12	SENT_19	[p1l754t1920r934b1951],
12	changes	NNS	O	change	prep_with	9	SENT_19	[p1l947t1920r1080b1959],
13	in	IN	O	in	_	0	SENT_19	[p1l1093t1920r1125b1950],
14	the	DT	O	the	det	15	SENT_19	[p1l1138t1920r1188b1950],
15	metabolism	NN	O	metabolism	prep_in	12	SENT_19	[p1l1201t1920r1397b1951],
16	or	CC	O	or	_	0	SENT_19	[p1l1410t1930r1445b1951],
17	effects	NNS	O	effect	conj_or	12	SENT_19	[p1l1457t1920r1562b1950],
18	of	IN	O	of	_	0	SENT_19	[p1l1576t1920r1615b1951],
19	medications	NNS	O	medication	prep_of	17	SENT_19	[p1l1620t1920r1830b1957],
20	,	,	O	,	_	0	SENT_19	[p1l1620t1920r1830b1957],
21	and	CC	O	and	_	0	SENT_19	[p1l1845t1920r1906b1951],
22	some	DT	O	some	nsubjpass	26	SENT_19	[p1l1919t1930r2006b1951],
23	are	VBP	O	be	aux	26	SENT_19	[p1l2019t1930r2068b1950],
24	now	RB	DATE	now	advmod	26	SENT_19	[p1l669t1979r741b2000],
25	being	VBG	O	be	auxpass	26	SENT_19	[p1l749t1969r842b2008],
26	used	VBN	O	use	conj_and	9	SENT_19	[p1l850t1969r926b2000],
27	to	TO	O	to	aux	28	SENT_19	[p1l936t1976r967b2000],
28	predict	VB	O	predict	xcomp	26	SENT_19	[p1l977t1969r1093b2008],
29	clinical	JJ	O	clinical	amod	31	SENT_19	[p1l1102t1969r1218b1999],
30	response	NN	O	response	nn	31	SENT_19	[p1l1228t1971r1468b2008],
31	.3	NN	NUMBER	.3	dobj	28	SENT_19	[p1l1228t1971r1468b2008],
32	‘	CD	NUMBER	‘	num	33	SENT_19	[p1l1228t1971r1468b2008],
33	5	CD	NUMBER	5	dep	41	SENT_19	[p1l1228t1971r1468b2008],
34	»	NN	O	»	dep	41	SENT_19	[p1l1228t1971r1468b2008],
35	11	CD	NUMBER	11	num	34	SENT_19	[p1l1228t1971r1468b2008],
36	Because	IN	O	because	dep	41	SENT_19	[p1l1478t1972r1609b2000],
37	most	JJS	O	most	amod	39	SENT_19	[p1l1619t1975r1704b2000],
38	drug	NN	O	drug	nn	39	SENT_19	[p1l1712t1969r1789b2008],
39	effects	NNS	O	effect	nsubjpass	41	SENT_19	[p1l1798t1969r1903b1999],
40	are	VBP	O	be	auxpass	41	SENT_19	[p1l1913t1979r1962b1999],
41	determined	VBN	O	determine	dep	26	SENT_19	[p1l1973t1969r2067b2000, p1l669t2018r774b2049],
42	by	IN	O	by	_	0	SENT_19	[p1l786t2018r824b2057],
43	the	DT	O	the	det	44	SENT_19	[p1l835t2018r886b2048],
44	interplay	NN	O	interplay	agent	41	SENT_19	[p1l898t2018r1043b2057],
45	of	IN	O	of	_	0	SENT_19	[p1l1055t2018r1093b2049],
46	several	JJ	O	several	amod	48	SENT_19	[p1l1100t2018r1210b2049],
47	gene	NN	O	gene	nn	48	SENT_19	[p1l1223t2028r1300b2057],
48	products	NNS	O	product	prep_of	44	SENT_19	[p1l1312t2018r1456b2057],
49	that	WDT	O	that	nsubj	50	SENT_19	[p1l1470t2018r1535b2048],
50	inﬂuence	VBP	O	inﬂuence	rcmod	44	SENT_19	[p1l1546t2018r1697b2049],
51	the	DT	O	the	det	52	SENT_19	[p1l1710t2018r1761b2048],
52	pharmacokinetics	NNS	O	pharmacokinetic	dobj	50	SENT_19	[p1l1773t2018r2067b2057],
53	and	CC	O	and	_	0	SENT_19	[p1l669t2067r729b2098],
54	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	52	SENT_19	[p1l737t2067r1057b2106],
55	of	IN	O	of	_	0	SENT_19	[p1l1067t2067r1106b2098],
56	medications	NNS	O	medication	prep_of	52	SENT_19	[p1l1107t2067r1315b2104],
57	,	,	O	,	_	0	SENT_19	[p1l1107t2067r1315b2104],
58	including	VBG	O	include	_	0	SENT_19	[p1l1326t2067r1482b2106],
59	inherited	VBN	O	inherit	amod	60	SENT_19	[p1l1490t2067r1636b2098],
60	differences	NNS	O	difference	prep_including	26	SENT_19	[p1l1645t2067r1823b2098],
61	in	IN	O	in	_	0	SENT_19	[p1l1832t2067r1864b2097],
62	drug	NN	O	drug	nn	63	SENT_19	[p1l1873t2067r1950b2106],
63	targets	NNS	O	target	prep_in	60	SENT_19	[p1l1957t2073r2067b2106],
64	(	VBP	O	(	_	0	SENT_19	[p1l671t2119r751b2155],
65	e.g.	FW	O	e.g.	dobj	64	SENT_19	[p1l671t2119r751b2155],
66	,	,	O	,	_	0	SENT_19	[p1l671t2119r751b2155],
67	receptors	NNS	O	receptor	conj_and	65	SENT_19	[p1l764t2119r928b2155],
68	)	CD	NUMBER	)	num	67	SENT_19	[p1l764t2119r928b2155],
69	and	CC	O	and	_	0	SENT_19	[p1l940t2116r1001b2147],
70	drug	NN	O	drug	nn	71	SENT_19	[p1l1012t2116r1090b2155],
71	disposition	NN	O	disposition	dobj	64	SENT_19	[p1l1100t2116r1283b2155],
72	(	CD	NUMBER	(	nsubj	64	SENT_19	[p1l1296t2119r1376b2155],
73	e.g.	FW	O	e.g.	dep	72	SENT_19	[p1l1296t2119r1376b2155],
74	,	,	O	,	_	0	SENT_19	[p1l1296t2119r1376b2155],
75	metabolizing	VBG	O	metabolize	dep	73	SENT_19	[p1l1389t2116r1609b2155],
76	enzymes	NNS	O	enzyme	nsubj	79	SENT_19	[p1l1619t2126r1759b2155],
77	and	CC	O	and	_	0	SENT_19	[p1l1771t2116r1832b2147],
78	transporters	NNS	O	transporter	conj_and	76	SENT_19	[p1l1843t2119r2066b2155],
79	)	VBP	O	)	dep	75	SENT_19	[p1l1843t2119r2066b2155],
80	,	,	O	,	_	0	SENT_19	[p1l1843t2119r2066b2155],
81	polygenic	JJ	O	polygenic	amod	82	SENT_19	[p1l669t2165r827b2204],
82	determinants	NNS	O	determinant	nsubj	86	SENT_19	[p1l837t2165r1054b2196],
83	of	IN	O	of	_	0	SENT_19	[p1l1065t2165r1103b2196],
84	drug	NN	O	drug	nn	85	SENT_19	[p1l1106t2165r1184b2204],
85	effects	NNS	O	effect	prep_of	82	SENT_19	[p1l1192t2165r1297b2195],
86	(	VBP	O	(	dep	79	SENT_19	[p1l1309t2165r1380b2204],
87	Fig	NN	O	fig	dobj	86	SENT_19	[p1l1309t2165r1380b2204],
88	.	.	O	.	_	0	SENT_19	[p1l1309t2165r1380b2204],

1	1	CD	NUMBER	1	num	2	SENT_20	[p1l1393t2167r1422b2200],
2	)	CD	NUMBER	)	nsubj	6	SENT_20	[p1l1393t2167r1422b2200],
3	have	VBP	O	have	aux	6	SENT_20	[p1l1434t2165r1507b2196],
4	become	VBN	O	become	cop	6	SENT_20	[p1l1517t2165r1644b2196],
5	increasingly	RB	O	increasingly	advmod	6	SENT_20	[p1l1654t2165r1853b2204],
6	important	JJ	O	important	_	0	SENT_20	[p1l1861t2165r2029b2204],
7	in	IN	O	in	_	0	SENT_20	[p1l2036t2165r2068b2195],
8	pharmacogenomics	NNS	O	pharmacogenomic	prep_in	6	SENT_20	[p1l669t2214r1011b2253],
9	.	.	O	.	_	0	SENT_20	[p1l669t2214r1011b2253],

1	In	IN	O	in	_	0	SENT_21	[p1l1024t2217r1058b2244],
2	this	DT	O	this	det	3	SENT_21	[p1l1069t2214r1129b2244],
3	review	NN	O	review	prep_in	6	SENT_21	[p1l1140t2214r1253b2251],
4	,	,	O	,	_	0	SENT_21	[p1l1140t2214r1253b2251],
5	we	PRP	O	we	nsubj	6	SENT_21	[p1l1264t2224r1311b2245],
6	focus	VBP	O	focus	_	0	SENT_21	[p1l1321t2214r1410b2245],
7	on	IN	O	on	_	0	SENT_21	[p1l1422t2224r1463b2245],
8	the	DT	O	the	det	10	SENT_21	[p1l1474t2214r1525b2244],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_21	[p1l1536t2214r1725b2253],
10	consequences	NNS	O	consequence	prep_on	6	SENT_21	[p1l1735t2224r1967b2253],
11	of	IN	O	of	_	0	SENT_21	[p1l1979t2214r2018b2245],
12	inherited	VBN	O	inherit	amod	13	SENT_21	[p1l2022t2214r2067b2244, p1l669t2263r785b2294],
13	differences	NNS	O	difference	prep_of	10	SENT_21	[p1l799t2263r978b2294],
14	in	IN	O	in	_	0	SENT_21	[p1l992t2263r1023b2293],
15	drug	NN	O	drug	nn	16	SENT_21	[p1l1037t2263r1114b2302],
16	disposition	NN	O	disposition	prep_in	13	SENT_21	[p1l1126t2263r1310b2302],
17	and	CC	O	and	_	0	SENT_21	[p1l1322t2263r1383b2294],
18	drug	NN	O	drug	nn	19	SENT_21	[p1l1396t2263r1474b2302],
19	targets	NNS	O	target	prep_in	13	SENT_21	[p1l1486t2269r1606b2302],
20	.	.	O	.	_	0	SENT_21	[p1l1486t2269r1606b2302],

1	An	DT	O	a	det	4	SENT_22	[p1l1620t2266r1667b2293],
2	accompanying	VBG	O	accompany	amod	4	SENT_22	[p1l1680t2263r1920b2302],
3	review	NN	O	review	nn	4	SENT_22	[p1l1932t2263r2067b2294],
4	”	NN	O	”	nsubj	5	SENT_22	[p1l1932t2263r2067b2294],
5	focuses	VBZ	O	focus	_	0	SENT_22	[p1l669t2312r791b2343],
6	on	IN	O	on	_	0	SENT_22	[p1l803t2322r844b2343],
7	the	DT	O	the	det	8	SENT_22	[p1l855t2312r905b2342],
8	pharmacogenetics	NNS	O	pharmacogenetic	prep_on	5	SENT_22	[p1l915t2312r1217b2351],
9	of	IN	O	of	_	0	SENT_22	[p1l1229t2312r1268b2343],
10	drug	NN	O	drug	nn	11	SENT_22	[p1l1272t2312r1349b2351],
11	metabolism	NN	O	metabolism	prep_of	8	SENT_22	[p1l1359t2312r1564b2343],
12	.	.	O	.	_	0	SENT_22	[p1l1359t2312r1564b2343],

1	This	DT	O	this	det	2	SENT_23	[p1l1575t2312r1647b2342],
2	review	NN	O	review	nsubjpass	5	SENT_23	[p1l1659t2312r1764b2343],
3	is	VBZ	O	be	auxpass	5	SENT_23	[p1l1773t2312r1799b2342],
4	not	RB	O	not	neg	5	SENT_23	[p1l1810t2318r1866b2343],
5	meant	VBN	O	mean	_	0	SENT_23	[p1l1875t2318r1979b2342],
6	to	TO	O	to	aux	8	SENT_23	[p1l1988t2319r2019b2343],
7	be	VB	O	be	cop	8	SENT_23	[p1l2030t2312r2068b2343],
8	exhaustive	JJ	O	exhaustive	xcomp	5	SENT_23	[p1l669t2361r852b2398],
9	;	:	O	;	_	0	SENT_23	[p1l669t2361r852b2398],
10	rather	RB	O	rather	advmod	16	SENT_23	[p1l865t2361r972b2398],
11	,	,	O	,	_	0	SENT_23	[p1l865t2361r972b2398],
12	clinically	RB	O	clinically	advmod	13	SENT_23	[p1l986t2361r1135b2400],
13	relevant	JJ	O	relevant	amod	14	SENT_23	[p1l1144t2361r1278b2392],
14	examples	NNS	O	example	nsubjpass	16	SENT_23	[p1l1287t2361r1442b2400],
15	are	VBP	O	be	auxpass	16	SENT_23	[p1l1454t2371r1503b2391],
16	used	VBN	O	use	parataxis	5	SENT_23	[p1l1514t2361r1591b2392],
17	to	TO	O	to	aux	18	SENT_23	[p1l1602t2367r1634b2392],
18	illustrate	VB	O	illustrate	xcomp	16	SENT_23	[p1l1645t2361r1792b2392],
19	how	WRB	O	how	advmod	22	SENT_23	[p1l1803t2361r1876b2392],
20	pharmacogenomics	NNS	O	pharmacogenomic	nsubj	22	SENT_23	[p1l1885t2361r2067b2400, p1l669t2411r830b2449],
21	can	MD	O	can	aux	22	SENT_23	[p1l842t2420r898b2440],
22	provide	VB	O	provide	ccomp	18	SENT_23	[p1l907t2410r1029b2449],
23	molecular	JJ	O	molecular	amod	25	SENT_23	[p1l1039t2410r1204b2441],
24	diagnostic	JJ	O	diagnostic	amod	25	SENT_23	[p1l1213t2410r1383b2449],
25	methods	NNS	O	method	dobj	22	SENT_23	[p1l1392t2410r1535b2441],
26	that	WDT	O	that	nsubj	27	SENT_23	[p1l1546t2410r1611b2440],
27	improve	VBP	O	improve	rcmod	25	SENT_23	[p1l1618t2411r1752b2449],
28	drug	NN	O	drug	nn	29	SENT_23	[p1l1763t2410r1840b2449],
29	therapy	NN	O	therapy	dobj	27	SENT_23	[p1l1848t2410r1976b2449],
30	.	.	O	.	_	0	SENT_23	[p1l1848t2410r1976b2449],

1	GENETIC	JJ	O	genetic	amod	2	SENT_24	[p1l690t2547r880b2570],
2	POLYMORPHISMS	NNS	O	polymorphism	_	0	SENT_24	[p1l899t2547r1267b2570],
3	INFLUENCING	VBG	O	influence	dep	2	SENT_24	[p1l1286t2547r1600b2570],
4	DRUG	NN	O	drug	nn	5	SENT_24	[p1l1618t2547r1739b2570],
5	DISPOSITION	NN	O	disposition	dobj	3	SENT_24	[p1l1757t2547r2042b2570],

1	The	DT	O	the	det	2	SENT_25	[p1l668t2635r730b2665],
2	field	NN	O	field	dep	5	SENT_25	[p1l744t2635r816b2666],
3	of	IN	O	of	_	0	SENT_25	[p1l829t2635r868b2666],
4	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	2	SENT_25	[p1l873t2635r1175b2674],
5	began	VBD	O	begin	_	0	SENT_25	[p1l1189t2635r1288b2674],
6	with	IN	O	with	_	0	SENT_25	[p1l1299t2635r1372b2666],
7	a	DT	O	a	det	8	SENT_25	[p1l1385t2645r1402b2665],
8	focus	NN	O	focus	prep_with	5	SENT_25	[p1l1415t2635r1502b2666],
9	on	IN	O	on	_	0	SENT_25	[p1l1516t2645r1557b2666],
10	drug	NN	O	drug	nn	11	SENT_25	[p1l1571t2635r1648b2674],
11	metabolism	NN	O	metabolism	prep_on	8	SENT_25	[p1l1660t2635r1898b2672],
12	,	,	O	,	_	0	SENT_25	[p1l1660t2635r1898b2672],
13	”	NN	O	”	appos	11	SENT_25	[p1l1660t2635r1898b2672],
14	but	CC	O	but	cc	18	SENT_25	[p1l1912t2635r1967b2666],
15	it	PRP	O	it	nsubjpass	18	SENT_25	[p1l1977t2635r2001b2665],
16	has	VBZ	O	have	aux	18	SENT_25	[p1l2012t2635r2067b2665],
17	been	VBN	O	be	auxpass	18	SENT_25	[p1l669t2684r746b2715],
18	extended	VBN	O	extend	ccomp	5	SENT_25	[p1l755t2684r900b2715],
19	to	TO	O	to	aux	20	SENT_25	[p1l908t2690r939b2715],
20	encompass	VB	O	encompass	xcomp	18	SENT_25	[p1l948t2694r1130b2723],
21	the	DT	O	the	det	23	SENT_25	[p1l1139t2684r1189b2714],
22	full	JJ	O	full	amod	23	SENT_25	[p1l1197t2684r1250b2715],
23	spectrum	NN	O	spectrum	dobj	20	SENT_25	[p1l1259t2690r1411b2723],
24	of	IN	O	of	_	0	SENT_25	[p1l1419t2684r1458b2715],
25	drug	NN	O	drug	nn	26	SENT_25	[p1l1459t2684r1536b2723],
26	disposition	NN	O	disposition	prep_of	23	SENT_25	[p1l1543t2684r1734b2723],
27	,	,	O	,	_	0	SENT_25	[p1l1543t2684r1734b2723],
28	including	VBG	O	include	_	0	SENT_25	[p1l1744t2684r1900b2723],
29	a	DT	O	a	det	31	SENT_25	[p1l1907t2694r1924b2714],
30	growing	VBG	O	grow	amod	31	SENT_25	[p1l1932t2685r2069b2723],
31	list	NN	O	list	prep_including	18	SENT_25	[p1l669t2733r720b2763],
32	of	IN	O	of	_	0	SENT_25	[p1l728t2733r767b2764],
33	transporters	NNS	O	transporter	prep_of	31	SENT_25	[p1l769t2739r969b2772],
34	that	WDT	O	that	nsubj	35	SENT_25	[p1l979t2733r1044b2763],
35	inﬂuence	VBP	O	inﬂuence	rcmod	33	SENT_25	[p1l1052t2733r1203b2764],
36	drug	NN	O	drug	nn	37	SENT_25	[p1l1213t2733r1291b2772],
37	absorption	NN	O	absorption	dobj	35	SENT_25	[p1l1299t2733r1486b2772],
38	,	,	O	,	_	0	SENT_25	[p1l1299t2733r1486b2772],
39	distribution	NN	O	distribution	dobj	35	SENT_25	[p1l1498t2733r1701b2770],
40	,	,	O	,	_	0	SENT_25	[p1l1498t2733r1701b2770],
41	and	CC	O	and	_	0	SENT_25	[p1l1712t2733r1773b2764],
42	excretion	NN	O	excretion	nn	43	SENT_25	[p1l1783t2734r2025b2764],
43	.3	NN	NUMBER	.3	dobj	35	SENT_25	[p1l1783t2734r2025b2764],
44	‘	CD	NUMBER	‘	num	45	SENT_25	[p1l1783t2734r2025b2764],
45	5a13	NN	O	5a13	nsubj	5	SENT_25	[p1l1783t2734r2025b2764],

1	N	NN	O	n	nn	3	SENT_26	[p1l974t2844r988b2860],
2	ENGLJ	NN	O	englj	nn	3	SENT_26	[p1l1003t2844r1087b2866],
3	MED	NN	O	med	_	0	SENT_26	[p1l1102t2844r1155b2859],
4	348	CD	NUMBER	348	num	6	SENT_26	[p1l1167t2838r1238b2866],
5	;	:	O	;	_	0	SENT_26	[p1l1167t2838r1238b2866],
6	6	CD	NUMBER	6	dep	3	SENT_26	[p1l1167t2838r1238b2866],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_26	[p1l1273t2844r1484b2866],
8	FEBRUARY	NNP	DATE	FEBRUARY	dep	3	SENT_26	[p1l1523t2844r1651b2860],
9	6	CD	DATE	6	num	8	SENT_26	[p1l1664t2838r1685b2864],
10	,	,	DATE	,	_	0	SENT_26	[p1l1664t2838r1685b2864],
11	2003	CD	DATE	2003	num	8	SENT_26	[p1l1698t2844r1762b2866],

1	The	DT	O	the	det	4	SENT_27	[p1l881t2941r932b2965],
2	New	NNP	O	New	nn	4	SENT_27	[p1l941t2942r1003b2965],
3	England	NNP	O	England	nn	4	SENT_27	[p1l1013t2941r1123b2972],
4	Joumal	NNP	O	Joumal	_	0	SENT_27	[p1l1132t2941r1229b2965],
5	of	IN	O	of	_	0	SENT_27	[p1l1239t2941r1268b2965],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_27	[p1l1275t2941r1400b2965],

1	Downloaded	VBN	O	download	_	0	SENT_28	[p1l324t2982r493b3005],
2	from	IN	O	from	_	0	SENT_28	[p1l502t2982r567b3005],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_28	[p1l576t2982r694b3012],
4	at	IN	O	at	_	0	SENT_28	[p1l704t2985r727b3005],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_28	[p1l736t2982r918b3005],
6	on	IN	O	on	_	0	SENT_28	[p1l928t2989r960b3005],
7	January	NNP	DATE	January	prep_on	1	SENT_28	[p1l969t2982r1071b3012],
8	5	CD	DATE	5	num	7	SENT_28	[p1l1081t2982r1104b3009],
9	,	,	DATE	,	_	0	SENT_28	[p1l1081t2982r1104b3009],
10	2014	CD	DATE	2014	num	7	SENT_28	[p1l1115t2982r1187b3005],
11	.	.	O	.	_	0	SENT_28	[p1l1115t2982r1187b3005],

1	For	IN	O	for	_	0	SENT_29	[p1l1197t2982r1244b3005],
2	personal	JJ	O	personal	amod	3	SENT_29	[p1l1252t2982r1364b3012],
3	use	NN	O	use	pobj	1	SENT_29	[p1l1373t2989r1417b3005],
4	only	RB	O	only	advmod	3	SENT_29	[p1l1427t2982r1491b3012],
5	.	.	O	.	_	0	SENT_29	[p1l1427t2982r1491b3012],

1	No	DT	O	no	det	3	SENT_30	[p1l1502t2982r1542b3005],
2	other	JJ	O	other	amod	3	SENT_30	[p1l1552t2982r1620b3005],
3	uses	NNS	O	use	_	0	SENT_30	[p1l1628t2989r1684b3005],
4	without	IN	O	without	_	0	SENT_30	[p1l1694t2982r1795b3005],
5	permission	NN	O	permission	prep_without	3	SENT_30	[p1l1804t2982r1956b3012],
6	.	.	O	.	_	0	SENT_30	[p1l1804t2982r1956b3012],

1	Copyright	NN	O	copyright	_	0	SENT_31	[p1l674t3023r808b3054],
2	©	CD	NUMBER	©	num	6	SENT_31	[p1l818t3023r841b3047],
3	2003	CD	DATE	2003	num	6	SENT_31	[p1l851t3023r915b3047],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_31	[p1l926t3023r1117b3047],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_31	[p1l1127t3023r1234b3047],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_31	[p1l1245t3023r1350b3054],
7	.	.	O	.	_	0	SENT_31	[p1l1245t3023r1350b3054],

1	All	DT	O	all	det	2	SENT_32	[p1l1361t3023r1402b3047],
2	rights	NNS	O	rights	nsubj	3	SENT_32	[p1l1411t3023r1486b3054],
3	reserved	VBN	O	reserve	_	0	SENT_32	[p1l1496t3023r1615b3047],
4	.	.	O	.	_	0	SENT_32	[p1l1496t3023r1615b3047],

1	D	NN	O	d	nn	2	SENT_33	[p1l806t3067r826b3086],
2	RU	NN	O	ru	_	0	SENT_33	[p1l832t3067r876b3086],
3	G	NN	O	g	nn	4	SENT_33	[p1l880t3067r901b3086],
4	TH	NN	O	th	dep	2	SENT_33	[p1l913t3067r958b3086],
5	E	NN	O	e	nn	7	SENT_33	[p1l964t3067r980b3086],
6	RA	NN	O	ra	nn	7	SENT_33	[p1l985t3067r1026b3086],
7	PY	NN	O	py	dep	2	SENT_33	[p1l1031t3067r1066b3086],

1	AUC	NN	O	auc	_	0	SENT_34	[p2l859t227r977b248],
2	=	JJ	O	=	amod	1	SENT_34	[p2l859t227r977b248],
3	100	CD	NUMBER	100	tmod	2	SENT_34	[p2l859t227r977b248],

1	Drug	NN	O	drug	nn	2	SENT_35	[p2l146t329r209b358],
2	Metabolism	NN	O	metabolism	_	0	SENT_35	[p2l220t327r369b351],
3	(	CD	NUMBER	(	num	5	SENT_35	[p2l170t362r345b393],
4	Degradation	NN	O	degradation	nn	5	SENT_35	[p2l170t362r345b393],
5	)	NN	O	)	dep	2	SENT_35	[p2l170t362r345b393],

1	Concentration	NN	O	concentration	_	0	SENT_36	[p2l495t275r515b443],

1	Drug	NN	O	drug	nn	2	SENT_37	[p2l165t759r229b787],
2	Receptor	NN	O	receptor	_	0	SENT_37	[p2l239t759r351b787],
3	(	CD	NUMBER	(	num	5	SENT_37	[p2l200t792r314b823],
4	Eﬁicacy	NN	O	eﬁicacy	nn	5	SENT_37	[p2l200t792r314b823],
5	)	NN	O	)	dep	2	SENT_37	[p2l200t792r314b823],

1	on	IN	O	on	_	0	SENT_38	[p2l501t700r522b713],
2	.	.	O	.	_	0	SENT_38	[p2l495t717r515b735],

1	E	NN	O	e	_	0	SENT_39	[p2l495t717r515b735],
2	‘	CD	NUMBER	‘	num	5	SENT_39	[p2l493t740r515b752],
3	U	NNP	O	U	nn	5	SENT_39	[p2l493t740r515b752],
4	c	NN	O	c	nn	5	SENT_39	[p2l501t755r515b767],
5	o	NN	O	o	dep	1	SENT_39	[p2l501t770r515b784],
6	a.	IN	O	a.	_	0	SENT_39	[p2l501t786r522b798],
7	U1	NN	O	u1	nn	10	SENT_39	[p2l501t802r515b812],
8	cu	NN	O	cu	nn	10	SENT_39	[p2l501t814r515b826],
9	cz	NN	O	cz	nn	10	SENT_39	[p2l495t828r515b841],
10	o	NN	O	o	prep_a.	5	SENT_39	[p2l494t852r516b876],
11	\	CD	NUMBER	\	num	12	SENT_39	[p2l494t852r516b876],
12	°	NN	O	°	dep	1	SENT_39	[p2l494t852r516b876],

1	Polygenic	NNP	MISC	Polygenic	nn	3	SENT_40	[p2l161t1405r282b1436],
2	Drug	NNP	MISC	Drug	nn	3	SENT_40	[p2l292t1408r356b1436],
3	Response	NNP	MISC	Response	_	0	SENT_40	[p2l197t1443r320b1471],

1	Figure	NNP	O	Figure	_	0	SENT_41	[p2l122t1782r206b1815],
2	1	CD	NUMBER	1	dep	1	SENT_41	[p2l217t1784r238b1807],
3	.	.	O	.	_	0	SENT_41	[p2l217t1784r238b1807],

1	Polygenic	NNP	O	Polygenic	nn	2	SENT_42	[p2l250t1782r379b1815],
2	Determinants	NNPS	O	Determinants	_	0	SENT_42	[p2l389t1782r575b1807],
3	of	IN	O	of	_	0	SENT_42	[p2l585t1781r616b1807],
4	Drug	NNP	O	Drug	nn	5	SENT_42	[p2l621t1784r689b1815],
5	Response	NNP	O	Response	prep_of	2	SENT_42	[p2l699t1784r838b1814],
6	.	.	O	.	_	0	SENT_42	[p2l699t1784r838b1814],

1	AUC	NN	O	auc	_	0	SENT_43	[p2l1366t227r1484b248],
2	=	JJ	O	=	amod	4	SENT_43	[p2l1366t227r1484b248],
3	200	CD	NUMBER	200	tmod	2	SENT_43	[p2l1366t227r1484b248],
4	AUC	NN	O	auc	dep	1	SENT_43	[p2l1871t227r1944b248],
5	=	JJ	O	=	amod	4	SENT_43	[p2l1871t227r1944b248],
6	400	CD	NUMBER	400	tmod	5	SENT_43	[p2l1952t227r1995b248],

1	Receptor	NN	O	receptor	nn	2	SENT_44	[p2l1024t1082r1129b1109],
2	genotype	NN	O	genotype	_	0	SENT_44	[p2l1021t1118r1129b1143],

1	Moderate	JJ	O	moderate	amod	2	SENT_45	[p2l1730t1365r1844b1387],
2	(	NN	O	(	_	0	SENT_45	[p2l1855t1366r1923b1394],
3	15	CD	PERCENT	15	number	4	SENT_45	[p2l1855t1366r1923b1394],
4	%	NN	PERCENT	%	amod	2	SENT_45	[p2l1855t1366r1923b1394],
5	)	CD	NUMBER	)	npadvmod	6	SENT_45	[p2l1855t1366r1923b1394],
6	Moderate	JJ	O	moderate	dep	2	SENT_45	[p2l1730t1427r1844b1449],

1	Moderate	JJ	O	moderate	_	0	SENT_46	[p2l1730t1489r1844b1511],

1	High	JJ	O	high	amod	2	SENT_47	[p2l1730t1551r1785b1580],
2	(	NN	O	(	_	0	SENT_47	[p2l1798t1552r1867b1580],
3	80	CD	PERCENT	80	num	4	SENT_47	[p2l1798t1552r1867b1580],
4	%	NN	PERCENT	%	dep	2	SENT_47	[p2l1798t1552r1867b1580],
5	)	CD	NUMBER	)	dep	2	SENT_47	[p2l1798t1552r1867b1580],

1	The	DT	O	the	det	3	SENT_48	[p2l119t1832r169b1857],
2	potential	JJ	O	potential	amod	3	SENT_48	[p2l180t1832r297b1865],
3	effects	NNS	O	effect	nsubj	85	SENT_48	[p2l308t1832r395b1857],
4	oftwo	JJ	O	oftwo	amod	6	SENT_48	[p2l404t1832r486b1857],
5	genetic	JJ	O	genetic	amod	6	SENT_48	[p2l496t1834r593b1865],
6	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_48	[p2l603t1832r816b1865],
7	are	VBP	O	be	cop	8	SENT_48	[p2l826t1841r866b1857],
8	illustrated	JJ	O	illustrated	rcmod	3	SENT_48	[p2l876t1832r1018b1862],
9	,	,	O	,	_	0	SENT_48	[p2l876t1832r1018b1862],
10	one	CD	NUMBER	one	appos	8	SENT_48	[p2l1029t1841r1078b1857],
11	involving	VBG	O	involve	dep	10	SENT_48	[p2l1088t1832r1211b1865],
12	a	DT	O	a	det	17	SENT_48	[p2l1219t1841r1232b1857],
13	drug-metabolizing	JJ	O	drug-metabolizing	amod	17	SENT_48	[p2l1242t1832r1494b1865],
14	enzyme	NN	O	enzyme	nn	17	SENT_48	[p2l1502t1841r1606b1865],
15	(	CD	NUMBER	(	num	17	SENT_48	[p2l1618t1834r1681b1865],
16	top	JJ	O	top	amod	17	SENT_48	[p2l1618t1834r1681b1865],
17	)	NN	O	)	dobj	11	SENT_48	[p2l1618t1834r1681b1865],
18	and	CC	O	and	_	0	SENT_48	[p2l1693t1832r1741b1857],
19	the	DT	O	the	det	27	SENT_48	[p2l1750t1832r1793b1857],
20	second	JJ	ORDINAL	second	amod	27	SENT_48	[p2l1802t1832r1897b1857],
21	involving	VBG	O	involve	dep	20	SENT_48	[p2l1909t1832r2031b1865],
22	a	DT	O	a	det	25	SENT_48	[p2l121t1882r133b1899],
23	drug	NN	O	drug	nn	25	SENT_48	[p2l142t1873r205b1907],
24	receptor	NN	O	receptor	nn	25	SENT_48	[p2l214t1878r326b1906],
25	(	NN	O	(	dobj	21	SENT_48	[p2l336t1873r459b1907],
26	middle	JJ	O	middle	amod	27	SENT_48	[p2l336t1873r459b1907],
27	)	NN	O	)	dobj	11	SENT_48	[p2l336t1873r459b1907],
28	,	,	O	,	_	0	SENT_48	[p2l336t1873r459b1907],
29	depicting	VBG	O	depict	dep	11	SENT_48	[p2l468t1874r595b1907],
30	differences	NNS	O	difference	dobj	29	SENT_48	[p2l603t1873r751b1899],
31	in	IN	O	in	_	0	SENT_48	[p2l761t1876r783b1898],
32	drug	NN	O	drug	nn	33	SENT_48	[p2l792t1874r855b1907],
33	clearance	NN	O	clearance	prep_in	30	SENT_48	[p2l863t1874r991b1899],
34	(	CD	NUMBER	(	num	36	SENT_48	[p2l1002t1874r1088b1907],
35	orthe	NN	O	orthe	nn	36	SENT_48	[p2l1002t1874r1088b1907],
36	area	NN	O	area	dobj	11	SENT_48	[p2l1097t1882r1152b1899],
37	under	IN	O	under	_	0	SENT_48	[p2l1162t1874r1241b1899],
38	the	DT	O	the	det	43	SENT_48	[p2l1247t1873r1290b1899],
39	plasma	NN	O	plasma	nn	43	SENT_48	[p2l1299t1873r1396b1906],
40	concentration	NN	O	concentration	nn	43	SENT_48	[p2l1405t1876r1673b1899],
41	—	CD	NUMBER	—	num	43	SENT_48	[p2l1405t1876r1673b1899],
42	time	NN	O	time	nn	43	SENT_48	[p2l1405t1876r1673b1899],
43	curve	NN	O	curve	prep_under	11	SENT_48	[p2l1682t1882r1754b1899],
44	[	CD	NUMBER	[	num	45	SENT_48	[p2l1763t1875r1850b1907],
45	AUC	NN	O	auc	dep	43	SENT_48	[p2l1763t1875r1850b1907],
46	]	CD	NUMBER	]	num	47	SENT_48	[p2l1763t1875r1850b1907],
47	)	NN	O	)	dep	43	SENT_48	[p2l1763t1875r1850b1907],
48	and	CC	O	and	_	0	SENT_48	[p2l1861t1874r1909b1899],
49	receptor	NN	O	receptor	nn	50	SENT_48	[p2l1920t1878r2032b1906],
50	sensitivity	NN	O	sensitivity	conj_and	43	SENT_48	[p2l121t1918r256b1948],
51	in	IN	O	in	_	0	SENT_48	[p2l266t1918r288b1940],
52	patients	NNS	O	patient	prep_in	50	SENT_48	[p2l301t1918r408b1948],
53	who	WP	O	who	nsubj	55	SENT_48	[p2l418t1915r474b1941],
54	are	VBP	O	be	cop	55	SENT_48	[p2l485t1924r525b1941],
55	homozygous	JJ	O	homozygous	rcmod	3	SENT_48	[p2l536t1915r710b1949],
56	for	IN	O	for	_	0	SENT_48	[p2l720t1915r758b1941],
57	the	DT	O	the	det	62	SENT_48	[p2l766t1915r809b1941],
58	wild-type	JJ	O	wild-type	amod	62	SENT_48	[p2l817t1915r939b1948],
59	allele	NN	O	allele	nn	62	SENT_48	[p2l950t1915r1018b1941],
60	(	CD	NUMBER	(	num	62	SENT_48	[p2l1031t1917r1165b1948],
61	WT/WT	NN	O	wt/wt	nn	62	SENT_48	[p2l1031t1917r1165b1948],
62	)	NN	O	)	prep_for	55	SENT_48	[p2l1031t1917r1165b1948],
63	,	,	O	,	_	0	SENT_48	[p2l1031t1917r1165b1948],
64	are	VBP	O	be	cop	65	SENT_48	[p2l1176t1924r1216b1941],
65	heterozygous	JJ	O	heterozygous	dep	62	SENT_48	[p2l1227t1915r1408b1949],
66	for	IN	O	for	_	0	SENT_48	[p2l1418t1915r1456b1940],
67	one	CD	NUMBER	one	prep_for	65	SENT_48	[p2l1465t1924r1515b1941],
68	wild-type	JJ	O	wild-type	amod	65	SENT_48	[p2l1523t1915r1646b1948],
69	and	CC	O	and	_	0	SENT_48	[p2l1656t1915r1704b1941],
70	one	CD	NUMBER	one	num	73	SENT_48	[p2l1715t1924r1765b1941],
71	variant	JJ	O	variant	amod	73	SENT_48	[p2l1774t1918r1867b1941],
72	(	NN	O	(	nn	73	SENT_48	[p2l1880t1917r1915b1948],
73	V	NN	O	v	dep	62	SENT_48	[p2l1880t1917r1915b1948],
74	)	CD	NUMBER	)	num	75	SENT_48	[p2l1880t1917r1915b1948],
75	allele	NN	O	allele	dep	73	SENT_48	[p2l1929t1915r1997b1941],
76	(	CD	NUMBER	(	num	78	SENT_48	[p2l123t1959r228b1990],
77	WT/V	NN	O	wt/v	nn	78	SENT_48	[p2l123t1959r228b1990],
78	)	NN	O	)	nsubj	65	SENT_48	[p2l123t1959r228b1990],
79	,	,	O	,	_	0	SENT_48	[p2l123t1959r228b1990],
80	or	CC	O	or	_	0	SENT_48	[p2l238t1966r266b1982],
81	have	VB	O	have	rcmod	3	SENT_48	[p2l275t1957r336b1982],
82	two	CD	NUMBER	two	num	84	SENT_48	[p2l343t1962r392b1982],
83	variant	JJ	O	variant	amod	84	SENT_48	[p2l400t1959r493b1982],
84	alleles	NNS	O	allele	dobj	81	SENT_48	[p2l502t1957r583b1982],
85	(	VBP	O	(	_	0	SENT_48	[p2l596t1959r664b1990],
86	V/V	NN	O	v/v	nn	87	SENT_48	[p2l596t1959r664b1990],
87	)	NN	O	)	dobj	85	SENT_48	[p2l596t1959r664b1990],
88	for	IN	O	for	_	0	SENT_48	[p2l675t1957r713b1982],
89	the	DT	O	the	det	91	SENT_48	[p2l720t1957r762b1982],
90	two	CD	NUMBER	two	num	91	SENT_48	[p2l770t1962r819b1982],
91	polymorphisms	NNS	O	polymorphism	prep_for	87	SENT_48	[p2l829t1957r1047b1990],
92	.	.	O	.	_	0	SENT_48	[p2l829t1957r1047b1990],

1	At	IN	O	at	_	0	SENT_49	[p2l1057t1959r1086b1982],
2	the	DT	O	the	det	3	SENT_49	[p2l1093t1957r1135b1982],
3	bottom	NN	O	bottom	prep_at	5	SENT_49	[p2l1146t1957r1242b1982],
4	are	VBP	O	be	auxpass	5	SENT_49	[p2l1253t1966r1292b1982],
5	shown	VBN	O	show	_	0	SENT_49	[p2l1302t1957r1388b1982],
6	the	DT	O	the	det	9	SENT_49	[p2l1397t1957r1440b1982],
7	nine	CD	NUMBER	nine	num	9	SENT_49	[p2l1450t1959r1506b1982],
8	potential	JJ	O	potential	amod	9	SENT_49	[p2l1516t1957r1632b1990],
9	combinations	NNS	O	combination	dobj	5	SENT_49	[p2l1643t1957r1828b1982],
10	ofdrugmetabolism	NN	O	ofdrugmetabolism	nn	13	SENT_49	[p2l1838t1957r2038b1990, p2l120t1999r193b2024],
11	and	CC	O	and	_	0	SENT_49	[p2l204t1999r251b2024],
12	drug-receptor	NN	O	drug-receptor	conj_and	10	SENT_49	[p2l262t1999r449b2032],
13	genotypes	NNS	O	genotype	dep	9	SENT_49	[p2l457t2003r595b2032],
14	and	CC	O	and	_	0	SENT_49	[p2l605t1999r653b2024],
15	the	DT	O	the	det	18	SENT_49	[p2l662t1999r705b2024],
16	corresponding	JJ	O	corresponding	amod	18	SENT_49	[p2l714t1999r914b2032],
17	drug-response	JJ	O	drug-response	amod	18	SENT_49	[p2l922t1999r1120b2032],
18	phenotypes	NNS	O	phenotype	conj_and	9	SENT_49	[p2l1130t1999r1286b2032],
19	calculated	VBN	O	calculate	partmod	18	SENT_49	[p2l1296t1999r1431b2024],
20	from	IN	O	from	_	0	SENT_49	[p2l1441t1998r1505b2024],
21	data	NNS	O	datum	prep_from	19	SENT_49	[p2l1515t1999r1573b2024],
22	at	IN	O	at	_	0	SENT_49	[p2l1583t2003r1607b2024],
23	the	DT	O	the	det	24	SENT_49	[p2l1614t1999r1657b2024],
24	top	NN	O	top	prep_at	21	SENT_49	[p2l1665t2003r1717b2031],
25	,	,	O	,	_	0	SENT_49	[p2l1665t2003r1717b2031],
26	yielding	VBG	O	yield	partmod	5	SENT_49	[p2l1727t1999r1833b2032],
27	therapeutic	JJ	O	therapeutic	amod	28	SENT_49	[p2l1840t1999r1996b2031],
28	indexes	NNS	O	index	nsubj	29	SENT_49	[p2l2005t2001r2037b2023, p2l120t2040r195b2066],
29	(	VBP	O	(	ccomp	26	SENT_49	[p2l208t2040r423b2073],
30	efﬁcacyztoxicity	JJ	O	efﬁcacyztoxicity	amod	31	SENT_49	[p2l208t2040r423b2073],
31	ratios	NNS	O	ratio	nsubj	32	SENT_49	[p2l433t2042r517b2073],
32	)	VBP	O	)	ccomp	29	SENT_49	[p2l433t2042r517b2073],
33	ranging	VBG	O	range	xcomp	32	SENT_49	[p2l531t2043r634b2074],
34	from	IN	O	from	_	0	SENT_49	[p2l643t2040r706b2066],
35	13	CD	PERCENT	13	num	36	SENT_49	[p2l720t2042r747b2065],
36	(	CD	PERCENT	(	prep_from	33	SENT_49	[p2l762t2042r800b2073],
37	65	CD	PERCENT	65	num	38	SENT_49	[p2l762t2042r800b2073],
38	percent	NN	PERCENT	percent	nsubjpass	5	SENT_49	[p2l813t2043r937b2073],
39	:5	CD	PERCENT	:5	num	40	SENT_49	[p2l813t2043r937b2073],
40	percent	NN	PERCENT	percent	dep	38	SENT_49	[p2l950t2042r1060b2073],
41	)	CD	NUMBER	)	number	43	SENT_49	[p2l950t2042r1060b2073],
42	to	TO	O	to	dep	43	SENT_49	[p2l1071t2045r1098b2066],
43	0.125	CD	PERCENT	0.125	num	45	SENT_49	[p2l1108t2042r1179b2066],
44	(	CD	PERCENT	(	number	45	SENT_49	[p2l1194t2042r1235b2073],
45	10	CD	PERCENT	10	dep	38	SENT_49	[p2l1194t2042r1235b2073],
46	percent	NN	PERCENT	percent	nn	49	SENT_49	[p2l1246t2042r1388b2073],
47	:80	CD	PERCENT	:80	num	49	SENT_49	[p2l1246t2042r1388b2073],
48	percent	NN	PERCENT	percent	nn	49	SENT_49	[p2l1399t2042r1519b2073],
49	)	NN	O	)	dep	45	SENT_49	[p2l1399t2042r1519b2073],
50	.	.	O	.	_	0	SENT_49	[p2l1399t2042r1519b2073],

1	DRUG	NN	O	drug	nn	2	SENT_50	[p2l95t2196r184b2216],
2	METABOLISM	NN	O	metabolism	nsubj	23	SENT_50	[p2l203t2196r411b2215],
3	There	EX	O	there	expl	4	SENT_50	[p2l92t2243r187b2274],
4	are	VBP	O	be	rcmod	2	SENT_50	[p2l200t2253r249b2274],
5	more	JJR	O	more	mwe	6	SENT_50	[p2l262t2253r348b2274],
6	than	IN	O	than	quantmod	7	SENT_50	[p2l361t2243r434b2274],
7	30	CD	NUMBER	30	num	8	SENT_50	[p2l447t2245r486b2274],
8	families	NNS	O	family	nsubj	4	SENT_50	[p2l499t2243r629b2274],
9	of	IN	O	of	_	0	SENT_50	[p2l643t2243r682b2274],
10	drug	NN	O	drug	nn	13	SENT_50	[p2l689t2243r916b2282],
11	—	CD	NUMBER	—	num	13	SENT_50	[p2l689t2243r916b2282],
12	metabo	NN	O	metabo	nn	13	SENT_50	[p2l689t2243r916b2282],
13	—	NN	O	—	prep_of	8	SENT_50	[p2l689t2243r916b2282],
14	lizing	VBG	O	lize	dep	8	SENT_50	[p2l93t2292r187b2331],
15	enzymes	NNS	O	enzyme	dobj	14	SENT_50	[p2l201t2302r342b2331],
16	in	IN	O	in	_	0	SENT_50	[p2l357t2293r389b2322],
17	humans	NNS	O	human	prep_in	14	SENT_50	[p2l404t2292r605b2329],
18	,3	CD	NUMBER	,3	num	19	SENT_50	[p2l404t2292r605b2329],
19	v14	NN	O	v14	tmod	14	SENT_50	[p2l404t2292r605b2329],
20	and	CC	O	and	_	0	SENT_50	[p2l619t2292r680b2323],
21	essentially	RB	O	essentially	advmod	19	SENT_50	[p2l695t2292r865b2331],
22	all	DT	O	all	tmod	14	SENT_50	[p2l878t2292r917b2323],
23	have	VBP	O	have	_	0	SENT_50	[p2l93t2341r166b2372],
24	genetic	JJ	O	genetic	amod	25	SENT_50	[p2l176t2342r294b2380],
25	variants	NNS	O	variant	dobj	23	SENT_50	[p2l301t2342r440b2378],
26	,	,	O	,	_	0	SENT_50	[p2l301t2342r440b2378],
27	many	JJ	O	many	nsubj	30	SENT_50	[p2l452t2351r543b2380],
28	of	IN	O	of	_	0	SENT_50	[p2l551t2341r590b2372],
29	which	WDT	O	which	prep_of	27	SENT_50	[p2l591t2341r692b2372],
30	translate	VBP	O	translate	rcmod	25	SENT_50	[p2l702t2341r843b2372],
31	into	IN	O	into	_	0	SENT_50	[p2l852t2342r916b2372],
32	functional	JJ	O	functional	amod	33	SENT_50	[p2l93t2390r261b2421],
33	changes	NNS	O	change	prep_into	30	SENT_50	[p2l271t2390r404b2429],
34	in	IN	O	in	_	0	SENT_50	[p2l414t2391r446b2420],
35	the	DT	O	the	det	36	SENT_50	[p2l456t2390r506b2421],
36	proteins	NNS	O	protein	prep_in	33	SENT_50	[p2l516t2391r651b2429],
37	encoded	VBN	O	encode	partmod	36	SENT_50	[p2l662t2390r809b2421],
38	.	.	O	.	_	0	SENT_50	[p2l662t2390r809b2421],

1	These	DT	O	these	det	3	SENT_51	[p2l819t2390r917b2421],
2	monogenic	JJ	O	monogenic	amod	3	SENT_51	[p2l93t2440r277b2478],
3	traits	NNS	O	trait	nsubjpass	5	SENT_51	[p2l284t2440r365b2470],
4	are	VBP	O	be	auxpass	5	SENT_51	[p2l373t2449r421b2470],
5	discussed	VBN	O	discuss	_	0	SENT_51	[p2l429t2439r585b2470],
6	by	IN	O	by	_	0	SENT_51	[p2l593t2439r631b2478],
7	Weinshilboum	NNP	O	Weinshilboum	nn	9	SENT_51	[p2l635t2439r917b2470],
8	.1	CD	NUMBER	.1	num	9	SENT_51	[p2l635t2439r917b2470],
9	Z	NN	O	z	agent	5	SENT_51	[p2l635t2439r917b2470],
10	But	CC	O	but	_	0	SENT_51	[p2l93t2491r151b2519],
11	there	EX	O	there	expl	12	SENT_51	[p2l160t2488r242b2519],
12	is	VBZ	O	be	conj_but	5	SENT_51	[p2l253t2489r279b2519],
13	an	DT	O	a	det	15	SENT_51	[p2l290t2498r329b2519],
14	instructive	JJ	O	instructive	amod	15	SENT_51	[p2l340t2489r511b2519],
15	example	NN	O	example	nsubj	12	SENT_51	[p2l522t2488r659b2527],
16	of	IN	O	of	_	0	SENT_51	[p2l670t2488r709b2519],
17	a	DT	O	a	det	19	SENT_51	[p2l713t2498r730b2519],
18	multigenic	JJ	O	multigenic	amod	19	SENT_51	[p2l740t2488r917b2527],
19	eﬂfect	NN	O	eﬂfect	prep_of	15	SENT_51	[p2l93t2537r183b2568],
20	involving	VBG	O	involve	_	0	SENT_51	[p2l188t2537r338b2576],
21	the	DT	O	the	det	23	SENT_51	[p2l344t2537r394b2568],
22	CYP3A	NN	O	cyp3a	nn	23	SENT_51	[p2l402t2539r512b2568],
23	family	NN	O	family	prep_involving	19	SENT_51	[p2l519t2537r620b2576],
24	of	IN	O	of	_	0	SENT_51	[p2l626t2537r665b2568],
25	P	NN	O	p	prep_of	23	SENT_51	[p2l665t2539r758b2568],
26	—	CD	NUMBER	—	number	27	SENT_51	[p2l665t2539r758b2568],
27	450	CD	NUMBER	450	num	28	SENT_51	[p2l665t2539r758b2568],
28	enzymes	NNS	O	enzyme	dep	25	SENT_51	[p2l767t2547r915b2576],
29	.	.	O	.	_	0	SENT_51	[p2l767t2547r915b2576],

1	About	IN	DURATION	about	_	0	SENT_52	[p2l92t2586r196b2617],
2	three	CD	DURATION	three	num	3	SENT_52	[p2l206t2586r290b2617],
3	quarters	NNS	DURATION	quarter	pobj	1	SENT_52	[p2l303t2593r439b2625],
4	of	IN	O	of	_	0	SENT_52	[p2l452t2586r492b2617],
5	whites	NNS	O	whites	prep_of	3	SENT_52	[p2l495t2586r605b2617],
6	and	CC	O	and	_	0	SENT_52	[p2l617t2586r678b2617],
7	half	NN	O	half	prep_of	3	SENT_52	[p2l690t2586r761b2617],
8	of	IN	O	of	_	0	SENT_52	[p2l766t2586r806b2617],
9	blacks	NNS	O	black	prep_of	3	SENT_52	[p2l811t2586r916b2617],

1	N	NN	O	n	nn	2	SENT_53	[p2l542t2706r556b2722],
2	ENGL	NN	ORGANIZATION	engl	_	0	SENT_53	[p2l571t2706r655b2728],
3	)	CD	NUMBER	)	num	4	SENT_53	[p2l571t2706r655b2728],
4	MED	NN	O	med	dep	2	SENT_53	[p2l670t2706r723b2722],
5	348	CD	NUMBER	348	num	7	SENT_53	[p2l735t2700r806b2728],
6	;	:	O	;	_	0	SENT_53	[p2l735t2700r806b2728],
7	6	CD	NUMBER	6	dep	4	SENT_53	[p2l735t2700r806b2728],
8	WWW.NEjM.ORG	NN	O	www.nejm.org	dep	2	SENT_53	[p2l841t2706r1052b2728],

1	have	VB	O	have	_	0	SENT_54	[p2l956t2194r1032b2225],
2	a	DT	O	a	det	4	SENT_54	[p2l1054t2204r1071b2225],
3	genetic	JJ	O	genetic	amod	4	SENT_54	[p2l1093t2195r1216b2233],
4	inability	NN	O	inability	dobj	1	SENT_54	[p2l1238t2194r1379b2233],
5	to	TO	O	to	aux	6	SENT_54	[p2l1400t2201r1431b2225],
6	express	VB	O	express	infmod	4	SENT_54	[p2l1455t2204r1581b2233],
7	functional	JJ	O	functional	acomp	6	SENT_54	[p2l1604t2194r1779b2225],
8	CYP3A5	NN	O	cyp3a5	dobj	6	SENT_54	[p2l956t2245r1132b2274],
9	.15	CD	NUMBER	.15	num	8	SENT_54	[p2l956t2245r1132b2274],
10	The	DT	O	the	det	11	SENT_54	[p2l1142t2243r1205b2274],
11	lack	NN	O	lack	nsubj	19	SENT_54	[p2l1214t2243r1282b2274],
12	of	IN	O	of	_	0	SENT_54	[p2l1290t2243r1329b2274],
13	functional	JJ	O	functional	amod	14	SENT_54	[p2l1331t2243r1499b2274],
14	CYP3A5	NN	O	cyp3a5	prep_of	11	SENT_54	[p2l1509t2245r1638b2274],
15	may	MD	O	may	aux	19	SENT_54	[p2l1649t2253r1718b2282],
16	not	RB	O	not	neg	19	SENT_54	[p2l1726t2250r1782b2274],
17	be	VB	O	be	cop	19	SENT_54	[p2l956t2292r993b2323],
18	readily	RB	O	readily	advmod	19	SENT_54	[p2l1004t2292r1115b2331],
19	evident	JJ	O	evident	rcmod	8	SENT_54	[p2l1124t2292r1250b2329],
20	,	,	O	,	_	0	SENT_54	[p2l1124t2292r1250b2329],
21	because	IN	O	because	mark	29	SENT_54	[p2l1264t2292r1393b2323],
22	many	JJ	O	many	amod	23	SENT_54	[p2l1404t2302r1495b2331],
23	medications	NNS	O	medication	nsubjpass	29	SENT_54	[p2l1504t2292r1704b2323],
24	metabolized	VBN	O	metabolize	partmod	23	SENT_54	[p2l1716t2302r1779b2323, p2l956t2341r1108b2372],
25	by	IN	O	by	_	0	SENT_54	[p2l1122t2341r1160b2380],
26	CYP3A5	NN	O	cyp3a5	agent	24	SENT_54	[p2l1173t2343r1302b2372],
27	are	VBP	O	be	auxpass	29	SENT_54	[p2l1318t2351r1367b2372],
28	also	RB	O	also	advmod	29	SENT_54	[p2l1381t2341r1446b2372],
29	metabolized	VBN	O	metabolize	advcl	19	SENT_54	[p2l1461t2341r1664b2372],
30	by	IN	O	by	_	0	SENT_54	[p2l1679t2341r1717b2380],
31	the	DT	O	the	det	34	SENT_54	[p2l1729t2341r1780b2372],
32	universally	RB	O	universally	advmod	33	SENT_54	[p2l956t2390r1129b2429],
33	expressed	VBN	O	express	amod	34	SENT_54	[p2l1136t2390r1294b2429],
34	CYP3A4	NN	O	cyp3a4	agent	29	SENT_54	[p2l1302t2392r1440b2421],
35	.	.	O	.	_	0	SENT_54	[p2l1302t2392r1440b2421],

1	For	IN	O	for	_	0	SENT_55	[p2l1450t2393r1505b2421],
2	medications	NNS	O	medication	prep_for	18	SENT_55	[p2l1512t2390r1709b2421],
3	that	WDT	O	that	nsubjpass	6	SENT_55	[p2l1718t2390r1782b2421],
4	are	VBP	O	be	auxpass	6	SENT_55	[p2l956t2449r1005b2470],
5	equally	RB	O	equally	advmod	6	SENT_55	[p2l1018t2439r1135b2478],
6	metabolized	VBN	O	metabolize	rcmod	2	SENT_55	[p2l1146t2439r1349b2470],
7	by	IN	O	by	prep	6	SENT_55	[p2l1362t2439r1400b2478],
8	both	CC	O	both	prep	6	SENT_55	[p2l1412t2439r1487b2470],
9	enzymes	NNS	O	enzyme	dep	8	SENT_55	[p2l1500t2449r1651b2478],
10	,	,	O	,	_	0	SENT_55	[p2l1500t2449r1651b2478],
11	the	DT	O	the	det	13	SENT_55	[p2l1666t2439r1716b2470],
12	net	JJ	O	net	amod	13	SENT_55	[p2l1729t2446r1782b2470],
13	rate	NN	O	rate	nsubj	18	SENT_55	[p2l956t2495r1016b2519],
14	of	IN	O	of	_	0	SENT_55	[p2l1024t2488r1063b2519],
15	metabolism	NN	O	metabolism	prep_of	13	SENT_55	[p2l1064t2488r1258b2519],
16	is	VBZ	O	be	cop	18	SENT_55	[p2l1265t2489r1291b2519],
17	the	DT	O	the	det	18	SENT_55	[p2l1300t2488r1349b2519],
18	sum	NN	O	sum	_	0	SENT_55	[p2l1358t2498r1427b2519],
19	of	IN	O	of	_	0	SENT_55	[p2l1435t2488r1474b2519],
20	that	DT	O	that	det	28	SENT_55	[p2l1475t2488r1539b2519],
21	due	JJ	O	due	_	0	SENT_55	[p2l1545t2488r1603b2519],
22	to	TO	O	to	_	0	SENT_55	[p2l1611t2495r1642b2519],
23	CYP3A4	NN	O	cyp3a4	prep_due_to	28	SENT_55	[p2l1650t2490r1780b2519],
24	and	CC	O	and	_	0	SENT_55	[p2l956t2537r1016b2568],
25	that	IN	O	that	dep	26	SENT_55	[p2l1028t2537r1093b2568],
26	due	JJ	O	due	prep_of	18	SENT_55	[p2l1103t2537r1161b2568],
27	to	TO	O	to	dep	26	SENT_55	[p2l1173t2544r1204b2568],
28	CYP3A5	NN	O	cyp3a5	prep_of	18	SENT_55	[p2l1216t2539r1357b2574],
29	;	:	O	;	_	0	SENT_55	[p2l1216t2539r1357b2574],
30	the	DT	O	the	det	31	SENT_55	[p2l1371t2537r1421b2568],
31	existence	NN	O	existence	nsubj	37	SENT_55	[p2l1433t2538r1582b2568],
32	of	IN	O	of	_	0	SENT_55	[p2l1594t2537r1633b2568],
33	this	DT	O	this	det	35	SENT_55	[p2l1638t2537r1697b2568],
34	dual	JJ	O	dual	amod	35	SENT_55	[p2l1710t2537r1780b2568],
35	pathway	NN	O	pathway	prep_of	31	SENT_55	[p2l955t2586r1092b2625],
36	partially	RB	O	partially	advmod	37	SENT_55	[p2l1099t2586r1232b2625],
37	obscures	VBZ	O	obscure	parataxis	18	SENT_55	[p2l1239t2586r1382b2617],
38	the	DT	O	the	det	40	SENT_55	[p2l1392t2586r1442b2617],
39	clinical	JJ	O	clinical	amod	40	SENT_55	[p2l1451t2586r1567b2617],
40	eﬂfects	NNS	O	eﬂfects	dobj	37	SENT_55	[p2l1575t2586r1679b2617],
41	of	IN	O	of	_	0	SENT_55	[p2l1689t2586r1728b2617],
42	geFEBRUARY	NN	O	gefebruary	prep_of	40	SENT_55	[p2l1730t2596r1779b2625, p2l1092t2706r1219b2722],

1	6	CD	NUMBER	6	_	0	SENT_56	[p2l1232t2700r1253b2726],
2	,	,	O	,	_	0	SENT_56	[p2l1232t2700r1253b2726],
3	2003	CD	DATE	2003	num	4	SENT_56	[p2l1266t2706r1330b2728],
4	539	CD	NUMBER	539	appos	1	SENT_56	[p2l2010t2705r2066b2727],

1	The	DT	O	the	det	5	SENT_57	[p2l752t2803r802b2827],
2	New	NNP	O	New	nn	5	SENT_57	[p2l812t2804r874b2827],
3	England	NNP	O	England	nn	5	SENT_57	[p2l883t2803r994b2834],
4	J	NNP	O	J	nn	5	SENT_57	[p2l1002t2804r1015b2827],
5	oumal	NN	O	oumal	_	0	SENT_57	[p2l1016t2803r1100b2827],
6	of	IN	O	of	_	0	SENT_57	[p2l1110t2803r1138b2827],
7	Medicine	NN	O	medicine	prep_of	5	SENT_57	[p2l1145t2803r1270b2827],

1	Downloaded	VBN	O	download	_	0	SENT_58	[p2l194t2844r364b2867],
2	from	IN	O	from	_	0	SENT_58	[p2l372t2844r437b2867],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_58	[p2l446t2844r564b2874],
4	at	IN	O	at	_	0	SENT_58	[p2l574t2848r597b2867],
5	UW-Madison	NN	O	uw-madison	prep_at	3	SENT_58	[p2l606t2844r788b2867],
6	on	IN	O	on	_	0	SENT_58	[p2l798t2851r830b2867],
7	J	NN	O	j	prep_on	1	SENT_58	[p2l839t2844r851b2867],
8	anuary	JJ	O	anuary	amod	7	SENT_58	[p2l853t2851r942b2874],
9	5	CD	NUMBER	5	tmod	8	SENT_58	[p2l952t2844r974b2872],
10	,	,	O	,	_	0	SENT_58	[p2l952t2844r974b2872],
11	2014	CD	DATE	2014	dobj	1	SENT_58	[p2l985t2844r1057b2867],
12	.	.	O	.	_	0	SENT_58	[p2l985t2844r1057b2867],

1	For	IN	O	for	_	0	SENT_59	[p2l1068t2844r1114b2867],
2	personal	JJ	O	personal	amod	3	SENT_59	[p2l1122t2844r1234b2874],
3	use	NN	O	use	pobj	1	SENT_59	[p2l1244t2851r1287b2867],
4	only	RB	O	only	advmod	3	SENT_59	[p2l1297t2844r1362b2874],
5	.	.	O	.	_	0	SENT_59	[p2l1297t2844r1362b2874],

1	No	DT	O	no	det	3	SENT_60	[p2l1372t2844r1412b2867],
2	other	JJ	O	other	amod	3	SENT_60	[p2l1422t2844r1490b2867],
3	uses	NNS	O	use	_	0	SENT_60	[p2l1498t2851r1554b2867],
4	without	IN	O	without	_	0	SENT_60	[p2l1565t2844r1666b2867],
5	permission	NN	O	permission	prep_without	3	SENT_60	[p2l1674t2844r1827b2874],
6	.	.	O	.	_	0	SENT_60	[p2l1674t2844r1827b2874],

1	Copyright	NN	O	copyright	_	0	SENT_61	[p2l544t2885r678b2916],
2	©	CD	NUMBER	©	num	6	SENT_61	[p2l688t2885r711b2909],
3	2003	CD	DATE	2003	num	6	SENT_61	[p2l721t2885r785b2909],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_61	[p2l796t2885r987b2909],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_61	[p2l997t2885r1105b2909],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_61	[p2l1115t2885r1220b2916],
7	.	.	O	.	_	0	SENT_61	[p2l1115t2885r1220b2916],

1	All	DT	O	all	det	2	SENT_62	[p2l1231t2885r1272b2909],
2	rights	NNS	O	rights	nsubj	3	SENT_62	[p2l1282t2885r1356b2916],
3	reserved	VBN	O	reserve	_	0	SENT_62	[p2l1366t2885r1485b2909],
4	.	.	O	.	_	0	SENT_62	[p2l1366t2885r1485b2909],

1	The	DT	O	the	det	4	SENT_63	[p2l715t2991r752b3012],
2	NEW	NNP	O	NEW	nn	4	SENT_63	[p2l765t2993r845b3012],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_63	[p2l859t2993r1034b3012],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_63	[p2l1048t2993r1214b3019],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_63	[p2l1228t2991r1444b3018],

1	netic	JJ	O	netic	amod	2	SENT_64	[p2l11t3215r214b3293],
2	polymorphism	NN	O	polymorphism	nsubj	6	SENT_64	[p2l241t3214r873b3315],
3	of	IN	O	of	_	0	SENT_64	[p2l904t3214r1006b3293],
4	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_64	[p2l1017t3220r1354b3293],
5	but	CC	O	but	cc	6	SENT_64	[p2l1388t3215r1530b3294],
6	contributes	VBZ	O	contribute	_	0	SENT_64	[p2l1556t3215r2035b3294],
7	to	TO	O	to	_	0	SENT_64	[p2l2068t3231r2148b3293],
8	the	DT	O	the	det	10	SENT_64	[p2l12t3343r142b3421],
9	large	JJ	O	large	amod	10	SENT_64	[p2l176t3343r386b3443],
10	range	NN	O	range	prep_to	6	SENT_64	[p2l421t3368r659b3443],
11	of	IN	O	of	_	0	SENT_64	[p2l695t3342r797b3421],
12	total	JJ	O	total	amod	14	SENT_64	[p2l813t3343r1004b3421],
13	CYP3A	NN	O	cyp3a	nn	14	SENT_64	[p2l1039t3348r1329b3421],
14	activity	NN	O	activity	prep_of	10	SENT_64	[p2l1360t3343r1657b3443],
15	in	IN	O	in	_	0	SENT_64	[p2l1688t3343r1769b3420],
16	humans	NNS	O	human	prep_in	14	SENT_64	[p2l1804t3343r2147b3422],
17	(	CD	NUMBER	(	num	18	SENT_64	[p2l16t3471r205b3571],
18	Fig	NN	O	fig	dep	16	SENT_64	[p2l16t3471r205b3571],
19	.	.	O	.	_	0	SENT_64	[p2l16t3471r205b3571],

1	2	CD	NUMBER	2	num	2	SENT_65	[p2l243t3476r351b3562],
2	)	CD	NUMBER	)	_	0	SENT_65	[p2l243t3476r351b3562],
3	.	.	O	.	_	0	SENT_65	[p2l243t3476r351b3562],

1	The	DT	O	the	det	3	SENT_66	[p2l386t3471r550b3549],
2	CYP3A	NN	O	cyp3a	nn	3	SENT_66	[p2l583t3476r877b3549],
3	pathway	NN	O	pathway	nsubj	8	SENT_66	[p2l905t3471r1269b3571],
4	of	IN	O	of	_	0	SENT_66	[p2l1297t3470r1400b3549],
5	drug	NN	O	drug	nn	6	SENT_66	[p2l1414t3470r1618b3571],
6	elimination	NN	O	elimination	prep_of	3	SENT_66	[p2l1648t3470r2148b3549],
7	is	VBZ	O	be	cop	8	SENT_66	[p2l11t3599r77b3677],
8	further	JJ	O	further	_	0	SENT_66	[p2l122t3598r426b3678],
9	confounded	VBN	O	confound	partmod	8	SENT_66	[p2l467t3598r978b3678],
10	by	IN	O	by	_	0	SENT_66	[p2l1018t3599r1116b3699],
11	the	DT	O	the	det	12	SENT_66	[p2l1152t3599r1282b3677],
12	presence	NN	O	presence	agent	9	SENT_66	[p2l1321t3624r1697b3699],
13	of	IN	O	of	_	0	SENT_66	[p2l1739t3598r1839b3677],
14	singlenucleotide	NN	O	singlenucleotide	prep_of	12	SENT_66	[p2l1862t3599r2148b3699, p3l11t21r455b100],

1	polymorphisms	NNS	O	polymorphism	conj_negcc	1	SENT_67	[p3l477t21r1151b121],
2	in	IN	O	in	_	0	SENT_67	[p3l1176t21r1258b98],
3	the	DT	O	the	det	5	SENT_67	[p3l1282t21r1412b99],
4	CYP3A4	NN	O	cyp3a4	nn	5	SENT_67	[p3l1434t26r1738b99],
5	gene	NN	O	gene	prep_for	1	SENT_67	[p3l1762t46r1961b121],
6	that	WDT	O	that	nsubj	7	SENT_67	[p3l1986t21r2153b99],
7	alter	VBP	O	alter	rcmod	5	SENT_67	[p3l11t149r200b227],
8	the	DT	O	the	det	9	SENT_67	[p3l221t149r350b227],
9	activity	NN	O	activity	dobj	7	SENT_67	[p3l373t149r671b249],
10	of	IN	O	of	_	0	SENT_67	[p3l691t148r791b227],
11	this	DT	O	this	det	12	SENT_67	[p3l797t149r950b227],
12	enzyme	NN	O	enzyme	prep_of	9	SENT_67	[p3l977t174r1299b249],
13	for	IN	O	for	_	0	SENT_67	[p3l1323t148r1447b227],
14	some	DT	O	some	det	15	SENT_67	[p3l1469t174r1695b227],
15	substrates	NNS	O	substrate	prep_for	12	SENT_67	[p3l1719t149r2147b228],
16	but	CC	O	but	_	0	SENT_67	[p3l12t277r154b356],
17	not	RB	O	not	_	0	SENT_67	[p3l181t293r325b355],
18	for	IN	O	for	_	0	SENT_67	[p3l353t276r477b355],
19	others	NNS	O	other	dep	1	SENT_67	[p3l508t277r884b355],
20	.16	CD	NUMBER	.16	num	19	SENT_67	[p3l508t277r884b355],
21	The	DT	O	the	det	23	SENT_67	[p3l914t277r1076b355],
22	genetic	JJ	O	genetic	amod	23	SENT_67	[p3l1109t277r1415b377],
23	basis	NN	O	basis	nsubj	33	SENT_67	[p3l1448t277r1658b355],
24	of	IN	O	of	_	0	SENT_67	[p3l1693t276r1795b355],
25	CYP3A5	NN	O	cyp3a5	nn	26	SENT_67	[p3l1809t282r2145b355],
26	deﬁciency	NN	O	deﬁciency	prep_of	23	SENT_67	[p3l12t404r450b505],
27	is	VBZ	O	be	cop	33	SENT_67	[p3l494t405r560b483],
28	predominantly	RB	O	predominantly	advmod	33	SENT_67	[p3l611t405r1256b505],
29	a	DT	O	a	det	33	SENT_67	[p3l1301t431r1346b483],
30	single	JJ	O	single	amod	33	SENT_67	[p3l1395t405r2148b505],
31	—	NN	O	—	nn	33	SENT_67	[p3l1395t405r2148b505],
32	nucleotide	NN	O	nucleotide	nn	33	SENT_67	[p3l1395t405r2148b505],
33	polymorphism	NN	O	polymorphism	rcmod	19	SENT_67	[p3l10t533r654b633],
34	in	IN	O	in	_	0	SENT_67	[p3l696t533r779b610],
35	intron	NN	O	intron	prep_in	33	SENT_67	[p3l821t533r1090b611],
36	3	CD	NUMBER	3	num	35	SENT_67	[p3l1134t538r1177b611],
37	that	WDT	O	that	nsubj	38	SENT_67	[p3l1224t533r1395b611],
38	creates	VBZ	O	create	rcmod	33	SENT_67	[p3l1433t549r1730b611],
39	a	DT	O	a	det	42	SENT_67	[p3l1774t559r1818b611],
40	cryptic	JJ	O	cryptic	amod	42	SENT_67	[p3l1861t533r2149b633],
41	splice	NN	O	splice	nn	42	SENT_67	[p3l13t661r259b761],
42	site	NN	O	site	dobj	38	SENT_67	[p3l294t661r441b739],
43	causing	VBG	O	cause	partmod	42	SENT_67	[p3l475t661r804b761],
44	131	CD	NUMBER	131	num	45	SENT_67	[p3l836t666r986b739],
45	nucleotides	NNS	O	nucleotide	dobj	43	SENT_67	[p3l1018t660r1504b740],
46	of	IN	O	of	_	0	SENT_67	[p3l1538t660r1639b739],
47	the	DT	O	the	det	49	SENT_67	[p3l1652t661r1782b739],
48	intronic	JJ	O	intronic	amod	49	SENT_67	[p3l1813t661r2149b739],
49	sequence	NN	O	sequence	prep_of	45	SENT_67	[p3l13t814r403b889],
50	to	TO	O	to	aux	52	SENT_67	[p3l431t805r511b867],
51	be	VB	O	be	auxpass	52	SENT_67	[p3l541t789r637b867],
52	inserted	VBN	O	insert	xcomp	43	SENT_67	[p3l665t788r1007b867],
53	into	IN	O	into	_	0	SENT_67	[p3l1034t789r1200b867],
54	the	DT	O	the	det	55	SENT_67	[p3l1230t789r1360b867],
55	RNA	NN	MISC	rna	prep_into	52	SENT_67	[p3l1387t795r1614b884],
56	,	,	O	,	_	0	SENT_67	[p3l1387t795r1614b884],
57	introducing	VBG	O	introduce	xcomp	43	SENT_67	[p3l1647t788r2152b889],
58	a	DT	O	a	det	60	SENT_67	[p3l11t943r55b995],
59	termination	NN	O	termination	nn	60	SENT_67	[p3l76t917r579b995],
60	codon	NN	O	codon	dobj	57	SENT_67	[p3l602t917r864b995],
61	that	WDT	O	that	nsubj	63	SENT_67	[p3l887t917r1055b995],
62	prematurely	RB	O	prematurely	advmod	63	SENT_67	[p3l1070t917r1588b1017],
63	truncates	VBZ	O	truncate	rcmod	60	SENT_67	[p3l1606t933r1995b996],
64	the	DT	O	the	det	65	SENT_67	[p3l2019t916r2148b995],
65	CYP3A5	NN	O	cyp3a5	dobj	63	SENT_67	[p3l11t1051r347b1124],
66	protein	NN	O	protein	dep	19	SENT_67	[p3l385t1046r801b1146],
67	.15	CD	NUMBER	.15	num	66	SENT_67	[p3l385t1046r801b1146],
68	Although	IN	O	although	mark	72	SENT_67	[p3l835t1046r1239b1146],
69	it	PRP	O	it	nsubj	72	SENT_67	[p3l1273t1046r1334b1124],
70	is	VBZ	O	be	cop	72	SENT_67	[p3l1362t1046r1428b1124],
71	now	RB	DATE	now	advmod	72	SENT_67	[p3l1465t1071r1650b1125],
72	possible	JJ	O	possible	dep	66	SENT_67	[p3l1680t1046r2032b1146],
73	to	TO	O	to	prep	72	SENT_67	[p3l2068t1062r2148b1124],

1	oo	NN	O	oo	nn	3	SENT_68	[p4l308t384r338b437],
2	O	NN	O	o	nn	3	SENT_68	[p4l344t384r378b437],
3	O	NN	O	o	_	0	SENT_68	[p4l308t594r339b646],
4	\	CD	NUMBER	\	num	5	SENT_68	[p4l308t594r339b646],
5	O	NN	O	o	dep	3	SENT_68	[p4l344t593r378b646],

1	No.	NN	O	no.	_	0	SENT_69	[p4l121t834r176b948],
2	of	IN	O	of	_	0	SENT_69	[p4l114t733r176b809],
3	People	NNS	O	people	prep_of	1	SENT_69	[p4l115t501r194b718],

1	I	PRP	O	I	_	0	SENT_70	[p4l308t1014r338b1065],
2	\	VBP	O	\	dep	1	SENT_70	[p4l308t1014r338b1065],
3	)	SYM	O	)	dep	1	SENT_70	[p4l308t1014r338b1065],
4	-	:	O	-	_	0	SENT_70	[p4l306t805r339b855],
5	i	FW	O	i	dep	1	SENT_70	[p4l306t805r339b855],
6	>	JJR	O	>	amod	8	SENT_70	[p4l306t805r339b855],
7	O	NN	O	o	nn	8	SENT_70	[p4l344t1012r378b1066],
8	O	NN	O	o	dep	5	SENT_70	[p4l344t803r378b857],
9	A	NN	O	a	nn	10	SENT_70	[p4l306t2358r339b2409],
10	O	NN	O	o	dep	5	SENT_70	[p4l344t2357r378b2410],

1	2	CD	NUMBER	2	num	2	SENT_71	[p4l115t2054r176b2106],
2	9	CD	NUMBER	9	_	0	SENT_71	[p4l135t2113r194b2150],
3	.	.	O	.	_	0	SENT_71	[p4l135t2113r194b2150],

1	o	NN	O	o	nn	3	SENT_72	[p4l135t2156r176b2194],
2	m	NN	O	m	nn	3	SENT_72	[p4l135t2197r176b2232],
3	n.	NN	O	n.	_	0	SENT_72	[p4l121t2234r175b2272],
4	u.	NN	O	u.	nn	8	SENT_72	[p4l114t2287r175b2323],
5	o	NN	O	o	nn	8	SENT_72	[p4l135t2325r176b2363],
6	o	NN	O	o	nn	8	SENT_72	[p4l135t2388r176b2446],
7	'	''	O	'	_	0	SENT_72	[p4l135t2388r176b2446],
8	Z	NN	O	z	dep	3	SENT_72	[p4l121t2455r175b2501],

1	l	NN	O	l	_	0	SENT_73	[p4l308t2568r338b2619],
2	\	SYM	O	\	dep	3	SENT_73	[p4l308t2568r338b2619],
3	)	CD	NUMBER	)	rcmod	1	SENT_73	[p4l308t2568r338b2619],
4	C	NN	O	c	dep	1	SENT_73	[p4l344t2566r378b2620],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_74	[p4l739t2984r1004b3040],
2	and	CC	O	and	_	0	SENT_74	[p4l1029t2979r1147b3040],
3	CYP3A5	NN	O	cyp3a5	nn	4	SENT_74	[p4l1174t2984r1435b3040],
4	Activity	NN	O	activity	conj_and	1	SENT_74	[p4l1461t2980r1707b3059],

1	Figure	NN	O	figure	_	0	SENT_75	[p4l85t3234r303b3316],
2	2	CD	NUMBER	2	dep	1	SENT_75	[p4l326t3238r386b3296],
3	.	.	O	.	_	0	SENT_75	[p4l326t3238r386b3296],

1	Simulated	JJ	O	simulated	amod	2	SENT_76	[p4l412t3231r767b3296],
2	Activities	NNS	O	activity	_	0	SENT_76	[p4l792t3233r1116b3296],
3	of	IN	O	of	_	0	SENT_76	[p4l1140t3231r1222b3296],
4	Cytochromes	NNP	O	Cytochromes	nn	6	SENT_76	[p4l1230t3231r1695b3317],
5	P-450	NN	O	p-450	nn	6	SENT_76	[p4l1726t3236r1919b3296],
6	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_76	[p4l79t3344r363b3404],
7	and	CC	O	and	_	0	SENT_76	[p4l386t3340r513b3404],
8	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_76	[p4l540t3344r819b3404],
9	in	IN	O	in	_	0	SENT_76	[p4l849t3341r907b3404],
10	Blacks	NNPS	O	Blacks	prep_in	2	SENT_76	[p4l940t3340r1160b3404],
11	and	CC	O	and	_	0	SENT_76	[p4l1187t3340r1313b3404],
12	Whites	NNPS	O	Whites	prep_in	2	SENT_76	[p4l1338t3340r1605b3405],
13	.	.	O	.	_	0	SENT_76	[p4l1338t3340r1605b3405],

1	The	DT	O	the	det	3	SENT_77	[p4l78t3470r208b3534],
2	simulated	JJ	O	simulated	amod	3	SENT_77	[p4l236t3470r581b3535],
3	activities	NNS	O	activity	nsubjpass	18	SENT_77	[p4l612t3475r917b3534],
4	ofCYP3A4	NN	O	ofcyp3a4	npadvmod	6	SENT_77	[p4l946t3469r1316b3534],
5	(	CD	NUMBER	(	num	4	SENT_77	[p4l1350t3470r1555b3555],
6	black	JJ	O	black	amod	3	SENT_77	[p4l1350t3470r1555b3555],
7	dashed	VBN	O	dash	partmod	3	SENT_77	[p4l1579t3470r1830b3534],
8	lines	NNS	O	line	nn	9	SENT_77	[p4l1863t3470r2046b3555],
9	)	NN	O	)	dobj	7	SENT_77	[p4l1863t3470r2046b3555],
10	and	CC	O	and	_	0	SENT_77	[p4l82t3578r206b3643],
11	CYP3A5	NN	O	cyp3a5	dobj	7	SENT_77	[p4l237t3582r512b3643],
12	(	CD	NUMBER	(	npadvmod	13	SENT_77	[p4l550t3578r760b3663],
13	white	JJ	O	white	amod	9	SENT_77	[p4l550t3578r760b3663],
14	dashed	VBN	O	dash	partmod	9	SENT_77	[p4l787t3578r1037b3643],
15	lines	NNS	O	line	nn	16	SENT_77	[p4l1070t3578r1253b3663],
16	)	NN	O	)	dobj	14	SENT_77	[p4l1070t3578r1253b3663],
17	are	VBP	O	be	auxpass	18	SENT_77	[p4l1288t3601r1392b3643],
18	shown	VBN	O	show	_	0	SENT_77	[p4l1419t3578r1644b3643],
19	in	IN	O	in	_	0	SENT_77	[p4l1678t3584r1733b3642],
20	blacks	NNS	O	black	prep_in	18	SENT_77	[p4l1766t3578r1979b3643],
21	(	CD	NUMBER	(	num	22	SENT_77	[p4l88t3686r300b3771],
22	Panel	NN	O	panel	dep	20	SENT_77	[p4l88t3686r300b3771],
23	A	DT	O	a	det	24	SENT_77	[p4l327t3691r399b3771],
24	)	NN	O	)	dep	20	SENT_77	[p4l327t3691r399b3771],
25	and	CC	O	and	_	0	SENT_77	[p4l434t3686r558b3751],
26	whites	NNS	O	whites	conj_and	20	SENT_77	[p4l586t3686r812b3751],
27	(	CD	NUMBER	(	num	30	SENT_77	[p4l847t3686r1059b3771],
28	Panel	NN	O	panel	nn	30	SENT_77	[p4l847t3686r1059b3771],
29	B	NN	O	b	nn	30	SENT_77	[p4l1095t3692r1184b3771],
30	)	NN	O	)	dep	26	SENT_77	[p4l1095t3692r1184b3771],
31	,	,	O	,	_	0	SENT_77	[p4l1095t3692r1184b3771],
32	assuming	VBG	O	assume	xcomp	18	SENT_77	[p4l1215t3692r1560b3772],
33	a	DT	O	a	det	35	SENT_77	[p4l1586t3709r1618b3751],
34	normal	JJ	O	normal	amod	35	SENT_77	[p4l1650t3686r1894b3751],
35	dis-I-vii	NN	O	dis-i-vii	dobj	32	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
36	-	:	O	-	_	0	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
37	\	CD	NUMBER	\	number	38	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
38	|	CD	NUMBER	|	num	39	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
39	|	NN	O	|	dep	35	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
40	+	CC	O	+	_	0	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
41	ir	NN	O	ir	nn	43	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
42	\	CD	NUMBER	\	num	43	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
43	n	NN	O	n	conj_+	39	SENT_77	[p4l1924t3686r2048b3751, p4l78t3794r382b3834],
44	'	''	O	'	_	0	SENT_77	[p4l415t3794r537b3834],
45	1If	NN	O	1if	dep	35	SENT_77	[p4l415t3794r537b3834],
46	'	''	O	'	_	0	SENT_77	[p4l415t3794r537b3834],
47	If	IN	O	if	rcmod	45	SENT_77	[p4l415t3794r537b3834],
48	'	''	O	'	_	0	SENT_77	[p4l415t3794r537b3834],
49	|	JJ	O	|	amod	50	SENT_77	[p4l415t3794r537b3834],
50	r1	NN	O	r1	dep	35	SENT_77	[p4l570t3817r598b3834],
51	1n	NN	O	1n	rcmod	50	SENT_77	[p4l634t3798r710b3834],
52	"	''	O	"	punct	51	SENT_77	[p4l738t3793r867b3834],
53	+	CC	O	+	rcmod	51	SENT_77	[p4l738t3793r867b3834],
54	Ir	SYM	O	ir	dep	51	SENT_77	[p4l900t3817r1093b3834],
55	-	:	O	-	_	0	SENT_77	[p4l900t3817r1093b3834],
56	‘	NN	O	‘	nn	57	SENT_77	[p4l900t3817r1093b3834],
57	inn-A	NN	O	inn-a	dep	50	SENT_77	[p4l900t3817r1093b3834],
58	in	IN	O	in	_	0	SENT_77	[p4l1122t3800r1177b3834],
59	nr-I-i	JJ	O	nr-i-i	amod	60	SENT_77	[p4l1210t3800r1453b3834],
60	\	NN	O	\	prep_in	57	SENT_77	[p4l1210t3800r1453b3834],
61	:	:	O	:	_	0	SENT_77	[p4l1210t3800r1453b3834],
62	i	FW	O	i	dep	50	SENT_77	[p4l1210t3800r1453b3834],
63	+	CC	O	+	_	0	SENT_77	[p4l1210t3800r1453b3834],
64	u	FW	O	u	conj_+	62	SENT_77	[p4l1210t3800r1453b3834],
65	/	:	O	/	punct	66	SENT_77	[p4l1485t3794r1735b3834],
66	clnruxnn	NN	O	clnruxnn	dep	64	SENT_77	[p4l1485t3794r1735b3834],
67	in	IN	O	in	_	0	SENT_77	[p4l1768t3800r1823b3834],
68	nrl	NN	O	nrl	prep_in	64	SENT_77	[p4l1857t3794r1982b3834],
69	-	:	O	-	_	0	SENT_77	[p4l1857t3794r1982b3834],
70	\	NN	O	\	dep	50	SENT_77	[p4l1857t3794r1982b3834],
71	i	FW	O	i	dep	70	SENT_77	[p4l1857t3794r1982b3834],

1	LIIUULIUII	CD	NUMBER	liiuuliuii	num	3	SENT_78	[p5l85t6r382b31],
2	GIILJ	NN	O	giilj	nn	3	SENT_78	[p5l413t6r537b31],
3	G	NN	O	g	_	0	SENT_78	[p5l568t6r601b31],
4	J.	NNP	O	J.	nn	5	SENT_78	[p5l634t6r867b31],
5	U	NNP	O	U	poss	3	SENT_78	[p5l634t6r867b31],
6	'	POS	O	'	_	0	SENT_78	[p5l634t6r867b31],
7	I	PRP	O	I	nsubj	8	SENT_78	[p5l634t6r867b31],
8	\	VBP	O	\	rcmod	3	SENT_78	[p5l634t6r867b31],
9	JI	NNP	O	JI	nn	10	SENT_78	[p5l634t6r867b31],
10	\	NNP	O	\	dobj	8	SENT_78	[p5l634t6r867b31],
11	.	.	O	.	_	0	SENT_78	[p5l634t6r867b31],

1	J	NNP	O	J	nn	4	SENT_79	[p5l634t6r867b31],
2	IGIIBC	NNP	O	IGIIBC	nn	4	SENT_79	[p5l900t6r1093b51],
3	III	NNP	O	III	nn	4	SENT_79	[p5l1123t6r1178b30],
4	O.L.I.	NNP	O	O.L.I.	_	0	SENT_79	[p5l1209t6r1447b51],
5	.	.	O	.	_	0	SENT_79	[p5l1209t6r1447b51],

1	IVIl	NN	O	ivil	_	0	SENT_80	[p5l1209t6r1447b51],
2	.	.	O	.	_	0	SENT_80	[p5l1209t6r1447b51],

1	y	NN	O	y	nsubj	9	SENT_81	[p5l1209t6r1447b51],
2	\	CD	NUMBER	\	num	1	SENT_81	[p5l1485t6r1735b51],
3	3IIVJVVII	CD	NUMBER	3iivjvvii	num	8	SENT_81	[p5l1485t6r1735b51],
4	III	CD	NUMBER	iii	num	8	SENT_81	[p5l1769t6r1823b30],
5	GIUI	NN	MISC	giuus	nn	8	SENT_81	[p5l1855t6r2009b31],
6	'	''	O	'	_	0	SENT_81	[p5l1855t6r2009b31],
7	trary	JJ	O	trary	amod	8	SENT_81	[p5l78t87r238b160],
8	units	NNS	O	unit	dep	1	SENT_81	[p5l264t80r459b159],
9	)	VBP	O	)	_	0	SENT_81	[p5l264t80r459b159],
10	among	IN	O	among	_	0	SENT_81	[p5l493t97r739b160],
11	those	DT	O	those	nsubj	12	SENT_81	[p5l760t74r955b139],
12	expressing	VBG	O	express	prepc_among	9	SENT_81	[p5l980t81r1357b160],
13	functional	JJ	O	functional	amod	14	SENT_81	[p5l1379t73r1731b139],
14	forms	NNS	O	form	dobj	12	SENT_81	[p5l1758t73r1963b139],
15	of	IN	O	of	_	0	SENT_81	[p5l1990t73r2067b139],
16	these	DT	O	these	det	17	SENT_81	[p5l78t182r268b247],
17	enzymes	NNS	O	enzyme	prep_of	14	SENT_81	[p5l294t205r621b268],
18	,	,	O	,	_	0	SENT_81	[p5l294t205r621b268],
19	and	CC	O	and	_	0	SENT_81	[p5l652t182r776b247],
20	further	RB	O	further	advmod	21	SENT_81	[p5l804t182r1046b247],
21	assuming	VBG	O	assume	prepc_among	9	SENT_81	[p5l1070t189r1416b268],
22	that	IN	O	that	complm	25	SENT_81	[p5l1439t182r1577b247],
23	all	DT	O	all	det	24	SENT_81	[p5l1603t182r1674b247],
24	patients	NNS	O	patient	nsubj	25	SENT_81	[p5l1709t189r1986b267],
25	express	VBP	O	express	ccomp	21	SENT_81	[p5l81t313r342b375],
26	CYP3A4	NN	O	cyp3a4	dobj	25	SENT_81	[p5l371t295r669b367],
27	,	,	O	,	_	0	SENT_81	[p5l371t295r669b367],
28	but	CC	O	but	_	0	SENT_81	[p5l702t291r813b355],
29	that	IN	O	that	complm	39	SENT_81	[p5l835t291r974b355],
30	only	RB	O	only	quantmod	31	SENT_81	[p5l999t291r1144b376],
31	25	CD	PERCENT	25	num	33	SENT_81	[p5l1169t296r1244b355],
32	percent	NN	PERCENT	percent	nn	33	SENT_81	[p5l1278t303r1540b375],
33	ofwhites	NNS	O	ofwhite	nsubj	39	SENT_81	[p5l1565t290r1879b355],
34	and	CC	O	and	_	0	SENT_81	[p5l1908t291r2032b355],
35	50	CD	PERCENT	50	num	36	SENT_81	[p5l82t403r163b464],
36	percent	NN	PERCENT	percent	conj_and	33	SENT_81	[p5l189t412r450b484],
37	of	IN	O	of	_	0	SENT_81	[p5l472t398r549b464],
38	blacks	NNS	O	black	prep_of	36	SENT_81	[p5l564t399r776b464],
39	express	VBP	O	express	conj_but	25	SENT_81	[p5l801t422r1063b484],
40	functional	JJ	O	functional	amod	41	SENT_81	[p5l1087t398r1439b464],
41	CYP3A5	NN	O	cyp3a5	dobj	39	SENT_81	[p5l1467t403r1742b464],
42	because	IN	O	because	_	0	SENT_81	[p5l1774t399r2056b464],
43	ofgenetic	JJ	O	ofgenetic	amod	44	SENT_81	[p5l81t507r425b593],
44	polymorphism	NN	O	polymorphism	prep_because	39	SENT_81	[p5l454t507r987b593],
45	.	.	O	.	_	0	SENT_81	[p5l454t507r987b593],

1	The	DT	O	the	det	3	SENT_82	[p5l1013t507r1144b572],
2	solid	JJ	O	solid	amod	3	SENT_82	[p5l1172t507r1334b572],
3	area	NN	O	area	nsubj	4	SENT_82	[p5l1365t530r1508b572],
4	reﬂects	VBZ	O	reﬂects	_	0	SENT_82	[p5l1540t507r1787b572],
5	the	DT	O	the	det	7	SENT_82	[p5l1813t507r1923b572],
6	combined	JJ	O	combined	amod	7	SENT_82	[p5l81t615r430b680],
7	activity	NN	O	activity	dobj	4	SENT_82	[p5l461t621r706b700],
8	of	IN	O	of	_	0	SENT_82	[p5l730t614r807b680],
9	CYP3A4	NN	O	cyp3a4	prep_of	7	SENT_82	[p5l821t620r1100b680],
10	and	CC	O	and	_	0	SENT_82	[p5l1128t615r1252b680],
11	CYP3A5	NN	O	cyp3a5	prep_of	7	SENT_82	[p5l1283t620r1557b680],
12	in	IN	O	in	_	0	SENT_82	[p5l1591t621r1647b679],
13	the	DT	O	the	det	15	SENT_82	[p5l1674t615r1784b680],
14	two	CD	NUMBER	two	num	15	SENT_82	[p5l1809t627r1935b680],
15	populations	NNS	O	population	prep_in	4	SENT_82	[p5l85t723r502b808],
16	for	IN	O	for	_	0	SENT_82	[p5l527t722r625b789],
17	medications	NNS	O	medication	prep_for	15	SENT_82	[p5l651t723r1081b789],
18	that	WDT	O	that	nsubjpass	20	SENT_82	[p5l1106t723r1246b789],
19	are	VBP	O	be	auxpass	20	SENT_82	[p5l1270t747r1374b789],
20	metabolized	VBN	O	metabolize	rcmod	17	SENT_82	[p5l1403t723r1832b789],
21	equally	RB	O	equally	advmod	20	SENT_82	[p5l1861t723r2073b808, p5l84t831r133b917],
22	by	IN	O	by	_	0	SENT_82	[p5l160t831r233b917],
23	the	DT	O	the	det	25	SENT_82	[p5l255t831r365b897],
24	two	CD	NUMBER	two	num	25	SENT_82	[p5l389t844r515b897],
25	enzymes	NNS	O	enzyme	agent	20	SENT_82	[p5l542t855r870b917],
26	.	.	O	.	_	0	SENT_82	[p5l542t855r870b917],

1	determine	VB	O	determine	ccomp	30	SENT_83	[p5l14t1236r442b1315],
2	which	WDT	O	which	dep	4	SENT_83	[p5l470t1237r730b1316],
3	patients	NNS	O	patient	nsubj	4	SENT_83	[p5l761t1237r1096b1337],
4	express	VBP	O	express	dep	1	SENT_83	[p5l1131t1263r1443b1337],
5	both	CC	O	both	dep	4	SENT_83	[p5l1479t1237r1671b1315],
6	ﬁinctional	JJ	O	ﬁinctional	amod	7	SENT_83	[p5l1703t1236r2135b1316],
7	enzymes	NNS	O	enzyme	nsubj	8	SENT_83	[p5l14t1390r370b1465],
8	(	VBP	O	(	conj	4	SENT_83	[p5l396t1365r571b1460],
9	i.e.	FW	O	i.e.	dobj	8	SENT_83	[p5l396t1365r571b1460],
10	,	,	O	,	_	0	SENT_83	[p5l396t1365r571b1460],
11	CYP3A4	NN	O	cyp3a4	dobj	8	SENT_83	[p5l596t1370r929b1443],
12	and	CC	O	and	_	0	SENT_83	[p5l948t1365r1101b1443],
13	CYP3A5	NN	O	cyp3a5	nn	14	SENT_83	[p5l1120t1370r1508b1460],
14	)	NN	O	)	conj_and	9	SENT_83	[p5l1120t1370r1508b1460],
15	,	,	O	,	_	0	SENT_83	[p5l1120t1370r1508b1460],
16	the	DT	O	the	det	18	SENT_83	[p5l1534t1365r1661b1443],
17	clinical	JJ	O	clinical	amod	18	SENT_83	[p5l1681t1365r1974b1443],
18	importance	NN	O	importance	nsubj	30	SENT_83	[p5l1993t1365r2134b1442, p5l11t1509r377b1593],
19	of	IN	O	of	_	0	SENT_83	[p5l408t1492r508b1571],
20	these	DT	O	these	det	21	SENT_83	[p5l521t1493r739b1571],
21	variants	NNS	O	variant	prep_of	18	SENT_83	[p5l766t1493r1096b1572],
22	for	IN	O	for	_	0	SENT_83	[p5l1130t1492r1252b1571],
23	the	DT	O	the	det	25	SENT_83	[p5l1281t1492r1410b1571],
24	many	JJ	O	many	amod	25	SENT_83	[p5l1441t1518r1675b1593],
25	drugs	NNS	O	drug	prep_for	21	SENT_83	[p5l1702t1493r1939b1593],
26	metabolized	VBN	O	metabolize	partmod	25	SENT_83	[p5l1972t1519r2133b1571, p5l14t1621r403b1699],
27	by	IN	O	by	_	0	SENT_83	[p5l429t1621r525b1721],
28	CYP3A	NN	O	cyp3a	agent	26	SENT_83	[p5l546t1626r833b1699],
29	remains	VBZ	O	remain	cop	30	SENT_83	[p5l855t1621r1194b1699],
30	unclear	JJ	O	unclear	_	0	SENT_83	[p5l1221t1621r1551b1700],
31	.	.	O	.	_	0	SENT_83	[p5l1221t1621r1551b1700],

1	onuc	NN	O	onuc	_	0	SENT_84	[p5l18t1905r245b1954],
2	;	:	O	;	_	0	SENT_84	[p5l18t1905r245b1954],
3	TRANSPORTERS	NNS	O	transporter	dep	1	SENT_84	[p5l285t1905r929b1954],

1	Transport	NN	O	transport	nn	2	SENT_85	[p5l10t2011r433b2105],
2	proteins	NNS	O	protein	nsubj	3	SENT_85	[p5l452t2006r800b2105],
3	have	VBP	O	have	_	0	SENT_85	[p5l828t2006r1015b2084],
4	an	DT	O	a	det	6	SENT_85	[p5l1042t2031r1141b2083],
5	important	JJ	O	important	amod	6	SENT_85	[p5l1167t2006r1600b2105],
6	role	NN	O	role	dobj	3	SENT_85	[p5l1620t2006r1781b2083],
7	in	IN	O	in	_	0	SENT_85	[p5l1806t2006r1887b2082],
8	regulating	VBG	O	regulate	prepc_in	6	SENT_85	[p5l1913t2031r2133b2105, p5l12t2134r254b2234],
9	the	DT	O	the	det	10	SENT_85	[p5l274t2134r401b2212],
10	absorption	NN	O	absorption	dobj	8	SENT_85	[p5l423t2134r901b2234],
11	,	,	O	,	_	0	SENT_85	[p5l423t2134r901b2234],
12	distribution	NN	O	distribution	conj_and	10	SENT_85	[p5l930t2134r1444b2229],
13	,	,	O	,	_	0	SENT_85	[p5l930t2134r1444b2229],
14	and	CC	O	and	_	0	SENT_85	[p5l1472t2133r1626b2212],
15	excretion	NN	O	excretion	conj_and	10	SENT_85	[p5l1649t2134r2031b2212],
16	of	IN	O	of	_	0	SENT_85	[p5l2054t2133r2154b2212],
17	many	JJ	O	many	amod	18	SENT_85	[p5l13t2287r250b2362],
18	medications	NNS	O	medication	prep_of	10	SENT_85	[p5l269t2261r822b2340],
19	.	.	O	.	_	0	SENT_85	[p5l269t2261r822b2340],

1	Members	NNS	O	member	_	0	SENT_86	[p5l849t2262r1252b2340],
2	of	IN	O	of	_	0	SENT_86	[p5l1279t2261r1381b2340],
3	the	DT	O	the	det	5	SENT_86	[p5l1387t2261r1518b2340],
4	adenosine	NN	O	adenosine	nn	5	SENT_86	[p5l1542t2262r1980b2340],
5	triphosphate	NN	O	triphosphate	prep_of	1	SENT_86	[p5l2006t2262r2132b2340, p5l11t2390r464b2490],
6	(	CD	NUMBER	(	num	8	SENT_86	[p5l494t2390r1118b2490],
7	ATP	NN	O	atp	nn	8	SENT_86	[p5l494t2390r1118b2490],
8	)	NN	O	)	dep	5	SENT_86	[p5l494t2390r1118b2490],
9	.	.	O	.	_	0	SENT_86	[p5l494t2390r1118b2490],

1	—	NN	O	—	_	0	SENT_87	[p5l494t2390r1118b2490],
2	.	.	O	.	_	0	SENT_87	[p5l494t2390r1118b2490],

1	binding	VBG	O	bind	amod	3	SENT_88	[p5l494t2390r1118b2490],
2	cassette	NN	O	cassette	nn	3	SENT_88	[p5l1141t2406r1467b2468],
3	family	NN	O	family	nsubj	7	SENT_88	[p5l1493t2389r1757b2490],
4	of	IN	O	of	_	0	SENT_88	[p5l1779t2389r1879b2468],
5	membrane	NN	O	membrane	nn	6	SENT_88	[p5l1885t2416r2133b2468, p5l14t2518r248b2595],
6	transporters	NNS	O	transporter	prep_of	3	SENT_88	[p5l270t2523r861b2617],
7	“	VBP	O	“	_	0	SENT_88	[p5l270t2523r861b2617],
8	are	VBP	O	be	ccomp	7	SENT_88	[p5l882t2543r1006b2595],
9	among	IN	O	among	_	0	SENT_88	[p5l1028t2542r1324b2617],
10	the	DT	O	the	prep_among	8	SENT_88	[p5l1343t2518r1470b2595],
11	most	RBS	O	most	advmod	10	SENT_88	[p5l1492t2533r1707b2595],
12	extensively	RB	O	extensively	advmod	13	SENT_88	[p5l1724t2518r2134b2596, p5l12t2646r82b2746],
13	studied	VBN	O	study	partmod	10	SENT_88	[p5l102t2646r409b2725],
14	transporters	NNS	O	transporter	dobj	13	SENT_88	[p5l431t2662r945b2746],
15	involved	VBN	O	involve	partmod	14	SENT_88	[p5l968t2645r1318b2725],
16	in	IN	O	in	_	0	SENT_88	[p5l1339t2646r1420b2723],
17	drug	NN	O	drug	nn	18	SENT_88	[p5l1443t2646r1642b2746],
18	disposition	NN	O	disposition	prep_in	15	SENT_88	[p5l1662t2645r2135b2746],
19	and	CC	O	and	_	0	SENT_88	[p5l12t2774r167b2852],
20	effects	NNS	O	effect	conj_and	18	SENT_88	[p5l193t2773r488b2852],
21	.	.	O	.	_	0	SENT_88	[p5l193t2773r488b2852],

1	A	DT	O	a	det	2	SENT_89	[p5l515t2781r581b2851],
2	member	NN	O	member	nsubjpass	16	SENT_89	[p5l604t2774r960b2852],
3	of	IN	O	of	_	0	SENT_89	[p5l983t2773r1083b2852],
4	the	DT	O	the	det	9	SENT_89	[p5l1090t2774r1219b2852],
5	ATP	NN	O	atp	nn	9	SENT_89	[p5l1240t2774r1785b2874],
6	—	NN	O	—	nn	9	SENT_89	[p5l1240t2774r1785b2874],
7	binding	NN	O	binding	nn	9	SENT_89	[p5l1240t2774r1785b2874],
8	cassette	NN	O	cassette	nn	9	SENT_89	[p5l1807t2790r2135b2852],
9	family	NN	O	family	prep_of	2	SENT_89	[p5l13t2901r289b3002],
10	,	,	O	,	_	0	SENT_89	[p5l13t2901r289b3002],
11	P	NN	O	p	nn	13	SENT_89	[p5l336t2902r977b3002],
12	—	CD	NUMBER	—	num	13	SENT_89	[p5l336t2902r977b3002],
13	glycoprotein	NN	O	glycoprotein	appos	9	SENT_89	[p5l336t2902r977b3002],
14	,	,	O	,	_	0	SENT_89	[p5l336t2902r977b3002],
15	is	VBZ	O	be	auxpass	16	SENT_89	[p5l1024t2902r1089b2980],
16	encoded	VBN	O	encode	_	0	SENT_89	[p5l1133t2902r1488b2980],
17	by	IN	O	by	_	0	SENT_89	[p5l1530t2902r1627b3002],
18	the	DT	O	the	det	22	SENT_89	[p5l1664t2902r1793b2980],
19	human	JJ	O	human	amod	22	SENT_89	[p5l1836t2902r2135b2981],
20	ABCB1	NN	O	abcb1	nn	22	SENT_89	[p5l6t3035r271b3108],
21	gene	NN	O	gene	nn	22	SENT_89	[p5l307t3055r506b3130],
22	(	NN	O	(	agent	16	SENT_89	[p5l544t3030r741b3121],
23	also	RB	O	also	advmod	24	SENT_89	[p5l544t3030r741b3121],
24	called	VBD	O	call	partmod	22	SENT_89	[p5l776t3029r1019b3108],
25	MDR1	NN	O	mdr1	nn	26	SENT_89	[p5l1051t3037r1372b3121],
26	)	NN	O	)	dobj	24	SENT_89	[p5l1051t3037r1372b3121],
27	.	.	O	.	_	0	SENT_89	[p5l1051t3037r1372b3121],

1	A	DT	O	a	det	3	SENT_90	[p5l1408t3037r1474b3107],
2	principal	JJ	O	principal	amod	3	SENT_90	[p5l1503t3030r1881b3130],
3	function	NN	O	function	nsubj	12	SENT_90	[p5l1914t3029r2132b3109, p5l14t3158r179b3236],
4	of	IN	O	of	_	0	SENT_90	[p5l204t3157r305b3236],
5	P-glycoprotein	NN	O	p-glycoprotein	prep_of	3	SENT_90	[p5l310t3158r928b3258],
6	is	VBZ	O	be	cop	12	SENT_90	[p5l953t3158r1017b3236],
7	the	DT	O	the	det	12	SENT_90	[p5l1044t3158r1174b3236],
8	energy	NN	O	energy	nn	12	SENT_90	[p5l1199t3157r1967b3258],
9	—	NN	O	—	nn	12	SENT_90	[p5l1199t3157r1967b3258],
10	dependent	JJ	O	dependent	amod	12	SENT_90	[p5l1199t3157r1967b3258],
11	cellular	JJ	O	cellular	amod	12	SENT_90	[p5l1988t3158r2133b3236, p5l12t3285r201b3365],
12	efﬂux	NN	O	efﬂux	_	0	SENT_90	[p5l219t3285r453b3365],
13	of	IN	O	of	_	0	SENT_90	[p5l471t3285r570b3364],
14	substrates	NNS	O	substrate	prep_of	12	SENT_90	[p5l573t3286r1012b3381],
15	,	,	O	,	_	0	SENT_90	[p5l573t3286r1012b3381],
16	including	VBG	O	include	_	0	SENT_90	[p5l1037t3286r1435b3386],
17	bilirubin	NN	O	bilirubin	prep_including	12	SENT_90	[p5l1452t3286r1832b3381],
18	,	,	O	,	_	0	SENT_90	[p5l1452t3286r1832b3381],
19	several	JJ	O	several	amod	21	SENT_90	[p5l1859t3286r2136b3364],
20	anticancer	JJ	O	anticancer	amod	21	SENT_90	[p5l12t3414r452b3492],
21	drugs	NNS	O	drug	appos	17	SENT_90	[p5l475t3414r738b3514],
22	,	,	O	,	_	0	SENT_90	[p5l475t3414r738b3514],
23	cardiac	JJ	O	cardiac	amod	24	SENT_90	[p5l769t3414r1068b3492],
24	glycosides	NNS	O	glycoside	appos	17	SENT_90	[p5l1092t3413r1551b3514],
25	,	,	O	,	_	0	SENT_90	[p5l1092t3413r1551b3514],
26	immunosup	JJ	O	immunosup	amod	29	SENT_90	[p5l1582t3414r2133b3514],
27	—	NN	O	—	nn	29	SENT_90	[p5l1582t3414r2133b3514],
28	pressive	JJ	O	pressive	amod	29	SENT_90	[p5l11t3542r350b3641],
29	agents	NNS	O	agent	appos	17	SENT_90	[p5l375t3558r674b3641],
30	,	,	O	,	_	0	SENT_90	[p5l375t3558r674b3641],
31	glucocorticoids	NNS	O	glucocorticoid	appos	17	SENT_90	[p5l704t3542r1381b3641],
32	,	,	O	,	_	0	SENT_90	[p5l704t3542r1381b3641],
33	human	JJ	O	human	amod	41	SENT_90	[p5l1412t3542r1711b3620],
34	immuno	NN	O	immuno	nn	41	SENT_90	[p5l1736t3542r2133b3620],
35	—	NN	O	—	nn	41	SENT_90	[p5l1736t3542r2133b3620],
36	deﬁciency	NN	O	deﬁciency	nn	41	SENT_90	[p5l14t3669r429b3770],
37	virus	NN	O	virus	nn	41	SENT_90	[p5l439t3670r638b3749],
38	(	CD	NUMBER	(	num	41	SENT_90	[p5l664t3677r884b3761],
39	HIV	NN	MISC	hiv	nn	41	SENT_90	[p5l664t3677r884b3761],
40	)	NN	O	)	nn	41	SENT_90	[p5l664t3677r884b3761],
41	type	NN	O	type	appos	17	SENT_90	[p5l909t3686r1076b3770],
42	1	CD	NUMBER	1	num	44	SENT_90	[p5l1099t3675r1143b3747],
43	protease	NN	O	protease	nn	44	SENT_90	[p5l1162t3686r1511b3770],
44	inhibitors	NNS	O	inhibitor	dep	41	SENT_90	[p5l1530t3670r1958b3765],
45	,	,	O	,	_	0	SENT_90	[p5l1530t3670r1958b3765],
46	and	CC	O	and	_	0	SENT_90	[p5l1982t3670r2136b3748],
47	many	JJ	O	many	amod	49	SENT_90	[p6l13t46r244b120],
48	other	JJ	O	other	amod	49	SENT_90	[p6l262t21r482b98],
49	medications	NNS	O	medication	nsubj	50	SENT_90	[p6l501t21r1007b98],
50	(	VBP	O	(	conj_and	12	SENT_90	[p6l1035t21r1215b120],
51	Fig	NN	O	fig	dobj	50	SENT_90	[p6l1035t21r1215b120],
52	.	.	O	.	_	0	SENT_90	[p6l1035t21r1215b120],

1	3	CD	NUMBER	3	num	2	SENT_91	[p6l1243t26r1635b111],
2	)	NN	O	)	nsubj	15	SENT_91	[p6l1243t26r1635b111],
3	.17	CD	NUMBER	.17	num	4	SENT_91	[p6l1243t26r1635b111],
4	v21	NN	O	v21	dep	2	SENT_91	[p6l1243t26r1635b111],
5	»	CD	NUMBER	»	number	6	SENT_91	[p6l1243t26r1635b111],
6	22	CD	NUMBER	22	num	8	SENT_91	[p6l1243t26r1635b111],
7	The	DT	O	the	det	8	SENT_91	[p6l1654t21r1813b98],
8	expression	NN	O	expression	dep	2	SENT_91	[p6l1836t46r2134b120, p6l15t149r189b227],
9	of	IN	O	of	_	0	SENT_91	[p6l212t148r313b227],
10	P-glycoprotein	NN	O	p-glycoprotein	prep_of	8	SENT_91	[p6l315t149r934b249],
11	in	IN	O	in	_	0	SENT_91	[p6l957t149r1038b226],
12	many	JJ	O	many	amod	14	SENT_91	[p6l1061t174r1295b249],
13	normal	JJ	O	normal	amod	14	SENT_91	[p6l1314t149r1621b227],
14	tissues	NNS	O	tissue	prep_in	10	SENT_91	[p6l1645t149r1927b228],
15	suggests	VBZ	O	suggest	_	0	SENT_91	[p6l1954t175r2133b249, p6l12t293r221b377],
16	that	IN	O	that	complm	18	SENT_91	[p6l244t277r409b355],
17	it	PRP	O	it	nsubj	18	SENT_91	[p6l424t277r483b355],
18	has	VBZ	O	have	ccomp	15	SENT_91	[p6l498t277r638b355],
19	a	DT	O	a	det	20	SENT_91	[p6l659t303r704b355],
20	role	NN	O	role	dobj	18	SENT_91	[p6l722t277r881b355],
21	in	IN	O	in	_	0	SENT_91	[p6l901t277r982b354],
22	the	DT	O	the	det	24	SENT_91	[p6l1002t277r1130b355],
23	excretion	NN	O	excretion	nn	24	SENT_91	[p6l1151t277r1533b355],
24	ofxenobiotics	NNS	O	ofxenobiotic	prep_in	20	SENT_91	[p6l1555t276r2133b355],
25	and	CC	O	and	_	0	SENT_91	[p6l12t404r167b482],
26	metabolites	NNS	O	metabolite	prep_in	20	SENT_91	[p6l196t404r689b482],
27	into	IN	O	into	_	0	SENT_91	[p6l720t404r885b482],
28	urine	NN	O	urine	prep_into	18	SENT_91	[p6l914t404r1157b498],
29	,	,	O	,	_	0	SENT_91	[p6l914t404r1157b498],
30	bile	NN	O	bile	appos	28	SENT_91	[p6l1191t404r1367b498],
31	,	,	O	,	_	0	SENT_91	[p6l1191t404r1367b498],
32	and	CC	O	and	_	0	SENT_91	[p6l1400t404r1555b482],
33	the	DT	O	the	det	35	SENT_91	[p6l1584t404r1714b481],
34	intestinal	JJ	O	intestinal	amod	35	SENT_91	[p6l1742t404r2135b481],
35	lumen.-7-3	NN	O	lumen.-7-3	conj_and	18	SENT_91	[p6l12t532r496b611],
36	»	CD	NUMBER	»	num	35	SENT_91	[p6l12t532r496b611],
37	-7	CD	NUMBER	-7	num	38	SENT_91	[p6l12t532r496b611],
38	-4	CD	NUMBER	-4	npadvmod	39	SENT_91	[p6l12t532r496b611],
39	At	IN	O	at	dep	35	SENT_91	[p6l542t539r640b610],
40	the	DT	O	the	det	44	SENT_91	[p6l686t532r815b610],
41	blood	NN	O	blood	nn	44	SENT_91	[p6l867t531r1385b610],
42	—	NN	O	—	nn	44	SENT_91	[p6l867t531r1385b610],
43	brain	NN	O	brain	nn	44	SENT_91	[p6l867t531r1385b610],
44	barrier	NN	O	barrier	pobj	39	SENT_91	[p6l1436t532r1737b627],
45	,	,	O	,	_	0	SENT_91	[p6l1436t532r1737b627],
46	Pglycoprotein	NN	PERSON	pglycoprotein	nsubj	51	SENT_91	[p6l1792t532r2133b632, p6l11t660r324b760],
47	in	IN	O	in	_	0	SENT_91	[p6l347t660r429b737],
48	the	DT	O	the	det	50	SENT_91	[p6l453t660r584b738],
49	choroid	NN	O	choroid	nn	50	SENT_91	[p6l609t660r941b738],
50	plexus	NN	O	plexus	prep_in	46	SENT_91	[p6l963t660r1238b760],
51	limits	VBZ	O	limit	ccomp	15	SENT_91	[p6l1262t660r1506b738],
52	the	DT	O	the	det	53	SENT_91	[p6l1533t660r1663b738],
53	accumulaFigure	NN	O	accumulafigure	dobj	51	SENT_91	[p6l1686t660r2132b739, p6l90t1051r306b1133],

1	3	CD	NUMBER	3	num	2	SENT_92	[p6l331t1055r365b1113],
2	(	NN	O	(	_	0	SENT_92	[p6l398t1048r632b1134],
3	facing	VBG	O	face	partmod	2	SENT_92	[p6l398t1048r632b1134],
4	page	NN	O	page	nn	5	SENT_92	[p6l658t1055r868b1134],
5	)	NN	O	)	dobj	3	SENT_92	[p6l658t1055r868b1134],
6	.	.	O	.	_	0	SENT_92	[p6l658t1055r868b1134],

1	Functional	JJ	O	functional	amod	2	SENT_93	[p6l899t1049r1260b1114],
2	Consequences	NNS	O	consequence	nsubj	11	SENT_93	[p6l1287t1054r1796b1132],
3	of	IN	O	of	_	0	SENT_93	[p6l1820t1048r1901b1114],
4	Genetic	JJ	O	genetic	amod	5	SENT_93	[p6l85t1158r356b1221],
5	Polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_93	[p6l383t1156r930b1242],
6	in	IN	O	in	_	0	SENT_93	[p6l958t1158r1016b1220],
7	the	DT	O	the	det	10	SENT_93	[p6l1042t1157r1154b1221],
8	Human	JJ	O	human	amod	10	SENT_93	[p6l1182t1163r1442b1221],
9	P-Glycoprotein	NN	O	p-glycoprotein	nn	10	SENT_93	[p6l1475t1157r1988b1242],
10	Transporter	NN	O	transporter	prep_in	5	SENT_93	[p6l83t1270r491b1348],
11	Gene	NN	O	gene	_	0	SENT_93	[p6l512t1269r697b1328],
12	ABCB1	NN	O	abcb1	dobj	11	SENT_93	[p6l716t1269r959b1328],
13	(	CD	NUMBER	(	num	12	SENT_93	[p6l993t1270r1087b1349],
14	or	CC	O	or	_	0	SENT_93	[p6l993t1270r1087b1349],
15	MDR1	NN	O	mdr1	nn	16	SENT_93	[p6l1112t1270r1381b1349],
16	)	NN	O	)	conj_or	12	SENT_93	[p6l1112t1270r1381b1349],
17	.	.	O	.	_	0	SENT_93	[p6l1112t1270r1381b1349],

1	The	DT	O	the	det	6	SENT_94	[p6l83t1393r212b1457],
2	schematic	JJ	O	schematic	amod	6	SENT_94	[p6l235t1393r591b1457],
3	diagram	NN	O	diagram	nn	6	SENT_94	[p6l611t1393r895b1478],
4	ofthe	NN	O	ofthe	nn	6	SENT_94	[p6l921t1392r1112b1457],
5	human	JJ	O	human	amod	6	SENT_94	[p6l1136t1393r1376b1457],
6	P-glycoprotein	NN	MISC	p-glycoprotein	nsubjpass	8	SENT_94	[p6l1406t1393r1902b1478],
7	was	VBD	O	be	auxpass	8	SENT_94	[p6l1923t1415r2055b1457],
8	adapted	VBN	O	adapt	_	0	SENT_94	[p6l87t1500r364b1585],
9	from	IN	O	from	_	0	SENT_94	[p6l392t1499r555b1565],
10	Kim	NNP	PERSON	Kim	nsubj	17	SENT_94	[p6l591t1506r719b1564],
11	et	FW	O	et	nn	12	SENT_94	[p6l748t1512r810b1565],
12	al.	FW	O	al.	dep	10	SENT_94	[p6l836t1500r1001b1576],
13	,18	CD	NUMBER	,18	dep	10	SENT_94	[p6l836t1500r1001b1576],
14	with	IN	O	with	_	0	SENT_94	[p6l1024t1500r1168b1565],
15	each	DT	O	each	det	16	SENT_94	[p6l1198t1500r1354b1565],
16	circle	NN	O	circle	prep_with	13	SENT_94	[p6l1383t1500r1564b1565],
17	representing	VBG	O	represent	prepc_from	8	SENT_94	[p6l1594t1506r2034b1586],
18	an	DT	O	a	det	20	SENT_94	[p6l87t1631r163b1672],
19	amino	NN	O	amino	nn	20	SENT_94	[p6l194t1614r415b1672],
20	acid	NN	O	acid	nsubj	26	SENT_94	[p6l442t1608r578b1672],
21	and	CC	O	and	_	0	SENT_94	[p6l609t1608r732b1672],
22	each	DT	O	each	det	23	SENT_94	[p6l761t1608r917b1672],
23	color	NN	O	color	nsubj	26	SENT_94	[p6l947t1608r1123b1672],
24	a	DT	O	a	det	26	SENT_94	[p6l1147t1631r1180b1672],
25	different	JJ	O	different	amod	26	SENT_94	[p6l1207t1607r1501b1672],
26	exon	NN	O	exon	xcomp	17	SENT_94	[p6l1526t1631r1683b1672],
27	encoding	VBG	O	encode	partmod	26	SENT_94	[p6l1713t1608r2037b1693],
28	the	DT	O	the	det	31	SENT_94	[p6l83t1715r193b1779],
29	corresponding	JJ	O	corresponding	amod	31	SENT_94	[p6l218t1715r732b1800],
30	amino	NN	O	amino	nn	31	SENT_94	[p6l757t1721r977b1779],
31	acids	NNS	O	acid	dobj	27	SENT_94	[p6l1005t1715r1201b1779],
32	.	.	O	.	_	0	SENT_94	[p6l1005t1715r1201b1779],

1	Two	CD	NUMBER	two	num	3	SENT_95	[p6l1227t1721r1366b1779],
2	single-nucleotide	JJ	O	single-nucleotide	amod	3	SENT_95	[p6l1394t1715r1993b1800],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	11	SENT_95	[p6l90t1823r636b1907],
4	in	IN	O	in	_	0	SENT_95	[p6l665t1828r720b1886],
5	the	DT	O	the	det	8	SENT_95	[p6l745t1823r854b1887],
6	human	JJ	O	human	amod	8	SENT_95	[p6l881t1823r1121b1887],
7	ABCB1	NN	O	abcb1	nn	8	SENT_95	[p6l1145t1827r1386b1887],
8	gene	NN	O	gene	prep_in	3	SENT_95	[p6l1415t1845r1579b1908],
9	have	VBP	O	have	aux	11	SENT_95	[p6l1606t1823r1762b1887],
10	been	VBN	O	be	auxpass	11	SENT_95	[p6l1789t1823r1948b1887],
11	associated	VBN	O	associate	_	0	SENT_95	[p6l1977t1845r2072b1887, p6l87t1930r374b1995],
12	with	IN	O	with	_	0	SENT_95	[p6l400t1930r545b1995],
13	altered	JJ	O	altered	amod	15	SENT_95	[p6l575t1930r809b1994],
14	drug	NN	O	drug	nn	15	SENT_95	[p6l838t1930r999b2015],
15	disposition	NN	O	disposition	prep_with	11	SENT_95	[p6l1024t1930r1412b2014],
16	(	CD	NUMBER	(	num	17	SENT_95	[p6l1449t1930r1699b2015],
17	Panels	NNPS	O	Panels	nsubj	31	SENT_95	[p6l1449t1930r1699b2015],
18	A	DT	O	a	amod	17	SENT_95	[p6l1725t1934r1791b2006],
19	,	,	O	,	_	0	SENT_95	[p6l1725t1934r1791b2006],
20	B	NN	O	b	dep	18	SENT_95	[p6l1826t1936r1884b2006],
21	,	,	O	,	_	0	SENT_95	[p6l1826t1936r1884b2006],
22	C	NN	O	c	dep	20	SENT_95	[p6l1913t1935r1977b2006],
23	,	,	O	,	_	0	SENT_95	[p6l1913t1935r1977b2006],
24	and	CC	O	and	_	0	SENT_95	[p6l87t2037r210b2101],
25	E	NN	O	e	nsubj	31	SENT_95	[p6l245t2043r304b2122],
26	)	CD	NUMBER	)	num	25	SENT_95	[p6l245t2043r304b2122],
27	or	CC	O	or	_	0	SENT_95	[p6l337t2060r409b2101],
28	altered	VBN	O	alter	amod	30	SENT_95	[p6l433t2037r666b2102],
29	drug	NN	O	drug	nn	30	SENT_95	[p6l696t2037r857b2122],
30	effects	NNS	O	effect	conj_or	25	SENT_95	[p6l881t2037r1105b2102],
31	(	VBP	O	(	rcmod	15	SENT_95	[p6l1141t2037r1351b2122],
32	Panel	NN	O	panel	nn	33	SENT_95	[p6l1141t2037r1351b2122],
33	D	NN	O	d	dobj	31	SENT_95	[p6l1386t2043r1485b2122],
34	)	CD	NUMBER	)	num	33	SENT_95	[p6l1386t2043r1485b2122],
35	.	.	O	.	_	0	SENT_95	[p6l1386t2043r1485b2122],

1	The	DT	O	the	dep	147	SENT_96	[p6l1511t2037r1641b2101],
2	synonymous	JJ	O	synonymous	dep	147	SENT_96	[p6l1668t2060r1931b2122, p6l90t2167r281b2210],
3	single-nucleotide	JJ	O	single-nucleotide	dep	147	SENT_96	[p6l311t2145r910b2230],
4	polymorphism	NN	O	polymorphism	dep	147	SENT_96	[p6l940t2145r1447b2229],
5	(	NN	O	(	dep	147	SENT_96	[p6l1484t2150r1541b2229],
6	a	DT	O	a	dep	147	SENT_96	[p6l1484t2150r1541b2229],
7	singlenucleotide	NN	O	singlenucleotide	dep	147	SENT_96	[p6l1570t2145r2059b2230, p6l83t2252r214b2317],
8	polymorphism	NN	O	polymorphism	dep	147	SENT_96	[p6l244t2252r751b2337],
9	that	WDT	O	that	dep	147	SENT_96	[p6l778t2252r916b2317],
10	does	VBZ	O	do	dep	147	SENT_96	[p6l940t2252r1103b2317],
11	not	RB	O	not	dep	147	SENT_96	[p6l1135t2265r1246b2317],
12	alter	VB	O	alter	dep	147	SENT_96	[p6l1271t2252r1425b2317],
13	the	DT	O	the	dep	147	SENT_96	[p6l1445t2252r1554b2317],
14	amino	NN	O	amino	dep	147	SENT_96	[p6l1582t2258r1801b2317],
15	acid	NN	O	acid	dep	147	SENT_96	[p6l1829t2252r1965b2317],
16	encoded	VBD	O	encode	dep	147	SENT_96	[p6l86t2359r407b2444],
17	)	CD	NUMBER	)	dep	147	SENT_96	[p6l86t2359r407b2444],
18	in	IN	O	in	dep	147	SENT_96	[p6l444t2365r499b2423],
19	exon	NN	O	exon	dep	147	SENT_96	[p6l529t2382r687b2424],
20	26	CD	NUMBER	26	dep	147	SENT_96	[p6l716t2365r796b2424],
21	(	CD	NUMBER	(	dep	147	SENT_96	[p6l829t2359r960b2444],
22	the	DT	O	the	dep	147	SENT_96	[p6l829t2359r960b2444],
23	3435C	NN	O	3435c	dep	147	SENT_96	[p6l988t2364r1338b2424],
24	—	CD	NUMBER	—	dep	147	SENT_96	[p6l988t2364r1338b2424],
25	>	JJR	O	>	dep	147	SENT_96	[p6l988t2364r1338b2424],
26	T	NN	O	t	dep	147	SENT_96	[p6l988t2364r1338b2424],
27	single-nucleotide	JJ	O	single-nucleotide	dep	147	SENT_96	[p6l1364t2359r1963b2444],
28	polymorphism	NN	O	polymorphism	dep	147	SENT_96	[p6l90t2467r624b2551],
29	)	NN	O	)	dep	147	SENT_96	[p6l90t2467r624b2551],
30	has	VBZ	O	have	dep	147	SENT_96	[p6l660t2467r774b2532],
31	been	VBN	O	be	dep	147	SENT_96	[p6l806t2467r965b2532],
32	associated	VBN	O	associate	dep	147	SENT_96	[p6l997t2467r1362b2532],
33	with	IN	O	with	dep	147	SENT_96	[p6l1390t2467r1533b2532],
34	higher	JJR	O	higher	dep	147	SENT_96	[p6l1566t2467r1786b2552],
35	oral	JJ	O	oral	dep	147	SENT_96	[p6l1810t2467r1935b2532],
36	bioavailability	NN	O	bioavailability	dep	147	SENT_96	[p6l89t2574r567b2659],
37	ofdigoxin	NN	O	ofdigoxin	dep	147	SENT_96	[p6l589t2574r928b2659],
38	in	IN	O	in	dep	147	SENT_96	[p6l959t2580r1015b2638],
39	patients	NNS	O	patient	dep	147	SENT_96	[p6l1047t2580r1323b2658],
40	homozygous	JJ	O	homozygous	dep	147	SENT_96	[p6l1353t2574r1801b2659],
41	for	IN	O	for	dep	147	SENT_96	[p6l1827t2574r1924b2639],
42	the	DT	O	the	dep	147	SENT_96	[p6l1944t2574r2053b2639],
43	T	NN	O	t	dep	147	SENT_96	[p6l83t2687r129b2745],
44	nucleotide	NN	O	nucleotide	dep	147	SENT_96	[p6l155t2681r519b2746],
45	(	CD	NUMBER	(	dep	147	SENT_96	[p6l552t2681r762b2766],
46	Panel	NN	O	panel	dep	147	SENT_96	[p6l552t2681r762b2766],
47	A	DT	O	a	dep	147	SENT_96	[p6l789t2686r839b2745],
48	[	NN	O	[	dep	147	SENT_96	[p6l865t2686r1047b2766],
49	Cmax	NN	O	cmax	dep	147	SENT_96	[p6l865t2686r1047b2766],
50	denotes	VBZ	O	denote	dep	147	SENT_96	[p6l1071t2681r1348b2746],
51	maximal	JJ	O	maximal	dep	147	SENT_96	[p6l1379t2681r1670b2746],
52	concentration	NN	O	concentration	dep	147	SENT_96	[p6l1699t2694r2069b2746, p6l83t2794r339b2873],
53	]	NN	O	]	dep	147	SENT_96	[p6l1699t2694r2069b2746, p6l83t2794r339b2873],
54	)	CD	NUMBER	)	dep	147	SENT_96	[p6l1699t2694r2069b2746, p6l83t2794r339b2873],
55	19	CD	NUMBER	19	dep	147	SENT_96	[p6l1699t2694r2069b2746, p6l83t2794r339b2873],
56	but	CC	O	but	dep	147	SENT_96	[p6l364t2789r474b2854],
57	lower	JJR	O	lower	dep	147	SENT_96	[p6l498t2789r684b2854],
58	plasma	NN	O	plasma	dep	147	SENT_96	[p6l707t2789r956b2873],
59	concentrations	NNS	O	concentration	dep	147	SENT_96	[p6l979t2795r1502b2854],
60	after	IN	O	after	dep	147	SENT_96	[p6l1526t2788r1683b2854],
61	oral	JJ	O	oral	dep	147	SENT_96	[p6l1702t2789r1828b2854],
62	doses	NNS	O	dose	dep	147	SENT_96	[p6l1854t2789r2055b2854],
63	offexofenadine	NN	O	offexofenadine	dep	147	SENT_96	[p6l86t2896r621b2961],
64	(	CD	NUMBER	(	dep	147	SENT_96	[p6l655t2896r865b2981],
65	Panel	NN	O	panel	dep	147	SENT_96	[p6l655t2896r865b2981],
66	B	NN	O	b	dep	147	SENT_96	[p6l900t2902r1038b2981],
67	)	CD	NUMBER	)	dep	147	SENT_96	[p6l900t2902r1038b2981],
68	18	CD	NUMBER	18	dep	147	SENT_96	[p6l900t2902r1038b2981],
69	and	CC	O	and	dep	147	SENT_96	[p6l1065t2896r1188b2961],
70	nelfinavir	NN	O	nelfinavir	dep	147	SENT_96	[p6l1221t2896r1544b2961],
71	(	CD	NUMBER	(	dep	147	SENT_96	[p6l1574t2896r1784b2981],
72	Panel	NN	O	panel	dep	147	SENT_96	[p6l1574t2896r1784b2981],
73	C	NN	O	c	dep	147	SENT_96	[p6l1815t2901r1983b2981],
74	)	CD	NUMBER	)	dep	147	SENT_96	[p6l1815t2901r1983b2981],
75	.2	NN	NUMBER	.2	dep	147	SENT_96	[p6l1815t2901r1983b2981],
76	°	NN	O	°	dep	147	SENT_96	[p6l1815t2901r1983b2981],
77	This	DT	O	this	dep	147	SENT_96	[p6l83t3003r230b3068],
78	single-nucleotide	JJ	O	single-nucleotide	dep	147	SENT_96	[p6l260t3003r859b3089],
79	polymorphism	NN	O	polymorphism	dep	147	SENT_96	[p6l888t3003r1395b3089],
80	has	VBZ	O	have	dep	147	SENT_96	[p6l1428t3003r1542b3068],
81	also	RB	O	also	dep	147	SENT_96	[p6l1571t3003r1709b3068],
82	been	VBN	O	be	dep	147	SENT_96	[p6l1739t3003r1899b3068],
83	linked	VBN	O	link	dep	147	SENT_96	[p6l89t3111r290b3176],
84	to	TO	O	to	dep	147	SENT_96	[p6l318t3123r385b3176],
85	better	JJR	O	better	dep	147	SENT_96	[p6l416t3111r617b3176],
86	CD4	NN	O	cd4	dep	147	SENT_96	[p6l641t3116r790b3176],
87	cell	NN	O	cell	dep	147	SENT_96	[p6l816t3111r926b3176],
88	recovery	NN	O	recovery	dep	147	SENT_96	[p6l959t3134r1247b3196],
89	in	IN	O	in	dep	147	SENT_96	[p6l1274t3117r1329b3175],
90	HIV-infected	JJ	O	hiv-infected	dep	147	SENT_96	[p6l1365t3110r1799b3176],
91	patients	NNS	O	patient	dep	147	SENT_96	[p6l1832t3134r1934b3195, p6l83t3225r278b3283],
92	who	WP	O	who	dep	147	SENT_96	[p6l302t3219r447b3283],
93	are	VBP	O	be	dep	147	SENT_96	[p6l474t3242r577b3283],
94	treated	VBN	O	treat	dep	147	SENT_96	[p6l600t3219r841b3283],
95	with	IN	O	with	dep	147	SENT_96	[p6l868t3218r1011b3283],
96	nelﬁnavir	NN	O	nelﬁnavir	dep	147	SENT_96	[p6l1044t3218r1367b3283],
97	and	CC	O	and	dep	147	SENT_96	[p6l1390t3218r1513b3283],
98	other	JJ	O	other	dep	147	SENT_96	[p6l1542t3219r1726b3283],
99	antiretroviral	JJ	O	antiretroviral	dep	147	SENT_96	[p6l1749t3225r2072b3283, p6l84t3326r226b3390],
100	agents	NNS	O	agent	dep	147	SENT_96	[p6l257t3338r484b3411],
101	(	VBP	O	(	dep	147	SENT_96	[p6l520t3326r730b3411],
102	Panel	NN	O	panel	dep	147	SENT_96	[p6l520t3326r730b3411],
103	D	NN	O	d	dep	147	SENT_96	[p6l765t3332r937b3411],
104	)	CD	NUMBER	)	dep	147	SENT_96	[p6l765t3332r937b3411],
105	.2	NN	NUMBER	.2	dep	147	SENT_96	[p6l765t3332r937b3411],
106	°	CD	NUMBER	°	dep	147	SENT_96	[p6l765t3332r937b3411],
107	The	DT	O	the	dep	147	SENT_96	[p6l957t3326r1087b3390],
108	single-nucleotide	JJ	O	single-nucleotide	dep	147	SENT_96	[p6l1114t3326r1714b3411],
109	polymorphism	NN	O	polymorphism	dep	147	SENT_96	[p6l90t3434r596b3518],
110	at	IN	O	at	dep	147	SENT_96	[p6l624t3446r687b3498],
111	nucleotide	NN	O	nucleotide	dep	147	SENT_96	[p6l712t3434r1074b3498],
112	2677	CD	DATE	2677	dep	147	SENT_96	[p6l1098t3439r1263b3498],
113	(	CD	NUMBER	(	dep	147	SENT_96	[p6l1294t3439r1528b3518],
114	G	NN	O	g	dep	147	SENT_96	[p6l1294t3439r1528b3518],
115	—	CD	NUMBER	—	dep	147	SENT_96	[p6l1294t3439r1528b3518],
116	>	JJR	O	>	dep	147	SENT_96	[p6l1294t3439r1528b3518],
117	T	NN	O	t	dep	147	SENT_96	[p6l1294t3439r1528b3518],
118	)	NN	O	)	dep	147	SENT_96	[p6l1294t3439r1528b3518],
119	has	VBZ	O	have	dep	147	SENT_96	[p6l1562t3434r1676b3498],
120	been	VBN	O	be	dep	147	SENT_96	[p6l1705t3434r1864b3498],
121	associated	VBN	O	associate	dep	147	SENT_96	[p6l1892t3456r2073b3498, p6l86t3541r290b3605],
122	with	IN	O	with	dep	147	SENT_96	[p6l314t3541r458b3605],
123	lower	JJR	O	lower	dep	147	SENT_96	[p6l489t3541r675b3605],
124	plasma	NN	O	plasma	dep	147	SENT_96	[p6l700t3541r948b3625],
125	fexofenadine	NN	O	fexofenadine	dep	147	SENT_96	[p6l972t3540r1420b3605],
126	concentrations	NNS	O	concentration	dep	147	SENT_96	[p6l1444t3547r1966b3605],
127	in	IN	O	in	dep	147	SENT_96	[p6l1995t3547r2051b3604],
128	patients	NNS	O	patient	dep	147	SENT_96	[p6l90t3654r365b3732],
129	homozygous	JJ	O	homozygous	dep	147	SENT_96	[p6l396t3648r844b3733],
130	for	IN	O	for	dep	147	SENT_96	[p6l870t3648r968b3712],
131	the	DT	O	the	dep	147	SENT_96	[p6l989t3648r1098b3712],
132	T	NN	O	t	dep	147	SENT_96	[p6l1121t3654r1167b3711],
133	nucleotide	NN	O	nucleotide	dep	147	SENT_96	[p6l1194t3648r1556b3712],
134	at	IN	O	at	dep	147	SENT_96	[p6l1583t3660r1645b3712],
135	position	NN	O	position	dep	147	SENT_96	[p6l1673t3654r1952b3732],
136	2677	CD	DATE	2677	dep	147	SENT_96	[p6l86t3761r251b3821],
137	(	CD	NUMBER	(	dep	147	SENT_96	[p6l285t3756r495b3834],
138	Panel	NN	O	panel	dep	147	SENT_96	[p6l285t3756r495b3834],
139	E	NN	O	e	dep	147	SENT_96	[p6l530t3761r685b3834],
140	)	CD	NUMBER	)	dep	147	SENT_96	[p6l530t3761r685b3834],
141	.18	CD	NUMBER	.18	dep	147	SENT_96	[p6l530t3761r685b3834],
142	The	DT	O	the	dep	147	SENT_96	[p6l708t3756r837b3820],
143	panels	NNS	O	panel	dep	147	SENT_96	[p6l868t3756r1089b3834],
144	have	VBP	O	have	dep	147	SENT_96	[p6l1120t3756r1277b3820],
145	been	VBN	O	be	dep	147	SENT_96	[p6l1306t3756r1465b3820],
146	adapted	VBN	O	adapt	dep	147	SENT_96	[p6l1496t3756r1774b3834],
147	from	IN	O	from	_	0	SENT_96	[p6l1802t3755r1965b3820],

1	Kim	NNP	PERSON	Kim	_	0	SENT_97	[p7l91t41r219b98],
2	et	FW	O	et	nn	4	SENT_97	[p7l248t6r311b100],
3	a	FW	O	a	nn	4	SENT_97	[p7l337t35r502b111],
4	|	NN	O	|	dep	1	SENT_97	[p7l337t35r502b111],
5	.	.	O	.	_	0	SENT_97	[p7l337t35r502b111],

1	,18	CD	NUMBER	,18	num	2	SENT_98	[p7l337t35r502b111],
2	I-loffmeyer	NN	O	i-loffmeyer	_	0	SENT_98	[p7l533t6r902b120],
3	et	FW	O	et	nn	4	SENT_98	[p7l924t48r987b100],
4	aI.	FW	O	ai.	dep	2	SENT_98	[p7l1012t35r1176b111],
5	,19	CD	NUMBER	,19	dep	4	SENT_98	[p7l1012t35r1176b111],
6	and	CC	O	and	_	0	SENT_98	[p7l1204t35r1327b100],
7	Fellay	NNP	PERSON	Fellay	dep	4	SENT_98	[p7l1363t35r1551b120],
8	et	FW	O	et	nn	12	SENT_98	[p7l1575t6r1637b100],
9	a	FW	O	a	nn	12	SENT_98	[p7l1663t35r1808b100],
10	|	FW	O	|	nn	12	SENT_98	[p7l1663t35r1808b100],
11	.2	NN	NUMBER	.2	nn	12	SENT_98	[p7l1663t35r1808b100],
12	°	NN	O	°	dep	2	SENT_98	[p7l1663t35r1808b100],

1	540	CD	NUMBER	540	num	4	SENT_99	[p7l149t297r205b320],
2	N	NN	O	n	nn	4	SENT_99	[p7l884t299r898b315],
3	ENGLJ	NN	O	englj	nn	4	SENT_99	[p7l913t299r997b321],
4	MED	NN	O	med	_	0	SENT_99	[p7l1012t299r1065b315],
5	348	CD	NUMBER	348	dep	4	SENT_99	[p7l1077t293r1148b321],
6	;	:	O	;	_	0	SENT_99	[p7l1077t293r1148b321],
7	6	CD	NUMBER	6	num	8	SENT_99	[p7l1077t293r1148b321],
8	WWW	NN	O	www	dep	4	SENT_99	[p7l1183t299r1303b321],
9	.	.	O	.	_	0	SENT_99	[p7l1183t299r1303b321],

1	NEj	NN	O	nej	nn	3	SENT_100	[p7l1183t299r1303b321],
2	M.ORG	NN	O	m.org	nn	3	SENT_100	[p7l1311t299r1394b315],
3	FEBRUARY	NN	DATE	february	_	0	SENT_100	[p7l1434t299r1561b315],
4	6	CD	DATE	6	dep	3	SENT_100	[p7l1574t293r1595b319],
5	,	,	DATE	,	_	0	SENT_100	[p7l1574t293r1595b319],
6	2003	CD	DATE	2003	appos	4	SENT_100	[p7l1608t299r1672b321],

1	The	DT	O	the	det	4	SENT_101	[p7l935t332r986b356],
2	New	NNP	O	New	nn	4	SENT_101	[p7l995t333r1057b356],
3	England	NNP	O	England	nn	4	SENT_101	[p7l1066t332r1177b363],
4	Journal	NNP	O	Journal	_	0	SENT_101	[p7l1186t332r1283b356],
5	of	IN	O	of	_	0	SENT_101	[p7l1293t332r1322b356],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_101	[p7l1329t332r1454b356],

1	Downloaded	VBN	O	download	_	0	SENT_102	[p7l377t373r547b396],
2	from	IN	O	from	_	0	SENT_102	[p7l556t373r620b396],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_102	[p7l629t373r747b403],
4	at	IN	O	at	_	0	SENT_102	[p7l757t377r781b396],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_102	[p7l789t373r972b396],
6	on	IN	O	on	_	0	SENT_102	[p7l981t380r1014b396],
7	January	NNP	DATE	January	prep_on	1	SENT_102	[p7l1022t373r1125b403],
8	5	CD	DATE	5	num	7	SENT_102	[p7l1135t373r1158b400],
9	,	,	DATE	,	_	0	SENT_102	[p7l1135t373r1158b400],
10	2014	CD	DATE	2014	num	7	SENT_102	[p7l1168t373r1241b396],
11	.	.	O	.	_	0	SENT_102	[p7l1168t373r1241b396],

1	For	IN	O	for	_	0	SENT_103	[p7l1251t373r1298b396],
2	personal	JJ	O	personal	amod	3	SENT_103	[p7l1306t373r1418b403],
3	use	NN	O	use	pobj	1	SENT_103	[p7l1427t380r1471b396],
4	only	RB	O	only	advmod	3	SENT_103	[p7l1481t373r1545b403],
5	.	.	O	.	_	0	SENT_103	[p7l1481t373r1545b403],

1	No	DT	O	no	det	3	SENT_104	[p7l1556t373r1596b396],
2	other	JJ	O	other	amod	3	SENT_104	[p7l1606t373r1674b396],
3	uses	NNS	O	use	_	0	SENT_104	[p7l1682t380r1738b396],
4	without	IN	O	without	_	0	SENT_104	[p7l1748t373r1849b396],
5	permission	NN	O	permission	prep_without	3	SENT_104	[p7l1858t373r2010b403],
6	.	.	O	.	_	0	SENT_104	[p7l1858t373r2010b403],

1	Copyright	NN	O	copyright	_	0	SENT_105	[p7l727t414r862b445],
2	©	CD	NUMBER	©	num	6	SENT_105	[p7l871t414r895b438],
3	2003	CD	DATE	2003	num	6	SENT_105	[p7l905t414r969b438],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_105	[p7l979t414r1171b438],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_105	[p7l1180t414r1288b438],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_105	[p7l1299t414r1404b445],
7	.	.	O	.	_	0	SENT_105	[p7l1299t414r1404b445],

1	All	DT	O	all	det	2	SENT_106	[p7l1415t414r1456b438],
2	rights	NNS	O	rights	nsubj	3	SENT_106	[p7l1465t414r1540b445],
3	reserved	VBN	O	reserve	_	0	SENT_106	[p7l1550t414r1669b438],
4	.	.	O	.	_	0	SENT_106	[p7l1550t414r1669b438],

1	D	NN	O	d	nn	2	SENT_107	[p7l807t460r827b479],
2	RUG	NN	O	rug	_	0	SENT_107	[p7l833t460r902b479],
3	T	NN	O	t	nn	6	SENT_107	[p7l914t460r932b479],
4	H	NN	O	h	nn	6	SENT_107	[p7l937t460r959b479],
5	E	NN	O	e	nn	6	SENT_107	[p7l965t460r981b479],
6	RAPY	NN	O	rapy	dep	2	SENT_107	[p7l986t460r1067b479],

1	Fexofenadine	NN	O	fexofenadine	_	0	SENT_108	[p7l1357t592r1557b621],

1	Digoxin	NN	O	digoxin	nn	2	SENT_109	[p7l123t893r158b1006],
2	Cmax	NN	O	cmax	_	0	SENT_109	[p7l123t816r157b880],
3	(	CD	NUMBER	(	num	4	SENT_109	[p7l121t668r158b801],
4	yg/liter	NN	O	yg/liter	dep	2	SENT_109	[p7l121t668r158b801],
5	)	CD	NUMBER	)	num	7	SENT_109	[p7l121t668r158b801],
6	Plasma	NN	O	plasma	nn	7	SENT_109	[p7l980t822r1008b930],
7	Drug	NN	O	drug	dep	4	SENT_109	[p7l982t733r1017b807],
8	Concentration	NN	O	concentration	nn	11	SENT_109	[p7l1024t792r1050b1008],
9	(	CD	NUMBER	(	num	11	SENT_109	[p7l1021t661r1059b775],
10	ng/ml	NN	O	ng/ml	nn	11	SENT_109	[p7l1021t661r1059b775],
11	)	NN	O	)	dep	2	SENT_109	[p7l1021t661r1059b775],

1	Time	NNP	O	Time	_	0	SENT_110	[p7l1374t1124r1452b1150],
2	(	CD	NUMBER	(	num	1	SENT_110	[p7l1467t1121r1518b1159],
3	hr	NN	DURATION	hr	nn	5	SENT_110	[p7l1467t1121r1518b1159],
4	)	NN	O	)	nn	5	SENT_110	[p7l1467t1121r1518b1159],
5	3435C	NN	O	3435c	dep	1	SENT_110	[p7l910t1164r1055b1187],
6	—	CD	NUMBER	—	dep	5	SENT_110	[p7l910t1164r1055b1187],
7	>	JJR	O	>	amod	9	SENT_110	[p7l910t1164r1055b1187],
8	T	NN	O	t	nn	9	SENT_110	[p7l910t1164r1055b1187],
9	I1145I	NN	O	i1145us	dep	1	SENT_110	[p7l937t1202r1026b1225],

1	Nelfinavir	NNP	O	Nelfinavir	_	0	SENT_111	[p7l465t1246r613b1275],
2	CD4	NN	O	cd4	nn	3	SENT_111	[p7l1430t1251r1495b1277],
3	Count	NN	O	count	dep	1	SENT_111	[p7l1508t1251r1599b1277],

1	\	NN	O	\	_	0	SENT_112	[p7l249t1376r262b1399],
2	I	CD	NUMBER	i	num	3	SENT_112	[p7l249t1376r262b1399],
3	U1	NN	O	u1	dep	1	SENT_112	[p7l265t1376r277b1399],
4	U1	NN	O	u1	nn	5	SENT_112	[p7l248t1468r260b1491],
5	o	NN	O	o	dep	1	SENT_112	[p7l264t1467r279b1491],

1	Plasma	NN	O	plasma	nn	3	SENT_113	[p7l120t1489r149b1597],
2	Drug	NN	O	drug	nn	3	SENT_113	[p7l123t1399r158b1474],
3	Concentration	NN	O	concentration	_	0	SENT_113	[p7l164t1487r190b1703],
4	(	CD	NUMBER	(	num	6	SENT_113	[p7l162t1300r199b1470],
5	percentile	NN	O	percentile	nn	6	SENT_113	[p7l162t1300r199b1470],
6	)	NN	O	)	dep	3	SENT_113	[p7l162t1300r199b1470],

1	CD4	NN	O	cd4	nn	2	SENT_114	[p7l1168t1594r1195b1659],
2	Count	NN	O	count	_	0	SENT_114	[p7l1169t1490r1195b1581],
3	(	CD	NUMBER	(	num	4	SENT_114	[p7l1166t1339r1203b1475],
4	cells/p	NNS	O	cells/p	dep	2	SENT_114	[p7l1166t1339r1203b1475],
5	.	.	O	.	_	0	SENT_114	[p7l1166t1339r1203b1475],

1	|	NN	O	|	_	0	SENT_115	[p7l1166t1339r1203b1475],
2	)	SYM	O	)	dep	1	SENT_115	[p7l1166t1339r1203b1475],

1	Duration	NN	O	duration	nn	2	SENT_116	[p7l1329t1771r1461b1797],
2	ofAntiretroviral	NN	O	ofantiretroviral	_	0	SENT_116	[p7l1475t1768r1714b1797],

1	Treatment	NN	O	treatment	_	0	SENT_117	[p7l1398t1813r1555b1838],
2	(	CD	NUMBER	(	num	4	SENT_117	[p7l1570t1812r1639b1847],
3	mo	NN	DURATION	mo	nn	4	SENT_117	[p7l1570t1812r1639b1847],
4	)	NN	O	)	dep	1	SENT_117	[p7l1570t1812r1639b1847],

1	Fexofenadine	NN	O	fexofenadine	_	0	SENT_118	[p7l499t2554r699b2583],

1	2677G	CD	NUMBER	2677g	num	2	SENT_119	[p7l1437t2742r1523b2766],
2	—	CD	NUMBER	—	_	0	SENT_119	[p7l1529t2743r1586b2765],
3	>	JJR	O	>	amod	5	SENT_119	[p7l1529t2743r1586b2765],
4	T	NN	O	t	nn	5	SENT_119	[p7l1529t2743r1586b2765],
5	A8935	NN	O	a8935	dep	2	SENT_119	[p7l1467t2780r1553b2803],

1	Plasma	NN	O	plasma	nn	3	SENT_120	[p7l122t2797r150b2905],
2	Drug	NN	O	drug	nn	3	SENT_120	[p7l125t2708r159b2782],
3	Concentration	NN	O	concentration	_	0	SENT_120	[p7l166t2767r192b2983],
4	(	CD	NUMBER	(	num	6	SENT_120	[p7l164t2636r201b2750],
5	ng/ml	NN	O	ng/ml	nn	6	SENT_120	[p7l164t2636r201b2750],
6	)	NN	O	)	dep	3	SENT_120	[p7l164t2636r201b2750],

1	Time	NNP	O	Time	_	0	SENT_121	[p7l517t3078r594b3104],
2	(	CD	NUMBER	(	num	4	SENT_121	[p7l609t3075r660b3113],
3	hr	NN	DURATION	hr	nn	4	SENT_121	[p7l609t3075r660b3113],
4	)	NN	O	)	dep	1	SENT_121	[p7l609t3075r660b3113],

1	N	NN	O	n	nn	3	SENT_122	[p7l543t3221r557b3237],
2	ENGLJ	NN	O	englj	nn	3	SENT_122	[p7l572t3221r656b3243],
3	MED	NN	O	med	_	0	SENT_122	[p7l671t3221r724b3237],
4	348	CD	NUMBER	348	dep	3	SENT_122	[p7l736t3215r807b3243],
5	;	:	O	;	_	0	SENT_122	[p7l736t3215r807b3243],
6	6	CD	NUMBER	6	num	7	SENT_122	[p7l736t3215r807b3243],
7	WWW	NN	O	www	dep	3	SENT_122	[p7l842t3221r936b3237],
8	.	.	O	.	_	0	SENT_122	[p7l842t3221r936b3237],

1	N	NN	O	n	nn	2	SENT_123	[p7l842t3221r936b3237],
2	E	NN	O	e	_	0	SENT_123	[p7l944t3221r962b3243],
3	]	CD	NUMBER	]	num	5	SENT_123	[p7l944t3221r962b3243],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_123	[p7l970t3221r1053b3237],
5	FEBRUARY	NNP	DATE	FEBRUARY	dep	2	SENT_123	[p7l1092t3221r1220b3237],
6	6,2003	CD	NUMBER	6,2003	number	7	SENT_123	[p7l1233t3215r1331b3243],
7	541	CD	NUMBER	541	dep	5	SENT_123	[p7l2011t3219r2067b3242],

1	The	DT	O	the	det	4	SENT_124	[p7l752t3254r803b3277],
2	New	NNP	O	New	nn	4	SENT_124	[p7l813t3254r874b3277],
3	England	NNP	O	England	nn	4	SENT_124	[p7l884t3254r994b3284],
4	Journal	NNP	O	Journal	_	0	SENT_124	[p7l1003t3254r1101b3277],
5	of	IN	O	of	_	0	SENT_124	[p7l1110t3254r1139b3277],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_124	[p7l1146t3254r1271b3277],

1	Downloaded	VBN	O	download	_	0	SENT_125	[p7l195t3294r365b3317],
2	from	IN	O	from	_	0	SENT_125	[p7l373t3294r438b3317],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_125	[p7l446t3294r565b3324],
4	at	IN	O	at	_	0	SENT_125	[p7l575t3298r598b3317],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_125	[p7l607t3294r789b3317],
6	on	IN	O	on	_	0	SENT_125	[p7l799t3301r831b3317],
7	January	NNP	DATE	January	prep_on	1	SENT_125	[p7l840t3294r942b3324],
8	5	CD	DATE	5	num	7	SENT_125	[p7l952t3294r975b3321],
9	,	,	DATE	,	_	0	SENT_125	[p7l952t3294r975b3321],
10	2014	CD	DATE	2014	num	7	SENT_125	[p7l986t3294r1058b3317],
11	.	.	O	.	_	0	SENT_125	[p7l986t3294r1058b3317],

1	For	IN	O	for	_	0	SENT_126	[p7l1068t3294r1115b3317],
2	personal	JJ	O	personal	amod	3	SENT_126	[p7l1123t3294r1235b3324],
3	use	NN	O	use	pobj	1	SENT_126	[p7l1245t3301r1288b3317],
4	only	RB	O	only	advmod	3	SENT_126	[p7l1298t3294r1362b3324],
5	.	.	O	.	_	0	SENT_126	[p7l1298t3294r1362b3324],

1	No	DT	O	no	det	3	SENT_127	[p7l1373t3294r1413b3317],
2	other	JJ	O	other	amod	3	SENT_127	[p7l1423t3294r1491b3317],
3	uses	NNS	O	use	_	0	SENT_127	[p7l1499t3301r1555b3317],
4	without	IN	O	without	_	0	SENT_127	[p7l1565t3294r1666b3317],
5	permission	NN	O	permission	prep_without	3	SENT_127	[p7l1675t3294r1827b3324],
6	.	.	O	.	_	0	SENT_127	[p7l1675t3294r1827b3324],

1	Copyright	NN	O	copyright	_	0	SENT_128	[p7l545t3334r679b3364],
2	©	CD	NUMBER	©	num	6	SENT_128	[p7l689t3334r712b3358],
3	2003	CD	DATE	2003	num	6	SENT_128	[p7l722t3334r786b3358],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_128	[p7l796t3334r988b3357],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_128	[p7l997t3334r1106b3357],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_128	[p7l1116t3334r1221b3364],
7	.	.	O	.	_	0	SENT_128	[p7l1116t3334r1221b3364],

1	All	DT	O	all	det	2	SENT_129	[p7l1232t3334r1273b3357],
2	rights	NNS	O	rights	nsubj	3	SENT_129	[p7l1282t3334r1357b3364],
3	reserved	VBN	O	reserve	_	0	SENT_129	[p7l1367t3334r1486b3357],
4	.	.	O	.	_	0	SENT_129	[p7l1367t3334r1486b3357],

1	The	DT	O	the	det	4	SENT_130	[p7l715t3439r752b3460],
2	NEW	NNP	O	NEW	nn	4	SENT_130	[p7l765t3441r845b3460],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_130	[p7l859t3441r1034b3460],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_130	[p7l1048t3441r1214b3467],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_130	[p7l1228t3439r1444b3466],

1	tion	NN	O	tion	_	0	SENT_131	[p7l14t3663r182b3741],
2	of	IN	O	of	_	0	SENT_131	[p7l207t3662r309b3741],
3	many	JJ	O	many	amod	4	SENT_131	[p7l314t3688r551b3763],
4	drugs	NNS	O	drug	prep_of	1	SENT_131	[p7l571t3662r809b3763],
5	in	IN	O	in	dep	1	SENT_131	[p7l834t3663r916b3740],
6	the	DT	O	the	det	7	SENT_131	[p7l941t3662r1070b3741],
7	brain	NN	O	brain	pobj	5	SENT_131	[p7l1095t3662r1339b3758],
8	,	,	O	,	_	0	SENT_131	[p7l1095t3662r1339b3758],
9	including	VBG	O	include	_	0	SENT_131	[p7l1368t3662r1777b3763],
10	digoxin	NN	O	digoxin	prep_including	7	SENT_131	[p7l1799t3662r2143b3763],
11	,	,	O	,	_	0	SENT_131	[p7l1799t3662r2143b3763],

1	ivermectin	NN	O	ivermectin	dep	171	SENT_132	[p8l12t21r477b116],
2	,	,	O	,	_	0	SENT_132	[p8l12t21r477b116],
3	Vinblastine	NNP	O	Vinblastine	dep	171	SENT_132	[p8l499t20r982b116],
4	,	,	O	,	_	0	SENT_132	[p8l499t20r982b116],
5	dexamethasone	NN	O	dexamethasone	dep	171	SENT_132	[p8l1009t20r1689b116],
6	,	,	O	,	_	0	SENT_132	[p8l1009t20r1689b116],
7	cyclospor	NN	O	cyclospor	dep	171	SENT_132	[p8l1716t21r2147b121],
8	—	CD	NUMBER	—	dep	171	SENT_132	[p8l1716t21r2147b121],
9	ine	NN	O	ine	dep	171	SENT_132	[p8l12t149r163b244],
10	,	,	O	,	_	0	SENT_132	[p8l12t149r163b244],
11	domperidone	NN	O	domperidone	dep	171	SENT_132	[p8l195t148r792b249],
12	,	,	O	,	_	0	SENT_132	[p8l195t148r792b249],
13	and	CC	O	and	dep	171	SENT_132	[p8l822t148r979b227],
14	loperamide	NN	O	loperamide	dep	171	SENT_132	[p8l1003t149r1703b249],
15	.23	CD	NUMBER	.23	dep	171	SENT_132	[p8l1003t149r1703b249],
16	‘	CD	NUMBER	‘	dep	171	SENT_132	[p8l1003t149r1703b249],
17	25	CD	NUMBER	25	dep	171	SENT_132	[p8l1003t149r1703b249],
18	A	DT	O	a	dep	171	SENT_132	[p8l1729t156r1795b226],
19	synonymous	JJ	O	synonymous	dep	171	SENT_132	[p8l1820t174r2145b249, p8l13t302r247b356],
20	single	JJ	O	single	dep	171	SENT_132	[p8l279t276r1013b377],
21	—	NN	O	—	dep	171	SENT_132	[p8l279t276r1013b377],
22	nucleotide	NN	O	nucleotide	dep	171	SENT_132	[p8l279t276r1013b377],
23	polymorphism	NN	O	polymorphism	dep	171	SENT_132	[p8l1039t277r1671b377],
24	(	CD	NUMBER	(	dep	171	SENT_132	[p8l1704t277r1885b372],
25	i.e.	FW	O	i.e.	dep	171	SENT_132	[p8l1704t277r1885b372],
26	,	,	O	,	_	0	SENT_132	[p8l1704t277r1885b372],
27	a	DT	O	a	dep	171	SENT_132	[p8l1918t303r1963b355],
28	single	JJ	O	single	dep	171	SENT_132	[p8l1991t277r2147b355, p8l12t404r619b505],
29	—	NN	O	—	dep	171	SENT_132	[p8l1991t277r2147b355, p8l12t404r619b505],
30	nucleotide	NN	O	nucleotide	dep	171	SENT_132	[p8l1991t277r2147b355, p8l12t404r619b505],
31	polymorphism	NN	O	polymorphism	dep	171	SENT_132	[p8l661t405r1293b505],
32	that	WDT	O	that	dep	171	SENT_132	[p8l1336t405r1504b483],
33	does	VBZ	O	do	dep	171	SENT_132	[p8l1542t404r1735b483],
34	not	RB	O	not	dep	171	SENT_132	[p8l1781t421r1925b483],
35	alter	VB	O	alter	dep	171	SENT_132	[p8l1962t404r2151b483],
36	the	DT	O	the	dep	171	SENT_132	[p8l14t533r141b612],
37	amino	NN	O	amino	dep	171	SENT_132	[p8l161t534r428b612],
38	acid	NN	O	acid	dep	171	SENT_132	[p8l449t534r618b612],
39	encoded	VBD	O	encode	dep	171	SENT_132	[p8l640t534r1018b625],
40	)	CD	NUMBER	)	dep	171	SENT_132	[p8l640t534r1018b625],
41	in	IN	O	in	dep	171	SENT_132	[p8l1043t534r1124b611],
42	exon	NN	O	exon	dep	171	SENT_132	[p8l1145t559r1343b612],
43	26	CD	NUMBER	26	dep	171	SENT_132	[p8l1363t539r1463b612],
44	(	CD	NUMBER	(	dep	171	SENT_132	[p8l1489t539r1980b625],
45	3435C	NN	O	3435c	dep	171	SENT_132	[p8l1489t539r1980b625],
46	+	CC	O	+	dep	171	SENT_132	[p8l1489t539r1980b625],
47	T	NN	O	t	dep	171	SENT_132	[p8l1489t539r1980b625],
48	)	NN	O	)	dep	171	SENT_132	[p8l1489t539r1980b625],
49	has	VBZ	O	have	dep	171	SENT_132	[p8l2006t533r2146b612],
50	been	VBN	O	be	dep	171	SENT_132	[p8l14t661r212b740],
51	associated	VBN	O	associate	dep	171	SENT_132	[p8l232t661r666b740],
52	with	IN	O	with	dep	171	SENT_132	[p8l681t661r870b741],
53	Variable	JJ	O	variable	dep	171	SENT_132	[p8l885t661r1213b741],
54	expression	NN	O	expression	dep	171	SENT_132	[p8l1235t662r1685b762],
55	of	IN	O	of	dep	171	SENT_132	[p8l1707t661r1807b740],
56	P	NN	O	p	dep	171	SENT_132	[p8l1807t662r2147b762, p8l11t790r318b890],
57	—	CD	NUMBER	—	dep	171	SENT_132	[p8l1807t662r2147b762, p8l11t790r318b890],
58	glycoprotein	NN	O	glycoprotein	dep	171	SENT_132	[p8l1807t662r2147b762, p8l11t790r318b890],
59	in	IN	O	in	dep	171	SENT_132	[p8l344t790r425b867],
60	the	DT	O	the	dep	171	SENT_132	[p8l452t790r582b868],
61	duodenum	NN	O	duodenum	dep	171	SENT_132	[p8l609t790r1096b885],
62	;	:	O	;	_	0	SENT_132	[p8l609t790r1096b885],
63	in	IN	O	in	dep	171	SENT_132	[p8l1126t790r1208b867],
64	patients	NNS	O	patient	dep	171	SENT_132	[p8l1234t790r1570b890],
65	homozygous	JJ	O	homozygous	dep	171	SENT_132	[p8l1598t789r2145b890],
66	for	IN	O	for	dep	171	SENT_132	[p8l13t917r136b996],
67	the	DT	O	the	dep	171	SENT_132	[p8l156t917r285b996],
68	T	NN	O	t	dep	171	SENT_132	[p8l304t923r365b995],
69	allele	NN	O	allele	dep	171	SENT_132	[p8l384t917r627b1013],
70	,	,	O	,	_	0	SENT_132	[p8l384t917r627b1013],
71	duodenal	JJ	O	duodenal	dep	171	SENT_132	[p8l655t917r1051b997],
72	expression	NN	O	expression	dep	171	SENT_132	[p8l1073t918r1529b1018],
73	of	IN	O	of	dep	171	SENT_132	[p8l1551t917r1653b996],
74	P	NN	O	p	dep	171	SENT_132	[p8l1655t918r2147b1018, p8l14t1046r171b1124],
75	—	CD	NUMBER	—	dep	171	SENT_132	[p8l1655t918r2147b1018, p8l14t1046r171b1124],
76	glycoprotein	NN	O	glycoprotein	dep	171	SENT_132	[p8l1655t918r2147b1018, p8l14t1046r171b1124],
77	was	VBD	O	be	dep	171	SENT_132	[p8l195t1072r357b1125],
78	less	JJR	O	less	dep	171	SENT_132	[p8l387t1045r543b1124],
79	than	IN	O	than	dep	171	SENT_132	[p8l574t1046r763b1124],
80	half	NN	O	half	dep	171	SENT_132	[p8l792t1045r972b1124],
81	that	IN	O	that	dep	171	SENT_132	[p8l982t1046r1150b1124],
82	in	IN	O	in	dep	171	SENT_132	[p8l1173t1046r1254b1123],
83	patients	NNS	O	patient	dep	171	SENT_132	[p8l1282t1046r1618b1146],
84	with	IN	O	with	dep	171	SENT_132	[p8l1645t1046r1834b1125],
85	the	DT	O	the	dep	171	SENT_132	[p8l1864t1046r1993b1124],
86	CC	NN	O	cc	dep	171	SENT_132	[p8l2022t1051r2145b1124],
87	genotype	NN	O	genotype	dep	171	SENT_132	[p8l12t1179r500b1274],
88	.19	CD	NUMBER	.19	dep	171	SENT_132	[p8l12t1179r500b1274],
89	CD56	NN	O	cd56	dep	171	SENT_132	[p8l522t1179r817b1252],
90	+	CC	O	+	dep	171	SENT_132	[p8l522t1179r817b1252],
91	natural	JJ	O	natural	dep	171	SENT_132	[p8l837t1174r1133b1253],
92	killer	NN	O	killer	dep	171	SENT_132	[p8l1152t1173r1368b1253],
93	cells	NNS	O	cell	dep	171	SENT_132	[p8l1386t1174r1566b1252],
94	from	IN	O	from	dep	171	SENT_132	[p8l1588t1173r1794b1252],
95	subjects	NNS	O	subject	dep	171	SENT_132	[p8l1816t1174r2147b1274],
96	homozygous	JJ	O	homozygous	dep	171	SENT_132	[p8l13t1301r555b1402],
97	for	IN	O	for	dep	171	SENT_132	[p8l583t1301r705b1380],
98	3435C	NN	O	3435c	dep	171	SENT_132	[p8l729t1307r997b1380],
99	demonstrated	VBD	O	demonstrate	dep	171	SENT_132	[p8l1025t1302r1609b1380],
100	signiﬁcantly	RB	O	signiﬁcantly	dep	171	SENT_132	[p8l1636t1301r2153b1402],
101	lower	JJR	O	lower	dep	171	SENT_132	[p8l12t1430r251b1509],
102	ex	FW	O	ex	dep	171	SENT_132	[p8l283t1456r374b1508],
103	vivo	FW	O	vivo	dep	171	SENT_132	[p8l401t1430r568b1509],
104	retention	NN	O	retention	dep	171	SENT_132	[p8l605t1430r990b1508],
105	of	IN	O	of	dep	171	SENT_132	[p8l1026t1429r1127b1508],
106	the	DT	O	the	dep	171	SENT_132	[p8l1143t1430r1273b1508],
107	P	NN	O	p	dep	171	SENT_132	[p8l1306t1429r1929b1530],
108	—	CD	NUMBER	—	dep	171	SENT_132	[p8l1306t1429r1929b1530],
109	glycoprotein	NN	O	glycoprotein	dep	171	SENT_132	[p8l1306t1429r1929b1530],
110	substrate	NN	O	substrate	dep	171	SENT_132	[p8l1965t1430r2147b1509, p8l15t1574r245b1636],
111	rhodamine	NN	O	rhodamine	dep	171	SENT_132	[p8l270t1558r737b1636],
112	(	CD	NUMBER	(	dep	171	SENT_132	[p8l768t1558r949b1653],
113	i.e.	FW	O	i.e.	dep	171	SENT_132	[p8l768t1558r949b1653],
114	,	,	O	,	_	0	SENT_132	[p8l768t1558r949b1653],
115	higher	JJR	O	higher	dep	171	SENT_132	[p8l979t1557r1259b1658],
116	P	NN	O	p	dep	171	SENT_132	[p8l1279t1557r1902b1658],
117	—	CD	NUMBER	—	dep	171	SENT_132	[p8l1279t1557r1902b1658],
118	glycoprotein	NN	O	glycoprotein	dep	171	SENT_132	[p8l1279t1557r1902b1658],
119	function	NN	O	function	dep	171	SENT_132	[p8l1927t1557r2147b1637, p8l14t1686r325b1777],
120	)	CD	NUMBER	)	dep	171	SENT_132	[p8l1927t1557r2147b1637, p8l14t1686r325b1777],
121	.26	CD	NUMBER	.26	dep	171	SENT_132	[p8l1927t1557r2147b1637, p8l14t1686r325b1777],
122	Digoxin	NN	O	digoxin	dep	171	SENT_132	[p8l347t1686r710b1786],
123	,	,	O	,	_	0	SENT_132	[p8l347t1686r710b1786],
124	another	DT	O	another	dep	171	SENT_132	[p8l737t1686r1069b1764],
125	P	NN	O	p	dep	171	SENT_132	[p8l1087t1686r1710b1786],
126	—	CD	NUMBER	—	dep	171	SENT_132	[p8l1087t1686r1710b1786],
127	glycoprotein	NN	O	glycoprotein	dep	171	SENT_132	[p8l1087t1686r1710b1786],
128	substrate	NN	O	substrate	dep	171	SENT_132	[p8l1733t1686r2142b1781],
129	,	,	O	,	_	0	SENT_132	[p8l1733t1686r2142b1781],
130	has	VBZ	O	have	dep	171	SENT_132	[p8l13t1813r157b1892],
131	signiﬁcantly	RB	O	signiﬁcantly	dep	171	SENT_132	[p8l189t1813r725b1914],
132	higher	JJR	O	higher	dep	171	SENT_132	[p8l749t1813r1033b1914],
133	bioavailability	NN	O	bioavailability	dep	171	SENT_132	[p8l1059t1813r1666b1914],
134	in	IN	O	in	dep	171	SENT_132	[p8l1689t1814r1771b1891],
135	subjects	NNS	O	subject	dep	171	SENT_132	[p8l1800t1814r2144b1914],
136	with	IN	O	with	dep	171	SENT_132	[p8l8t1942r202b2021],
137	the	DT	O	the	dep	171	SENT_132	[p8l243t1942r376b2020],
138	343	CD	NUMBER	343	dep	171	SENT_132	[p8l418t1947r570b2020],
139	STT	NN	O	stt	dep	171	SENT_132	[p8l583t1947r754b2020],
140	genotype	NN	O	genotype	dep	171	SENT_132	[p8l792t1947r1405b2042],
141	.19	CD	NUMBER	.19	dep	171	SENT_132	[p8l792t1947r1405b2042],
142	’27	CD	NUMBER	’27	dep	171	SENT_132	[p8l792t1947r1405b2042],
143	As	IN	O	as	dep	171	SENT_132	[p8l1443t1949r1549b2020],
144	is	VBZ	O	be	dep	171	SENT_132	[p8l1591t1942r1658b2020],
145	typical	JJ	O	typical	dep	171	SENT_132	[p8l1702t1942r1982b2042],
146	for	IN	O	for	dep	171	SENT_132	[p8l2023t1941r2149b2020],
147	many	JJ	O	many	dep	171	SENT_132	[p8l13t2095r246b2170],
148	pharmacogenetic	JJ	O	pharmacogenetic	dep	171	SENT_132	[p8l265t2070r998b2170],
149	traits	NNS	O	trait	dep	171	SENT_132	[p8l1022t2070r1256b2165],
150	,	,	O	,	_	0	SENT_132	[p8l1022t2070r1256b2165],
151	there	EX	O	there	dep	171	SENT_132	[p8l1287t2070r1498b2148],
152	is	VBZ	O	be	dep	171	SENT_132	[p8l1522t2070r1587b2148],
153	considerable	JJ	O	considerable	dep	171	SENT_132	[p8l1614t2070r2148b2148],
154	racial	JJ	O	racial	dep	171	SENT_132	[p8l13t2197r242b2276],
155	variation	NN	O	variation	dep	171	SENT_132	[p8l273t2198r648b2277],
156	in	IN	O	in	dep	171	SENT_132	[p8l684t2198r766b2275],
157	the	DT	O	the	dep	171	SENT_132	[p8l803t2197r933b2276],
158	frequency	NN	O	frequency	dep	171	SENT_132	[p8l969t2197r1389b2298],
159	of	IN	O	of	dep	171	SENT_132	[p8l1422t2197r1523b2276],
160	the	DT	O	the	dep	171	SENT_132	[p8l1542t2197r1672b2276],
161	3435C	NN	O	3435c	dep	171	SENT_132	[p8l1709t2203r2150b2276],
162	+	CC	O	+	dep	171	SENT_132	[p8l1709t2203r2150b2276],
163	T	NN	O	t	dep	171	SENT_132	[p8l1709t2203r2150b2276],
164	single	JJ	O	single	dep	171	SENT_132	[p8l15t2325r749b2426],
165	—	NN	O	—	dep	171	SENT_132	[p8l15t2325r749b2426],
166	nucleotide	NN	O	nucleotide	dep	171	SENT_132	[p8l15t2325r749b2426],
167	polymorphism	NN	O	polymorphism	dep	171	SENT_132	[p8l772t2326r1623b2426],
168	.28	CD	NUMBER	.28	dep	171	SENT_132	[p8l772t2326r1623b2426],
169	‘	NN	O	‘	dep	171	SENT_132	[p8l772t2326r1623b2426],
170	3	CD	NUMBER	3	dep	171	SENT_132	[p8l772t2326r1623b2426],
171	°	NN	O	°	_	0	SENT_132	[p8l772t2326r1623b2426],

1	The	DT	O	the	det	5	SENT_133	[p8l139t2454r300b2532],
2	343	CD	PERCENT	343	number	3	SENT_133	[p8l321t2459r471b2532],
3	5C	CD	PERCENT	5c	dep	4	SENT_133	[p8l481t2459r759b2532],
4	%	NN	PERCENT	%	dep	5	SENT_133	[p8l481t2459r759b2532],
5	T	NN	O	t	nsubj	60	SENT_133	[p8l481t2459r759b2532],
6	single	JJ	O	single	amod	9	SENT_133	[p8l778t2454r1504b2554],
7	—	NN	O	—	nn	9	SENT_133	[p8l778t2454r1504b2554],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_133	[p8l778t2454r1504b2554],
9	polymorphism	NN	O	polymorphism	nsubj	10	SENT_133	[p8l1523t2453r2148b2554],
10	is	VBZ	O	be	rcmod	5	SENT_133	[p8l12t2582r77b2660],
11	in	IN	O	in	_	0	SENT_133	[p8l101t2582r182b2659],
12	linkage	NN	O	linkage	nn	13	SENT_133	[p8l203t2582r512b2682],
13	disequilibrium	NN	O	disequilibrium	prep_in	10	SENT_133	[p8l535t2581r1155b2682],
14	with	IN	O	with	_	0	SENT_133	[p8l1173t2582r1361b2661],
15	a	DT	O	a	det	35	SENT_133	[p8l1383t2608r1427b2660],
16	nonsynonymous	JJ	O	nonsynonymous	amod	35	SENT_133	[p8l1448t2607r2146b2682],
17	single	JJ	O	single	amod	20	SENT_133	[p8l15t2709r749b2810],
18	—	NN	O	—	nn	20	SENT_133	[p8l15t2709r749b2810],
19	nucleotide	NN	O	nucleotide	nn	20	SENT_133	[p8l15t2709r749b2810],
20	polymorphism	NN	O	polymorphism	dep	16	SENT_133	[p8l772t2710r1404b2810],
21	(	CD	NUMBER	(	dep	20	SENT_133	[p8l1432t2710r1614b2805],
22	i.e.	FW	O	i.e.	dep	20	SENT_133	[p8l1432t2710r1614b2805],
23	,	,	O	,	_	0	SENT_133	[p8l1432t2710r1614b2805],
24	one	CD	NUMBER	one	appos	20	SENT_133	[p8l1644t2735r1797b2788],
25	causing	VBG	O	cause	partmod	24	SENT_133	[p8l1822t2710r2151b2810],
26	an	DT	O	a	det	30	SENT_133	[p8l12t2863r112b2916],
27	amino	NN	O	amino	nn	30	SENT_133	[p8l134t2838r402b2916],
28	acid	NN	O	acid	nn	30	SENT_133	[p8l424t2838r595b2916],
29	change	NN	O	change	nn	30	SENT_133	[p8l617t2838r946b2938],
30	)	NN	O	)	dobj	25	SENT_133	[p8l617t2838r946b2938],
31	in	IN	O	in	_	0	SENT_133	[p8l973t2838r1054b2915],
32	exon	NN	O	exon	prep_in	30	SENT_133	[p8l1076t2863r1275b2916],
33	21	CD	NUMBER	21	number	34	SENT_133	[p8l1297t2843r1397b2915],
34	(	CD	NUMBER	(	num	35	SENT_133	[p8l1425t2843r1916b2933],
35	2677GaT	NN	O	2677gat	prep_with	13	SENT_133	[p8l1425t2843r1916b2933],
36	,	,	O	,	_	0	SENT_133	[p8l1425t2843r1916b2933],
37	leading	VBG	O	lead	partmod	60	SENT_133	[p8l1942t2838r2147b2916, p8l12t2966r154b3066],
38	to	TO	O	to	_	0	SENT_133	[p8l181t2982r260b3044],
39	Ala893Ser	NN	O	ala893ser	nn	40	SENT_133	[p8l288t2966r762b3057],
40	)	NN	O	)	prep_to	37	SENT_133	[p8l288t2966r762b3057],
41	that	WDT	O	that	nsubj	42	SENT_133	[p8l797t2966r968b3044],
42	alters	VBZ	O	alter	rcmod	40	SENT_133	[p8l992t2966r1225b3044],
43	P	NN	O	p	nn	46	SENT_133	[p8l1256t2965r1892b3066],
44	—	CD	NUMBER	—	num	46	SENT_133	[p8l1256t2965r1892b3066],
45	glycoprotein	NN	O	glycoprotein	nn	46	SENT_133	[p8l1256t2965r1892b3066],
46	function	NN	O	function	dobj	42	SENT_133	[p8l1921t2965r2145b3045, p8l14t3094r296b3172],
47	.18	CD	NUMBER	.18	nsubj	55	SENT_133	[p8l1921t2965r2145b3045, p8l14t3094r296b3172],
48	Because	IN	O	because	_	0	SENT_133	[p8l326t3100r674b3173],
49	these	DT	O	these	det	54	SENT_133	[p8l705t3094r929b3172],
50	two	CD	NUMBER	two	num	54	SENT_133	[p8l960t3110r1115b3173],
51	single	JJ	O	single	amod	54	SENT_133	[p8l1148t3094r1900b3194],
52	—	NN	O	—	nn	54	SENT_133	[p8l1148t3094r1900b3194],
53	nucleotide	NN	O	nucleotide	nn	54	SENT_133	[p8l1148t3094r1900b3194],
54	polymorphisms	NNS	O	polymorphism	prep_because	47	SENT_133	[p8l1930t3094r2145b3194, p8l13t3222r512b3322],
55	travel	VBP	O	travel	rcmod	46	SENT_133	[p8l558t3222r786b3301],
56	together	RB	O	together	advmod	55	SENT_133	[p8l827t3222r1200b3322],
57	,	,	O	,	_	0	SENT_133	[p8l827t3222r1200b3322],
58	it	PRP	O	it	nsubj	60	SENT_133	[p8l1246t3222r1306b3300],
59	is	VBZ	O	be	cop	60	SENT_133	[p8l1341t3222r1406b3300],
60	unclear	JJ	O	unclear	_	0	SENT_133	[p8l1449t3222r1764b3301],
61	Whether	IN	O	whether	complm	67	SENT_133	[p8l1798t3221r2151b3301],
62	the	DT	O	the	det	63	SENT_133	[p8l14t3350r145b3428],
63	3435C	NN	O	3435c	nsubj	67	SENT_133	[p8l175t3355r622b3428],
64	+	CC	O	+	_	0	SENT_133	[p8l175t3355r622b3428],
65	T	NN	O	t	nn	66	SENT_133	[p8l175t3355r622b3428],
66	polymorphism	NN	O	polymorphism	conj_+	63	SENT_133	[p8l646t3350r1290b3450],
67	is	VBZ	O	be	ccomp	60	SENT_133	[p8l1318t3350r1384b3428],
68	of	IN	O	of	_	0	SENT_133	[p8l1415t3349r1518b3428],
69	functional	JJ	O	functional	amod	70	SENT_133	[p8l1527t3349r1971b3429],
70	importance	NN	O	importance	prep_of	67	SENT_133	[p8l1999t3350r2145b3427, p8l11t3494r394b3578],
71	or	CC	O	or	_	0	SENT_133	[p8l442t3503r533b3556],
72	is	VBZ	O	be	auxpass	74	SENT_133	[p8l576t3478r642b3556],
73	simply	RB	O	simply	advmod	74	SENT_133	[p8l693t3478r982b3578],
74	linked	VBN	O	link	conj_or	60	SENT_133	[p8l1024t3477r1295b3557],
75	with	IN	O	with	_	0	SENT_133	[p8l1336t3477r1530b3557],
76	the	DT	O	the	det	78	SENT_133	[p8l1577t3477r1709b3556],
77	causative	JJ	O	causative	amod	78	SENT_133	[p8l1757t3478r2147b3557],
78	polymorphism	NN	O	polymorphism	prep_with	74	SENT_133	[p8l11t3605r655b3706],
79	in	IN	O	in	_	0	SENT_133	[p8l681t3606r763b3683],
80	exon	NN	O	exon	prep_in	78	SENT_133	[p8l791t3631r995b3684],
81	21	CD	NUMBER	21	num	80	SENT_133	[p8l1021t3611r1149b3684],
82	.	.	O	.	_	0	SENT_133	[p8l1021t3611r1149b3684],

1	The	DT	O	the	det	2	SENT_134	[p8l1178t3606r1342b3684],
2	2677G	NN	O	2677g	_	0	SENT_134	[p8l1369t3611r1828b3684],
3	+	CC	O	+	_	0	SENT_134	[p8l1369t3611r1828b3684],
4	T	NN	O	t	conj_+	2	SENT_134	[p8l1369t3611r1828b3684],
5	singlenucleotide	NN	O	singlenucleotide	dep	2	SENT_134	[p8l1853t3606r2145b3706, p9l13t21r451b100],

1	polymorphism	NN	O	polymorphism	nsubjpass	4	SENT_135	[p9l473t21r1098b121],
2	has	VBZ	O	have	aux	4	SENT_135	[p9l1121t21r1261b99],
3	been	VBN	O	be	auxpass	4	SENT_135	[p9l1287t20r1486b99],
4	associated	VBN	O	associate	_	0	SENT_135	[p9l1507t21r1942b99],
5	with	IN	O	with	_	0	SENT_135	[p9l1960t21r2148b100],
6	enhanced	VBN	O	enhance	amod	7	SENT_135	[p9l14t149r416b227],
7	P	NN	O	p	prep_with	4	SENT_135	[p9l434t148r1045b249],
8	—	CD	NUMBER	—	num	10	SENT_135	[p9l434t148r1045b249],
9	glycoprotein	NN	O	glycoprotein	nn	10	SENT_135	[p9l434t148r1045b249],
10	function	NN	O	function	dep	12	SENT_135	[p9l1065t148r1418b228],
11	in	FW	O	in	nn	12	SENT_135	[p9l1436t149r1518b226],
12	vitro	FW	O	vitro	advmod	4	SENT_135	[p9l1533t149r1722b228],
13	and	CC	O	and	_	0	SENT_135	[p9l1743t149r1898b227],
14	lower	JJR	O	lower	amod	17	SENT_135	[p9l1916t149r2152b228],
15	plasma	NN	O	plasma	nn	17	SENT_135	[p9l11t276r320b377],
16	fexofenadine	NN	O	fexofenadine	nn	17	SENT_135	[p9l346t276r894b355],
17	concentrations	NNS	O	concentration	conj_and	4	SENT_135	[p9l923t277r1554b355],
18	in	IN	O	in	_	0	SENT_135	[p9l1583t277r1664b354],
19	humans	NNS	O	human	prep_in	17	SENT_135	[p9l1692t276r2146b372],
20	,18	CD	NUMBER	,18	num	21	SENT_135	[p9l1692t276r2146b372],
21	effects	NNS	O	effect	dep	19	SENT_135	[p9l14t404r285b483],
22	opposite	JJ	O	opposite	dep	21	SENT_135	[p9l313t405r678b505],
23	to	TO	O	to	_	0	SENT_135	[p9l704t421r784b483],
24	those	DT	O	those	prep_to	17	SENT_135	[p9l811t405r1038b483],
25	reported	VBN	O	report	partmod	24	SENT_135	[p9l1064t404r1425b505],
26	with	IN	O	with	_	0	SENT_135	[p9l1445t405r1636b484],
27	digoXin	NN	O	digoxin	prep_with	25	SENT_135	[p9l1661t404r2092b505],
28	.27	CD	NUMBER	.27	num	27	SENT_135	[p9l1661t404r2092b505],

1	The	DT	O	the	det	2	SENT_136	[p9l139t532r303b611],
2	associations	NNS	O	association	nsubjpass	28	SENT_136	[p9l342t533r872b611],
3	between	IN	O	between	_	0	SENT_136	[p9l914t533r1272b612],
4	treatment	NN	O	treatment	nn	5	SENT_136	[p9l1311t549r1737b611],
5	outcome	NN	O	outcome	prep_between	2	SENT_136	[p9l1771t549r2146b612],
6	and	CC	O	and	_	0	SENT_136	[p9l12t660r171b739],
7	genetic	JJ	O	genetic	amod	8	SENT_136	[p9l216t661r521b761],
8	variants	NNS	O	variant	conj_and	2	SENT_136	[p9l558t661r892b740],
9	in	IN	O	in	_	0	SENT_136	[p9l935t661r1017b738],
10	CYP3A4	NN	O	cyp3a4	prep_in	8	SENT_136	[p9l1058t666r1387b756],
11	,	,	O	,	_	0	SENT_136	[p9l1058t666r1387b756],
12	CYP3A5	NN	O	cyp3a5	conj_and	10	SENT_136	[p9l1433t666r1762b756],
13	,	,	O	,	_	0	SENT_136	[p9l1433t666r1762b756],
14	CYPZD6	NN	O	cypzd6	conj_and	10	SENT_136	[p9l1807t667r2143b756],
15	,	,	O	,	_	0	SENT_136	[p9l1807t667r2143b756],
16	CYPZCI9	NN	O	cypzci9	conj_and	10	SENT_136	[p9l11t795r389b884],
17	,	,	O	,	_	0	SENT_136	[p9l11t795r389b884],
18	the	DT	O	the	det	22	SENT_136	[p9l429t789r558b867],
19	chemokine	NN	O	chemokine	nn	22	SENT_136	[p9l594t788r1065b868],
20	receptor	NN	O	receptor	nn	22	SENT_136	[p9l1100t805r1453b889],
21	gene	NN	O	gene	nn	22	SENT_136	[p9l1484t814r1684b889],
22	CCRS	NN	O	ccr	conj_and	10	SENT_136	[p9l1717t795r1952b884],
23	,	,	O	,	_	0	SENT_136	[p9l1717t795r1952b884],
24	and	CC	O	and	_	0	SENT_136	[p9l1991t788r2148b867],
25	ABCB1	NN	O	abcb1	conj_and	10	SENT_136	[p9l6t922r271b995],
26	have	VBP	O	have	aux	28	SENT_136	[p9l295t916r483b996],
27	been	VBN	O	be	auxpass	28	SENT_136	[p9l506t917r705b995],
28	examined	VBN	O	examine	dep	58	SENT_136	[p9l728t916r1134b995],
29	in	IN	O	in	_	0	SENT_136	[p9l1156t917r1237b994],
30	HIV	NN	O	hiv	nn	33	SENT_136	[p9l1258t916r1793b995],
31	—	NN	O	—	nn	33	SENT_136	[p9l1258t916r1793b995],
32	infected	JJ	O	infected	amod	33	SENT_136	[p9l1258t916r1793b995],
33	patients	NNS	O	patient	prep_in	28	SENT_136	[p9l1813t917r2146b1017],
34	receiving	VBG	O	receive	xcomp	28	SENT_136	[p9l13t1045r389b1145],
35	combination	NN	O	combination	dobj	34	SENT_136	[p9l407t1044r938b1123],
36	antiretroviral	JJ	O	antiretroviral	amod	37	SENT_136	[p9l959t1045r1496b1124],
37	therapy	NN	O	therapy	dep	52	SENT_136	[p9l1516t1045r1828b1145],
38	with	IN	O	with	_	0	SENT_136	[p9l1839t1045r2026b1124],
39	either	CC	O	either	preconj	42	SENT_136	[p9l2048t1045r2148b1123, p9l14t1173r181b1251],
40	a	DT	O	a	det	42	SENT_136	[p9l198t1199r242b1251],
41	protease	NN	O	protease	nn	42	SENT_136	[p9l260t1189r613b1273],
42	inhibitor	NN	O	inhibitor	prep_with	37	SENT_136	[p9l632t1172r1003b1251],
43	or	CC	O	or	_	0	SENT_136	[p9l1021t1198r1110b1251],
44	a	DT	O	a	det	47	SENT_136	[p9l1126t1199r1170b1251],
45	nonnucleoside	JJ	O	nonnucleoside	amod	47	SENT_136	[p9l1189t1172r1804b1252],
46	reversetranscriptase	NN	O	reversetranscriptase	nn	47	SENT_136	[p9l1825t1199r2147b1252, p9l14t1301r564b1401],
47	inhibitor	NN	O	inhibitor	prep_with	37	SENT_136	[p9l624t1300r1104b1379],
48	.2	NN	NUMBER	.2	dep	52	SENT_136	[p9l624t1300r1104b1379],
49	°	CD	NUMBER	°	num	48	SENT_136	[p9l624t1300r1104b1379],
50	The	DT	O	the	det	52	SENT_136	[p9l1162t1301r1324b1379],
51	ABCB1	NN	O	abcb1	nn	52	SENT_136	[p9l1378t1306r1645b1379],
52	3435C	NN	O	3435c	dep	56	SENT_136	[p9l1709t1306r2150b1379],
53	—	CD	NUMBER	—	num	55	SENT_136	[p9l1709t1306r2150b1379],
54	>	JJR	O	>	amod	55	SENT_136	[p9l1709t1306r2150b1379],
55	T	NN	O	t	dep	52	SENT_136	[p9l1709t1306r2150b1379],
56	polymorphism	NN	O	polymorphism	dep	34	SENT_136	[p9l11t1429r643b1529],
57	was	VBD	O	be	auxpass	58	SENT_136	[p9l664t1455r826b1508],
58	associated	VBN	O	associate	_	0	SENT_136	[p9l852t1428r1291b1507],
59	with	IN	O	with	_	0	SENT_136	[p9l1311t1429r1501b1508],
60	significant	JJ	O	significant	amod	61	SENT_136	[p9l1528t1428r1982b1529],
61	differences	NNS	O	difference	prep_with	58	SENT_136	[p9l2002t1428r2147b1507, p9l13t1556r362b1635],
62	in	IN	O	in	_	0	SENT_136	[p9l387t1557r468b1634],
63	the	DT	O	the	det	65	SENT_136	[p9l492t1557r622b1635],
64	plasma	NN	O	plasma	nn	65	SENT_136	[p9l644t1557r953b1657],
65	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	61	SENT_136	[p9l973t1556r1735b1657],
66	of	IN	O	of	_	0	SENT_136	[p9l1761t1556r1862b1635],
67	nelfin	NN	O	nelfin	prep_of	65	SENT_136	[p9l1867t1556r2147b1635],
68	—	CD	NUMBER	—	num	71	SENT_136	[p9l1867t1556r2147b1635],
69	avir	NN	O	avir	nn	71	SENT_136	[p9l12t1685r167b1764],
70	(	CD	NUMBER	(	num	71	SENT_136	[p9l193t1685r377b1785],
71	Fig	NN	O	fig	nsubjpass	58	SENT_136	[p9l193t1685r377b1785],
72	.	.	O	.	_	0	SENT_136	[p9l193t1685r377b1785],

1	3	CD	NUMBER	3	_	0	SENT_137	[p9l408t1690r485b1776],
2	)	NN	O	)	dep	1	SENT_137	[p9l408t1690r485b1776],
3	and	CC	O	and	_	0	SENT_137	[p9l514t1684r670b1763],
4	efavirenz	NN	O	efavirenz	dep	1	SENT_137	[p9l696t1684r1101b1764],
5	.	.	O	.	_	0	SENT_137	[p9l696t1684r1101b1764],

1	Recovery	NN	O	recovery	nsubj	12	SENT_138	[p9l1130t1691r1512b1785],
2	of	IN	O	of	_	0	SENT_138	[p9l1533t1684r1634b1763],
3	the	DT	O	the	det	6	SENT_138	[p9l1641t1685r1770b1763],
4	CD4	NN	O	cd4	nn	6	SENT_138	[p9l1795t1690r1981b1763],
5	cell	NN	O	cell	nn	6	SENT_138	[p9l2006t1685r2148b1763],
6	count	NN	O	count	prep_of	1	SENT_138	[p9l14t1829r258b1892],
7	was	VBD	O	be	cop	9	SENT_138	[p9l282t1839r444b1892],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_138	[p9l483t1812r1006b1913],
9	greater	JJR	O	greater	_	0	SENT_138	[p9l1036t1829r1335b1913],
10	and	CC	O	and	_	0	SENT_138	[p9l1366t1812r1522b1891],
11	more	RBR	O	more	advmod	12	SENT_138	[p9l1557t1838r1777b1891],
12	rapid	JJ	O	rapid	conj_and	9	SENT_138	[p9l1812t1813r2032b1913],
13	in	IN	O	in	_	0	SENT_138	[p9l2066t1813r2148b1890],
14	patients	NNS	O	patient	prep_in	9	SENT_138	[p9l11t1942r347b2042],
15	with	IN	O	with	_	0	SENT_138	[p9l369t1942r560b2021],
16	the	DT	O	the	det	18	SENT_138	[p9l583t1942r713b2020],
17	TT	NN	O	tt	nn	18	SENT_138	[p9l733t1947r855b2019],
18	genotype	NN	O	genotype	prep_with	14	SENT_138	[p9l875t1958r1260b2042],
19	than	IN	O	than	dep	9	SENT_138	[p9l1284t1942r1474b2020],
20	in	IN	O	in	_	0	SENT_138	[p9l1497t1942r1578b2019],
21	patients	NNS	O	patient	prep_in	9	SENT_138	[p9l1600t1942r1937b2042],
22	with	IN	O	with	_	0	SENT_138	[p9l1957t1942r2148b2021],
23	either	CC	O	either	preconj	25	SENT_138	[p9l14t2070r258b2148],
24	the	DT	O	the	det	25	SENT_138	[p9l283t2069r412b2148],
25	CT	NN	O	ct	prep_with	21	SENT_138	[p9l440t2075r564b2148],
26	or	CC	O	or	_	0	SENT_138	[p9l588t2095r678b2148],
27	the	DT	O	the	det	31	SENT_138	[p9l703t2069r832b2148],
28	CC	NN	O	cc	nn	31	SENT_138	[p9l860t2075r984b2148],
29	genotype	NN	O	genotype	nn	31	SENT_138	[p9l1013t2086r1398b2170],
30	(	CD	NUMBER	(	num	31	SENT_138	[p9l1431t2070r1615b2170],
31	Fig	NN	O	fig	prep_with	21	SENT_138	[p9l1431t2070r1615b2170],
32	.	.	O	.	_	0	SENT_138	[p9l1431t2070r1615b2170],

1	3	CD	NUMBER	3	_	0	SENT_139	[p9l1649t2075r1754b2161],
2	)	NN	O	)	dep	1	SENT_139	[p9l1649t2075r1754b2161],
3	.	.	O	.	_	0	SENT_139	[p9l1649t2075r1754b2161],

1	Of	IN	O	of	_	0	SENT_140	[p9l1787t2069r1908b2148],
2	many	JJ	O	many	amod	3	SENT_140	[p9l1917t2095r2152b2170],
3	variables	NNS	O	variable	prep_of	22	SENT_140	[p9l8t2197r382b2277],
4	evaluated	VBN	O	evaluate	partmod	3	SENT_140	[p9l423t2198r841b2293],
5	,	,	O	,	_	0	SENT_140	[p9l423t2198r841b2293],
6	only	RB	O	only	advmod	9	SENT_140	[p9l885t2198r1067b2298],
7	the	DT	O	the	det	9	SENT_140	[p9l1101t2197r1230b2276],
8	ABCB1	NN	O	abcb1	nn	9	SENT_140	[p9l1261t2203r1528b2276],
9	genotype	NN	O	genotype	nsubj	22	SENT_140	[p9l1568t2214r1954b2298],
10	and	CC	O	and	_	0	SENT_140	[p9l1991t2197r2148b2276],
11	the	DT	O	the	det	15	SENT_140	[p9l14t2326r143b2404],
12	base	NN	O	base	nn	15	SENT_140	[p9l171t2325r552b2404],
13	—	NN	O	—	nn	15	SENT_140	[p9l171t2325r552b2404],
14	line	NN	O	line	nn	15	SENT_140	[p9l171t2325r552b2404],
15	number	NN	O	number	nsubj	22	SENT_140	[p9l579t2325r916b2405],
16	of	IN	O	of	_	0	SENT_140	[p9l941t2325r1042b2404],
17	HIV	NN	O	hiv	nn	19	SENT_140	[p9l1049t2333r1220b2404],
18	RNA	NN	O	rna	nn	19	SENT_140	[p9l1241t2332r1448b2409],
19	copies	NNS	O	copy	prep_of	15	SENT_140	[p9l1472t2326r1738b2426],
20	were	VBD	O	be	cop	22	SENT_140	[p9l1763t2352r1965b2405],
21	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_140	[p9l1993t2326r2147b2426, p9l13t2453r342b2532],
22	predictors	NNS	O	predictor	_	0	SENT_140	[p9l357t2453r787b2554],
23	of	IN	O	of	_	0	SENT_140	[p9l811t2453r912b2532],
24	CD4	NN	O	cd4	nn	26	SENT_140	[p9l916t2459r1102b2532],
25	recovery	NN	O	recovery	nn	26	SENT_140	[p9l1123t2460r1575b2554],
26	.2	NN	NUMBER	.2	prep_of	22	SENT_140	[p9l1123t2460r1575b2554],
27	°	CD	NUMBER	°	tmod	26	SENT_140	[p9l1123t2460r1575b2554],
28	However	RB	O	however	advmod	27	SENT_140	[p9l1595t2461r1990b2549],
29	,	,	O	,	_	0	SENT_140	[p9l1595t2461r1990b2549],
30	the	DT	O	the	det	32	SENT_140	[p9l2017t2454r2147b2532],
31	ABCB1	NN	O	abcb1	nn	32	SENT_140	[p9l6t2587r271b2660],
32	2677G	NN	O	2677g	appos	26	SENT_140	[p9l299t2587r749b2660],
33	+	CC	O	+	_	0	SENT_140	[p9l299t2587r749b2660],
34	T	NN	O	t	appos	26	SENT_140	[p9l299t2587r749b2660],
35	single	JJ	O	single	amod	38	SENT_140	[p9l773t2582r1498b2682],
36	—	NN	O	—	nn	38	SENT_140	[p9l773t2582r1498b2682],
37	nucleotide	NN	O	nucleotide	nn	38	SENT_140	[p9l773t2582r1498b2682],
38	polymorphism	NN	O	polymorphism	nsubjpass	41	SENT_140	[p9l1523t2581r2148b2682],
39	was	VBD	O	be	auxpass	41	SENT_140	[p9l8t2736r172b2789],
40	not	RB	O	not	neg	41	SENT_140	[p9l200t2726r347b2788],
41	genotyped	VBN	O	genotype	rcmod	22	SENT_140	[p9l367t2710r841b2810],
42	,	,	O	,	_	0	SENT_140	[p9l367t2710r841b2810],
43	so	IN	O	so	dep	22	SENT_140	[p9l874t2735r966b2788],
44	it	PRP	O	it	nsubj	46	SENT_140	[p9l993t2710r1054b2788],
45	remains	VBZ	O	remain	cop	46	SENT_140	[p9l1074t2710r1422b2788],
46	unclear	JJ	O	unclear	ccomp	22	SENT_140	[p9l1450t2710r1772b2789],
47	whether	IN	O	whether	complm	54	SENT_140	[p9l1790t2710r2149b2789],
48	the	DT	O	the	det	49	SENT_140	[p9l14t2838r145b2916],
49	3435C	NN	O	3435c	nsubjpass	58	SENT_140	[p9l196t2843r644b2916],
50	+	CC	O	+	_	0	SENT_140	[p9l196t2843r644b2916],
51	T	NN	O	t	nn	52	SENT_140	[p9l196t2843r644b2916],
52	polymorphism	NN	O	polymorphism	conj_+	49	SENT_140	[p9l689t2838r1332b2938],
53	is	VBZ	O	be	cop	54	SENT_140	[p9l1381t2838r1448b2916],
54	causative	JJ	O	causative	ccomp	46	SENT_140	[p9l1501t2838r1890b2917],
55	or	CC	O	or	_	0	SENT_140	[p9l1941t2863r2032b2916],
56	is	VBZ	O	be	auxpass	58	SENT_140	[p9l2078t2838r2144b2916],
57	simply	RB	O	simply	advmod	58	SENT_140	[p9l15t2966r304b3066],
58	linked	VBN	O	link	conj_or	54	SENT_140	[p9l329t2965r600b3045],
59	with	IN	O	with	_	0	SENT_140	[p9l624t2965r818b3045],
60	another	DT	O	another	det	61	SENT_140	[p9l847t2966r1185b3044],
61	polymorphism	NN	O	polymorphism	prep_with	58	SENT_140	[p9l1210t2966r1854b3066],
62	that	WDT	O	that	nsubj	64	SENT_140	[p9l1884t2966r2055b3044],
63	is	VBZ	O	be	cop	64	SENT_140	[p9l2079t2966r2144b3044],
64	causative	JJ	O	causative	rcmod	61	SENT_140	[p9l14t3066r429b3145],
65	.	.	O	.	_	0	SENT_140	[p9l14t3066r429b3145],

1	This	DT	O	this	det	2	SENT_141	[p9l139t3194r325b3272],
2	example	NN	O	example	nsubj	3	SENT_141	[p9l359t3193r711b3294],
3	illustrates	VBZ	O	illustrate	_	0	SENT_141	[p9l742t3194r1156b3273],
4	a	DT	O	a	det	6	SENT_141	[p9l1188t3220r1233b3272],
5	common	JJ	O	common	amod	6	SENT_141	[p9l1262t3219r1645b3272],
6	problem	NN	O	problem	dobj	3	SENT_141	[p9l1674t3193r2036b3294],
7	in	IN	O	in	_	0	SENT_141	[p9l2066t3194r2148b3271],
8	association	NN	O	association	nn	9	SENT_141	[p9l12t3322r490b3400],
9	studies	NNS	O	study	prep_in	6	SENT_141	[p9l514t3322r835b3417],
10	,	,	O	,	_	0	SENT_141	[p9l514t3322r835b3417],
11	namely	RB	O	namely	advmod	9	SENT_141	[p9l862t3321r1183b3422],
12	,	,	O	,	_	0	SENT_141	[p9l862t3321r1183b3422],
13	biologic	JJ	O	biologic	amod	14	SENT_141	[p9l1212t3321r1555b3422],
14	plausibility	NN	O	plausibility	appos	9	SENT_141	[p9l1576t3321r2060b3422],
15	.	.	O	.	_	0	SENT_141	[p9l1576t3321r2060b3422],

1	It	PRP	O	it	nsubj	4	SENT_142	[p9l2087t3329r2153b3400],
2	is	VBZ	O	be	cop	4	SENT_142	[p9l12t3450r77b3528],
3	not	RB	O	not	neg	4	SENT_142	[p9l108t3466r252b3528],
4	obvious	JJ	O	obvious	_	0	SENT_142	[p9l277t3450r604b3529],
5	how	WRB	O	how	advmod	14	SENT_142	[p9l635t3450r820b3529],
6	greater	JJR	O	greater	amod	7	SENT_142	[p9l845t3466r1143b3550],
7	efficacy	NN	O	efficacy	dep	5	SENT_142	[p9l1170t3449r1491b3550],
8	(	CD	NUMBER	(	num	11	SENT_142	[p9l1520t3455r1736b3541],
9	CD4	NN	O	cd4	nn	11	SENT_142	[p9l1520t3455r1736b3541],
10	recovery	NN	O	recovery	nn	11	SENT_142	[p9l1765t3457r2142b3550],
11	)	NN	O	)	nsubjpass	14	SENT_142	[p9l1765t3457r2142b3550],
12	could	MD	O	could	aux	14	SENT_142	[p9l14t3578r251b3657],
13	be	VB	O	be	auxpass	14	SENT_142	[p9l294t3578r391b3656],
14	linked	VBN	O	link	ccomp	4	SENT_142	[p9l431t3577r702b3657],
15	to	TO	O	to	_	0	SENT_142	[p9l745t3594r825b3656],
16	a	DT	O	a	det	20	SENT_142	[p9l868t3604r912b3656],
17	single	JJ	O	single	amod	20	SENT_142	[p9l954t3577r1706b3678],
18	—	NN	O	—	nn	20	SENT_142	[p9l954t3577r1706b3678],
19	nucleotide	NN	O	nucleotide	nn	20	SENT_142	[p9l954t3577r1706b3678],
20	polymorphism	NN	O	polymorphism	prep_to	14	SENT_142	[p9l1746t3578r2145b3678, p9l11t3705r286b3806],
21	associated	VBN	O	associate	partmod	20	SENT_142	[p9l332t3705r780b3784],
22	with	IN	O	with	_	0	SENT_142	[p9l823t3706r1016b3785],
23	lower	JJR	O	lower	amod	26	SENT_142	[p9l1062t3706r1306b3785],
24	plasma	NN	O	plasma	nn	26	SENT_142	[p9l1349t3705r1663b3806],
25	drug	NN	O	drug	nn	26	SENT_142	[p9l1709t3706r1912b3806],
26	concentrations	NNS	O	concentration	prep_with	21	SENT_142	[p9l1957t3731r2145b3784, p10l14t21r524b116],
27	,	,	O	,	_	0	SENT_142	[p9l1957t3731r2145b3784, p10l14t21r524b116],

1	unless	IN	O	unless	mark	3	SENT_143	[p10l554t21r827b100],
2	there	EX	O	there	expl	3	SENT_143	[p10l854t20r1072b99],
3	are	VBP	O	be	_	0	SENT_143	[p10l1095t47r1224b99],
4	speciﬁc	JJ	O	speciﬁc	amod	5	SENT_143	[p10l1250t20r1578b121],
5	effects	NNS	O	effect	nsubj	3	SENT_143	[p10l1602t20r1880b99],
6	of	IN	O	of	_	0	SENT_143	[p10l1907t20r2008b99],
7	the	DT	O	the	det	9	SENT_143	[p10l2014t21r2147b99],
8	ABCB1	NN	O	abcb1	nn	9	SENT_143	[p10l6t154r277b227],
9	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_143	[p10l316t148r989b249],
10	that	WDT	O	that	nsubj	11	SENT_143	[p10l1028t149r1195b227],
11	cause	VBP	O	cause	rcmod	5	SENT_143	[p10l1227t175r1458b228],
12	decreased	VBN	O	decrease	amod	14	SENT_143	[p10l1496t148r1914b227],
13	drug	NN	O	drug	nn	14	SENT_143	[p10l1951t148r2151b249],
14	efﬂux	NN	O	efﬂux	dobj	11	SENT_143	[p10l14t276r254b356],
15	from	IN	O	from	_	0	SENT_143	[p10l278t276r486b355],
16	CD4	NN	O	cd4	nn	17	SENT_143	[p10l513t282r699b355],
17	leukocytes	NNS	O	leukocyte	prep_from	14	SENT_143	[p10l724t277r1191b377],
18	.	.	O	.	_	0	SENT_143	[p10l724t277r1191b377],

1	Overexpression	NN	O	overexpression	nsubj	15	SENT_144	[p10l1223t277r1881b377],
2	of	IN	O	of	_	0	SENT_144	[p10l1908t276r2009b355],
3	the	DT	O	the	det	4	SENT_144	[p10l2018t277r2147b355],
4	gene	NN	O	gene	prep_of	1	SENT_144	[p10l12t430r211b505],
5	for	IN	O	for	_	0	SENT_144	[p10l233t404r355b483],
6	another	DT	O	another	det	10	SENT_144	[p10l373t404r701b483],
7	ABC	NNP	ORGANIZATION	ABC	nn	10	SENT_144	[p10l716t410r903b483],
8	transporter	NN	O	transporter	nn	10	SENT_144	[p10l928t421r1401b505],
9	(	CD	NUMBER	(	num	10	SENT_144	[p10l1424t410r1734b500],
10	ABCC4	NN	O	abcc4	prep_for	4	SENT_144	[p10l1424t410r1734b500],
11	,	,	O	,	_	0	SENT_144	[p10l1424t410r1734b500],
12	or	CC	O	or	_	0	SENT_144	[p10l1761t430r1851b483],
13	MRP4	NN	O	mrp4	nn	14	SENT_144	[p10l1868t411r2142b496],
14	)	NN	O	)	prep_for	4	SENT_144	[p10l1868t411r2142b496],
15	confers	VBZ	O	confer	ccomp	41	SENT_144	[p10l14t532r324b611],
16	resistance	NN	O	resistance	dobj	15	SENT_144	[p10l358t533r783b611],
17	to	TO	O	to	_	0	SENT_144	[p10l815t549r895b611],
18	some	DT	O	some	det	19	SENT_144	[p10l930t558r1156b611],
19	nucleoside	NN	O	nucleoside	prep_to	15	SENT_144	[p10l1188t532r1643b612],
20	antiretrovi	JJ	O	antiretrovi	amod	23	SENT_144	[p10l1675t533r2147b612],
21	—	NN	O	—	nn	23	SENT_144	[p10l1675t533r2147b612],
22	ral	NN	O	ral	nn	23	SENT_144	[p10l13t661r121b739],
23	agents	NNS	O	agent	nsubj	24	SENT_144	[p10l153t677r428b761],
24	(	VBP	O	(	rcmod	19	SENT_144	[p10l467t668r675b761],
25	e.g.	FW	O	e.g.	dobj	24	SENT_144	[p10l467t668r675b761],
26	,	,	O	,	_	0	SENT_144	[p10l467t668r675b761],
27	zidovudine	NN	O	zidovudine	nsubj	36	SENT_144	[p10l714t660r1327b752],
28	)	CD	NUMBER	)	number	29	SENT_144	[p10l714t660r1327b752],
29	.31	CD	NUMBER	.31	num	27	SENT_144	[p10l714t660r1327b752],
30	Despite	IN	O	despite	_	0	SENT_144	[p10l1358t661r1679b761],
31	the	DT	O	the	det	32	SENT_144	[p10l1712t661r1842b739],
32	uncertainty	NN	O	uncertainty	prep_despite	27	SENT_144	[p10l1875t686r2146b740, p10l14t789r254b889],
33	about	IN	O	about	_	0	SENT_144	[p10l278t789r523b868],
34	the	DT	O	the	det	35	SENT_144	[p10l548t789r678b867],
35	mechanisms	NNS	O	mechanism	prep_about	32	SENT_144	[p10l707t788r1244b867],
36	involved	VBN	O	involve	rcmod	25	SENT_144	[p10l1275t788r1650b884],
37	,	,	O	,	_	0	SENT_144	[p10l1275t788r1650b884],
38	the	DT	O	the	det	40	SENT_144	[p10l1686t788r1816b867],
39	clinical	JJ	O	clinical	amod	40	SENT_144	[p10l1846t789r2148b867],
40	value	NN	O	value	nsubj	41	SENT_144	[p10l8t917r227b996],
41	is	VBZ	O	be	_	0	SENT_144	[p10l257t917r322b995],
42	that	IN	O	that	complm	48	SENT_144	[p10l355t917r522b995],
43	a	DT	O	a	det	46	SENT_144	[p10l547t943r591b995],
44	host	NN	O	host	nn	46	SENT_144	[p10l620t916r807b995],
45	genetic	JJ	O	genetic	amod	46	SENT_144	[p10l832t917r1138b1017],
46	marker	NN	O	marker	nsubj	63	SENT_144	[p10l1167t916r1475b996],
47	can	MD	O	can	aux	48	SENT_144	[p10l1502t942r1647b995],
48	predict	VB	O	predict	ccomp	41	SENT_144	[p10l1676t916r1978b1017],
49	immune	JJ	O	immune	amod	50	SENT_144	[p10l2002t917r2147b994, p10l13t1070r254b1124],
50	recovery	NN	O	recovery	dobj	48	SENT_144	[p10l288t1070r641b1145],
51	after	IN	O	after	_	0	SENT_144	[p10l670t1044r864b1123],
52	the	DT	O	the	det	53	SENT_144	[p10l895t1045r1025b1123],
53	initiation	NN	O	initiation	prep_after	48	SENT_144	[p10l1059t1045r1447b1123],
54	of	IN	O	of	_	0	SENT_144	[p10l1481t1044r1582b1123],
55	antiretroviral	JJ	O	antiretroviral	amod	56	SENT_144	[p10l1597t1045r2148b1124],
56	treatment	NN	O	treatment	prep_of	53	SENT_144	[p10l14t1189r430b1251],
57	and	CC	O	and	_	0	SENT_144	[p10l452t1172r631b1268],
58	,	,	O	,	_	0	SENT_144	[p10l452t1172r631b1268],
59	if	IN	O	if	mark	60	SENT_144	[p10l664t1172r740b1250],
60	validated	VBN	O	validate	parataxis	48	SENT_144	[p10l744t1172r1150b1268],
61	,	,	O	,	_	0	SENT_144	[p10l744t1172r1150b1268],
62	may	MD	O	may	aux	63	SENT_144	[p10l1183t1199r1360b1273],
63	offer	VB	O	offer	conj_and	48	SENT_144	[p10l1384t1172r1586b1251],
64	a	DT	O	a	det	66	SENT_144	[p10l1610t1199r1655b1251],
65	new	JJ	O	new	amod	66	SENT_144	[p10l1681t1198r1857b1252],
66	strategy	NN	O	strategy	dobj	63	SENT_144	[p10l1882t1189r2147b1251, p10l12t1327r110b1401],
67	in	IN	O	in	_	0	SENT_144	[p10l130t1301r211b1378],
68	tailoring	VBG	O	tailor	prepc_in	63	SENT_144	[p10l237t1301r605b1401],
69	HIV	NN	MISC	hiv	nn	70	SENT_144	[p10l626t1308r796b1379],
70	therapy	NN	O	therapy	dobj	68	SENT_144	[p10l819t1301r1148b1401],
71	.	.	O	.	_	0	SENT_144	[p10l819t1301r1148b1401],

1	GENETIC	JJ	O	genetic	amod	2	SENT_145	[p10l334t1637r840b1697],
2	POLYMORPHISM	NN	O	polymorphism	_	0	SENT_145	[p10l895t1637r1812b1697],

1	OF	IN	O	of	_	0	SENT_146	[p10l548t1744r683b1804],
2	DRUG	NN	O	drug	nn	3	SENT_146	[p10l737t1744r1056b1804],
3	TARGETS	NNS	O	target	pobj	1	SENT_146	[p10l1103t1744r1598b1804],

1	Genetic	JJ	O	genetic	amod	2	SENT_147	[p10l13t1978r346b2056],
2	variation	NN	O	variation	nsubj	6	SENT_147	[p10l371t1978r754b2057],
3	in	IN	O	in	_	0	SENT_147	[p10l784t1978r867b2055],
4	drug	NN	O	drug	nn	5	SENT_147	[p10l898t1978r1102b2078],
5	targets	NNS	O	target	prep_in	2	SENT_147	[p10l1129t1994r1422b2078],
6	(	VBP	O	(	ccomp	25	SENT_147	[p10l1459t1985r1672b2078],
7	e.g.	FW	O	e.g.	dobj	6	SENT_147	[p10l1459t1985r1672b2078],
8	,	,	O	,	_	0	SENT_147	[p10l1459t1985r1672b2078],
9	receptors	NNS	O	receptor	nsubj	10	SENT_147	[p10l1708t1984r2141b2078],
10	)	VBP	O	)	dep	6	SENT_147	[p10l1708t1984r2141b2078],
11	can	MD	O	can	aux	12	SENT_147	[p10l14t2131r160b2184],
12	have	VB	O	have	ccomp	10	SENT_147	[p10l193t2106r385b2185],
13	a	DT	O	a	det	15	SENT_147	[p10l418t2132r463b2184],
14	profound	JJ	O	profound	amod	15	SENT_147	[p10l492t2105r902b2206],
15	effect	NN	O	effect	dobj	12	SENT_147	[p10l935t2105r1175b2184],
16	on	IN	O	on	_	0	SENT_147	[p10l1204t2131r1312b2184],
17	drug	NN	O	drug	nn	18	SENT_147	[p10l1345t2105r1549b2206],
18	efﬁcacy	NN	O	efﬁcacy	prep_on	15	SENT_147	[p10l1579t2105r1920b2206],
19	,	,	O	,	_	0	SENT_147	[p10l1579t2105r1920b2206],
20	with	IN	O	with	_	0	SENT_147	[p10l1953t2105r2147b2185],
21	over	IN	O	over	amod	23	SENT_147	[p10l14t2259r190b2313],
22	25	CD	NUMBER	25	num	23	SENT_147	[p10l211t2239r308b2312],
23	examples	NNS	O	example	prep_with	25	SENT_147	[p10l337t2234r728b2334],
24	already	RB	O	already	advmod	25	SENT_147	[p10l753t2233r1055b2334],
25	identiﬁed	VBD	O	identiﬁed	_	0	SENT_147	[p10l1073t2233r1474b2312],
26	(	CD	NUMBER	(	num	27	SENT_147	[p10l1502t2233r1755b2325],
27	Table	NNP	O	Table	dobj	25	SENT_147	[p10l1502t2233r1755b2325],
28	1	CD	NUMBER	1	num	27	SENT_147	[p10l1782t2239r1993b2325],
29	)	CD	NUMBER	)	num	30	SENT_147	[p10l1782t2239r1993b2325],
30	.3	NN	NUMBER	.3	nsubj	41	SENT_147	[p10l1782t2239r1993b2325],
31	‘	CD	NUMBER	‘	number	32	SENT_147	[p10l1782t2239r1993b2325],
32	5	CD	NUMBER	5	num	34	SENT_147	[p10l1782t2239r1993b2325],
33	Sequence	NN	O	sequence	nn	34	SENT_147	[p10l2023t2239r2147b2312, p10l14t2387r312b2462],
34	variants	NNS	O	variant	npadvmod	30	SENT_147	[p10l331t2362r663b2441],
35	with	IN	O	with	_	0	SENT_147	[p10l684t2362r875b2441],
36	a	DT	O	a	det	38	SENT_147	[p10l898t2388r942b2440],
37	direct	JJ	O	direct	amod	38	SENT_147	[p10l965t2361r1208b2440],
38	effect	NN	O	effect	prep_with	30	SENT_147	[p10l1228t2361r1463b2440],
39	on	IN	O	on	_	0	SENT_147	[p10l1483t2387r1589b2440],
40	response	NN	O	response	prep_on	38	SENT_147	[p10l1613t2387r1994b2462],
41	occur	VBP	O	occur	rcmod	27	SENT_147	[p10l2019t2387r2147b2440, p10l14t2516r151b2569],
42	in	IN	O	in	_	0	SENT_147	[p10l178t2490r262b2567],
43	the	DT	O	the	det	44	SENT_147	[p10l293t2490r425b2568],
44	gene	NN	O	gene	nsubj	52	SENT_147	[p10l457t2515r660b2590],
45	for	IN	O	for	_	0	SENT_147	[p10l692t2489r817b2568],
46	the	DT	O	the	prep_for	44	SENT_147	[p10l846t2489r978b2568],
47	,	,	O	,	_	0	SENT_147	[p10l1004t2490r1837b2590],
48	B2	NN	O	b2	nn	50	SENT_147	[p10l1004t2490r1837b2590],
49	—	NN	O	—	nn	50	SENT_147	[p10l1004t2490r1837b2590],
50	adrenoreceptor	NN	O	adrenoreceptor	appos	46	SENT_147	[p10l1004t2490r1837b2590],
51	,	,	O	,	_	0	SENT_147	[p10l1004t2490r1837b2590],
52	affecting	VBG	O	affect	prepc_in	41	SENT_147	[p10l1873t2489r2145b2568, p10l12t2618r153b2718],
53	the	DT	O	the	det	54	SENT_147	[p10l178t2617r308b2696],
54	response	NN	O	response	dobj	52	SENT_147	[p10l336t2643r718b2718],
55	to	TO	O	to	prep	52	SENT_147	[p10l746t2634r826b2696],
56	,	,	O	,	_	0	SENT_147	[p10l851t2618r1563b2718],
57	B2	NN	O	b2	nn	59	SENT_147	[p10l851t2618r1563b2718],
58	—	CD	NUMBER	—	num	59	SENT_147	[p10l851t2618r1563b2718],
59	agonists43	NN	O	agonists43	dobj	52	SENT_147	[p10l851t2618r1563b2718],
60	»	CD	NUMBER	»	number	61	SENT_147	[p10l851t2618r1563b2718],
61	44	CD	NUMBER	44	dep	59	SENT_147	[p10l851t2618r1563b2718],
62	;	:	O	;	_	0	SENT_147	[p10l851t2618r1563b2718],
63	arachidonate	NN	O	arachidonate	dep	59	SENT_147	[p10l1595t2618r2147b2696],
64	5	CD	NUMBER	5	number	65	SENT_147	[p10l15t2746r662b2846],
65	—	CD	NUMBER	—	num	66	SENT_147	[p10l15t2746r662b2846],
66	lipoXygenase	NN	O	lipoxygenase	dep	27	SENT_147	[p10l15t2746r662b2846],
67	(	CD	NUMBER	(	num	69	SENT_147	[p10l693t2751r1080b2841],
68	ALOX5	NN	O	alox5	nn	69	SENT_147	[p10l693t2751r1080b2841],
69	)	NN	O	)	dep	27	SENT_147	[p10l693t2751r1080b2841],
70	,	,	O	,	_	0	SENT_147	[p10l693t2751r1080b2841],
71	affecting	VBG	O	affect	partmod	69	SENT_147	[p10l1109t2745r1484b2846],
72	the	DT	O	the	det	73	SENT_147	[p10l1506t2746r1636b2824],
73	response	NN	O	response	dobj	71	SENT_147	[p10l1661t2771r2042b2846],
74	to	TO	O	to	_	0	SENT_147	[p10l2067t2762r2147b2824],
75	ALOX5	NN	O	alox5	nn	77	SENT_147	[p10l9t2879r312b2952],
76	inhibitors	NNS	O	inhibitor	nn	77	SENT_147	[p10l353t2874r891b2969],
77	“	NN	O	“	prep_to	71	SENT_147	[p10l353t2874r891b2969],
78	;	:	O	;	_	0	SENT_147	[p10l353t2874r891b2969],
79	and	CC	O	and	_	0	SENT_147	[p10l934t2874r1092b2952],
80	angiotensin	NN	O	angiotensin	conj_and	27	SENT_147	[p10l1130t2874r2150b2974],
81	—	CD	NUMBER	—	num	80	SENT_147	[p10l1130t2874r2150b2974],
82	converting	VBG	O	convert	partmod	80	SENT_147	[p10l1130t2874r2150b2974],
83	enzyme	NN	O	enzyme	dobj	82	SENT_147	[p10l14t3027r341b3102],
84	(	CD	NUMBER	(	num	86	SENT_147	[p10l369t3007r640b3097],
85	ACE	NN	O	ace	nn	86	SENT_147	[p10l369t3007r640b3097],
86	)	NN	O	)	nsubj	25	SENT_147	[p10l369t3007r640b3097],
87	,	,	O	,	_	0	SENT_147	[p10l369t3007r640b3097],
88	affecting	VBG	O	affect	partmod	25	SENT_147	[p10l666t3001r1042b3102],
89	the	DT	O	the	det	91	SENT_147	[p10l1060t3002r1190b3080],
90	renoprotective	JJ	O	renoprotective	amod	91	SENT_147	[p10l1212t3002r1823b3102],
91	actions	NNS	O	action	dobj	88	SENT_147	[p10l1844t3002r2145b3080],
92	of	IN	O	of	_	0	SENT_147	[p10l14t3129r115b3208],
93	ACE	NN	O	ace	nn	94	SENT_147	[p10l126t3135r309b3208],
94	inhibitors	NNS	O	inhibitor	prep_of	91	SENT_147	[p10l345t3130r874b3208],
95	.	.	O	.	_	0	SENT_147	[p10l345t3130r874b3208],

1	-	:	O	-	_	0	SENT_148	[p10l345t3130r874b3208],
2	“	NN	O	“	nn	3	SENT_148	[p10l345t3130r874b3208],
3	*	NN	O	*	_	0	SENT_148	[p10l345t3130r874b3208],
4	2	CD	NUMBER	2	num	6	SENT_148	[p10l345t3130r874b3208],
5	Genetic	JJ	O	genetic	amod	6	SENT_148	[p10l908t3130r1235b3208],
6	differences	NNS	O	difference	nsubj	9	SENT_148	[p10l1270t3129r1735b3208],
7	may	MD	O	may	aux	9	SENT_148	[p10l1772t3156r1949b3230],
8	also	RB	O	also	advmod	9	SENT_148	[p10l1978t3130r2146b3208],
9	have	VB	O	have	rcmod	3	SENT_148	[p10l13t3257r202b3337],
10	indirect	JJ	O	indirect	amod	11	SENT_148	[p10l230t3257r561b3336],
11	effects	NNS	O	effect	dobj	9	SENT_148	[p10l584t3257r856b3336],
12	on	IN	O	on	_	0	SENT_148	[p10l887t3283r994b3336],
13	drug	NN	O	drug	nn	14	SENT_148	[p10l1024t3257r1224b3358],
14	response	NN	O	response	prep_on	11	SENT_148	[p10l1249t3283r1630b3358],
15	that	WDT	O	that	nsubj	17	SENT_148	[p10l1659t3258r1827b3336],
16	are	VBP	O	be	cop	17	SENT_148	[p10l1850t3284r1976b3336],
17	unrelated	JJ	O	unrelated	rcmod	11	SENT_148	[p10l2005t3283r2147b3337, p10l13t3385r300b3464],
18	to	TO	O	to	_	0	SENT_148	[p10l339t3402r418b3464],
19	drug	NN	O	drug	nn	20	SENT_148	[p10l459t3386r659b3486],
20	metabolism	NN	O	metabolism	prep_to	17	SENT_148	[p10l694t3386r1202b3464],
21	or	CC	O	or	_	0	SENT_148	[p10l1241t3411r1331b3464],
22	transport	NN	O	transport	conj_or	20	SENT_148	[p10l1367t3402r1782b3486],
23	,	,	O	,	_	0	SENT_148	[p10l1367t3402r1782b3486],
24	such	JJ	O	such	_	0	SENT_148	[p10l1828t3386r2023b3465],
25	as	IN	O	as	_	0	SENT_148	[p10l2061t3412r2145b3464],
26	methylation	NN	O	methylation	prep_such_as	17	SENT_148	[p10l13t3514r521b3614],
27	of	IN	O	of	_	0	SENT_148	[p10l552t3513r653b3592],
28	the	DT	O	the	det	32	SENT_148	[p10l664t3513r794b3592],
29	methylguanine	NN	O	methylguanine	nn	32	SENT_148	[p10l824t3514r1459b3614],
30	methyltransfer	NN	O	methyltransfer	nn	32	SENT_148	[p10l1489t3513r2147b3614],
31	—	CD	NUMBER	—	num	32	SENT_148	[p10l1489t3513r2147b3614],
32	ase	NN	O	ase	prep_of	26	SENT_148	[p10l12t3668r147b3720],
33	(	CD	NUMBER	(	num	37	SENT_148	[p10l186t3647r557b3733],
34	MGMT	NNP	ORGANIZATION	MGMT	nn	37	SENT_148	[p10l186t3647r557b3733],
35	)	CD	NUMBER	)	num	37	SENT_148	[p10l186t3647r557b3733],
36	gene	NN	O	gene	nn	37	SENT_148	[p10l596t3667r799b3742],
37	promoter	NN	O	promoter	dep	32	SENT_148	[p10l832t3658r1262b3742],
38	,	,	O	,	_	0	SENT_148	[p10l832t3658r1262b3742],
39	which	WDT	O	which	nsubj	40	SENT_148	[p10l1297t3641r1563b3721],
40	alters	VBZ	O	alter	ccomp	17	SENT_148	[p10l1596t3642r1829b3720],
41	the	DT	O	the	det	42	SENT_148	[p10l1865t3642r1997b3720],
42	response	NN	O	response	dobj	40	SENT_148	[p10l2031t3668r2145b3720, p11l15t46r315b121],

1	of	IN	O	of	_	0	SENT_149	[p11l343t20r443b99],
2	gliomas	NNS	O	glioma	prep_of	14	SENT_149	[p11l448t21r785b121],
3	to	TO	O	to	_	0	SENT_149	[p11l812t37r891b99],
4	treatment	NN	O	treatment	prep_to	2	SENT_149	[p11l917t37r1334b99],
5	with	IN	O	with	_	0	SENT_149	[p11l1348t21r1538b100],
6	carmustine	NN	O	carmustine	prep_with	4	SENT_149	[p11l1563t21r2145b100],
7	.63	CD	NUMBER	.63	num	6	SENT_149	[p11l1563t21r2145b100],
8	The	DT	O	the	det	9	SENT_149	[p11l10t150r171b228],
9	mechanism	NN	O	mechanism	nsubjpass	14	SENT_149	[p11l192t150r684b228],
10	of	IN	O	of	_	0	SENT_149	[p11l706t149r806b228],
11	this	DT	O	this	det	12	SENT_149	[p11l808t149r960b228],
12	effect	NN	O	effect	prep_of	9	SENT_149	[p11l984t149r1217b228],
13	is	VBZ	O	be	auxpass	14	SENT_149	[p11l1231t150r1296b228],
14	related	VBN	O	relate	_	0	SENT_149	[p11l1319t150r1603b228],
15	to	TO	O	to	_	0	SENT_149	[p11l1625t166r1703b228],
16	a	DT	O	a	det	17	SENT_149	[p11l1725t176r1770b228],
17	decrease	NN	O	decrease	prep_to	14	SENT_149	[p11l1790t150r2148b228],
18	in	IN	O	in	_	0	SENT_149	[p11l12t278r95b355],
19	the	DT	O	the	det	20	SENT_149	[p11l125t278r258b356],
20	efﬁciency	NN	O	efﬁciency	prep_in	17	SENT_149	[p11l289t277r704b378],
21	of	IN	O	of	_	0	SENT_149	[p11l731t277r832b356],
22	repair	NN	O	repair	prep_of	20	SENT_149	[p11l845t278r1101b378],
23	of	IN	O	of	_	0	SENT_149	[p11l1129t277r1231b356],
24	alkylated	VBN	O	alkylate	prepc_of	22	SENT_149	[p11l1243t277r1627b378],
25	DNA	NN	O	dna	dobj	24	SENT_149	[p11l1656t284r1872b356],
26	in	IN	O	in	_	0	SENT_149	[p11l1898t278r1981b355],
27	patients	NNS	O	patient	prep_in	25	SENT_149	[p11l2010t304r2145b378, p11l14t406r250b484],
28	with	IN	O	with	_	0	SENT_149	[p11l282t406r473b485],
29	methylated	VBN	O	methylate	prepc_with	24	SENT_149	[p11l505t406r975b506],
30	MGMT	NNP	O	MGMT	dobj	29	SENT_149	[p11l1004t411r1330b484],
31	.	.	O	.	_	0	SENT_149	[p11l1004t411r1330b484],

1	It	PRP	O	it	nsubj	3	SENT_150	[p11l1366t413r1432b484],
2	is	VBZ	O	be	cop	3	SENT_150	[p11l1459t406r1524b484],
3	critical	JJ	O	critical	dep	45	SENT_150	[p11l1560t406r1845b484],
4	to	TO	O	to	aux	5	SENT_150	[p11l1878t422r1957b484],
5	distinguish	VB	O	distinguish	xcomp	3	SENT_150	[p11l1992t405r2147b484, p11l14t534r364b634],
6	this	DT	O	this	det	8	SENT_150	[p11l391t534r544b612],
7	target	NN	O	target	nn	8	SENT_150	[p11l574t550r825b634],
8	mechanism	NN	O	mechanism	dobj	5	SENT_150	[p11l846t533r1343b612],
9	from	IN	O	from	_	0	SENT_150	[p11l1370t533r1578b612],
10	genetic	JJ	O	genetic	amod	11	SENT_150	[p11l1605t534r1910b634],
11	polymorphisms	NNS	O	polymorphism	nsubj	15	SENT_150	[p11l1935t534r2147b634, p11l13t662r512b762],
12	in	IN	O	in	_	0	SENT_150	[p11l561t662r643b739],
13	drug	NN	O	drug	prep_in	11	SENT_150	[p11l692t662r1514b762],
14	—	CD	NUMBER	—	num	13	SENT_150	[p11l692t662r1514b762],
15	metabolizing	VBG	O	metabolize	prepc_from	5	SENT_150	[p11l692t662r1514b762],
16	enzymes	NNS	O	enzyme	dobj	15	SENT_150	[p11l1559t687r1930b762],
17	that	WDT	O	that	nsubj	18	SENT_150	[p11l1981t662r2152b740],
18	affect	VBP	O	affect	rcmod	16	SENT_150	[p11l12t789r255b868],
19	response	NN	O	response	dobj	18	SENT_150	[p11l300t815r680b890],
20	by	IN	O	by	_	0	SENT_150	[p11l728t790r826b890],
21	altering	VBG	O	alter	prepc_by	18	SENT_150	[p11l867t790r1197b890],
22	drug	NN	O	drug	nn	23	SENT_150	[p11l1241t789r1441b890],
23	concentrations	NNS	O	concentration	dobj	21	SENT_150	[p11l1485t790r2142b885],
24	,	,	O	,	_	0	SENT_150	[p11l1485t790r2142b885],
25	such	JJ	O	such	_	0	SENT_150	[p11l15t917r210b997],
26	as	IN	O	as	_	0	SENT_150	[p11l234t944r318b996],
27	the	DT	O	the	det	30	SENT_150	[p11l345t918r474b996],
28	thiopurine	JJ	O	thiopurine	amod	30	SENT_150	[p11l500t918r946b1018],
29	methyltransferase	NN	O	methyltransferase	nn	30	SENT_150	[p11l972t917r1732b1018],
30	polymorphism	NN	O	polymorphism	prep_such_as	23	SENT_150	[p11l1755t917r2147b1018, p11l11t1046r281b1146],
31	associated	VBN	O	associate	partmod	30	SENT_150	[p11l321t1046r759b1124],
32	with	IN	O	with	_	0	SENT_150	[p11l794t1046r985b1125],
33	the	DT	O	the	det	35	SENT_150	[p11l1025t1046r1154b1124],
34	hematopoietic	JJ	O	hematopoietic	amod	35	SENT_150	[p11l1195t1046r1805b1146],
35	toxicity	NN	O	toxicity	prep_with	31	SENT_150	[p11l1844t1046r2152b1146],
36	of	IN	O	of	_	0	SENT_150	[p11l14t1173r115b1252],
37	mercaptopurine54	NN	O	mercaptopurine54	prep_of	35	SENT_150	[p11l124t1174r995b1274],
38	‘	CD	NUMBER	‘	number	39	SENT_150	[p11l124t1174r995b1274],
39	55	CD	NUMBER	55	dep	37	SENT_150	[p11l124t1174r995b1274],
40	and	CC	O	and	_	0	SENT_150	[p11l1024t1173r1180b1252],
41	susceptibility	NN	O	susceptibility	prep_of	35	SENT_150	[p11l1209t1174r1770b1274],
42	to	TO	O	to	_	0	SENT_150	[p11l1794t1190r1873b1252],
43	radiation	NN	O	radiation	nn	44	SENT_150	[p11l1902t1173r2146b1252, p11l14t1302r558b1381],
44	—	NN	O	—	prep_to	41	SENT_150	[p11l1902t1173r2146b1252, p11l14t1302r558b1381],
45	induced	VBD	O	induce	_	0	SENT_150	[p11l1902t1173r2146b1252, p11l14t1302r558b1381],
46	brain	NN	O	brain	nn	47	SENT_150	[p11l584t1302r805b1380],
47	tumors	NNS	O	tumor	dobj	45	SENT_150	[p11l830t1306r1245b1381],
48	.57	CD	NUMBER	.57	nsubj	45	SENT_150	[p11l830t1306r1245b1381],

1	The	DT	O	the	det	5	SENT_151	[p11l139t1430r302b1508],
2	[	CD	NUMBER	[	number	3	SENT_151	[p11l349t1429r1149b1530],
3	32	CD	NUMBER	32	num	5	SENT_151	[p11l349t1429r1149b1530],
4	—	NN	O	—	nn	5	SENT_151	[p11l349t1429r1149b1530],
5	adrenoreceptor	NN	O	adrenoreceptor	nsubj	13	SENT_151	[p11l349t1429r1149b1530],
6	(	CD	NUMBER	(	dep	5	SENT_151	[p11l1204t1430r1487b1521],
7	coded	VBN	O	code	partmod	5	SENT_151	[p11l1204t1430r1487b1521],
8	by	IN	O	by	_	0	SENT_151	[p11l1540t1429r1637b1530],
9	the	DT	O	the	det	12	SENT_151	[p11l1686t1429r1816b1508],
10	ADRB2	NN	O	adrb2	nn	12	SENT_151	[p11l1862t1435r2144b1509],
11	gene	NN	O	gene	nn	12	SENT_151	[p11l12t1564r242b1658],
12	)	NN	O	)	agent	7	SENT_151	[p11l12t1564r242b1658],
13	illustrates	VBZ	O	illustrate	_	0	SENT_151	[p11l268t1558r682b1637],
14	another	DT	O	another	det	15	SENT_151	[p11l705t1557r1036b1636],
15	link	NN	O	link	dobj	13	SENT_151	[p11l1053t1558r1221b1637],
16	between	IN	O	between	_	0	SENT_151	[p11l1239t1558r1589b1637],
17	genetic	JJ	O	genetic	amod	18	SENT_151	[p11l1611t1558r1916b1658],
18	polymorphisms	NNS	O	polymorphism	prep_between	15	SENT_151	[p11l1935t1558r2147b1658, p11l13t1685r503b1786],
19	in	IN	O	in	_	0	SENT_151	[p11l531t1686r613b1763],
20	drug	NN	O	drug	nn	21	SENT_151	[p11l641t1685r841b1786],
21	targets	NNS	O	target	prep_in	18	SENT_151	[p11l865t1702r1152b1786],
22	and	CC	O	and	_	0	SENT_151	[p11l1181t1686r1338b1764],
23	clinical	JJ	O	clinical	amod	24	SENT_151	[p11l1365t1686r1667b1764],
24	responses	NNS	O	response	conj_and	21	SENT_151	[p11l1694t1711r2142b1786],
25	.	.	O	.	_	0	SENT_151	[p11l1694t1711r2142b1786],

1	Genetic	JJ	O	genetic	amod	2	SENT_152	[p11l13t1814r340b1892],
2	polymorphism	NN	O	polymorphism	dep	10	SENT_152	[p11l381t1813r1012b1914],
3	of	IN	O	of	_	0	SENT_152	[p11l1056t1813r1158b1892],
4	the	DT	O	the	prep_of	2	SENT_152	[p11l1183t1814r1313b1892],
5	,	,	O	,	_	0	SENT_152	[p11l1350t1813r2151b1914],
6	B2	NN	O	b2	nn	8	SENT_152	[p11l1350t1813r2151b1914],
7	—	NN	O	—	nn	8	SENT_152	[p11l1350t1813r2151b1914],
8	adrenoreceptor	NN	O	adrenoreceptor	appos	4	SENT_152	[p11l1350t1813r2151b1914],
9	can	MD	O	can	aux	10	SENT_152	[p11l14t1967r157b2020],
10	alter	VB	O	alter	_	0	SENT_152	[p11l179t1942r366b2020],
11	the	DT	O	the	det	12	SENT_152	[p11l386t1942r514b2020],
12	process	NN	O	process	dobj	10	SENT_152	[p11l536t1967r854b2042],
13	of	IN	O	of	_	0	SENT_152	[p11l880t1941r980b2020],
14	signal	NN	O	signal	nn	15	SENT_152	[p11l985t1942r1235b2042],
15	transduction	NN	O	transduction	prep_of	12	SENT_152	[p11l1258t1941r1793b2021],
16	by	IN	O	by	_	0	SENT_152	[p11l1816t1942r1912b2042],
17	these	DT	O	these	det	18	SENT_152	[p11l1931t1942r2148b2020],
18	receptors	NNS	O	receptor	prep_by	10	SENT_152	[p11l13t2075r637b2170],
19	.4344	CD	NUMBER	.4344	dep	18	SENT_152	[p11l13t2075r637b2170],
20	Three	CD	NUMBER	three	num	24	SENT_152	[p11l670t2069r920b2148],
21	single	JJ	O	single	amod	24	SENT_152	[p11l959t2069r1710b2170],
22	—	NN	O	—	nn	24	SENT_152	[p11l959t2069r1710b2170],
23	nucleotide	NN	O	nucleotide	nn	24	SENT_152	[p11l959t2069r1710b2170],
24	polymor542	NN	O	polymor542	nsubj	10	SENT_152	[p11l1746t2070r2145b2170, p11l149t2236r205b2259],

1	N	NN	O	n	nn	3	SENT_153	[p11l884t2238r898b2254],
2	ENGLJ	NN	O	englj	nn	3	SENT_153	[p11l913t2238r997b2260],
3	MED	NN	O	med	_	0	SENT_153	[p11l1012t2238r1065b2253],
4	348	CD	NUMBER	348	dep	3	SENT_153	[p11l1077t2232r1148b2260],
5	;	:	O	;	_	0	SENT_153	[p11l1077t2232r1148b2260],
6	6	CD	NUMBER	6	num	7	SENT_153	[p11l1077t2232r1148b2260],
7	www	NN	O	www	dep	3	SENT_153	[p11l1183t2238r1257b2254],
8	.	.	O	.	_	0	SENT_153	[p11l1183t2238r1257b2254],

1	E	NN	O	e	nn	3	SENT_154	[p11l1285t2238r1295b2253],
2	M.ORG	NN	O	m.org	nn	3	SENT_154	[p11l1311t2238r1394b2254],
3	FEBRUARY	NN	DATE	february	_	0	SENT_154	[p11l1434t2238r1561b2254],
4	6,2003	CD	DATE	6,2003	dep	3	SENT_154	[p11l1574t2232r1672b2260],

1	The	DT	O	the	det	3	SENT_155	[p11l935t2271r986b2295],
2	New	NNP	O	New	nn	3	SENT_155	[p11l995t2272r1057b2295],
3	England	NNP	O	England	_	0	SENT_155	[p11l1066t2271r1177b2302],
4	Joum	NNP	O	Joum	nn	5	SENT_155	[p11l1186t2272r1259b2295],
5	Medicine	NNP	O	Medicine	dep	3	SENT_155	[p11l1329t2271r1454b2295],

1	Downloaded	VBN	O	download	_	0	SENT_156	[p11l377t2312r547b2335],
2	from	IN	O	from	_	0	SENT_156	[p11l556t2312r620b2335],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_156	[p11l629t2312r747b2342],
4	at	IN	O	at	_	0	SENT_156	[p11l758t2316r781b2335],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_156	[p11l789t2312r972b2335],
6	on	IN	O	on	_	0	SENT_156	[p11l981t2319r1014b2335],
7	January	NNP	DATE	January	prep_on	1	SENT_156	[p11l1022t2312r1125b2342],
8	5	CD	DATE	5	num	7	SENT_156	[p11l1135t2312r1158b2339],
9	,	,	DATE	,	_	0	SENT_156	[p11l1135t2312r1158b2339],
10	2014	CD	DATE	2014	num	7	SENT_156	[p11l1169t2312r1241b2335],
11	.	.	O	.	_	0	SENT_156	[p11l1169t2312r1241b2335],

1	For	IN	O	for	_	0	SENT_157	[p11l1251t2312r1298b2335],
2	personal	JJ	O	personal	amod	3	SENT_157	[p11l1306t2312r1418b2342],
3	use	NN	O	use	pobj	1	SENT_157	[p11l1427t2319r1471b2335],
4	only	RB	O	only	advmod	3	SENT_157	[p11l1481t2312r1545b2342],
5	.	.	O	.	_	0	SENT_157	[p11l1481t2312r1545b2342],

1	No	DT	O	no	det	3	SENT_158	[p11l1556t2312r1596b2335],
2	other	JJ	O	other	amod	3	SENT_158	[p11l1606t2312r1674b2335],
3	uses	NNS	O	use	_	0	SENT_158	[p11l1682t2319r1738b2335],
4	without	IN	O	without	_	0	SENT_158	[p11l1748t2312r1849b2335],
5	permission	NN	O	permission	prep_without	3	SENT_158	[p11l1858t2312r2010b2342],
6	.	.	O	.	_	0	SENT_158	[p11l1858t2312r2010b2342],

1	Copyright	NN	O	copyright	_	0	SENT_159	[p11l727t2353r862b2384],
2	©	CD	NUMBER	©	num	6	SENT_159	[p11l871t2353r895b2377],
3	2003	CD	DATE	2003	num	6	SENT_159	[p11l905t2353r969b2377],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_159	[p11l979t2353r1170b2377],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_159	[p11l1180t2353r1288b2377],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_159	[p11l1299t2353r1404b2384],
7	.	.	O	.	_	0	SENT_159	[p11l1299t2353r1404b2384],

1	All	DT	O	all	det	2	SENT_160	[p11l1415t2353r1456b2377],
2	rights	NNS	O	rights	nsubj	3	SENT_160	[p11l1465t2353r1540b2384],
3	reserved	VBN	O	reserve	_	0	SENT_160	[p11l1550t2353r1669b2377],
4	.	.	O	.	_	0	SENT_160	[p11l1550t2353r1669b2377],

1	D	NN	O	d	nn	4	SENT_161	[p11l950t2397r970b2416],
2	RU	NN	O	ru	nn	4	SENT_161	[p11l976t2397r1020b2416],
3	G	NN	O	g	nn	4	SENT_161	[p11l1024t2397r1045b2416],
4	T	NN	O	t	_	0	SENT_161	[p11l1057t2397r1075b2416],
5	H	NN	O	h	nn	8	SENT_161	[p11l1080t2397r1102b2416],
6	E	NN	O	e	nn	8	SENT_161	[p11l1108t2397r1124b2416],
7	RA	NN	O	ra	nn	8	SENT_161	[p11l1129t2397r1170b2416],
8	PY	NN	O	py	dep	4	SENT_161	[p11l1175t2397r1210b2416],

1	Table	NNP	O	Table	_	0	SENT_162	[p11l263t2531r334b2556],
2	1	CD	NUMBER	1	dep	1	SENT_162	[p11l344t2533r366b2555],
3	.	.	O	.	_	0	SENT_162	[p11l344t2533r366b2555],

1	Genetic	JJ	O	genetic	amod	2	SENT_163	[p11l376t2531r481b2556],
2	Polymorphisms	NNS	O	polymorphism	_	0	SENT_163	[p11l492t2530r704b2563],
3	in	IN	O	in	_	0	SENT_163	[p11l715t2531r737b2555],
4	Drug	NN	O	drug	nn	6	SENT_163	[p11l750t2533r817b2563],
5	Target	NN	O	target	nn	6	SENT_163	[p11l825t2533r910b2563],
6	Genes	NNS	O	gene	prep_in	2	SENT_163	[p11l918t2532r1004b2556],
7	That	WDT	O	that	nsubj	11	SENT_163	[p11l1013t2530r1075b2556],
8	Can	MD	O	can	aux	11	SENT_163	[p11l1083t2532r1134b2556],
9	Inﬂuence	NNP	O	Inﬂuence	nn	11	SENT_163	[p11l1146t2530r1271b2556],
10	Drug	NNP	O	Drug	nn	11	SENT_163	[p11l1282t2533r1350b2563],
11	Response	NNP	O	Response	rcmod	6	SENT_163	[p11l1360t2532r1515b2563],
12	.	.	O	.	_	0	SENT_163	[p11l1360t2532r1515b2563],

1	‘	SYM	O	‘	dep	4	SENT_164	[p11l1360t2532r1515b2563],
2	-	:	O	-	_	0	SENT_164	[p11l1360t2532r1515b2563],
3	'	''	O	'	_	0	SENT_164	[p11l1360t2532r1515b2563],
4	=	JJ	O	=	_	0	SENT_164	[p11l1360t2532r1515b2563],

1	ene	NN	O	ene	_	0	SENT_165	[p11l286t2620r331b2635],
2	Of	IN	O	of	dep	1	SENT_165	[p11l339t2620r366b2635],
3	ene	NN	O	ene	nn	5	SENT_165	[p11l395t2620r441b2635],
4	Vo	NNP	PERSON	Vo	nn	5	SENT_165	[p11l468t2620r492b2635],
5	LI	NNP	PERSON	LI	pobj	2	SENT_165	[p11l511t2620r524b2635],

1	Medication	NN	O	medication	nn	2	SENT_166	[p11l854t2614r986b2636],
2	Drug	NN	O	drug	_	0	SENT_166	[p11l1271t2616r1330b2643],
3	Elfect	NNP	O	Elfect	nn	4	SENT_166	[p11l1339t2614r1405b2636],
4	Associated	NNP	O	Associated	dep	2	SENT_166	[p11l1412t2614r1541b2636],
5	with	IN	O	with	_	0	SENT_166	[p11l1549t2614r1600b2636],
6	Polymorphism	NN	O	polymorphism	prep_with	4	SENT_166	[p11l1611t2614r1783b2643],

1	ACE	NN	O	ace	nn	2	SENT_167	[p11l711t2687r764b2709],
2	inhibitors	NNS	O	inhibitor	nsubj	3	SENT_167	[p11l775t2686r895b2710],
3	(	VBP	O	(	_	0	SENT_167	[p11l908t2688r967b2717],
4	e.g.	FW	O	e.g.	dobj	3	SENT_167	[p11l908t2688r967b2717],
5	,	,	O	,	_	0	SENT_167	[p11l908t2688r967b2717],
6	enalapril	NN	O	enalapril	appos	4	SENT_167	[p11l978t2686r1096b2717],
7	)	CD	NUMBER	)	num	9	SENT_167	[p11l978t2686r1096b2717],
8	Renoprotective	JJ	O	renoprotective	amod	9	SENT_167	[p11l1160t2688r1351b2717],
9	effects	NNS	O	effect	dep	6	SENT_167	[p11l1360t2686r1449b2714],
10	,	,	O	,	_	0	SENT_167	[p11l1360t2686r1449b2714],
11	blood-pressure	JJ	O	blood-pressure	amod	12	SENT_167	[p11l1461t2686r1653b2717],
12	reduction	NN	O	reduction	appos	4	SENT_167	[p11l1664t2686r1791b2714],
13	,	,	O	,	_	0	SENT_167	[p11l1664t2686r1791b2714],
14	reduction	NN	O	reduction	appos	4	SENT_167	[p11l1803t2686r1881b2710, p11l1207t2726r1256b2747],
15	in	IN	O	in	_	0	SENT_167	[p11l1267t2726r1288b2747],
16	left	JJ	O	left	amod	18	SENT_167	[p11l1300t2723r1337b2747],
17	ventricular	JJ	O	ventricular	amod	18	SENT_167	[p11l1346t2723r1482b2747],
18	mass	NN	O	mass	prep_in	14	SENT_167	[p11l1492t2732r1565b2751],
19	,	,	O	,	_	0	SENT_167	[p11l1492t2732r1565b2751],
20	endothelial	JJ	O	endothelial	amod	21	SENT_167	[p11l1575t2723r1716b2747],
21	function32	NN	O	function32	appos	18	SENT_167	[p11l1726t2723r1887b2747],
22	'	''	O	'	_	0	SENT_167	[p11l1726t2723r1887b2747],
23	4	CD	NUMBER	4	number	24	SENT_167	[p11l1726t2723r1887b2747],
24	°	CD	NUMBER	°	dep	4	SENT_167	[p11l1726t2723r1887b2747],
25	Fluvastatin	NNP	O	Fluvastatin	nn	27	SENT_167	[p11l714t2761r851b2785],
26	Lipid	NN	O	lipid	nn	27	SENT_167	[p11l1160t2761r1219b2792],
27	changes	NNS	O	change	dep	24	SENT_167	[p11l1230t2761r1334b2792],
28	.	.	O	.	_	0	SENT_167	[p11l1371t2781r1375b2784],

1	.	.	O	.	_	0	SENT_168	[p11l1395t2781r1406b2789],

1	,	,	O	,	_	0	SENT_169	[p11l1395t2781r1406b2789],
2	reductions	NNS	O	reduction	_	0	SENT_169	[p11l1418t2761r1552b2785],
3	in	IN	O	in	_	0	SENT_169	[p11l1563t2763r1584b2784],
4	low-density	JJ	O	low-density	amod	6	SENT_169	[p11l1595t2761r1739b2792],
5	lipoprotein	NN	O	lipoprotein	nn	6	SENT_169	[p11l1749t2761r1886b2792],
6	cholestero	NN	O	cholestero	prep_in	2	SENT_169	[p11l1208t2798r1341b2822],
7	an	DT	O	a	det	10	SENT_169	[p11l1358t2807r1386b2822],
8	apolipoprotein	NN	O	apolipoprotein	nn	10	SENT_169	[p11l1414t2798r1601b2829],
9	B	NN	O	b	nn	10	SENT_169	[p11l1614t2800r1646b2829],
10	)	NN	O	)	dep	6	SENT_169	[p11l1614t2800r1646b2829],
11	;	:	O	;	_	0	SENT_169	[p11l1614t2800r1646b2829],
12	progression	NN	O	progression	nn	17	SENT_169	[p11l1658t2801r1808b2830],
13	or	CC	O	or	_	0	SENT_169	[p11l1818t2807r1844b2822],
14	regression	NN	O	regression	nn	17	SENT_169	[p11l1854t2807r1885b2822, p11l1208t2838r1315b2867],
15	ofcoronary	JJ	O	ofcoronary	amod	17	SENT_169	[p11l1326t2836r1470b2867],
16	atherosclerosis	NN	O	atherosclerosis	nn	17	SENT_169	[p11l1479t2836r1696b2860],
17	“	NN	O	“	dep	6	SENT_169	[p11l1479t2836r1696b2860],

1	Arachidonate	NN	O	arachidonate	nn	4	SENT_170	[p11l263t2898r434b2922],
2	5-lipoxygenase	NN	O	5-lipoxygenase	nn	4	SENT_170	[p11l444t2898r631b2930],
3	Leukotriene	NN	MISC	leukotriene	nn	4	SENT_170	[p11l714t2898r862b2922],
4	inhibitors	NNS	O	inhibitor	nsubj	5	SENT_170	[p11l873t2898r993b2922],
5	Improvement	NN	O	improvement	_	0	SENT_170	[p11l1160t2901r1333b2929],
6	in	IN	O	in	_	0	SENT_170	[p11l1343t2901r1363b2922],
7	FEV142	NN	O	fev142	prep_in	5	SENT_170	[p11l1376t2900r1459b2927],
8	[	CD	NUMBER	[	num	12	SENT_170	[p11l263t2961r443b2992],
9	32-Adrenergic	JJ	O	32-adrenergic	amod	12	SENT_170	[p11l263t2961r443b2992],
10	receptor	NN	O	receptor	nn	12	SENT_170	[p11l453t2965r558b2992],
11	[	NN	O	[	nn	12	SENT_170	[p11l711t2962r863b2992],
12	32-Agonists	NNS	O	32-agonist	nsubj	13	SENT_170	[p11l711t2962r863b2992],
13	(	VBP	O	(	rcmod	7	SENT_170	[p11l875t2963r935b2992],
14	e.g.	FW	O	e.g.	dobj	13	SENT_170	[p11l875t2963r935b2992],
15	,	,	O	,	_	0	SENT_170	[p11l875t2963r935b2992],
16	albuterol	NN	O	albuterol	nn	18	SENT_170	[p11l946t2961r1067b2992],
17	)	NN	O	)	nn	18	SENT_170	[p11l946t2961r1067b2992],
18	Bronchodilatation	NN	ORGANIZATION	bronchodilatation	appos	14	SENT_170	[p11l1160t2961r1395b2989],
19	,	,	O	,	_	0	SENT_170	[p11l1160t2961r1395b2989],
20	susceptibi	NN	O	susceptibus	appos	18	SENT_170	[p11l1406t2961r1534b2992],
21	i	FW	O	i	tmod	13	SENT_170	[p11l1546t2963r1550b2984],
22	o	NN	O	o	nn	24	SENT_170	[p11l1592t2969r1606b2985],
23	agonist-induced	JJ	O	agonist-induced	amod	24	SENT_170	[p11l1617t2961r1821b2992],
24	dediov	NN	O	dediov	dep	21	SENT_170	[p11l1832t2961r1870b2985, p11l1428t2998r1481b3022],

1	scu	NN	O	scu	nn	2	SENT_171	[p11l1498t3007r1539b3022],
2	ar	NN	O	ar	_	0	SENT_171	[p11l1550t3007r1574b3022],
3	effects43	NN	O	effects43	dep	2	SENT_171	[p11l1583t2998r1720b3022],
4	'	''	O	'	_	0	SENT_171	[p11l1583t2998r1720b3022],
5	5	CD	NUMBER	5	num	6	SENT_171	[p11l1583t2998r1720b3022],
6	°	NN	O	°	dep	2	SENT_171	[p11l1583t2998r1720b3022],

1	Bradykinin	NN	O	bradykinin	nn	3	SENT_172	[p11l266t3061r398b3092],
2	B2	NN	O	b2	nn	3	SENT_172	[p11l411t3063r440b3084],
3	receptor	NN	O	receptor	_	0	SENT_172	[p11l451t3066r557b3092],
4	ACE	NN	O	ace	nn	7	SENT_172	[p11l711t3063r764b3085],
5	inhibitors	NNS	O	inhibitor	nn	7	SENT_172	[p11l775t3061r895b3085],
6	ACE-inhibitor	NN	O	ace-inhibitor	nn	7	SENT_172	[p11l1157t3061r1447b3085],
7	—	NN	O	—	dep	3	SENT_172	[p11l1157t3061r1447b3085],
8	induced	JJ	O	induced	amod	10	SENT_172	[p11l1157t3061r1447b3085],
9	cough	NN	O	cough	nn	10	SENT_172	[p11l1458t3061r1559b3092],
10	“	NN	O	“	dep	3	SENT_172	[p11l1458t3061r1559b3092],

1	Antipsychotics	NNS	O	antipsychotic	nsubj	10	SENT_173	[p11l711t3124r899b3155],
2	(	CD	NUMBER	(	num	1	SENT_173	[p11l909t3125r961b3155],
3	e.g.	FW	O	e.g.	dep	1	SENT_173	[p11l909t3125r961b3155],
4	haloperidol	NN	O	haloperidol	dep	1	SENT_173	[p11l970t3124r1121b3154],
5	,	,	O	,	_	0	SENT_173	[p11l970t3124r1121b3154],
6	An	DT	O	a	det	7	SENT_173	[p11l1157t3125r1190b3147],
7	i	FW	O	i	appos	4	SENT_173	[p11l1204t3126r1208b3147],
8	s	VBZ	O	s	cop	10	SENT_173	[p11l1229t3132r1239b3147],
9	chotic	JJ	O	chotic	amod	10	SENT_173	[p11l1255t3124r1332b3147],
10	response	NN	O	response	_	0	SENT_173	[p11l1342t3132r1457b3154],
11	(	CD	NUMBER	(	num	12	SENT_173	[p11l1469t3126r1520b3155],
12	D2	NN	O	d2	dep	10	SENT_173	[p11l1469t3126r1520b3155],
13	,	,	O	,	_	0	SENT_173	[p11l1469t3126r1520b3155],
14	D3	NN	O	d3	appos	12	SENT_173	[p11l1533t3125r1573b3151],
15	,	,	O	,	_	0	SENT_173	[p11l1533t3125r1573b3151],
16	D4	NN	O	d4	nn	17	SENT_173	[p11l1586t3126r1637b3154],
17	)	NN	O	)	appos	12	SENT_173	[p11l1586t3126r1637b3154],
18	,	,	O	,	_	0	SENT_173	[p11l1586t3126r1637b3154],
19	antipsychoticclozapine	JJ	O	antipsychoticclozapine	amod	20	SENT_173	[p11l1648t3124r1826b3155, p11l762t3161r892b3192],
20	)	NN	O	)	appos	12	SENT_173	[p11l1648t3124r1826b3155, p11l762t3161r892b3192],

1	in	IN	O	in	_	0	SENT_174	[p11l1209t3163r1229b3184],
2	uced	JJ	O	uced	amod	3	SENT_174	[p11l1250t3161r1307b3185],
3	tardive	JJ	O	tardive	amod	10	SENT_174	[p11l1315t3161r1400b3185],
4	dyskinesia	NN	O	dyskinesium	nn	10	SENT_174	[p11l1407t3161r1535b3192],
5	(	NN	O	(	nn	10	SENT_174	[p11l1546t3163r1607b3192],
6	D3	NN	O	d3	nn	10	SENT_174	[p11l1546t3163r1607b3192],
7	)	NN	O	)	nn	10	SENT_174	[p11l1546t3163r1607b3192],
8	,	,	O	,	_	0	SENT_174	[p11l1546t3163r1607b3192],
9	antipsychotic	JJ	O	antipsychotic	amod	10	SENT_174	[p11l1616t3161r1890b3192],
10	—	NN	O	—	prep_in	11	SENT_174	[p11l1616t3161r1890b3192],
11	induced	VBD	O	induce	_	0	SENT_174	[p11l1616t3161r1890b3192],
12	acute	JJ	O	acute	amod	15	SENT_174	[p11l1208t3203r1275b3222],
13	akathisia	NN	O	akathisium	nn	15	SENT_174	[p11l1285t3199r1397b3222],
14	(	NN	O	(	nn	15	SENT_174	[p11l1409t3200r1520b3230],
15	D3	NN	O	d3	iobj	11	SENT_174	[p11l1409t3200r1520b3230],
16	)	CD	NUMBER	)	number	17	SENT_174	[p11l1409t3200r1520b3230],
17	52	CD	NUMBER	52	dobj	11	SENT_174	[p11l1409t3200r1520b3230],
18	'55	CD	NUMBER	'55	num	19	SENT_174	[p11l1409t3200r1520b3230],
19	sensitization	NN	O	sensitization	nsubj	11	SENT_174	[p11l1209t3001r1378b3026],
20	,	,	O	,	_	0	SENT_174	[p11l1209t3001r1378b3026],
21	car	NN	O	car	appos	19	SENT_174	[p11l1388t3007r1426b3022],
22	a	DT	O	a	dep	21	SENT_174	[p11l1483t3007r1495b3022],

1	Estrogen	NN	MISC	estrogen	nn	2	SENT_175	[p11l266t3263r376b3292],
2	receptor	NN	O	receptor	_	0	SENT_175	[p11l388t3266r519b3292],
3	—	NN	O	—	dep	2	SENT_175	[p11l388t3266r519b3292],
4	a	DT	O	a	dep	3	SENT_175	[p11l388t3266r519b3292],
5	Conjugated	VBN	MISC	conjugate	partmod	2	SENT_175	[p11l712t3261r857b3292],
6	estrogens	NNS	O	estrogen	nn	7	SENT_175	[p11l868t3266r992b3292],
7	Increase	NN	O	increase	dobj	5	SENT_175	[p11l1160t3263r1265b3285],
8	in	IN	O	in	_	0	SENT_175	[p11l1275t3263r1296b3284],
9	bone	NN	O	bone	nn	11	SENT_175	[p11l1308t3261r1369b3285],
10	mineral	NN	O	mineral	nn	11	SENT_175	[p11l1380t3261r1474b3285],
11	density57	NN	O	density57	prep_in	7	SENT_175	[p11l1485t3261r1599b3292],

1	H	NN	O	h	nn	4	SENT_176	[p11l714t3301r732b3322],
2	ooooooo	NN	O	ooooooo	nn	4	SENT_176	[p11l736t3307r845b3322],
3	repl	NN	O	repl	nn	4	SENT_176	[p11l848t3299r893b3329],
4	aaaa	NN	O	aaaa	_	0	SENT_176	[p11l897t3307r963b3322],
5	ent	NN	O	ent	nn	7	SENT_176	[p11l967t3303r1006b3322],
6	therapy	NN	O	therapy	nn	7	SENT_176	[p11l1014t3299r1110b3330],
7	Increase	NN	O	increase	dep	4	SENT_176	[p11l1160t3301r1265b3322],
8	in	IN	O	in	_	0	SENT_176	[p11l1275t3301r1296b3322],
9	high-density	JJ	O	high-density	amod	12	SENT_176	[p11l1307t3299r1463b3330],
10	lipoprotein	NN	O	lipoprotein	nn	12	SENT_176	[p11l1473t3299r1610b3329],
11	cholesterol	NN	O	cholesterol	nn	12	SENT_176	[p11l1621t3299r1786b3322],
12	“	NN	O	“	prep_in	7	SENT_176	[p11l1621t3299r1786b3322],

1	Glycoprotein	NN	PERSON	glycoprotein	nn	2	SENT_177	[p11l264t3361r427b3392],
2	Illa	NN	PERSON	illum	_	0	SENT_177	[p11l440t3363r478b3385],
3	subunit	NN	O	subunit	nn	4	SENT_177	[p11l489t3361r585b3385],
4	ofg	NN	O	ofg	rcmod	2	SENT_177	[p11l594t3361r669b3392],
5	|	CD	NUMBER	|	dep	4	SENT_177	[p11l594t3361r669b3392],
6	y	SYM	O	y	dep	4	SENT_177	[p11l594t3361r669b3392],
7	-	:	O	-	_	0	SENT_177	[p11l594t3361r669b3392],
8	Aspirin	NN	O	aspirin	dep	2	SENT_177	[p11l711t3363r801b3392],
9	or	CC	O	or	_	0	SENT_177	[p11l812t3369r838b3385],
10	glycoprotein	NN	O	glycoprotein	nn	11	SENT_177	[p11l847t3361r1003b3392],
11	IIb/IIIa	NN	O	iib/iiia	dep	2	SENT_177	[p11l1016t3361r1102b3392],
12	Antiplatelet	JJ	O	antiplatelet	amod	13	SENT_177	[p11l1157t3361r1305b3392],
13	effect59	NN	O	effect59	dep	2	SENT_177	[p11l1314t3361r1406b3385],

1	coprotein	NN	O	coprotein	nn	3	SENT_178	[p11l314t3401r435b3429],
2	Ilb/Illa	NN	O	ilb/illa	nn	3	SENT_178	[p11l447t3399r534b3430],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_178	[p11l763t3399r884b3422],
4	r	NN	O	r	dep	3	SENT_178	[p11l297t3470r305b3484],
5	i	LS	O	i	dep	4	SENT_178	[p11l367t3463r371b3485],
6	-	:	O	-	_	0	SENT_178	[p11l421t3476r428b3479],
7	oxytryptamine	NN	O	oxytryptamine	nn	9	SENT_178	[p11l487t3463r675b3492],
8	)	CD	NUMBER	)	num	9	SENT_178	[p11l487t3463r675b3492],
9	Antidepre	NNP	O	Antidepre	dep	3	SENT_178	[p11l711t3461r837b3492],
10	ts	NNS	O	t	dep	9	SENT_178	[p11l898t3466r920b3485],
11	(	CD	NUMBER	(	num	10	SENT_178	[p11l932t3461r1123b3492],
12	e.g.	FW	O	e.g.	dep	9	SENT_178	[p11l932t3461r1123b3492],
13	,	,	O	,	_	0	SENT_178	[p11l932t3461r1123b3492],
14	c	NN	O	c	nn	16	SENT_178	[p11l932t3461r1123b3492],
15	|	NN	O	|	nn	16	SENT_178	[p11l932t3461r1123b3492],
16	omipra	NN	O	omipra	appos	12	SENT_178	[p11l932t3461r1123b3492],
17	-	:	O	-	_	0	SENT_178	[p11l932t3461r1123b3492],
18	5-Hydroxytryptamineneurotransmission	NN	O	5-hydroxytryptamineneurotransmission	dep	9	SENT_178	[p11l1159t3461r1887b3492],
19	,	,	O	,	_	0	SENT_178	[p11l1159t3461r1887b3492],
20	antidepressant	JJ	O	antidepressant	amod	21	SENT_178	[p11l1159t3461r1887b3492],
21	mine	NN	O	mine	appos	18	SENT_178	[p11l763t3501r833b3527],
22	,	,	O	,	_	0	SENT_178	[p11l763t3501r833b3527],
23	uoxetine	NN	O	uoxetine	appos	18	SENT_178	[p11l860t3501r1124b3530],
24	,	,	O	,	_	0	SENT_178	[p11l860t3501r1124b3530],
25	paroxetine	NN	O	paroxetine	nn	27	SENT_178	[p11l860t3501r1124b3530],
26	)	CD	NUMBER	)	num	27	SENT_178	[p11l860t3501r1124b3530],
27	response5	NN	O	response5	appos	18	SENT_178	[p11l1209t3501r1379b3530],
28	°	CD	NUMBER	°	number	29	SENT_178	[p11l1209t3501r1379b3530],
29	'52	CD	NUMBER	'52	dep	27	SENT_178	[p11l1209t3501r1379b3530],

1	7	CD	NUMBER	7	number	2	SENT_179	[p11l237t3596r251b3609],
2	*	CD	NUMBER	*	num	4	SENT_179	[p11l237t3596r251b3609],
3	The	DT	O	the	det	4	SENT_179	[p11l261t3594r308b3617],
4	examples	NNS	O	example	nsubj	7	SENT_179	[p11l318t3594r437b3624],
5	shown	VBN	O	show	partmod	4	SENT_179	[p11l447t3594r529b3617],
6	are	VBP	O	be	cop	7	SENT_179	[p11l540t3602r577b3617],
7	illustrative	JJ	O	illustrative	_	0	SENT_179	[p11l588t3594r719b3617],
8	and	CC	O	and	_	0	SENT_179	[p11l729t3594r774b3617],
9	not	RB	O	not	conj_and	7	SENT_179	[p11l786t3598r826b3617],
10	re	VB	O	re	dep	7	SENT_179	[p11l837t3602r858b3617],
11	resentative	JJ	O	resentative	amod	12	SENT_179	[p11l879t3596r1017b3617],
12	ofall	NN	O	ofall	dobj	10	SENT_179	[p11l1026t3593r1085b3617],
13	published	VBN	O	publish	partmod	12	SENT_179	[p11l1097t3594r1220b3624],
14	studies	NNS	O	study	dobj	13	SENT_179	[p11l1232t3594r1329b3621],
15	,	,	O	,	_	0	SENT_179	[p11l1232t3594r1329b3621],
16	which	WDT	O	which	nsubj	17	SENT_179	[p11l1339t3594r1413b3617],
17	exceed	VBP	O	exceed	rcmod	14	SENT_179	[p11l1423t3594r1507b3617],
18	the	DT	O	the	det	21	SENT_179	[p11l1517t3594r1557b3617],
19	scope	NN	O	scope	nn	21	SENT_179	[p11l1567t3602r1640b3624],
20	ofthis	NN	O	ofthi	nn	21	SENT_179	[p11l1650t3593r1728b3617],
21	review	NN	O	review	dobj	17	SENT_179	[p11l1739t3596r1821b3617],
22	.	.	O	.	_	0	SENT_179	[p11l1739t3596r1821b3617],

1	ACE	NN	O	ace	nsubj	9	SENT_180	[p11l1831t3595r1884b3617],
2	denotes	VBZ	O	denote	_	0	SENT_180	[p11l262t3631r363b3655],
3	angiotensin	NN	O	angiotensin	nn	4	SENT_180	[p11l373t3633r669b3662],
4	—	NN	O	—	dobj	2	SENT_180	[p11l373t3633r669b3662],
5	converting	VBG	O	convert	partmod	4	SENT_180	[p11l373t3633r669b3662],
6	enzyme	NN	O	enzyme	dobj	5	SENT_180	[p11l678t3639r783b3662],
7	,	,	O	,	_	0	SENT_180	[p11l678t3639r783b3662],
8	and	CC	O	and	_	0	SENT_180	[p11l794t3631r839b3655],
9	forced	VBD	O	force	conj_and	2	SENT_180	[p11l919t3631r997b3655],
10	expiratory	JJ	O	expiratory	amod	11	SENT_180	[p11l1008t3633r1134b3662],
11	volume	NN	O	volume	dobj	9	SENT_180	[p11l1142t3631r1236b3655],
12	in	IN	O	in	_	0	SENT_180	[p11l1247t3633r1267b3654],
13	one	CD	DURATION	one	num	14	SENT_180	[p11l1278t3639r1324b3655],
14	second	NN	NUMBER	second	prep_in	9	SENT_180	[p11l1334t3631r1431b3655],
15	.	.	O	.	_	0	SENT_180	[p11l1334t3631r1431b3655],

1	phisms	NNS	O	phism	nsubjpass	6	SENT_181	[p12l9t130r325b230],
2	in	IN	O	in	_	0	SENT_181	[p12l350t130r431b207],
3	ADRB2	NN	O	adrb2	prep_in	1	SENT_181	[p12l446t135r726b209],
4	have	VBP	O	have	aux	6	SENT_181	[p12l752t130r940b209],
5	been	VBN	O	be	auxpass	6	SENT_181	[p12l963t130r1162b208],
6	associated	VBN	O	associate	_	0	SENT_181	[p12l1184t130r1620b208],
7	With	IN	O	with	_	0	SENT_181	[p12l1638t130r1827b209],
8	altered	JJ	O	altered	amod	9	SENT_181	[p12l1848t130r2135b208],
9	expression	NN	O	expression	prep_with	6	SENT_181	[p12l11t258r483b358],
10	,	,	O	,	_	0	SENT_181	[p12l11t258r483b358],
11	doWn	NN	O	down	nn	13	SENT_181	[p12l513t258r1236b358],
12	—	NN	O	—	nn	13	SENT_181	[p12l513t258r1236b358],
13	regulation	NN	O	regulation	conj_or	9	SENT_181	[p12l513t258r1236b358],
14	,	,	O	,	_	0	SENT_181	[p12l513t258r1236b358],
15	or	CC	O	or	_	0	SENT_181	[p12l1265t283r1354b336],
16	coupling	NN	O	coupling	prep_with	6	SENT_181	[p12l1375t257r1747b358],
17	of	IN	O	of	_	0	SENT_181	[p12l1767t257r1867b336],
18	the	DT	O	the	det	19	SENT_181	[p12l1873t258r2001b336],
19	receptor	NN	O	receptor	prep_of	16	SENT_181	[p12l2024t284r2135b336, p12l11t402r274b486],
20	in	IN	O	in	_	0	SENT_181	[p12l291t386r371b463],
21	response	NN	O	response	prep_in	19	SENT_181	[p12l392t411r765b486],
22	to	TO	O	to	prep	6	SENT_181	[p12l786t402r864b464],
23	,	,	O	,	_	0	SENT_181	[p12l881t385r1662b486],
24	B2	NN	O	b2	nn	27	SENT_181	[p12l881t385r1662b486],
25	—	NN	O	—	nn	27	SENT_181	[p12l881t385r1662b486],
26	adrenoreceptor	NN	O	adrenoreceptor	nn	27	SENT_181	[p12l881t385r1662b486],
27	agonists	NNS	O	agonist	nsubj	32	SENT_181	[p12l1678t386r2133b486],
28	.43	CD	NUMBER	.43	num	32	SENT_181	[p12l1678t386r2133b486],
29	Single	JJ	O	single	amod	32	SENT_181	[p12l13t514r752b614],
30	—	NN	O	—	nn	32	SENT_181	[p12l13t514r752b614],
31	nucleotide	NN	O	nucleotide	nn	32	SENT_181	[p12l13t514r752b614],
32	polymorphisms	NNS	O	polymorphism	xcomp	6	SENT_181	[p12l790t514r1460b614],
33	resulting	VBG	O	result	partmod	32	SENT_181	[p12l1501t514r1880b614],
34	in	IN	O	in	_	0	SENT_181	[p12l1915t514r1996b591],
35	an	DT	O	a	det	36	SENT_181	[p12l2035t539r2135b592],
36	Arg	NN	O	arg	prep_in	33	SENT_181	[p12l7t642r467b742],
37	.	.	O	.	_	0	SENT_181	[p12l7t642r467b742],

1	—	NN	O	—	_	0	SENT_182	[p12l7t642r467b742],
2	.	.	O	.	_	0	SENT_182	[p12l7t642r467b742],

1	to	TO	O	to	_	0	SENT_183	[p12l7t642r467b742],
2	.	.	O	.	_	0	SENT_183	[p12l7t642r467b742],

1	—	NN	O	—	_	0	SENT_184	[p12l7t642r467b742],
2	.	.	O	.	_	0	SENT_184	[p12l7t642r467b742],

1	Gly	RB	O	gly	advmod	4	SENT_185	[p12l7t642r467b742],
2	amino	NN	O	amino	nn	4	SENT_185	[p12l499t642r767b720],
3	acid	NN	O	acid	nn	4	SENT_185	[p12l806t642r976b720],
4	change	NN	O	change	_	0	SENT_185	[p12l1015t642r1316b742],
5	at	IN	O	at	_	0	SENT_185	[p12l1353t658r1432b720],
6	codon	NN	O	codon	prep_at	4	SENT_185	[p12l1464t642r1726b720],
7	16	CD	NUMBER	16	dep	4	SENT_185	[p12l1766t647r1863b720],
8	and	CC	O	and	_	0	SENT_185	[p12l1900t642r2056b720],
9	a	DT	O	a	det	10	SENT_185	[p12l2092t668r2137b720],
10	Gln	NN	O	gln	dep	4	SENT_185	[p12l11t770r491b849],
11	.	.	O	.	_	0	SENT_185	[p12l11t770r491b849],

1	—	NN	O	—	_	0	SENT_186	[p12l11t770r491b849],
2	.	.	O	.	_	0	SENT_186	[p12l11t770r491b849],

1	to	TO	O	to	_	0	SENT_187	[p12l11t770r491b849],
2	.	.	O	.	_	0	SENT_187	[p12l11t770r491b849],

1	—	NN	O	—	_	0	SENT_188	[p12l11t770r491b849],
2	.	.	O	.	_	0	SENT_188	[p12l11t770r491b849],

1	Glu	NNP	O	Glu	nn	2	SENT_189	[p12l11t770r491b849],
2	change	NN	O	change	nsubj	8	SENT_189	[p12l514t770r821b870],
3	at	IN	O	at	_	0	SENT_189	[p12l845t786r925b848],
4	codon	NN	O	codon	prep_at	2	SENT_189	[p12l944t770r1209b848],
5	27	CD	NUMBER	27	num	4	SENT_189	[p12l1233t775r1334b848],
6	are	VBP	O	be	cop	8	SENT_189	[p12l1358t796r1486b848],
7	relatively	RB	O	relatively	advmod	8	SENT_189	[p12l1510t769r1896b870],
8	common	JJ	O	common	_	0	SENT_189	[p12l1915t795r2133b848, p12l11t923r232b993],
9	,	,	O	,	_	0	SENT_189	[p12l1915t795r2133b848, p12l11t923r232b993],
10	with	IN	O	with	dep	8	SENT_189	[p12l260t898r452b977],
11	allele	NN	O	allele	nn	12	SENT_189	[p12l478t898r702b976],
12	frequencies	NNS	O	frequency	pobj	10	SENT_189	[p12l729t897r1225b998],
13	of	IN	O	of	_	0	SENT_189	[p12l1255t897r1357b976],
14	0.4	CD	NUMBER	0.4	num	16	SENT_189	[p12l1366t903r1498b976],
15	to	TO	O	to	dep	16	SENT_189	[p12l1525t914r1605b976],
16	0.6	CD	NUMBER	0.6	prep_of	12	SENT_189	[p12l1633t903r1790b993],
17	,	,	O	,	_	0	SENT_189	[p12l1633t903r1790b993],
18	and	CC	O	and	_	0	SENT_189	[p12l1822t898r1980b976],
19	are	VBP	O	be	conj_and	8	SENT_189	[p12l2006t924r2134b976],
20	under	IN	O	under	_	0	SENT_189	[p12l11t1026r264b1105],
21	intensive	JJ	O	intensive	amod	22	SENT_189	[p12l287t1026r663b1105],
22	investigation	NN	O	investigation	prep_under	19	SENT_189	[p12l688t1026r1232b1126],
23	for	IN	O	for	_	0	SENT_189	[p12l1257t1025r1380b1104],
24	their	PRP$	O	they	poss	26	SENT_189	[p12l1403t1026r1601b1104],
25	clinical	JJ	O	clinical	amod	26	SENT_189	[p12l1624t1025r1924b1104],
26	relevance	NN	O	relevance	prep_for	22	SENT_189	[p12l1949t1026r2134b1104, p12l6t1150r268b1204],
27	.	.	O	.	_	0	SENT_189	[p12l1949t1026r2134b1104, p12l6t1150r268b1204],

1	A	DT	O	a	det	3	SENT_190	[p12l136t1260r202b1330],
2	recent	JJ	O	recent	amod	3	SENT_190	[p12l234t1269r497b1331],
3	study	NN	O	study	nsubj	7	SENT_190	[p12l529t1252r754b1353],
4	of	IN	O	of	_	0	SENT_190	[p12l786t1252r886b1331],
5	agonist	NN	O	agonist	nn	6	SENT_190	[p12l902t1252r1644b1353],
6	—	NN	O	—	prep_of	3	SENT_190	[p12l902t1252r1644b1353],
7	mediated	VBD	O	mediate	_	0	SENT_190	[p12l902t1252r1644b1353],
8	vasodilata	JJ	O	vasodilata	amod	10	SENT_190	[p12l1674t1252r2134b1332],
9	—	NN	O	—	nn	10	SENT_190	[p12l1674t1252r2134b1332],
10	tion	NN	O	tion	nsubj	13	SENT_190	[p12l11t1381r180b1459],
11	and	CC	O	and	_	0	SENT_190	[p12l220t1381r378b1459],
12	desensitization44	NN	O	desensitization44	conj_and	10	SENT_190	[p12l418t1381r1156b1459],
13	revealed	VBD	O	reveal	ccomp	7	SENT_190	[p12l1195t1381r1546b1460],
14	that	IN	O	that	complm	25	SENT_190	[p12l1586t1380r1756b1459],
15	patients	NNS	O	patient	nsubj	25	SENT_190	[p12l1789t1381r2131b1481],
16	Who	WP	O	who	nsubj	18	SENT_190	[p12l6t1509r192b1588],
17	were	VBD	O	be	cop	18	SENT_190	[p12l217t1535r419b1588],
18	homozygous	JJ	O	homozygous	rcmod	15	SENT_190	[p12l446t1509r990b1609],
19	for	IN	O	for	_	0	SENT_190	[p12l1019t1508r1142b1587],
20	Arg	NN	O	arg	prep_for	18	SENT_190	[p12l1161t1516r1319b1609],
21	at	IN	O	at	_	0	SENT_190	[p12l1341t1525r1420b1587],
22	ADRB2	NN	O	adrb2	nn	23	SENT_190	[p12l1435t1514r1716b1588],
23	codon	NN	O	codon	prep_at	18	SENT_190	[p12l1746t1508r2007b1587],
24	16	CD	NUMBER	16	num	23	SENT_190	[p12l2037t1514r2134b1587],
25	had	VBD	O	have	ccomp	13	SENT_190	[p12l11t1637r166b1715],
26	nearly	RB	O	nearly	advmod	27	SENT_190	[p12l193t1637r451b1737],
27	complete	JJ	O	complete	amod	28	SENT_190	[p12l476t1637r864b1737],
28	desensitization	NN	O	desensitization	dobj	25	SENT_190	[p12l892t1636r1531b1715],
29	after	IN	O	after	_	0	SENT_190	[p12l1559t1636r1752b1715],
30	continuous	JJ	O	continuous	amod	31	SENT_190	[p12l1778t1637r2134b1716, p12l11t1790r157b1844],
31	infusion	NN	O	infusion	prep_after	25	SENT_190	[p12l189t1764r541b1844],
32	of	IN	O	of	_	0	SENT_190	[p12l572t1764r673b1843],
33	isoproterenol	NN	O	isoproterenol	prep_of	31	SENT_190	[p12l684t1764r1278b1865],
34	,	,	O	,	_	0	SENT_190	[p12l684t1764r1278b1865],
35	with	IN	O	with	_	0	SENT_190	[p12l1309t1765r1499b1844],
36	venodilatation	NN	O	venodilatation	prep_with	25	SENT_190	[p12l1525t1764r2135b1844],
37	decreasing	VBG	O	decrease	partmod	36	SENT_190	[p12l11t1893r469b1993],
38	from	IN	O	from	_	0	SENT_190	[p12l486t1892r694b1971],
39	44	CD	PERCENT	44	num	40	SENT_190	[p12l713t1898r816b1971],
40	percent	NN	PERCENT	percent	prep_from	37	SENT_190	[p12l836t1909r1156b1993],
41	at	IN	O	at	_	0	SENT_190	[p12l1172t1909r1251b1971],
42	base	NN	O	base	nn	43	SENT_190	[p12l1268t1893r1454b1971],
43	line	NN	O	line	prep_at	40	SENT_190	[p12l1474t1893r1628b1971],
44	to	TO	O	to	_	0	SENT_190	[p12l1651t1909r1730b1971],
45	8	CD	PERCENT	8	num	46	SENT_190	[p12l1753t1898r1798b1971],
46	percent	NN	PERCENT	percent	prep_to	37	SENT_190	[p12l1820t1909r2140b1993],
47	after	IN	O	after	_	0	SENT_190	[p12l10t2020r201b2099],
48	90	CD	DURATION	90	num	49	SENT_190	[p12l219t2026r318b2099],
49	minutes	NNS	NUMBER	minute	prep_after	46	SENT_190	[p12l339t2021r677b2100],
50	of	IN	O	of	_	0	SENT_190	[p12l700t2020r800b2099],
51	infusion	NN	O	infusion	nn	53	SENT_190	[p12l801t2020r1149b2100],
52	(	CD	NUMBER	(	num	53	SENT_190	[p12l1175t2021r1356b2121],
53	Fig	NN	O	fig	prep_of	49	SENT_190	[p12l1175t2021r1356b2121],
54	.	.	O	.	_	0	SENT_190	[p12l1175t2021r1356b2121],

1	4	CD	NUMBER	4	_	0	SENT_191	[p12l1380t2026r1486b2112],
2	)	NN	O	)	dep	1	SENT_191	[p12l1380t2026r1486b2112],
3	.	.	O	.	_	0	SENT_191	[p12l1380t2026r1486b2112],

1	In	IN	O	in	_	0	SENT_192	[p12l1510t2028r1597b2098],
2	contrast	NN	O	contrast	prep_in	13	SENT_192	[p12l1619t2037r1979b2116],
3	,	,	O	,	_	0	SENT_192	[p12l1619t2037r1979b2116],
4	pa	NN	O	pa	nn	6	SENT_192	[p12l2003t2047r2135b2121],
5	—	NN	O	—	nn	6	SENT_192	[p12l2003t2047r2135b2121],
6	tients	NNS	O	tient	nsubj	13	SENT_192	[p12l11t2149r238b2227],
7	homozygous	JJ	O	homozygous	amod	6	SENT_192	[p12l266t2148r810b2249],
8	for	IN	O	for	_	0	SENT_192	[p12l838t2148r961b2227],
9	Gly	NN	O	gly	prep_for	7	SENT_192	[p12l984t2149r1130b2249],
10	at	IN	O	at	_	0	SENT_192	[p12l1152t2165r1230b2227],
11	codon	NN	O	codon	prep_at	9	SENT_192	[p12l1252t2148r1513b2227],
12	16	CD	NUMBER	16	num	11	SENT_192	[p12l1543t2154r1640b2227],
13	had	VBD	O	have	_	0	SENT_192	[p12l1666t2149r1822b2227],
14	no	DT	O	no	det	16	SENT_192	[p12l1847t2174r1953b2227],
15	signiﬁcant	JJ	O	signiﬁcant	amod	16	SENT_192	[p12l1982t2149r2134b2249, p12l11t2276r330b2355],
16	change	NN	O	change	dobj	13	SENT_192	[p12l346t2277r642b2377],
17	in	IN	O	in	_	0	SENT_192	[p12l661t2277r742b2354],
18	venodilatation	NN	O	venodilatation	prep_in	13	SENT_192	[p12l757t2277r1375b2372],
19	,	,	O	,	_	0	SENT_192	[p12l757t2277r1375b2372],
20	regardless	RB	O	regardless	_	0	SENT_192	[p12l1401t2277r1822b2377],
21	of	IN	O	of	_	0	SENT_192	[p12l1845t2276r1944b2355],
22	their	PRP$	O	they	poss	25	SENT_192	[p12l1946t2277r2139b2355],
23	codon	NN	O	codon	nn	25	SENT_192	[p12l11t2405r272b2483],
24	27	CD	NUMBER	27	num	25	SENT_192	[p12l310t2410r410b2483],
25	status	NN	O	status	prep_regardless_of	13	SENT_192	[p12l451t2421r721b2484],
26	.	.	O	.	_	0	SENT_192	[p12l451t2421r721b2484],

1	Polymorphism	NN	O	polymorphism	nsubj	5	SENT_193	[p12l763t2405r1389b2505],
2	at	IN	O	at	_	0	SENT_193	[p12l1427t2421r1506b2483],
3	codon	NN	O	codon	prep_at	1	SENT_193	[p12l1539t2405r1800b2483],
4	27	CD	NUMBER	27	num	3	SENT_193	[p12l1838t2410r1938b2483],
5	Was	VBD	O	be	_	0	SENT_193	[p12l1972t2431r2134b2484],
6	also	RB	O	also	advmod	5	SENT_193	[p12l10t2533r177b2611],
7	of	IN	O	of	_	0	SENT_193	[p12l207t2532r307b2611],
8	ﬁinctional	JJ	O	ﬁinctional	amod	9	SENT_193	[p12l317t2532r748b2612],
9	relevance	NN	O	relevance	prep_of	5	SENT_193	[p12l776t2533r1191b2628],
10	;	:	O	;	_	0	SENT_193	[p12l776t2533r1191b2628],
11	subjects	NNS	O	subject	nsubj	17	SENT_193	[p12l1224t2532r1559b2633],
12	homozygous	JJ	O	homozygous	amod	11	SENT_193	[p12l1589t2533r2133b2633],
13	for	IN	O	for	_	0	SENT_193	[p12l11t2660r131b2739],
14	the	DT	O	the	det	16	SENT_193	[p12l149t2661r276b2739],
15	Glu	NNP	O	Glu	nn	16	SENT_193	[p12l296t2661r449b2740],
16	allele	NN	O	allele	prep_for	12	SENT_193	[p12l468t2661r681b2739],
17	had	VBD	O	have	parataxis	5	SENT_193	[p12l701t2660r854b2739],
18	higher	JJR	O	higher	amod	20	SENT_193	[p12l874t2661r1147b2761],
19	maximal	JJ	O	maximal	amod	20	SENT_193	[p12l1164t2661r1525b2739],
20	venodilatation	NN	O	venodilatation	dobj	17	SENT_193	[p12l1540t2660r2136b2740],
21	in	IN	O	in	_	0	SENT_193	[p12l10t2789r92b2866],
22	response	NN	O	response	prep_in	20	SENT_193	[p12l127t2814r514b2889],
23	to	TO	O	to	_	0	SENT_193	[p12l550t2805r631b2867],
24	isoproterenol	NN	O	isoproterenol	prep_to	17	SENT_193	[p12l666t2788r1250b2889],
25	than	IN	O	than	_	0	SENT_193	[p12l1285t2789r1476b2867],
26	those	DT	O	those	prep_than	24	SENT_193	[p12l1512t2789r1744b2867],
27	with	IN	O	with	_	0	SENT_193	[p12l1775t2789r1967b2868],
28	the	DT	O	the	det	32	SENT_193	[p12l2003t2788r2134b2867],
29	codon	NN	O	codon	nn	32	SENT_193	[p12l11t2917r277b2995],
30	27	CD	NUMBER	27	num	32	SENT_193	[p12l303t2922r404b2995],
31	Gln	NN	O	gln	nn	32	SENT_193	[p12l432t2917r590b2995],
32	genotype	NN	O	genotype	prep_with	26	SENT_193	[p12l616t2933r1032b3017],
33	,	,	O	,	_	0	SENT_193	[p12l616t2933r1032b3017],
34	regardless	RB	O	regardless	_	0	SENT_193	[p12l1064t2917r1504b3017],
35	of	IN	O	of	_	0	SENT_193	[p12l1533t2916r1635b2995],
36	their	PRP$	O	they	poss	39	SENT_193	[p12l1643t2916r1845b2995],
37	codon	NN	O	codon	nn	39	SENT_193	[p12l1869t2917r2134b2995],
38	16	CD	NUMBER	16	num	39	SENT_193	[p12l14t3050r112b3122],
39	status	NN	O	status	prep_regardless_of	32	SENT_193	[p12l141t3060r386b3123],
40	(	CD	NUMBER	(	num	41	SENT_193	[p12l418t3045r601b3144],
41	Fig	NN	O	fig	dep	32	SENT_193	[p12l418t3045r601b3144],
42	.	.	O	.	_	0	SENT_193	[p12l418t3045r601b3144],

1	4	CD	NUMBER	4	_	0	SENT_194	[p12l630t3050r825b3135],
2	)	CD	NUMBER	)	num	3	SENT_194	[p12l630t3050r825b3135],
3	.44	CD	NUMBER	.44	dep	1	SENT_194	[p12l630t3050r825b3135],

1	These	DT	O	these	det	2	SENT_195	[p12l136t3172r385b3251],
2	results	NNS	O	result	nsubj	5	SENT_195	[p12l408t3173r682b3252],
3	are	VBP	O	be	cop	5	SENT_195	[p12l706t3199r831b3251],
4	generally	RB	O	generally	advmod	5	SENT_195	[p12l854t3173r1236b3273],
5	consistent	JJ	O	consistent	_	0	SENT_195	[p12l1255t3173r1687b3251],
6	with	IN	O	with	_	0	SENT_195	[p12l1700t3172r1887b3252],
7	those	DT	O	those	prep_with	5	SENT_195	[p12l1911t3173r2135b3251],
8	of	IN	O	of	_	0	SENT_195	[p12l11t3300r112b3379],
9	studies	NNS	O	study	prep_of	7	SENT_195	[p12l130t3301r424b3380],
10	showing	VBG	O	show	partmod	9	SENT_195	[p12l463t3301r828b3401],
11	that	IN	O	that	complm	30	SENT_195	[p12l860t3301r1027b3379],
12	the	DT	O	the	det	15	SENT_195	[p12l1057t3300r1187b3379],
13	forced	JJ	O	forced	amod	15	SENT_195	[p12l1222t3300r1489b3379],
14	expiratory	JJ	O	expiratory	amod	15	SENT_195	[p12l1524t3301r1950b3401],
15	volume	NN	O	volume	nsubj	30	SENT_195	[p12l1976t3301r2134b3380, p12l11t3455r193b3508],
16	in	IN	O	in	_	0	SENT_195	[p12l215t3429r295b3506],
17	one	CD	DURATION	one	num	20	SENT_195	[p12l317t3454r469b3507],
18	second	JJ	NUMBER	second	amod	20	SENT_195	[p12l492t3429r788b3507],
19	(	NN	O	(	nn	20	SENT_195	[p12l814t3436r1080b3525],
20	FEV1	NN	O	fev1	nn	21	SENT_195	[p12l814t3436r1080b3525],
21	)	NN	O	)	prep_in	15	SENT_195	[p12l814t3436r1080b3525],
22	after	IN	O	after	_	0	SENT_195	[p12l1105t3428r1299b3507],
23	a	DT	O	a	det	26	SENT_195	[p12l1317t3455r1361b3507],
24	single	JJ	O	single	amod	26	SENT_195	[p12l1382t3429r1632b3529],
25	oral	JJ	O	oral	amod	26	SENT_195	[p12l1655t3429r1816b3507],
26	dose	NN	O	dose	prep_after	21	SENT_195	[p12l1838t3429r2031b3507],
27	of	IN	O	of	_	0	SENT_195	[p12l2053t3428r2153b3507],
28	albuterol	NN	O	albuterol	prep_of	26	SENT_195	[p12l10t3557r390b3636],
29	was	VBD	O	be	cop	30	SENT_195	[p12l420t3583r581b3636],
30	higher	JJR	O	higher	ccomp	10	SENT_195	[p12l618t3557r898b3657],
31	by	IN	O	by	_	0	SENT_195	[p12l930t3557r1028b3657],
32	a	DT	O	a	det	33	SENT_195	[p12l1057t3583r1102b3635],
33	factor	NN	O	factor	prep_by	30	SENT_195	[p12l1134t3556r1382b3635],
34	of	IN	O	of	_	0	SENT_195	[p12l1414t3556r1515b3635],
35	6.5	CD	NUMBER	6.5	prep_of	33	SENT_195	[p12l1531t3562r1657b3635],
36	in	IN	O	in	_	0	SENT_195	[p12l1695t3557r1777b3634],
37	patients	NNS	O	patient	prep_in	30	SENT_195	[p12l1809t3557r2146b3657],
38	with	IN	O	with	_	0	SENT_195	[p12l6t3685r197b3764],
39	the	DT	O	the	det	41	SENT_195	[p12l234t3684r363b3763],
40	Arg/Arg	NN	O	arg/arg	nn	41	SENT_195	[p12l398t3690r743b3785],
41	genotype	NN	O	genotype	prep_with	37	SENT_195	[p12l776t3701r1162b3785],
42	at	IN	O	at	_	0	SENT_195	[p12l1199t3701r1278b3763],
43	codon	NN	O	codon	prep_at	30	SENT_195	[p12l1311t3685r1573b3763],
44	16	CD	NUMBER	16	num	43	SENT_195	[p12l1614t3690r1711b3763],
45	of	IN	O	of	_	0	SENT_195	[p12l1750t3684r1851b3763],
46	ADRB2	NN	O	adrb2	prep_of	43	SENT_195	[p12l1862t3690r2144b3764],

1	than	IN	O	than	dep	9	SENT_196	[p13l11t21r201b99],
2	in	IN	O	in	_	0	SENT_196	[p13l228t21r310b98],
3	those	DT	O	those	prep_in	1	SENT_196	[p13l338t21r567b99],
4	with	IN	O	with	_	0	SENT_196	[p13l591t21r781b100],
5	the	DT	O	the	det	7	SENT_196	[p13l810t21r940b99],
6	GlylGly	NNP	O	GlylGly	nn	7	SENT_196	[p13l968t21r1293b121],
7	genotype	NN	O	genotype	prep_with	3	SENT_196	[p13l1317t37r1702b121],
8	(	CD	NUMBER	(	num	9	SENT_196	[p13l1736t21r1920b121],
9	Fig	NN	O	fig	_	0	SENT_196	[p13l1736t21r1920b121],
10	.	.	O	.	_	0	SENT_196	[p13l1736t21r1920b121],

1	4	CD	NUMBER	4	number	2	SENT_197	[p13l1952t26r2146b112],
2	)	CD	NUMBER	)	num	3	SENT_197	[p13l1952t26r2146b112],
3	.48	CD	NUMBER	.48	nsubj	21	SENT_197	[p13l1952t26r2146b112],
4	However	RB	O	however	advmod	3	SENT_197	[p13l10t156r405b244],
5	,	,	O	,	_	0	SENT_197	[p13l10t156r405b244],
6	the	DT	O	the	det	7	SENT_197	[p13l434t149r564b227],
7	inﬂuence	NN	O	inﬂuence	appos	3	SENT_197	[p13l587t148r981b228],
8	of	IN	O	of	_	0	SENT_197	[p13l1006t148r1107b227],
9	this	DT	O	this	det	10	SENT_197	[p13l1113t148r1266b227],
10	genotype	NN	O	genotype	prep_of	7	SENT_197	[p13l1292t165r1677b249],
11	was	VBD	O	be	cop	12	SENT_197	[p13l1697t175r1859b228],
12	different	JJ	O	different	partmod	10	SENT_197	[p13l1886t148r2147b227, p13l11t293r145b355],
13	in	IN	O	in	_	0	SENT_197	[p13l160t277r241b354],
14	patients	NNS	O	patient	prep_in	12	SENT_197	[p13l259t277r593b377],
15	receiving	VBG	O	receive	partmod	14	SENT_197	[p13l615t277r995b377],
16	long	RB	O	long	advmod	15	SENT_197	[p13l1012t277r1459b377],
17	—	RB	O	—	advmod	15	SENT_197	[p13l1012t277r1459b377],
18	term	NN	O	term	tmod	12	SENT_197	[p13l1012t277r1459b377],
19	,	,	O	,	_	0	SENT_197	[p13l1012t277r1459b377],
20	regularly	RB	O	regularly	advmod	21	SENT_197	[p13l1484t276r1857b377],
21	scheduled	VBN	O	schedule	_	0	SENT_197	[p13l1875t277r2148b355, p13l11t404r189b484],
22	therapy	NN	O	therapy	dobj	21	SENT_197	[p13l213t405r529b505],
23	with	IN	O	with	_	0	SENT_197	[p13l543t404r732b484],
24	inhaled	VBN	O	inhale	prepc_with	22	SENT_197	[p13l755t404r1068b483],
25	,8	CD	NUMBER	,8	number	26	SENT_197	[p13l1086t405r1565b505],
26	—	CD	NUMBER	—	num	27	SENT_197	[p13l1086t405r1565b505],
27	agonists	NNS	O	agonist	dobj	24	SENT_197	[p13l1086t405r1565b505],
28	.	.	O	.	_	0	SENT_197	[p13l1086t405r1565b505],

1	Among	IN	O	among	dep	123	SENT_198	[p13l1591t412r1910b505],
2	these	DT	O	these	dep	123	SENT_198	[p13l1931t405r2148b483],
3	patients	NNS	O	patient	dep	123	SENT_198	[p13l10t533r380b633],
4	,	,	O	,	_	0	SENT_198	[p13l10t533r380b633],
5	those	DT	O	those	dep	123	SENT_198	[p13l425t533r658b611],
6	with	IN	O	with	dep	123	SENT_198	[p13l691t533r885b612],
7	the	DT	O	the	dep	123	SENT_198	[p13l924t533r1055b611],
8	ArglArg	NNP	O	ArglArg	dep	123	SENT_198	[p13l1090t538r1442b633],
9	genotype	NN	O	genotype	dep	123	SENT_198	[p13l1477t549r1870b633],
10	had	VBD	O	have	dep	123	SENT_198	[p13l1909t533r2066b611],
11	a	DT	O	a	dep	123	SENT_198	[p13l2104t559r2149b611],
12	gradual	JJ	O	gradual	dep	123	SENT_198	[p13l10t661r328b761],
13	decline	NN	O	decline	dep	123	SENT_198	[p13l349t661r647b739],
14	in	IN	O	in	dep	123	SENT_198	[p13l667t661r748b738],
15	the	DT	O	the	dep	123	SENT_198	[p13l769t661r898b739],
16	morning	NN	TIME	morning	dep	123	SENT_198	[p13l918t661r1291b761],
17	peak	NN	O	peak	dep	123	SENT_198	[p13l1307t661r1510b761],
18	expiratory	JJ	O	expiratory	dep	123	SENT_198	[p13l1526t661r1950b761],
19	ﬂow	NN	O	ﬂow	dep	123	SENT_198	[p13l1966t660r2152b740],
20	measured	VBN	O	measure	dep	123	SENT_198	[p13l11t789r426b868],
21	before	IN	O	before	dep	123	SENT_198	[p13l448t788r716b867],
22	they	PRP	O	they	dep	123	SENT_198	[p13l738t789r916b889],
23	had	VBD	O	have	dep	123	SENT_198	[p13l933t788r1089b867],
24	used	VBN	O	use	dep	123	SENT_198	[p13l1111t788r1307b868],
25	medication	NN	O	medication	dep	123	SENT_198	[p13l1329t788r1830b884],
26	,	,	O	,	_	0	SENT_198	[p13l1329t788r1830b884],
27	whereas	IN	O	whereas	dep	123	SENT_198	[p13l1852t789r2147b868, p13l10t943r97b995],
28	no	DT	O	no	dep	123	SENT_198	[p13l137t942r245b995],
29	change	NN	O	change	dep	123	SENT_198	[p13l285t917r599b1017],
30	was	VBD	O	be	dep	123	SENT_198	[p13l633t943r799b996],
31	observed	VBN	O	observe	dep	123	SENT_198	[p13l840t917r1233b996],
32	in	IN	O	in	dep	123	SENT_198	[p13l1269t917r1353b994],
33	patients	NNS	O	patient	dep	123	SENT_198	[p13l1390t917r1741b1017],
34	with	IN	O	with	dep	123	SENT_198	[p13l1776t916r1973b996],
35	the	DT	O	the	dep	123	SENT_198	[p13l2011t917r2145b995],
36	Gly/Gly	NNP	O	Gly/Gly	dep	123	SENT_198	[p13l11t1044r342b1145],
37	genotype	NN	O	genotype	dep	123	SENT_198	[p13l361t1050r864b1145],
38	.47	CD	NUMBER	.47	dep	123	SENT_198	[p13l361t1050r864b1145],
39	In	IN	O	in	dep	123	SENT_198	[p13l886t1052r973b1122],
40	addition	NN	O	addition	dep	123	SENT_198	[p13l995t1045r1373b1140],
41	,	,	O	,	_	0	SENT_198	[p13l995t1045r1373b1140],
42	the	DT	O	the	dep	123	SENT_198	[p13l1401t1044r1531b1123],
43	morning	NN	TIME	morning	dep	123	SENT_198	[p13l1553t1045r1930b1145],
44	peak	NN	O	peak	dep	123	SENT_198	[p13l1948t1045r2153b1145],
45	expiratory	JJ	O	expiratory	dep	123	SENT_198	[p13l11t1173r436b1273],
46	ﬂow	NN	O	ﬂow	dep	123	SENT_198	[p13l469t1172r656b1252],
47	deteriorated	VBD	O	deteriorate	dep	123	SENT_198	[p13l692t1173r1199b1251],
48	dramatically	RB	O	dramatically	dep	123	SENT_198	[p13l1238t1173r1757b1273],
49	after	IN	O	after	dep	123	SENT_198	[p13l1791t1172r1983b1251],
50	the	DT	O	the	dep	123	SENT_198	[p13l2019t1172r2148b1251],
51	cessation	NN	O	cessation	dep	123	SENT_198	[p13l11t1301r401b1379],
52	of	IN	O	of	dep	123	SENT_198	[p13l440t1300r541b1379],
53	therapy	NN	O	therapy	dep	123	SENT_198	[p13l561t1300r881b1401],
54	in	IN	O	in	dep	123	SENT_198	[p13l915t1301r997b1378],
55	patients	NNS	O	patient	dep	123	SENT_198	[p13l1035t1301r1372b1401],
56	with	IN	O	with	dep	123	SENT_198	[p13l1409t1301r1599b1380],
57	the	DT	O	the	dep	123	SENT_198	[p13l1640t1300r1769b1379],
58	Arg/Arg	NN	O	arg/arg	dep	123	SENT_198	[p13l1806t1306r2152b1401],
59	genotype	NN	O	genotype	dep	123	SENT_198	[p13l10t1445r420b1529],
60	,	,	O	,	_	0	SENT_198	[p13l10t1445r420b1529],
61	but	CC	O	but	dep	123	SENT_198	[p13l458t1428r600b1508],
62	not	RB	O	not	dep	123	SENT_198	[p13l627t1445r771b1507],
63	in	IN	O	in	dep	123	SENT_198	[p13l798t1429r879b1506],
64	those	DT	O	those	dep	123	SENT_198	[p13l912t1429r1140b1507],
65	with	IN	O	with	dep	123	SENT_198	[p13l1168t1429r1358b1508],
66	the	DT	O	the	dep	123	SENT_198	[p13l1391t1429r1520b1507],
67	Gly/Gly	NNP	O	Gly/Gly	dep	123	SENT_198	[p13l1553t1429r1878b1529],
68	genotype	NN	O	genotype	dep	123	SENT_198	[p13l1905t1454r2147b1529, p13l11t1562r293b1657],
69	.47	CD	NUMBER	.47	dep	123	SENT_198	[p13l1905t1454r2147b1529, p13l11t1562r293b1657],
70	These	DT	O	these	dep	123	SENT_198	[p13l315t1556r567b1635],
71	data	NNS	O	datum	dep	123	SENT_198	[p13l592t1557r772b1635],
72	suggest	VBP	O	suggest	dep	123	SENT_198	[p13l796t1573r1124b1657],
73	that	IN	O	that	dep	123	SENT_198	[p13l1143t1557r1311b1635],
74	a	DT	O	a	dep	123	SENT_198	[p13l1330t1583r1374b1635],
75	codon	NN	O	codon	dep	123	SENT_198	[p13l1397t1556r1660b1635],
76	16	CD	NUMBER	16	dep	123	SENT_198	[p13l1687t1562r1785b1635],
77	Arg/Arg	NN	O	arg/arg	dep	123	SENT_198	[p13l1806t1562r2152b1657],
78	genotype	NN	O	genotype	dep	123	SENT_198	[p13l10t1701r396b1785],
79	may	MD	O	may	dep	123	SENT_198	[p13l428t1711r606b1785],
80	identify	VB	O	identify	dep	123	SENT_198	[p13l632t1684r955b1785],
81	patients	NNS	O	patient	dep	123	SENT_198	[p13l981t1685r1318b1785],
82	at	IN	O	at	dep	123	SENT_198	[p13l1351t1701r1430b1763],
83	risk	NN	O	risk	dep	123	SENT_198	[p13l1457t1685r1620b1764],
84	for	IN	O	for	dep	123	SENT_198	[p13l1647t1684r1770b1763],
85	deleterious	JJ	O	deleterious	dep	123	SENT_198	[p13l1800t1685r2147b1763, p13l11t1838r157b1892],
86	or	CC	O	or	dep	123	SENT_198	[p13l190t1838r279b1891],
87	nonbeneﬁcial	JJ	O	nonbeneﬁcial	dep	123	SENT_198	[p13l306t1812r883b1891],
88	effects	NNS	O	effect	dep	123	SENT_198	[p13l913t1812r1181b1891],
89	of	IN	O	of	dep	123	SENT_198	[p13l1214t1812r1315b1891],
90	regularly	RB	O	regularly	dep	123	SENT_198	[p13l1326t1813r1699b1913],
91	scheduled	VBN	O	schedule	dep	123	SENT_198	[p13l1726t1813r2149b1892],
92	therapy	NN	O	therapy	dep	123	SENT_198	[p13l11t1940r328b2041],
93	with	IN	O	with	dep	123	SENT_198	[p13l343t1941r533b2020],
94	inhaled	VBN	O	inhale	dep	123	SENT_198	[p13l556t1940r873b2019],
95	[	NN	O	[	dep	123	SENT_198	[p13l894t1941r1381b2041],
96	3	CD	NUMBER	3	dep	123	SENT_198	[p13l894t1941r1381b2041],
97	—	NN	O	—	dep	123	SENT_198	[p13l894t1941r1381b2041],
98	agonists	NNS	O	agonist	dep	123	SENT_198	[p13l894t1941r1381b2041],
99	;	:	O	;	_	0	SENT_198	[p13l894t1941r1381b2041],
100	the	DT	O	the	dep	123	SENT_198	[p13l1410t1941r1540b2019],
101	data	NNS	O	datum	dep	123	SENT_198	[p13l1567t1941r1747b2019],
102	also	RB	O	also	dep	123	SENT_198	[p13l1770t1941r1938b2019],
103	suggest	VBP	O	suggest	dep	123	SENT_198	[p13l1966t1967r2147b2041, p13l10t2085r187b2169],
104	that	IN	O	that	dep	123	SENT_198	[p13l205t2069r372b2147],
105	these	DT	O	these	dep	123	SENT_198	[p13l390t2069r610b2147],
106	patients	NNS	O	patient	dep	123	SENT_198	[p13l632t2069r968b2169],
107	may	MD	O	may	dep	123	SENT_198	[p13l993t2095r1171b2169],
108	be	VB	O	be	dep	123	SENT_198	[p13l1190t2068r1286b2147],
109	candidates	NNS	O	candidate	dep	123	SENT_198	[p13l1309t2069r1760b2147],
110	for	IN	O	for	dep	123	SENT_198	[p13l1784t2068r1908b2147],
111	alternative	JJ	O	alternative	dep	123	SENT_198	[p13l1927t2069r2147b2147, p13l11t2197r259b2276],
112	schedules	NNS	O	schedule	dep	123	SENT_198	[p13l284t2196r692b2276],
113	of	IN	O	of	dep	123	SENT_198	[p13l716t2196r816b2275],
114	therapy	NN	O	therapy	dep	123	SENT_198	[p13l820t2197r1144b2297],
115	,	,	O	,	_	0	SENT_198	[p13l820t2197r1144b2297],
116	earlier	JJR	O	earlier	dep	123	SENT_198	[p13l1172t2197r1435b2275],
117	initiation	NN	O	initiation	dep	123	SENT_198	[p13l1453t2197r1834b2275],
118	of	IN	O	of	dep	123	SENT_198	[p13l1856t2196r1956b2275],
119	antiinﬂammatory	JJ	O	antiinﬂammatory	dep	123	SENT_198	[p13l1958t2197r2148b2275, p13l10t2324r605b2425],
120	agents	NNS	O	agent	dep	123	SENT_198	[p13l629t2341r935b2425],
121	,	,	O	,	_	0	SENT_198	[p13l629t2341r935b2425],
122	or	CC	O	or	dep	123	SENT_198	[p13l971t2350r1062b2403],
123	both	DT	O	both	_	0	SENT_198	[p13l1088t2325r1311b2403],
124	.	.	O	.	_	0	SENT_198	[p13l1088t2325r1311b2403],

1	These	DT	O	these	det	2	SENT_199	[p13l1342t2325r1599b2403],
2	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_199	[p13l1628t2324r1987b2425],
3	are	VBP	O	be	cop	5	SENT_199	[p13l2018t2351r2147b2403],
4	also	RB	O	also	advmod	5	SENT_199	[p13l10t2453r181b2531],
5	consistent	JJ	O	consistent	_	0	SENT_199	[p13l209t2453r654b2531],
6	with	IN	O	with	_	0	SENT_199	[p13l668t2452r857b2532],
7	the	DT	O	the	det	9	SENT_199	[p13l881t2453r1010b2531],
8	aforementioned	JJ	O	aforementioned	amod	9	SENT_199	[p13l1033t2452r1714b2531],
9	desensitization	NN	O	desensitization	prep_with	5	SENT_199	[p13l1739t2453r2147b2531, p13l10t2581r274b2659],
10	of	IN	O	of	_	0	SENT_199	[p13l306t2580r407b2659],
11	the	DT	O	the	det	15	SENT_199	[p13l420t2581r550b2659],
12	,8	CD	NUMBER	,8	number	13	SENT_199	[p13l577t2584r639b2680],
13	2	CD	NUMBER	2	num	15	SENT_199	[p13l647t2580r1378b2681],
14	—	NN	O	—	nn	15	SENT_199	[p13l647t2580r1378b2681],
15	adrenoreceptor	NN	O	adrenoreceptor	prep_of	9	SENT_199	[p13l647t2580r1378b2681],
16	in	IN	O	in	_	0	SENT_199	[p13l1405t2581r1487b2658],
17	patients	NNS	O	patient	prep_in	15	SENT_199	[p13l1518t2581r1854b2681],
18	with	IN	O	with	_	0	SENT_199	[p13l1883t2581r2074b2660],
19	a	DT	O	a	det	23	SENT_199	[p13l2105t2607r2149b2659],
20	codon	NN	O	codon	nn	23	SENT_199	[p13l11t2709r274b2787],
21	16	CD	NUMBER	16	num	23	SENT_199	[p13l303t2714r401b2787],
22	ArglArg	NN	O	arglarg	nn	23	SENT_199	[p13l422t2714r768b2809],
23	genotype	NN	O	genotype	prep_with	17	SENT_199	[p13l790t2714r1287b2809],
24	.44	CD	NUMBER	.44	dep	23	SENT_199	[p13l790t2714r1287b2809],

1	At	IN	O	at	quantmod	3	SENT_200	[p13l137t2844r237b2915],
2	least	JJS	O	least	mwe	1	SENT_200	[p13l259t2837r462b2915],
3	13	CD	NUMBER	13	num	8	SENT_200	[p13l488t2842r584b2915],
4	distinct	JJ	O	distinct	amod	8	SENT_200	[p13l616t2837r945b2915],
5	single	JJ	O	single	amod	8	SENT_200	[p13l969t2837r1721b2937],
6	—	NN	O	—	nn	8	SENT_200	[p13l969t2837r1721b2937],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_200	[p13l969t2837r1721b2937],
8	polymorphisms	NNS	O	polymorphism	nsubjpass	11	SENT_200	[p13l1748t2836r2148b2937, p13l10t2965r316b3065],
9	have	VBP	O	have	aux	11	SENT_200	[p13l347t2965r534b3044],
10	been	VBN	O	be	auxpass	11	SENT_200	[p13l563t2965r761b3043],
11	identiﬁed	VBN	O	identiﬁed	_	0	SENT_200	[p13l789t2964r1187b3043],
12	in	IN	O	in	_	0	SENT_200	[p13l1215t2965r1296b3042],
13	ADRB2	NN	O	adrb2	prep_in	11	SENT_200	[p13l1317t2969r1708b3044],
14	.45	CD	NUMBER	.45	num	13	SENT_200	[p13l1317t2969r1708b3044],
15	This	DT	O	this	det	16	SENT_200	[p13l1734t2965r1917b3043],
16	ﬁnding	NN	O	ﬁnding	nsubj	18	SENT_200	[p13l1948t2964r2147b3043, p13l10t3093r148b3193],
17	has	VBZ	O	have	aux	18	SENT_200	[p13l167t3093r307b3171],
18	led	VBN	O	lead	rcmod	13	SENT_200	[p13l332t3093r456b3171],
19	to	TO	O	to	_	0	SENT_200	[p13l479t3109r558b3171],
20	evaluation	NN	O	evaluation	prep_to	18	SENT_200	[p13l582t3093r1020b3172],
21	of	IN	O	of	_	0	SENT_200	[p13l1047t3092r1150b3171],
22	the	DT	O	the	det	23	SENT_200	[p13l1158t3093r1290b3171],
23	importance	NN	O	importance	prep_of	20	SENT_200	[p13l1317t3093r1817b3193],
24	of	IN	O	of	_	0	SENT_200	[p13l1844t3092r1947b3171],
25	hapN	NN	O	hapn	prep_of	23	SENT_200	[p13l1954t3093r2148b3193, p13l492t3261r506b3277],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_201	[p13l521t3261r605b3283],
2	MED	NNP	O	MED	_	0	SENT_201	[p13l620t3261r673b3276],
3	348	CD	NUMBER	348	num	2	SENT_201	[p13l685t3255r756b3283],
4	;	:	O	;	_	0	SENT_201	[p13l685t3255r756b3283],
5	6	CD	NUMBER	6	num	7	SENT_201	[p13l685t3255r756b3283],
6	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	7	SENT_201	[p13l791t3261r1002b3283],
7	FEBRUARV	NN	O	februarv	dep	2	SENT_201	[p13l1041t3261r1169b3277],
8	6,2003	CD	NUMBER	6,2003	number	9	SENT_201	[p13l1182t3255r1279b3283],
9	543	CD	NUMBER	543	dep	7	SENT_201	[p13l1960t3259r2015b3282],

1	The	DT	O	the	det	4	SENT_202	[p13l701t3294r752b3318],
2	New	NNP	O	New	nn	4	SENT_202	[p13l761t3295r823b3318],
3	England	NNP	O	England	nn	4	SENT_202	[p13l833t3294r943b3325],
4	Journal	NNP	O	Journal	_	0	SENT_202	[p13l952t3294r1049b3318],
5	of	IN	O	of	_	0	SENT_202	[p13l1059t3294r1088b3318],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_202	[p13l1095t3294r1220b3318],

1	Downloaded	VBN	O	download	_	0	SENT_203	[p13l144t3335r313b3358],
2	from	IN	O	from	_	0	SENT_203	[p13l322t3335r387b3358],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_203	[p13l395t3335r514b3365],
4	at	IN	O	at	_	0	SENT_203	[p13l524t3339r547b3358],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_203	[p13l556t3335r738b3358],
6	on	IN	O	on	_	0	SENT_203	[p13l748t3342r780b3358],
7	January	NNP	DATE	January	prep_on	1	SENT_203	[p13l789t3335r891b3365],
8	5	CD	DATE	5	num	7	SENT_203	[p13l901t3335r924b3362],
9	,	,	DATE	,	_	0	SENT_203	[p13l901t3335r924b3362],
10	2014	CD	DATE	2014	num	7	SENT_203	[p13l935t3335r1007b3358],
11	.	.	O	.	_	0	SENT_203	[p13l935t3335r1007b3358],

1	For	IN	O	for	_	0	SENT_204	[p13l1017t3335r1064b3358],
2	personal	JJ	O	personal	amod	3	SENT_204	[p13l1072t3335r1184b3365],
3	use	NN	O	use	pobj	1	SENT_204	[p13l1194t3342r1237b3358],
4	only	RB	O	only	advmod	3	SENT_204	[p13l1247t3335r1311b3365],
5	.	.	O	.	_	0	SENT_204	[p13l1247t3335r1311b3365],

1	No	DT	O	no	det	3	SENT_205	[p13l1322t3335r1362b3358],
2	other	JJ	O	other	amod	3	SENT_205	[p13l1372t3335r1440b3358],
3	uses	NNS	O	use	_	0	SENT_205	[p13l1448t3342r1504b3358],
4	without	IN	O	without	_	0	SENT_205	[p13l1514t3335r1615b3358],
5	permission	NN	O	permission	prep_without	3	SENT_205	[p13l1624t3335r1776b3365],
6	.	.	O	.	_	0	SENT_205	[p13l1624t3335r1776b3365],

1	Copyright	NN	O	copyright	_	0	SENT_206	[p13l494t3376r628b3407],
2	©	CD	NUMBER	©	num	6	SENT_206	[p13l638t3376r661b3400],
3	2003	CD	DATE	2003	num	6	SENT_206	[p13l671t3376r735b3400],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_206	[p13l746t3376r937b3400],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_206	[p13l947t3376r1055b3400],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_206	[p13l1065t3376r1170b3407],
7	.	.	O	.	_	0	SENT_206	[p13l1065t3376r1170b3407],

1	All	DT	O	all	det	2	SENT_207	[p13l1181t3376r1222b3400],
2	rights	NNS	O	rights	nsubj	3	SENT_207	[p13l1231t3376r1306b3407],
3	reserved	VBN	O	reserve	_	0	SENT_207	[p13l1316t3376r1435b3400],
4	.	.	O	.	_	0	SENT_207	[p13l1316t3376r1435b3400],

1	Th	NN	O	th	_	0	SENT_208	[p13l715t3482r742b3503],
2	e	SYM	O	e	dep	4	SENT_208	[p13l744t3489r752b3503],
3	N	NN	O	n	nn	4	SENT_208	[p13l765t3484r788b3503],
4	E	NN	O	e	rcmod	1	SENT_208	[p13l795t3484r812b3503],
5	W	NN	O	w	nn	14	SENT_208	[p13l815t3484r845b3503],
6	E	NN	O	e	nn	14	SENT_208	[p13l859t3484r876b3503],
7	N	NN	O	n	nn	14	SENT_208	[p13l882t3484r905b3503],
8	G	NN	O	g	nn	14	SENT_208	[p13l911t3484r933b3503],
9	L	NN	O	l	nn	14	SENT_208	[p13l938t3484r955b3503],
10	A	NN	O	a	nn	14	SENT_208	[p13l957t3484r978b3503],
11	ND	NN	O	nd	nn	14	SENT_208	[p13l982t3484r1060b3510],
12	]	CD	NUMBER	]	num	14	SENT_208	[p13l982t3484r1060b3510],
13	OOOOO	NN	O	ooooo	nn	14	SENT_208	[p13l1065t3484r1193b3503],
14	L	NN	O	l	dep	1	SENT_208	[p13l1197t3484r1214b3503],
15	of	IN	O	of	_	0	SENT_208	[p13l1228t3482r1251b3509],
16	IIIIII	NNP	O	IIIIII	nn	17	SENT_208	[p13l1257t3484r1390b3503],
17	NE	NNS	O	ne	prep_of	14	SENT_208	[p13l1397t3484r1444b3503],

1	lotype	NN	O	lotype	nn	2	SENT_209	[p13l10t3706r261b3806],
2	structure	NN	O	structure	_	0	SENT_209	[p13l284t3722r654b3785],
3	as	IN	O	as	dep	2	SENT_209	[p13l676t3732r759b3784],
4	compared	VBN	O	compare	pcomp	3	SENT_209	[p13l784t3705r1203b3806],
5	with	IN	O	with	pcomp	4	SENT_209	[p13l1221t3706r1408b3785],
6	individual	JJ	O	individual	amod	7	SENT_209	[p13l1429t3705r1844b3785],
7	singlenucleotide	NN	O	singlenucleotide	pobj	5	SENT_209	[p13l1867t3705r2147b3806, p14l10t20r449b100],

1	polymorphisms	NNS	O	polymorphism	_	0	SENT_210	[p14l468t20r1136b121],
2	in	IN	O	in	_	0	SENT_210	[p14l1158t21r1239b98],
3	determining	VBG	O	determine	prepc_in	1	SENT_210	[p14l1261t20r1784b121],
4	receptor	NN	O	receptor	nn	5	SENT_210	[p14l1801t37r2151b121],
5	function	NN	O	function	dobj	3	SENT_210	[p14l10t148r370b228],
6	and	CC	O	and	_	0	SENT_210	[p14l398t148r557b227],
7	pharmacologic	JJ	O	pharmacologic	amod	8	SENT_210	[p14l583t149r1238b249],
8	response	NN	O	response	dobj	3	SENT_210	[p14l1266t174r1680b249],
9	.	.	O	.	_	0	SENT_210	[p14l1266t174r1680b249],

1	Among	IN	O	among	_	0	SENT_211	[p14l1708t156r2025b249],
2	77	CD	NUMBER	77	number	3	SENT_211	[p14l2047t156r2147b227],
3	white	JJ	O	white	amod	11	SENT_211	[p14l6t277r266b372],
4	,	,	O	,	_	0	SENT_211	[p14l6t277r266b372],
5	black	JJ	O	black	amod	11	SENT_211	[p14l297t276r545b372],
6	,	,	O	,	_	0	SENT_211	[p14l297t276r545b372],
7	Asian	JJ	MISC	asian	amod	11	SENT_211	[p14l571t277r835b372],
8	,	,	O	,	_	0	SENT_211	[p14l571t277r835b372],
9	and	CC	O	and	_	0	SENT_211	[p14l864t276r1021b355],
10	Hispanic	JJ	O	hispanic	amod	11	SENT_211	[p14l1044t277r1425b377],
11	subjects	NNS	O	subject	prep_among	25	SENT_211	[p14l1451t277r1813b377],
12	,	,	O	,	_	0	SENT_211	[p14l1451t277r1813b377],
13	only	RB	O	only	quantmod	14	SENT_211	[p14l1844t277r2026b377],
14	12	CD	NUMBER	12	num	16	SENT_211	[p14l2049t282r2147b354],
15	distinct	JJ	O	distinct	amod	16	SENT_211	[p14l11t404r331b483],
16	haplotypes	NNS	O	haplotype	nsubjpass	25	SENT_211	[p14l378t405r836b505],
17	of	IN	O	of	_	0	SENT_211	[p14l891t404r992b483],
18	the	DT	O	the	det	22	SENT_211	[p14l1026t405r1156b483],
19	8192	CD	DATE	8192	num	22	SENT_211	[p14l1209t410r1416b483],
20	possible	JJ	O	possible	amod	22	SENT_211	[p14l1467t404r1820b505],
21	ADRB2	NN	O	adrb2	nn	22	SENT_211	[p14l1864t410r2144b484],
22	haplotypes	NNS	O	haplotype	prep_of	16	SENT_211	[p14l10t533r468b633],
23	were	VBD	O	be	auxpass	25	SENT_211	[p14l489t559r692b612],
24	actually	RB	O	actually	advmod	25	SENT_211	[p14l715t532r1041b633],
25	observed	VBN	O	observe	_	0	SENT_211	[p14l1060t532r1548b612],
26	.45	CD	NUMBER	.45	dobj	25	SENT_211	[p14l1060t532r1548b612],
27	The	DT	O	the	det	31	SENT_211	[p14l1568t533r1730b611],
28	broncho	NN	O	broncho	nn	31	SENT_211	[p14l1754t533r2146b611],
29	—	NN	O	—	nn	31	SENT_211	[p14l1754t533r2146b611],
30	dilator	NN	O	dilator	nn	31	SENT_211	[p14l11t660r290b739],
31	response	NN	O	response	nsubj	42	SENT_211	[p14l309t686r689b761],
32	to	TO	O	to	_	0	SENT_211	[p14l712t677r791b739],
33	inhaled	VBN	O	inhale	prepc_to	31	SENT_211	[p14l813t661r1127b739],
34	,8	CD	NUMBER	,8	number	35	SENT_211	[p14l1143t661r1562b761],
35	—	CD	NUMBER	—	num	37	SENT_211	[p14l1143t661r1562b761],
36	agonist	NN	O	agonist	nn	37	SENT_211	[p14l1143t661r1562b761],
37	therapy	NN	O	therapy	dobj	33	SENT_211	[p14l1579t660r1896b761],
38	in	IN	O	in	_	0	SENT_211	[p14l1913t661r1994b738],
39	patients	NNS	O	patient	prep_in	33	SENT_211	[p14l2014t687r2147b761, p14l11t789r242b867],
40	with	IN	O	with	_	0	SENT_211	[p14l268t789r459b868],
41	asthma	NN	O	asthma	prep_with	33	SENT_211	[p14l487t788r799b867],
42	revealed	VBD	O	reveal	rcmod	26	SENT_211	[p14l827t788r1173b868],
43	a	DT	O	a	det	45	SENT_211	[p14l1201t815r1246b867],
44	stronger	JJR	O	stronger	amod	45	SENT_211	[p14l1274t805r1634b889],
45	association	NN	O	association	dobj	42	SENT_211	[p14l1660t789r2147b867],
46	between	IN	O	between	_	0	SENT_211	[p14l11t917r369b996],
47	bronchodilator	NN	O	bronchodilator	nn	48	SENT_211	[p14l407t916r1065b995],
48	response	NN	O	response	prep_between	45	SENT_211	[p14l1099t942r1488b1017],
49	and	CC	O	and	_	0	SENT_211	[p14l1526t917r1684b995],
50	haplotype	NN	O	haplotype	prep_between	45	SENT_211	[p14l1722t917r2146b1017],
51	than	IN	O	than	dep	42	SENT_211	[p14l11t1044r199b1123],
52	between	IN	O	between	_	0	SENT_211	[p14l224t1044r571b1124],
53	bronchodilator	NN	O	bronchodilator	nn	54	SENT_211	[p14l595t1045r1228b1123],
54	response	NN	O	response	prep_between	42	SENT_211	[p14l1248t1070r1624b1145],
55	and	CC	O	and	_	0	SENT_211	[p14l1648t1044r1803b1123],
56	any	DT	O	any	det	60	SENT_211	[p14l1826t1070r1973b1145],
57	single	JJ	O	single	amod	60	SENT_211	[p14l1993t1045r2147b1123, p14l10t1172r632b1273],
58	—	NN	O	—	nn	60	SENT_211	[p14l1993t1045r2147b1123, p14l10t1172r632b1273],
59	nucleotide	NN	O	nucleotide	nn	60	SENT_211	[p14l1993t1045r2147b1123, p14l10t1172r632b1273],
60	polymorphism	NN	O	polymorphism	prep_between	42	SENT_211	[p14l656t1172r1300b1273],
61	alone	RB	O	alone	advmod	62	SENT_211	[p14l1325t1173r1673b1251],
62	.46	CD	NUMBER	.46	tmod	42	SENT_211	[p14l1325t1173r1673b1251],
63	This	DT	O	this	nsubj	66	SENT_211	[p14l1695t1173r1884b1251],
64	is	VBZ	O	be	cop	66	SENT_211	[p14l1911t1173r1978b1251],
65	not	RB	O	not	neg	66	SENT_211	[p14l2005t1189r2152b1251],
66	surprising	JJ	O	surprising	rcmod	62	SENT_211	[p14l12t1301r482b1401],
67	,	,	O	,	_	0	SENT_211	[p14l12t1301r482b1401],
68	because	IN	O	because	mark	77	SENT_211	[p14l517t1301r858b1380],
69	haplotype	NN	O	haplotype	nn	70	SENT_211	[p14l886t1300r1311b1401],
70	structure	NN	O	structure	nsubj	77	SENT_211	[p14l1342t1317r1727b1380],
71	is	VBZ	O	be	cop	77	SENT_211	[p14l1756t1301r1822b1379],
72	often	RB	O	often	advmod	77	SENT_211	[p14l1853t1300r2075b1379],
73	a	DT	O	a	det	77	SENT_211	[p14l2103t1327r2148b1379],
74	better	JJR	O	better	amod	77	SENT_211	[p14l11t1429r262b1507],
75	predictor	NN	O	predictor	nn	77	SENT_211	[p14l284t1429r685b1529],
76	ofphenotypic	JJ	O	ofphenotypic	amod	77	SENT_211	[p14l709t1428r1302b1529],
77	consequences	NNS	O	consequence	advcl	66	SENT_211	[p14l1329t1454r1930b1529],
78	than	IN	O	than	mark	81	SENT_211	[p14l1958t1429r2148b1507],
79	are	VBP	O	be	cop	81	SENT_211	[p14l10t1583r135b1635],
80	individual	JJ	O	individual	amod	81	SENT_211	[p14l158t1557r576b1636],
81	polymorphisms	NNS	O	polymorphism	dep	77	SENT_211	[p14l598t1556r1290b1657],
82	.	.	O	.	_	0	SENT_211	[p14l598t1556r1290b1657],

1	This	DT	O	this	det	2	SENT_212	[p14l1316t1557r1500b1635],
2	result	NN	O	result	nsubj	3	SENT_212	[p14l1526t1557r1766b1636],
3	suggests	VBZ	O	suggest	_	0	SENT_212	[p14l1786t1573r2146b1657],
4	that	IN	O	that	complm	8	SENT_212	[p14l11t1685r177b1763],
5	it	PRP	O	it	nsubj	8	SENT_212	[p14l198t1685r257b1763],
6	would	MD	O	would	aux	8	SENT_212	[p14l274t1685r538b1764],
7	be	VB	O	be	cop	8	SENT_212	[p14l565t1685r660b1763],
8	desirable	JJ	O	desirable	ccomp	3	SENT_212	[p14l688t1685r1066b1763],
9	to	TO	O	to	aux	10	SENT_212	[p14l1094t1701r1172b1763],
10	develop	VB	O	develop	xcomp	8	SENT_212	[p14l1200t1685r1521b1785],
11	simple	JJ	O	simple	amod	15	SENT_212	[p14l1550t1684r1834b1785],
12	but	CC	O	but	_	0	SENT_212	[p14l1862t1685r2004b1764],
13	robust	JJ	O	robust	amod	15	SENT_212	[p14l2026t1710r2147b1763, p14l11t1813r201b1892],
14	molecular	JJ	O	molecular	amod	15	SENT_212	[p14l228t1812r667b1892],
15	methods	NNS	O	method	dobj	10	SENT_212	[p14l696t1812r1075b1891],
16	to	TO	O	to	aux	17	SENT_212	[p14l1110t1829r1190b1891],
17	determine	VB	O	determine	xcomp	10	SENT_212	[p14l1225t1813r1667b1891],
18	the	DT	O	the	det	22	SENT_212	[p14l1700t1813r1833b1891],
19	haplo	NN	O	haplo	nn	22	SENT_212	[p14l1866t1813r2145b1913],
20	—	NN	O	—	nn	22	SENT_212	[p14l1866t1813r2145b1913],
21	type	NN	O	type	nn	22	SENT_212	[p14l11t1957r182b2041],
22	structure	NN	O	structure	dobj	17	SENT_212	[p14l209t1957r585b2020],
23	of	IN	O	of	_	0	SENT_212	[p14l612t1940r713b2019],
24	patients	NNS	O	patient	prep_of	22	SENT_212	[p14l718t1941r1167b2041],
25	.58	CD	NUMBER	.58	dep	24	SENT_212	[p14l718t1941r1167b2041],

1	GENETIC	JJ	O	genetic	amod	2	SENT_213	[p14l301t2298r807b2358],
2	POLYMORPHISMS	NNS	O	polymorphism	_	0	SENT_213	[p14l862t2298r1843b2359],
3	WITH	IN	O	with	dep	2	SENT_213	[p14l343t2407r646b2466],
4	INDIRECT	JJ	O	indirect	amod	5	SENT_213	[p14l703t2407r1277b2467],
5	EFFECTS	NNS	O	effect	pobj	3	SENT_213	[p14l1329t2407r1796b2467],

1	ON	IN	O	on	_	0	SENT_214	[p14l486t2514r645b2574],
2	DRUG	NN	O	drug	nn	3	SENT_214	[p14l703t2514r1022b2574],
3	RESPONSE	NN	O	response	pobj	1	SENT_214	[p14l1075t2514r1659b2574],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	20	SENT_215	[p14l9t2748r674b2848],
2	in	IN	O	in	_	0	SENT_215	[p14l696t2748r777b2825],
3	genes	NNS	O	gene	prep_in	1	SENT_215	[p14l798t2773r1038b2848],
4	encoding	VBG	O	encode	partmod	3	SENT_215	[p14l1061t2748r1455b2848],
5	proteins	NNS	O	protein	dobj	4	SENT_215	[p14l1471t2748r1818b2848],
6	that	WDT	O	that	nsubj	10	SENT_215	[p14l1841t2747r2008b2826],
7	are	VBP	O	be	cop	10	SENT_215	[p14l2023t2774r2148b2826],
8	neither	DT	O	neither	det	10	SENT_215	[p14l10t2875r314b2954],
9	direct	JJ	O	direct	amod	10	SENT_215	[p14l346t2875r589b2954],
10	targets	NNS	O	target	rcmod	5	SENT_215	[p14l619t2892r907b2976],
11	of	IN	O	of	_	0	SENT_215	[p14l944t2875r1045b2954],
12	medications	NNS	O	medication	prep_of	10	SENT_215	[p14l1061t2876r1579b2954],
13	nor	CC	O	nor	_	0	SENT_215	[p14l1617t2901r1765b2954],
14	involved	VBN	O	involve	rcmod	5	SENT_215	[p14l1796t2875r2148b2955],
15	in	IN	O	in	_	0	SENT_215	[p14l10t3004r92b3081],
16	their	PRP$	O	they	poss	17	SENT_215	[p14l114t3004r312b3082],
17	disposition	NN	O	disposition	prep_in	14	SENT_215	[p14l332t3004r809b3104],
18	have	VBP	O	have	aux	20	SENT_215	[p14l831t3003r1020b3083],
19	been	VBN	O	be	auxpass	20	SENT_215	[p14l1043t3003r1244b3082],
20	shown	VBN	O	show	dep	30	SENT_215	[p14l1268t3004r1548b3083],
21	to	TO	O	to	aux	22	SENT_215	[p14l1571t3020r1651b3082],
22	alter	VB	O	alter	xcomp	20	SENT_215	[p14l1674t3004r1863b3082],
23	the	DT	O	the	det	24	SENT_215	[p14l1882t3004r2012b3082],
24	response	NN	O	response	dobj	22	SENT_215	[p14l2035t3030r2147b3082, p14l12t3157r308b3232],
25	to	TO	O	to	_	0	SENT_215	[p14l335t3148r414b3210],
26	treatment	NN	O	treatment	prep_to	22	SENT_215	[p14l442t3148r859b3210],
27	in	IN	O	in	_	0	SENT_215	[p14l880t3132r962b3209],
28	certain	JJ	O	certain	amod	29	SENT_215	[p14l989t3132r1280b3210],
29	situations	NNS	O	situation	prep_in	26	SENT_215	[p14l1307t3132r1720b3211],
30	(	VBP	O	(	_	0	SENT_215	[p14l1753t3132r2009b3223],
31	Table	NNP	O	Table	dobj	30	SENT_215	[p14l1753t3132r2009b3223],
32	2	CD	NUMBER	2	num	31	SENT_215	[p14l2035t3137r2142b3223],
33	)	CD	NUMBER	)	nsubj	30	SENT_215	[p14l2035t3137r2142b3223],
34	.	.	O	.	_	0	SENT_215	[p14l2035t3137r2142b3223],

1	For	IN	O	for	_	0	SENT_216	[p14l9t3267r157b3338],
2	example	NN	O	example	prep_for	10	SENT_216	[p14l181t3260r567b3360],
3	,	,	O	,	_	0	SENT_216	[p14l181t3260r567b3360],
4	inherited	VBN	O	inherit	amod	5	SENT_216	[p14l599t3260r993b3338],
5	differences	NNS	O	difference	nsubj	10	SENT_216	[p14l1021t3259r1497b3338],
6	in	IN	O	in	_	0	SENT_216	[p14l1526t3260r1608b3337],
7	coagulation	NN	O	coagulation	nn	8	SENT_216	[p14l1637t3260r2147b3360],
8	factors	NNS	O	factor	prep_in	5	SENT_216	[p14l10t3387r303b3466],
9	can	MD	O	can	aux	10	SENT_216	[p14l338t3413r483b3466],
10	predispose	VB	O	predispose	_	0	SENT_216	[p14l511t3387r976b3488],
11	women	NNS	O	woman	dobj	10	SENT_216	[p14l1001t3413r1321b3467],
12	taking	VBG	O	take	xcomp	10	SENT_216	[p14l1352t3388r1625b3488],
13	oral	JJ	O	oral	amod	14	SENT_216	[p14l1652t3388r1814b3466],
14	contraceptives	NNS	O	contraceptive	dobj	12	SENT_216	[p14l1844t3404r2146b3466, p14l11t3516r337b3616],
15	to	TO	O	to	_	0	SENT_216	[p14l362t3532r441b3594],
16	deep	JJ	O	deep	amod	18	SENT_216	[p14l464t3516r867b3616],
17	—	NN	O	—	nn	18	SENT_216	[p14l464t3516r867b3616],
18	vein	NN	O	vein	prep_to	12	SENT_216	[p14l464t3516r867b3616],
19	or	CC	O	or	_	0	SENT_216	[p14l889t3541r977b3594],
20	cerebral	JJ	O	cerebral	amod	23	SENT_216	[p14l998t3515r1535b3595],
21	—	NN	O	—	nn	23	SENT_216	[p14l998t3515r1535b3595],
22	vein	NN	O	vein	nn	23	SENT_216	[p14l998t3515r1535b3595],
23	thrombosis	NN	O	thrombosis	prep_to	12	SENT_216	[p14l1557t3515r2148b3611],
24	,8	CD	NUMBER	,8	number	25	SENT_216	[p14l1557t3515r2148b3611],
25	°	CD	NUMBER	°	num	23	SENT_216	[p14l1557t3515r2148b3611],
26	whereas	IN	O	whereas	mark	27	SENT_216	[p14l6t3644r356b3723],
27	polymorphisms	NNS	O	polymorphism	dep	23	SENT_216	[p14l394t3644r1068b3744],
28	in	IN	O	in	_	0	SENT_216	[p14l1108t3644r1189b3721],
29	the	DT	O	the	det	30	SENT_216	[p14l1227t3644r1357b3722],
30	gene	NN	O	gene	prep_in	27	SENT_216	[p14l1395t3669r1595b3744],
31	for	IN	O	for	_	0	SENT_216	[p14l1633t3643r1757b3722],
32	the	DT	O	the	det	33	SENT_216	[p14l1792t3644r1922b3722],
33	cholesterol	NN	O	cholesterol	prep_for	30	SENT_216	[p14l1961t3644r2147b3722, p15l10t21r327b99],

1	ester	NN	O	ester	nn	3	SENT_217	[p15l357t37r564b99],
2	transfer	NN	O	transfer	nn	3	SENT_217	[p15l593t20r933b99],
3	protein	NN	O	protein	nsubjpass	6	SENT_217	[p15l959t21r1274b121],
4	have	VBP	O	have	aux	6	SENT_217	[p15l1305t20r1498b100],
5	been	VBN	O	be	auxpass	6	SENT_217	[p15l1529t21r1733b99],
6	linked	VBN	O	link	_	0	SENT_217	[p15l1762t20r2034b100],
7	to	TO	O	to	_	0	SENT_217	[p15l2065t37r2145b99],
8	the	DT	O	the	det	9	SENT_217	[p15l11t148r140b227],
9	progression	NN	O	progression	prep_to	6	SENT_217	[p15l163t149r675b249],
10	of	IN	O	of	_	0	SENT_217	[p15l699t148r800b227],
11	atherosclerosis	NN	O	atherosclerosis	prep_of	9	SENT_217	[p15l804t149r1444b227],
12	with	IN	O	with	_	0	SENT_217	[p15l1465t148r1655b228],
13	pravastatin	NN	O	pravastatin	nn	14	SENT_217	[p15l1678t149r2148b249],
14	therapy	NN	O	therapy	prep_with	6	SENT_217	[p15l11t276r425b377],
15	.75	CD	NUMBER	.75	num	14	SENT_217	[p15l11t276r425b377],

1	Genetic	JJ	O	genetic	amod	2	SENT_218	[p15l140t405r464b483],
2	variation	NN	O	variation	nsubj	9	SENT_218	[p15l482t405r853b484],
3	in	IN	O	in	_	0	SENT_218	[p15l874t405r956b482],
4	cellular	JJ	O	cellular	amod	6	SENT_218	[p15l979t404r1289b484],
5	ion	NN	O	ion	nn	6	SENT_218	[p15l1308t405r1443b483],
6	transporters	NNS	O	transporter	prep_in	2	SENT_218	[p15l1467t421r1979b505],
7	can	MD	O	can	aux	9	SENT_218	[p15l2005t430r2148b483],
8	also	RB	O	also	advmod	9	SENT_218	[p15l10t533r178b611],
9	have	VB	O	have	_	0	SENT_218	[p15l210t533r399b612],
10	an	DT	O	a	det	12	SENT_218	[p15l430t558r531b611],
11	indirect	JJ	O	indirect	amod	12	SENT_218	[p15l561t532r891b611],
12	role	NN	O	role	dobj	9	SENT_218	[p15l917t533r1079b611],
13	in	IN	O	in	_	0	SENT_218	[p15l1109t533r1191b610],
14	predisposing	VBG	O	predispose	prepc_in	12	SENT_218	[p15l1221t532r1783b633],
15	patients	NNS	O	patient	dobj	14	SENT_218	[p15l1809t533r2145b633],
16	to	TO	O	to	_	0	SENT_218	[p15l11t677r90b739],
17	toxic	JJ	O	toxic	amod	18	SENT_218	[p15l114t661r316b739],
18	effects	NNS	O	effect	prep_to	14	SENT_218	[p15l339t660r610b739],
19	of	IN	O	of	_	0	SENT_218	[p15l635t660r737b739],
20	drugs	NNS	O	drug	prep_of	18	SENT_218	[p15l741t661r1006b761],
21	.	.	O	.	_	0	SENT_218	[p15l741t661r1006b761],

1	For	IN	O	for	_	0	SENT_219	[p15l1032t668r1177b739],
2	example	NN	O	example	prep_for	14	SENT_219	[p15l1197t661r1574b761],
3	,	,	O	,	_	0	SENT_219	[p15l1197t661r1574b761],
4	patients	NNS	O	patient	nsubj	14	SENT_219	[p15l1601t661r1938b761],
5	with	IN	O	with	_	0	SENT_219	[p15l1958t661r2148b740],
6	variant	JJ	O	variant	amod	7	SENT_219	[p15l6t789r303b868],
7	alleles	NNS	O	allele	prep_with	4	SENT_219	[p15l328t788r589b867],
8	for	IN	O	for	_	0	SENT_219	[p15l622t788r746b867],
9	sodium	NN	O	sodium	nn	12	SENT_219	[p15l776t788r1094b868],
10	or	CC	O	or	_	0	SENT_219	[p15l1126t814r1215b867],
11	potassium	NN	O	potassium	nn	12	SENT_219	[p15l1242t789r1690b889],
12	transporters	NNS	O	transporter	prep_for	7	SENT_219	[p15l1721t805r2147b889, p15l11t943r131b995],
13	may	MD	O	may	aux	14	SENT_219	[p15l159t943r336b1017],
14	have	VB	O	have	_	0	SENT_219	[p15l358t917r546b996],
15	substantial	JJ	O	substantial	amod	16	SENT_219	[p15l574t917r1041b996],
16	morbidity	NN	O	morbidity	dobj	14	SENT_219	[p15l1066t917r1487b1017],
17	or	CC	O	or	_	0	SENT_219	[p15l1509t942r1599b995],
18	mortality	NN	O	mortality	dobj	14	SENT_219	[p15l1622t917r2013b1017],
19	resulting	VBG	O	result	xcomp	14	SENT_219	[p15l2035t943r2147b995, p15l12t1045r307b1145],
20	from	IN	O	from	_	0	SENT_219	[p15l342t1044r550b1123],
21	drug	NN	O	drug	nn	22	SENT_219	[p15l589t1045r1165b1145],
22	—	NN	O	—	prep_from	19	SENT_219	[p15l589t1045r1165b1145],
23	induced	VBD	O	induce	partmod	22	SENT_219	[p15l589t1045r1165b1145],
24	long	RB	O	long	advmod	23	SENT_219	[p15l1201t1044r1565b1145],
25	.	.	O	.	_	0	SENT_219	[p15l1201t1044r1565b1145],

1	—	NN	O	—	_	0	SENT_220	[p15l1201t1044r1565b1145],
2	.	.	O	.	_	0	SENT_220	[p15l1201t1044r1565b1145],

1	QT	NN	O	qt	_	0	SENT_221	[p15l1201t1044r1565b1145],
2	syndrome	NN	O	syndrome	dep	1	SENT_221	[p15l1601t1044r2044b1145],
3	.	.	O	.	_	0	SENT_221	[p15l1601t1044r2044b1145],

1	A	DT	O	a	det	2	SENT_222	[p15l2084t1052r2151b1122],
2	mutation	NN	O	mutation	_	0	SENT_222	[p15l10t1173r402b1252],
3	in	IN	O	in	_	0	SENT_222	[p15l430t1173r512b1250],
4	KCNE2	NN	O	kcne2	prep_in	2	SENT_222	[p15l539t1179r839b1268],
5	,	,	O	,	_	0	SENT_222	[p15l539t1179r839b1268],
6	the	DT	O	the	det	7	SENT_222	[p15l873t1173r1003b1251],
7	gene	NN	O	gene	appos	2	SENT_222	[p15l1033t1198r1233b1273],
8	for	IN	O	for	_	0	SENT_222	[p15l1261t1172r1386b1251],
9	an	DT	O	a	det	12	SENT_222	[p15l1411t1198r1512b1251],
10	integral	JJ	O	integral	amod	12	SENT_222	[p15l1540t1173r1868b1273],
11	membrane	NN	O	membrane	nn	12	SENT_222	[p15l1896t1199r2146b1251, p15l11t1301r250b1379],
12	subunit	NN	O	subunit	prep_for	7	SENT_222	[p15l285t1301r610b1380],
13	that	WDT	O	that	nsubj	14	SENT_222	[p15l638t1301r806b1379],
14	assembles	VBZ	O	assemble	rcmod	7	SENT_222	[p15l833t1300r1269b1379],
15	With	IN	O	with	_	0	SENT_222	[p15l1300t1300r1490b1380],
16	HERG	NN	O	herg	prep_with	18	SENT_222	[p15l1522t1306r1791b1384],
17	to	TO	O	to	aux	18	SENT_222	[p15l1826t1317r1905b1379],
18	form	VB	O	form	xcomp	14	SENT_222	[p15l1939t1300r2148b1379],

1	IK1	NN	O	ik1	_	0	SENT_223	[p15l9t1436r123b1528],
2	.	.	O	.	_	0	SENT_223	[p15l9t1436r123b1528],

1	potassium	NN	O	potassium	nn	2	SENT_224	[p15l147t1429r594b1529],
2	channels	NNS	O	channel	_	0	SENT_224	[p15l622t1429r1025b1524],
3	,	,	O	,	_	0	SENT_224	[p15l622t1429r1025b1524],
4	was	VBD	O	be	auxpass	5	SENT_224	[p15l1052t1455r1215b1508],
5	identified	VBN	O	identify	dep	2	SENT_224	[p15l1243t1428r1650b1507],
6	in	IN	O	in	_	0	SENT_224	[p15l1676t1429r1757b1506],
7	a	DT	O	a	det	8	SENT_224	[p15l1784t1455r1829b1507],
8	patient	NN	O	patient	prep_in	5	SENT_224	[p15l1853t1429r2153b1529],
9	who	WP	O	who	nsubj	10	SENT_224	[p15l6t1557r190b1636],
10	had	VBD	O	have	rcmod	8	SENT_224	[p15l216t1556r372b1635],
11	cardiac	JJ	O	cardiac	amod	12	SENT_224	[p15l398t1556r699b1635],
12	arrhythmia	NN	O	arrhythmium	dobj	10	SENT_224	[p15l724t1556r1196b1657],
13	after	IN	O	after	_	0	SENT_224	[p15l1219t1556r1414b1635],
14	receiving	VBG	O	receive	prepc_after	10	SENT_224	[p15l1436t1557r1821b1657],
15	clarith	JJ	O	clarith	amod	21	SENT_224	[p15l1844t1556r2146b1635],
16	—	NN	O	—	nn	21	SENT_224	[p15l1844t1556r2146b1635],
17	romycin	NN	O	romycin	nn	21	SENT_224	[p15l10t1685r466b1785],
18	.76	CD	NUMBER	.76	num	21	SENT_224	[p15l10t1685r466b1785],
19	Additional	JJ	O	additional	amod	21	SENT_224	[p15l513t1684r959b1763],
20	KCNE2	NN	O	kcne2	nn	21	SENT_224	[p15l1007t1691r1277b1763],
21	variants	NNS	O	variant	nsubjpass	24	SENT_224	[p15l1327t1685r1657b1764],
22	have	VBP	O	have	aux	24	SENT_224	[p15l1709t1684r1897b1764],
23	been	VBN	O	be	auxpass	24	SENT_224	[p15l1949t1685r2148b1763],
24	associated	VBN	O	associate	ccomp	14	SENT_224	[p15l10t1812r446b1891],
25	with	IN	O	with	_	0	SENT_224	[p15l469t1812r658b1892],
26	the	DT	O	the	det	27	SENT_224	[p15l686t1813r816b1891],
27	development	NN	O	development	prep_with	24	SENT_224	[p15l846t1812r1399b1913],
28	of	IN	O	of	_	0	SENT_224	[p15l1423t1812r1525b1891],
29	a	DT	O	a	det	33	SENT_224	[p15l1534t1839r1579b1891],
30	very	RB	O	very	advmod	31	SENT_224	[p15l1601t1839r1775b1913],
31	long	JJ	O	long	amod	33	SENT_224	[p15l1798t1813r1993b1913],
32	QT	NN	O	qt	nn	33	SENT_224	[p15l2018t1818r2151b1911],
33	interval	NN	O	interval	prep_of	27	SENT_224	[p15l10t1941r318b2020],
34	after	IN	O	after	_	0	SENT_224	[p15l337t1940r527b2019],
35	therapy	NN	O	therapy	prep_after	24	SENT_224	[p15l544t1940r856b2041],
36	with	IN	O	with	_	0	SENT_224	[p15l868t1941r1055b2020],
37	trimethoprim	NN	O	trimethoprim	prep_with	24	SENT_224	[p15l1075t1940r2148b2041],
38	—	CD	NUMBER	—	num	41	SENT_224	[p15l1075t1940r2148b2041],
39	sulfameth	NN	O	sulfameth	nn	41	SENT_224	[p15l1075t1940r2148b2041],
40	—	NN	O	—	nn	41	SENT_224	[p15l1075t1940r2148b2041],
41	oxazole	NN	O	oxazole	nsubjpass	5	SENT_224	[p15l11t2069r356b2164],
42	,	,	O	,	_	0	SENT_224	[p15l11t2069r356b2164],
43	with	IN	O	with	_	0	SENT_224	[p15l379t2069r569b2148],
44	sulfamethoxazole	NN	O	sulfamethoxazole	prep_with	2	SENT_224	[p15l593t2068r1343b2148],
45	inhibiting	VBG	O	inhibit	partmod	44	SENT_224	[p15l1365t2069r1791b2169],
46	potassium	NN	O	potassium	nn	47	SENT_224	[p15l1809t2069r2147b2169, p15l10t2223r149b2276],
47	channels	NNS	O	channel	dobj	45	SENT_224	[p15l179t2196r562b2275],
48	encoded	VBN	O	encode	partmod	47	SENT_224	[p15l594t2197r956b2275],
49	by	IN	O	by	_	0	SENT_224	[p15l985t2196r1084b2297],
50	the	DT	O	the	det	54	SENT_224	[p15l1108t2196r1240b2275],
51	KCNE2	NN	O	kcne2	nn	54	SENT_224	[p15l1266t2203r1543b2275],
52	(	CD	NUMBER	(	num	54	SENT_224	[p15l1579t2202r1922b2288],
53	STAA	NN	ORGANIZATION	staa	nn	54	SENT_224	[p15l1579t2202r1922b2288],
54	)	NN	O	)	agent	48	SENT_224	[p15l1579t2202r1922b2288],
55	variant	JJ	O	variant	amod	54	SENT_224	[p15l1952t2197r2145b2276, p15l10t2332r258b2403],
56	.77	CD	NUMBER	.77	tmod	55	SENT_224	[p15l1952t2197r2145b2276, p15l10t2332r258b2403],
57	Because	IN	O	because	mark	60	SENT_224	[p15l296t2331r638b2404],
58	KCNE2	NN	O	kcne2	nn	59	SENT_224	[p15l673t2331r945b2403],
59	variants	NNS	O	variant	nsubj	60	SENT_224	[p15l981t2325r1315b2404],
60	occur	VBP	O	occur	advcl	48	SENT_224	[p15l1354t2350r1590b2404],
61	in	IN	O	in	prep	60	SENT_224	[p15l1622t2325r1704b2402],
62	about	IN	O	about	pcomp	61	SENT_224	[p15l1740t2325r1985b2404],
63	1.6	CD	NUMBER	1.6	pobj	62	SENT_224	[p15l2020t2330r2147b2403],

1	percent	NN	O	percent	nsubj	12	SENT_225	[p15l9t2469r331b2553],
2	of	IN	O	of	_	0	SENT_225	[p15l359t2452r459b2531],
3	the	DT	O	the	det	4	SENT_225	[p15l473t2452r603b2531],
4	population	NN	O	population	prep_of	1	SENT_225	[p15l634t2453r1100b2553],
5	and	CC	O	and	_	0	SENT_225	[p15l1131t2453r1289b2531],
6	their	PRP$	O	they	poss	7	SENT_225	[p15l1321t2453r1519b2531],
7	effect	NN	O	effect	prep_of	1	SENT_225	[p15l1548t2452r1783b2531],
8	on	IN	O	on	_	0	SENT_225	[p15l1811t2478r1918b2531],
9	drug	NN	O	drug	nn	10	SENT_225	[p15l1950t2452r2151b2553],
10	actions	NNS	O	action	prep_on	7	SENT_225	[p15l10t2581r318b2659],
11	can	MD	O	can	aux	12	SENT_225	[p15l352t2606r499b2659],
12	cause	VB	O	cause	ccomp	18	SENT_225	[p15l531t2607r767b2660],
13	death	NN	O	death	dobj	12	SENT_225	[p15l799t2581r1061b2676],
14	,	,	O	,	_	0	SENT_225	[p15l799t2581r1061b2676],
15	they	PRP	O	they	nsubj	18	SENT_225	[p15l1099t2580r1280b2681],
16	are	VBP	O	be	cop	18	SENT_225	[p15l1305t2607r1434b2659],
17	excellent	JJ	O	excellent	amod	18	SENT_225	[p15l1466t2580r1852b2659],
18	candidates	NNS	O	candidate	_	0	SENT_225	[p15l1878t2580r2145b2659, p15l11t2708r232b2787],
19	for	IN	O	for	_	0	SENT_225	[p15l275t2708r401b2787],
20	polygenic	JJ	O	polygenic	amod	21	SENT_225	[p15l437t2709r856b2809],
21	strategies	NNS	O	strategy	prep_for	18	SENT_225	[p15l898t2709r1309b2809],
22	to	TO	O	to	aux	23	SENT_225	[p15l1352t2725r1433b2787],
23	prevent	VB	O	prevent	infmod	18	SENT_225	[p15l1474t2725r1800b2809],
24	serious	JJ	O	serious	amod	26	SENT_225	[p15l1837t2709r2144b2788],
25	drug	NN	O	drug	nn	26	SENT_225	[p15l11t2836r593b2937],
26	—	NN	O	—	nsubj	27	SENT_225	[p15l11t2836r593b2937],
27	induced	VBD	O	induce	ccomp	23	SENT_225	[p15l11t2836r593b2937],
28	toxic	JJ	O	toxic	amod	29	SENT_225	[p15l618t2837r820b2915],
29	effects	NNS	O	effect	dobj	27	SENT_225	[p15l846t2836r1142b2915],
30	.	.	O	.	_	0	SENT_225	[p15l846t2836r1142b2915],

1	Genetic	JJ	O	genetic	amod	2	SENT_226	[p15l144t2965r470b3043],
2	polymorphism	NN	O	polymorphism	nsubj	11	SENT_226	[p15l498t2964r1129b3065],
3	in	IN	O	in	_	0	SENT_226	[p15l1159t2965r1240b3042],
4	the	DT	O	the	det	6	SENT_226	[p15l1271t2965r1401b3043],
5	apolipoprotein	NN	O	apolipoprotein	nn	6	SENT_226	[p15l1431t2965r2064b3065],
6	E	NN	O	e	prep_in	2	SENT_226	[p15l2092t2972r2144b3042],
7	(	CD	NUMBER	(	num	10	SENT_226	[p15l19t3098r290b3184],
8	APOE	NN	ORGANIZATION	apoe	nn	10	SENT_226	[p15l19t3098r290b3184],
9	)	NN	O	)	nn	10	SENT_226	[p15l19t3098r290b3184],
10	gene	NN	O	gene	dep	6	SENT_226	[p15l320t3118r519b3193],
11	appears	VBZ	O	appear	_	0	SENT_226	[p15l543t3119r871b3193],
12	to	TO	O	to	aux	13	SENT_226	[p15l898t3109r977b3171],
13	have	VB	O	have	xcomp	11	SENT_226	[p15l1003t3093r1192b3172],
14	a	DT	O	a	det	15	SENT_226	[p15l1216t3119r1261b3171],
15	role	NN	O	role	dobj	13	SENT_226	[p15l1283t3093r1444b3171],
16	in	IN	O	in	_	0	SENT_226	[p15l1468t3093r1550b3170],
17	predicting	VBG	O	predict	prepc_in	15	SENT_226	[p15l1573t3092r2012b3193],
18	responses	NNS	O	response	dobj	17	SENT_226	[p15l2034t3119r2145b3171, p15l16t3246r353b3321],
19	to	TO	O	to	_	0	SENT_226	[p15l388t3237r467b3299],
20	therapy	NN	O	therapy	prep_to	17	SENT_226	[p15l501t3220r818b3321],
21	for	IN	O	for	_	0	SENT_226	[p15l846t3220r970b3299],
22	Alzheimer	NN	O	alzheimer	poss	24	SENT_226	[p15l995t3221r1507b3299],
23	’s	POS	O	’s	_	0	SENT_226	[p15l995t3221r1507b3299],
24	disease	NN	O	disease	prep_for	20	SENT_226	[p15l1541t3221r1846b3299],
25	and	CC	O	and	_	0	SENT_226	[p15l1877t3220r2034b3299],
26	to	TO	O	to	_	0	SENT_226	[p15l2066t3237r2145b3299],
27	lipid	NN	O	lipid	nn	28	SENT_226	[p15l13t3349r622b3449],
28	—	NN	O	—	conj_and	20	SENT_226	[p15l13t3349r622b3449],
29	loWering	VBG	O	lower	partmod	28	SENT_226	[p15l13t3349r622b3449],
30	drugs	NNS	O	drug	dobj	29	SENT_226	[p15l665t3348r1327b3449],
31	.7	CD	NUMBER	.7	number	32	SENT_226	[p15l665t3348r1327b3449],
32	°	CD	NUMBER	°	npadvmod	33	SENT_226	[p15l665t3348r1327b3449],
33	>	JJR	O	>	amod	30	SENT_226	[p15l665t3348r1327b3449],
34	71	CD	NUMBER	71	npadvmod	35	SENT_226	[p15l665t3348r1327b3449],
35	>	JJR	O	>	dep	88	SENT_226	[p15l665t3348r1327b3449],
36	82	CD	NUMBER	82	number	37	SENT_226	[p15l665t3348r1327b3449],
37	’83	CD	NUMBER	’83	nsubj	88	SENT_226	[p15l665t3348r1327b3449],
38	There	EX	O	there	expl	39	SENT_226	[p15l1370t3348r1616b3427],
39	are	VBP	O	be	rcmod	37	SENT_226	[p15l1661t3375r1787b3427],
40	numerous	JJ	O	numerous	amod	42	SENT_226	[p15l1832t3374r2144b3428, p15l15t3502r160b3556],
41	allelic	JJ	O	allelic	amod	42	SENT_226	[p15l195t3476r442b3555],
42	variants	NNS	O	variant	nsubj	39	SENT_226	[p15l470t3477r803b3556],
43	of	IN	O	of	_	0	SENT_226	[p15l839t3476r940b3555],
44	the	DT	O	the	det	47	SENT_226	[p15l954t3477r1084b3555],
45	human	JJ	O	human	amod	47	SENT_226	[p15l1117t3477r1418b3556],
46	APOE	NN	O	apoe	nn	47	SENT_226	[p15l1443t3482r1663b3555],
47	gene	NN	O	gene	prep_of	42	SENT_226	[p15l1695t3502r1895b3577],
48	(	CD	NUMBER	(	amod	47	SENT_226	[p15l1933t3483r2140b3577],
49	e.g.	FW	O	e.g.	dep	48	SENT_226	[p15l1933t3483r2140b3577],
50	,	,	O	,	_	0	SENT_226	[p15l1933t3483r2140b3577],
51	APOE	NNP	O	APOE	appos	49	SENT_226	[p15l7t3610r225b3683],
52	53	CD	NUMBER	53	num	51	SENT_226	[p15l247t3612r365b3700],
53	,	,	O	,	_	0	SENT_226	[p15l247t3612r365b3700],
54	APOE	NNP	O	APOE	nn	55	SENT_226	[p15l385t3610r603b3683],
55	e4	NN	O	e4	appos	49	SENT_226	[p15l625t3612r743b3700],
56	,	,	O	,	_	0	SENT_226	[p15l625t3612r743b3700],
57	APOE	NNP	ORGANIZATION	APOE	conj_or	55	SENT_226	[p15l763t3610r981b3683],
58	65	CD	NUMBER	65	num	57	SENT_226	[p15l1003t3612r1121b3700],
59	,	,	O	,	_	0	SENT_226	[p15l1003t3612r1121b3700],
60	etc.	FW	O	etc.	nn	61	SENT_226	[p15l1149t3612r1350b3700],
61	)	FW	O	)	conj_or	55	SENT_226	[p15l1149t3612r1350b3700],
62	,	,	O	,	_	0	SENT_226	[p15l1149t3612r1350b3700],
63	which	WDT	O	which	nsubj	64	SENT_226	[p15l1374t3604r1633b3684],
64	contain	VBP	O	contain	rcmod	61	SENT_226	[p15l1656t3605r1972b3683],
65	one	CD	NUMBER	one	dobj	64	SENT_226	[p15l1995t3630r2147b3683],
66	or	CC	O	or	_	0	SENT_226	[p16l15t49r105b102],
67	more	JJR	O	more	amod	71	SENT_226	[p16l131t49r352b102],
68	single	JJ	O	single	amod	71	SENT_226	[p16l383t23r1117b124],
69	—	NN	O	—	nn	71	SENT_226	[p16l383t23r1117b124],
70	nucleotide	NN	O	nucleotide	nn	71	SENT_226	[p16l383t23r1117b124],
71	polymorphisms	NNS	O	polymorphism	conj_or	55	SENT_226	[p16l1145t24r1818b124],
72	that	WDT	O	that	nsubj	73	SENT_226	[p16l1850t24r2017b102],
73	alter	VBP	O	alter	rcmod	71	SENT_226	[p16l2041t23r2145b102, p16l15t168r127b230],
74	the	DT	O	the	det	77	SENT_226	[p16l147t152r277b230],
75	amino	NN	O	amino	nn	77	SENT_226	[p16l300t152r569b230],
76	acid	NN	O	acid	nn	77	SENT_226	[p16l593t152r765b230],
77	sequence	NN	O	sequence	dobj	73	SENT_226	[p16l789t177r1178b252],
78	of	IN	O	of	_	0	SENT_226	[p16l1202t151r1303b230],
79	the	DT	O	the	prep_of	77	SENT_226	[p16l1308t152r1437b230],
80	encoded	VBN	O	encode	partmod	79	SENT_226	[p16l1461t151r1817b230],
81	protein	NN	O	protein	nn	84	SENT_226	[p16l1838t152r2147b252],
82	(	CD	NUMBER	(	num	84	SENT_226	[p16l19t286r114b371],
83	e.	NN	O	e.	nn	84	SENT_226	[p16l19t286r114b371],
84	g.	NN	O	g.	dobj	80	SENT_226	[p16l124t306r226b380],
85	,	,	O	,	_	0	SENT_226	[p16l124t306r226b380],
86	apolipoprotein	NN	O	apolipoprotein	appos	84	SENT_226	[p16l260t280r892b380],
87	64	CD	NUMBER	64	num	86	SENT_226	[p16l920t285r1016b358],
88	has	VBZ	O	have	dep	29	SENT_226	[p16l1044t280r1186b358],
89	a	DT	O	a	det	92	SENT_226	[p16l1216t306r1261b358],
90	Cys112Arg	NN	O	cys112arg	nn	92	SENT_226	[p16l1288t285r1753b380],
91	change	NN	O	change	nn	92	SENT_226	[p16l1780t280r2140b380],
92	)	NN	O	)	dobj	88	SENT_226	[p16l1780t280r2140b380],
93	.	.	O	.	_	0	SENT_226	[p16l1780t280r2140b380],

1	In	IN	O	in	_	0	SENT_227	[p16l13t415r100b485],
2	a	DT	O	a	det	3	SENT_227	[p16l125t434r169b486],
3	study	NN	O	study	prep_in	23	SENT_227	[p16l195t408r421b508],
4	of	IN	O	of	_	0	SENT_227	[p16l442t407r543b486],
5	treatment	NN	O	treatment	prep_of	3	SENT_227	[p16l551t424r967b486],
6	of	IN	O	of	_	0	SENT_227	[p16l987t407r1089b486],
7	Alzheimer	NN	O	alzheimer	poss	9	SENT_227	[p16l1091t407r1603b486],
8	’s	POS	O	’s	_	0	SENT_227	[p16l1091t407r1603b486],
9	disease	NN	O	disease	prep_of	5	SENT_227	[p16l1631t408r1936b486],
10	with	IN	O	with	_	0	SENT_227	[p16l1956t408r2147b487],
11	tacrine	NN	O	tacrine	prep_with	9	SENT_227	[p16l15t536r325b631],
12	,	,	O	,	_	0	SENT_227	[p16l15t536r325b631],
13	83	CD	PERCENT	83	num	14	SENT_227	[p16l354t541r450b614],
14	percent	NN	PERCENT	percent	nsubj	23	SENT_227	[p16l476t552r794b636],
15	of	IN	O	of	_	0	SENT_227	[p16l813t535r913b614],
16	the	DT	O	the	det	17	SENT_227	[p16l918t535r1046b614],
17	patients	NNS	O	patient	prep_of	14	SENT_227	[p16l1068t536r1401b636],
18	without	IN	O	without	_	0	SENT_227	[p16l1421t536r1754b615],
19	any	DT	O	any	det	22	SENT_227	[p16l1771t561r1918b636],
20	APOE	NN	O	apoe	nn	22	SENT_227	[p16l1929t541r2147b614],
21	e4	NN	O	e4	nn	22	SENT_227	[p16l14t671r108b741],
22	allele	NN	O	allele	prep_without	17	SENT_227	[p16l129t663r343b742],
23	showed	VBD	O	show	_	0	SENT_227	[p16l366t663r686b743],
24	improvement	NN	O	improvement	dobj	23	SENT_227	[p16l706t664r1274b764],
25	in	IN	O	in	_	0	SENT_227	[p16l1289t664r1370b741],
26	total	JJ	O	total	amod	27	SENT_227	[p16l1390t663r1578b742],
27	response	NN	O	response	prep_in	23	SENT_227	[p16l1598t689r1973b764],
28	and	CC	O	and	_	0	SENT_227	[p16l1993t663r2148b742],
29	cognitive	JJ	O	cognitive	amod	30	SENT_227	[p16l15t792r405b892],
30	response	NN	O	response	prep_in	23	SENT_227	[p16l446t817r834b892],
31	after	IN	O	after	_	0	SENT_227	[p16l874t791r1073b870],
32	30	CD	DURATION	30	num	33	SENT_227	[p16l1111t797r1212b870],
33	weeks	NNS	NUMBER	week	prep_after	23	SENT_227	[p16l1248t791r1539b887],
34	,	,	O	,	_	0	SENT_227	[p16l1248t791r1539b887],
35	as	IN	O	as	mark	60	SENT_227	[p16l1585t818r1670b870],
36	compared	VBN	O	compare	_	0	SENT_227	[p16l1714t792r2145b892],
37	with	IN	O	with	prepc_compared_with	60	SENT_227	[p16l10t919r202b999],
38	40	CD	PERCENT	40	num	39	SENT_227	[p16l233t925r335b998],
39	percent	NN	PERCENT	percent	pobj	60	SENT_227	[p16l368t936r690b1020],
40	of	IN	O	of	_	0	SENT_227	[p16l718t919r819b998],
41	patients	NNS	O	patient	prep_of	39	SENT_227	[p16l831t920r1167b1020],
42	with	IN	O	with	_	0	SENT_227	[p16l1197t919r1387b999],
43	at	IN	O	at	quantmod	45	SENT_227	[p16l1419t936r1498b998],
44	least	JJS	O	least	mwe	43	SENT_227	[p16l1523t920r1721b998],
45	one	CD	NUMBER	one	num	47	SENT_227	[p16l1749t945r1902b998],
46	APOE	NN	O	apoe	nn	47	SENT_227	[p16l1927t925r2147b998],
47	e4	NN	O	e4	prep_with	41	SENT_227	[p16l14t1055r110b1125],
48	allele	NN	O	allele	tmod	47	SENT_227	[p16l150t1048r488b1126],
49	.72	CD	NUMBER	.72	num	48	SENT_227	[p16l150t1048r488b1126],
50	However	RB	O	however	advmod	48	SENT_227	[p16l528t1055r928b1143],
51	,	,	O	,	_	0	SENT_227	[p16l528t1055r928b1143],
52	the	DT	O	the	det	55	SENT_227	[p16l975t1048r1107b1126],
53	greatest	JJS	O	greatest	amod	55	SENT_227	[p16l1147t1064r1492b1148],
54	individual	JJ	O	individual	amod	55	SENT_227	[p16l1526t1047r1959b1127],
55	improvement	NN	O	improvement	nsubjpass	60	SENT_227	[p16l1997t1048r2144b1125, p16l13t1192r483b1276],
56	in	IN	O	in	_	0	SENT_227	[p16l501t1176r582b1253],
57	this	DT	O	this	det	58	SENT_227	[p16l604t1176r757b1254],
58	study	NN	O	study	prep_in	55	SENT_227	[p16l783t1176r1009b1276],
59	was	VBD	O	be	auxpass	60	SENT_227	[p16l1021t1202r1183b1255],
60	seen	VBN	O	see	advcl	23	SENT_227	[p16l1208t1201r1395b1254],
61	in	IN	O	in	_	0	SENT_227	[p16l1416t1176r1498b1253],
62	a	DT	O	a	det	63	SENT_227	[p16l1518t1202r1563b1254],
63	patient	NN	O	patient	prep_in	60	SENT_227	[p16l1582t1176r1881b1276],
64	with	IN	O	with	_	0	SENT_227	[p16l1893t1176r2083b1255],
65	a	DT	O	a	det	69	SENT_227	[p16l2104t1202r2148b1254],
66	single	JJ	O	single	amod	69	SENT_227	[p16l16t1304r267b1404],
67	APOE	NNP	O	APOE	nn	69	SENT_227	[p16l288t1309r507b1382],
68	e4	NN	O	e4	nn	69	SENT_227	[p16l534t1311r629b1381],
69	allele	NN	O	allele	prep_with	63	SENT_227	[p16l657t1304r900b1399],
70	,	,	O	,	_	0	SENT_227	[p16l657t1304r900b1399],
71	the	DT	O	the	det	73	SENT_227	[p16l933t1304r1063b1382],
72	unfavorable	JJ	O	unfavorable	amod	73	SENT_227	[p16l1091t1303r1591b1383],
73	genotype	NN	O	genotype	appos	69	SENT_227	[p16l1619t1320r2027b1404],
74	,	,	O	,	_	0	SENT_227	[p16l1619t1320r2027b1404],
75	illustrating	VBG	O	illustrate	xcomp	60	SENT_227	[p16l2060t1304r2145b1381, p16l13t1432r427b1532],
76	that	IN	O	that	complm	83	SENT_227	[p16l449t1432r616b1510],
77	a	DT	O	a	det	79	SENT_227	[p16l636t1458r681b1510],
78	single	JJ	O	single	amod	79	SENT_227	[p16l706t1432r957b1532],
79	gene	NN	O	gene	nsubj	83	SENT_227	[p16l982t1457r1182b1532],
80	will	MD	O	will	aux	83	SENT_227	[p16l1203t1431r1360b1511],
81	not	RB	O	not	neg	83	SENT_227	[p16l1385t1448r1529b1510],
82	always	RB	O	always	advmod	83	SENT_227	[p16l1548t1432r1824b1532],
83	predict	VBP	O	predict	ccomp	75	SENT_227	[p16l1850t1431r2152b1532],
84	the	DT	O	the	det	85	SENT_227	[p16l15t1559r142b1638],
85	response	NN	O	response	dobj	83	SENT_227	[p16l163t1585r536b1660],
86	to	TO	O	to	_	0	SENT_227	[p16l557t1576r635b1638],
87	a	DT	O	a	det	89	SENT_227	[p16l657t1586r701b1638],
88	given	VBN	O	give	amod	89	SENT_227	[p16l719t1560r940b1660],
89	treatment	NN	O	treatment	prep_to	85	SENT_227	[p16l961t1566r1471b1638],
90	.	.	O	.	_	0	SENT_227	[p16l961t1566r1471b1638],

1	”	NN	O	”	nn	3	SENT_228	[p16l961t1566r1471b1638],
2	F	NN	O	f	nn	3	SENT_228	[p16l1490t1567r1538b1637],
3	ollow	NN	O	ollow	_	0	SENT_228	[p16l1544t1559r1915b1660],
4	—	CD	NUMBER	—	tmod	3	SENT_228	[p16l1544t1559r1915b1660],
5	up	RP	O	up	advmod	4	SENT_228	[p16l1544t1559r1915b1660],
6	studies	NNS	O	study	nsubj	7	SENT_228	[p16l1938t1559r2145b1639, p16l14t1688r127b1766],
7	indicate	VBP	O	indicate	dep	3	SENT_228	[p16l170t1687r512b1766],
8	that	IN	O	that	complm	18	SENT_228	[p16l555t1687r725b1766],
9	the	DT	O	the	det	10	SENT_228	[p16l762t1688r894b1766],
10	interaction	NN	O	interaction	nsubj	18	SENT_228	[p16l936t1688r1406b1766],
11	between	IN	O	between	_	0	SENT_228	[p16l1449t1688r1806b1767],
12	tacrine	NN	O	tacrine	nn	13	SENT_228	[p16l1849t1688r2145b1766],
13	treatment	NN	O	treatment	prep_between	10	SENT_228	[p16l15t1832r439b1894],
14	and	CC	O	and	_	0	SENT_228	[p16l476t1816r635b1894],
15	APOE	NN	O	apoe	nn	16	SENT_228	[p16l671t1821r893b1894],
16	genotype	NN	O	genotype	prep_between	10	SENT_228	[p16l936t1832r1328b1916],
17	was	VBD	O	be	cop	18	SENT_228	[p16l1367t1842r1530b1895],
18	strongest	JJS	O	strongest	ccomp	7	SENT_228	[p16l1577t1832r1985b1916],
19	for	IN	O	for	_	0	SENT_228	[p16l2022t1815r2148b1894],
20	women	NNS	O	woman	prep_for	18	SENT_228	[p16l10t1969r357b2039],
21	,	,	O	,	_	0	SENT_228	[p16l10t1969r357b2039],
22	again	RB	O	again	advmod	23	SENT_228	[p16l395t1944r625b2044],
23	suggesting	VBG	O	suggest	partmod	3	SENT_228	[p16l657t1944r1122b2044],
24	that	IN	O	that	complm	28	SENT_228	[p16l1149t1944r1317b2022],
25	many	JJ	O	many	amod	26	SENT_228	[p16l1341t1969r1577b2044],
26	genes	NNS	O	gene	nsubjpass	28	SENT_228	[p16l1602t1969r1843b2044],
27	are	VBP	O	be	auxpass	28	SENT_228	[p16l1874t1970r2000b2022],
28	involved	VBN	O	involve	ccomp	23	SENT_228	[p16l2031t1944r2145b2021, p16l10t2072r279b2151],
29	in	IN	O	in	_	0	SENT_228	[p16l302t2072r384b2149],
30	determining	VBG	O	determine	prepc_in	28	SENT_228	[p16l409t2071r936b2172],
31	the	DT	O	the	det	32	SENT_228	[p16l957t2071r1086b2150],
32	efficacy	NN	O	efficacy	dobj	30	SENT_228	[p16l1112t2071r1432b2172],
33	of	IN	O	of	_	0	SENT_228	[p16l1451t2071r1552b2150],
34	a	DT	O	a	det	35	SENT_228	[p16l1557t2098r1602b2150],
35	treatment	NN	O	treatment	prep_of	3	SENT_228	[p16l1625t2088r2059b2150],
36	.	.	O	.	_	0	SENT_228	[p16l1625t2088r2059b2150],

1	84	CD	NUMBER	84	nsubjpass	17	SENT_229	[p16l2069t2077r2147b2123],
2	The	DT	O	the	det	4	SENT_229	[p16l140t2200r303b2278],
3	molecular	JJ	O	molecular	amod	4	SENT_229	[p16l329t2199r756b2279],
4	basis	NN	O	basis	dep	1	SENT_229	[p16l780t2200r990b2278],
5	for	IN	O	for	_	0	SENT_229	[p16l1019t2199r1142b2278],
6	an	DT	O	a	det	7	SENT_229	[p16l1165t2225r1266b2278],
7	association	NN	O	association	prep_for	4	SENT_229	[p16l1292t2200r1769b2278],
8	between	IN	O	between	_	0	SENT_229	[p16l1795t2200r2147b2279],
9	apolipoprotein	NN	O	apolipoprotein	nn	10	SENT_229	[p16l14t2328r646b2428],
10	genotype	NN	O	genotype	prep_between	7	SENT_229	[p16l687t2344r1072b2428],
11	and	CC	O	and	_	0	SENT_229	[p16l1114t2327r1270b2406],
12	tacrine	NN	O	tacrine	nn	13	SENT_229	[p16l1312t2328r1603b2406],
13	efficacy	NN	O	efficacy	conj_and	1	SENT_229	[p16l1645t2327r1965b2428],
14	has	VBZ	O	have	aux	17	SENT_229	[p16l2003t2328r2144b2406],
15	not	RB	O	not	neg	17	SENT_229	[p16l14t2472r158b2534],
16	been	VBN	O	be	auxpass	17	SENT_229	[p16l177t2455r377b2534],
17	elucidated	VBN	O	elucidate	_	0	SENT_229	[p16l401t2455r857b2551],
18	,	,	O	,	_	0	SENT_229	[p16l401t2455r857b2551],
19	but	CC	O	but	_	0	SENT_229	[p16l887t2456r1029b2535],
20	it	PRP	O	it	nsubjpass	23	SENT_229	[p16l1046t2456r1106b2534],
21	has	VBZ	O	have	aux	23	SENT_229	[p16l1125t2456r1266b2534],
22	been	VBN	O	be	auxpass	23	SENT_229	[p16l1293t2456r1493b2534],
23	postulated	VBN	O	postulate	conj_but	17	SENT_229	[p16l1515t2455r1960b2556],
24	that	IN	O	that	complm	30	SENT_229	[p16l1984t2455r2152b2534],
25	the	DT	O	the	det	28	SENT_229	[p16l15t2584r144b2662],
26	APOE	NNP	O	APOE	nn	28	SENT_229	[p16l161t2589r380b2662],
27	e4	NN	O	e4	nn	28	SENT_229	[p16l403t2591r498b2661],
28	genotype	NN	O	genotype	nsubj	30	SENT_229	[p16l521t2600r906b2684],
29	may	MD	O	may	aux	30	SENT_229	[p16l929t2610r1107b2684],
30	have	VB	O	have	ccomp	23	SENT_229	[p16l1125t2584r1314b2663],
31	an	DT	O	a	det	32	SENT_229	[p16l1337t2609r1438b2662],
32	effect	NN	O	effect	dobj	30	SENT_229	[p16l1461t2583r1696b2662],
33	on	IN	O	on	_	0	SENT_229	[p16l1715t2609r1822b2662],
34	cholinergic	JJ	O	cholinergic	amod	35	SENT_229	[p16l1846t2583r2145b2662, p16l15t2712r217b2812],
35	dysfunction	NN	O	dysfunction	prep_on	32	SENT_229	[p16l237t2711r726b2812],
36	in	IN	O	in	_	0	SENT_229	[p16l745t2712r826b2789],
37	Alzheimer	NN	O	alzheimer	poss	39	SENT_229	[p16l842t2711r1343b2790],
38	’s	POS	O	’s	_	0	SENT_229	[p16l842t2711r1343b2790],
39	disease	NN	O	disease	prep_in	35	SENT_229	[p16l1366t2711r1664b2790],
40	that	WDT	O	that	nsubjpass	45	SENT_229	[p16l1684t2712r1849b2790],
41	can	MD	O	can	aux	45	SENT_229	[p16l1864t2728r2153b2790],
42	not	RB	O	not	neg	45	SENT_229	[p16l1864t2728r2153b2790],
43	be	VB	O	be	auxpass	45	SENT_229	[p16l15t2839r110b2918],
44	consistently	RB	O	consistently	advmod	45	SENT_229	[p16l131t2840r634b2940],
45	overcome	VBN	O	overcome	rcmod	32	SENT_229	[p16l651t2865r1055b2919],
46	by	IN	O	by	_	0	SENT_229	[p16l1077t2839r1173b2940],
47	therapy	NN	O	therapy	agent	45	SENT_229	[p16l1189t2839r1504b2940],
48	with	IN	O	with	_	0	SENT_229	[p16l1516t2839r1704b2919],
49	acetylcho	NN	O	acetylcho	nn	52	SENT_229	[p16l1723t2839r2145b2940],
50	—	NN	O	—	nn	52	SENT_229	[p16l1723t2839r2145b2940],
51	linesterase	NN	O	linesterase	nn	52	SENT_229	[p16l13t2968r465b3046],
52	inhibitors	NNS	O	inhibitor	prep_with	45	SENT_229	[p16l503t2968r918b3046],
53	such	JJ	O	such	_	0	SENT_229	[p16l961t2968r1156b3047],
54	as	IN	O	as	_	0	SENT_229	[p16l1194t2994r1279b3046],
55	tacrine	NN	O	tacrine	prep_such_as	52	SENT_229	[p16l1320t2968r1634b3046],
56	.	.	O	.	_	0	SENT_229	[p16l1320t2968r1634b3046],

1	A	DT	O	a	nsubj	2	SENT_230	[p16l1675t2975r1741b3045],
2	randomized	VBN	O	randomize	_	0	SENT_230	[p16l1776t2968r2145b3046, p16l14t3095r208b3191],
3	,	,	O	,	_	0	SENT_230	[p16l1776t2968r2145b3046, p16l14t3095r208b3191],

1	placebo	NN	O	placebo	npadvmod	3	SENT_231	[p16l235t3096r1029b3196],
2	—	CD	NUMBER	—	num	1	SENT_231	[p16l235t3096r1029b3196],
3	controlled	JJ	O	controlled	amod	4	SENT_231	[p16l235t3096r1029b3196],
4	study	NN	O	study	nsubj	17	SENT_231	[p16l1053t3095r1278b3196],
5	of	IN	O	of	_	0	SENT_231	[p16l1297t3095r1397b3174],
6	the	DT	O	the	det	10	SENT_231	[p16l1402t3096r1530b3174],
7	noradrenergic	JJ	O	noradrenergic	amod	10	SENT_231	[p16l1553t3096r2148b3196],
8	vasopressinergic	JJ	O	vasopressinergic	amod	10	SENT_231	[p16l10t3225r722b3325],
9	agonist	NN	O	agonist	nn	10	SENT_231	[p16l761t3225r1078b3325],
10	S12024	NN	O	s12024	prep_of	4	SENT_231	[p16l1114t3230r1426b3303],
11	in	IN	O	in	_	0	SENT_231	[p16l1464t3225r1546b3302],
12	patients	NNS	O	patient	prep_in	10	SENT_231	[p16l1584t3225r1920b3325],
13	with	IN	O	with	_	0	SENT_231	[p16l1956t3225r2147b3304],
14	Alzheimer	NN	O	alzheimer	poss	16	SENT_231	[p16l11t3352r522b3431],
15	’s	POS	O	’s	_	0	SENT_231	[p16l11t3352r522b3431],
16	disease	NN	O	disease	prep_with	12	SENT_231	[p16l558t3352r862b3431],
17	found	VBD	O	find	_	0	SENT_231	[p16l895t3352r1147b3432],
18	the	DT	O	the	det	20	SENT_231	[p16l1180t3352r1310b3431],
19	greatest	JJS	O	greatest	amod	20	SENT_231	[p16l1343t3369r1681b3453],
20	protection	NN	O	protection	dobj	17	SENT_231	[p16l1707t3353r2147b3453],
21	of	IN	O	of	_	0	SENT_231	[p16l15t3480r116b3559],
22	cognition	NN	O	cognition	prep_of	20	SENT_231	[p16l143t3481r549b3581],
23	in	IN	O	in	_	0	SENT_231	[p16l593t3481r674b3558],
24	patients	NNS	O	patient	prep_in	17	SENT_231	[p16l718t3481r1054b3581],
25	with	IN	O	with	_	0	SENT_231	[p16l1097t3481r1287b3560],
26	the	DT	O	the	det	29	SENT_231	[p16l1332t3481r1462b3559],
27	APOE	NNP	O	APOE	nn	29	SENT_231	[p16l1499t3486r1719b3559],
28	e4	NN	O	e4	nn	29	SENT_231	[p16l1763t3488r1858b3558],
29	geno	NN	O	geno	prep_with	24	SENT_231	[p16l1903t3506r2144b3581],
30	—	CD	NUMBER	—	num	31	SENT_231	[p16l1903t3506r2144b3581],
31	type	NN	O	type	tmod	17	SENT_231	[p16l15t3614r294b3709],
32	.85	CD	NUMBER	.85	num	33	SENT_231	[p16l15t3614r294b3709],
33	Conﬁrmation	NN	O	conﬁrmation	nsubj	38	SENT_231	[p16l327t3608r905b3687],
34	of	IN	O	of	_	0	SENT_231	[p16l937t3608r1038b3687],
35	these	DT	O	these	det	36	SENT_231	[p16l1051t3609r1270b3687],
36	results	NNS	O	result	prep_of	33	SENT_231	[p16l1301t3608r1579b3688],
37	may	MD	O	may	aux	38	SENT_231	[p16l1612t3635r1789b3709],
38	offer	VB	O	offer	rcmod	31	SENT_231	[p16l1816t3608r2018b3687],
39	an	DT	O	a	det	40	SENT_231	[p16l2046t3634r2147b3687],
40	approach	NN	O	approach	dobj	38	SENT_231	[p17l14t21r411b121],
41	to	TO	O	to	_	0	SENT_231	[p17l439t37r518b99],
42	the	DT	O	the	det	43	SENT_231	[p17l547t21r677b99],
43	selection	NN	O	selection	prep_to	38	SENT_231	[p17l706t20r1080b99],
44	of	IN	O	of	_	0	SENT_231	[p17l1108t20r1209b99],
45	initial	JJ	O	initial	amod	46	SENT_231	[p17l1217t21r1461b99],
46	therapy	NN	O	therapy	prep_of	43	SENT_231	[p17l1488t20r1806b121],
47	for	IN	O	for	_	0	SENT_231	[p17l1829t20r1952b99],
48	Alzheimer	NN	O	alzheimer	poss	50	SENT_231	[p17l1973t20r2145b98, p17l14t149r382b227],
49	’s	POS	O	’s	_	0	SENT_231	[p17l1973t20r2145b98, p17l14t149r382b227],
50	disease	NN	O	disease	prep_for	46	SENT_231	[p17l419t149r747b244],
51	,	,	O	,	_	0	SENT_231	[p17l419t149r747b244],
52	with	IN	O	with	_	0	SENT_231	[p17l783t149r973b228],
53	S12024	NN	O	s12024	nn	56	SENT_231	[p17l1010t154r1322b227],
54	or	CC	O	or	_	0	SENT_231	[p17l1357t174r1446b227],
55	similar	JJ	O	similar	conj_or	53	SENT_231	[p17l1480t149r1776b227],
56	medications	NNS	O	medication	prep_with	38	SENT_231	[p17l1807t148r2145b227, p17l15t278r222b356],
57	being	VBG	O	be	auxpass	58	SENT_231	[p17l253t278r493b378],
58	recommended	VBN	O	recommend	partmod	56	SENT_231	[p17l517t278r1133b356],
59	for	IN	O	for	_	0	SENT_231	[p17l1160t277r1283b356],
60	patients	NNS	O	patient	prep_for	58	SENT_231	[p17l1307t278r1643b378],
61	carrying	VBG	O	carry	partmod	60	SENT_231	[p17l1674t278r2021b378],
62	an	DT	O	a	det	65	SENT_231	[p17l2045t303r2147b356],
63	APOE	NN	O	apoe	nn	65	SENT_231	[p17l7t412r227b485],
64	E4	NN	O	e4	nn	65	SENT_231	[p17l251t414r346b484],
65	allele	NN	O	allele	dobj	61	SENT_231	[p17l371t407r613b485],
66	.	.	O	.	_	0	SENT_231	[p17l371t407r613b485],

1	Both	DT	O	both	preconj	3	SENT_232	[p17l142t535r344b613],
2	phenotypic	JJ	O	phenotypic	amod	3	SENT_232	[p17l379t535r852b635],
3	analysis	NN	O	analysis	nsubj	12	SENT_232	[p17l885t535r1217b635],
4	and	CC	O	and	_	0	SENT_232	[p17l1254t535r1411b613],
5	genotypic	JJ	O	genotypic	amod	6	SENT_232	[p17l1446t535r1859b635],
6	analysis	NN	O	analysis	conj_and	3	SENT_232	[p17l1893t535r2145b635, p17l16t663r122b741],
7	of	IN	O	of	_	0	SENT_232	[p17l147t662r248b741],
8	the	DT	O	the	det	10	SENT_232	[p17l252t663r382b741],
9	APOE	NNP	ORGANIZATION	APOE	nn	10	SENT_232	[p17l397t668r616b741],
10	polymorphism	NN	O	polymorphism	prep_of	3	SENT_232	[p17l637t663r1268b763],
11	have	VBP	O	have	aux	12	SENT_232	[p17l1289t662r1479b742],
12	shown	VBN	O	show	_	0	SENT_232	[p17l1503t663r1783b742],
13	an	DT	O	a	det	15	SENT_232	[p17l1805t688r1906b741],
14	asso	JJ	O	asso	amod	15	SENT_232	[p17l1927t688r2145b741],
15	—	NN	O	—	dobj	12	SENT_232	[p17l1927t688r2145b741],

1	Figure	NNP	O	Figure	_	0	SENT_233	[p17l84t1055r301b1137],
2	4	CD	NUMBER	4	number	3	SENT_233	[p17l324t1059r365b1117],
3	(	CD	NUMBER	(	dep	1	SENT_233	[p17l393t1053r629b1138],
4	facing	VBG	O	face	partmod	1	SENT_233	[p17l393t1053r629b1138],
5	page	NN	O	page	nn	6	SENT_233	[p17l655t1059r866b1138],
6	)	NN	O	)	dobj	4	SENT_233	[p17l655t1059r866b1138],
7	.	.	O	.	_	0	SENT_233	[p17l655t1059r866b1138],

1	Functional	JJ	O	functional	amod	2	SENT_234	[p17l897t1053r1259b1118],
2	Consequence	NN	O	consequence	nsubj	11	SENT_234	[p17l1286t1058r1761b1137],
3	of	IN	O	of	_	0	SENT_234	[p17l1784t1052r1865b1118],
4	Genetic	JJ	O	genetic	amod	5	SENT_234	[p17l1874t1058r1995b1118, p17l82t1163r250b1226],
5	Polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_234	[p17l277t1161r827b1246],
6	in	IN	O	in	_	0	SENT_234	[p17l854t1163r913b1225],
7	the	DT	O	the	det	9	SENT_234	[p17l938t1161r1051b1226],
8	[	CD	NUMBER	[	num	9	SENT_234	[p17l1072t1161r1742b1245],
9	32-Adrenoreceptor	NN	O	32-adrenoreceptor	prep_in	5	SENT_234	[p17l1072t1161r1742b1245],
10	(	CD	NUMBER	(	num	9	SENT_234	[p17l1768t1161r2010b1247],
11	Coded	VBN	O	code	_	0	SENT_234	[p17l1768t1161r2010b1247],
12	by	IN	O	by	_	0	SENT_234	[p17l81t1269r158b1354],
13	the	DT	O	the	det	15	SENT_234	[p17l178t1269r291b1334],
14	ADRB2	NN	O	adrb2	nn	15	SENT_234	[p17l310t1274r569b1333],
15	Gene	NN	O	gene	prep_by	11	SENT_234	[p17l592t1274r800b1355],
16	)	CD	NUMBER	)	dobj	11	SENT_234	[p17l592t1274r800b1355],
17	at	IN	O	at	_	0	SENT_234	[p17l828t1279r894b1334],
18	Codons	NNS	O	codon	prep_at	16	SENT_234	[p17l915t1269r1182b1334],
19	16	CD	NUMBER	16	num	18	SENT_234	[p17l1210t1274r1289b1334],
20	and	CC	O	and	_	0	SENT_234	[p17l1314t1269r1440b1334],
21	27	CD	NUMBER	27	conj_and	18	SENT_234	[p17l1467t1274r1569b1334],
22	.	.	O	.	_	0	SENT_234	[p17l1467t1274r1569b1334],

1	A	DT	O	a	det	4	SENT_235	[p17l77t1402r127b1462],
2	homozygous	JJ	O	homozygous	amod	4	SENT_235	[p17l154t1398r604b1484],
3	Glu	NNP	O	Glu	nn	4	SENT_235	[p17l633t1398r751b1463],
4	genotype	NN	O	genotype	nsubjpass	9	SENT_235	[p17l781t1411r1101b1484],
5	at	IN	O	at	_	0	SENT_235	[p17l1128t1411r1190b1463],
6	codon	NN	O	codon	prep_at	4	SENT_235	[p17l1215t1398r1429b1463],
7	27	CD	NUMBER	27	num	6	SENT_235	[p17l1459t1404r1539b1463],
8	is	VBZ	O	be	auxpass	9	SENT_235	[p17l1568t1405r1617b1463],
9	associated	VBN	O	associate	dep	55	SENT_235	[p17l1646t1398r2014b1463],
10	with	IN	O	with	_	0	SENT_235	[p17l77t1506r221b1571],
11	greater	JJR	O	greater	amod	12	SENT_235	[p17l252t1519r500b1592],
12	venodilatation	NN	O	venodilatation	prep_with	9	SENT_235	[p17l520t1506r1023b1571],
13	after	IN	O	after	_	0	SENT_235	[p17l1054t1506r1212b1571],
14	the	DT	O	the	det	15	SENT_235	[p17l1232t1506r1342b1571],
15	administration	NN	O	administration	prep_after	12	SENT_235	[p17l1369t1506r1885b1571],
16	of	IN	O	of	_	0	SENT_235	[p17l1915t1506r1992b1571],
17	isoproterenol	NN	O	isoproterenol	nn	20	SENT_235	[p17l82t1615r548b1699],
18	(	CD	NUMBER	(	num	20	SENT_235	[p17l585t1615r796b1699],
19	Panel	NN	O	panel	nn	20	SENT_235	[p17l585t1615r796b1699],
20	A	NN	O	a	prep_of	15	SENT_235	[p17l824t1619r993b1699],
21	)	CD	NUMBER	)	number	22	SENT_235	[p17l824t1619r993b1699],
22	.44	CD	NUMBER	.44	dobj	9	SENT_235	[p17l824t1619r993b1699],
23	A	DT	O	a	det	26	SENT_235	[p17l1016t1619r1066b1678],
24	homozygous	JJ	O	homozygous	amod	26	SENT_235	[p17l1092t1615r1543b1700],
25	Arg	NN	O	arg	nn	26	SENT_235	[p17l1568t1619r1691b1700],
26	genotype	NN	O	genotype	nsubjpass	31	SENT_235	[p17l1716t1627r2035b1700],
27	at	IN	O	at	_	0	SENT_235	[p17l81t1735r142b1787],
28	codon	NN	O	codon	prep_at	26	SENT_235	[p17l163t1722r377b1787],
29	16	CD	NUMBER	16	num	28	SENT_235	[p17l407t1727r483b1787],
30	is	VBZ	O	be	auxpass	31	SENT_235	[p17l507t1728r557b1787],
31	associated	VBN	O	associate	rcmod	22	SENT_235	[p17l581t1722r949b1787],
32	with	IN	O	with	_	0	SENT_235	[p17l972t1722r1117b1787],
33	greater	JJR	O	greater	amod	35	SENT_235	[p17l1143t1735r1390b1808],
34	airway	NN	O	airway	nn	35	SENT_235	[p17l1410t1728r1630b1808],
35	response	NN	O	response	prep_with	31	SENT_235	[p17l1653t1745r1971b1807],
36	to	TO	O	to	_	0	SENT_235	[p17l1991t1735r2059b1787],
37	oral	JJ	O	oral	amod	38	SENT_235	[p17l80t1830r206b1895],
38	albuterol	NN	O	albuterol	prep_to	35	SENT_235	[p17l238t1830r543b1895],
39	(	CD	NUMBER	(	num	41	SENT_235	[p17l581t1830r792b1915],
40	Panel	NN	O	panel	nn	41	SENT_235	[p17l581t1830r792b1915],
41	B	NN	O	b	dep	35	SENT_235	[p17l828t1836r966b1915],
42	)	CD	NUMBER	)	number	43	SENT_235	[p17l828t1836r966b1915],
43	48	CD	NUMBER	48	dep	41	SENT_235	[p17l828t1836r966b1915],
44	and	CC	O	and	_	0	SENT_235	[p17l993t1830r1116b1895],
45	greater	JJR	O	greater	amod	46	SENT_235	[p17l1147t1843r1394b1916],
46	desensitization	NN	O	desensitization	prep_with	31	SENT_235	[p17l1417t1830r1950b1895],
47	to	TO	O	to	_	0	SENT_235	[p17l1978t1843r2046b1895],
48	isoproterenol	NN	O	isoproterenol	nn	51	SENT_235	[p17l82t1938r548b2023],
49	(	CD	NUMBER	(	num	51	SENT_235	[p17l585t1938r796b2023],
50	Panel	NN	O	panel	nn	51	SENT_235	[p17l585t1938r796b2023],
51	C	NN	O	c	prep_to	46	SENT_235	[p17l827t1943r994b2023],
52	)	CD	NUMBER	)	number	53	SENT_235	[p17l827t1943r994b2023],
53	.44	CD	NUMBER	.44	num	54	SENT_235	[p17l827t1943r994b2023],
54	FEV1	NN	O	fev1	nsubj	55	SENT_235	[p17l1025t1944r1186b2018],
55	denotes	VBZ	O	denote	_	0	SENT_235	[p17l1214t1938r1493b2003],
56	forced	VBN	O	force	amod	58	SENT_235	[p17l1519t1937r1736b2003],
57	expiratory	JJ	O	expiratory	amod	58	SENT_235	[p17l1766t1944r1996b2023, p17l77t2059r212b2132],
58	volume	NN	O	volume	dobj	55	SENT_235	[p17l234t2046r496b2111],
59	in	IN	O	in	_	0	SENT_235	[p17l525t2052r580b2110],
60	one	CD	DURATION	one	num	61	SENT_235	[p17l611t2069r738b2111],
61	second	NN	NUMBER	second	prep_in	58	SENT_235	[p17l766t2046r1033b2111],
62	.	.	O	.	_	0	SENT_235	[p17l766t2046r1033b2111],

1	544	CD	NUMBER	544	num	4	SENT_236	[p17l149t2304r205b2327],
2	N	NN	O	n	nn	4	SENT_236	[p17l884t2306r898b2322],
3	ENGLJ	NN	O	englj	nn	4	SENT_236	[p17l913t2306r997b2328],
4	MED	NN	O	med	_	0	SENT_236	[p17l1012t2306r1065b2321],
5	348	CD	NUMBER	348	dep	4	SENT_236	[p17l1077t2300r1148b2328],
6	;	:	O	;	_	0	SENT_236	[p17l1077t2300r1148b2328],
7	6	CD	NUMBER	6	num	8	SENT_236	[p17l1077t2300r1148b2328],
8	WWW	NN	O	www	dep	4	SENT_236	[p17l1183t2306r1295b2322],
9	.	.	O	.	_	0	SENT_236	[p17l1183t2306r1295b2322],

1	NE	NN	O	ne	nn	3	SENT_237	[p17l1183t2306r1295b2322],
2	M.ORG	NN	O	m.org	nn	3	SENT_237	[p17l1311t2306r1394b2322],
3	FEBRUARY	NN	DATE	february	_	0	SENT_237	[p17l1434t2306r1561b2322],
4	6	CD	DATE	6	dep	3	SENT_237	[p17l1574t2300r1595b2326],
5	,	,	DATE	,	_	0	SENT_237	[p17l1574t2300r1595b2326],
6	2003	CD	DATE	2003	appos	4	SENT_237	[p17l1608t2306r1672b2328],

1	The	DT	O	the	det	5	SENT_238	[p17l935t2339r986b2363],
2	New	NNP	O	New	nn	5	SENT_238	[p17l995t2340r1057b2363],
3	England	NNP	O	England	nn	5	SENT_238	[p17l1066t2339r1177b2370],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_238	[p17l1186t2340r1275b2363],
5	o	NN	O	o	_	0	SENT_238	[p17l1293t2347r1308b2363],
6	Medicine	NN	O	medicine	dep	5	SENT_238	[p17l1329t2339r1454b2363],

1	Downloaded	VBN	O	download	_	0	SENT_239	[p17l377t2380r547b2403],
2	from	IN	O	from	_	0	SENT_239	[p17l556t2380r620b2403],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_239	[p17l629t2380r747b2410],
4	at	IN	O	at	_	0	SENT_239	[p17l758t2384r781b2403],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_239	[p17l789t2380r972b2403],
6	on	IN	O	on	_	0	SENT_239	[p17l981t2387r1014b2403],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_239	[p17l1022t2380r1083b2403],
8	5	CD	DATE	5	num	7	SENT_239	[p17l1135t2380r1158b2407],
9	,	,	DATE	,	_	0	SENT_239	[p17l1135t2380r1158b2407],
10	2014	CD	DATE	2014	num	7	SENT_239	[p17l1169t2380r1241b2403],
11	.	.	O	.	_	0	SENT_239	[p17l1169t2380r1241b2403],

1	For	IN	O	for	_	0	SENT_240	[p17l1251t2380r1298b2403],
2	personal	JJ	O	personal	amod	3	SENT_240	[p17l1306t2380r1418b2410],
3	use	NN	O	use	pobj	1	SENT_240	[p17l1427t2387r1471b2403],
4	only	RB	O	only	advmod	3	SENT_240	[p17l1481t2380r1545b2410],
5	.	.	O	.	_	0	SENT_240	[p17l1481t2380r1545b2410],

1	No	DT	O	no	det	3	SENT_241	[p17l1556t2380r1596b2403],
2	other	JJ	O	other	amod	3	SENT_241	[p17l1606t2380r1674b2403],
3	uses	NNS	O	use	_	0	SENT_241	[p17l1682t2387r1738b2403],
4	without	IN	O	without	_	0	SENT_241	[p17l1748t2380r1849b2403],
5	permission	NN	O	permission	prep_without	3	SENT_241	[p17l1858t2380r2010b2410],
6	.	.	O	.	_	0	SENT_241	[p17l1858t2380r2010b2410],

1	Copyright	NN	O	copyright	nsubj	6	SENT_242	[p17l727t2421r862b2452],
2	©	CD	NUMBER	©	num	1	SENT_242	[p17l871t2421r895b2445],
3	2003	CD	DATE	2003	num	5	SENT_242	[p17l905t2421r969b2445],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_242	[p17l979t2422r1064b2445],
5	u	NN	O	u	dep	1	SENT_242	[p17l1096t2429r1112b2445],
6	etts	VBZ	O	ett	_	0	SENT_242	[p17l1126t2425r1170b2445],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_242	[p17l1180t2421r1288b2445],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_242	[p17l1299t2421r1404b2452],
9	.	.	O	.	_	0	SENT_242	[p17l1299t2421r1404b2452],

1	All	DT	O	all	det	2	SENT_243	[p17l1415t2421r1456b2445],
2	rights	NNS	O	rights	nsubj	3	SENT_243	[p17l1465t2421r1540b2452],
3	reserved	VBN	O	reserve	_	0	SENT_243	[p17l1550t2421r1669b2445],
4	.	.	O	.	_	0	SENT_243	[p17l1550t2421r1669b2445],

1	D	NN	O	d	nn	2	SENT_244	[p17l806t2467r826b2486],
2	RUG	NN	O	rug	_	0	SENT_244	[p17l832t2467r901b2486],
3	TH	NN	O	th	nn	6	SENT_244	[p17l913t2467r958b2486],
4	E	NN	O	e	nn	6	SENT_244	[p17l964t2467r980b2486],
5	RA	NN	O	ra	nn	6	SENT_244	[p17l985t2467r1026b2486],
6	PY	NN	O	py	dep	2	SENT_244	[p17l1031t2467r1066b2486],

1	Venodilatation	NNP	O	Venodilatation	_	0	SENT_245	[p18l1054t40r1276b68],

1	Gln	NN	O	gln	_	0	SENT_246	[p18l180t312r231b341],
2	or	CC	O	or	_	0	SENT_246	[p18l245t322r276b341],
3	Glu	NN	O	glu	conj_or	1	SENT_246	[p18l287t312r339b341],
4	at	IN	O	at	_	0	SENT_246	[p18l170t359r197b382],
5	codon	NN	O	codon	prep_at	1	SENT_246	[p18l209t354r302b382],
6	27	CD	NUMBER	27	num	5	SENT_246	[p18l315t357r350b382],

1	Maximal	JJ	O	maximal	amod	3	SENT_247	[p18l710t379r738b506],
2	Venodilative	NNP	O	Venodilative	nn	3	SENT_247	[p18l710t179r738b367],
3	Response	NN	O	response	_	0	SENT_247	[p18l754t434r789b580],
4	to	TO	O	to	_	0	SENT_247	[p18l757t393r780b423],
5	Isoproterenol	NN	O	isoproterenol	prep_to	3	SENT_247	[p18l752t175r789b378],
6	(	CD	PERCENT	(	num	7	SENT_247	[p18l753t108r789b158],
7	%	NN	PERCENT	%	dep	3	SENT_247	[p18l753t108r789b158],
8	)	CD	NUMBER	)	dep	7	SENT_247	[p18l753t108r789b158],

1	Gln/Gln	NN	O	gln/gln	nn	2	SENT_248	[p18l986t618r1095b651],
2	Glu/Glu	NN	O	glu/glu	_	0	SENT_248	[p18l1240t618r1349b651],

1	Acute	JJ	O	acute	amod	2	SENT_249	[p18l484t732r571b758],
2	Airway	NNP	O	Airway	_	0	SENT_249	[p18l582t732r684b767],
3	Response	NN	O	response	dep	2	SENT_249	[p18l697t733r844b767],
4	to	TO	O	to	_	0	SENT_249	[p18l855t735r884b758],
5	/	:	O	/	punct	6	SENT_249	[p18l895t732r1047b767],
6	3-Agonist	JJ	O	3-agonist	dep	7	SENT_249	[p18l895t732r1047b767],
7	Desensitization	NN	O	desensitization	prep_to	3	SENT_249	[p18l1566t732r1801b758],

1	-6	CD	NUMBER	-6	_	0	SENT_250	[p18l689t842r736b865],
2	-	:	O	-	_	0	SENT_250	[p18l689t842r736b865],
3	Arg/Arg	NN	O	arg/arg	dep	1	SENT_250	[p18l745t839r854b871],
4	-	:	O	-	_	0	SENT_250	[p18l689t883r736b900],
5	I	PRP	O	I	dep	3	SENT_250	[p18l689t883r736b900],
6	-	:	O	-	_	0	SENT_250	[p18l689t883r736b900],
7	Arg/Gly	NN	O	arg/gly	dep	1	SENT_250	[p18l745t878r852b911],
8	or	CC	O	or	_	0	SENT_250	[p18l861t887r889b903],
9	Gly/Gly	NN	O	gly/gly	conj_or	7	SENT_250	[p18l899t878r1001b911],

1	-6	CD	NUMBER	-6	_	0	SENT_251	[p18l1602t841r1649b864],
2	-	:	O	-	_	0	SENT_251	[p18l1602t841r1649b864],
3	Arg/Arg	NN	O	arg/arg	nn	4	SENT_251	[p18l1658t838r1769b870],
4	—	NN	O	—	nsubj	5	SENT_251	[p18l1602t882r1649b899],
5	l	NN	O	l	dep	1	SENT_251	[p18l1602t882r1649b899],
6	—	CD	NUMBER	—	num	7	SENT_251	[p18l1602t882r1649b899],
7	Arg/Gly	NN	O	arg/gly	dobj	5	SENT_251	[p18l1658t876r1766b909],
8	or	CC	O	or	_	0	SENT_251	[p18l1776t885r1804b901],
9	Gly/Gly	NN	O	gly/gly	dobj	5	SENT_251	[p18l1814t876r1918b909],

1	Change	NNP	O	Change	dep	6	SENT_252	[p18l332t1078r370b1193],
2	in	IN	O	in	_	0	SENT_252	[p18l335t1041r360b1065],
3	FEV1	NN	PERCENT	fev1	prep_in	1	SENT_252	[p18l335t954r369b1025],
4	(	CD	PERCENT	(	num	5	SENT_252	[p18l334t888r370b938],
5	%	NN	PERCENT	%	dep	6	SENT_252	[p18l334t888r370b938],
6	)	CD	NUMBER	)	dep	10	SENT_252	[p18l334t888r370b938],
7	to	TO	O	to	_	0	SENT_252	[p18l1255t1169r1278b1199],
8	Isoproterenol	NNP	O	Isoproterenol	prep_to	6	SENT_252	[p18l1249t951r1286b1154],
9	(	CD	PERCENT	(	num	10	SENT_252	[p18l1251t884r1286b934],
10	%	NN	PERCENT	%	dep	34	SENT_252	[p18l1251t884r1286b934],
11	)	CD	NUMBER	)	num	12	SENT_252	[p18l1251t884r1286b934],
12	\	NN	O	\	dep	10	SENT_252	[p18l1306t853r1319b876],
13	l	NN	O	l	nn	15	SENT_252	[p18l1306t853r1319b876],
14	tv	NN	O	tv	nn	15	SENT_252	[p18l1218t866r1236b881],
15	V7	NN	O	v7	dep	12	SENT_252	[p18l1218t884r1236b897],
16	:	:	O	:	_	0	SENT_252	[p18l1218t902r1236b916],
17	o	NN	O	o	nn	20	SENT_252	[p18l1218t921r1236b938],
18	D.	NNP	O	D.	nn	20	SENT_252	[p18l1218t941r1245b957],
19	U	NNP	O	U	nn	20	SENT_252	[p18l1218t962r1236b974],
20	)	NNP	O	)	dep	12	SENT_252	[p18l1218t962r1236b974],
21	in	IN	O	in	_	0	SENT_252	[p18l1218t977r1236b992],
22	DC	NNP	ORGANIZATION	DC	prep_in	20	SENT_252	[p18l1210t995r1236b1012],
23	a	DT	O	a	dep	22	SENT_252	[p18l1218t1026r1236b1041],
24	;	:	O	;	_	0	SENT_252	[p18l1218t1026r1236b1041],
25	.2	NN	NUMBER	.2	dep	22	SENT_252	[p18l1210t1043r1236b1066],
26	4	CD	NUMBER	4	num	25	SENT_252	[p18l1213t1069r1236b1080],
27	-	:	O	-	_	0	SENT_252	[p18l1213t1069r1236b1080],
28	’	CD	NUMBER	’	num	29	SENT_252	[p18l1213t1069r1236b1080],
29	L	NN	O	l	dep	12	SENT_252	[p18l1208t1082r1236b1104],
30	‘	CD	NUMBER	‘	number	31	SENT_252	[p18l1208t1082r1236b1104],
31	‘	CD	NUMBER	‘	dep	29	SENT_252	[p18l1208t1110r1236b1135],
32	E	NN	O	e	nn	34	SENT_252	[p18l1208t1110r1236b1135],
33	O	NN	O	o	nn	34	SENT_252	[p18l1218t1138r1236b1155],
34	E	NN	O	e	_	0	SENT_252	[p18l1218t1159r1236b1193],
35	>	JJR	O	>	dep	34	SENT_252	[p18l1210t1193r1236b1214],

1	6	CD	NUMBER	6	number	2	SENT_253	[p18l714t1340r728b1363],
2	8	CD	NUMBER	8	_	0	SENT_253	[p18l807t1340r821b1363],
3	60	CD	DURATION	60	num	4	SENT_253	[p18l1667t1338r1698b1362],
4	Hours	NNS	DURATION	hour	dep	2	SENT_253	[p18l721t1389r814b1415],
5	Minutes	NNPS	DURATION	Minutes	dep	2	SENT_253	[p18l1617t1389r1740b1415],

1	Arg	NN	O	arg	_	0	SENT_254	[p18l493t1468r547b1503],
2	or	CC	O	or	_	0	SENT_254	[p18l558t1476r589b1494],
3	Gly	NN	O	gly	conj_or	1	SENT_254	[p18l600t1466r649b1503],
4	at	IN	O	at	_	0	SENT_254	[p18l481t1513r508b1536],
5	codon	NN	O	codon	prep_at	1	SENT_254	[p18l520t1508r613b1536],
6	16	CD	NUMBER	16	num	5	SENT_254	[p18l629t1510r661b1536],

1	_	NN	O	_	_	0	SENT_255	[p18l882t1641r893b1651],
2	.	.	O	.	_	0	SENT_255	[p18l904t1633r915b1643],

1	o	NN	O	o	_	0	SENT_256	[p18l928t1628r938b1639],
2	-	:	O	-	_	0	SENT_256	[p18l950t1619r1005b1641],
3	o	NN	O	o	dep	1	SENT_256	[p18l950t1619r1005b1641],
4	-	:	O	-	_	0	SENT_256	[p18l950t1619r1005b1641],
5	-	:	O	-	_	0	SENT_256	[p18l1016t1626r1027b1636],
6	-	:	O	-	_	0	SENT_256	[p18l1038t1626r1049b1636],
7	-	:	O	-	_	0	SENT_256	[p18l1060t1626r1071b1636],
8	-	:	O	-	_	0	SENT_256	[p18l1082t1626r1093b1636],
9	-	:	O	-	_	0	SENT_256	[p18l1104t1626r1114b1636],
10	-	:	O	-	_	0	SENT_256	[p18l1126t1626r1136b1636],
11	-	:	O	-	_	0	SENT_256	[p18l1148t1626r1158b1636],
12	-	:	O	-	_	0	SENT_256	[p18l1170t1626r1180b1636],
13	-	:	O	-	_	0	SENT_256	[p18l1192t1626r1202b1636],
14	-	:	O	-	_	0	SENT_256	[p18l1214t1626r1224b1636],
15	-	:	O	-	_	0	SENT_256	[p18l1236t1626r1246b1636],
16	-	:	O	-	_	0	SENT_256	[p18l1257t1626r1268b1636],
17	-	:	O	-	_	0	SENT_256	[p18l1279t1626r1290b1636],
18	-	:	O	-	_	0	SENT_256	[p18l1301t1626r1312b1636],
19	NH2	NN	O	nh2	dep	21	SENT_256	[p18l1345t1618r1411b1651],
20	Human	JJ	O	human	amod	21	SENT_256	[p18l1491t1618r1604b1643],
21	B2-Adrenoreceptor	NN	O	b2-adrenoreceptor	dep	24	SENT_256	[p18l1615t1615r1910b1652],
22	I	PRP	O	I	dep	21	SENT_256	[p18l847t1767r858b1777],
23	I	PRP	O	I	dep	21	SENT_256	[p18l847t1744r858b1755],
24	I	PRP	O	I	dep	26	SENT_256	[p18l846t1721r856b1731],
25	U	NNP	O	U	nn	26	SENT_256	[p18l845t1697r855b1708],
26	U	NNP	O	U	dep	1	SENT_256	[p18l847t1675r858b1685],
27	,	,	O	,	_	0	SENT_256	[p18l840t1784r867b1896],
28	...	:	O	...	_	0	SENT_256	[p18l840t1784r867b1896],
29	o	NN	O	o	dep	26	SENT_256	[p18l840t1784r867b1896],
30	_	IN	O	_	prep	26	SENT_256	[p18l863t1656r873b1666],

1	Q	NNP	O	Q	_	0	SENT_257	[p18l1707t1970r1719b1982],
2	(	CD	NUMBER	(	num	1	SENT_257	[p18l1708t1953r1718b1959],
3	‘	CD	NUMBER	‘	num	4	SENT_257	[p18l1718t1953r1742b2042],
4	.9	NN	NUMBER	.9	dep	1	SENT_257	[p18l1718t1953r1742b2042],
5	!	.	O	!	_	0	SENT_257	[p18l1718t1953r1742b2042],

1	OgO	NN	O	ogo	_	0	SENT_258	[p18l1718t1953r1742b2042],
2	‘	NN	O	‘	dep	1	SENT_258	[p18l1718t1953r1742b2042],
3	.	.	O	.	_	0	SENT_258	[p18l1718t1953r1742b2042],

1	(	NN	O	(	nn	2	SENT_259	[p18l1718t1953r1742b2042],
2	OiO	NN	O	oio	_	0	SENT_259	[p18l1742t1993r1766b2050],
3	‘	CD	NUMBER	‘	number	4	SENT_259	[p18l1742t1993r1766b2050],
4	¢	CD	NUMBER	¢	dep	2	SENT_259	[p18l1742t1993r1766b2050],
5	air	NN	O	air	dep	4	SENT_259	[p18l1742t2048r1766b2088],
6	an	DT	O	a	dep	5	SENT_259	[p18l1742t1979r1758b1997],
7	-	:	O	-	_	0	SENT_259	[p18l1742t1957r1758b1974],
8	I	PRP	O	I	dep	2	SENT_259	[p18l1742t1957r1758b1974],
9	,	,	O	,	_	0	SENT_259	[p18l1764t2024r1789b2112],
10	_	IN	O	_	dep	8	SENT_259	[p18l1764t2024r1789b2112],
11	I	PRP	O	I	pobj	10	SENT_259	[p18l1764t2024r1789b2112],
12	,	,	O	,	_	0	SENT_259	[p18l1764t2024r1789b2112],
13	.	.	O	.	_	0	SENT_259	[p18l1764t2024r1789b2112],

1	n	NN	O	n	nn	7	SENT_260	[p18l1764t2024r1789b2112],
2	,	,	O	,	_	0	SENT_260	[p18l1764t2024r1789b2112],
3	o.	NN	O	o.	dep	7	SENT_260	[p18l1764t2024r1789b2112],
4	,	,	O	,	_	0	SENT_260	[p18l1764t2024r1789b2112],
5	_	NN	O	_	dep	7	SENT_260	[p18l1764t2024r1789b2112],
6	o	NN	O	o	nn	7	SENT_260	[p18l1764t2024r1789b2112],
7	O	NN	O	o	_	0	SENT_260	[p18l1764t2002r1782b2020],
8	o	NN	O	o	dep	7	SENT_260	[p18l1764t1979r1782b1997],
9	,5	CD	NUMBER	,5	num	8	SENT_260	[p18l1789t2070r1813b2112],
10	;	:	O	;	_	0	SENT_260	[p18l1789t2070r1813b2112],
11	I	PRP	O	I	dep	8	SENT_260	[p18l1789t2048r1804b2065],
12	c	NN	O	c	dep	11	SENT_260	[p18l1789t2024r1805b2042],
13	a	DT	O	a	dep	12	SENT_260	[p18l1812t2070r1827b2088],

1	@	SYM	O	@	dep	2	SENT_261	[p18l1352t2530r1456b2556],
2	3	CD	NUMBER	3	_	0	SENT_261	[p18l1352t2530r1456b2556],
3	+	CC	O	+	cc	2	SENT_261	[p18l1352t2530r1456b2556],
4	Ooiiiiiliiliiiiiliini	NNP	O	Ooiiiiiliiliiiiiliini	dep	2	SENT_261	[p18l1487t2525r1999b2544],
5	‘	CD	NUMBER	‘	num	4	SENT_261	[p18l1487t2525r1999b2544],

1	N	NN	O	n	nn	3	SENT_262	[p18l542t2688r556b2704],
2	ENGLJ	NN	O	englj	nn	3	SENT_262	[p18l571t2688r655b2710],
3	MED	NN	O	med	_	0	SENT_262	[p18l670t2688r723b2704],
4	348	CD	NUMBER	348	dep	3	SENT_262	[p18l735t2682r806b2710],
5	;	:	O	;	_	0	SENT_262	[p18l735t2682r806b2710],
6	6	CD	NUMBER	6	num	7	SENT_262	[p18l735t2682r806b2710],
7	WWW	NN	O	www	dep	3	SENT_262	[p18l841t2688r961b2710],
8	.	.	O	.	_	0	SENT_262	[p18l841t2688r961b2710],

1	NEj	NN	O	nej	nn	3	SENT_263	[p18l841t2688r961b2710],
2	M.ORG	NN	O	m.org	nn	3	SENT_263	[p18l969t2688r1053b2704],
3	FEBRUARY	NN	DATE	february	_	0	SENT_263	[p18l1092t2688r1219b2704],
4	6	CD	DATE	6	dep	3	SENT_263	[p18l1232t2682r1253b2708],
5	,	,	DATE	,	_	0	SENT_263	[p18l1232t2682r1253b2708],
6	2003	CD	DATE	2003	num	7	SENT_263	[p18l1266t2688r1330b2710],
7	545	CD	NUMBER	545	appos	4	SENT_263	[p18l2010t2686r2065b2709],

1	The	DT	O	the	det	4	SENT_264	[p18l751t2721r802b2744],
2	New	NNP	O	New	nn	4	SENT_264	[p18l812t2721r873b2744],
3	England	NNP	O	England	nn	4	SENT_264	[p18l883t2721r994b2751],
4	Journal	NNP	O	Journal	_	0	SENT_264	[p18l1002t2721r1100b2744],
5	of	IN	O	of	_	0	SENT_264	[p18l1110t2721r1138b2744],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_264	[p18l1145t2721r1270b2744],

1	Downloaded	VBN	O	download	_	0	SENT_265	[p18l194t2761r364b2784],
2	from	IN	O	from	_	0	SENT_265	[p18l372t2761r437b2784],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_265	[p18l445t2761r564b2791],
4	at	IN	O	at	_	0	SENT_265	[p18l574t2765r597b2784],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_265	[p18l606t2761r788b2784],
6	on	IN	O	on	_	0	SENT_265	[p18l798t2768r830b2784],
7	January	NNP	DATE	January	prep_on	1	SENT_265	[p18l839t2761r942b2791],
8	5	CD	DATE	5	num	7	SENT_265	[p18l951t2761r974b2789],
9	,	,	DATE	,	_	0	SENT_265	[p18l951t2761r974b2789],
10	2014	CD	DATE	2014	num	7	SENT_265	[p18l985t2761r1057b2784],
11	.	.	O	.	_	0	SENT_265	[p18l985t2761r1057b2784],

1	For	IN	O	for	_	0	SENT_266	[p18l1068t2761r1114b2784],
2	personal	JJ	O	personal	amod	3	SENT_266	[p18l1122t2761r1235b2791],
3	use	NN	O	use	pobj	1	SENT_266	[p18l1244t2768r1287b2784],
4	only	RB	O	only	advmod	3	SENT_266	[p18l1297t2761r1362b2791],
5	.	.	O	.	_	0	SENT_266	[p18l1297t2761r1362b2791],

1	No	DT	O	no	det	3	SENT_267	[p18l1372t2761r1412b2784],
2	other	JJ	O	other	amod	3	SENT_267	[p18l1422t2761r1490b2784],
3	uses	NNS	O	use	_	0	SENT_267	[p18l1498t2768r1554b2784],
4	without	IN	O	without	_	0	SENT_267	[p18l1565t2761r1666b2784],
5	permission	NN	O	permission	prep_without	3	SENT_267	[p18l1674t2761r1827b2791],
6	.	.	O	.	_	0	SENT_267	[p18l1674t2761r1827b2791],

1	Copyright	NN	O	copyright	_	0	SENT_268	[p18l544t2801r678b2831],
2	©	CD	NUMBER	©	num	6	SENT_268	[p18l688t2801r711b2825],
3	2003	CD	DATE	2003	num	6	SENT_268	[p18l721t2801r785b2825],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_268	[p18l796t2801r987b2824],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_268	[p18l997t2801r1105b2824],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_268	[p18l1115t2801r1220b2831],
7	.	.	O	.	_	0	SENT_268	[p18l1115t2801r1220b2831],

1	All	DT	O	all	det	2	SENT_269	[p18l1231t2801r1273b2824],
2	rights	NNS	O	rights	nsubj	3	SENT_269	[p18l1282t2801r1356b2831],
3	reserved	VBN	O	reserve	_	0	SENT_269	[p18l1366t2801r1485b2824],
4	.	.	O	.	_	0	SENT_269	[p18l1366t2801r1485b2824],

1	The	DT	O	the	det	4	SENT_270	[p18l857t2843r895b2865],
2	NEW	NNP	O	NEW	nn	4	SENT_270	[p18l907t2845r988b2865],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_270	[p18l1002t2845r1177b2865],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_270	[p18l1191t2845r1357b2872],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_270	[p18l1371t2843r1587b2871],

1	Table	NNP	O	Table	_	0	SENT_271	[p19l119t40r190b65],
2	2	CD	NUMBER	2	dep	1	SENT_271	[p19l199t42r222b65],
3	.	.	O	.	_	0	SENT_271	[p19l199t42r222b65],

1	Genetic	JJ	O	genetic	amod	2	SENT_272	[p19l232t40r337b65],
2	Polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_272	[p19l348t39r560b72],
3	in	IN	O	in	_	0	SENT_272	[p19l571t40r594b64],
4	Disease-Modifying	NNP	O	Disease-Modifying	nn	7	SENT_272	[p19l606t39r861b72],
5	or	CC	O	or	_	0	SENT_272	[p19l870t48r898b65],
6	Treatment-Modifying	NNP	O	Treatment-Modifying	nn	7	SENT_272	[p19l905t39r1194b72],
7	Genes	NNS	MISC	gene	prep_in	2	SENT_272	[p19l1202t41r1288b65],
8	That	WDT	MISC	that	nsubj	12	SENT_272	[p19l1297t39r1360b65],
9	Can	MD	MISC	can	aux	12	SENT_272	[p19l1368t41r1419b65],
10	Inﬂuence	NNP	MISC	Inﬂuence	nn	12	SENT_272	[p19l1431t39r1556b65],
11	Drug	NNP	MISC	Drug	nn	12	SENT_272	[p19l1566t42r1634b72],
12	Response	NNP	MISC	Response	_	0	SENT_272	[p19l1645t41r1800b72],
13	.	.	O	.	_	0	SENT_272	[p19l1645t41r1800b72],

1	*	NN	O	*	_	0	SENT_273	[p19l1645t41r1800b72],

1	Inﬂuence	NN	O	inﬂuence	nn	4	SENT_274	[p19l1584t120r1702b144],
2	ofPolymorphi	NN	O	ofpolymorphus	nn	4	SENT_274	[p19l1710t120r1889b152],
3	m	NN	O	m	nn	4	SENT_274	[p19l1906t129r1928b144],
4	Gene	NN	O	gene	dep	22	SENT_274	[p19l120t160r188b182],
5	or	CC	O	or	_	0	SENT_274	[p19l196t166r222b182],
6	Gene	NN	ORGANIZATION	gene	nn	8	SENT_274	[p19l230t160r297b182],
7	Product	NNP	ORGANIZATION	Product	nn	8	SENT_274	[p19l307t158r406b182],
8	Disease	NNP	ORGANIZATION	Disease	dep	22	SENT_274	[p19l510t159r610b182],
9	or	CC	ORGANIZATION	or	_	0	SENT_274	[p19l618t166r644b182],
10	Response	NNP	ORGANIZATION	Response	nn	12	SENT_274	[p19l654t160r776b189],
11	Association	NNP	ORGANIZATION	Association	nn	12	SENT_274	[p19l784t159r932b182],
12	Medication	NN	ORGANIZATION	medication	dep	22	SENT_274	[p19l1135t158r1276b182],
13	on	IN	O	on	_	0	SENT_274	[p19l1594t166r1625b182],
14	Drug	NN	O	drug	nn	15	SENT_274	[p19l1637t160r1700b189],
15	Effect	NN	O	effect	prep_on	4	SENT_274	[p19l1710t158r1780b182],
16	or	CC	O	or	_	0	SENT_274	[p19l1788t166r1814b182],
17	Toxicity	NN	O	toxicity	nn	19	SENT_274	[p19l1821t159r1918b189],
18	Adducin	NN	O	adducin	nn	19	SENT_274	[p19l120t232r225b256],
19	Hypertension	NN	O	hypertension	conj_or	15	SENT_274	[p19l506t234r676b263],
20	Diuretics	NNS	O	diuretic	dep	22	SENT_274	[p19l979t234r1092b256],
21	Myocardial	JJ	O	myocardial	amod	22	SENT_274	[p19l1475t232r1613b263],
22	infarction	NN	O	infarction	dep	27	SENT_274	[p19l1624t232r1744b256],
23	or	CC	O	or	_	0	SENT_274	[p19l1755t241r1781b256],
24	strokes	NNS	O	stroke	dep	27	SENT_274	[p19l1790t232r1904b256],
25	“	CD	NUMBER	“	num	27	SENT_274	[p19l1790t232r1904b256],
26	Apolipoprotein	NN	O	apolipoprotein	nn	27	SENT_274	[p19l120t295r312b326],
27	E	NN	O	e	_	0	SENT_274	[p19l324t297r337b318],
28	(	CD	NUMBER	(	num	32	SENT_274	[p19l349t296r441b326],
29	APOE	NNP	ORGANIZATION	APOE	nn	32	SENT_274	[p19l349t296r441b326],
30	)	CD	NUMBER	)	num	32	SENT_274	[p19l349t296r441b326],
31	Progression	NN	O	progression	nn	32	SENT_274	[p19l506t297r656b326],
32	ofatherosclerosis	NN	O	ofatherosclerosis	nsubj	34	SENT_274	[p19l666t295r899b323],
33	,	,	O	,	_	0	SENT_274	[p19l666t295r899b323],
34	is	VBZ	O	be	rcmod	27	SENT_274	[p19l911t297r938b319],
35	-	:	O	-	_	0	SENT_274	[p19l911t297r938b319],
36	Statins	NNS	MISC	statin	nsubj	37	SENT_274	[p19l978t297r1064b319],
37	(	VBP	O	(	parataxis	34	SENT_274	[p19l1077t297r1136b326],
38	e.g.	FW	O	e.g.	dobj	37	SENT_274	[p19l1077t297r1136b326],
39	,	,	O	,	_	0	SENT_274	[p19l1077t297r1136b326],
40	simvastatin	NN	O	simvastatin	appos	38	SENT_274	[p19l1147t297r1303b326],
41	)	CD	NUMBER	)	num	40	SENT_274	[p19l1147t297r1303b326],
42	Enhanced	VBN	O	enhance	partmod	40	SENT_274	[p19l1475t295r1598b319],
43	survival7	NN	O	survival7	nn	45	SENT_274	[p19l1609t295r1759b319],
44	°	CD	NUMBER	°	num	45	SENT_274	[p19l1609t295r1759b319],
45	v71	NN	O	v71	dobj	42	SENT_274	[p19l1609t295r1759b319],

1	chem	NN	O	chem	_	0	SENT_275	[p19l554t332r630b356],
2	"	''	O	"	punct	1	SENT_275	[p19l554t332r630b356],
3	d	NN	O	d	nn	5	SENT_275	[p19l694t332r715b356],
4	"	''	O	"	punct	5	SENT_275	[p19l694t332r715b356],
5	lar	NN	O	lar	dep	1	SENT_275	[p19l810t332r841b356],
6	events	NNS	O	event	dep	1	SENT_275	[p19l849t337r930b356],

1	Apolipoprotein	NN	O	apolipoprotein	nn	2	SENT_276	[p19l120t395r312b426],
2	E	NN	O	e	dep	12	SENT_276	[p19l324t397r337b418],
3	(	CD	NUMBER	(	num	4	SENT_276	[p19l349t396r441b426],
4	APOE	NNP	O	APOE	dep	2	SENT_276	[p19l349t396r441b426],
5	)	CD	NUMBER	)	num	4	SENT_276	[p19l349t396r441b426],
6	Alzheimer	NNP	O	Alzheimer	poss	8	SENT_276	[p19l503t395r654b419],
7	's	POS	O	's	_	0	SENT_276	[p19l503t395r654b419],
8	disease	NN	O	disease	dep	4	SENT_276	[p19l664t395r759b419],
9	Tacrine	NNP	O	Tacrine	dep	12	SENT_276	[p19l976t397r1067b419],
10	Clinical	JJ	O	clinical	amod	12	SENT_276	[p19l1473t395r1565b419],
11	improvement	NN	O	improvement	nn	12	SENT_276	[p19l1576t397r1772b426],
12	”	NN	O	”	dep	24	SENT_276	[p19l1576t397r1772b426],
13	H	NN	O	h	prep	12	SENT_276	[p19l123t460r140b481],
14	LA	NNP	ORGANIZATION	LA	nn	20	SENT_276	[p19l147t459r177b481],
15	Toxicity	NNP	ORGANIZATION	Toxicity	nn	20	SENT_276	[p19l503t460r597b488],
16	Abacavir	NNP	ORGANIZATION	Abacavir	nn	20	SENT_276	[p19l976t457r1087b481],
17	Hyp	NNP	ORGANIZATION	Hyp	nn	20	SENT_276	[p19l1475t460r1524b488],
18	eeeee	NN	O	eeeee	nn	20	SENT_276	[p19l1527t466r1594b481],
19	sitivity	NN	O	sitivity	nn	20	SENT_276	[p19l1598t460r1679b488],
20	reaction73r74	NN	O	reaction73r74	dep	13	SENT_276	[p19l1689t460r1846b481],
21	Cholesterol	NNP	O	Cholesterol	nn	24	SENT_276	[p19l121t520r265b544],
22	ester	NN	O	ester	nn	24	SENT_276	[p19l275t524r338b544],
23	transfer	NN	O	transfer	nn	24	SENT_276	[p19l345t520r445b544],
24	Progression	NN	O	progression	_	0	SENT_276	[p19l506t522r656b551],
25	ofatherosclerosis	NN	O	ofatherosclerosis	nn	26	SENT_276	[p19l666t520r892b544],
26	Statins	NNS	MISC	statin	nsubj	27	SENT_276	[p19l978t522r1064b544],
27	(	VBP	O	(	rcmod	24	SENT_276	[p19l1077t522r1136b551],
28	e.g.	FW	O	e.g.	dep	27	SENT_276	[p19l1077t522r1136b551],
29	,	,	O	,	_	0	SENT_276	[p19l1077t522r1136b551],
30	pravastatin	NN	O	pravastatin	appos	28	SENT_276	[p19l1148t522r1298b551],
31	)	CD	NUMBER	)	num	30	SENT_276	[p19l1148t522r1298b551],
32	Slowing	VBG	O	slow	amod	34	SENT_276	[p19l1474t520r1574b551],
33	ofprogression	NN	O	ofprogression	nn	34	SENT_276	[p19l1581t520r1764b551],
34	ofatherosclerosis	NN	O	ofatherosclerosis	dep	30	SENT_276	[p19l1773t520r1998b544],
35	by	IN	O	by	_	0	SENT_276	[p19l2008t520r2034b551],
36	protein	NN	O	protein	nn	38	SENT_276	[p19l172t560r260b588],
37	(	CD	NUMBER	(	num	38	SENT_276	[p19l274t559r359b588],
38	CETP	NN	O	cetp	prep_by	30	SENT_276	[p19l274t559r359b588],
39	)	CD	NUMBER	)	num	42	SENT_276	[p19l274t559r359b588],
40	pravastatin75	NN	O	pravastatin75	nn	42	SENT_276	[p19l1524t560r1688b588],
41	Ion	NN	O	ion	nn	42	SENT_276	[p19l123t622r160b644],
42	channels	NNS	O	channel	tmod	27	SENT_276	[p19l171t620r284b644],
43	(	CD	NUMBER	(	num	45	SENT_276	[p19l297t622r325b651],
44	H	NN	O	h	nn	45	SENT_276	[p19l297t622r325b651],
45	ERG	NN	O	erg	dep	42	SENT_276	[p19l331t622r391b648],
46	,	,	O	,	_	0	SENT_276	[p19l331t622r391b648],
47	Congenital	JJ	O	congenital	amod	49	SENT_276	[p19l504t620r640b651],
48	long-QT	JJ	O	long-qt	amod	49	SENT_276	[p19l652t620r756b651],
49	syndrome	NN	O	syndrome	appos	42	SENT_276	[p19l765t620r891b651],
50	Erythromycin	NNP	O	Erythromycin	dep	49	SENT_276	[p19l979t620r1153b651],
51	,	,	O	,	_	0	SENT_276	[p19l979t620r1153b651],
52	terfenadine	NN	O	terfenadine	nn	57	SENT_276	[p19l1163t620r1315b648],
53	,	,	O	,	_	0	SENT_276	[p19l1163t620r1315b648],
54	cisa	NN	O	cisa	dep	57	SENT_276	[p19l1325t622r1382b644],
55	—	CD	NUMBER	—	num	57	SENT_276	[p19l1325t622r1382b644],
56	Increased	VBN	O	increase	amod	57	SENT_276	[p19l1475t620r1596b644],
57	risk	NN	O	risk	appos	49	SENT_276	[p19l1608t620r1651b644],
58	ofdrug-induced	JJ	O	ofdrug-induced	amod	59	SENT_276	[p19l1660t620r1862b651],
59	torsade	NN	O	torsade	dep	42	SENT_276	[p19l1872t620r1968b644],
60	de	IN	O	de	amod	59	SENT_276	[p19l1977t620r2007b644],

1	KvLQT1	NN	O	kvlqt1	_	0	SENT_277	[p19l173t659r278b688],
2	,	,	O	,	_	0	SENT_277	[p19l173t659r278b688],
3	Mink	NNP	ORGANIZATION	Mink	appos	1	SENT_277	[p19l290t658r359b685],
4	,	,	O	,	_	0	SENT_277	[p19l290t658r359b685],
5	MiRP1	NN	O	mirp1	nn	7	SENT_277	[p19l371t660r462b689],
6	)	NN	O	)	nn	7	SENT_277	[p19l371t660r462b689],
7	pride	NN	O	pride	appos	1	SENT_277	[p19l1028t658r1098b688],
8	,	,	O	,	_	0	SENT_277	[p19l1028t658r1098b688],
9	clarithromycin	NN	O	clarithromycin	appos	1	SENT_277	[p19l1109t658r1300b688],
10	,	,	O	,	_	0	SENT_277	[p19l1109t658r1300b688],
11	quinidine	NN	O	quinidine	nn	12	SENT_277	[p19l1310t658r1430b688],
12	pointes75	NN	O	pointes75	appos	1	SENT_277	[p19l1524t660r1673b688],
13	'73	CD	NUMBER	'73	dep	12	SENT_277	[p19l1524t660r1673b688],

1	Me	PRP	O	I	_	0	SENT_278	[p19l123t722r161b744],
2	h	NN	O	h	rcmod	1	SENT_278	[p19l173t720r186b743],
3	uanine	NN	O	uanine	nn	4	SENT_278	[p19l226t722r311b744],
4	methy	NN	O	methy	dep	2	SENT_278	[p19l322t720r415b751],
5	|	SYM	O	|	dep	2	SENT_278	[p19l322t720r415b751],
6	-	:	O	-	_	0	SENT_278	[p19l322t720r415b751],
7	Glioma	NN	O	glioma	nn	9	SENT_278	[p19l504t720r597b744],
8	Carmustine	NN	O	carmustine	nn	9	SENT_278	[p19l977t722r1125b744],
9	Response	NN	O	response	dep	1	SENT_278	[p19l1475t722r1597b751],
10	of	IN	O	of	_	0	SENT_278	[p19l1607t720r1634b744],
11	glioma	NN	O	glioma	prep_of	9	SENT_278	[p19l1640t720r1726b751],
12	to	TO	O	to	_	0	SENT_278	[p19l1735t725r1760b744],
13	carmustine53	NN	O	carmustine53	prep_to	1	SENT_278	[p19l1769t722r1936b744],

1	ransferase	NN	O	ransferase	_	0	SENT_279	[p19l182t757r312b781],
2	(	CD	NUMBER	(	num	3	SENT_279	[p19l324t759r379b789],
3	MG	NN	O	mg	dep	1	SENT_279	[p19l324t759r379b789],
4	MT	NN	O	mt	nn	5	SENT_279	[p19l385t760r433b789],
5	)	NN	O	)	dep	1	SENT_279	[p19l385t760r433b789],

1	Parkin	NNP	PERSON	Parkin	nn	2	SENT_280	[p19l122t820r198b844],
2	Parkinson	NNP	PERSON	Parkinson	poss	5	SENT_280	[p19l506t820r653b844],
3	's	POS	O	's	_	0	SENT_280	[p19l506t820r653b844],
4	disease	NN	O	disease	nn	5	SENT_280	[p19l663t820r757b844],
5	Levodopa	NN	O	levodopa	_	0	SENT_280	[p19l979t820r1101b851],
6	Clinical	JJ	O	clinical	amod	7	SENT_280	[p19l1473t820r1565b844],
7	improvementand	NN	O	improvementand	dep	5	SENT_280	[p19l1574t820r1798b851],
8	levodopa-induced	JJ	O	levodopa-induced	amod	9	SENT_280	[p19l1807t820r2033b851],
9	dyskinesias79	NNS	O	dyskinesias79	dep	5	SENT_280	[p19l1523t858r1693b889],

1	Prothrombin	NNP	O	Prothrombin	dep	8	SENT_281	[p19l123t920r283b944],
2	and	CC	O	and	_	0	SENT_281	[p19l294t920r339b944],
3	factor	NN	O	factor	nn	4	SENT_281	[p19l349t920r423b944],
4	V	NN	O	v	dep	8	SENT_281	[p19l431t922r448b944],
5	Deep	JJ	O	deep	amod	6	SENT_281	[p19l506t922r631b951],
6	—	NN	O	—	dep	8	SENT_281	[p19l506t922r631b951],
7	vein	NN	O	vein	nn	8	SENT_281	[p19l506t922r631b951],
8	thrombosis	NN	O	thrombosis	dep	21	SENT_281	[p19l641t920r788b944],
9	and	CC	O	and	_	0	SENT_281	[p19l798t920r843b944],
10	Oral	JJ	O	oral	amod	11	SENT_281	[p19l977t920r1030b944],
11	contraceptives	NNS	O	contraceptive	conj_and	8	SENT_281	[p19l1041t922r1227b951],
12	Increased	VBN	O	increase	amod	13	SENT_281	[p19l1475t920r1596b944],
13	risk	NN	O	risk	nsubj	21	SENT_281	[p19l1605t920r1649b944],
14	of	IN	O	of	_	0	SENT_281	[p19l1656t920r1684b944],
15	-	:	O	-	_	0	SENT_281	[p19l1750t922r1808b944],
16	vein	NN	O	vein	prep_of	13	SENT_281	[p19l1750t922r1808b944],
17	and	CC	O	and	_	0	SENT_281	[p19l1817t920r1862b944],
18	cerebral	JJ	O	cerebral	amod	20	SENT_281	[p19l1871t920r2033b944],
19	—	NN	O	—	nn	20	SENT_281	[p19l1871t920r2033b944],
20	vein	NN	O	vein	prep_of	13	SENT_281	[p19l1871t920r2033b944],
21	cerebral	JJ	O	cerebral	_	0	SENT_281	[p19l554t958r716b981],
22	—	CD	NUMBER	—	num	33	SENT_281	[p19l554t958r716b981],
23	vein	NN	O	vein	nn	33	SENT_281	[p19l554t958r716b981],
24	thrombosis	NN	O	thrombosis	nn	33	SENT_281	[p19l726t958r873b981],
25	thrombosis	NN	O	thrombosis	nn	33	SENT_281	[p19l1522t958r1669b981],
26	wi	NN	O	wus	nn	33	SENT_281	[p19l1678t960r1705b981],
27	oral	JJ	O	oral	amod	33	SENT_281	[p19l1742t958r1788b981],
28	contraceptives3	NN	O	contraceptives3	nn	33	SENT_281	[p19l1798t960r2009b988],
29	°	NN	O	°	nn	33	SENT_281	[p19l1798t960r2009b988],
30	Stromelysin-1	NN	O	stromelysin-1	nn	33	SENT_281	[p19l121t1020r295b1051],
31	Atherosclerosis	NN	O	atherosclerosis	nn	33	SENT_281	[p19l503t1020r701b1044],
32	progression	NN	O	progression	nn	33	SENT_281	[p19l712t1022r862b1051],
33	Statins	NNS	MISC	statin	dobj	21	SENT_281	[p19l977t1022r1064b1044],
34	(	VBP	O	(	rcmod	33	SENT_281	[p19l1077t1022r1136b1051],
35	e.g.	FW	O	e.g.	dobj	34	SENT_281	[p19l1077t1022r1136b1051],
36	,	,	O	,	_	0	SENT_281	[p19l1077t1022r1136b1051],
37	pravastatin	NN	O	pravastatin	nn	39	SENT_281	[p19l1148t1022r1298b1051],
38	)	CD	NUMBER	)	num	39	SENT_281	[p19l1148t1022r1298b1051],
39	Reduction	NN	O	reduction	appos	35	SENT_281	[p19l1475t1020r1601b1044],
40	in	IN	O	in	_	0	SENT_281	[p19l1612t1022r1632b1044],
41	cardiovascular	JJ	O	cardiovascular	amod	42	SENT_281	[p19l1642t1020r1828b1044],
42	ev	NN	O	ev	prep_in	39	SENT_281	[p19l1836t1028r1863b1044],
43	by	IN	O	by	_	0	SENT_281	[p19l1927t1020r1954b1051],
44	pravastatin	NN	O	pravastatin	prep_by	21	SENT_281	[p19l1963t1028r2039b1051, p19l1524t1060r1593b1081],

1	(	NN	O	(	nn	2	SENT_282	[p19l1606t1058r1684b1089],
2	death	NN	O	death	_	0	SENT_282	[p19l1606t1058r1684b1089],
3	myocardial	JJ	O	myocardial	amod	2	SENT_282	[p19l1704t1058r1841b1089],
4	in	IN	O	in	dep	3	SENT_282	[p19l1853t1060r1873b1081],
5	arction	NN	O	arction	pobj	4	SENT_282	[p19l1886t1060r1981b1086],
6	,	,	O	,	_	0	SENT_282	[p19l1886t1060r1981b1086],
7	,	,	O	,	_	0	SENT_282	[p19l1706t1115r1710b1123],
8	and	CC	O	and	_	0	SENT_282	[p19l1721t1095r1766b1119],
9	others	NNS	O	other	conj_and	2	SENT_282	[p19l1777t1095r1875b1126],
10	)	CD	NUMBER	)	num	9	SENT_282	[p19l1777t1095r1875b1126],
11	;	:	O	;	_	0	SENT_282	[p19l1777t1095r1875b1126],
12	reduction	NN	O	reduction	nn	14	SENT_282	[p19l1887t1095r2006b1119],
13	t	NN	O	t	nn	14	SENT_282	[p19l1536t1100r1545b1119],
14	k	NN	O	k	dep	2	SENT_282	[p19l1575t1095r1587b1119],
15	,	,	O	,	_	0	SENT_282	[p19l1604t1115r1607b1123],
16	angina	NN	O	angina	appos	14	SENT_282	[p19l1618t1097r1703b1126],
17	in	IN	O	in	dep	2	SENT_282	[p19l1524t1135r1544b1156],
18	risk	NN	O	risk	pobj	17	SENT_282	[p19l1556t1133r1600b1156],
19	of	IN	O	of	_	0	SENT_282	[p19l1609t1132r1637b1156],
20	repeated	VBN	O	repeat	amod	22	SENT_282	[p19l1643t1133r1751b1163],
21	angioplasty	NN	O	angioplasty	nn	22	SENT_282	[p19l1762t1133r1934b1164],
22	“	NN	O	“	prep_of	18	SENT_282	[p19l1762t1133r1934b1164],

1	’	NN	O	’	nn	2	SENT_283	[p19l93t1230r107b1243],
2	~	NN	O	~	nsubj	49	SENT_283	[p19l93t1230r107b1243],
3	‘	CD	NUMBER	‘	nsubj	8	SENT_283	[p19l93t1230r107b1243],
4	The	DT	O	the	det	5	SENT_283	[p19l117t1228r165b1251],
5	examples	NNS	O	example	nsubj	6	SENT_283	[p19l174t1228r293b1258],
6	shown	VBN	O	show	rcmod	3	SENT_283	[p19l304t1228r385b1251],
7	are	VBP	O	be	cop	8	SENT_283	[p19l396t1236r434b1251],
8	illustrative	JJ	O	illustrative	rcmod	2	SENT_283	[p19l444t1228r576b1251],
9	and	CC	O	and	_	0	SENT_283	[p19l585t1228r630b1251],
10	not	RB	O	not	conj_and	2	SENT_283	[p19l642t1232r683b1251],
11	representative	JJ	O	representative	amod	12	SENT_283	[p19l693t1230r873b1258],
12	ofall	NN	O	ofall	dep	2	SENT_283	[p19l883t1227r942b1251],
13	published	VBN	O	publish	partmod	12	SENT_283	[p19l954t1228r1077b1258],
14	studies	NNS	O	study	dobj	13	SENT_283	[p19l1088t1228r1186b1255],
15	,	,	O	,	_	0	SENT_283	[p19l1088t1228r1186b1255],
16	which	WDT	O	which	nsubj	17	SENT_283	[p19l1196t1228r1269b1251],
17	exceed	VBP	O	exceed	rcmod	14	SENT_283	[p19l1280t1228r1364b1251],
18	the	DT	O	the	det	22	SENT_283	[p19l1374t1228r1414b1251],
19	scope	NN	O	scope	nn	22	SENT_283	[p19l1423t1236r1497b1258],
20	ofthis	NN	O	ofthi	nn	22	SENT_283	[p19l1506t1227r1584b1251],
21	review	NN	O	review	nn	22	SENT_283	[p19l1596t1236r1678b1251],
22	ciation	NN	O	ciation	dobj	17	SENT_283	[p19l15t1447r299b1524],
23	between	IN	O	between	_	0	SENT_283	[p19l321t1447r670b1526],
24	APOE	NNP	O	APOE	nn	25	SENT_283	[p19l684t1452r903b1524],
25	genotype	NN	O	genotype	prep_between	22	SENT_283	[p19l923t1463r1306b1546],
26	and	CC	O	and	_	0	SENT_283	[p19l1327t1447r1482b1524],
27	the	DT	O	the	det	28	SENT_283	[p19l1504t1447r1633b1524],
28	response	NN	O	response	dobj	17	SENT_283	[p19l1654t1472r2032b1546],
29	to	TO	O	to	_	0	SENT_283	[p19l2055t1463r2134b1524],
30	lipid	NN	O	lipid	nn	31	SENT_283	[p19l13t1574r619b1673],
31	—	NN	O	—	prep_to	28	SENT_283	[p19l13t1574r619b1673],
32	lowering	VBG	O	lower	xcomp	17	SENT_283	[p19l13t1574r619b1673],
33	medications	NNS	O	medication	nsubj	35	SENT_283	[p19l658t1573r1496b1651],
34	.82	CD	NUMBER	.82	npadvmod	35	SENT_283	[p19l658t1573r1496b1651],
35	>	JJR	O	>	xcomp	32	SENT_283	[p19l658t1573r1496b1651],
36	86	CD	NUMBER	86	num	37	SENT_283	[p19l658t1573r1496b1651],
37	‘	NN	O	‘	dep	35	SENT_283	[p19l658t1573r1496b1651],
38	89	CD	NUMBER	89	npadvmod	39	SENT_283	[p19l658t1573r1496b1651],
39	In	IN	O	in	dep	35	SENT_283	[p19l1537t1581r1625b1650],
40	most	JJS	O	most	amod	41	SENT_283	[p19l1667t1590r1883b1651],
41	studies	NNS	O	study	pobj	39	SENT_283	[p19l1922t1574r2133b1652, p19l13t1701r149b1795],
42	,	,	O	,	_	0	SENT_283	[p19l1922t1574r2133b1652, p19l13t1701r149b1795],
43	patients	NNS	O	patient	appos	41	SENT_283	[p19l178t1701r512b1800],
44	with	IN	O	with	_	0	SENT_283	[p19l535t1701r724b1780],
45	an	DT	O	a	det	48	SENT_283	[p19l748t1726r848b1778],
46	APOE	NN	O	apoe	nn	48	SENT_283	[p19l866t1706r1084b1778],
47	e2	NN	O	e2	nn	48	SENT_283	[p19l1108t1707r1199b1778],
48	allele	NN	O	allele	prep_with	43	SENT_283	[p19l1227t1700r1445b1778],
49	had	VBD	O	have	_	0	SENT_283	[p19l1470t1701r1625b1778],
50	the	DT	O	the	det	52	SENT_283	[p19l1650t1701r1778b1778],
51	greatest	JJS	O	greatest	amod	52	SENT_283	[p19l1804t1717r2140b1800],
52	diminution	NN	O	diminution	dobj	49	SENT_283	[p19l15t1827r490b1906],
53	of	IN	O	of	_	0	SENT_283	[p19l525t1827r625b1905],
54	low	JJ	O	low	amod	58	SENT_283	[p19l641t1828r1134b1927],
55	—	NN	O	—	nn	58	SENT_283	[p19l641t1828r1134b1927],
56	density	NN	O	density	nn	58	SENT_283	[p19l641t1828r1134b1927],
57	lipoprotein	NN	O	lipoprotein	nn	58	SENT_283	[p19l1163t1828r1635b1927],
58	cholesterol	NN	O	cholesterol	prep_of	52	SENT_283	[p19l1670t1828r2135b1905],
59	after	IN	O	after	_	0	SENT_283	[p19l13t1954r207b2032],
60	drug	NN	O	drug	nn	61	SENT_283	[p19l243t1955r442b2054],
61	therapy	NN	O	therapy	prep_after	49	SENT_283	[p19l478t1955r806b2054],
62	.	.	O	.	_	0	SENT_283	[p19l478t1955r806b2054],

1	The	DT	O	the	det	2	SENT_284	[p19l847t1955r1008b2032],
2	decrease	NN	O	decrease	nsubj	4	SENT_284	[p19l1049t1955r1408b2032],
3	was	VBD	O	be	cop	4	SENT_284	[p19l1443t1981r1603b2033],
4	greatest	JJS	O	greatest	_	0	SENT_284	[p19l1644t1971r1981b2054],
5	for	IN	O	for	_	0	SENT_284	[p19l2015t1954r2138b2032],
6	those	DT	O	those	prep_for	4	SENT_284	[p19l15t2081r241b2159],
7	with	IN	O	with	_	0	SENT_284	[p19l267t2081r455b2160],
8	APOE	NN	ORGANIZATION	apoe	prep_with	6	SENT_284	[p19l478t2087r696b2159],
9	62	CD	NUMBER	62	num	8	SENT_284	[p19l726t2088r844b2176],
10	,	,	O	,	_	0	SENT_284	[p19l726t2088r844b2176],
11	followed	VBN	O	follow	partmod	6	SENT_284	[p19l879t2081r1246b2160],
12	by	IN	O	by	_	0	SENT_284	[p19l1276t2082r1373b2181],
13	APOE	NNP	ORGANIZATION	APOE	agent	11	SENT_284	[p19l1391t2087r1610b2159],
14	63	CD	NUMBER	63	num	13	SENT_284	[p19l1638t2088r1728b2159],
15	and	CC	O	and	cc	4	SENT_284	[p19l1762t2082r1918b2159],
16	then	RB	O	then	advmod	4	SENT_284	[p19l1948t2082r2134b2159],
17	APOE	NNP	ORGANIZATION	APOE	tmod	4	SENT_284	[p19l7t2215r226b2288],
18	64	CD	NUMBER	64	num	17	SENT_284	[p19l258t2217r376b2287],
19	.	.	O	.	_	0	SENT_284	[p19l258t2217r376b2287],

1	This	DT	O	this	det	2	SENT_285	[p19l412t2209r597b2288],
2	result	NN	O	result	nsubjpass	4	SENT_285	[p19l633t2210r873b2289],
3	was	VBD	O	be	auxpass	4	SENT_285	[p19l897t2236r1058b2289],
4	observed	VBN	O	observe	_	0	SENT_285	[p19l1094t2210r1469b2289],
5	after	IN	O	after	_	0	SENT_285	[p19l1502t2209r1695b2288],
6	treatment	NN	O	treatment	prep_after	4	SENT_285	[p19l1726t2226r2140b2288],
7	with	IN	O	with	_	0	SENT_285	[p19l9t2337r202b2415],
8	a	DT	O	a	det	10	SENT_285	[p19l232t2363r277b2414],
9	diverse	JJ	O	diverse	amod	10	SENT_285	[p19l308t2336r607b2415],
10	range	NN	O	range	prep_with	4	SENT_285	[p19l639t2362r880b2436],
11	of	IN	O	of	_	0	SENT_285	[p19l913t2336r1014b2414],
12	lipid	NN	O	lipid	nn	13	SENT_285	[p19l1027t2336r1647b2436],
13	—	NN	O	—	prep_of	10	SENT_285	[p19l1027t2336r1647b2436],
14	lowering	VBG	O	lower	xcomp	4	SENT_285	[p19l1027t2336r1647b2436],
15	agents	NNS	O	agent	dobj	14	SENT_285	[p19l1675t2353r1979b2436],
16	,	,	O	,	_	0	SENT_285	[p19l1675t2353r1979b2436],
17	including	VBG	O	include	_	0	SENT_285	[p19l2016t2337r2133b2413, p19l15t2464r341b2563],
18	probucol	NN	O	probucol	prep_including	4	SENT_285	[p19l361t2464r766b2563],
19	,	,	O	,	_	0	SENT_285	[p19l361t2464r766b2563],
20	gemﬁbrozil	NN	O	gemﬁbrozil	appos	18	SENT_285	[p19l795t2463r1312b2563],
21	,	,	O	,	_	0	SENT_285	[p19l795t2463r1312b2563],
22	and	CC	O	and	_	0	SENT_285	[p19l1340t2464r1496b2541],
23	many	JJ	O	many	amod	30	SENT_285	[p19l1520t2489r1754b2563],
24	different	JJ	O	different	amod	30	SENT_285	[p19l1774t2463r2140b2541],
25	3	CD	NUMBER	3	number	26	SENT_285	[p19l15t2591r1590b2690],
26	—	CD	NUMBER	—	dep	24	SENT_285	[p19l15t2591r1590b2690],
27	hydroXy	NN	O	hydroxy	nn	30	SENT_285	[p19l15t2591r1590b2690],
28	—	CD	NUMBER	—	number	29	SENT_285	[p19l15t2591r1590b2690],
29	3	CD	NUMBER	3	num	30	SENT_285	[p19l15t2591r1590b2690],
30	—	NN	O	—	nsubj	64	SENT_285	[p19l15t2591r1590b2690],
31	methylglutaryl	NN	O	methylglutaryl	nn	34	SENT_285	[p19l15t2591r1590b2690],
32	—	NN	O	—	nn	34	SENT_285	[p19l15t2591r1590b2690],
33	coenzyme	NN	O	coenzyme	nn	34	SENT_285	[p19l15t2591r1590b2690],
34	A	NN	O	a	nsubjpass	60	SENT_285	[p19l1608t2598r1674b2667],
35	—	CD	NUMBER	—	num	37	SENT_285	[p19l1688t2590r2135b2669],
36	reductase	NN	O	reductase	nn	37	SENT_285	[p19l1688t2590r2135b2669],
37	inhibitors	NNS	O	inhibitor	nsubj	40	SENT_285	[p19l13t2718r436b2795],
38	(	CD	NUMBER	(	num	39	SENT_285	[p19l475t2718r917b2808],
39	statins	NNS	O	statin	dep	37	SENT_285	[p19l475t2718r917b2808],
40	)	VBP	O	)	rcmod	34	SENT_285	[p19l475t2718r917b2808],
41	.33	CD	NUMBER	.33	dobj	40	SENT_285	[p19l475t2718r917b2808],
42	However	RB	O	however	advmod	40	SENT_285	[p19l949t2725r1334b2812],
43	,	,	O	,	_	0	SENT_285	[p19l949t2725r1334b2812],
44	a	DT	O	a	det	48	SENT_285	[p19l1370t2744r1414b2795],
45	signiﬁcant	JJ	O	signiﬁcant	amod	48	SENT_285	[p19l1444t2717r1885b2817],
46	effect	NN	O	effect	nn	48	SENT_285	[p19l1912t2717r2140b2795],
47	ofAPOE	NN	O	ofapoe	nn	48	SENT_285	[p19l15t2844r330b2922],
48	genotype	NN	O	genotype	dobj	40	SENT_285	[p19l351t2861r731b2944],
49	on	IN	O	on	_	0	SENT_285	[p19l754t2870r860b2922],
50	the	DT	O	the	det	51	SENT_285	[p19l881t2844r1010b2922],
51	response	NN	O	response	prep_on	48	SENT_285	[p19l1031t2870r1410b2944],
52	to	TO	O	to	_	0	SENT_285	[p19l1432t2861r1510b2922],
53	lipid	NN	O	lipid	nn	54	SENT_285	[p19l1532t2844r2138b2944],
54	—	NN	O	—	prep_to	40	SENT_285	[p19l1532t2844r2138b2944],
55	lowering	VBG	O	lower	partmod	54	SENT_285	[p19l1532t2844r2138b2944],
56	agents	NNS	O	agent	dobj	55	SENT_285	[p19l13t2988r285b3071],
57	has	VBZ	O	have	aux	60	SENT_285	[p19l313t2971r454b3049],
58	not	RB	O	not	neg	60	SENT_285	[p19l481t2988r624b3049],
59	been	VBN	O	be	auxpass	60	SENT_285	[p19l644t2972r843b3049],
60	observed	VBN	O	observe	rcmod	30	SENT_285	[p19l869t2972r1244b3050],
61	in	IN	O	in	_	0	SENT_285	[p19l1268t2972r1349b3048],
62	all	DT	O	all	det	63	SENT_285	[p19l1373t2972r1472b3049],
63	studies	NNS	O	study	prep_in	60	SENT_285	[p19l1498t2972r1901b3050],
64	.33	VBP	NUMBER	.33	conj_and	4	SENT_285	[p19l1498t2972r1901b3050],

1	In	IN	O	in	_	0	SENT_286	[p19l141t3106r228b3175],
2	addition	NN	O	addition	prep_in	73	SENT_286	[p19l250t3099r625b3193],
3	,	,	O	,	_	0	SENT_286	[p19l250t3099r625b3193],
4	although	IN	O	although	mark	9	SENT_286	[p19l653t3098r1034b3198],
5	the	DT	O	the	det	7	SENT_286	[p19l1057t3099r1186b3176],
6	APOE4	NN	O	apoe4	nn	7	SENT_286	[p19l1202t3104r1472b3176],
7	allele	NN	O	allele	nsubjpass	9	SENT_286	[p19l1495t3098r1712b3176],
8	was	VBD	O	be	auxpass	9	SENT_286	[p19l1731t3125r1892b3177],
9	associated	VBN	O	associate	dep	73	SENT_286	[p19l1916t3124r2133b3176, p19l15t3226r261b3303],
10	with	IN	O	with	_	0	SENT_286	[p19l288t3226r476b3305],
11	less	JJR	O	less	amod	12	SENT_286	[p19l507t3226r661b3303],
12	reduction	NN	O	reduction	prep_with	9	SENT_286	[p19l695t3226r1098b3304],
13	in	IN	O	in	_	0	SENT_286	[p19l1129t3226r1209b3302],
14	total	JJ	O	total	amod	20	SENT_286	[p19l1241t3226r1431b3303],
15	and	CC	O	and	_	0	SENT_286	[p19l1460t3226r1616b3303],
16	low	JJ	O	low	amod	20	SENT_286	[p19l1645t3225r2139b3325],
17	—	NN	O	—	nn	20	SENT_286	[p19l1645t3225r2139b3325],
18	density	NN	O	density	nn	20	SENT_286	[p19l1645t3225r2139b3325],
19	lipoprotein	NN	O	lipoprotein	nn	20	SENT_286	[p19l13t3353r495b3452],
20	cholesterol	NN	O	cholesterol	prep_in	12	SENT_286	[p19l531t3352r1008b3430],
21	and	CC	O	and	_	0	SENT_286	[p19l1041t3352r1200b3430],
22	a	DT	O	a	det	24	SENT_286	[p19l1234t3379r1278b3430],
23	smaller	JJR	O	smaller	amod	24	SENT_286	[p19l1313t3352r1633b3430],
24	increase	NN	O	increase	prep_with	9	SENT_286	[p19l1665t3353r2017b3430],
25	in	IN	O	in	_	0	SENT_286	[p19l2052t3353r2134b3429],
26	high	JJ	O	high	amod	30	SENT_286	[p19l14t3479r548b3579],
27	—	NN	O	—	nn	30	SENT_286	[p19l14t3479r548b3579],
28	density	NN	O	density	nn	30	SENT_286	[p19l14t3479r548b3579],
29	lipoprotein	NN	O	lipoprotein	nn	30	SENT_286	[p19l569t3480r1041b3579],
30	cholesterol	NN	O	cholesterol	prep_in	24	SENT_286	[p19l1068t3479r1534b3557],
31	after	IN	O	after	_	0	SENT_286	[p19l1559t3479r1752b3557],
32	ﬂuvasta	NN	O	ﬂuvasta	nn	35	SENT_286	[p19l1776t3479r2134b3558],
33	—	CD	NUMBER	—	num	35	SENT_286	[p19l1776t3479r2134b3558],
34	tin	NN	O	tin	nn	35	SENT_286	[p19l15t3607r125b3684],
35	therapy	NN	O	therapy	prep_after	9	SENT_286	[p19l176t3607r504b3706],
36	,	,	O	,	_	0	SENT_286	[p19l176t3607r504b3706],
37	there	EX	O	there	expl	38	SENT_286	[p19l561t3607r772b3684],
38	was	VBD	O	be	parataxis	73	SENT_286	[p19l818t3633r979b3685],
39	no	DT	O	no	det	41	SENT_286	[p19l1031t3632r1137b3684],
40	apparent	JJ	O	apparent	amod	41	SENT_286	[p19l1188t3623r1567b3706],
41	inﬂuence	NN	O	inﬂuence	nsubj	38	SENT_286	[p19l1611t3606r2001b3685],
42	of	IN	O	of	_	0	SENT_286	[p19l2053t3606r2153b3684],
43	genotype	NN	O	genotype	prep_of	41	SENT_286	[p20l13t37r396b120],
44	on	IN	O	on	_	0	SENT_286	[p20l419t46r525b98],
45	the	DT	O	the	det	46	SENT_286	[p20l547t21r676b98],
46	progression	NN	O	progression	prep_on	43	SENT_286	[p20l696t21r1204b120],
47	of	IN	O	of	_	0	SENT_286	[p20l1227t20r1326b98],
48	coronary	JJ	O	coronary	amod	50	SENT_286	[p20l1330t46r1705b120],
49	artery	NN	O	artery	nn	50	SENT_286	[p20l1721t37r1962b120],
50	disease	NN	O	disease	prep_of	46	SENT_286	[p20l1980t21r2134b98, p20l15t174r189b225],
51	or	CC	O	or	_	0	SENT_286	[p20l212t173r301b225],
52	the	DT	O	the	det	53	SENT_286	[p20l320t148r448b225],
53	incidence	NN	O	incidence	conj_or	46	SENT_286	[p20l469t148r867b225],
54	of	IN	O	of	_	0	SENT_286	[p20l890t147r990b225],
55	clinical	JJ	O	clinical	amod	56	SENT_286	[p20l994t148r1290b225],
56	events	NNS	O	event	prep_of	53	SENT_286	[p20l1312t153r1678b226],
57	.88	CD	NUMBER	.88	npadvmod	58	SENT_286	[p20l1312t153r1678b226],
58	Thus	RB	O	thus	advmod	43	SENT_286	[p20l1697t148r1933b242],
59	,	,	O	,	_	0	SENT_286	[p20l1697t148r1933b242],
60	prospective	JJ	O	prospective	amod	62	SENT_286	[p20l1958t173r2134b247, p20l16t275r342b374],
61	clinical	JJ	O	clinical	amod	62	SENT_286	[p20l365t275r661b352],
62	evaluations	NNS	O	evaluation	nsubjpass	73	SENT_286	[p20l682t275r1148b353],
63	with	IN	O	with	_	0	SENT_286	[p20l1167t274r1355b353],
64	robust	JJ	O	robust	amod	67	SENT_286	[p20l1375t275r1649b353],
65	clinical	JJ	O	clinical	amod	67	SENT_286	[p20l1666t274r1963b352],
66	end	NN	O	end	nn	67	SENT_286	[p20l1984t274r2135b352],
67	points	NNS	O	point	prep_with	62	SENT_286	[p20l12t402r277b501],
68	and	CC	O	and	_	0	SENT_286	[p20l320t402r476b479],
69	sufficient	JJ	O	sufficient	amod	71	SENT_286	[p20l519t401r917b480],
70	sample	NN	O	sample	nn	71	SENT_286	[p20l956t402r1256b501],
71	sizes	NNS	O	size	conj_and	67	SENT_286	[p20l1300t402r1500b479],
72	are	VBP	O	be	auxpass	73	SENT_286	[p20l1544t428r1669b479],
73	needed	VBN	O	need	_	0	SENT_286	[p20l1711t401r2012b479],
74	to	TO	O	to	aux	75	SENT_286	[p20l2055t418r2134b479],
75	deﬁne	VB	O	deﬁne	xcomp	73	SENT_286	[p20l15t528r274b606],
76	better	JJR	O	better	amod	78	SENT_286	[p20l309t529r553b606],
77	the	DT	O	the	det	78	SENT_286	[p20l584t529r713b606],
78	usefulness	NN	O	usefulness	dobj	75	SENT_286	[p20l748t528r1191b607],
79	of	IN	O	of	_	0	SENT_286	[p20l1228t528r1328b606],
80	the	DT	O	the	det	82	SENT_286	[p20l1344t529r1473b606],
81	APOE	NNP	ORGANIZATION	APOE	nn	82	SENT_286	[p20l1500t534r1718b606],
82	genotype	NN	O	genotype	prep_of	78	SENT_286	[p20l1751t545r2134b628],
83	in	IN	O	in	_	0	SENT_286	[p20l13t656r94b732],
84	selecting	VBG	O	select	prepc_in	75	SENT_286	[p20l138t656r513b755],
85	the	DT	O	the	det	86	SENT_286	[p20l553t656r682b733],
86	treatment	NN	O	treatment	dobj	84	SENT_286	[p20l725t672r1139b733],
87	of	IN	O	of	_	0	SENT_286	[p20l1177t655r1277b733],
88	hyperlipidemia	NN	O	hyperlipidemia	nn	91	SENT_286	[p20l1301t656r1939b755],
89	and	CC	O	and	_	0	SENT_286	[p20l1979t656r2135b733],
90	cardiovascular	JJ	O	cardiovascular	conj_and	88	SENT_286	[p20l15t782r623b861],
91	disease	NN	O	disease	prep_of	86	SENT_286	[p20l646t782r972b860],
92	.	.	O	.	_	0	SENT_286	[p20l646t782r972b860],

1	The	DT	O	the	det	3	SENT_287	[p20l999t783r1160b860],
2	potential	JJ	O	potential	amod	3	SENT_287	[p20l1183t783r1559b882],
3	usefulness	NN	O	usefulness	nsubjpass	14	SENT_287	[p20l1583t782r2026b861],
4	of	IN	O	of	_	0	SENT_287	[p20l2053t782r2153b860],
5	the	DT	O	the	det	7	SENT_287	[p20l11t911r138b989],
6	APOE	NNP	ORGANIZATION	APOE	nn	7	SENT_287	[p20l153t916r370b989],
7	genotype	NN	O	genotype	prep_of	3	SENT_287	[p20l390t927r767b1011],
8	in	IN	O	in	_	0	SENT_287	[p20l789t911r869b988],
9	predicting	VBG	O	predict	prepc_in	7	SENT_287	[p20l889t910r1319b1011],
10	treatment	NN	O	treatment	nn	11	SENT_287	[p20l1338t927r1745b989],
11	response	NN	O	response	dobj	9	SENT_287	[p20l1762t936r2135b1011],
12	must	MD	O	must	aux	14	SENT_287	[p20l10t1055r227b1118],
13	be	VB	O	be	auxpass	14	SENT_287	[p20l260t1039r356b1117],
14	balanced	VBN	O	balance	_	0	SENT_287	[p20l393t1038r769b1117],
15	by	IN	O	by	_	0	SENT_287	[p20l807t1039r904b1139],
16	the	DT	O	the	det	17	SENT_287	[p20l936t1039r1065b1117],
17	concern	NN	O	concern	agent	14	SENT_287	[p20l1104t1064r1441b1117],
18	that	IN	O	that	complm	22	SENT_287	[p20l1478t1039r1645b1117],
19	it	PRP	O	it	nsubjpass	22	SENT_287	[p20l1676t1039r1736b1117],
20	could	MD	O	could	aux	22	SENT_287	[p20l1769t1038r2001b1118],
21	be	VB	O	be	auxpass	22	SENT_287	[p20l2039t1039r2135b1117],
22	used	VBN	O	use	ccomp	14	SENT_287	[p20l10t1166r205b1246],
23	by	IN	O	by	_	0	SENT_287	[p20l232t1166r329b1267],
24	insurance	NN	O	insurance	nn	25	SENT_287	[p20l350t1167r762b1246],
25	companies	NNS	O	company	agent	22	SENT_287	[p20l789t1167r1272b1267],
26	,	,	O	,	_	0	SENT_287	[p20l789t1167r1272b1267],
27	health	NN	O	health	nn	28	SENT_287	[p20l1303t1166r1566b1245],
28	systems	NNS	O	system	conj_and	25	SENT_287	[p20l1593t1183r1948b1267],
29	,	,	O	,	_	0	SENT_287	[p20l1593t1183r1948b1267],
30	and	CC	O	and	_	0	SENT_287	[p20l1979t1167r2135b1245],
31	others	NNS	O	other	conj_and	25	SENT_287	[p20l11t1295r273b1373],
32	to	TO	O	to	aux	33	SENT_287	[p20l299t1311r378b1373],
33	identify	VB	O	identify	xcomp	22	SENT_287	[p20l402t1294r723b1395],
34	those	DT	O	those	dobj	33	SENT_287	[p20l742t1294r969b1373],
35	at	IN	O	at	_	0	SENT_287	[p20l991t1311r1071b1373],
36	high	JJ	O	high	amod	37	SENT_287	[p20l1088t1295r1281b1395],
37	risk	NN	O	risk	prep_at	34	SENT_287	[p20l1304t1295r1465b1374],
38	for	IN	O	for	_	0	SENT_287	[p20l1483t1294r1607b1373],
39	Alzheimer	NN	O	alzheimer	poss	41	SENT_287	[p20l1623t1295r2132b1373],
40	’s	POS	O	’s	_	0	SENT_287	[p20l1623t1295r2132b1373],
41	disease	NN	O	disease	prep_for	33	SENT_287	[p20l11t1423r338b1518],
42	,	,	O	,	_	0	SENT_287	[p20l11t1423r338b1518],
43	coronary	JJ	O	coronary	amod	45	SENT_287	[p20l366t1448r740b1523],
44	artery	NN	O	artery	nn	45	SENT_287	[p20l757t1439r998b1523],
45	disease	NN	O	disease	conj_and	41	SENT_287	[p20l1016t1423r1343b1518],
46	,	,	O	,	_	0	SENT_287	[p20l1016t1423r1343b1518],
47	and	CC	O	and	_	0	SENT_287	[p20l1368t1423r1525b1501],
48	possibly	RB	O	possibly	advmod	50	SENT_287	[p20l1544t1423r1896b1523],
49	other	JJ	O	other	amod	50	SENT_287	[p20l1914t1423r2137b1501],
50	illnesses	NNS	O	illness	conj_and	41	SENT_287	[p20l10t1552r479b1630],
51	.82	CD	NUMBER	.82	dep	50	SENT_287	[p20l10t1552r479b1630],

1	MOLECULAR	NNP	O	MOLECULAR	nn	2	SENT_288	[p20l33t1887r729b1946],
2	DIAGNOSTIC	NNP	O	DIAGNOSTIC	_	0	SENT_288	[p20l774t1887r1491b1946],
3	METHODS	NNS	O	method	dep	2	SENT_288	[p20l1540t1887r2090b1946],

1	FOR	IN	O	for	_	0	SENT_289	[p20l112t1992r330b2051],
2	OPTIMIZING	VBG	O	optimize	pcomp	1	SENT_289	[p20l376t1992r1097b2051],
3	DRUG	NN	O	drug	nn	4	SENT_289	[p20l1150t1992r1467b2051],
4	THERAPY	NN	O	therapy	dobj	2	SENT_289	[p20l1514t1992r2028b2051],

1	The	DT	O	the	det	2	SENT_290	[p20l7t2224r168b2303],
2	potential	NN	O	potential	nsubj	4	SENT_290	[p20l194t2224r570b2325],
3	is	VBZ	O	be	cop	4	SENT_290	[p20l595t2225r660b2303],
4	enormous	JJ	O	enormous	_	0	SENT_290	[p20l690t2250r1117b2304],
5	for	IN	O	for	_	0	SENT_290	[p20l1145t2224r1269b2303],
6	pharmacogenomics	NNS	O	pharmacogenomic	prep_for	4	SENT_290	[p20l1291t2225r2132b2325],
7	to	TO	O	to	aux	8	SENT_290	[p20l11t2369r90b2431],
8	yield	VB	O	yield	xcomp	4	SENT_290	[p20l139t2352r339b2453],
9	a	DT	O	a	det	11	SENT_290	[p20l390t2379r435b2431],
10	powerful	JJ	O	powerful	amod	11	SENT_290	[p20l484t2352r864b2453],
11	set	NN	O	set	dobj	8	SENT_290	[p20l918t2369r1037b2431],
12	of	IN	O	of	_	0	SENT_290	[p20l1086t2352r1186b2431],
13	molecular	JJ	O	molecular	amod	15	SENT_290	[p20l1220t2353r1646b2432],
14	diagnostic	JJ	O	diagnostic	amod	15	SENT_290	[p20l1696t2353r2135b2453],
15	methods	NNS	O	method	prep_of	11	SENT_290	[p20l10t2481r378b2559],
16	that	WDT	O	that	nsubj	20	SENT_290	[p20l404t2481r570b2559],
17	will	MD	O	will	aux	20	SENT_290	[p20l584t2481r740b2560],
18	become	VB	O	become	cop	20	SENT_290	[p20l763t2481r1091b2559],
19	routine	JJ	O	routine	amod	20	SENT_290	[p20l1114t2481r1419b2560],
20	tools	NNS	O	tool	rcmod	11	SENT_290	[p20l1442t2480r1646b2559],
21	with	IN	O	with	_	0	SENT_290	[p20l1667t2481r1856b2560],
22	which	WDT	O	which	dobj	25	SENT_290	[p20l1874t2481r2135b2560],
23	clinicians	NNS	O	clinician	nsubj	25	SENT_290	[p20l11t2609r410b2687],
24	will	MD	O	will	aux	25	SENT_290	[p20l446t2608r602b2688],
25	select	VB	O	select	prepc_with	20	SENT_290	[p20l642t2609r880b2687],
26	medications	NNS	O	medication	dobj	25	SENT_290	[p20l913t2609r1429b2687],
27	and	CC	O	and	_	0	SENT_290	[p20l1469t2609r1624b2687],
28	drug	NN	O	drug	nn	29	SENT_290	[p20l1662t2609r1862b2709],
29	doses	NNS	O	dose	dobj	25	SENT_290	[p20l1898t2609r2132b2687],
30	for	IN	O	for	_	0	SENT_290	[p20l10t2736r133b2815],
31	individual	JJ	O	individual	amod	32	SENT_290	[p20l158t2736r579b2816],
32	patients	NNS	O	patient	prep_for	25	SENT_290	[p20l606t2737r966b2837],
33	.	.	O	.	_	0	SENT_290	[p20l606t2737r966b2837],

1	A	DT	O	a	det	2	SENT_291	[p20l996t2744r1062b2814],
2	patient	NN	O	patient	poss	4	SENT_291	[p20l1086t2737r1449b2837],
3	’s	POS	O	’s	_	0	SENT_291	[p20l1086t2737r1449b2837],
4	genotype	NN	O	genotype	nsubj	5	SENT_291	[p20l1479t2753r1863b2837],
5	needs	VBZ	O	need	_	0	SENT_291	[p20l1891t2736r2132b2815],
6	to	TO	O	to	aux	8	SENT_291	[p20l11t2881r90b2943],
7	be	VB	O	be	auxpass	8	SENT_291	[p20l118t2865r214b2943],
8	determined	VBN	O	determine	xcomp	5	SENT_291	[p20l242t2865r726b2943],
9	only	RB	O	only	advmod	10	SENT_291	[p20l754t2865r935b2965],
10	once	RB	DATE	once	advmod	8	SENT_291	[p20l958t2890r1155b2943],
11	for	IN	O	for	_	0	SENT_291	[p20l1182t2864r1305b2943],
12	any	DT	O	any	det	14	SENT_291	[p20l1328t2890r1477b2965],
13	given	VBN	O	give	amod	14	SENT_291	[p20l1498t2865r1722b2965],
14	gene	NN	O	gene	prep_for	8	SENT_291	[p20l1749t2890r1971b2965],
15	,	,	O	,	_	0	SENT_291	[p20l1749t2890r1971b2965],
16	because	IN	O	because	mark	26	SENT_291	[p20l2004t2865r2133b2943, p20l11t3019r239b3072],
17	except	IN	O	except	_	0	SENT_291	[p20l263t3009r531b3093],
18	for	IN	O	for	prepc_except_for	26	SENT_291	[p20l549t2992r671b3071],
19	rare	JJ	O	rare	amod	21	SENT_291	[p20l691t3019r851b3071],
20	somatic	JJ	O	somatic	amod	21	SENT_291	[p20l877t2993r1204b3071],
21	mutations	NNS	O	mutation	pobj	26	SENT_291	[p20l1226t2993r1677b3088],
22	,	,	O	,	_	0	SENT_291	[p20l1226t2993r1677b3088],
23	it	PRP	O	it	nsubj	26	SENT_291	[p20l1705t2993r1765b3071],
24	does	VBZ	O	do	aux	26	SENT_291	[p20l1783t2993r1973b3071],
25	not	RB	O	not	neg	26	SENT_291	[p20l1998t3009r2140b3071],
26	change	VB	O	change	advcl	5	SENT_291	[p20l11t3121r331b3221],
27	.	.	O	.	_	0	SENT_291	[p20l11t3121r331b3221],

1	Genotyping	VBG	O	genotype	amod	2	SENT_292	[p20l358t3121r851b3221],
2	methods	NNS	O	method	nsubj	4	SENT_292	[p20l869t3120r1232b3199],
3	are	VBP	O	be	aux	4	SENT_292	[p20l1255t3147r1379b3199],
4	improving	VBG	O	improve	_	0	SENT_292	[p20l1400t3121r1837b3221],
5	so	RB	O	so	advmod	6	SENT_292	[p20l1856t3146r1945b3199],
6	rapidly	RB	O	rapidly	advmod	4	SENT_292	[p20l1968t3147r2134b3221, p20l10t3249r162b3349],
7	that	IN	O	that	dep	12	SENT_292	[p20l181t3248r347b3327],
8	it	PRP	O	it	nsubj	12	SENT_292	[p20l365t3249r424b3327],
9	will	MD	O	will	aux	12	SENT_292	[p20l439t3249r596b3328],
10	soon	RB	O	soon	advmod	12	SENT_292	[p20l620t3274r824b3327],
11	be	VB	O	be	cop	12	SENT_292	[p20l848t3249r944b3327],
12	simple	JJ	O	simple	ccomp	6	SENT_292	[p20l970t3249r1251b3349],
13	to	TO	O	to	aux	14	SENT_292	[p20l1276t3265r1355b3327],
14	test	VB	O	test	xcomp	12	SENT_292	[p20l1381t3265r1532b3327],
15	for	IN	O	for	_	0	SENT_292	[p20l1551t3248r1674b3327],
16	thousands	NNS	O	thousand	prep_for	14	SENT_292	[p20l1696t3248r2132b3328],
17	of	IN	O	of	_	0	SENT_292	[p20l11t3376r112b3455],
18	single	JJ	O	single	amod	21	SENT_292	[p20l127t3376r858b3477],
19	—	NN	O	—	nn	21	SENT_292	[p20l127t3376r858b3477],
20	nucleotide	NN	O	nucleotide	nn	21	SENT_292	[p20l127t3376r858b3477],
21	polymorphisms	NNS	O	polymorphism	prep_of	16	SENT_292	[p20l890t3377r1560b3477],
22	in	IN	O	in	_	0	SENT_292	[p20l1594t3377r1675b3454],
23	one	CD	NUMBER	one	num	24	SENT_292	[p20l1709t3402r1861b3455],
24	assay	NN	O	assay	prep_in	14	SENT_292	[p20l1893t3403r2129b3477],
25	.	.	O	.	_	0	SENT_292	[p20l1893t3403r2129b3477],

1	It	PRP	O	it	nsubj	4	SENT_293	[p20l9t3512r75b3583],
2	may	MD	O	may	aux	4	SENT_293	[p20l98t3531r275b3605],
3	be	VB	O	be	cop	4	SENT_293	[p20l299t3504r394b3583],
4	possible	JJ	O	possible	_	0	SENT_293	[p20l421t3505r772b3605],
5	to	TO	O	to	aux	6	SENT_293	[p20l801t3521r880b3583],
6	collect	VB	O	collect	xcomp	4	SENT_293	[p20l910t3504r1187b3583],
7	a	DT	O	a	det	10	SENT_293	[p20l1210t3531r1255b3583],
8	single	JJ	O	single	amod	10	SENT_293	[p20l1283t3505r1532b3605],
9	blood	NN	O	blood	nn	10	SENT_293	[p20l1562t3504r1804b3583],
10	sample	NN	O	sample	dobj	6	SENT_293	[p20l1834t3505r2135b3605],
11	from	IN	O	from	_	0	SENT_293	[p20l10t3632r216b3711],
12	a	DT	O	a	det	13	SENT_293	[p20l235t3659r280b3711],
13	patient	NN	O	patient	prep_from	6	SENT_293	[p20l296t3633r610b3733],
14	,	,	O	,	_	0	SENT_293	[p20l296t3633r610b3733],
15	submit	VB	O	submit	dep	6	SENT_293	[p20l637t3633r932b3712],
16	a	DT	O	a	det	18	SENT_293	[p20l946t3659r991b3711],
17	small	JJ	O	small	amod	18	SENT_293	[p20l1011t3633r1236b3711],
18	aliquot	NN	O	aliquot	dobj	15	SENT_293	[p20l1255t3632r1551b3733],
19	for	IN	O	for	_	0	SENT_293	[p20l1566t3632r1688b3711],
20	analysis	NN	O	analysis	prep_for	15	SENT_293	[p20l1705t3633r2031b3733],
21	of	IN	O	of	_	0	SENT_293	[p20l2054t3632r2154b3711],
22	a	DT	O	a	det	23	SENT_293	[p21l10t47r54b99],
23	panel	NN	O	panel	prep_of	20	SENT_293	[p21l72t21r302b121],
24	of	IN	O	of	_	0	SENT_293	[p21l323t20r423b99],
25	genotypes	NNS	O	genotype	prep_of	23	SENT_293	[p21l425t37r846b121],
26	(	CD	NUMBER	(	num	28	SENT_293	[p21l874t28r967b112],
27	e.	NN	O	e.	nn	28	SENT_293	[p21l874t28r967b112],
28	g.	NN	O	g.	dep	25	SENT_293	[p21l976t47r1077b121],
29	,	,	O	,	_	0	SENT_293	[p21l976t47r1077b121],
30	20,000	CD	NUMBER	20,000	num	34	SENT_293	[p21l1104t26r1389b116],
31	single	JJ	O	single	amod	34	SENT_293	[p21l1413t20r2135b121],
32	—	NN	O	—	nn	34	SENT_293	[p21l1413t20r2135b121],
33	nucleotide	NN	O	nucleotide	nn	34	SENT_293	[p21l1413t20r2135b121],
34	polymorphisms	NNS	O	polymorphism	dobj	6	SENT_293	[p21l9t148r678b249],
35	in	IN	O	in	_	0	SENT_293	[p21l710t149r792b226],
36	5000	CD	DATE	5000	num	37	SENT_293	[p21l824t154r1028b227],
37	genes	NNS	O	gene	prep_in	34	SENT_293	[p21l1059t156r1359b249],
38	)	RB	O	)	advmod	4	SENT_293	[p21l1059t156r1359b249],
39	,	,	O	,	_	0	SENT_293	[p21l1059t156r1359b249],
40	and	CC	O	and	_	0	SENT_293	[p21l1394t149r1550b227],
41	test	NN	O	test	conj_and	4	SENT_293	[p21l1580t165r1732b227],
42	for	IN	O	for	_	0	SENT_293	[p21l1757t148r1879b227],
43	those	DT	O	those	prep_for	41	SENT_293	[p21l1907t148r2135b227],
44	that	WDT	O	that	nsubj	47	SENT_293	[p21l11t276r174b355],
45	are	VBP	O	be	cop	47	SENT_293	[p21l191t303r315b355],
46	important	JJ	O	important	amod	47	SENT_293	[p21l336t277r761b377],
47	determinants	NNS	O	determinant	rcmod	43	SENT_293	[p21l780t277r1327b355],
48	of	IN	O	of	_	0	SENT_293	[p21l1353t276r1452b355],
49	drug	NN	O	drug	nn	50	SENT_293	[p21l1457t277r1653b377],
50	disposition	NN	O	disposition	prep_of	47	SENT_293	[p21l1673t276r2136b377],

1	546	CD	NUMBER	546	num	4	SENT_294	[p21l149t456r205b479],
2	N	NN	O	n	nn	4	SENT_294	[p21l884t458r898b474],
3	ENGLJ	NN	O	englj	nn	4	SENT_294	[p21l913t458r997b480],
4	MED	NN	O	med	_	0	SENT_294	[p21l1012t458r1065b473],
5	348	CD	NUMBER	348	dep	4	SENT_294	[p21l1077t452r1148b480],
6	;	:	O	;	_	0	SENT_294	[p21l1077t452r1148b480],
7	6	CD	NUMBER	6	num	8	SENT_294	[p21l1077t452r1148b480],
8	WWW	NN	O	www	dep	4	SENT_294	[p21l1183t458r1295b474],
9	.	.	O	.	_	0	SENT_294	[p21l1183t458r1295b474],

1	NE	NN	O	ne	nn	3	SENT_295	[p21l1183t458r1295b474],
2	M.ORG	NN	O	m.org	nn	3	SENT_295	[p21l1311t458r1394b474],
3	FEBRUARY	NN	DATE	february	_	0	SENT_295	[p21l1434t458r1561b474],
4	6	CD	DATE	6	dep	3	SENT_295	[p21l1574t452r1595b478],
5	,	,	DATE	,	_	0	SENT_295	[p21l1574t452r1595b478],
6	2003	CD	DATE	2003	appos	4	SENT_295	[p21l1608t458r1672b480],

1	The	DT	O	the	det	5	SENT_296	[p21l935t491r986b515],
2	New	NNP	O	New	nn	5	SENT_296	[p21l995t492r1057b515],
3	England	NNP	O	England	nn	5	SENT_296	[p21l1066t491r1177b522],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_296	[p21l1186t492r1275b515],
5	o	NN	O	o	_	0	SENT_296	[p21l1293t499r1308b515],
6	Medicine	NN	O	medicine	dep	5	SENT_296	[p21l1329t491r1454b515],

1	Downloaded	VBN	O	download	_	0	SENT_297	[p21l377t532r547b555],
2	from	IN	O	from	_	0	SENT_297	[p21l556t532r620b555],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_297	[p21l629t532r747b562],
4	at	IN	O	at	_	0	SENT_297	[p21l758t536r781b555],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_297	[p21l789t532r972b555],
6	on	IN	O	on	_	0	SENT_297	[p21l981t539r1014b555],
7	January	NNP	DATE	January	prep_on	1	SENT_297	[p21l1022t532r1125b562],
8	5	CD	DATE	5	num	7	SENT_297	[p21l1135t532r1158b559],
9	,	,	DATE	,	_	0	SENT_297	[p21l1135t532r1158b559],
10	2014	CD	DATE	2014	num	7	SENT_297	[p21l1169t532r1241b555],
11	.	.	O	.	_	0	SENT_297	[p21l1169t532r1241b555],

1	For	IN	O	for	_	0	SENT_298	[p21l1251t532r1298b555],
2	personal	JJ	O	personal	amod	3	SENT_298	[p21l1306t532r1418b562],
3	use	NN	O	use	pobj	1	SENT_298	[p21l1427t539r1471b555],
4	only	RB	O	only	advmod	3	SENT_298	[p21l1481t532r1545b562],
5	.	.	O	.	_	0	SENT_298	[p21l1481t532r1545b562],

1	No	DT	O	no	det	3	SENT_299	[p21l1556t532r1596b555],
2	other	JJ	O	other	amod	3	SENT_299	[p21l1606t532r1674b555],
3	uses	NNS	O	use	_	0	SENT_299	[p21l1682t539r1738b555],
4	without	IN	O	without	_	0	SENT_299	[p21l1748t532r1849b555],
5	permission	NN	O	permission	prep_without	3	SENT_299	[p21l1858t532r2010b562],
6	.	.	O	.	_	0	SENT_299	[p21l1858t532r2010b562],

1	Copyright	NN	O	copyright	_	0	SENT_300	[p21l727t573r862b604],
2	©	CD	NUMBER	©	num	6	SENT_300	[p21l871t573r895b597],
3	2003	CD	DATE	2003	num	6	SENT_300	[p21l905t573r969b597],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_300	[p21l979t573r1170b597],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_300	[p21l1180t573r1288b597],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_300	[p21l1299t573r1404b604],
7	.	.	O	.	_	0	SENT_300	[p21l1299t573r1404b604],

1	All	DT	O	all	det	2	SENT_301	[p21l1415t573r1456b597],
2	rights	NNS	O	rights	nsubj	3	SENT_301	[p21l1465t573r1540b604],
3	reserved	VBN	O	reserve	_	0	SENT_301	[p21l1550t573r1669b597],
4	.	.	O	.	_	0	SENT_301	[p21l1550t573r1669b597],

1	DRUG	NN	O	drug	nn	2	SENT_302	[p21l950t679r1045b698],
2	THERAPY	NN	O	therapy	_	0	SENT_302	[p21l1057t679r1210b698],

1	and	CC	O	and	_	0	SENT_303	[p21l10t892r166b971],
2	effects	NNS	O	effect	dep	1	SENT_303	[p21l191t892r486b971],
3	.	.	O	.	_	0	SENT_303	[p21l191t892r486b971],

1	In	IN	O	in	_	0	SENT_304	[p21l515t900r602b970],
2	our	PRP$	O	we	poss	3	SENT_304	[p21l628t918r772b972],
3	opinion	NN	O	opinion	prep_in	12	SENT_304	[p21l794t893r1148b993],
4	,	,	O	,	_	0	SENT_304	[p21l794t893r1148b993],
5	genotyping	VBG	O	genotype	amod	6	SENT_304	[p21l1178t893r1659b993],
6	results	NNS	O	result	nsubj	12	SENT_304	[p21l1679t893r1957b972],
7	will	MD	O	will	aux	12	SENT_304	[p21l1979t892r2136b972],
8	be	VB	O	be	cop	12	SENT_304	[p21l11t1020r107b1099],
9	of	IN	O	of	amod	12	SENT_304	[p21l134t1020r234b1099],
10	greatest	JJS	O	greatest	amod	12	SENT_304	[p21l241t1037r578b1121],
11	clinical	JJ	O	clinical	amod	12	SENT_304	[p21l599t1020r900b1099],
12	value	NN	O	value	_	0	SENT_304	[p21l921t1020r1139b1100],
13	if	IN	O	if	mark	16	SENT_304	[p21l1164t1020r1239b1098],
14	they	PRP	O	they	nsubjpass	26	SENT_304	[p21l1247t1021r1423b1121],
15	are	VBP	O	be	auxpass	16	SENT_304	[p21l1444t1047r1570b1099],
16	reported	VBN	O	report	advcl	12	SENT_304	[p21l1595t1021r1954b1121],
17	and	CC	O	and	_	0	SENT_304	[p21l1980t1020r2135b1099],
18	interpreted	VBN	O	interpret	advcl	12	SENT_304	[p21l10t1148r472b1249],
19	according	VBG	O	accord	_	0	SENT_304	[p21l492t1148r911b1249],
20	to	TO	O	to	prepc_according_to	16	SENT_304	[p21l929t1165r1007b1227],
21	the	DT	O	the	det	22	SENT_304	[p21l1030t1149r1158b1227],
22	patient	NN	O	patient	poss	24	SENT_304	[p21l1178t1149r1536b1249],
23	’s	POS	O	’s	_	0	SENT_304	[p21l1178t1149r1536b1249],
24	diagnosis	NN	O	diagnosis	pobj	16	SENT_304	[p21l1560t1149r1958b1249],
25	and	CC	O	and	_	0	SENT_304	[p21l1981t1148r2136b1227],
26	recommended	VBD	O	recommend	advcl	12	SENT_304	[p21l11t1276r623b1355],
27	treatment	NN	O	treatment	nn	28	SENT_304	[p21l648t1293r1063b1355],
28	options	NNS	O	option	dobj	26	SENT_304	[p21l1083t1277r1426b1377],
29	.	.	O	.	_	0	SENT_304	[p21l1083t1277r1426b1377],

1	CHALLENGES	NNS	O	challenge	_	0	SENT_305	[p21l177t1592r922b1651],
2	FOR	IN	O	for	_	0	SENT_305	[p21l978t1592r1197b1651],
3	THE	DT	DATE	the	det	4	SENT_305	[p21l1238t1592r1460b1650],
4	FUTURE	NN	DATE	future	prep_for	1	SENT_305	[p21l1514t1592r1956b1651],

1	There	EX	O	there	expl	2	SENT_306	[p21l7t1787r252b1865],
2	are	VBP	O	be	_	0	SENT_306	[p21l284t1813r410b1865],
3	a	DT	O	a	det	4	SENT_306	[p21l442t1813r486b1865],
4	number	NN	O	number	nsubj	2	SENT_306	[p21l517t1786r853b1866],
5	of	IN	O	of	_	0	SENT_306	[p21l883t1786r984b1865],
6	critical	JJ	O	critical	amod	7	SENT_306	[p21l998t1786r1282b1865],
7	issues	NNS	O	issue	prep_of	4	SENT_306	[p21l1313t1787r1566b1866],
8	that	WDT	O	that	nsubjpass	11	SENT_306	[p21l1601t1787r1767b1865],
9	must	MD	O	must	aux	11	SENT_306	[p21l1794t1803r2011b1866],
10	be	VB	O	be	auxpass	11	SENT_306	[p21l2039t1786r2135b1865],
11	considered	VBN	O	consider	rcmod	4	SENT_306	[p21l11t1914r474b1993],
12	as	IN	O	as	mark	15	SENT_306	[p21l501t1941r585b1993],
13	strategies	NNS	O	strategy	nsubjpass	15	SENT_306	[p21l616t1915r1015b2015],
14	are	VBP	O	be	auxpass	15	SENT_306	[p21l1044t1941r1170b1993],
15	developed	VBN	O	develop	advcl	11	SENT_306	[p21l1199t1914r1623b2015],
16	to	TO	O	to	aux	17	SENT_306	[p21l1651t1931r1730b1993],
17	elucidate	VB	O	elucidate	xcomp	15	SENT_306	[p21l1759t1915r2135b1994],
18	the	DT	O	the	det	20	SENT_306	[p21l11t2043r140b2121],
19	inherited	VBN	O	inherit	amod	20	SENT_306	[p21l176t2042r558b2121],
20	determinants	NNS	O	determinant	dobj	17	SENT_306	[p21l596t2042r1156b2121],
21	of	IN	O	of	_	0	SENT_306	[p21l1195t2042r1295b2121],
22	drug	NN	O	drug	nn	23	SENT_306	[p21l1314t2043r1513b2143],
23	effects	NNS	O	effect	prep_of	20	SENT_306	[p21l1547t2042r1843b2121],
24	.	.	O	.	_	0	SENT_306	[p21l1547t2042r1843b2121],

1	A	DT	O	a	det	3	SENT_307	[p21l1881t2050r1947b2120],
2	formidable	JJ	O	formidable	amod	3	SENT_307	[p21l1981t2042r2134b2121, p21l11t2171r352b2249],
3	one	CD	NUMBER	one	nsubj	4	SENT_307	[p21l377t2196r529b2249],
4	is	VBZ	O	be	_	0	SENT_307	[p21l553t2171r618b2249],
5	that	IN	O	that	complm	18	SENT_307	[p21l644t2171r811b2249],
6	the	DT	O	the	det	8	SENT_307	[p21l831t2171r960b2249],
7	inherited	VBN	O	inherit	amod	8	SENT_307	[p21l984t2171r1366b2249],
8	component	NN	O	component	nsubj	18	SENT_307	[p21l1391t2187r1879b2271],
9	of	IN	O	of	_	0	SENT_307	[p21l1900t2170r1999b2249],
10	the	DT	O	the	det	11	SENT_307	[p21l2006t2170r2135b2249],
11	response	NN	O	response	prep_of	8	SENT_307	[p21l11t2324r389b2399],
12	to	TO	O	to	_	0	SENT_307	[p21l425t2315r504b2377],
13	drugs	NNS	O	drug	prep_to	11	SENT_307	[p21l541t2298r779b2399],
14	is	VBZ	O	be	cop	18	SENT_307	[p21l815t2299r880b2377],
15	often	RB	O	often	advmod	18	SENT_307	[p21l918t2298r1134b2377],
16	polygenic	JJ	O	polygenic	amod	18	SENT_307	[p21l1168t2299r1576b2399],
17	(	NN	O	(	nn	18	SENT_307	[p21l1616t2299r1798b2399],
18	Fig	NN	O	fig	ccomp	4	SENT_307	[p21l1616t2299r1798b2399],
19	.	.	O	.	_	0	SENT_307	[p21l1616t2299r1798b2399],

1	1	CD	NUMBER	1	_	0	SENT_308	[p21l1842t2304r1945b2390],
2	)	NN	O	)	dep	1	SENT_308	[p21l1842t2304r1945b2390],
3	.	.	O	.	_	0	SENT_308	[p21l1842t2304r1945b2390],

1	Approaches	NNS	O	approach	nsubj	9	SENT_309	[p21l1982t2306r2134b2399, p21l9t2426r387b2527],
2	for	IN	O	for	_	0	SENT_309	[p21l413t2426r535b2505],
3	elucidating	VBG	O	elucidate	prepc_for	1	SENT_309	[p21l557t2427r1024b2527],
4	polygenic	JJ	O	polygenic	amod	5	SENT_309	[p21l1044t2426r1448b2527],
5	determinants	NNS	O	determinant	dobj	3	SENT_309	[p21l1473t2427r2027b2505],
6	of	IN	O	of	_	0	SENT_309	[p21l2054t2426r2154b2505],
7	drug	NN	O	drug	nn	8	SENT_309	[p21l11t2555r208b2655],
8	response	NN	O	response	prep_of	5	SENT_309	[p21l225t2580r596b2655],
9	include	VBP	O	include	_	0	SENT_309	[p21l617t2555r920b2634],
10	the	DT	O	the	det	11	SENT_309	[p21l941t2555r1068b2633],
11	use	NN	O	use	nsubj	16	SENT_309	[p21l1089t2581r1227b2634],
12	of	IN	O	of	_	0	SENT_309	[p21l1248t2554r1348b2633],
13	anonymous	JJ	O	anonymous	amod	15	SENT_309	[p21l1349t2580r1833b2655],
14	singlenucleotide	NN	O	singlenucleotide	nn	15	SENT_309	[p21l1858t2555r2135b2655, p21l11t2682r461b2762],
15	polymorphism	NN	O	polymorphism	prep_of	11	SENT_309	[p21l507t2682r1148b2783],
16	maps	VBZ	O	map	ccomp	9	SENT_309	[p21l1194t2709r1424b2783],
17	to	TO	O	to	aux	18	SENT_309	[p21l1474t2699r1554b2761],
18	perform	VB	O	perform	xcomp	16	SENT_309	[p21l1601t2682r1955b2783],
19	genome	NN	O	genome	nn	22	SENT_309	[p21l2002t2709r2132b2783, p21l11t2811r493b2890],
20	—	NN	O	—	nn	22	SENT_309	[p21l2002t2709r2132b2783, p21l11t2811r493b2890],
21	wide	JJ	O	wide	amod	22	SENT_309	[p21l2002t2709r2132b2783, p21l11t2811r493b2890],
22	searches	NNS	O	search	dobj	18	SENT_309	[p21l525t2810r882b2889],
23	for	IN	O	for	_	0	SENT_309	[p21l914t2810r1038b2889],
24	polymorphisms	NNS	O	polymorphism	prep_for	22	SENT_309	[p21l1064t2810r1734b2911],
25	associated	VBN	O	associate	partmod	24	SENT_309	[p21l1766t2811r2134b2889, p21l11t2938r107b3017],
26	with	IN	O	with	_	0	SENT_309	[p21l126t2939r316b3018],
27	drug	NN	O	drug	nn	28	SENT_309	[p21l340t2939r539b3039],
28	effects	NNS	O	effect	prep_with	25	SENT_309	[p21l560t2938r855b3034],
29	,	,	O	,	_	0	SENT_309	[p21l560t2938r855b3034],
30	and	CC	O	and	_	0	SENT_309	[p21l884t2938r1040b3017],
31	candidate	NN	O	candidate	nn	34	SENT_309	[p21l1064t2938r1708b3039],
32	—	NN	O	—	nn	34	SENT_309	[p21l1064t2938r1708b3039],
33	gene	NN	O	gene	nn	34	SENT_309	[p21l1064t2938r1708b3039],
34	strategies	NNS	O	strategy	conj_and	22	SENT_309	[p21l1733t2939r2132b3039],
35	based	VBN	O	base	partmod	34	SENT_309	[p21l11t3066r257b3145],
36	on	IN	O	on	_	0	SENT_309	[p21l304t3092r411b3145],
37	existing	VBG	O	exist	amod	38	SENT_309	[p21l458t3067r798b3167],
38	knowledge	NN	O	knowledge	prep_on	35	SENT_309	[p21l841t3066r1312b3167],
39	of	IN	O	of	_	0	SENT_309	[p21l1359t3066r1460b3145],
40	a	DT	O	a	det	41	SENT_309	[p21l1488t3093r1532b3145],
41	medication	NN	O	medication	poss	43	SENT_309	[p21l1576t3066r2132b3145],
42	’s	POS	O	’s	_	0	SENT_309	[p21l1576t3066r2132b3145],
43	mechanisms	NNS	O	mechanism	prep_of	38	SENT_309	[p21l11t3195r541b3273],
44	of	IN	O	of	_	0	SENT_309	[p21l566t3194r665b3273],
45	action	NN	O	action	prep_of	38	SENT_309	[p21l668t3195r924b3273],
46	and	CC	O	and	_	0	SENT_309	[p21l945t3194r1099b3273],
47	pathways	NNS	O	pathway	conj_and	38	SENT_309	[p21l1119t3195r1508b3295],
48	of	IN	O	of	_	0	SENT_309	[p21l1532t3194r1632b3273],
49	metabolism	NN	O	metabolism	prep_of	47	SENT_309	[p21l1635t3195r2136b3273],
50	and	CC	O	and	_	0	SENT_309	[p21l10t3322r166b3401],
51	disposition	NN	O	disposition	prep_of	47	SENT_309	[p21l197t3322r694b3423],
52	.	.	O	.	_	0	SENT_309	[p21l197t3322r694b3423],

1	Both	DT	O	both	predet	3	SENT_310	[p21l728t3322r929b3401],
2	these	DT	O	these	det	3	SENT_310	[p21l960t3323r1178b3401],
3	strategies	NNS	O	strategy	nsubj	4	SENT_310	[p21l1211t3323r1610b3423],
4	have	VBP	O	have	_	0	SENT_310	[p21l1642t3323r1830b3402],
5	potential	JJ	O	potential	amod	6	SENT_310	[p21l1859t3339r2134b3423, p21l11t3451r140b3529],
6	value	NN	O	value	dobj	4	SENT_310	[p21l162t3451r380b3530],
7	and	CC	O	and	_	0	SENT_310	[p21l407t3451r563b3529],
8	limitations	NNS	O	limitation	dobj	4	SENT_310	[p21l589t3451r1075b3546],
9	,	,	O	,	_	0	SENT_310	[p21l589t3451r1075b3546],
10	as	IN	O	as	mark	28	SENT_310	[p21l1107t3477r1192b3529],
11	shown	VBN	O	show	partmod	28	SENT_310	[p21l1222t3451r1502b3530],
12	in	IN	O	in	_	0	SENT_310	[p21l1528t3451r1610b3528],
13	previous	JJ	O	previous	amod	14	SENT_310	[p21l1636t3451r1993b3551],
14	reviews	NNS	O	review	prep_in	11	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
15	.5	CD	NUMBER	.5	number	16	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
16	»	CD	NUMBER	»	dep	14	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
17	9	CD	NUMBER	9	num	18	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
18	°	NN	O	°	dep	16	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
19	»	CD	NUMBER	»	num	20	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
20	91	CD	NUMBER	91	dobj	11	SENT_310	[p21l2022t3477r2134b3529, p21l6t3579r517b3658],
21	However	RB	O	however	advmod	20	SENT_310	[p21l545t3586r938b3674],
22	,	,	O	,	_	0	SENT_310	[p21l545t3586r938b3674],
23	the	DT	O	the	det	27	SENT_310	[p21l973t3579r1102b3657],
24	candidate	NN	O	candidate	nn	27	SENT_310	[p21l1132t3578r1776b3679],
25	—	NN	O	—	nn	27	SENT_310	[p21l1132t3578r1776b3679],
26	gene	NN	O	gene	nn	27	SENT_310	[p21l1132t3578r1776b3679],
27	strategy	NN	O	strategy	nsubj	28	SENT_310	[p21l1808t3595r2139b3679],
28	has	VBZ	O	have	advcl	4	SENT_310	[p21l11t3707r152b3785],
29	the	DT	O	the	det	30	SENT_310	[p21l180t3707r308b3785],
30	advantage	NN	O	advantage	dobj	28	SENT_310	[p21l334t3706r760b3807],
31	of	IN	O	of	_	0	SENT_310	[p21l786t3706r887b3785],
32	focusing	VBG	O	focus	prepc_of	30	SENT_310	[p21l894t3706r1263b3807],
33	resources	NNS	O	resource	dobj	32	SENT_310	[p21l1285t3732r1686b3786],
34	on	IN	O	on	_	0	SENT_310	[p21l1714t3732r1820b3785],
35	a	DT	O	a	det	36	SENT_310	[p21l1845t3733r1890b3785],
36	manageable	JJ	O	manageable	prep_on	32	SENT_310	[p21l1914t3732r2134b3785, p22l10t20r329b121],

1	number	NN	O	number	dep	16	SENT_311	[p22l356t21r692b100],
2	of	IN	O	of	_	0	SENT_311	[p22l717t20r817b99],
3	genes	NNS	O	gene	prep_of	1	SENT_311	[p22l825t46r1065b121],
4	and	CC	O	and	_	0	SENT_311	[p22l1093t20r1250b99],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_311	[p22l1274t21r1944b121],
6	that	WDT	O	that	nsubj	8	SENT_311	[p22l1973t21r2140b99],
7	are	VBP	O	be	cop	8	SENT_311	[p22l10t175r135b227],
8	likely	JJ	O	likely	rcmod	1	SENT_311	[p22l164t148r391b249],
9	to	TO	O	to	aux	11	SENT_311	[p22l415t165r494b227],
10	be	VB	O	be	cop	11	SENT_311	[p22l525t149r620b227],
11	important	JJ	O	important	xcomp	8	SENT_311	[p22l648t149r1100b249],
12	,	,	O	,	_	0	SENT_311	[p22l648t149r1100b249],
13	and	CC	O	and	cc	16	SENT_311	[p22l1135t148r1290b227],
14	it	PRP	O	it	nsubj	16	SENT_311	[p22l1318t149r1378b227],
15	has	VBZ	O	have	aux	16	SENT_311	[p22l1402t149r1543b227],
16	produced	VBN	O	produce	_	0	SENT_311	[p22l1572t149r1973b249],
17	encouraging	JJ	O	encouraging	amod	18	SENT_311	[p22l2003t174r2134b227, p22l11t277r442b377],
18	results	NNS	O	result	dep	29	SENT_311	[p22l468t277r745b356],
19	in	IN	O	in	_	0	SENT_311	[p22l776t277r858b354],
20	a	DT	O	a	det	21	SENT_311	[p22l887t303r931b355],
21	number	NN	O	number	prep_in	18	SENT_311	[p22l959t277r1296b356],
22	of	IN	O	of	_	0	SENT_311	[p22l1323t276r1424b355],
23	studies	NNS	O	study	prep_of	21	SENT_311	[p22l1437t276r1946b356],
24	.2	NN	NUMBER	.2	dep	29	SENT_311	[p22l1437t276r1946b356],
25	°	CD	NUMBER	°	num	24	SENT_311	[p22l1437t276r1946b356],
26	»	CD	NUMBER	»	number	27	SENT_311	[p22l1437t276r1946b356],
27	52	CD	NUMBER	52	num	29	SENT_311	[p22l1437t276r1946b356],
28	The	DT	O	the	det	29	SENT_311	[p22l1973t276r2134b355],
29	limitations	NNS	O	limitation	dep	35	SENT_311	[p22l10t405r464b483],
30	of	IN	O	of	_	0	SENT_311	[p22l489t404r589b483],
31	this	DT	O	this	det	32	SENT_311	[p22l593t405r744b483],
32	approach	NN	O	approach	prep_of	29	SENT_311	[p22l767t404r1160b505],
33	are	VBP	O	be	cop	35	SENT_311	[p22l1181t431r1305b483],
34	the	DT	O	the	det	35	SENT_311	[p22l1328t405r1456b483],
35	incompleteness	NN	O	incompleteness	dep	16	SENT_311	[p22l1478t405r2134b505],
36	of	IN	O	of	_	0	SENT_311	[p22l11t532r113b611],
37	knowledge	NN	O	knowledge	prep_of	35	SENT_311	[p22l133t533r605b633],
38	of	IN	O	of	_	0	SENT_311	[p22l644t532r745b611],
39	a	DT	O	a	det	40	SENT_311	[p22l765t559r810b611],
40	medication	NN	O	medication	poss	44	SENT_311	[p22l847t532r1402b611],
41	’s	POS	O	’s	_	0	SENT_311	[p22l847t532r1402b611],
42	pharmacokinet	NN	O	pharmacokinet	nn	44	SENT_311	[p22l1442t533r2132b633],
43	—	NN	O	—	nn	44	SENT_311	[p22l1442t533r2132b633],
44	ics	NNS	O	ic	prep_of	37	SENT_311	[p22l10t661r122b739],
45	and	CC	O	and	_	0	SENT_311	[p22l163t660r321b739],
46	mechanisms	NNS	O	mechanism	prep_of	37	SENT_311	[p22l361t660r905b739],
47	of	IN	O	of	_	0	SENT_311	[p22l949t660r1050b739],
48	action	NN	O	action	prep_of	35	SENT_311	[p22l1070t661r1359b739],
49	.	.	O	.	_	0	SENT_311	[p22l1070t661r1359b739],

1	Gene	NNP	O	Gene	nn	4	SENT_312	[p22l1404t661r2134b761],
2	—	NN	O	—	nn	4	SENT_312	[p22l1404t661r2134b761],
3	expression	NN	O	expression	nn	4	SENT_312	[p22l1404t661r2134b761],
4	profiling92	NN	O	profiling92	nsubj	11	SENT_312	[p22l9t788r578b889],
5	»	CD	NUMBER	»	number	6	SENT_312	[p22l9t788r578b889],
6	93	CD	NUMBER	93	dep	4	SENT_312	[p22l9t788r578b889],
7	and	CC	O	and	_	0	SENT_312	[p22l603t789r760b867],
8	proteomic	JJ	O	proteomic	amod	9	SENT_312	[p22l780t789r1216b889],
9	studies94	NN	O	studies94	conj_and	4	SENT_312	[p22l1239t788r1617b868],
10	are	VBP	O	be	aux	11	SENT_312	[p22l1638t815r1763b867],
11	evolving	VBG	O	evolve	_	0	SENT_312	[p22l1787t789r2138b889],
12	strategies	NNS	O	strategy	dobj	11	SENT_312	[p22l12t917r411b1017],
13	for	IN	O	for	_	0	SENT_312	[p22l443t916r566b995],
14	identifying	VBG	O	identify	prepc_for	11	SENT_312	[p22l593t916r1052b1017],
15	genes	NNS	O	gene	dobj	14	SENT_312	[p22l1078t942r1318b1017],
16	that	WDT	O	that	nsubj	18	SENT_312	[p22l1351t916r1518b995],
17	may	MD	O	may	aux	18	SENT_312	[p22l1542t943r1719b1017],
18	inﬂuence	VB	O	inﬂuence	rcmod	15	SENT_312	[p22l1744t916r2135b996],
19	drug	NN	O	drug	nn	20	SENT_312	[p22l11t1045r211b1145],
20	response	NN	O	response	dobj	18	SENT_312	[p22l233t1070r635b1145],
21	.	.	O	.	_	0	SENT_312	[p22l233t1070r635b1145],

1	REFERENCES	NNS	O	reference	_	0	SENT_313	[p22l14t1339r483b1380],

1	1	LS	NUMBER	1	_	0	SENT_314	[p22l12t1437r48b1476],
2	.	.	O	.	_	0	SENT_314	[p22l12t1437r48b1476],

1	Vesell	NNP	O	Vesell	_	0	SENT_315	[p22l104t1432r241b1476],
2	ES	NN	O	e	dep	1	SENT_315	[p22l279t1435r352b1476],
3	.	.	O	.	_	0	SENT_315	[p22l279t1435r352b1476],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_316	[p22l392t1432r804b1488],
2	perspectives	NNS	O	perspective	nsubj	3	SENT_316	[p22l841t1446r1043b1488, p22l10t1503r113b1547],
3	gained	VBN	O	gain	_	0	SENT_316	[p22l137t1503r295b1559],
4	from	IN	O	from	_	0	SENT_316	[p22l318t1502r434b1547],
5	twin	NN	O	twin	nn	8	SENT_316	[p22l457t1503r560b1547],
6	and	CC	O	and	_	0	SENT_316	[p22l582t1503r670b1547],
7	family	NN	O	family	conj_and	5	SENT_316	[p22l692t1502r841b1559],
8	studies	NNS	O	study	prep_from	3	SENT_316	[p22l861t1503r1040b1547],
9	.	.	O	.	_	0	SENT_316	[p22l861t1503r1040b1547],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_317	[p22l9t1574r263b1618],
2	Ther	NNP	O	Ther	_	0	SENT_317	[p22l275t1574r389b1618],
3	1989	CD	DATE	1989	num	2	SENT_317	[p22l403t1577r790b1627],
4	;	:	O	;	_	0	SENT_317	[p22l403t1577r790b1627],
5	41:535	CD	NUMBER	41:535	number	6	SENT_317	[p22l403t1577r790b1627],
6	-52	CD	NUMBER	-52	dep	2	SENT_317	[p22l403t1577r790b1627],
7	.	.	O	.	_	0	SENT_317	[p22l403t1577r790b1627],

1	2	LS	NUMBER	2	_	0	SENT_318	[p22l9t1650r48b1689],
2	.	.	O	.	_	0	SENT_318	[p22l9t1650r48b1689],

1	Kalow	NNP	MISC	Kalow	nn	2	SENT_319	[p22l106t1645r257b1690],
2	W	NNP	O	W	_	0	SENT_319	[p22l267t1649r326b1698],
3	,	,	O	,	_	0	SENT_319	[p22l267t1649r326b1698],
4	Tang	NNP	PERSON	Tang	nn	5	SENT_319	[p22l342t1648r462b1701],
5	BK	NNP	PERSON	BK	appos	2	SENT_319	[p22l474t1649r557b1698],
6	,	,	O	,	_	0	SENT_319	[p22l474t1649r557b1698],
7	Endrenyi	NNP	O	Endrenyi	nn	11	SENT_319	[p22l574t1645r786b1701],
8	I.	NNP	O	I.	nn	11	SENT_319	[p22l800t1649r830b1689],
9	Hypoth	NNP	O	Hypoth	nn	11	SENT_319	[p22l848t1645r1043b1701],
10	—	NN	O	—	nn	11	SENT_319	[p22l848t1645r1043b1701],
11	esis	NN	O	esis	appos	2	SENT_319	[p22l10t1716r111b1760],
12	:	:	O	:	_	0	SENT_319	[p22l10t1716r111b1760],
13	comparisons	NNS	O	comparison	nsubj	23	SENT_319	[p22l138t1716r443b1772],
14	of	IN	O	of	_	0	SENT_319	[p22l469t1715r525b1760],
15	inter	NN	O	inter	nn	16	SENT_319	[p22l538t1716r666b1760],
16	—	NN	O	—	prep_of	13	SENT_319	[p22l538t1716r666b1760],
17	and	CC	O	and	_	0	SENT_319	[p22l690t1716r777b1760],
18	intra-indi	JJ	O	intra-indi	amod	21	SENT_319	[p22l801t1716r1043b1760],
19	—	NN	O	—	nn	21	SENT_319	[p22l801t1716r1043b1760],
20	vidual	JJ	O	vidual	amod	21	SENT_319	[p22l7t1787r151b1831],
21	variations	NNS	O	variation	prep_of	13	SENT_319	[p22l183t1787r416b1831],
22	can	MD	O	can	aux	23	SENT_319	[p22l453t1801r534b1830],
23	substitute	VB	O	substitute	dep	2	SENT_319	[p22l570t1787r801b1831],
24	for	IN	O	for	_	0	SENT_319	[p22l837t1786r906b1830],
25	twin	JJ	O	twin	amod	26	SENT_319	[p22l940t1787r1044b1831],
26	studies	NNS	O	study	prep_for	23	SENT_319	[p22l11t1858r175b1902],
27	in	IN	O	in	_	0	SENT_319	[p22l192t1858r237b1901],
28	drug	NN	O	drug	nn	29	SENT_319	[p22l253t1858r365b1914],
29	research	NN	O	research	prep_in	26	SENT_319	[p22l378t1858r590b1902],
30	.	.	O	.	_	0	SENT_319	[p22l378t1858r590b1902],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_320	[p22l608t1858r1043b1914],
2	1998	CD	DATE	1998	num	1	SENT_320	[p22l12t1932r339b1982],
3	;	:	O	;	_	0	SENT_320	[p22l12t1932r339b1982],
4	8:283	CD	NUMBER	8:283	number	5	SENT_320	[p22l12t1932r339b1982],
5	—	CD	NUMBER	—	dep	1	SENT_320	[p22l12t1932r339b1982],
6	9	CD	NUMBER	9	dep	5	SENT_320	[p22l12t1932r339b1982],
7	.	.	O	.	_	0	SENT_320	[p22l12t1932r339b1982],

1	3	LS	NUMBER	3	_	0	SENT_321	[p22l10t2005r48b2044],
2	.	.	O	.	_	0	SENT_321	[p22l10t2005r48b2044],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_322	[p22l105t2004r241b2044],
2	WE	NNP	O	WE	_	0	SENT_322	[p22l273t2004r371b2053],
3	,	,	O	,	_	0	SENT_322	[p22l273t2004r371b2053],
4	Relling	NNP	O	Relling	nn	5	SENT_322	[p22l406t2000r577b2056],
5	MV	NNP	O	MV	appos	2	SENT_322	[p22l607t2004r694b2044],
6	.	.	O	.	_	0	SENT_322	[p22l607t2004r694b2044],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_323	[p22l729t2000r1042b2056, p22l10t2071r198b2115],
2	:	:	O	:	_	0	SENT_323	[p22l729t2000r1042b2056, p22l10t2071r198b2115],
3	translating	VBG	O	translate	dep	1	SENT_323	[p22l239t2071r497b2127],
4	functional	JJ	O	functional	amod	5	SENT_323	[p22l533t2070r775b2115],
5	genomics	NNS	O	genomic	dobj	3	SENT_323	[p22l813t2071r1042b2127],
6	into	IN	O	into	_	0	SENT_323	[p22l10t2142r102b2186],
7	rational	JJ	O	rational	amod	8	SENT_323	[p22l139t2142r321b2186],
8	therapeutics	NNS	O	therapeutics	prep_into	3	SENT_323	[p22l357t2142r660b2198],
9	.	.	O	.	_	0	SENT_323	[p22l357t2142r660b2198],

1	Science	NN	O	science	_	0	SENT_324	[p22l700t2142r875b2186],
2	1999	CD	DATE	1999	num	1	SENT_324	[p22l913t2145r1041b2195],
3	;	:	O	;	_	0	SENT_324	[p22l913t2145r1041b2195],
4	286:487	CD	NUMBER	286:487	number	5	SENT_324	[p22l10t2216r293b2257],
5	—	CD	NUMBER	—	dep	1	SENT_324	[p22l10t2216r293b2257],
6	91	CD	NUMBER	91	dep	5	SENT_324	[p22l10t2216r293b2257],
7	.	.	O	.	_	0	SENT_324	[p22l10t2216r293b2257],

1	4	LS	NUMBER	4	_	0	SENT_325	[p22l9t2289r48b2328],
2	.	.	O	.	_	0	SENT_325	[p22l9t2289r48b2328],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_326	[p22l105t2288r241b2328],
2	WE	NNP	O	WE	_	0	SENT_326	[p22l272t2288r370b2337],
3	,	,	O	,	_	0	SENT_326	[p22l272t2288r370b2337],
4	Johnson	NNP	PERSON	Johnson	nn	5	SENT_326	[p22l399t2284r600b2335],
5	IA	NNP	O	IA	appos	2	SENT_326	[p22l626t2288r695b2335],
6	.	.	O	.	_	0	SENT_326	[p22l626t2288r695b2335],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_327	[p22l729t2284r1043b2340, p22l10t2355r198b2399],
2	:	:	O	:	_	0	SENT_327	[p22l729t2284r1043b2340, p22l10t2355r198b2399],
3	the	DT	O	the	det	5	SENT_327	[p22l216t2355r288b2399],
4	inherited	VBN	O	inherit	amod	5	SENT_327	[p22l303t2355r518b2399],
5	basis	NN	O	basis	dep	1	SENT_327	[p22l533t2355r651b2399],
6	for	IN	O	for	_	0	SENT_327	[p22l668t2354r736b2399],
7	interindivid	NN	O	interindivid	npadvmod	9	SENT_327	[p22l750t2355r1043b2399],
8	—	CD	NUMBER	—	num	7	SENT_327	[p22l750t2355r1043b2399],
9	ual	JJ	O	ual	amod	10	SENT_327	[p22l10t2426r80b2470],
10	differences	NNS	O	difference	prep_for	5	SENT_327	[p22l98t2425r357b2470],
11	in	IN	O	in	_	0	SENT_327	[p22l376t2426r421b2469],
12	drug	NN	O	drug	nn	13	SENT_327	[p22l439t2426r551b2482],
13	response	NN	O	response	prep_in	5	SENT_327	[p22l567t2440r793b2482],
14	.	.	O	.	_	0	SENT_327	[p22l567t2440r793b2482],

1	Annu	NNP	O	Annu	nn	3	SENT_328	[p22l811t2430r942b2470],
2	Rev	NN	O	rev	nn	3	SENT_328	[p22l959t2430r1045b2473],
3	Genomics	NNS	O	genomic	_	0	SENT_328	[p22l10t2497r251b2541],
4	Hum	NNP	O	Hum	nn	5	SENT_328	[p22l266t2501r387b2541],
5	Genet	NNP	O	Genet	dep	3	SENT_328	[p22l401t2500r545b2541],
6	2001	CD	DATE	2001	num	5	SENT_328	[p22l556t2500r856b2550],
7	;	:	O	;	_	0	SENT_328	[p22l556t2500r856b2550],
8	2:9	CD	NUMBER	2:9	number	9	SENT_328	[p22l556t2500r856b2550],
9	—	CD	NUMBER	—	dep	3	SENT_328	[p22l556t2500r856b2550],
10	39	CD	NUMBER	39	dep	9	SENT_328	[p22l556t2500r856b2550],
11	.	.	O	.	_	0	SENT_328	[p22l556t2500r856b2550],

1	5	CD	NUMBER	5	_	0	SENT_329	[p22l11t2573r48b2612],
2	.	.	O	.	_	0	SENT_329	[p22l11t2573r48b2612],

1	McLeod	NNP	PERSON	McLeod	nn	2	SENT_330	[p22l104t2568r294b2612],
2	HL	NNS	O	hl	_	0	SENT_330	[p22l323t2572r407b2621],
3	,	,	O	,	_	0	SENT_330	[p22l323t2572r407b2621],
4	Evans	NNP	PERSON	Evans	nn	5	SENT_330	[p22l437t2572r573b2612],
5	WE	NNP	O	WE	appos	2	SENT_330	[p22l601t2572r698b2612],
6	.	.	O	.	_	0	SENT_330	[p22l601t2572r698b2612],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_331	[p22l729t2568r1043b2624, p22l10t2639r198b2683],
2	:	:	O	:	_	0	SENT_331	[p22l729t2568r1043b2624, p22l10t2639r198b2683],
3	unlocking	VBG	O	unlock	dep	1	SENT_331	[p22l221t2639r463b2695],
4	the	DT	O	the	det	6	SENT_331	[p22l482t2639r554b2683],
5	human	JJ	O	human	amod	6	SENT_331	[p22l575t2639r743b2683],
6	genome	NN	O	genome	dobj	3	SENT_331	[p22l764t2653r955b2695],
7	for	IN	O	for	_	0	SENT_331	[p22l976t2638r1045b2683],
8	better	JJR	O	better	amod	10	SENT_331	[p22l10t2710r147b2754],
9	drug	NN	O	drug	nn	10	SENT_331	[p22l173t2710r285b2766],
10	therapy	NN	O	therapy	prep_for	3	SENT_331	[p22l310t2710r494b2766],
11	.	.	O	.	_	0	SENT_331	[p22l310t2710r494b2766],

1	Annu	NNP	PERSON	Annu	nn	4	SENT_332	[p22l521t2714r652b2754],
2	Rev	NN	PERSON	rev	nn	4	SENT_332	[p22l678t2714r765b2757],
3	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_332	[p22l789t2710r1043b2754],
4	Toxicol	NNP	O	Toxicol	_	0	SENT_332	[p22l8t2781r181b2825],
5	2001	CD	DATE	2001	num	4	SENT_332	[p22l195t2784r584b2834],
6	;	:	O	;	_	0	SENT_332	[p22l195t2784r584b2834],
7	41:101	CD	NUMBER	41:101	number	8	SENT_332	[p22l195t2784r584b2834],
8	—	CD	NUMBER	—	dep	4	SENT_332	[p22l195t2784r584b2834],
9	21	CD	NUMBER	21	dep	8	SENT_332	[p22l195t2784r584b2834],
10	.	.	O	.	_	0	SENT_332	[p22l195t2784r584b2834],

1	6	CD	NUMBER	6	_	0	SENT_333	[p22l10t2857r48b2896],
2	.	.	O	.	_	0	SENT_333	[p22l10t2857r48b2896],

1	Kalow	NNP	O	Kalow	nn	3	SENT_334	[p22l106t2852r257b2897],
2	W.	NNP	O	W.	nn	3	SENT_334	[p22l289t2856r347b2896],
3	Familial	NNP	O	Familial	_	0	SENT_334	[p22l386t2852r578b2896],
4	incidence	NN	O	incidence	dep	3	SENT_334	[p22l614t2852r840b2896],
5	of	IN	O	of	_	0	SENT_334	[p22l877t2851r933b2896],
6	low	JJ	O	low	amod	8	SENT_334	[p22l958t2852r1045b2896],
7	pseudocholinesterase	NN	O	pseudocholinesterase	nn	8	SENT_334	[p22l9t2923r523b2979],
8	level	NN	O	level	prep_of	4	SENT_334	[p22l545t2923r663b2967],
9	.	.	O	.	_	0	SENT_334	[p22l545t2923r663b2967],

1	Lancet	NNP	O	Lancet	_	0	SENT_335	[p22l688t2927r845b2967],
2	1956	CD	DATE	1956	num	1	SENT_335	[p22l867t2926r1041b2976],
3	;	:	O	;	_	0	SENT_335	[p22l867t2926r1041b2976],
4	2	CD	NUMBER	2	num	6	SENT_335	[p22l867t2926r1041b2976],
5	:	:	O	:	_	0	SENT_335	[p22l867t2926r1041b2976],
6	576	CD	NUMBER	576	dep	1	SENT_335	[p22l11t2997r109b3038],
7	.	.	O	.	_	0	SENT_335	[p22l11t2997r109b3038],

1	7	CD	NUMBER	7	_	0	SENT_336	[p22l1118t1437r1155b1476],
2	.	.	O	.	_	0	SENT_336	[p22l1118t1437r1155b1476],

1	Carson	NNP	ORGANIZATION	Carson	nn	2	SENT_337	[p22l1214t1435r1382b1476],
2	PE	NNP	ORGANIZATION	PE	_	0	SENT_337	[p22l1402t1436r1476b1485],
3	,	,	O	,	_	0	SENT_337	[p22l1402t1436r1476b1485],
4	Flanagan	NNP	PERSON	Flanagan	nn	5	SENT_337	[p22l1499t1432r1716b1488],
5	CL	NN	O	cl	appos	2	SENT_337	[p22l1737t1435r1814b1485],
6	,	,	O	,	_	0	SENT_337	[p22l1737t1435r1814b1485],
7	Ickes	NNP	PERSON	Ickes	nn	8	SENT_337	[p22l1837t1432r1958b1476],
8	CE	NNP	O	CE	appos	2	SENT_337	[p22l1980t1435r2059b1485],
9	,	,	O	,	_	0	SENT_337	[p22l1980t1435r2059b1485],
10	Alving	NNP	PERSON	Alving	nn	11	SENT_337	[p22l2081t1432r2150b1475, p22l1115t1503r1219b1559],
11	AS	NNP	O	AS	appos	2	SENT_337	[p22l1248t1506r1326b1547],
12	.	.	O	.	_	0	SENT_337	[p22l1248t1506r1326b1547],

1	Enzymatic	JJ	MISC	enzymatic	amod	2	SENT_338	[p22l1362t1503r1610b1559],
2	deﬁciency	NN	O	deﬁciency	_	0	SENT_338	[p22l1643t1502r1881b1559],
3	in	IN	O	in	_	0	SENT_338	[p22l1912t1503r1958b1546],
4	primaquine	NN	O	primaquine	nn	7	SENT_338	[p22l1991t1503r2150b1559, p22l1118t1574r1474b1630],
5	—	NN	O	—	nn	7	SENT_338	[p22l1991t1503r2150b1559, p22l1118t1574r1474b1630],
6	sensitive	JJ	O	sensitive	amod	7	SENT_338	[p22l1991t1503r2150b1559, p22l1118t1574r1474b1630],
7	erythrocytes	NNS	O	erythrocyte	prep_in	2	SENT_338	[p22l1497t1574r1795b1630],
8	.	.	O	.	_	0	SENT_338	[p22l1497t1574r1795b1630],

1	Science	NNP	O	Science	_	0	SENT_339	[p22l1822t1574r1997b1618],
2	1956	CD	DATE	1956	num	1	SENT_339	[p22l2021t1577r2149b1627],
3	;	:	O	;	_	0	SENT_339	[p22l2021t1577r2149b1627],
4	124:484	CD	NUMBER	124:484	number	5	SENT_339	[p22l1119t1648r1371b1689],
5	—	CD	NUMBER	—	dep	1	SENT_339	[p22l1119t1648r1371b1689],
6	5	CD	NUMBER	5	dep	5	SENT_339	[p22l1119t1648r1371b1689],
7	.	.	O	.	_	0	SENT_339	[p22l1119t1648r1371b1689],

1	8	CD	NUMBER	8	_	0	SENT_340	[p22l1117t1720r1155b1760],
2	.	.	O	.	_	0	SENT_340	[p22l1117t1720r1155b1760],

1	Hughes	NNP	ORGANIZATION	Hughes	nn	7	SENT_341	[p22l1214t1716r1397b1772],
2	HB	NNP	ORGANIZATION	HB	nn	7	SENT_341	[p22l1412t1720r1501b1769],
3	,	,	O	,	_	0	SENT_341	[p22l1412t1720r1501b1769],
4	BiehlJP	NNP	O	BiehlJP	appos	7	SENT_341	[p22l1518t1716r1706b1769],
5	,	,	O	,	_	0	SENT_341	[p22l1518t1716r1706b1769],
6	Jones	NNP	PERSON	Jones	appos	7	SENT_341	[p22l1718t1720r1849b1767],
7	AP	NNP	O	AP	_	0	SENT_341	[p22l1863t1720r1936b1769],
8	,	,	O	,	_	0	SENT_341	[p22l1863t1720r1936b1769],
9	Schmidt	NNP	PERSON	Schmidt	nn	10	SENT_341	[p22l1955t1716r2153b1760],
10	LH	NNP	O	LH	appos	7	SENT_341	[p22l1116t1791r1201b1830],
11	.	.	O	.	_	0	SENT_341	[p22l1116t1791r1201b1830],

1	Metabolism	NN	O	metabolism	nsubj	7	SENT_342	[p22l1237t1787r1521b1830],
2	of	IN	O	of	_	0	SENT_342	[p22l1556t1786r1612b1830],
3	isoniazid	NN	O	isoniazid	prep_of	1	SENT_342	[p22l1635t1787r1851b1830],
4	in	IN	O	in	_	0	SENT_342	[p22l1884t1787r1930b1830],
5	man	NN	O	man	prep_in	3	SENT_342	[p22l1964t1801r2069b1830],
6	as	IN	O	as	advmod	7	SENT_342	[p22l2103t1801r2150b1830],
7	related	JJ	O	related	_	0	SENT_342	[p22l1117t1858r1278b1902],
8	to	TO	O	to	_	0	SENT_342	[p22l1295t1867r1339b1902],
9	the	DT	O	the	det	10	SENT_342	[p22l1357t1858r1429b1902],
10	occurrence	NN	O	occurrence	prep_to	7	SENT_342	[p22l1447t1872r1706b1902],
11	of	IN	O	of	_	0	SENT_342	[p22l1723t1857r1779b1902],
12	peripheral	JJ	O	peripheral	amod	13	SENT_342	[p22l1785t1858r2029b1914],
13	neuritis	NN	O	neuritis	prep_of	10	SENT_342	[p22l2046t1872r2150b1902, p22l1117t1929r1222b1973],
14	.	.	O	.	_	0	SENT_342	[p22l2046t1872r2150b1902, p22l1117t1929r1222b1973],

1	Am	VBP	O	be	cop	2	SENT_343	[p22l1237t1933r1321b1972],
2	Rev	NN	O	rev	_	0	SENT_343	[p22l1334t1933r1421b1975],
3	Tuberc	JJ	O	tuberc	amod	4	SENT_343	[p22l1431t1929r1595b1973],
4	1954	CD	DATE	1954	dep	2	SENT_343	[p22l1611t1932r1997b1982],
5	;	:	O	;	_	0	SENT_343	[p22l1611t1932r1997b1982],
6	70:266	CD	NUMBER	70:266	number	7	SENT_343	[p22l1611t1932r1997b1982],
7	—	CD	NUMBER	—	dep	2	SENT_343	[p22l1611t1932r1997b1982],
8	73	CD	NUMBER	73	dep	7	SENT_343	[p22l1611t1932r1997b1982],
9	.	.	O	.	_	0	SENT_343	[p22l1611t1932r1997b1982],

1	9	CD	NUMBER	9	_	0	SENT_344	[p22l1117t2005r1155b2044],
2	.	.	O	.	_	0	SENT_344	[p22l1117t2005r1155b2044],

1	Evans	NNP	ORGANIZATION	Evans	nn	2	SENT_345	[p22l1213t2004r1349b2044],
2	DAP	NNP	ORGANIZATION	DAP	_	0	SENT_345	[p22l1373t2004r1484b2053],
3	,	,	O	,	_	0	SENT_345	[p22l1373t2004r1484b2053],
4	Manley	NNP	PERSON	Manley	nn	5	SENT_345	[p22l1508t2000r1682b2056],
5	KA	NN	O	ka	appos	2	SENT_345	[p22l1703t2004r1787b2053],
6	,	,	O	,	_	0	SENT_345	[p22l1703t2004r1787b2053],
7	McKusick	NNP	PERSON	McKusick	nn	8	SENT_345	[p22l1812t2000r2051b2045],
8	VA.	NNP	O	VA.	appos	5	SENT_345	[p22l2069t2004r2147b2044],
9	.	.	O	.	_	0	SENT_345	[p22l2069t2004r2147b2044],

1	Genetic	JJ	O	genetic	amod	2	SENT_346	[p22l1117t2071r1300b2115],
2	control	NN	O	control	_	0	SENT_346	[p22l1318t2071r1488b2115],
3	of	IN	O	of	_	0	SENT_346	[p22l1506t2070r1563b2115],
4	isoniazid	NN	O	isoniazid	nn	5	SENT_346	[p22l1570t2071r1786b2115],
5	metabolism	NN	O	metabolism	prep_of	2	SENT_346	[p22l1804t2071r2087b2115],
6	in	IN	O	in	_	0	SENT_346	[p22l2105t2071r2150b2114],
7	man	NN	O	man	prep_in	2	SENT_346	[p22l1117t2156r1235b2186],
8	.	.	O	.	_	0	SENT_346	[p22l1117t2156r1235b2186],

1	Br	NNP	O	Br	nsubj	2	SENT_347	[p22l1252t2146r1307b2186],
2	Med	VBD	O	med	_	0	SENT_347	[p22l1317t2142r1451b2193],
3	]	CD	NUMBER	]	num	4	SENT_347	[p22l1317t2142r1451b2193],
4	1960	CD	DATE	1960	dobj	2	SENT_347	[p22l1466t2145r1823b2195],
5	;	:	O	;	_	0	SENT_347	[p22l1466t2145r1823b2195],
6	2:485	CD	NUMBER	2:485	number	7	SENT_347	[p22l1466t2145r1823b2195],
7	—	CD	NUMBER	—	dep	4	SENT_347	[p22l1466t2145r1823b2195],
8	91	CD	NUMBER	91	dep	7	SENT_347	[p22l1466t2145r1823b2195],
9	.	.	O	.	_	0	SENT_347	[p22l1466t2145r1823b2195],

1	10	CD	NUMBER	10	_	0	SENT_348	[p22l1119t2217r1183b2257],
2	.	.	O	.	_	0	SENT_348	[p22l1119t2217r1183b2257],

1	Sachidanandam	FW	PERSON	sachidanandam	_	0	SENT_349	[p22l1215t2213r1594b2257],
2	R	NN	PERSON	r	dep	1	SENT_349	[p22l1663t2217r1711b2266],
3	,	,	O	,	_	0	SENT_349	[p22l1663t2217r1711b2266],
4	Weissman	NN	PERSON	weissman	nn	5	SENT_349	[p22l1782t2213r2028b2257],
5	D	NN	O	d	appos	2	SENT_349	[p22l2097t2217r2147b2266],
6	,	,	O	,	_	0	SENT_349	[p22l2097t2217r2147b2266],
7	Schmidt	NNP	PERSON	Schmidt	nn	8	SENT_349	[p22l1119t2284r1317b2328],
8	SC	NNP	O	SC	appos	2	SENT_349	[p22l1330t2287r1406b2337],
9	,	,	O	,	_	0	SENT_349	[p22l1330t2287r1406b2337],
10	et	FW	O	et	nn	11	SENT_349	[p22l1424t2293r1467b2328],
11	al.	FW	O	al.	appos	2	SENT_349	[p22l1479t2284r1531b2328],
12	.	.	O	.	_	0	SENT_349	[p22l1479t2284r1531b2328],

1	A	DT	O	a	det	2	SENT_350	[p22l1547t2288r1584b2327],
2	map	NN	O	map	_	0	SENT_350	[p22l1597t2298r1701b2340],
3	of	IN	O	of	_	0	SENT_350	[p22l1717t2283r1773b2328],
4	human	JJ	O	human	amod	7	SENT_350	[p22l1778t2284r1945b2328],
5	genome	NN	O	genome	nn	7	SENT_350	[p22l1960t2298r2151b2340],
6	sequence	NN	O	sequence	nn	7	SENT_350	[p22l1118t2369r1335b2411],
7	variation	NN	O	variation	prep_of	2	SENT_350	[p22l1353t2355r1562b2399],
8	containing	VBG	O	contain	partmod	2	SENT_350	[p22l1582t2355r1839b2411],
9	1.42	CD	NUMBER	1.42	number	10	SENT_350	[p22l1859t2358r1959b2399],
10	million	CD	NUMBER	million	num	13	SENT_350	[p22l1979t2355r2151b2399],
11	single	JJ	O	single	amod	13	SENT_350	[p22l1118t2426r1258b2482],
12	nucleotide	NN	O	nucleotide	nn	13	SENT_350	[p22l1289t2426r1537b2470],
13	polymorphisms	NNS	O	polymorphism	dobj	8	SENT_350	[p22l1566t2426r1956b2482],
14	.	.	O	.	_	0	SENT_350	[p22l1566t2426r1956b2482],

1	Nature	NNP	O	Nature	_	0	SENT_351	[p22l1989t2430r2151b2470],
2	2001	CD	DATE	2001	num	1	SENT_351	[p22l1117t2500r1536b2550],
3	;	:	O	;	_	0	SENT_351	[p22l1117t2500r1536b2550],
4	409:928	CD	NUMBER	409:928	number	5	SENT_351	[p22l1117t2500r1536b2550],
5	—	CD	NUMBER	—	dep	1	SENT_351	[p22l1117t2500r1536b2550],
6	33	CD	NUMBER	33	dep	5	SENT_351	[p22l1117t2500r1536b2550],
7	.	.	O	.	_	0	SENT_351	[p22l1117t2500r1536b2550],

1	11	CD	NUMBER	11	_	0	SENT_352	[p22l1119t2573r1183b2612],
2	.	.	O	.	_	0	SENT_352	[p22l1119t2573r1183b2612],

1	Yates	NNP	PERSON	Yates	nn	2	SENT_353	[p22l1212t2572r1332b2612],
2	CR	NN	O	cr	_	0	SENT_353	[p22l1353t2571r1437b2621],
3	,	,	O	,	_	0	SENT_353	[p22l1353t2571r1437b2621],
4	Krynetski	NNP	PERSON	Krynetski	nn	5	SENT_353	[p22l1460t2568r1686b2624],
5	EY	NNP	PERSON	EY	appos	2	SENT_353	[p22l1706t2572r1775b2621],
6	,	,	O	,	_	0	SENT_353	[p22l1706t2572r1775b2621],
7	Loennechen	NNP	O	Loennechen	nn	8	SENT_353	[p22l1797t2568r2087b2612],
8	T	NN	O	t	appos	2	SENT_353	[p22l2106t2571r2147b2621],
9	,	,	O	,	_	0	SENT_353	[p22l2106t2571r2147b2621],
10	et	FW	O	et	nn	11	SENT_353	[p22l1118t2648r1161b2683],
11	al.	FW	O	al.	appos	2	SENT_353	[p22l1193t2639r1246b2683],
12	.	.	O	.	_	0	SENT_353	[p22l1193t2639r1246b2683],

1	Molecular	JJ	O	molecular	amod	2	SENT_354	[p22l1283t2639r1523b2683],
2	diagnosis	NN	O	diagnosis	_	0	SENT_354	[p22l1557t2639r1783b2695],
3	of	IN	O	of	_	0	SENT_354	[p22l1820t2638r1876b2683],
4	thiopurine	NN	O	thiopurine	nn	5	SENT_354	[p22l1901t2639r2151b2695],
5	S	NN	O	s	prep_of	2	SENT_354	[p22l1119t2709r1579b2766],
6	—	CD	NUMBER	—	num	8	SENT_354	[p22l1119t2709r1579b2766],
7	methyltransferase	NN	O	methyltransferase	nn	8	SENT_354	[p22l1119t2709r1579b2766],
8	deﬁciency	NN	O	deﬁciency	dep	2	SENT_354	[p22l1594t2709r1838b2766],
9	:	:	O	:	_	0	SENT_354	[p22l1594t2709r1838b2766],
10	genetic	JJ	O	genetic	amod	11	SENT_354	[p22l1854t2710r2021b2766],
11	basis	NN	O	basis	dep	2	SENT_354	[p22l2035t2710r2150b2754],
12	for	IN	O	for	_	0	SENT_354	[p22l1117t2780r1186b2825],
13	azathioprine	NN	O	azathioprine	nn	16	SENT_354	[p22l1203t2781r1501b2837],
14	and	CC	O	and	_	0	SENT_354	[p22l1519t2781r1607b2825],
15	mercaptopurine	NN	O	mercaptopurine	nn	16	SENT_354	[p22l1624t2781r2005b2837],
16	intolerance	NN	O	intolerance	prep_for	11	SENT_354	[p22l2023t2781r2150b2825, p22l1118t2866r1284b2896],
17	.	.	O	.	_	0	SENT_354	[p22l2023t2781r2150b2825, p22l1118t2866r1284b2896],

1	Ann	NNP	O	Ann	nn	3	SENT_355	[p22l1299t2856r1399b2895],
2	Intern	NNP	O	Intern	nn	3	SENT_355	[p22l1412t2856r1557b2896],
3	Med	NNP	O	Med	_	0	SENT_355	[p22l1570t2852r1674b2896],
4	1997	CD	DATE	1997	num	3	SENT_355	[p22l1690t2855r2107b2905],
5	;	:	O	;	_	0	SENT_355	[p22l1690t2855r2107b2905],
6	126:608	CD	NUMBER	126:608	number	7	SENT_355	[p22l1690t2855r2107b2905],
7	-14	CD	NUMBER	-14	dep	3	SENT_355	[p22l1690t2855r2107b2905],
8	.	.	O	.	_	0	SENT_355	[p22l1690t2855r2107b2905],

1	12	CD	NUMBER	12	_	0	SENT_356	[p22l1119t2928r1184b2967],
2	.	.	O	.	_	0	SENT_356	[p22l1119t2928r1184b2967],

1	Weinshilboum	NNP	MISC	Weinshilboum	_	0	SENT_357	[p22l1212t2923r1560b2967],
2	R.	NNP	MISC	R.	nn	3	SENT_357	[p22l1579t2927r1626b2970],
3	Inheritance	NNP	MISC	Inheritance	dep	1	SENT_357	[p22l1648t2923r1916b2967],
4	and	CC	O	and	_	0	SENT_357	[p22l1935t2923r2022b2967],
5	drug	NN	O	drug	nn	6	SENT_357	[p22l2042t2923r2153b2979],
6	response	NN	O	response	dep	1	SENT_357	[p22l1117t3008r1344b3050],
7	.	.	O	.	_	0	SENT_357	[p22l1117t3008r1344b3050],

1	N	NN	O	n	nsubj	2	SENT_358	[p22l1361t2998r1404b3038],
2	EnglJMed	VBD	O	engljm	_	0	SENT_358	[p22l1417t2994r1673b3050],
3	2003	CD	DATE	2003	dobj	2	SENT_358	[p22l1687t2997r2106b3047],
4	;	:	O	;	_	0	SENT_358	[p22l1687t2997r2106b3047],
5	348:529	CD	NUMBER	348:529	num	6	SENT_358	[p22l1687t2997r2106b3047],
6	-37	CD	NUMBER	-37	dep	3	SENT_358	[p22l1687t2997r2106b3047],
7	.	.	O	.	_	0	SENT_358	[p22l1687t2997r2106b3047],

1	One	CD	NUMBER	one	nsubj	13	SENT_359	[p23l142t110r317b183],
2	of	IN	O	of	_	0	SENT_359	[p23l340t104r443b183],
3	the	DT	O	the	det	6	SENT_359	[p23l448t105r579b183],
4	most	RBS	O	most	advmod	5	SENT_359	[p23l602t121r824b183],
5	important	JJ	O	important	amod	6	SENT_359	[p23l841t105r1285b205],
6	challenges	NNS	O	challenge	prep_of	1	SENT_359	[p23l1303t104r1760b205],
7	in	IN	O	in	_	0	SENT_359	[p23l1785t105r1867b182],
8	deﬁning	VBG	O	deﬁning	prepc_in	6	SENT_359	[p23l1891t104r2144b183, p23l11t226r152b326],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_359	[p23l195t226r935b326],
10	traits	NNS	O	trait	dobj	8	SENT_359	[p23l981t226r1192b304],
11	is	VBZ	O	be	cop	13	SENT_359	[p23l1239t226r1304b304],
12	the	DT	O	the	det	13	SENT_359	[p23l1353t226r1483b304],
13	need	NN	O	need	_	0	SENT_359	[p23l1528t225r1729b304],
14	for	IN	O	for	_	0	SENT_359	[p23l1775t225r1899b304],
15	Wellcharacterized	JJ	MISC	wellcharacterized	amod	16	SENT_359	[p23l1937t225r2145b305, p23l12t346r593b425],
16	patients	NNS	O	patient	prep_for	13	SENT_359	[p23l632t347r976b447],
17	who	WP	O	who	nsubjpass	21	SENT_359	[p23l1013t346r1199b426],
18	have	VBP	O	have	aux	21	SENT_359	[p23l1240t347r1432b426],
19	been	VBN	O	be	auxpass	21	SENT_359	[p23l1473t347r1677b425],
20	uniformly	RB	O	uniformly	advmod	21	SENT_359	[p23l1717t346r2151b447],
21	treated	VBN	O	treat	rcmod	13	SENT_359	[p23l12t468r309b546],
22	and	CC	O	and	_	0	SENT_359	[p23l331t467r487b546],
23	systematically	RB	O	systematically	advmod	21	SENT_359	[p23l510t467r1102b568],
24	evaluated	VBN	O	evaluate	conj_and	21	SENT_359	[p23l1119t467r1513b547],
25	to	TO	O	to	aux	26	SENT_359	[p23l1534t484r1614b546],
26	make	VB	O	make	xcomp	24	SENT_359	[p23l1636t467r1866b547],
27	it	PRP	O	it	nsubj	28	SENT_359	[p23l1887t468r1947b546],
28	possible	JJ	O	possible	xcomp	26	SENT_359	[p23l1961t493r2145b568, p23l13t588r204b667],
29	to	TO	O	to	aux	30	SENT_359	[p23l230t605r308b667],
30	quantitate	VB	O	quantitate	xcomp	28	SENT_359	[p23l335t589r753b689],
31	drug	NN	O	drug	nn	32	SENT_359	[p23l778t588r976b689],
32	response	NN	O	response	dobj	30	SENT_359	[p23l996t614r1370b689],
33	objectively	RB	O	objectively	advmod	30	SENT_359	[p23l1395t589r1839b689],
34	.	.	O	.	_	0	SENT_359	[p23l1395t589r1839b689],

1	To	TO	O	to	_	0	SENT_360	[p23l1865t594r1970b667],
2	this	DT	O	this	det	3	SENT_360	[p23l1996t589r2146b667],
3	end	NN	O	end	prep_to	8	SENT_360	[p23l12t709r190b805],
4	,	,	O	,	_	0	SENT_360	[p23l12t709r190b805],
5	the	DT	O	the	det	6	SENT_360	[p23l230t710r360b788],
6	norm	NN	O	norm	nsubj	8	SENT_360	[p23l393t735r626b788],
7	should	MD	O	should	aux	8	SENT_360	[p23l662t709r950b789],
8	be	VB	O	be	_	0	SENT_360	[p23l984t710r1080b788],
9	to	TO	O	to	aux	10	SENT_360	[p23l1115t726r1194b788],
10	obtain	VB	O	obtain	xcomp	8	SENT_360	[p23l1230t710r1502b788],
11	genomic	JJ	O	genomic	amod	12	SENT_360	[p23l1535t710r1905b810],
12	DNA	NN	O	dna	dobj	10	SENT_360	[p23l1937t716r2150b788],
13	from	IN	O	from	_	0	SENT_360	[p23l12t830r223b909],
14	all	DT	O	all	det	15	SENT_360	[p23l263t830r365b909],
15	patients	NNS	O	patient	prep_from	10	SENT_360	[p23l403t831r746b931],
16	enrolled	VBN	O	enrol	partmod	15	SENT_360	[p23l790t830r1146b909],
17	in	IN	O	in	_	0	SENT_360	[p23l1185t831r1268b908],
18	clinical	JJ	O	clinical	amod	20	SENT_360	[p23l1309t830r1619b909],
19	drug	NN	O	drug	nn	20	SENT_360	[p23l1659t831r1863b931],
20	trials	NNS	O	trial	prep_in	16	SENT_360	[p23l1900t831r2140b926],
21	,	,	O	,	_	0	SENT_360	[p23l1900t831r2140b926],
22	along	IN	O	along	_	0	SENT_360	[p23l11t952r257b1052],
23	with	IN	O	with	_	0	SENT_360	[p23l277t952r466b1031],
24	appropriate	JJ	O	appropriate	amod	25	SENT_360	[p23l492t952r986b1052],
25	consent	NN	O	consent	prep_along_with	27	SENT_360	[p23l1012t968r1349b1030],
26	to	TO	O	to	aux	27	SENT_360	[p23l1370t968r1449b1030],
27	permit	VB	O	permit	xcomp	16	SENT_360	[p23l1475t952r1763b1052],
28	pharmacogenetic	JJ	O	pharmacogenetic	amod	29	SENT_360	[p23l1782t951r2145b1052, p23l12t1073r417b1173],
29	studies	NNS	O	study	dobj	27	SENT_360	[p23l456t1072r776b1152],
30	.	.	O	.	_	0	SENT_360	[p23l456t1072r776b1152],

1	Because	IN	O	because	mark	2	SENT_361	[p23l819t1079r1160b1152],
2	of	IN	O	of	advcl	12	SENT_361	[p23l1200t1072r1301b1151],
3	marked	JJ	O	marked	amod	5	SENT_361	[p23l1320t1072r1644b1152],
4	population	NN	O	population	nn	5	SENT_361	[p23l1681t1073r2147b1173],
5	heterogeneity	NN	O	heterogeneity	pobj	2	SENT_361	[p23l12t1194r589b1294],
6	,	,	O	,	_	0	SENT_361	[p23l12t1194r589b1294],
7	a	DT	O	a	det	9	SENT_361	[p23l616t1220r661b1272],
8	speciﬁc	NN	O	speciﬁc	nn	9	SENT_361	[p23l683t1193r995b1294],
9	genotype	NN	O	genotype	nsubj	12	SENT_361	[p23l1017t1210r1394b1294],
10	may	MD	O	may	aux	12	SENT_361	[p23l1416t1220r1592b1294],
11	be	VB	O	be	cop	12	SENT_361	[p23l1610t1193r1705b1272],
12	important	JJ	O	important	_	0	SENT_361	[p23l1726t1194r2153b1294],
13	in	IN	O	in	_	0	SENT_361	[p23l11t1315r94b1392],
14	determining	VBG	O	determine	prepc_in	12	SENT_361	[p23l121t1314r660b1415],
15	the	DT	O	the	det	16	SENT_361	[p23l684t1315r815b1393],
16	effects	NNS	O	effect	dobj	14	SENT_361	[p23l842t1314r1120b1393],
17	of	IN	O	of	_	0	SENT_361	[p23l1149t1314r1252b1393],
18	a	DT	O	a	det	19	SENT_361	[p23l1258t1341r1303b1393],
19	medication	NN	O	medication	prep_of	16	SENT_361	[p23l1328t1314r1815b1393],
20	for	IN	O	for	_	0	SENT_361	[p23l1840t1314r1966b1393],
21	one	CD	NUMBER	one	num	22	SENT_361	[p23l1991t1340r2145b1393],
22	population	NN	O	population	prep_for	14	SENT_361	[p23l11t1436r469b1536],
23	or	CC	O	or	_	0	SENT_361	[p23l490t1461r579b1514],
24	disease	NN	O	disease	prep_for	14	SENT_361	[p23l597t1436r896b1514],
25	but	CC	O	but	_	0	SENT_361	[p23l917t1436r1057b1515],
26	not	RB	O	not	_	0	SENT_361	[p23l1073t1452r1214b1514],
27	for	IN	O	for	_	0	SENT_361	[p23l1230t1435r1352b1514],
28	another	DT	O	another	prep_for	14	SENT_361	[p23l1368t1435r1716b1531],
29	;	:	O	;	_	0	SENT_361	[p23l1368t1435r1716b1531],
30	therefore	RB	O	therefore	advmod	36	SENT_361	[p23l1741t1435r2142b1531],
31	,	,	O	,	_	0	SENT_361	[p23l1741t1435r2142b1531],
32	pharmacogenomic	JJ	O	pharmacogenomic	amod	33	SENT_361	[p23l10t1557r815b1657],
33	relations	NNS	O	relation	nsubjpass	36	SENT_361	[p23l846t1557r1213b1635],
34	must	MD	O	must	aux	36	SENT_361	[p23l1246t1573r1464b1636],
35	be	VB	O	be	auxpass	36	SENT_361	[p23l1491t1557r1587b1635],
36	validated	VBN	O	validate	parataxis	12	SENT_361	[p23l1613t1556r1995b1636],
37	for	IN	O	for	_	0	SENT_361	[p23l2026t1556r2150b1635],
38	each	DT	O	each	det	40	SENT_361	[p23l12t1678r203b1756],
39	therapeutic	JJ	O	therapeutic	amod	40	SENT_361	[p23l239t1678r716b1778],
40	indication	NN	O	indication	prep_for	36	SENT_361	[p23l750t1678r1179b1756],
41	and	CC	O	and	_	0	SENT_361	[p23l1213t1677r1370b1756],
42	in	IN	O	in	_	0	SENT_361	[p23l1403t1678r1485b1755],
43	different	JJ	O	different	amod	44	SENT_361	[p23l1520t1677r1889b1756],
44	racial	JJ	O	racial	prep_in	36	SENT_361	[p23l1918t1678r2147b1756],
45	and	CC	O	and	_	0	SENT_361	[p23l11t1798r168b1877],
46	ethnic	JJ	O	ethnic	amod	47	SENT_361	[p23l201t1799r463b1877],
47	groups	NNS	O	group	prep_in	36	SENT_361	[p23l495t1824r816b1899],
48	.	.	O	.	_	0	SENT_361	[p23l495t1824r816b1899],

1	Remaining	VBG	O	remain	nsubj	7	SENT_362	[p23l854t1799r1327b1899],
2	cognizant	JJ	O	cognizant	amod	1	SENT_362	[p23l1358t1799r1782b1899],
3	of	IN	O	of	_	0	SENT_362	[p23l1811t1798r1912b1877],
4	these	DT	O	these	det	5	SENT_362	[p23l1927t1798r2147b1877],
5	caveats	NNS	O	caveat	prep_of	2	SENT_362	[p23l12t1936r308b1999],
6	will	MD	O	will	aux	7	SENT_362	[p23l332t1919r490b1999],
7	help	VB	O	help	_	0	SENT_362	[p23l515t1920r697b2020],
8	ensure	VB	O	ensure	dep	7	SENT_362	[p23l725t1945r1006b1999],
9	accurate	JJ	O	accurate	amod	10	SENT_362	[p23l1031t1936r1383b1999],
10	elucidation	NN	O	elucidation	dobj	8	SENT_362	[p23l1410t1919r1882b1999],
11	of	IN	O	of	_	0	SENT_362	[p23l1908t1919r2009b1998],
12	genetic	JJ	O	genetic	amod	13	SENT_362	[p23l2016t1946r2145b2020, p23l12t2041r216b2119],
13	determinants	NNS	O	determinant	prep_of	10	SENT_362	[p23l247t2041r810b2119],
14	of	IN	O	of	_	0	SENT_362	[p23l843t2040r944b2119],
15	drug	NN	O	drug	nn	16	SENT_362	[p23l957t2040r1157b2141],
16	response	NN	O	response	prep_of	13	SENT_362	[p23l1184t2066r1566b2141],
17	and	CC	O	and	_	0	SENT_362	[p23l1596t2041r1752b2119],
18	facilitate	VB	O	facilitate	dep	7	SENT_362	[p23l1783t2040r2147b2119],
19	the	DT	O	the	det	20	SENT_362	[p23l12t2162r142b2240],
20	translation	NN	O	translation	dobj	18	SENT_362	[p23l186t2162r645b2240],
21	of	IN	O	of	_	0	SENT_362	[p23l689t2161r790b2240],
22	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	20	SENT_362	[p23l813t2162r1659b2262],
23	into	IN	O	into	_	0	SENT_362	[p23l1703t2162r1869b2240],
24	widespread	JJ	O	widespread	amod	26	SENT_362	[p23l1909t2162r2145b2241, p23l13t2283r294b2383],
25	clinical	JJ	O	clinical	amod	26	SENT_362	[p23l319t2282r622b2361],
26	practice	NN	O	practice	prep_into	18	SENT_362	[p23l645t2283r1002b2383],
27	.	.	O	.	_	0	SENT_362	[p23l645t2283r1002b2383],

1	Supported	VBN	O	support	partmod	34	SENT_363	[p23l99t2415r429b2491],
2	in	IN	O	in	_	0	SENT_363	[p23l444t2416r505b2474],
3	part	NN	O	part	prep_in	1	SENT_363	[p23l520t2428r650b2491],
4	by	IN	O	by	_	0	SENT_363	[p23l663t2415r737b2491],
5	grants	NNS	O	grant	agent	1	SENT_363	[p23l749t2428r948b2492],
6	from	IN	O	from	_	0	SENT_363	[p23l966t2415r1122b2475],
7	the	DT	O	the	det	14	SENT_363	[p23l1139t2415r1236b2475],
8	National	NNP	ORGANIZATION	National	dep	14	SENT_363	[p23l1251t2415r1527b2475],
9	Institutes	NNPS	ORGANIZATION	Institutes	dep	8	SENT_363	[p23l1542t2416r1839b2475],
10	of	IN	ORGANIZATION	of	_	0	SENT_363	[p23l1857t2415r1934b2475],
11	Health	NNP	ORGANIZATION	Health	prep_of	8	SENT_363	[p23l1935t2415r2148b2475],
12	(	CD	NUMBER	(	num	11	SENT_363	[p23l15t2517r164b2581],
13	R37	NN	O	r37	nn	14	SENT_363	[p23l15t2517r164b2581],
14	CA36401	NN	O	ca36401	prep_from	1	SENT_363	[p23l182t2517r499b2585],
15	,	,	O	,	_	0	SENT_363	[p23l182t2517r499b2585],
16	R01	NN	O	r01	nn	17	SENT_363	[p23l519t2517r648b2576],
17	CA78224	NN	O	ca78224	nsubj	34	SENT_363	[p23l665t2517r982b2585],
18	,	,	O	,	_	0	SENT_363	[p23l665t2517r982b2585],
19	U01	NN	O	u01	nn	20	SENT_363	[p23l1003t2517r1135b2572],
20	GM61393	NN	O	gm61393	nsubj	34	SENT_363	[p23l1152t2517r1495b2585],
21	,	,	O	,	_	0	SENT_363	[p23l1152t2517r1495b2585],
22	U01	NN	O	u01	nn	23	SENT_363	[p23l1516t2517r1647b2572],
23	GM61394	NN	O	gm61394	nsubj	34	SENT_363	[p23l1665t2517r2008b2585],
24	,	,	O	,	_	0	SENT_363	[p23l1665t2517r2008b2585],
25	and	CC	O	and	_	0	SENT_363	[p23l2028t2512r2148b2572],
26	U01	NN	O	u01	nn	27	SENT_363	[p23l10t2597r142b2652],
27	GM63340	NN	O	gm63340	nsubj	34	SENT_363	[p23l190t2597r553b2665],
28	)	CD	NUMBER	)	num	33	SENT_363	[p23l190t2597r553b2665],
29	,	,	O	,	_	0	SENT_363	[p23l190t2597r553b2665],
30	Cancer	NNP	O	Cancer	dep	33	SENT_363	[p23l603t2597r826b2652],
31	Center	NNP	O	Center	nn	33	SENT_363	[p23l869t2597r1082b2652],
32	support	NN	O	support	nn	33	SENT_363	[p23l1126t2605r1377b2669],
33	grants	NNS	O	grant	dep	27	SENT_363	[p23l1419t2605r1618b2669],
34	(	VBP	O	(	_	0	SENT_363	[p23l1669t2597r1983b2661],
35	CA21765	NN	O	ca21765	dobj	34	SENT_363	[p23l1669t2597r1983b2661],
36	and	CC	O	and	_	0	SENT_363	[p23l2031t2593r2148b2652],
37	CA091842	NN	O	ca091842	nn	38	SENT_363	[p23l11t2694r388b2762],
38	)	NN	O	)	dobj	34	SENT_363	[p23l11t2694r388b2762],
39	,	,	O	,	_	0	SENT_363	[p23l11t2694r388b2762],
40	a	DT	O	a	det	41	SENT_363	[p23l415t2710r448b2749],
41	Center	NNP	O	Center	dobj	34	SENT_363	[p23l470t2694r682b2749],
42	of	IN	O	of	_	0	SENT_363	[p23l703t2689r779b2749],
43	Excellence	NNP	O	Excellence	nn	44	SENT_363	[p23l786t2689r1120b2749],
44	grant	NN	O	grant	prep_of	41	SENT_363	[p23l1143t2702r1314b2766],
45	from	IN	O	from	_	0	SENT_363	[p23l1334t2689r1490b2749],
46	the	DT	O	the	det	47	SENT_363	[p23l1514t2690r1611b2749],
47	State	NN	O	state	prep_from	41	SENT_363	[p23l1635t2694r1787b2749],
48	of	IN	O	of	_	0	SENT_363	[p23l1811t2689r1887b2749],
49	Tennessee	NNP	LOCATION	Tennessee	prep_of	47	SENT_363	[p23l1893t2694r2146b2749, p23l12t2807r127b2859],
50	,	,	O	,	_	0	SENT_363	[p23l1893t2694r2146b2749, p23l12t2807r127b2859],
51	a	DT	O	a	det	52	SENT_363	[p23l165t2807r199b2846],
52	grant	NN	O	grant	dobj	34	SENT_363	[p23l232t2799r404b2863],
53	from	IN	O	from	_	0	SENT_363	[p23l435t2786r592b2846],
54	the	DT	O	the	det	57	SENT_363	[p23l627t2786r724b2846],
55	Siteman	NNP	ORGANIZATION	Siteman	nn	57	SENT_363	[p23l760t2787r1018b2846],
56	Cancer	NNP	ORGANIZATION	Cancer	nn	57	SENT_363	[p23l1053t2791r1276b2846],
57	Center	NNP	ORGANIZATION	Center	prep_from	52	SENT_363	[p23l1309t2791r1532b2859],
58	,	,	O	,	_	0	SENT_363	[p23l1309t2791r1532b2859],
59	and	CC	O	and	_	0	SENT_363	[p23l1570t2786r1688b2846],
60	a	DT	O	a	det	61	SENT_363	[p23l1721t2807r1755b2846],
61	grant	NN	O	grant	dobj	34	SENT_363	[p23l1788t2799r1960b2863],
62	from	IN	O	from	_	0	SENT_363	[p23l1991t2786r2148b2846],
63	American	JJ	ORGANIZATION	american	amod	66	SENT_363	[p23l8t2884r318b2943],
64	Lebanese	JJ	ORGANIZATION	lebanese	amod	66	SENT_363	[p23l336t2884r631b2943],
65	Syrian	JJ	ORGANIZATION	syrian	amod	66	SENT_363	[p23l651t2884r845b2960],
66	Associated	NNP	ORGANIZATION	Associated	prep_from	61	SENT_363	[p23l861t2883r1206b2943],
67	Charities	NNPS	ORGANIZATION	Charities	dep	61	SENT_363	[p23l1224t2884r1528b2943],
68	.	.	O	.	_	0	SENT_363	[p23l1224t2884r1528b2943],

1	Dr.	NNP	O	Dr.	nn	2	SENT_364	[p23l96t2985r191b3040],
2	Evans	NNP	PERSON	Evans	nsubj	5	SENT_364	[p23l219t2986r402b3040],
3	became	VBD	O	become	cop	5	SENT_364	[p23l429t2980r671b3040],
4	a	DT	O	a	det	5	SENT_364	[p23l695t3001r729b3040],
5	member	NN	O	member	_	0	SENT_364	[p23l753t2980r1023b3040],
6	of	IN	O	of	_	0	SENT_364	[p23l1046t2980r1122b3040],
7	the	DT	O	the	det	11	SENT_364	[p23l1133t2981r1231b3040],
8	Clinical	JJ	ORGANIZATION	clinical	amod	11	SENT_364	[p23l1256t2980r1498b3040],
9	Genomics	NNP	ORGANIZATION	Genomics	nn	11	SENT_364	[p23l1523t2981r1848b3040],
10	Advisory	NNP	ORGANIZATION	Advisory	nn	11	SENT_364	[p23l1871t2980r2152b3057],
11	Board	NNP	ORGANIZATION	Board	prep_of	5	SENT_364	[p23l10t3077r200b3137],
12	of	IN	ORGANIZATION	of	_	0	SENT_364	[p23l224t3077r300b3137],
13	Merck	NNP	ORGANIZATION	Merck	prep_of	11	SENT_364	[p23l308t3077r513b3137],
14	and	CC	O	and	_	0	SENT_364	[p23l533t3077r650b3137],
15	a	DT	O	a	det	16	SENT_364	[p23l674t3098r707b3137],
16	member	NN	O	member	prep_of	5	SENT_364	[p23l730t3078r999b3137],
17	of	IN	O	of	_	0	SENT_364	[p23l1022t3077r1098b3137],
18	the	DT	O	the	det	21	SENT_364	[p23l1108t3078r1205b3137],
19	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	21	SENT_364	[p23l1231t3077r1524b3137],
20	Advisory	NNP	ORGANIZATION	Advisory	nn	21	SENT_364	[p23l1545t3077r1824b3154],
21	Board	NNP	ORGANIZATION	Board	prep_of	16	SENT_364	[p23l1844t3077r2034b3137],
22	for	IN	ORGANIZATION	for	_	0	SENT_364	[p23l2058t3077r2151b3137],
23	Signature	NNP	ORGANIZATION	Signature	nn	24	SENT_364	[p23l12t3175r315b3251],
24	Genetics	NNP	ORGANIZATION	Genetics	prep_for	5	SENT_364	[p23l334t3175r609b3234],
25	and	CC	O	and	_	0	SENT_364	[p23l628t3174r746b3234],
26	Gentris	NNP	ORGANIZATION	Gentris	prep_for	5	SENT_364	[p23l764t3175r999b3234],
27	after	IN	O	after	mark	31	SENT_364	[p23l1018t3174r1165b3234],
28	this	DT	O	this	det	29	SENT_364	[p23l1181t3175r1296b3234],
29	review	NN	O	review	nsubjpass	31	SENT_364	[p23l1315t3175r1520b3234],
30	was	VBD	O	be	auxpass	31	SENT_364	[p23l1532t3195r1654b3234],
31	Written	VBN	O	write	advcl	5	SENT_364	[p23l1670t3175r1917b3247],
32	,	,	O	,	_	0	SENT_364	[p23l1670t3175r1917b3247],
33	and	CC	O	and	_	0	SENT_364	[p23l1939t3174r2056b3234],
34	he	PRP	O	he	nsubj	38	SENT_364	[p23l2074t3175r2148b3234],
35	was	VBD	O	be	cop	38	SENT_364	[p23l7t3292r129b3332],
36	formerly	RB	O	formerly	advmod	38	SENT_364	[p23l147t3271r422b3348],
37	a	DT	O	a	det	38	SENT_364	[p23l435t3292r468b3331],
38	member	NN	O	member	conj_and	5	SENT_364	[p23l483t3271r752b3331],
39	of	IN	O	of	_	0	SENT_364	[p23l767t3271r842b3331],
40	the	DT	O	the	det	43	SENT_364	[p23l845t3272r942b3331],
41	Scientific	NNP	ORGANIZATION	Scientific	nn	43	SENT_364	[p23l960t3271r1252b3331],
42	Advisory	NNP	ORGANIZATION	Advisory	nn	43	SENT_364	[p23l1265t3271r1545b3348],
43	Board	NNP	ORGANIZATION	Board	prep_of	38	SENT_364	[p23l1556t3271r1747b3331],
44	of	IN	ORGANIZATION	of	_	0	SENT_364	[p23l1764t3271r1839b3331],
45	PPGX	NNP	ORGANIZATION	PPGX	prep_of	43	SENT_364	[p23l1840t3276r2039b3331],
46	.	.	O	.	_	0	SENT_364	[p23l1840t3276r2039b3331],

1	He	PRP	O	he	nsubj	3	SENT_365	[p23l2058t3277r2148b3331],
2	currently	RB	DATE	currently	advmod	3	SENT_365	[p23l11t3368r297b3445],
3	serves	VBZ	O	serve	_	0	SENT_365	[p23l320t3389r509b3428],
4	as	IN	O	as	_	0	SENT_365	[p23l535t3389r599b3428],
5	a	DT	O	a	det	6	SENT_365	[p23l625t3389r658b3428],
6	consultant	NN	O	consultant	prep_as	3	SENT_365	[p23l683t3368r1024b3428],
7	to	TO	O	to	_	0	SENT_365	[p23l1046t3381r1105b3428],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	9	SENT_365	[p23l1130t3368r1559b3445],
9	Squibb	NNP	O	Squibb	prep_to	3	SENT_365	[p23l1588t3369r1827b3445],
10	.	.	O	.	_	0	SENT_365	[p23l1588t3369r1827b3445],

1	He	PRP	O	he	nsubj	2	SENT_366	[p23l1856t3374r1946b3428],
2	holds	VBZ	O	hold	_	0	SENT_366	[p23l1971t3368r2146b3428],
3	no	DT	O	no	det	5	SENT_366	[p23l11t3485r91b3525],
4	equity	NN	O	equity	nn	5	SENT_366	[p23l111t3466r304b3542],
5	positions	NNS	O	position	dobj	2	SENT_366	[p23l318t3466r613b3542],
6	in	IN	O	in	_	0	SENT_366	[p23l632t3466r693b3524],
7	any	DT	O	any	prep_in	2	SENT_366	[p23l711t3485r822b3542],
8	of	IN	O	of	_	0	SENT_366	[p23l837t3465r913b3525],
9	these	DT	O	these	det	10	SENT_366	[p23l917t3466r1082b3525],
10	companies	NNS	O	company	prep_of	7	SENT_366	[p23l1101t3466r1465b3542],
11	.	.	O	.	_	0	SENT_366	[p23l1101t3466r1465b3542],

1	Dr.	NNP	O	Dr.	nn	2	SENT_367	[p23l1486t3470r1580b3525],
2	Evans	NNP	PERSON	Evans	poss	4	SENT_367	[p23l1601t3470r1838b3525],
3	’s	POS	O	’s	_	0	SENT_367	[p23l1601t3470r1838b3525],
4	laboratory	NN	O	laboratory	nsubjpass	6	SENT_367	[p23l1857t3465r2146b3525, p23l11t3583r71b3639],
5	is	VBZ	O	be	auxpass	6	SENT_367	[p23l90t3563r139b3622],
6	supported	VBN	O	support	_	0	SENT_367	[p23l164t3563r487b3639],
7	by	IN	O	by	_	0	SENT_367	[p23l511t3563r584b3639],
8	National	NNP	O	National	nn	9	SENT_367	[p23l602t3563r878b3622],
9	Institutes	NNPS	O	Institutes	agent	6	SENT_367	[p23l900t3563r1197b3622],
10	of	IN	O	of	_	0	SENT_367	[p23l1222t3562r1298b3622],
11	Health	NNP	O	Health	nn	12	SENT_367	[p23l1306t3563r1520b3622],
12	grants	NNS	O	grant	prep_of	9	SENT_367	[p23l1542t3575r1760b3639],
13	.	.	O	.	_	0	SENT_367	[p23l1542t3575r1760b3639],

1	He	PRP	O	he	nsubj	2	SENT_368	[p23l1787t3568r1877b3622],
2	receives	VBZ	O	receive	_	0	SENT_368	[p23l1900t3563r2147b3622],
3	no	DT	O	no	det	5	SENT_368	[p23l11t3679r91b3719],
4	research	NN	O	research	nn	5	SENT_368	[p23l127t3659r395b3719],
5	support	NN	O	support	dobj	2	SENT_368	[p23l431t3672r682b3736],
6	from	IN	O	from	_	0	SENT_368	[p23l714t3659r870b3719],
7	public	JJ	O	public	amod	10	SENT_368	[p23l904t3659r1104b3736],
8	or	CC	O	or	_	0	SENT_368	[p23l1139t3679r1207b3719],
9	private	JJ	O	private	amod	10	SENT_368	[p23l1239t3660r1453b3736],
10	companies	NNS	O	company	prep_from	2	SENT_368	[p23l1489t3660r1854b3736],
11	.	.	O	.	_	0	SENT_368	[p23l1489t3660r1854b3736],

1	Dr.	NNP	O	Dr.	nn	2	SENT_369	[p23l1892t3664r1986b3719],
2	McLeod	NNP	PERSON	McLeod	poss	4	SENT_369	[p23l2023t3665r2146b3719, p23l10t3756r217b3816],
3	’s	POS	O	’s	_	0	SENT_369	[p23l2023t3665r2146b3719, p23l10t3756r217b3816],
4	laboratory	NN	O	laboratory	nsubjpass	6	SENT_369	[p23l247t3756r575b3833],
5	is	VBZ	O	be	auxpass	6	SENT_369	[p23l601t3757r650b3816],
6	supported	VBN	O	support	_	0	SENT_369	[p23l682t3756r1005b3833],
7	by	IN	O	by	_	0	SENT_369	[p23l1035t3757r1108b3833],
8	grants	NNS	O	grant	agent	6	SENT_369	[p23l1134t3769r1332b3833],
9	from	IN	O	from	_	0	SENT_369	[p23l1363t3756r1520b3816],
10	the	DT	O	the	det	12	SENT_369	[p23l1550t3756r1647b3816],
11	National	NNP	O	National	nn	12	SENT_369	[p23l1675t3757r1952b3816],
12	Institutes	NNPS	O	Institutes	prep_from	8	SENT_369	[p23l1979t3757r2148b3816, p24l11t39r161b86],

1	of	IN	O	of	dep	2	SENT_370	[p24l182t26r257b86],
2	Health	NNP	O	Health	_	0	SENT_370	[p24l261t26r492b99],
3	,	,	O	,	_	0	SENT_370	[p24l261t26r492b99],
4	as	IN	O	as	_	0	SENT_370	[p24l514t47r577b86],
5	Well	NNP	O	Well	prep_as	7	SENT_370	[p24l593t26r725b87],
6	as	IN	O	as	dep	7	SENT_370	[p24l742t47r806b86],
7	by	IN	O	by	dep	2	SENT_370	[p24l826t27r899b103],
8	research	NN	O	research	nn	9	SENT_370	[p24l913t26r1181b86],
9	grants	NNS	O	grant	pobj	7	SENT_370	[p24l1198t39r1397b103],
10	from	IN	O	from	_	0	SENT_370	[p24l1417t26r1574b86],
11	N	NN	O	n	nn	13	SENT_370	[p24l1590t32r1646b86],
12	ovartis	NN	O	ovarti	nn	13	SENT_370	[p24l1649t27r1858b86],
13	Pharmaceuticals	NNS	O	pharmaceutical	prep_from	9	SENT_370	[p24l1876t26r2148b86, p24l11t123r283b183],
14	and	CC	O	and	_	0	SENT_370	[p24l317t123r435b183],
15	Ortho	NNP	ORGANIZATION	Ortho	nn	17	SENT_370	[p24l467t123r654b183],
16	Clinical	JJ	ORGANIZATION	clinical	amod	17	SENT_370	[p24l688t124r930b183],
17	Diagnostics	NNPS	ORGANIZATION	Diagnostics	pobj	7	SENT_370	[p24l961t124r1337b200],
18	for	IN	O	for	_	0	SENT_370	[p24l1371t123r1464b183],
19	projects	NNS	O	project	prep_for	17	SENT_370	[p24l1493t124r1743b200],
20	that	WDT	O	that	nsubj	23	SENT_370	[p24l1778t123r1904b183],
21	do	VBP	O	do	aux	23	SENT_370	[p24l1933t123r2011b183],
22	not	RB	O	not	neg	23	SENT_370	[p24l2044t136r2152b183],
23	overlap	VB	O	overlap	rcmod	19	SENT_370	[p24l11t221r241b297],
24	directly	RB	O	directly	advmod	23	SENT_370	[p24l261t220r497b297],
25	or	CC	O	or	_	0	SENT_370	[p24l513t240r580b280],
26	indirectly	RB	O	indirectly	advmod	23	SENT_370	[p24l596t220r897b297],
27	with	IN	O	with	_	0	SENT_370	[p24l909t221r1052b281],
28	the	DT	O	the	det	29	SENT_370	[p24l1071t221r1168b280],
29	contents	NNS	O	contents	prep_with	23	SENT_370	[p24l1188t233r1458b280],
30	of	IN	O	of	_	0	SENT_370	[p24l1479t220r1555b280],
31	this	DT	O	this	det	32	SENT_370	[p24l1560t220r1676b280],
32	article	NN	O	article	prep_of	29	SENT_370	[p24l1695t221r1908b280],
33	.	.	O	.	_	0	SENT_370	[p24l1695t221r1908b280],

1	13	CD	NUMBER	13	_	0	SENT_371	[p24l14t606r114b686],
2	.	.	O	.	_	0	SENT_371	[p24l127t668r146b686],

1	Meyer	NNP	PERSON	Meyer	nn	2	SENT_372	[p24l205t604r499b712],
2	UA	NNP	O	UA	_	0	SENT_372	[p24l516t604r688b686],
3	.	.	O	.	_	0	SENT_372	[p24l516t604r688b686],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_373	[p24l714t596r1581b712],
2	and	CC	O	and	_	0	SENT_373	[p24l1603t596r1780b686],
3	adverse	JJ	O	adverse	amod	5	SENT_373	[p24l1800t596r2151b688],
4	drug	NN	O	drug	nn	5	SENT_373	[p24l10t746r235b862],
5	reactions	NNS	O	reaction	conj_and	1	SENT_373	[p24l257t748r720b836],
6	.	.	O	.	_	0	SENT_373	[p24l257t748r720b836],

1	Lancet	NNP	O	Lancet	_	0	SENT_374	[p24l753t754r1079b836],
2	2000	CD	DATE	2000	num	1	SENT_374	[p24l1102t752r2030b856],
3	;	:	O	;	_	0	SENT_374	[p24l1102t752r2030b856],
4	356:1667	CD	NUMBER	356:1667	number	5	SENT_374	[p24l1102t752r2030b856],
5	—	CD	NUMBER	—	dep	1	SENT_374	[p24l1102t752r2030b856],
6	71	CD	NUMBER	71	dep	5	SENT_374	[p24l1102t752r2030b856],
7	.	.	O	.	_	0	SENT_374	[p24l1102t752r2030b856],

1	14	CD	NUMBER	14	_	0	SENT_375	[p24l14t908r146b986],
2	.	.	O	.	_	0	SENT_375	[p24l14t908r146b986],

1	Ingelman	NNP	O	Ingelman	_	0	SENT_376	[p24l207t896r1202b1012],
2	.	.	O	.	_	0	SENT_376	[p24l207t896r1202b1012],

1	—	NN	O	—	_	0	SENT_377	[p24l207t896r1202b1012],
2	.	.	O	.	_	0	SENT_377	[p24l207t896r1202b1012],

1	Sundberg	NNP	PERSON	Sundberg	nn	2	SENT_378	[p24l207t896r1202b1012],
2	M	NNP	O	M	_	0	SENT_378	[p24l1272t904r1398b1006],
3	,	,	O	,	_	0	SENT_378	[p24l1272t904r1398b1006],
4	Oscarson	NNP	O	Oscarson	nn	5	SENT_378	[p24l1481t902r1942b988],
5	M	NNP	O	M	appos	2	SENT_378	[p24l2015t904r2143b1006],
6	,	,	O	,	_	0	SENT_378	[p24l2015t904r2143b1006],
7	McLellan	NNP	PERSON	McLellan	nn	8	SENT_378	[p24l6t1046r459b1136],
8	RA	NN	O	ra	appos	5	SENT_378	[p24l532t1054r706b1142],
9	.	.	O	.	_	0	SENT_378	[p24l532t1054r706b1142],

1	Polymorphic	JJ	MISC	polymorphic	amod	5	SENT_379	[p24l787t1046r1415b1162],
2	human	JJ	O	human	amod	5	SENT_379	[p24l1491t1046r1838b1138],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_379	[p24l1915t1066r2147b1162, p24l10t1196r383b1288],
4	P450	NN	O	p450	nn	5	SENT_379	[p24l428t1202r670b1286],
5	enzymes	NNS	O	enzyme	_	0	SENT_379	[p24l719t1226r1172b1312],
6	:	:	O	:	_	0	SENT_379	[p24l719t1226r1172b1312],
7	an	DT	O	a	det	8	SENT_379	[p24l1222t1226r1338b1286],
8	opportunity	NN	O	opportunity	dep	5	SENT_379	[p24l1385t1198r1970b1312],
9	for	IN	O	for	_	0	SENT_379	[p24l2009t1194r2153b1286],
10	individualized	VBN	O	individualize	prepc_for	8	SENT_379	[p24l10t1346r702b1438],
11	drug	NN	O	drug	nn	12	SENT_379	[p24l730t1346r961b1462],
12	treatment	NN	O	treatment	dobj	10	SENT_379	[p24l987t1366r1488b1436],
13	.	.	O	.	_	0	SENT_379	[p24l987t1366r1488b1436],

1	Trends	NNS	O	trend	_	0	SENT_380	[p24l1519t1346r1856b1436],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_380	[p24l1884t1346r2147b1436, p24l10t1496r309b1588],
3	Sci	NNP	O	Sci	dep	1	SENT_380	[p24l339t1496r477b1588],
4	1999	CD	DATE	1999	num	3	SENT_380	[p24l508t1502r1248b1606],
5	;	:	O	;	_	0	SENT_380	[p24l508t1502r1248b1606],
6	20:342	CD	NUMBER	20:342	number	7	SENT_380	[p24l508t1502r1248b1606],
7	—	CD	NUMBER	—	dep	1	SENT_380	[p24l508t1502r1248b1606],
8	9	CD	NUMBER	9	dep	7	SENT_380	[p24l508t1502r1248b1606],
9	.	.	O	.	_	0	SENT_380	[p24l508t1502r1248b1606],

1	15	CD	NUMBER	15	_	0	SENT_381	[p24l14t1658r146b1736],
2	.	.	O	.	_	0	SENT_381	[p24l14t1658r146b1736],

1	Kuehl	NNP	PERSON	Kuehl	nn	2	SENT_382	[p24l209t1646r499b1740],
2	P	NN	O	p	_	0	SENT_382	[p24l534t1654r608b1756],
3	,	,	O	,	_	0	SENT_382	[p24l534t1654r608b1756],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_382	[p24l650t1646r967b1762],
5	J	NNP	PERSON	J	appos	2	SENT_382	[p24l989t1654r1057b1756],
6	,	,	O	,	_	0	SENT_382	[p24l989t1654r1057b1756],
7	Lin	NNP	O	Lin	nn	8	SENT_382	[p24l1099t1648r1256b1736],
8	Y	NN	O	y	appos	2	SENT_382	[p24l1290t1654r1368b1756],
9	,	,	O	,	_	0	SENT_382	[p24l1290t1654r1368b1756],
10	et	FW	O	et	nn	11	SENT_382	[p24l1413t1664r1501b1736],
11	al.	FW	O	al.	appos	2	SENT_382	[p24l1533t1646r1643b1736],
12	.	.	O	.	_	0	SENT_382	[p24l1533t1646r1643b1736],

1	Sequence	NN	O	sequence	nn	2	SENT_383	[p24l1689t1652r2147b1762],
2	diversity	NN	O	diversity	_	0	SENT_383	[p24l10t1796r421b1912],
3	in	IN	O	in	_	0	SENT_383	[p24l439t1796r534b1886],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_383	[p24l560t1802r893b1888],
5	promoters	NNS	O	promoter	prep_in	2	SENT_383	[p24l913t1814r1426b1912],
6	and	CC	O	and	_	0	SENT_383	[p24l1453t1796r1633b1886],
7	characterization	NN	O	characterization	prep_in	2	SENT_383	[p24l1659t1796r2147b1886, p24l10t1946r345b2036],
8	of	IN	O	of	_	0	SENT_383	[p24l378t1944r495b2036],
9	the	DT	O	the	det	11	SENT_383	[p24l506t1946r656b2036],
10	genetic	JJ	O	genetic	amod	11	SENT_383	[p24l688t1948r1041b2062],
11	basis	NN	O	basis	prep_of	2	SENT_383	[p24l1072t1946r1316b2036],
12	for	IN	O	for	_	0	SENT_383	[p24l1349t1944r1493b2036],
13	polymorphic	JJ	O	polymorphic	amod	15	SENT_383	[p24l1519t1946r2149b2062],
14	CYP3A5	NN	O	cyp3a5	nn	15	SENT_383	[p24l10t2102r397b2188],
15	expression	NN	O	expression	prep_for	11	SENT_383	[p24l475t2098r1029b2212],
16	.	.	O	.	_	0	SENT_383	[p24l475t2098r1029b2212],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_384	[p24l1105t2104r1288b2188],
2	Genet	NNP	PERSON	Genet	_	0	SENT_384	[p24l1354t2102r1653b2188],
3	2001	CD	DATE	2001	num	2	SENT_384	[p24l1718t2102r2143b2206],
4	;	:	O	;	_	0	SENT_384	[p24l1718t2102r2143b2206],
5	27	CD	NUMBER	27	num	7	SENT_384	[p24l1718t2102r2143b2206],
6	:	:	O	:	_	0	SENT_384	[p24l1718t2102r2143b2206],
7	383-91	CD	NUMBER	383-91	dep	2	SENT_384	[p24l10t2252r379b2338],
8	.	.	O	.	_	0	SENT_384	[p24l10t2252r379b2338],

1	16	CD	NUMBER	16	_	0	SENT_385	[p24l14t2406r146b2486],
2	.	.	O	.	_	0	SENT_385	[p24l14t2406r146b2486],

1	Sata	NNP	PERSON	Sata	nn	2	SENT_386	[p24l211t2402r415b2488],
2	F	NN	O	f	_	0	SENT_386	[p24l474t2404r548b2506],
3	,	,	O	,	_	0	SENT_386	[p24l474t2404r548b2506],
4	Sapone	NNP	O	Sapone	nn	5	SENT_386	[p24l620t2402r975b2512],
5	A	NNP	O	A	appos	2	SENT_386	[p24l1035t2404r1135b2506],
6	,	,	O	,	_	0	SENT_386	[p24l1035t2404r1135b2506],
7	Elizondo	NNP	PERSON	Elizondo	nn	8	SENT_386	[p24l1204t2396r1643b2486],
8	G	NNP	O	G	appos	2	SENT_386	[p24l1706t2402r1816b2506],
9	,	,	O	,	_	0	SENT_386	[p24l1706t2402r1816b2506],
10	et	FW	O	et	nn	11	SENT_386	[p24l1888t2414r1976b2486],
11	al.	FW	O	al.	appos	2	SENT_386	[p24l2033t2396r2141b2486],
12	.	.	O	.	_	0	SENT_386	[p24l2033t2396r2141b2486],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_387	[p24l10t2552r403b2638],
2	allelic	JJ	O	allelic	amod	3	SENT_387	[p24l425t2546r710b2636],
3	variants	NNS	O	variant	dep	1	SENT_387	[p24l728t2546r1113b2638],
4	with	IN	O	with	_	0	SENT_387	[p24l1134t2546r1354b2638],
5	amino	NN	O	amino	nn	7	SENT_387	[p24l1377t2548r1689b2636],
6	acid	NN	O	acid	nn	7	SENT_387	[p24l1714t2546r1912b2636],
7	sub	NN	O	sub	prep_with	3	SENT_387	[p24l1938t2546r2147b2638],
8	—	CD	NUMBER	—	dep	1	SENT_387	[p24l1938t2546r2147b2638],

1	stitutions	NNS	O	stitution	_	0	SENT_388	[p24l12t2696r469b2788],
2	in	IN	O	in	_	0	SENT_388	[p24l500t2696r596b2786],
3	exons	NNS	O	exon	prep_in	1	SENT_388	[p24l626t2726r905b2786],
4	7	CD	NUMBER	7	num	3	SENT_388	[p24l939t2704r993b2786],
5	and	CC	O	and	_	0	SENT_388	[p24l1023t2696r1204b2786],
6	12	CD	NUMBER	12	prep_in	1	SENT_388	[p24l1238t2702r1380b2786],
7	:	:	O	:	_	0	SENT_388	[p24l1238t2702r1380b2786],
8	evidence	NN	O	evidence	dep	1	SENT_388	[p24l1415t2696r1834b2788],
9	for	IN	O	for	_	0	SENT_388	[p24l1864t2694r2007b2788],
10	an	DT	O	a	det	12	SENT_388	[p24l2033t2726r2149b2786],
11	allelic	JJ	O	allelic	amod	12	SENT_388	[p24l10t2846r295b2936],
12	variant	NN	O	variant	prep_for	8	SENT_388	[p24l333t2846r674b2938],
13	with	IN	O	with	_	0	SENT_388	[p24l707t2846r927b2938],
14	altered	JJ	O	altered	amod	16	SENT_388	[p24l970t2846r1302b2936],
15	catalytic	JJ	O	catalytic	amod	16	SENT_388	[p24l1347t2846r1743b2962],
16	activity	NN	O	activity	prep_with	12	SENT_388	[p24l1786t2848r2141b2962],
17	.	.	O	.	_	0	SENT_388	[p24l1786t2848r2141b2962],

1	Clin	NNP	O	Clin	nn	3	SENT_389	[p24l10t2996r211b3088],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_389	[p24l237t2996r766b3088],
3	Ther	NNP	O	Ther	_	0	SENT_389	[p24l789t2996r1023b3086],
4	2000	CD	DATE	2000	num	3	SENT_389	[p24l1049t3002r1792b3106],
5	;	:	O	;	_	0	SENT_389	[p24l1049t3002r1792b3106],
6	67:48	CD	NUMBER	67:48	number	7	SENT_389	[p24l1049t3002r1792b3106],
7	—	CD	NUMBER	—	dep	3	SENT_389	[p24l1049t3002r1792b3106],
8	56	CD	NUMBER	56	dep	7	SENT_389	[p24l1049t3002r1792b3106],
9	.	.	O	.	_	0	SENT_389	[p24l1049t3002r1792b3106],

1	17	CD	NUMBER	17	_	0	SENT_390	[p24l14t3158r146b3236],
2	.	.	O	.	_	0	SENT_390	[p24l14t3158r146b3236],

1	Borst	NNP	PERSON	Borst	nn	2	SENT_391	[p24l207t3154r474b3236],
2	P	NN	PERSON	p	_	0	SENT_391	[p24l496t3154r570b3256],
3	,	,	O	,	_	0	SENT_391	[p24l496t3154r570b3256],
4	Evers	NNP	PERSON	Evers	nn	5	SENT_391	[p24l604t3154r861b3238],
5	R	NNP	PERSON	R	appos	2	SENT_391	[p24l893t3154r993b3256],
6	,	,	O	,	_	0	SENT_391	[p24l893t3154r993b3256],
7	Kool	NNP	LOCATION	Kool	nn	8	SENT_391	[p24l1027t3146r1260b3240],
8	M	NNP	LOCATION	M	appos	2	SENT_391	[p24l1286t3154r1413b3256],
9	,	,	O	,	_	0	SENT_391	[p24l1286t3154r1413b3256],
10	Wijnholds	NNP	O	Wijnholds	nn	13	SENT_391	[p24l1445t3146r1954b3262],
11	J.	NNP	O	J.	nn	13	SENT_391	[p24l1975t3154r2043b3250],
12	A	NNP	O	A	nn	13	SENT_391	[p24l2075t3154r2153b3236],
13	family	NN	O	family	appos	2	SENT_391	[p24l10t3294r317b3412],
14	of	IN	O	of	_	0	SENT_391	[p24l361t3294r477b3388],
15	drug	NN	O	drug	nn	16	SENT_391	[p24l502t3296r734b3412],
16	transporters	NNS	O	transporter	prep_of	13	SENT_391	[p24l777t3316r1406b3412],
17	:	:	O	:	_	0	SENT_391	[p24l777t3316r1406b3412],
18	the	DT	O	the	det	21	SENT_391	[p24l1459t3296r1609b3386],
19	multidrug	JJ	O	multidrug	amod	21	SENT_391	[p24l1655t3296r2153b3412],
20	resistance	NN	O	resistance	nn	21	SENT_391	[p24l10t3446r1051b3536],
21	—	NN	O	—	dep	2	SENT_391	[p24l10t3446r1051b3536],
22	associated	VBN	O	associate	partmod	21	SENT_391	[p24l10t3446r1051b3536],
23	proteins	NNS	O	protein	dobj	22	SENT_391	[p24l1098t3448r1531b3562],
24	.	.	O	.	_	0	SENT_391	[p24l1098t3448r1531b3562],

1	J	NNP	O	J	nn	4	SENT_392	[p24l1575t3454r1619b3552],
2	Natl	NNP	O	Natl	nn	4	SENT_392	[p24l1661t3446r1870b3538],
3	Cancer	NNP	O	Cancer	nn	4	SENT_392	[p24l1918t3452r2147b3538, p24l10t3626r156b3686],
4	Inst	NNP	O	Inst	_	0	SENT_392	[p24l180t3604r373b3686],
5	2000	CD	DATE	2000	num	4	SENT_392	[p24l397t3602r1324b3706],
6	;	:	O	;	_	0	SENT_392	[p24l397t3602r1324b3706],
7	92:1295	CD	NUMBER	92:1295	num	8	SENT_392	[p24l397t3602r1324b3706],
8	—	NN	O	—	dep	4	SENT_392	[p24l397t3602r1324b3706],
9	302	CD	NUMBER	302	dep	8	SENT_392	[p24l397t3602r1324b3706],
10	.	.	O	.	_	0	SENT_392	[p24l397t3602r1324b3706],

1	18	CD	NUMBER	18	_	0	SENT_393	[p25l14t35r146b119],
2	.	.	O	.	_	0	SENT_393	[p25l14t35r146b119],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_394	[p25l209t29r415b121],
2	RB	NN	O	rb	_	0	SENT_394	[p25l438t35r608b137],
3	,	,	O	,	_	0	SENT_394	[p25l438t35r608b137],
4	Leake	NNP	PERSON	Leake	nn	5	SENT_394	[p25l638t27r919b119],
5	BF	NNP	O	BF	appos	2	SENT_394	[p25l943t35r1086b137],
6	,	,	O	,	_	0	SENT_394	[p25l943t35r1086b137],
7	Choo	NNP	ORGANIZATION	Choo	nn	8	SENT_394	[p25l1118t27r1379b119],
8	EF	NNP	ORGANIZATION	EF	appos	2	SENT_394	[p25l1403t35r1543b137],
9	,	,	O	,	_	0	SENT_394	[p25l1403t35r1543b137],
10	et	FW	O	et	nn	12	SENT_394	[p25l1575t47r1665b117],
11	al.	FW	O	al.	nn	12	SENT_394	[p25l1682t27r1792b117],
12	l	NN	O	l	appos	2	SENT_394	[p25l1820t27r2147b117],
13	[	CD	NUMBER	[	num	16	SENT_394	[p25l1820t27r2147b117],
14	denti	NN	O	dentus	nn	16	SENT_394	[p25l1820t27r2147b117],
15	—	NN	O	—	nn	16	SENT_394	[p25l1820t27r2147b117],
16	ﬁcation	NN	O	ﬁcation	dep	2	SENT_394	[p25l10t175r381b267],
17	offunctionally	RB	O	offunctionally	advmod	18	SENT_394	[p25l409t175r1120b293],
18	variant	JJ	O	variant	amod	20	SENT_394	[p25l1136t177r1479b269],
19	MDR1	NN	O	mdr1	nn	20	SENT_394	[p25l1497t183r1818b273],
20	alleles	NNS	O	allele	dep	16	SENT_394	[p25l1846t177r2147b267],

1	N	NN	O	n	nn	3	SENT_395	[p25l493t374r506b390],
2	ENGLJ	NN	O	englj	nn	3	SENT_395	[p25l522t374r606b396],
3	MED	NN	O	med	_	0	SENT_395	[p25l621t374r673b389],
4	348	CD	NUMBER	348	dep	3	SENT_395	[p25l686t368r756b396],
5	;	:	O	;	_	0	SENT_395	[p25l686t368r756b396],
6	6	CD	NUMBER	6	num	7	SENT_395	[p25l686t368r756b396],
7	WWW	NN	O	www	dep	3	SENT_395	[p25l791t374r886b390],
8	.	.	O	.	_	0	SENT_395	[p25l791t374r886b390],

1	N	NN	O	n	nn	2	SENT_396	[p25l791t374r886b390],
2	EJ	NN	O	ej	_	0	SENT_396	[p25l894t374r911b396],
3	M.ORG	NN	O	m.org	nn	4	SENT_396	[p25l919t374r1003b390],
4	FEBRUARY	NN	DATE	february	dep	2	SENT_396	[p25l1042t374r1169b390],
5	6,2003	CD	NUMBER	6,2003	number	6	SENT_396	[p25l1182t368r1280b396],
6	547	CD	NUMBER	547	dep	4	SENT_396	[p25l1960t373r2016b395],

1	The	DT	O	the	det	4	SENT_397	[p25l702t407r753b431],
2	New	NNP	O	New	nn	4	SENT_397	[p25l762t408r824b431],
3	England	NNP	O	England	nn	4	SENT_397	[p25l833t407r944b438],
4	Journal	NNP	O	Journal	_	0	SENT_397	[p25l953t407r1050b431],
5	of	IN	O	of	_	0	SENT_397	[p25l1060t407r1089b431],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_397	[p25l1095t407r1220b431],

1	Downloaded	VBN	O	download	_	0	SENT_398	[p25l144t448r314b471],
2	from	IN	O	from	_	0	SENT_398	[p25l323t448r387b471],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_398	[p25l396t448r514b478],
4	at	IN	O	at	_	0	SENT_398	[p25l524t452r548b471],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_398	[p25l556t448r739b471],
6	on	IN	O	on	_	0	SENT_398	[p25l748t455r780b471],
7	January	NNP	DATE	January	prep_on	1	SENT_398	[p25l789t448r892b478],
8	5	CD	DATE	5	num	7	SENT_398	[p25l902t448r924b476],
9	,	,	DATE	,	_	0	SENT_398	[p25l902t448r924b476],
10	2014	CD	DATE	2014	num	7	SENT_398	[p25l935t448r1007b471],
11	.	.	O	.	_	0	SENT_398	[p25l935t448r1007b471],

1	or	CC	O	or	dep	4	SENT_399	[p25l1037t455r1064b471],
2	ersonal	JJ	O	ersonal	amod	3	SENT_399	[p25l1090t448r1185b471],
3	use	NN	O	use	npadvmod	4	SENT_399	[p25l1194t455r1237b471],
4	only	RB	O	only	_	0	SENT_399	[p25l1247t448r1312b478],
5	.	.	O	.	_	0	SENT_399	[p25l1247t448r1312b478],

1	No	DT	O	no	det	3	SENT_400	[p25l1322t448r1362b471],
2	other	JJ	O	other	amod	3	SENT_400	[p25l1372t448r1440b471],
3	uses	NNS	O	use	_	0	SENT_400	[p25l1449t455r1504b471],
4	without	IN	O	without	_	0	SENT_400	[p25l1515t448r1616b471],
5	permission	NN	O	permission	prep_without	3	SENT_400	[p25l1624t448r1777b478],
6	.	.	O	.	_	0	SENT_400	[p25l1624t448r1777b478],

1	Copyright	NN	O	copyright	nn	5	SENT_401	[p25l494t489r629b520],
2	©	CD	NUMBER	©	num	5	SENT_401	[p25l638t489r661b513],
3	2003	CD	DATE	2003	num	5	SENT_401	[p25l672t489r735b513],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_401	[p25l746t489r937b513],
5	Medica	NNP	ORGANIZATION	Medica	_	0	SENT_401	[p25l947t489r1047b513],
6	ociety	NN	O	ociety	dep	5	SENT_401	[p25l1084t489r1170b520],
7	.	.	O	.	_	0	SENT_401	[p25l1084t489r1170b520],

1	All	DT	O	all	det	2	SENT_402	[p25l1181t489r1223b513],
2	rights	NNS	O	rights	nsubj	3	SENT_402	[p25l1232t489r1307b520],
3	reserved	VBN	O	reserve	_	0	SENT_402	[p25l1316t489r1435b513],
4	.	.	O	.	_	0	SENT_402	[p25l1316t489r1435b513],

1	NNNNNNNNNNN	NNP	O	NNNNNNNNNNN	nn	4	SENT_403	[p25l715t595r978b616],
2	ND	NNP	O	ND	nn	4	SENT_403	[p25l982t597r1034b616],
3	JOURNAL	NNP	O	JOURNAL	nn	4	SENT_403	[p25l1048t597r1214b623],
4	afMEDICINE	NNP	O	afMEDICINE	_	0	SENT_403	[p25l1228t595r1444b622],

1	among	IN	O	among	_	0	SENT_404	[p25l9t950r355b1037],
2	European	JJ	MISC	european	amod	3	SENT_404	[p25l414t928r883b1035],
3	Americans	NNPS	MISC	Americans	pobj	1	SENT_404	[p25l946t922r1467b1011],
4	and	CC	O	and	_	0	SENT_404	[p25l1534t920r1712b1011],
5	African	NNP	MISC	African	nn	6	SENT_404	[p25l1775t920r2133b1011],
6	Americans	NNPS	MISC	Americans	conj_and	3	SENT_404	[p25l7t1071r555b1160],
7	.	.	O	.	_	0	SENT_404	[p25l7t1071r555b1160],

1	Clin	NNP	O	Clin	nn	3	SENT_405	[p25l612t1069r812b1160],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_405	[p25l859t1069r1382b1160],
3	Ther	NNP	O	Ther	_	0	SENT_405	[p25l1427t1069r1659b1160],
4	2001	CD	DATE	2001	num	3	SENT_405	[p25l1706t1077r2127b1178],
5	;	:	O	;	_	0	SENT_405	[p25l1706t1077r2127b1178],
6	70	CD	NUMBER	70	num	8	SENT_405	[p25l1706t1077r2127b1178],
7	:	:	O	:	_	0	SENT_405	[p25l1706t1077r2127b1178],
8	189-99	CD	NUMBER	189-99	dep	3	SENT_405	[p25l15t1225r375b1308],
9	.	.	O	.	_	0	SENT_405	[p25l15t1225r375b1308],

1	19	CD	NUMBER	19	_	0	SENT_406	[p25l15t1378r146b1457],
2	.	.	O	.	_	0	SENT_406	[p25l15t1378r146b1457],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_407	[p25l207t1366r753b1481],
2	S	NNP	O	S	_	0	SENT_407	[p25l798t1374r881b1477],
3	,	,	O	,	_	0	SENT_407	[p25l798t1374r881b1477],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_407	[p25l931t1366r1180b1457],
5	o	NN	O	o	appos	2	SENT_407	[p25l1219t1374r1324b1477],
6	,	,	O	,	_	0	SENT_407	[p25l1219t1374r1324b1477],
7	Von	NNP	PERSON	Von	nn	9	SENT_407	[p25l1372t1396r1556b1457],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_407	[p25l1599t1366r1975b1463],
9	O	NNP	PERSON	O	appos	2	SENT_407	[p25l2016t1374r2122b1477],
10	,	,	O	,	_	0	SENT_407	[p25l2016t1374r2122b1477],
11	et	FW	O	et	nn	12	SENT_407	[p25l11t1535r102b1606],
12	al.	FW	O	al.	appos	2	SENT_407	[p25l159t1517r272b1606],
13	.	.	O	.	_	0	SENT_407	[p25l159t1517r272b1606],

1	Functional	JJ	O	functional	amod	2	SENT_408	[p25l341t1515r885b1607],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_408	[p25l946t1517r1748b1632],
3	of	IN	O	of	_	0	SENT_408	[p25l1815t1515r1934b1606],
4	the	DT	O	the	det	9	SENT_408	[p25l1977t1517r2129b1606],
5	human	JJ	O	human	amod	9	SENT_408	[p25l11t1666r355b1756],
6	multidrug	JJ	O	multidrug	amod	9	SENT_408	[p25l383t1664r1404b1781],
7	—	NN	O	—	nn	9	SENT_408	[p25l383t1664r1404b1781],
8	resistance	NN	O	resistance	nn	9	SENT_408	[p25l383t1664r1404b1781],
9	gene	NN	O	gene	prep_of	2	SENT_408	[p25l1433t1694r1690b1781],
10	:	:	O	:	_	0	SENT_408	[p25l1433t1694r1690b1781],
11	multiple	JJ	O	multiple	dep	2	SENT_408	[p25l1724t1666r2131b1781],
12	se	FW	O	se	nn	13	SENT_408	[p25l13t1843r498b1930],
13	—	FW	O	—	advmod	14	SENT_408	[p25l13t1843r498b1930],
14	quence	FW	O	quence	rcmod	11	SENT_408	[p25l13t1843r498b1930],
15	variations	NNS	O	variation	dep	14	SENT_408	[p25l525t1815r1012b1905],
16	and	CC	O	and	_	0	SENT_408	[p25l1049t1813r1229b1904],
17	correlation	NN	O	correlation	conj_and	14	SENT_408	[p25l1263t1813r1793b1904],
18	of	IN	O	of	_	0	SENT_408	[p25l1827t1813r1943b1904],
19	one	CD	NUMBER	one	num	20	SENT_408	[p25l1957t1843r2131b1904],
20	allele	NN	O	allele	prep_of	17	SENT_408	[p25l9t1964r272b2053],
21	with	IN	O	with	_	0	SENT_408	[p25l309t1964r535b2054],
22	P	NN	O	p	nn	25	SENT_408	[p25l574t1964r1319b2079],
23	—	CD	NUMBER	—	num	25	SENT_408	[p25l574t1964r1319b2079],
24	glycoprotein	NN	O	glycoprotein	nn	25	SENT_408	[p25l574t1964r1319b2079],
25	expression	NN	O	expression	prep_with	20	SENT_408	[p25l1362t1964r1906b2079],
26	and	CC	O	and	_	0	SENT_408	[p25l1947t1962r2131b2053],
27	activity	NN	O	activity	conj_and	20	SENT_408	[p25l9t2113r359b2226],
28	in	FW	O	in	prep	27	SENT_408	[p25l407t2113r502b2200],
29	vivo	FW	O	vivo	pobj	28	SENT_408	[p25l551t2113r773b2203],
30	.	.	O	.	_	0	SENT_408	[p25l551t2113r773b2203],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_409	[p25l829t2119r1046b2202],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_409	[p25l1093t2111r1301b2203],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_409	[p25l1346t2111r1589b2202],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_409	[p25l1643t2113r1779b2202],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_409	[p25l1828t2121r1908b2202],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_409	[p25l1961t2119r2009b2202],
7	A	NNP	O	A	_	0	SENT_409	[p25l2060t2121r2135b2200],
8	2000	CD	DATE	2000	num	7	SENT_409	[p25l11t2268r808b2371],
9	;	:	O	;	_	0	SENT_409	[p25l11t2268r808b2371],
10	97:3473	CD	NUMBER	97:3473	number	11	SENT_409	[p25l11t2268r808b2371],
11	-8	CD	NUMBER	-8	dep	7	SENT_409	[p25l11t2268r808b2371],
12	.	.	O	.	_	0	SENT_409	[p25l11t2268r808b2371],

1	20	CD	NUMBER	20	_	0	SENT_410	[p25l9t2419r146b2500],
2	.	.	O	.	_	0	SENT_410	[p25l9t2419r146b2500],

1	Fellay	NNP	PERSON	Fellay	nn	2	SENT_411	[p25l207t2409r489b2524],
2	J	NNP	PERSON	J	_	0	SENT_411	[p25l509t2419r577b2520],
3	,	,	O	,	_	0	SENT_411	[p25l509t2419r577b2520],
4	Marzolini	NNP	PERSON	Marzolini	nn	5	SENT_411	[p25l618t2409r1093b2500],
5	C	NNP	O	C	appos	2	SENT_411	[p25l1130t2417r1226b2520],
6	,	,	O	,	_	0	SENT_411	[p25l1130t2417r1226b2520],
7	Meaden	NNP	PERSON	Meaden	nn	8	SENT_411	[p25l1267t2409r1655b2500],
8	ER	NN	O	er	appos	2	SENT_411	[p25l1690t2417r1854b2520],
9	,	,	O	,	_	0	SENT_411	[p25l1690t2417r1854b2520],
10	et	FW	O	et	nn	11	SENT_411	[p25l1899t2429r1987b2500],
11	al.	FW	O	al.	appos	2	SENT_411	[p25l2018t2409r2126b2500],
12	.	.	O	.	_	0	SENT_411	[p25l2018t2409r2126b2500],

1	Response	NN	O	response	dep	9	SENT_412	[p25l9t2566r480b2675],
2	to	TO	O	to	_	0	SENT_412	[p25l507t2578r599b2649],
3	antiretroviral	JJ	O	antiretroviral	amod	4	SENT_412	[p25l628t2558r1259b2650],
4	treatment	NN	O	treatment	prep_to	1	SENT_412	[p25l1288t2578r1764b2649],
5	in	IN	O	in	_	0	SENT_412	[p25l1787t2560r1880b2647],
6	HIV1	NN	O	hiv1	prep_in	4	SENT_412	[p25l1907t2568r2129b2649, p25l15t2706r499b2797],
7	—	CD	NUMBER	—	dep	9	SENT_412	[p25l1907t2568r2129b2649, p25l15t2706r499b2797],
8	infected	JJ	O	infected	amod	9	SENT_412	[p25l1907t2568r2129b2649, p25l15t2706r499b2797],
9	individuals	NNS	O	individual	dep	17	SENT_412	[p25l525t2706r1055b2797],
10	with	IN	O	with	_	0	SENT_412	[p25l1079t2706r1297b2797],
11	allelic	JJ	O	allelic	amod	12	SENT_412	[p25l1322t2706r1605b2797],
12	variants	NNS	O	variant	prep_with	9	SENT_412	[p25l1627t2708r2009b2797],
13	of	IN	O	of	_	0	SENT_412	[p25l2038t2706r2153b2797],
14	the	DT	O	the	det	16	SENT_412	[p25l11t2855r159b2946],
15	multidrug	JJ	O	multidrug	amod	16	SENT_412	[p25l222t2855r717b2972],
16	resistance	NN	O	resistance	prep_of	12	SENT_412	[p25l775t2857r1261b2946],
17	transporter	NN	O	transporter	dep	22	SENT_412	[p25l1324t2875r1872b2972],
18	1	CD	NUMBER	1	num	17	SENT_412	[p25l1935t2863r2016b2946],
19	:	:	O	:	_	0	SENT_412	[p25l1935t2863r2016b2946],
20	a	DT	O	a	det	22	SENT_412	[p25l2082t2886r2133b2946],
21	pharmacogenetics	NNS	O	pharmacogenetic	nn	22	SENT_412	[p25l9t3006r903b3121],
22	study	NN	O	study	_	0	SENT_412	[p25l954t3004r1226b3119],
23	.	.	O	.	_	0	SENT_412	[p25l954t3004r1226b3119],

1	Lancet	NNP	O	Lancet	_	0	SENT_413	[p25l1279t3014r1601b3095],
2	2002	CD	DATE	2002	num	1	SENT_413	[p25l1643t3012r2127b3115],
3	;	:	O	;	_	0	SENT_413	[p25l1643t3012r2127b3115],
4	359	CD	NUMBER	359	num	6	SENT_413	[p25l1643t3012r2127b3115],
5	:	:	O	:	_	0	SENT_413	[p25l1643t3012r2127b3115],
6	30-6	CD	NUMBER	30-6	dep	1	SENT_413	[p25l11t3158r254b3241],
7	.	.	O	.	_	0	SENT_413	[p25l11t3158r254b3241],

1	21	CD	NUMBER	21	_	0	SENT_414	[p25l9t3313r146b3392],
2	.	.	O	.	_	0	SENT_414	[p25l9t3313r146b3392],

1	Choo	NNP	ORGANIZATION	Choo	nn	2	SENT_415	[p25l209t3301r468b3392],
2	EF	NNP	ORGANIZATION	EF	_	0	SENT_415	[p25l494t3309r634b3412],
3	,	,	O	,	_	0	SENT_415	[p25l494t3309r634b3412],
4	Leake	NNP	PERSON	Leake	nn	5	SENT_415	[p25l666t3301r944b3392],
5	B	NNP	O	B	appos	2	SENT_415	[p25l970t3309r1063b3412],
6	,	,	O	,	_	0	SENT_415	[p25l970t3309r1063b3412],
7	Wandel	NNP	ORGANIZATION	Wandel	nn	8	SENT_415	[p25l1093t3301r1463b3392],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_415	[p25l1490t3309r1586b3412],
9	,	,	O	,	_	0	SENT_415	[p25l1490t3309r1586b3412],
10	et	FW	O	et	nn	11	SENT_415	[p25l1621t3321r1710b3392],
11	al.	FW	O	al.	appos	2	SENT_415	[p25l1730t3301r1839b3392],
12	.	.	O	.	_	0	SENT_415	[p25l1730t3301r1839b3392],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_416	[p25l1872t3301r2130b3392, p25l11t3452r601b3567],
2	inhibition	NN	O	inhibition	nsubj	8	SENT_416	[p25l681t3450r1164b3541],
3	of	IN	O	of	_	0	SENT_416	[p25l1247t3450r1362b3541],
4	P	NN	O	p	nn	7	SENT_416	[p25l1419t3452r2131b3567],
5	—	CD	NUMBER	—	num	7	SENT_416	[p25l1419t3452r2131b3567],
6	glycoprotein	NN	O	glycoprotein	nn	7	SENT_416	[p25l1419t3452r2131b3567],
7	transport	NN	O	transport	prep_of	2	SENT_416	[p25l11t3619r466b3716],
8	enhances	VBZ	O	enhance	_	0	SENT_416	[p25l495t3599r947b3690],
9	the	DT	O	the	det	10	SENT_416	[p25l984t3599r1133b3690],
10	distribution	NN	O	distribution	dobj	8	SENT_416	[p25l1170t3599r1743b3691],
11	of	IN	O	of	_	0	SENT_416	[p25l1779t3599r1894b3690],
12	HIV1	NN	O	hiv1	prep_of	10	SENT_416	[p25l1907t3609r2129b3690, p26l15t31r65b112],

1	protease	NN	O	protease	nn	2	SENT_417	[p26l106t43r517b140],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_417	[p26l559t23r1035b114],
3	into	IN	O	into	_	0	SENT_417	[p26l1079t25r1269b114],
4	brain	NN	O	brain	prep_into	2	SENT_417	[p26l1312t23r1566b114],
5	and	CC	O	and	_	0	SENT_417	[p26l1607t25r1785b114],
6	testes	NNS	O	testis	conj_and	4	SENT_417	[p26l1828t43r2126b114],
7	.	.	O	.	_	0	SENT_417	[p26l1828t43r2126b114],

1	Drug	NN	O	drug	nn	3	SENT_418	[p26l9t180r260b289],
2	Metab	NNP	O	Metab	nn	3	SENT_418	[p26l282t172r587b263],
3	Dispos	NNP	O	Dispos	_	0	SENT_418	[p26l616t174r952b289],
4	2000	CD	DATE	2000	num	3	SENT_418	[p26l984t180r1781b283],
5	;	:	O	;	_	0	SENT_418	[p26l984t180r1781b283],
6	28:655	CD	NUMBER	28:655	number	7	SENT_418	[p26l984t180r1781b283],
7	—	CD	NUMBER	—	dep	3	SENT_418	[p26l984t180r1781b283],
8	60	CD	NUMBER	60	dep	7	SENT_418	[p26l984t180r1781b283],
9	.	.	O	.	_	0	SENT_418	[p26l984t180r1781b283],

1	22	CD	NUMBER	22	_	0	SENT_419	[p26l9t333r146b412],
2	.	.	O	.	_	0	SENT_419	[p26l9t333r146b412],

1	Brinkmann	NNP	PERSON	Brinkmann	nn	2	SENT_420	[p26l207t321r763b412],
2	U	NNP	PERSON	U	_	0	SENT_420	[p26l804t329r903b432],
3	,	,	O	,	_	0	SENT_420	[p26l804t329r903b432],
4	Roots	NNS	O	root	appos	2	SENT_420	[p26l950t329r1231b418],
5	I	PRP	O	I	dep	4	SENT_420	[p26l1275t329r1336b432],
6	,	,	O	,	_	0	SENT_420	[p26l1275t329r1336b432],
7	Eichelbaum	NNP	PERSON	Eichelbaum	nn	9	SENT_420	[p26l1383t321r1961b412],
8	M.	NNP	O	M.	nn	9	SENT_420	[p26l2001t329r2125b412],
9	Pharmacogenetics	NNP	O	Pharmacogenetics	appos	2	SENT_420	[p26l9t472r899b587],
10	of	IN	O	of	_	0	SENT_420	[p26l998t470r1113b561],
11	the	DT	O	the	det	15	SENT_420	[p26l1186t472r1334b561],
12	human	JJ	O	human	amod	15	SENT_420	[p26l1429t472r1773b562],
13	drugtransporter	NN	O	drugtransporter	nn	15	SENT_420	[p26l1868t472r2131b587, p26l11t639r559b736],
14	gene	NN	O	gene	nn	15	SENT_420	[p26l580t649r808b736],
15	MDR1	NN	O	mdr1	prep_of	9	SENT_420	[p26l830t627r1178b716],
16	:	:	O	:	_	0	SENT_420	[p26l830t627r1178b716],
17	impact	NN	O	impact	dep	2	SENT_420	[p26l1205t621r1546b736],
18	of	IN	O	of	_	0	SENT_420	[p26l1565t619r1681b710],
19	polymorphisms	NNS	O	polymorphism	prep_of	17	SENT_420	[p26l1682t621r2131b736, p26l9t770r365b885],
20	on	IN	O	on	_	0	SENT_420	[p26l416t798r539b859],
21	pharmacotherapy	NN	O	pharmacotherapy	prep_on	19	SENT_420	[p26l584t770r1461b885],
22	.	.	O	.	_	0	SENT_420	[p26l584t770r1461b885],

1	Drug	NN	O	drug	nn	3	SENT_421	[p26l1512t776r1765b885],
2	Discov	NNP	O	Discov	nn	3	SENT_421	[p26l1807t770r2135b860],
3	Today	NNP	DATE	Today	_	0	SENT_421	[p26l7t919r300b1032],
4	2001	CD	DATE	2001	num	3	SENT_421	[p26l323t925r1000b1028],
5	;	:	O	;	_	0	SENT_421	[p26l323t925r1000b1028],
6	6:835	CD	NUMBER	6:835	number	7	SENT_421	[p26l323t925r1000b1028],
7	—	CD	NUMBER	—	dep	3	SENT_421	[p26l323t925r1000b1028],
8	9	CD	NUMBER	9	dep	7	SENT_421	[p26l323t925r1000b1028],
9	.	.	O	.	_	0	SENT_421	[p26l323t925r1000b1028],

1	23	CD	NUMBER	23	_	0	SENT_422	[p26l9t1078r146b1157],
2	.	.	O	.	_	0	SENT_422	[p26l9t1078r146b1157],

1	Rao	NNP	PERSON	Rao	nn	2	SENT_423	[p26l207t1074r393b1163],
2	W	NNP	O	W	_	0	SENT_423	[p26l422t1074r573b1177],
3	,	,	O	,	_	0	SENT_423	[p26l422t1074r573b1177],
4	]	NNP	O	]	nn	6	SENT_423	[p26l610t1066r1192b1157],
5	Dahlheimer	NNP	PERSON	Dahlheimer	nn	6	SENT_423	[p26l610t1066r1192b1157],
6	JL	NNP	O	JL	appos	2	SENT_423	[p26l1210t1074r1338b1177],
7	,	,	O	,	_	0	SENT_423	[p26l1210t1074r1338b1177],
8	Bardgett	NNP	PERSON	Bardgett	nn	9	SENT_423	[p26l1376t1066r1795b1183],
9	ME	NNP	O	ME	appos	2	SENT_423	[p26l1819t1074r2011b1177],
10	,	,	O	,	_	0	SENT_423	[p26l1819t1074r2011b1177],
11	et	FW	O	et	nn	12	SENT_423	[p26l2050t1086r2137b1157],
12	al.	FW	O	al.	appos	2	SENT_423	[p26l9t1217r118b1306],
13	.	.	O	.	_	0	SENT_423	[p26l9t1217r118b1306],

1	Choroicl	NNP	O	Choroicl	nsubj	2	SENT_424	[p26l171t1215r569b1306],
2	plexus	VBZ	O	plexus	_	0	SENT_424	[p26l614t1217r925b1332],
3	epithelial	JJ	O	epithelial	amod	4	SENT_424	[p26l974t1217r1423b1332],
4	expression	NN	O	expression	nsubj	13	SENT_424	[p26l1469t1217r1991b1332],
5	of	IN	O	of	_	0	SENT_424	[p26l2038t1215r2153b1306],
6	MDR1	NN	O	mdr1	nn	8	SENT_424	[p26l7t1372r324b1461],
7	P	NN	O	p	nn	8	SENT_424	[p26l359t1372r418b1453],
8	glycoprotein	NN	O	glycoprotein	prep_of	4	SENT_424	[p26l452t1366r1061b1481],
9	and	CC	O	and	_	0	SENT_424	[p26l1095t1364r1275b1455],
10	multidrug	JJ	O	multidrug	amod	12	SENT_424	[p26l1310t1366r1803b1481],
11	resistance-associated	JJ	O	resistance-associated	amod	12	SENT_424	[p26l1834t1366r2131b1455, p26l9t1513r777b1604],
12	protein	NN	O	protein	prep_of	4	SENT_424	[p26l840t1515r1194b1630],
13	contribute	VBP	O	contribute	ccomp	2	SENT_424	[p26l1259t1513r1760b1605],
14	to	TO	O	to	_	0	SENT_424	[p26l1825t1533r1916b1604],
15	the	DT	O	the	det	17	SENT_424	[p26l1983t1513r2132b1604],
16	blood	NN	O	blood	nn	17	SENT_424	[p26l11t1662r1265b1779],
17	—	NN	O	—	prep_to	13	SENT_424	[p26l11t1662r1265b1779],
18	cerebrospinal	JJ	O	cerebrospinal	amod	24	SENT_424	[p26l11t1662r1265b1779],
19	—	NN	O	—	nn	24	SENT_424	[p26l11t1662r1265b1779],
20	ﬂuid	NN	O	ﬂuid	nn	24	SENT_424	[p26l11t1662r1265b1779],
21	drug	NN	O	drug	nn	24	SENT_424	[p26l1332t1662r2131b1779, p26l9t1813r126b1926],
22	—	CD	NUMBER	—	num	24	SENT_424	[p26l1332t1662r2131b1779, p26l9t1813r126b1926],
23	permeability	NN	O	permeability	nn	24	SENT_424	[p26l1332t1662r2131b1779, p26l9t1813r126b1926],
24	barrier	NN	O	barrier	dep	17	SENT_424	[p26l149t1813r496b1902],
25	.	.	O	.	_	0	SENT_424	[p26l149t1813r496b1902],

1	Proc	NNP	O	Proc	nn	7	SENT_425	[p26l527t1819r743b1902],
2	Natl	NNP	O	Natl	nn	7	SENT_425	[p26l765t1813r972b1903],
3	Acad	NNP	O	Acad	nn	7	SENT_425	[p26l994t1811r1237b1902],
4	Sci	NNP	O	Sci	nn	7	SENT_425	[p26l1265t1813r1402b1902],
5	U	NNP	O	U	nn	7	SENT_425	[p26l1427t1821r1506b1902],
6	S	NNP	O	S	nn	7	SENT_425	[p26l1532t1819r1581b1902],
7	A	NNP	O	A	_	0	SENT_425	[p26l1607t1821r1683b1900],
8	1999	CD	DATE	1999	num	7	SENT_425	[p26l1710t1819r2127b1922],
9	;	:	O	;	_	0	SENT_425	[p26l1710t1819r2127b1922],
10	96	CD	NUMBER	96	num	12	SENT_425	[p26l1710t1819r2127b1922],
11	:	:	O	:	_	0	SENT_425	[p26l1710t1819r2127b1922],
12	3900-5	CD	NUMBER	3900-5	dep	7	SENT_425	[p26l11t1965r375b2048],
13	.	.	O	.	_	0	SENT_425	[p26l11t1965r375b2048],

1	24	CD	NUMBER	24	_	0	SENT_426	[p26l9t2120r146b2199],
2	.	.	O	.	_	0	SENT_426	[p26l9t2120r146b2199],

1	Thiebaut	NNP	PERSON	Thiebaut	nn	2	SENT_427	[p26l205t2108r644b2199],
2	F	NN	O	f	_	0	SENT_427	[p26l677t2116r751b2217],
3	,	,	O	,	_	0	SENT_427	[p26l677t2116r751b2217],
4	Tsuruo	NNP	PERSON	Tsuruo	nn	5	SENT_427	[p26l792t2116r1136b2199],
5	T	NN	PERSON	t	appos	2	SENT_427	[p26l1172t2116r1257b2219],
6	,	,	O	,	_	0	SENT_427	[p26l1172t2116r1257b2219],
7	Hamada	NNP	PERSON	Hamada	nn	8	SENT_427	[p26l1304t2108r1716b2199],
8	H	NNP	PERSON	H	appos	2	SENT_427	[p26l1753t2116r1866b2219],
9	,	,	O	,	_	0	SENT_427	[p26l1753t2116r1866b2219],
10	Gottesman	NNP	PERSON	Gottesman	nn	11	SENT_427	[p26l1912t2116r2130b2199, p26l11t2277r365b2348],
11	MM	NN	O	mm	appos	2	SENT_427	[p26l390t2267r616b2368],
12	,	,	O	,	_	0	SENT_427	[p26l390t2267r616b2368],
13	Pastan	NNP	PERSON	Pastan	nn	17	SENT_427	[p26l650t2265r971b2348],
14	I	PRP	O	I	dep	17	SENT_427	[p26l998t2267r1059b2368],
15	,	,	O	,	_	0	SENT_427	[p26l998t2267r1059b2368],
16	Willingham	NNP	PERSON	Willingham	dep	17	SENT_427	[p26l1092t2257r1677b2374],
17	MC	NNP	O	MC	appos	2	SENT_427	[p26l1702t2265r1902b2348],
18	.	.	O	.	_	0	SENT_427	[p26l1702t2265r1902b2348],

1	Cellular	JJ	O	cellular	amod	2	SENT_428	[p26l1939t2259r2131b2348, p26l9t2406r233b2498],
2	localization	NN	O	localization	_	0	SENT_428	[p26l293t2406r860b2497],
3	of	IN	O	of	_	0	SENT_428	[p26l925t2406r1042b2497],
4	the	DT	O	the	det	12	SENT_428	[p26l1085t2406r1234b2497],
5	multidrug	JJ	O	multidrug	amod	12	SENT_428	[p26l1300t2408r2131b2523, p26l9t2585r229b2646],
6	—	NN	O	—	nn	12	SENT_428	[p26l1300t2408r2131b2523, p26l9t2585r229b2646],
7	resistance	NN	O	resistance	nn	12	SENT_428	[p26l1300t2408r2131b2523, p26l9t2585r229b2646],
8	gene	NN	O	gene	nn	12	SENT_428	[p26l258t2585r486b2672],
9	product	NN	O	product	nn	12	SENT_428	[p26l512t2557r899b2672],
10	P	NN	O	p	nn	12	SENT_428	[p26l919t2557r1631b2672],
11	—	CD	NUMBER	—	num	12	SENT_428	[p26l919t2557r1631b2672],
12	glycoprotein	NN	O	glycoprotein	prep_of	2	SENT_428	[p26l919t2557r1631b2672],
13	in	IN	O	in	_	0	SENT_428	[p26l1658t2557r1752b2644],
14	normal	JJ	O	normal	amod	16	SENT_428	[p26l1779t2557r2133b2646],
15	human	JJ	O	human	amod	16	SENT_428	[p26l11t2703r355b2794],
16	tissues	NNS	O	tissue	prep_in	2	SENT_428	[p26l416t2705r771b2794],
17	.	.	O	.	_	0	SENT_428	[p26l416t2705r771b2794],

1	Proc	NNP	O	Proc	nn	5	SENT_429	[p26l836t2711r1052b2794],
2	Natl	NNP	O	Natl	nn	5	SENT_429	[p26l1109t2705r1316b2794],
3	Acad	NNP	O	Acad	nn	5	SENT_429	[p26l1372t2705r1613b2794],
4	Sci	NNP	O	Sci	nn	5	SENT_429	[p26l1676t2705r1813b2794],
5	USA	NNP	O	USA	_	0	SENT_429	[p26l1872t2711r2135b2794],

1	1987	CD	DATE	1987	_	0	SENT_430	[p26l15t2860r808b2963],
2	;	:	O	;	_	0	SENT_430	[p26l15t2860r808b2963],
3	84:7735	CD	NUMBER	84:7735	number	4	SENT_430	[p26l15t2860r808b2963],
4	-8	CD	NUMBER	-8	dep	1	SENT_430	[p26l15t2860r808b2963],
5	.	.	O	.	_	0	SENT_430	[p26l15t2860r808b2963],

1	25	CD	NUMBER	25	_	0	SENT_431	[p26l9t3013r146b3092],
2	.	.	O	.	_	0	SENT_431	[p26l9t3013r146b3092],

1	Schinkel	NNP	PERSON	Schinkel	nn	2	SENT_432	[p26l211t3001r626b3093],
2	AH	NNP	O	AH	nsubj	22	SENT_432	[p26l656t3009r844b3112],
3	,	,	O	,	_	0	SENT_432	[p26l656t3009r844b3112],
4	Wagenaar	NNP	PERSON	Wagenaar	nn	5	SENT_432	[p26l881t3009r1372b3118],
5	E	NNP	O	E	appos	2	SENT_432	[p26l1401t3009r1491b3112],
6	,	,	O	,	_	0	SENT_432	[p26l1401t3009r1491b3112],
7	Mol	NNP	ORGANIZATION	Mol	nn	8	SENT_432	[p26l1530t3001r1722b3092],
8	CA	NNP	O	CA	appos	2	SENT_432	[p26l1757t3009r1926b3112],
9	,	,	O	,	_	0	SENT_432	[p26l1757t3009r1926b3112],
10	van	NNP	O	van	nn	15	SENT_432	[p26l1963t3031r2132b3092],
11	Deemter	NNP	O	Deemter	nn	15	SENT_432	[p26l9t3158r429b3241],
12	L.	NNP	O	L.	nn	15	SENT_432	[p26l493t3160r577b3241],
13	P	NN	O	p	nn	15	SENT_432	[p26l652t3152r1364b3267],
14	—	CD	NUMBER	—	num	15	SENT_432	[p26l652t3152r1364b3267],
15	glycoprotein	NN	O	glycoprotein	appos	2	SENT_432	[p26l652t3152r1364b3267],
16	in	IN	O	in	_	0	SENT_432	[p26l1433t3152r1526b3239],
17	the	DT	O	the	det	19	SENT_432	[p26l1595t3150r1744b3241],
18	bloodbrain	NN	O	bloodbrain	nn	19	SENT_432	[p26l1815t3150r2131b3241, p26l11t3300r264b3389],
19	barrier	NN	O	barrier	prep_in	15	SENT_432	[p26l317t3300r646b3389],
20	of	IN	O	of	_	0	SENT_432	[p26l695t3298r810b3389],
21	mice	NNS	O	mouse	prep_of	19	SENT_432	[p26l841t3300r1073b3389],
22	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_432	[p26l1124t3298r1623b3389],
23	the	DT	O	the	det	25	SENT_432	[p26l1678t3300r1827b3389],
24	brain	NN	O	brain	nn	25	SENT_432	[p26l1880t3300r2133b3389],
25	penetration	NN	O	penetration	dobj	22	SENT_432	[p26l9t3449r571b3564],
26	and	CC	O	and	_	0	SENT_432	[p26l604t3447r784b3538],
27	pharmacological	JJ	O	pharmacological	amod	28	SENT_432	[p26l816t3447r1637b3564],
28	activity	NN	O	activity	conj_and	25	SENT_432	[p26l1668t3449r2009b3562],
29	of	IN	O	of	_	0	SENT_432	[p26l2038t3447r2153b3538],
30	many	JJ	O	many	amod	31	SENT_432	[p26l11t3626r280b3713],
31	drugs	NNS	O	drug	prep_of	25	SENT_432	[p26l304t3596r606b3713],
32	.	.	O	.	_	0	SENT_432	[p26l304t3596r606b3713],

1	J	NNP	O	J	nn	3	SENT_433	[p26l630t3606r674b3701],
2	Clin	NNP	O	Clin	nn	3	SENT_433	[p26l699t3598r899b3687],
3	Invest	NNP	O	Invest	_	0	SENT_433	[p26l926t3606r1220b3688],
4	1996	CD	DATE	1996	num	3	SENT_433	[p26l1247t3604r2102b3707],
5	;	:	O	;	_	0	SENT_433	[p26l1247t3604r2102b3707],
6	97:2517	CD	NUMBER	97:2517	number	7	SENT_433	[p26l1247t3604r2102b3707],
7	—	CD	NUMBER	—	dep	3	SENT_433	[p26l1247t3604r2102b3707],
8	24	CD	NUMBER	24	dep	7	SENT_433	[p26l1247t3604r2102b3707],
9	.	.	O	.	_	0	SENT_433	[p26l1247t3604r2102b3707],

1	26	CD	NUMBER	26	_	0	SENT_434	[p27l9t35r146b114],
2	.	.	O	.	_	0	SENT_434	[p27l9t35r146b114],

1	Hitzl	NN	O	hitzl	nn	2	SENT_435	[p27l207t23r448b114],
2	M	NN	O	m	nsubj	8	SENT_435	[p27l478t31r604b134],
3	,	,	O	,	_	0	SENT_435	[p27l478t31r604b134],
4	Drescher	NNP	PERSON	Drescher	nn	5	SENT_435	[p27l644t23r1085b114],
5	S	NNP	PERSON	S	appos	2	SENT_435	[p27l1120t31r1200b134],
6	,	,	O	,	_	0	SENT_435	[p27l1120t31r1200b134],
7	van	NNP	PERSON	van	appos	5	SENT_435	[p27l1237t53r1405b114],
8	der	VBD	PERSON	der	_	0	SENT_435	[p27l1441t23r1597b114],
9	Kuip	NNP	PERSON	Kuip	nn	10	SENT_435	[p27l1629t25r1860b138],
10	H	NNP	PERSON	H	dobj	8	SENT_435	[p27l1896t31r2007b134],
11	,	,	O	,	_	0	SENT_435	[p27l1896t31r2007b134],
12	et	FW	O	et	nn	13	SENT_435	[p27l2050t43r2139b114],
13	al.	FW	O	al.	appos	10	SENT_435	[p27l9t173r118b262],
14	.	.	O	.	_	0	SENT_435	[p27l9t173r118b262],

1	The	DT	O	the	det	2	SENT_436	[p27l189t171r375b262],
2	C3435T	NN	O	c3435t	_	0	SENT_436	[p27l444t179r828b262],
3	mutation	NN	O	mutation	dep	2	SENT_436	[p27l893t173r1340b262],
4	in	IN	O	in	_	0	SENT_436	[p27l1407t173r1502b260],
5	the	DT	O	the	det	6	SENT_436	[p27l1570t173r1718b262],
6	human	JJ	O	human	prep_in	3	SENT_436	[p27l1787t173r2132b262],

1	MDR1	NN	O	mdr1	nn	2	SENT_437	[p27l7t328r324b417],
2	gene	NN	O	gene	nsubjpass	4	SENT_437	[p27l355t350r585b437],
3	is	VBZ	O	be	auxpass	4	SENT_437	[p27l614t322r690b411],
4	associated	VBN	O	associate	_	0	SENT_437	[p27l723t320r1225b411],
5	with	IN	O	with	_	0	SENT_437	[p27l1251t322r1469b412],
6	altered	JJ	O	altered	amod	7	SENT_437	[p27l1498t320r1829b411],
7	efflux	NN	O	efflux	prep_with	4	SENT_437	[p27l1860t320r2136b412],
8	of	IN	O	of	_	0	SENT_437	[p27l11t469r126b560],
9	the	DT	O	the	det	14	SENT_437	[p27l153t471r302b560],
10	P	NN	O	p	nn	14	SENT_437	[p27l347t469r1060b586],
11	—	CD	NUMBER	—	num	14	SENT_437	[p27l347t469r1060b586],
12	glycoprotein	NN	O	glycoprotein	nn	14	SENT_437	[p27l347t469r1060b586],
13	substrate	NN	O	substrate	nn	14	SENT_437	[p27l1109t471r1550b561],
14	rhodamine	NN	O	rhodamine	prep_of	7	SENT_437	[p27l1597t469r2132b560],
15	123	CD	NUMBER	123	dep	14	SENT_437	[p27l15t625r183b708],
16	from	IN	O	from	_	0	SENT_437	[p27l232t617r470b708],
17	CD56	NN	O	cd56	prep_from	4	SENT_437	[p27l515t625r858b708],
18	+	CC	O	+	_	0	SENT_437	[p27l515t625r858b708],
19	natural	JJ	O	natural	amod	21	SENT_437	[p27l903t617r1245b708],
20	killer	NN	O	killer	nn	21	SENT_437	[p27l1289t617r1542b710],
21	cells	NNS	O	cell	prep_from	4	SENT_437	[p27l1583t617r1823b708],
22	.	.	O	.	_	0	SENT_437	[p27l1583t617r1823b708],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_438	[p27l1872t619r2131b708, p27l11t768r675b883],

1	2001	CD	DATE	2001	num	3	SENT_439	[p27l707t774r1443b877],
2	;	:	O	;	_	0	SENT_439	[p27l707t774r1443b877],
3	11:293	CD	NUMBER	11:293	_	0	SENT_439	[p27l707t774r1443b877],
4	—	CD	NUMBER	—	number	5	SENT_439	[p27l707t774r1443b877],
5	8	CD	NUMBER	8	num	3	SENT_439	[p27l707t774r1443b877],
6	.	.	O	.	_	0	SENT_439	[p27l707t774r1443b877],

1	27	CD	NUMBER	27	_	0	SENT_440	[p27l9t927r146b1006],
2	.	.	O	.	_	0	SENT_440	[p27l9t927r146b1006],

1	Sakaeda	FW	ORGANIZATION	sakaeda	_	0	SENT_441	[p27l211t915r605b1006],
2	T	NN	ORGANIZATION	t	dep	1	SENT_441	[p27l630t923r713b1026],
3	,	,	O	,	_	0	SENT_441	[p27l630t923r713b1026],
4	N	NN	O	n	nn	6	SENT_441	[p27l748t923r834b1006],
5	akamura	NN	O	akamura	nn	6	SENT_441	[p27l837t915r1265b1006],
6	T	NN	O	t	appos	2	SENT_441	[p27l1289t923r1374b1026],
7	,	,	O	,	_	0	SENT_441	[p27l1289t923r1374b1026],
8	Horinouchi	NNP	PERSON	Horinouchi	nn	9	SENT_441	[p27l1409t915r1975b1006],
9	M	NNP	O	M	appos	2	SENT_441	[p27l2000t923r2125b1026],
10	,	,	O	,	_	0	SENT_441	[p27l2000t923r2125b1026],
11	et	FW	O	et	nn	12	SENT_441	[p27l11t1084r100b1155],
12	al.	FW	O	al.	appos	2	SENT_441	[p27l135t1066r244b1155],
13	.	.	O	.	_	0	SENT_441	[p27l135t1066r244b1155],

1	MDR1	NN	O	mdr1	nn	3	SENT_442	[p27l290t1072r607b1161],
2	genotype	NN	O	genotype	nn	3	SENT_442	[p27l650t1064r1465b1181],
3	—	NN	O	—	nsubj	5	SENT_442	[p27l650t1064r1465b1181],
4	related	JJ	O	related	amod	5	SENT_442	[p27l650t1064r1465b1181],
5	pharmacol	NN	O	pharmacol	_	0	SENT_442	[p27l1506t1066r2131b1181, p27l11t1215r290b1304],
6	<	JJR	O	<	amod	7	SENT_442	[p27l1506t1066r2131b1181, p27l11t1215r290b1304],
7	inetics	NNS	O	inetic	dobj	5	SENT_442	[p27l1506t1066r2131b1181, p27l11t1215r290b1304],
8	of	IN	O	of	_	0	SENT_442	[p27l335t1213r452b1304],
9	digoxin	NN	O	digoxin	prep_of	7	SENT_442	[p27l473t1215r840b1330],
10	after	IN	O	after	_	0	SENT_442	[p27l881t1213r1103b1304],
11	single	JJ	O	single	amod	13	SENT_442	[p27l1142t1215r1431b1330],
12	oral	JJ	O	oral	amod	13	SENT_442	[p27l1473t1213r1659b1304],
13	administration	NN	O	administration	prep_after	5	SENT_442	[p27l1700t1213r2131b1304, p27l11t1364r335b1453],
14	in	IN	O	in	_	0	SENT_442	[p27l371t1364r464b1451],
15	healthy	JJ	O	healthy	amod	17	SENT_442	[p27l502t1362r858b1477],
16	Japanese	JJ	MISC	japanese	amod	17	SENT_442	[p27l879t1372r1315b1479],
17	subjects	NNS	O	subject	prep_in	13	SENT_442	[p27l1354t1364r1769b1477],
18	.	.	O	.	_	0	SENT_442	[p27l1354t1364r1769b1477],

1	Pharm	NNP	O	Pharm	nn	2	SENT_443	[p27l1811t1362r2133b1453],
2	Res	NNP	O	Res	_	0	SENT_443	[p27l9t1519r181b1608],
3	2001	CD	DATE	2001	num	2	SENT_443	[p27l211t1519r1010b1622],
4	;	:	O	;	_	0	SENT_443	[p27l211t1519r1010b1622],
5	18:1400	CD	NUMBER	18:1400	number	6	SENT_443	[p27l211t1519r1010b1622],
6	—	CD	NUMBER	—	dep	2	SENT_443	[p27l211t1519r1010b1622],
7	4	CD	NUMBER	4	dep	6	SENT_443	[p27l211t1519r1010b1622],
8	.	.	O	.	_	0	SENT_443	[p27l211t1519r1010b1622],

1	28	CD	NUMBER	28	_	0	SENT_444	[p27l9t1670r146b1751],
2	.	.	O	.	_	0	SENT_444	[p27l9t1670r146b1751],

1	Ameyaw	NNP	O	Ameyaw	nn	2	SENT_445	[p27l204t1670r622b1775],
2	MM	NN	O	mm	_	0	SENT_445	[p27l666t1668r891b1771],
3	,	,	O	,	_	0	SENT_445	[p27l666t1668r891b1771],
4	Regateiro	NN	O	regateiro	nn	5	SENT_445	[p27l950t1662r1415b1777],
5	F	NN	O	f	appos	2	SENT_445	[p27l1469t1668r1540b1771],
6	,	,	O	,	_	0	SENT_445	[p27l1469t1668r1540b1771],
7	Li	NNP	PERSON	Li	nn	8	SENT_445	[p27l1599t1662r1688b1749],
8	T	NN	PERSON	t	appos	2	SENT_445	[p27l1736t1668r1821b1771],
9	,	,	O	,	_	0	SENT_445	[p27l1736t1668r1821b1771],
10	et	FW	O	et	nn	11	SENT_445	[p27l1882t1680r1971b1751],
11	al.	FW	O	al.	appos	2	SENT_445	[p27l2016t1660r2125b1751],
12	.	.	O	.	_	0	SENT_445	[p27l2016t1660r2125b1751],

1	MDR1	NN	O	mdr1	nn	2	SENT_446	[p27l7t1817r324b1906],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_446	[p27l363t1809r1289b1926],
3	:	:	O	:	_	0	SENT_446	[p27l363t1809r1289b1926],
4	frequency	NN	O	frequency	nsubjpass	14	SENT_446	[p27l1332t1809r1813b1926],
5	of	IN	O	of	_	0	SENT_446	[p27l1848t1809r1965b1900],
6	the	DT	O	the	det	8	SENT_446	[p27l1983t1809r2132b1900],
7	C3435T	NN	O	c3435t	nn	8	SENT_446	[p27l11t1966r395b2049],
8	mutation	NN	O	mutation	prep_of	4	SENT_446	[p27l422t1960r870b2050],
9	in	IN	O	in	_	0	SENT_446	[p27l899t1960r992b2047],
10	exon	NN	O	exon	prep_in	8	SENT_446	[p27l1023t1988r1253b2049],
11	26	CD	NUMBER	26	num	10	SENT_446	[p27l1283t1966r1398b2049],
12	is	VBZ	O	be	auxpass	14	SENT_446	[p27l1429t1960r1503b2049],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_446	[p27l1538t1958r2137b2075],
14	inﬂuenced	VBN	O	inﬂuenced	dep	2	SENT_446	[p27l9t2107r524b2199],
15	by	IN	O	by	_	0	SENT_446	[p27l580t2107r692b2222],
16	ethnicity	NN	O	ethnicity	agent	14	SENT_446	[p27l744t2109r1176b2224],
17	.	.	O	.	_	0	SENT_446	[p27l744t2109r1176b2224],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_447	[p27l1237t2109r2129b2224],
2	2001	CD	DATE	2001	num	1	SENT_447	[p27l11t2264r808b2367],
3	;	:	O	;	_	0	SENT_447	[p27l11t2264r808b2367],
4	11:217	CD	NUMBER	11:217	number	5	SENT_447	[p27l11t2264r808b2367],
5	-21	CD	NUMBER	-21	dep	1	SENT_447	[p27l11t2264r808b2367],
6	.	.	O	.	_	0	SENT_447	[p27l11t2264r808b2367],

1	29	CD	NUMBER	29	_	0	SENT_448	[p27l9t2416r146b2495],
2	.	.	O	.	_	0	SENT_448	[p27l9t2416r146b2495],

1	McLeod	NNP	PERSON	McLeod	nn	2	SENT_449	[p27l205t2404r589b2495],
2	H.	NNP	O	H.	_	0	SENT_449	[p27l622t2412r731b2495],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_449	[p27l770t2404r1577b2495],
4	differences	NNS	O	difference	dep	2	SENT_449	[p27l1611t2404r2131b2495],
5	between	IN	O	between	_	0	SENT_449	[p27l11t2555r406b2646],
6	ethnic	JJ	O	ethnic	amod	7	SENT_449	[p27l432t2553r725b2644],
7	groups	NNS	O	group	prep_between	4	SENT_449	[p27l751t2583r1111b2670],
8	.	.	O	.	_	0	SENT_449	[p27l751t2583r1111b2670],

1	Lancet	NNP	O	Lancet	_	0	SENT_450	[p27l1142t2563r1459b2644],
2	2002	CD	DATE	2002	num	1	SENT_450	[p27l1480t2561r2104b2664],
3	;	:	O	;	_	0	SENT_450	[p27l1480t2561r2104b2664],
4	359:78	CD	NUMBER	359:78	dep	1	SENT_450	[p27l1480t2561r2104b2664],
5	.	.	O	.	_	0	SENT_450	[p27l1480t2561r2104b2664],

1	30	CD	NUMBER	30	_	0	SENT_451	[p27l11t2712r146b2793],
2	.	.	O	.	_	0	SENT_451	[p27l11t2712r146b2793],

1	Schaeffeler	NN	O	schaeffeler	nn	2	SENT_452	[p27l211t2702r749b2793],
2	E	NN	O	e	_	0	SENT_452	[p27l814t2710r903b2813],
3	,	,	O	,	_	0	SENT_452	[p27l814t2710r903b2813],
4	Eichelbaum	NNP	PERSON	Eichelbaum	nn	5	SENT_452	[p27l980t2702r1558b2793],
5	M	NNP	O	M	appos	2	SENT_452	[p27l1625t2710r1750b2813],
6	,	,	O	,	_	0	SENT_452	[p27l1625t2710r1750b2813],
7	Brinkmann	NNP	PERSON	Brinkmann	nn	8	SENT_452	[p27l1826t2702r2129b2793, p27l11t2881r292b2942],
8	U	NNP	PERSON	U	appos	2	SENT_452	[p27l337t2861r436b2962],
9	,	,	O	,	_	0	SENT_452	[p27l337t2861r436b2962],
10	et	FW	O	et	nn	11	SENT_452	[p27l489t2871r577b2942],
11	al.	FW	O	al.	appos	2	SENT_452	[p27l616t2853r725b2942],
12	.	.	O	.	_	0	SENT_452	[p27l616t2853r725b2942],

1	Frequency	NN	O	frequency	_	0	SENT_453	[p27l776t2861r1281b2968],
2	of	IN	O	of	_	0	SENT_453	[p27l1322t2851r1437b2942],
3	C3435T	NN	O	c3435t	nn	4	SENT_453	[p27l1463t2859r1847b2942],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_453	[p27l1888t2853r2131b2968, p27l11t3002r523b3117],
5	of	IN	O	of	_	0	SENT_453	[p27l553t3000r668b3091],
6	MDR1	NN	O	mdr1	nn	7	SENT_453	[p27l671t3008r988b3097],
7	gene	NN	O	gene	prep_of	1	SENT_453	[p27l1016t3030r1245b3117],
8	in	IN	O	in	_	0	SENT_453	[p27l1273t3002r1366b3089],
9	African	JJ	MISC	african	amod	10	SENT_453	[p27l1389t3000r1748b3091],
10	people	NNS	O	people	prep_in	1	SENT_453	[p27l1773t3000r2126b3117],
11	.	.	O	.	_	0	SENT_453	[p27l1773t3000r2126b3117],

1	Lancet	NNP	O	Lancet	_	0	SENT_454	[p27l9t3159r332b3240],
2	2001	CD	DATE	2001	num	1	SENT_454	[p27l355t3157r1154b3260],
3	;	:	O	;	_	0	SENT_454	[p27l355t3157r1154b3260],
4	358:383	CD	NUMBER	358:383	number	5	SENT_454	[p27l355t3157r1154b3260],
5	-4	CD	NUMBER	-4	dep	1	SENT_454	[p27l355t3157r1154b3260],
6	.	.	O	.	_	0	SENT_454	[p27l355t3157r1154b3260],

1	31	CD	NUMBER	31	_	0	SENT_455	[p27l11t3310r146b3389],
2	.	.	O	.	_	0	SENT_455	[p27l11t3310r146b3389],

1	Schuetz	NNP	PERSON	Schuetz	nn	2	SENT_456	[p27l211t3298r587b3389],
2	ID	NNP	O	ID	_	0	SENT_456	[p27l616t3306r763b3409],
3	,	,	O	,	_	0	SENT_456	[p27l616t3306r763b3409],
4	Connelly	NNP	PERSON	Connelly	nn	5	SENT_456	[p27l810t3298r1245b3413],
5	MC	NNP	O	MC	appos	2	SENT_456	[p27l1277t3306r1477b3409],
6	,	,	O	,	_	0	SENT_456	[p27l1277t3306r1477b3409],
7	Sun	NNP	O	Sun	nn	8	SENT_456	[p27l1526t3306r1708b3389],
8	D	NNP	O	D	appos	2	SENT_456	[p27l1745t3306r1847b3409],
9	,	,	O	,	_	0	SENT_456	[p27l1745t3306r1847b3409],
10	et	FW	O	et	nn	11	SENT_456	[p27l1894t3318r1983b3389],
11	al.	FW	O	al.	appos	2	SENT_456	[p27l2016t3298r2125b3389],
12	.	.	O	.	_	0	SENT_456	[p27l2016t3298r2125b3389],

1	MRP4	NN	O	mrp4	_	0	SENT_457	[p27l7t3455r332b3544],
2	:	:	O	:	_	0	SENT_457	[p27l7t3455r332b3544],
3	a	DT	O	a	det	6	SENT_457	[p27l394t3478r444b3538],
4	previously	RB	DATE	previously	advmod	5	SENT_457	[p27l499t3447r998b3564],
5	unidentiﬁed	JJ	O	unidentiﬁed	amod	6	SENT_457	[p27l1051t3447r1645b3539],
6	factor	NN	O	factor	dep	1	SENT_457	[p27l1702t3447r1985b3538],
7	in	IN	O	in	_	0	SENT_457	[p27l2040t3449r2133b3536],
8	resistance	NN	O	resistance	prep_in	6	SENT_457	[p27l11t3597r507b3686],
9	to	TO	O	to	_	0	SENT_457	[p27l596t3615r688b3686],
10	nucleoside	NN	O	nucleoside	nn	11	SENT_457	[p27l776t3595r1641b3686],
11	—	NN	O	—	prep_to	8	SENT_457	[p27l776t3595r1641b3686],
12	based	VBN	O	base	partmod	11	SENT_457	[p27l776t3595r1641b3686],
13	antiviral	JJ	O	antiviral	amod	14	SENT_457	[p27l1728t3595r2131b3686],
14	drugs	NNS	O	drug	dobj	12	SENT_457	[p28l11t36r320b153],
15	.	.	O	.	_	0	SENT_457	[p28l11t36r320b153],

1	Nat	NNP	O	Nat	nn	2	SENT_458	[p28l353t46r533b128],
2	Med	NNP	O	Med	_	0	SENT_458	[p28l553t36r768b127],
3	1999	CD	DATE	1999	num	2	SENT_458	[p28l800t44r1595b147],
4	;	:	O	;	_	0	SENT_458	[p28l800t44r1595b147],
5	5:1048	CD	NUMBER	5:1048	number	6	SENT_458	[p28l800t44r1595b147],
6	—	CD	NUMBER	—	dep	2	SENT_458	[p28l800t44r1595b147],
7	51	CD	NUMBER	51	dep	6	SENT_458	[p28l800t44r1595b147],
8	.	.	O	.	_	0	SENT_458	[p28l800t44r1595b147],

1	32	CD	NUMBER	32	_	0	SENT_459	[p28l9t303r74b341],
2	.	.	O	.	_	0	SENT_459	[p28l9t303r74b341],

1	Jacobsen	NNP	PERSON	Jacobsen	nn	2	SENT_460	[p28l99t297r313b348],
2	P	NN	PERSON	p	_	0	SENT_460	[p28l330t301r365b351],
3	,	,	O	,	_	0	SENT_460	[p28l330t301r365b351],
4	Rossing	NNP	PERSON	Rossing	nn	5	SENT_460	[p28l385t298r578b354],
5	K	NNP	PERSON	K	appos	2	SENT_460	[p28l594t301r642b351],
6	,	,	O	,	_	0	SENT_460	[p28l594t301r642b351],
7	Rossing	NNP	PERSON	Rossing	nn	8	SENT_460	[p28l662t298r855b354],
8	P	NN	O	p	appos	2	SENT_460	[p28l869t301r905b351],
9	,	,	O	,	_	0	SENT_460	[p28l869t301r905b351],
10	et	FW	O	et	nn	11	SENT_460	[p28l926t307r968b341],
11	al.	FW	O	al.	appos	2	SENT_460	[p28l982t297r1035b341],
12	.	.	O	.	_	0	SENT_460	[p28l982t297r1035b341],

1	Angiotensin	NN	O	angiotensin	_	0	SENT_461	[p28l7t369r297b425],
2	converting	VBG	O	convert	partmod	1	SENT_461	[p28l318t369r571b425],
3	enzyme	NN	O	enzyme	nn	7	SENT_461	[p28l589t383r769b425],
4	gene	NN	O	gene	nn	7	SENT_461	[p28l789t383r901b425],
5	poly	NN	O	poly	nn	7	SENT_461	[p28l920t368r1038b425],
6	—	NN	O	—	nn	7	SENT_461	[p28l920t368r1038b425],
7	morphism	NN	O	morphism	dobj	2	SENT_461	[p28l9t439r258b496],
8	and	CC	O	and	_	0	SENT_461	[p28l283t439r370b484],
9	ACE	NN	O	ace	nn	10	SENT_461	[p28l394t443r495b484],
10	inhibition	NN	O	inhibition	dobj	2	SENT_461	[p28l522t439r757b484],
11	in	IN	O	in	_	0	SENT_461	[p28l783t440r828b483],
12	diabetic	JJ	O	diabetic	amod	13	SENT_461	[p28l854t439r1039b484],
13	nephropathy	NN	O	nephropathy	prep_in	7	SENT_461	[p28l9t510r318b567],
14	.	.	O	.	_	0	SENT_461	[p28l9t510r318b567],

1	Kidney	NN	O	kidney	nn	2	SENT_462	[p28l335t510r501b567],
2	Int	NN	O	int	_	0	SENT_462	[p28l511t515r580b554],
3	1998	CD	DATE	1998	dep	2	SENT_462	[p28l593t514r979b564],
4	;	:	O	;	_	0	SENT_462	[p28l593t514r979b564],
5	53:1002	CD	NUMBER	53:1002	number	6	SENT_462	[p28l593t514r979b564],
6	—	CD	NUMBER	—	dep	2	SENT_462	[p28l593t514r979b564],
7	6	CD	NUMBER	6	dep	6	SENT_462	[p28l593t514r979b564],
8	.	.	O	.	_	0	SENT_462	[p28l593t514r979b564],

1	33	CD	NUMBER	33	_	0	SENT_463	[p28l9t588r74b626],
2	.	.	O	.	_	0	SENT_463	[p28l9t588r74b626],

1	Kohno	NNP	PERSON	Kohno	nn	2	SENT_464	[p28l104t582r264b627],
2	M	NNP	O	M	_	0	SENT_464	[p28l286t586r346b636],
3	,	,	O	,	_	0	SENT_464	[p28l286t586r346b636],
4	Yokokawa	NNP	PERSON	Yokokawa	nn	5	SENT_464	[p28l370t582r611b627],
5	K	NNP	PERSON	K	appos	2	SENT_464	[p28l632t586r680b636],
6	,	,	O	,	_	0	SENT_464	[p28l632t586r680b636],
7	Minami	NNP	ORGANIZATION	Minami	nn	8	SENT_464	[p28l705t583r891b626],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_464	[p28l911t586r972b636],
9	,	,	O	,	_	0	SENT_464	[p28l911t586r972b636],
10	et	FW	O	et	nn	11	SENT_464	[p28l999t591r1041b626],
11	al.	FW	O	al.	appos	2	SENT_464	[p28l8t653r61b697],
12	.	.	O	.	_	0	SENT_464	[p28l8t653r61b697],

1	Association	NNP	O	Association	nsubj	23	SENT_465	[p28l95t653r372b697],
2	between	IN	O	between	_	0	SENT_465	[p28l405t652r601b697],
3	angiotensin	NN	O	angiotensin	nn	5	SENT_465	[p28l633t653r1038b709],
4	—	CD	NUMBER	—	num	5	SENT_465	[p28l633t653r1038b709],
5	con	NN	O	con	prep_between	1	SENT_465	[p28l633t653r1038b709],
6	—	CD	NUMBER	—	num	5	SENT_465	[p28l633t653r1038b709],
7	verting	VBG	O	vert	partmod	1	SENT_465	[p28l6t724r173b780],
8	enzyme	NN	O	enzyme	nn	10	SENT_465	[p28l201t738r380b780],
9	gene	NN	O	gene	nn	10	SENT_465	[p28l409t738r520b780],
10	polymorphisms	NNS	O	polymorphism	dobj	7	SENT_465	[p28l548t724r922b780],
11	and	CC	O	and	_	0	SENT_465	[p28l952t723r1039b768],
12	regression	NN	O	regression	conj_and	10	SENT_465	[p28l9t795r256b851],
13	of	IN	O	of	_	0	SENT_465	[p28l272t794r328b839],
14	left	JJ	O	left	amod	16	SENT_465	[p28l333t794r411b838],
15	ventricular	JJ	O	ventricular	amod	16	SENT_465	[p28l422t794r677b839],
16	hypertrophy	NN	O	hypertrophy	prep_of	10	SENT_465	[p28l691t794r981b851],
17	in	IN	O	in	_	0	SENT_465	[p28l994t795r1039b838],
18	patients	NNS	O	patient	prep_in	7	SENT_465	[p28l8t866r195b922],
19	treated	VBN	O	treat	partmod	18	SENT_465	[p28l225t865r386b910],
20	with	IN	O	with	_	0	SENT_465	[p28l412t866r517b910],
21	angiotensin	NN	O	angiotensin	prep_with	19	SENT_465	[p28l545t866r1038b922],
22	—	CD	NUMBER	—	num	21	SENT_465	[p28l545t866r1038b922],
23	convert	VBP	O	convert	_	0	SENT_465	[p28l545t866r1038b922],
24	—	CD	NUMBER	—	num	27	SENT_465	[p28l545t866r1038b922],
25	ing	JJ	O	ing	amod	27	SENT_465	[p28l8t937r86b993],
26	enzyme	NN	O	enzyme	nn	27	SENT_465	[p28l99t951r279b993],
27	inhibitors	NNS	O	inhibitor	dobj	23	SENT_465	[p28l294t936r539b981],
28	.	.	O	.	_	0	SENT_465	[p28l294t936r539b981],

1	Am	VBP	O	be	cop	2	SENT_466	[p28l556t941r670b987],
2	]	CD	NUMBER	]	_	0	SENT_466	[p28l556t941r670b987],
3	Med	JJ	O	med	amod	2	SENT_466	[p28l683t936r787b981],
4	1999	CD	DATE	1999	tmod	3	SENT_466	[p28l804t940r1037b990],
5	;	:	O	;	_	0	SENT_466	[p28l804t940r1037b990],
6	106	CD	NUMBER	106	num	8	SENT_466	[p28l804t940r1037b990],
7	:	:	O	:	_	0	SENT_466	[p28l804t940r1037b990],
8	544-9	CD	NUMBER	544-9	dep	2	SENT_466	[p28l10t1011r157b1052],
9	.	.	O	.	_	0	SENT_466	[p28l10t1011r157b1052],

1	34	CD	NUMBER	34	_	0	SENT_467	[p28l9t1084r74b1122],
2	.	.	O	.	_	0	SENT_467	[p28l9t1084r74b1122],

1	Ohmichi	NNP	ORGANIZATION	Ohmichi	nn	2	SENT_468	[p28l105t1078r313b1123],
2	N	NNP	ORGANIZATION	N	_	0	SENT_468	[p28l333t1082r385b1132],
3	,	,	O	,	_	0	SENT_468	[p28l333t1082r385b1132],
4	Iwai	NNP	ORGANIZATION	Iwai	nn	5	SENT_468	[p28l409t1079r508b1123],
5	N	NNP	ORGANIZATION	N	appos	2	SENT_468	[p28l528t1082r580b1132],
6	,	,	O	,	_	0	SENT_468	[p28l528t1082r580b1132],
7	Uchida	NNP	LOCATION	Uchida	nn	8	SENT_468	[p28l605t1078r773b1123],
8	Y	NN	LOCATION	y	appos	2	SENT_468	[p28l792t1082r830b1132],
9	,	,	O	,	_	0	SENT_468	[p28l792t1082r830b1132],
10	Shichiri	NNP	O	Shichiri	nn	11	SENT_468	[p28l856t1078r1039b1123],
11	G	NNP	O	G	appos	2	SENT_468	[p28l9t1153r62b1203],
12	,	,	O	,	_	0	SENT_468	[p28l9t1153r62b1203],
13	Nakamura	NNP	PERSON	Nakamura	nn	14	SENT_468	[p28l82t1150r333b1194],
14	Y	NN	PERSON	y	appos	2	SENT_468	[p28l349t1154r386b1203],
15	,	,	O	,	_	0	SENT_468	[p28l349t1154r386b1203],
16	Kinoshita	NNP	PERSON	Kinoshita	nn	18	SENT_468	[p28l408t1150r639b1195],
17	M.	NNP	O	M.	nn	18	SENT_468	[p28l656t1154r716b1194],
18	Relationship	NN	O	relationship	appos	2	SENT_468	[p28l737t1149r1038b1206],
19	between	IN	O	between	_	0	SENT_468	[p28l9t1221r204b1265],
20	the	DT	O	the	det	21	SENT_468	[p28l235t1221r307b1265],
21	response	NN	O	response	prep_between	18	SENT_468	[p28l338t1235r550b1277],
22	to	TO	O	to	_	0	SENT_468	[p28l581t1230r625b1265],
23	the	DT	O	the	det	24	SENT_468	[p28l657t1220r729b1265],
24	angiotensin	NN	O	angiotensin	prep_to	21	SENT_468	[p28l759t1221r1039b1277],
25	converting	VBG	O	convert	partmod	24	SENT_468	[p28l9t1292r261b1348],
26	enzyme	NN	O	enzyme	nn	28	SENT_468	[p28l281t1306r461b1348],
27	inhibitor	NN	O	inhibitor	nn	28	SENT_468	[p28l483t1291r693b1336],
28	imidapril	NN	O	imidapril	nsubj	32	SENT_468	[p28l712t1291r931b1348],
29	and	CC	O	and	_	0	SENT_468	[p28l952t1291r1039b1336],
30	the	DT	O	the	det	31	SENT_468	[p28l9t1362r81b1407],
31	angiotensin	NN	O	angiotensin	conj_and	28	SENT_468	[p28l109t1363r388b1419],
32	converting	VBG	O	convert	dep	25	SENT_468	[p28l417t1363r669b1419],
33	enzyme	NN	O	enzyme	nn	34	SENT_468	[p28l696t1377r875b1419],
34	genotype	NN	O	genotype	dobj	32	SENT_468	[p28l904t1377r1038b1419, p28l9t1443r117b1490],
35	.	.	O	.	_	0	SENT_468	[p28l904t1377r1038b1419, p28l9t1443r117b1490],

1	AmJ	NN	O	amj	nn	2	SENT_469	[p28l132t1438r245b1485],
2	Hypertens	NNS	O	hyperten	_	0	SENT_469	[p28l258t1438r499b1490],
3	1997	CD	DATE	1997	dep	2	SENT_469	[p28l516t1437r872b1487],
4	;	:	O	;	_	0	SENT_469	[p28l516t1437r872b1487],
5	10:951	CD	NUMBER	10:951	number	6	SENT_469	[p28l516t1437r872b1487],
6	—	CD	NUMBER	—	dep	2	SENT_469	[p28l516t1437r872b1487],
7	5	CD	NUMBER	5	dep	6	SENT_469	[p28l516t1437r872b1487],
8	.	.	O	.	_	0	SENT_469	[p28l516t1437r872b1487],

1	35	CD	NUMBER	35	_	0	SENT_470	[p28l9t1510r74b1548],
2	.	.	O	.	_	0	SENT_470	[p28l9t1510r74b1548],

1	Okamura	NNP	PERSON	Okamura	nn	2	SENT_471	[p28l105t1504r327b1549],
2	A	NNP	O	A	_	0	SENT_471	[p28l341t1508r390b1558],
3	,	,	O	,	_	0	SENT_471	[p28l341t1508r390b1558],
4	Ohishi	NNP	O	Ohishi	nn	5	SENT_471	[p28l410t1504r569b1549],
5	M	NN	O	m	appos	2	SENT_471	[p28l585t1508r646b1558],
6	,	,	O	,	_	0	SENT_471	[p28l585t1508r646b1558],
7	Rakugi	NN	PERSON	rakugus	nn	8	SENT_471	[p28l666t1504r834b1561],
8	H	NN	PERSON	h	appos	2	SENT_471	[p28l850t1508r905b1558],
9	,	,	O	,	_	0	SENT_471	[p28l850t1508r905b1558],
10	et	FW	O	et	nn	11	SENT_471	[p28l926t1513r969b1548],
11	al.	FW	O	al.	appos	2	SENT_471	[p28l983t1504r1036b1548],
12	.	.	O	.	_	0	SENT_471	[p28l983t1504r1036b1548],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_472	[p28l8t1576r418b1632],
2	analysis	NN	O	analysis	nsubj	17	SENT_472	[p28l446t1575r630b1632],
3	of	IN	O	of	_	0	SENT_472	[p28l660t1575r717b1620],
4	the	DT	O	the	det	5	SENT_472	[p28l735t1576r807b1619],
5	effect	NN	O	effect	prep_of	2	SENT_472	[p28l836t1575r967b1619],
6	of	IN	O	of	_	0	SENT_472	[p28l993t1575r1049b1620],
7	angiotensin	NN	O	angiotensin	prep_of	5	SENT_472	[p28l8t1647r562b1703],
8	—	CD	NUMBER	—	num	7	SENT_472	[p28l8t1647r562b1703],
9	converting	VBG	O	convert	partmod	7	SENT_472	[p28l8t1647r562b1703],
10	enzyme	NN	O	enzyme	nn	11	SENT_472	[p28l606t1661r786b1703],
11	inhibitor	NN	O	inhibitor	dobj	9	SENT_472	[p28l831t1647r1040b1691],
12	on	IN	O	on	_	0	SENT_472	[p28l9t1732r69b1762],
13	restenosis	NN	O	restenosis	prep_on	11	SENT_472	[p28l83t1718r320b1762],
14	after	IN	O	after	_	0	SENT_472	[p28l335t1717r444b1761],
15	percutaneous	JJ	O	percutaneous	amod	16	SENT_472	[p28l456t1727r774b1774],
16	translumi	NNS	O	translumus	prep_after	9	SENT_472	[p28l791t1717r1037b1762],
17	—	VBP	O	—	_	0	SENT_472	[p28l791t1717r1037b1762],
18	nal	JJ	O	nal	amod	20	SENT_472	[p28l9t1788r80b1832],
19	coronary	JJ	O	coronary	amod	20	SENT_472	[p28l104t1803r313b1845],
20	angioplasty	NN	O	angioplasty	dobj	17	SENT_472	[p28l334t1788r614b1845],
21	.	.	O	.	_	0	SENT_472	[p28l334t1788r614b1845],

1	Angiology	NNP	O	Angiology	_	0	SENT_473	[p28l639t1788r885b1845],
2	1999	CD	DATE	1999	num	1	SENT_473	[p28l908t1792r1036b1842],
3	;	:	O	;	_	0	SENT_473	[p28l908t1792r1036b1842],
4	502811-22	CD	NUMBER	502811-22	dep	1	SENT_473	[p28l10t1863r262b1904],
5	.	.	O	.	_	0	SENT_473	[p28l10t1863r262b1904],

1	36	CD	NUMBER	36	_	0	SENT_474	[p28l9t1936r74b1975],
2	.	.	O	.	_	0	SENT_474	[p28l9t1936r74b1975],

1	Penno	NNP	PERSON	Penno	nn	2	SENT_475	[p28l104t1934r251b1974],
2	G	NNP	PERSON	G	_	0	SENT_475	[p28l264t1934r317b1984],
3	,	,	O	,	_	0	SENT_475	[p28l264t1934r317b1984],
4	Chaturvedi	NNP	PERSON	Chaturvedi	nn	5	SENT_475	[p28l332t1930r590b1975],
5	N	NNP	PERSON	N	appos	2	SENT_475	[p28l600t1934r652b1984],
6	,	,	O	,	_	0	SENT_475	[p28l600t1934r652b1984],
7	Talmud	NNP	O	Talmud	nn	9	SENT_475	[p28l665t1930r846b1975],
8	P	NN	O	p	nn	9	SENT_475	[p28l857t1934r915b1984],
9	]	NN	O	]	appos	2	SENT_475	[p28l857t1934r915b1984],
10	,	,	O	,	_	0	SENT_475	[p28l857t1934r915b1984],
11	et	FW	O	et	nn	12	SENT_475	[p28l931t1939r974b1974],
12	al.	FW	O	al.	appos	2	SENT_475	[p28l982t1930r1035b1974],
13	.	.	O	.	_	0	SENT_475	[p28l982t1930r1035b1974],

1	Effect	NN	O	effect	_	0	SENT_476	[p28l8t2001r146b2045],
2	of	IN	O	of	_	0	SENT_476	[p28l183t2001r239b2046],
3	angiotensin	NN	O	angiotensin	prep_of	1	SENT_476	[p28l267t2002r821b2058],
4	—	CD	NUMBER	—	num	3	SENT_476	[p28l267t2002r821b2058],
5	converting	VBG	O	convert	partmod	1	SENT_476	[p28l267t2002r821b2058],
6	enzyme	NN	O	enzyme	nn	8	SENT_476	[p28l859t2016r1039b2058],
7	(	CD	NUMBER	(	num	8	SENT_476	[p28l11t2076r145b2123],
8	ACE	NN	O	ace	dobj	5	SENT_476	[p28l11t2076r145b2123],
9	)	NN	O	)	nn	11	SENT_476	[p28l11t2076r145b2123],
10	gene	NN	O	gene	nn	11	SENT_476	[p28l169t2087r280b2129],
11	polymorphism	NN	O	polymorphism	dep	1	SENT_476	[p28l301t2072r652b2129],
12	on	IN	O	on	_	0	SENT_476	[p28l674t2087r734b2117],
13	progression	NN	O	progression	prep_on	11	SENT_476	[p28l755t2073r1039b2129],
14	of	IN	O	of	_	0	SENT_476	[p28l9t2144r65b2189],
15	renal	JJ	O	renal	amod	16	SENT_476	[p28l79t2144r197b2188],
16	disease	NN	O	disease	prep_of	13	SENT_476	[p28l222t2144r391b2189],
17	and	CC	O	and	_	0	SENT_476	[p28l416t2144r503b2189],
18	the	DT	O	the	det	19	SENT_476	[p28l528t2144r600b2188],
19	inﬂuence	NN	O	inﬂuence	prep_on	11	SENT_476	[p28l624t2144r843b2189],
20	of	IN	O	of	_	0	SENT_476	[p28l868t2144r924b2189],
21	ACE	NN	O	ace	nn	22	SENT_476	[p28l936t2148r1037b2189],
22	inhibition	NN	O	inhibition	prep_of	19	SENT_476	[p28l8t2215r243b2259],
23	in	IN	O	in	_	0	SENT_476	[p28l261t2215r306b2258],
24	IDDM	NN	ORGANIZATION	iddm	nn	25	SENT_476	[p28l323t2218r468b2258],
25	patients	NNS	O	patient	prep_in	22	SENT_476	[p28l486t2215r689b2271],
26	:	:	O	:	_	0	SENT_476	[p28l486t2215r689b2271],
27	findings	NNS	O	finding	dep	1	SENT_476	[p28l709t2214r904b2271],
28	from	IN	O	from	_	0	SENT_476	[p28l923t2214r1039b2259],
29	the	DT	O	the	det	33	SENT_476	[p28l9t2285r81b2329],
30	EUCLID	NNP	MISC	EUCLID	nn	33	SENT_476	[p28l102t2289r296b2330],
31	Randomized	NNP	MISC	Randomized	nn	33	SENT_476	[p28l318t2285r620b2332],
32	Controlled	NNP	MISC	Controlled	nn	33	SENT_476	[p28l642t2285r894b2330],
33	Trial	NNP	MISC	Trial	prep_from	27	SENT_476	[p28l914t2285r1036b2330],
34	:	:	O	:	_	0	SENT_476	[p28l914t2285r1036b2330],
35	EURODIAB	NNP	O	EURODIAB	nn	37	SENT_476	[p28l8t2360r281b2403],
36	Controlled	NNP	O	Controlled	nn	37	SENT_476	[p28l298t2356r550b2401],
37	Trial	NNP	O	Trial	dep	1	SENT_476	[p28l564t2356r673b2400],
38	of	IN	O	of	_	0	SENT_476	[p28l688t2356r745b2401],
39	Lisinopril	NNP	O	Lisinopril	prep_of	37	SENT_476	[p28l749t2356r978b2413],
40	in	IN	O	in	_	0	SENT_476	[p28l993t2357r1039b2400],
41	IDDM	NN	ORGANIZATION	iddm	prep_in	39	SENT_476	[p28l8t2431r167b2472],
42	.	.	O	.	_	0	SENT_476	[p28l8t2431r167b2472],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_477	[p28l183t2428r386b2472],
2	1998	CD	DATE	1998	num	1	SENT_477	[p28l403t2431r819b2481],
3	;	:	O	;	_	0	SENT_477	[p28l403t2431r819b2481],
4	47:1507	CD	DATE	47:1507	number	5	SENT_477	[p28l403t2431r819b2481],
5	-11	CD	DATE	-11	dep	1	SENT_477	[p28l403t2431r819b2481],
6	.	.	O	.	_	0	SENT_477	[p28l403t2431r819b2481],

1	37	CD	NUMBER	37	_	0	SENT_478	[p28l9t2504r74b2542],
2	.	.	O	.	_	0	SENT_478	[p28l9t2504r74b2542],

1	Perna	NNP	PERSON	Perna	nn	2	SENT_479	[p28l104t2502r238b2542],
2	A	NNP	O	A	_	0	SENT_479	[p28l259t2502r308b2552],
3	,	,	O	,	_	0	SENT_479	[p28l259t2502r308b2552],
4	Ruggenenti	NNP	PERSON	Ruggenenti	nn	5	SENT_479	[p28l335t2499r610b2555],
5	P	NN	PERSON	p	appos	2	SENT_479	[p28l634t2502r669b2552],
6	,	,	O	,	_	0	SENT_479	[p28l634t2502r669b2552],
7	Testa	NNP	PERSON	Testa	nn	8	SENT_479	[p28l695t2502r820b2542],
8	A	NNP	O	A	appos	2	SENT_479	[p28l841t2502r890b2552],
9	,	,	O	,	_	0	SENT_479	[p28l841t2502r890b2552],
10	et	FW	O	et	nn	11	SENT_479	[p28l918t2507r961b2542],
11	al.	FW	O	al.	appos	2	SENT_479	[p28l982t2498r1035b2542],
12	.	.	O	.	_	0	SENT_479	[p28l982t2498r1035b2542],

1	ACE	NN	O	ace	nn	2	SENT_480	[p28l7t2573r108b2614],
2	genotype	NN	O	genotype	nsubj	6	SENT_480	[p28l131t2579r345b2626],
3	and	CC	O	and	_	0	SENT_480	[p28l366t2569r453b2614],
4	ACE	NN	O	ace	nn	5	SENT_480	[p28l473t2573r574b2614],
5	inhibitors	NNS	O	inhibitor	nsubj	6	SENT_480	[p28l596t2569r827b2614],
6	induced	VBD	O	induce	_	0	SENT_480	[p28l850t2569r1038b2614],
7	renoprotection	NN	O	renoprotection	dobj	6	SENT_480	[p28l9t2641r361b2697],
8	in	IN	O	in	_	0	SENT_480	[p28l374t2641r420b2684],
9	chronic	JJ	O	chronic	amod	11	SENT_480	[p28l433t2640r612b2685],
10	proteinuric	JJ	O	proteinuric	amod	11	SENT_480	[p28l624t2641r888b2697],
11	nephropathies	NNS	O	nephropathy	prep_in	6	SENT_480	[p28l901t2641r1038b2697, p28l9t2712r243b2768],
12	.	.	O	.	_	0	SENT_480	[p28l901t2641r1038b2697, p28l9t2712r243b2768],

1	Kidney	NN	O	kidney	nn	2	SENT_481	[p28l259t2711r426b2768],
2	Int	NN	O	int	_	0	SENT_481	[p28l436t2716r505b2755],
3	2000	CD	DATE	2000	dep	2	SENT_481	[p28l516t2715r904b2765],
4	;	:	O	;	_	0	SENT_481	[p28l516t2715r904b2765],
5	57:274	CD	NUMBER	57:274	number	6	SENT_481	[p28l516t2715r904b2765],
6	—	CD	NUMBER	—	dep	2	SENT_481	[p28l516t2715r904b2765],
7	81	CD	NUMBER	81	dep	6	SENT_481	[p28l516t2715r904b2765],
8	.	.	O	.	_	0	SENT_481	[p28l516t2715r904b2765],

1	38	CD	NUMBER	38	_	0	SENT_482	[p28l9t2787r74b2827],
2	.	.	O	.	_	0	SENT_482	[p28l9t2787r74b2827],

1	Prasad	NNP	O	Prasad	nn	2	SENT_483	[p28l104t2782r261b2827],
2	A	NNP	O	A	_	0	SENT_483	[p28l276t2786r325b2836],
3	,	,	O	,	_	0	SENT_483	[p28l276t2786r325b2836],
4	Narayanan	NNP	PERSON	Narayanan	nn	5	SENT_483	[p28l344t2786r599b2838],
5	S	NNP	O	S	appos	2	SENT_483	[p28l618t2786r656b2836],
6	,	,	O	,	_	0	SENT_483	[p28l618t2786r656b2836],
7	Husain	NNP	PERSON	Husain	nn	8	SENT_483	[p28l677t2783r847b2827],
8	S	NNP	O	S	appos	2	SENT_483	[p28l866t2786r904b2836],
9	,	,	O	,	_	0	SENT_483	[p28l866t2786r904b2836],
10	et	FW	O	et	nn	11	SENT_483	[p28l926t2791r968b2826],
11	al.	FW	O	al.	appos	2	SENT_483	[p28l983t2782r1036b2826],
12	.	.	O	.	_	0	SENT_483	[p28l983t2782r1036b2826],

1	Insertion	NN	O	insertion	nn	4	SENT_484	[p28l8t2853r435b2898],
2	—	CD	NUMBER	—	num	4	SENT_484	[p28l8t2853r435b2898],
3	deletion	NN	O	deletion	nn	4	SENT_484	[p28l8t2853r435b2898],
4	polymorphism	NN	O	polymorphism	nsubj	9	SENT_484	[p28l479t2853r831b2910],
5	of	IN	O	of	_	0	SENT_484	[p28l876t2853r932b2898],
6	the	DT	O	the	det	8	SENT_484	[p28l967t2853r1039b2898],
7	ACE	NN	O	ace	nn	8	SENT_484	[p28l7t2928r108b2969],
8	gene	NN	O	gene	prep_of	4	SENT_484	[p28l132t2939r243b2981],
9	modulates	VBZ	O	modulate	_	0	SENT_484	[p28l267t2924r513b2969],
10	reversibility	NN	O	reversibility	dobj	9	SENT_484	[p28l537t2924r813b2981],
11	of	IN	O	of	_	0	SENT_484	[p28l834t2924r890b2969],
12	endothelial	JJ	O	endothelial	amod	13	SENT_484	[p28l904t2924r1038b2969, p28l9t2995r154b3039],
13	dysfunction	NN	O	dysfunction	prep_of	10	SENT_484	[p28l167t2995r445b3052],
14	with	IN	O	with	_	0	SENT_484	[p28l455t2995r561b3040],
15	ACE	NN	O	ace	nn	16	SENT_484	[p28l571t2999r672b3040],
16	inhibition	NN	O	inhibition	prep_with	9	SENT_484	[p28l686t2996r934b3040],
17	.	.	O	.	_	0	SENT_484	[p28l686t2996r934b3040],

1	Circulation	NN	O	circulation	_	0	SENT_485	[p28l949t2996r1038b3040, p28l9t3066r199b3111],
2	2000	CD	DATE	2000	num	1	SENT_485	[p28l213t3070r601b3120],
3	;	:	O	;	_	0	SENT_485	[p28l213t3070r601b3120],
4	102:35	CD	NUMBER	102:35	number	5	SENT_485	[p28l213t3070r601b3120],
5	—	CD	NUMBER	—	dep	1	SENT_485	[p28l213t3070r601b3120],
6	41	CD	NUMBER	41	dep	5	SENT_485	[p28l213t3070r601b3120],
7	.	.	O	.	_	0	SENT_485	[p28l213t3070r601b3120],

1	39	CD	NUMBER	39	_	0	SENT_486	[p28l9t3142r74b3181],
2	.	.	O	.	_	0	SENT_486	[p28l9t3142r74b3181],

1	Sasaki	NNP	PERSON	Sasaki	nn	2	SENT_487	[p28l106t3137r254b3182],
2	M	NNP	O	M	_	0	SENT_487	[p28l266t3141r327b3191],
3	,	,	O	,	_	0	SENT_487	[p28l266t3141r327b3191],
4	Oki	NNP	ORGANIZATION	Oki	nn	5	SENT_487	[p28l345t3137r429b3182],
5	T	NN	ORGANIZATION	t	appos	2	SENT_487	[p28l441t3141r482b3191],
6	,	,	O	,	_	0	SENT_487	[p28l441t3141r482b3191],
7	Iuchi	NNP	MISC	Iuchi	nn	8	SENT_487	[p28l499t3137r620b3182],
8	A	NNP	MISC	A	appos	2	SENT_487	[p28l632t3141r680b3191],
9	,	,	O	,	_	0	SENT_487	[p28l632t3141r680b3191],
10	et	FW	O	et	nn	11	SENT_487	[p28l698t3146r741b3181],
11	al.	FW	O	al.	appos	2	SENT_487	[p28l752t3137r805b3181],
12	.	.	O	.	_	0	SENT_487	[p28l752t3137r805b3181],

1	Relationship	NN	O	relationship	nn	2	SENT_488	[p28l821t3137r1038b3184, p28l9t3209r108b3265],
2	betvveen	NN	O	betvveen	_	0	SENT_488	[p28l142t3208r338b3253],
3	the	DT	O	the	det	4	SENT_488	[p28l371t3209r443b3253],
4	angiotensin	NN	O	angiotensin	dep	2	SENT_488	[p28l475t3209r755b3265],
5	converting	VBG	O	convert	partmod	2	SENT_488	[p28l788t3209r1041b3265],
6	enzyme	NN	O	enzyme	nn	8	SENT_488	[p28l9t3294r189b3336],
7	gene	NN	O	gene	nn	8	SENT_488	[p28l204t3294r315b3336],
8	polymorphism	NN	O	polymorphism	dobj	5	SENT_488	[p28l330t3280r681b3336],
9	and	CC	O	and	_	0	SENT_488	[p28l696t3279r783b3324],
10	the	DT	O	the	det	11	SENT_488	[p28l799t3279r871b3323],
11	effects	NNS	O	effect	dobj	5	SENT_488	[p28l887t3279r1038b3324],
12	of	IN	O	of	_	0	SENT_488	[p28l9t3350r65b3395],
13	enalapril	NN	O	enalapril	prep_of	11	SENT_488	[p28l76t3350r283b3407],
14	on	IN	O	on	_	0	SENT_488	[p28l304t3365r363b3395],
15	left	JJ	O	left	amod	17	SENT_488	[p28l383t3350r461b3395],
16	ventricular	JJ	O	ventricular	amod	17	SENT_488	[p28l477t3350r733b3395],
17	hypertrophy	NN	O	hypertrophy	prep_on	13	SENT_488	[p28l752t3350r1041b3407],
18	and	CC	O	and	_	0	SENT_488	[p28l8t3421r95b3466],
19	impaired	JJ	O	impaired	amod	20	SENT_488	[p28l123t3421r336b3478],
20	diastolic	JJ	O	diastolic	amod	21	SENT_488	[p28l365t3421r564b3466],
21	ﬁlling	NN	O	ﬁlling	dobj	5	SENT_488	[p28l592t3421r734b3478],
22	in	IN	O	in	_	0	SENT_488	[p28l761t3422r806b3465],
23	essential	JJ	O	essential	amod	24	SENT_488	[p28l835t3422r1039b3466],
24	hypertension	NN	O	hypertension	prep_in	21	SENT_488	[p28l9t3493r331b3549],
25	:	:	O	:	_	0	SENT_488	[p28l9t3493r331b3549],
26	M	NN	O	m	nn	28	SENT_488	[p28l349t3492r552b3537],
27	—	NN	O	—	nn	28	SENT_488	[p28l349t3492r552b3537],
28	mode	NN	O	mode	tmod	2	SENT_488	[p28l349t3492r552b3537],
29	and	CC	O	and	_	0	SENT_488	[p28l569t3492r656b3537],
30	pulsed	JJ	O	pulsed	amod	31	SENT_488	[p28l672t3492r829b3549],
31	Doppler	NNP	MISC	Doppler	dep	32	SENT_488	[p28l845t3492r1041b3549],
32	echocardiographic	JJ	O	echocardiographic	amod	33	SENT_488	[p28l9t3563r450b3620],
33	studies	NNS	O	study	conj_and	28	SENT_488	[p28l501t3564r679b3608],
34	.	.	O	.	_	0	SENT_488	[p28l501t3564r679b3608],

1	J	NN	O	j	nn	2	SENT_489	[p28l727t3568r748b3614],
2	Hypertens	NNS	O	hyperten	_	0	SENT_489	[p28l797t3568r1038b3620],
3	1996	CD	DATE	1996	dep	2	SENT_489	[p28l11t3638r396b3688],
4	;	:	O	;	_	0	SENT_489	[p28l11t3638r396b3688],
5	14:1403	CD	NUMBER	14:1403	number	6	SENT_489	[p28l11t3638r396b3688],
6	—	CD	NUMBER	—	dep	2	SENT_489	[p28l11t3638r396b3688],
7	8	CD	NUMBER	8	dep	6	SENT_489	[p28l11t3638r396b3688],
8	.	.	O	.	_	0	SENT_489	[p28l11t3638r396b3688],

1	40	CD	NUMBER	40	_	0	SENT_490	[p28l7t3710r74b3749],
2	.	.	O	.	_	0	SENT_490	[p28l7t3710r74b3749],

1	Stavroulakis	NNP	O	Stavroulakis	nn	2	SENT_491	[p28l106t3705r392b3750],
2	GA	NNP	O	GA	_	0	SENT_491	[p28l407t3709r496b3759],
3	,	,	O	,	_	0	SENT_491	[p28l407t3709r496b3759],
4	Makris	NNP	PERSON	Makris	nn	5	SENT_491	[p28l511t3705r674b3750],
5	TK	NN	O	tk	appos	2	SENT_491	[p28l687t3709r770b3759],
6	,	,	O	,	_	0	SENT_491	[p28l687t3709r770b3759],
7	Krespi	NNP	PERSON	Krespi	nn	8	SENT_491	[p28l786t3706r940b3761],
8	PG	NNP	O	PG	appos	2	SENT_491	[p28l952t3709r1036b3759],
9	,	,	O	,	_	0	SENT_491	[p28l952t3709r1036b3759],
10	et	FW	O	et	nn	11	SENT_491	[p28l9t3786r52b3821],
11	al.	FW	O	al.	appos	2	SENT_491	[p28l64t3776r117b3821],
12	.	.	O	.	_	0	SENT_491	[p28l64t3776r117b3821],

1	Predicting	VBG	O	predict	amod	2	SENT_492	[p28l135t3776r379b3833],
2	response	NN	O	response	_	0	SENT_492	[p28l392t3791r604b3833],
3	to	TO	O	to	_	0	SENT_492	[p28l620t3786r664b3821],
4	chronic	JJ	O	chronic	amod	6	SENT_492	[p28l681t3777r860b3821],
5	antihy	JJ	O	antihy	amod	6	SENT_492	[p28l875t3776r1038b3833],
6	—	NN	O	—	prep_to	2	SENT_492	[p28l875t3776r1038b3833],
7	44	CD	NUMBER	44	dep	6	SENT_492	[p28l1112t303r1179b341],
8	.	.	O	.	_	0	SENT_492	[p28l1112t303r1179b341],

1	Dishy	JJ	O	dishy	amod	2	SENT_493	[p28l1208t297r1345b353],
2	V	NN	O	v	_	0	SENT_493	[p28l1362t301r1401b351],
3	,	,	O	,	_	0	SENT_493	[p28l1362t301r1401b351],
4	Sofowora	NNP	O	Sofowora	nn	5	SENT_493	[p28l1427t297r1651b342],
5	GG	NNS	O	gg	appos	2	SENT_493	[p28l1672t301r1767b351],
6	,	,	O	,	_	0	SENT_493	[p28l1672t301r1767b351],
7	Xie	NN	O	xie	nn	8	SENT_493	[p28l1790t298r1864b341],
8	H	NN	O	h	appos	5	SENT_493	[p28l1885t301r2001b351],
9	.	.	O	.	_	0	SENT_493	[p28l1885t301r2001b351],

1	—	NN	O	—	_	0	SENT_494	[p28l1885t301r2001b351],
2	.	.	O	.	_	0	SENT_494	[p28l1885t301r2001b351],

1	G	NN	O	g	_	0	SENT_495	[p28l1885t301r2001b351],
2	,	,	O	,	_	0	SENT_495	[p28l1885t301r2001b351],
3	et	FW	O	et	nn	4	SENT_495	[p28l2026t306r2069b341],
4	al.	FW	O	al.	appos	1	SENT_495	[p28l2087t297r2140b341],
5	.	.	O	.	_	0	SENT_495	[p28l2087t297r2140b341],

1	The	DT	O	the	det	2	SENT_496	[p28l1111t368r1201b413],
2	effect	NN	O	effect	nsubj	15	SENT_496	[p28l1228t368r1359b413],
3	of	IN	O	of	_	0	SENT_496	[p28l1383t368r1440b413],
4	common	JJ	O	common	amod	5	SENT_496	[p28l1456t383r1669b413],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_496	[p28l1695t368r2069b425],
6	of	IN	O	of	_	0	SENT_496	[p28l2097t368r2153b413],
7	the	DT	O	the	det	11	SENT_496	[p28l1113t439r1185b483],
8	,82	CD	NUMBER	,82	num	9	SENT_496	[p28l1227t439r1561b496],
9	—	NN	O	—	npadvmod	10	SENT_496	[p28l1227t439r1561b496],
10	adrenergic	JJ	O	adrenergic	amod	11	SENT_496	[p28l1227t439r1561b496],
11	receptor	NN	O	receptor	prep_of	5	SENT_496	[p28l1605t448r1802b495],
12	on	IN	O	on	_	0	SENT_496	[p28l1846t453r1905b483],
13	agonist	NN	O	agonist	nn	14	SENT_496	[p28l1950t440r2142b496],
14	—	NN	O	—	prep_on	11	SENT_496	[p28l1950t440r2142b496],
15	mediated	VBD	O	mediate	_	0	SENT_496	[p28l1113t510r1331b555],
16	vascular	JJ	O	vascular	amod	17	SENT_496	[p28l1346t511r1540b555],
17	desensitization	NN	O	desensitization	dobj	15	SENT_496	[p28l1557t510r1927b555],
18	.	.	O	.	_	0	SENT_496	[p28l1557t510r1927b555],

1	N	NN	O	n	nn	2	SENT_497	[p28l1946t515r1988b555],
2	EnglJ	NN	O	englj	nsubj	3	SENT_497	[p28l2003t510r2145b567],
3	Med	VBD	O	med	_	0	SENT_497	[p28l1111t582r1215b627],
4	2001	CD	DATE	2001	dobj	3	SENT_497	[p28l1229t586r1646b636],
5	;	:	O	;	_	0	SENT_497	[p28l1229t586r1646b636],
6	345:1030	CD	NUMBER	345:1030	number	7	SENT_497	[p28l1229t586r1646b636],
7	—	CD	NUMBER	—	dep	4	SENT_497	[p28l1229t586r1646b636],
8	5	CD	NUMBER	5	dep	7	SENT_497	[p28l1229t586r1646b636],
9	.	.	O	.	_	0	SENT_497	[p28l1229t586r1646b636],

1	45	CD	NUMBER	45	_	0	SENT_498	[p28l1112t658r1179b696],
2	.	.	O	.	_	0	SENT_498	[p28l1112t658r1179b696],

1	Cockcroft	NNP	PERSON	Cockcroft	nn	2	SENT_499	[p28l1209t652r1443b697],
2	JR	NNP	O	JR	_	0	SENT_499	[p28l1451t656r1520b706],
3	,	,	O	,	_	0	SENT_499	[p28l1451t656r1520b706],
4	Gazis	NNP	ORGANIZATION	Gazis	nn	5	SENT_499	[p28l1539t653r1670b697],
5	AG	NNP	ORGANIZATION	AG	appos	2	SENT_499	[p28l1686t656r1775b706],
6	,	,	O	,	_	0	SENT_499	[p28l1686t656r1775b706],
7	Cross	NNP	ORGANIZATION	Cross	nn	8	SENT_499	[p28l1795t656r1927b697],
8	DJ	NNP	O	DJ	appos	2	SENT_499	[p28l1943t656r2012b706],
9	,	,	O	,	_	0	SENT_499	[p28l1943t656r2012b706],
10	et	FW	O	et	nn	11	SENT_499	[p28l2031t661r2074b696],
11	al.	FW	O	al.	appos	2	SENT_499	[p28l2087t652r2140b696],
12	.	.	O	.	_	0	SENT_499	[p28l2087t652r2140b696],

1	Beta	NN	O	beta	nn	2	SENT_500	[p28l1112t723r1621b780],
2	(	NN	O	(	_	0	SENT_500	[p28l1112t723r1621b780],
3	2	CD	NUMBER	2	num	4	SENT_500	[p28l1112t723r1621b780],
4	)	NN	O	)	dep	2	SENT_500	[p28l1112t723r1621b780],
5	.	.	O	.	_	0	SENT_500	[p28l1112t723r1621b780],

1	—	NN	O	—	_	0	SENT_501	[p28l1112t723r1621b780],
2	.	.	O	.	_	0	SENT_501	[p28l1112t723r1621b780],

1	adrenoceptor	NN	O	adrenoceptor	nn	2	SENT_502	[p28l1112t723r1621b780],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_502	[p28l1637t723r1988b780],
3	determines	VBZ	O	determine	_	0	SENT_502	[p28l2006t723r2142b768, p28l1113t795r1255b838],
4	vascular	JJ	O	vascular	amod	5	SENT_502	[p28l1269t794r1463b839],
5	reactivity	NN	O	reactivity	dobj	3	SENT_502	[p28l1476t795r1687b851],
6	in	IN	O	in	_	0	SENT_502	[p28l1699t795r1744b838],
7	humans	NNS	O	human	prep_in	5	SENT_502	[p28l1759t794r1964b839],
8	.	.	O	.	_	0	SENT_502	[p28l1759t794r1964b839],

1	Hypertension	NN	O	hypertension	_	0	SENT_503	[p28l1981t799r2142b851, p28l1113t866r1288b910],
2	2000	CD	DATE	2000	num	1	SENT_503	[p28l1302t869r1660b919],
3	;	:	O	;	_	0	SENT_503	[p28l1302t869r1660b919],
4	36:371	CD	NUMBER	36:371	number	5	SENT_503	[p28l1302t869r1660b919],
5	—	CD	NUMBER	—	dep	1	SENT_503	[p28l1302t869r1660b919],
6	5	CD	NUMBER	5	dep	5	SENT_503	[p28l1302t869r1660b919],
7	.	.	O	.	_	0	SENT_503	[p28l1302t869r1660b919],

1	46	CD	NUMBER	46	_	0	SENT_504	[p28l1112t941r1179b981],
2	.	.	O	.	_	0	SENT_504	[p28l1112t941r1179b981],

1	Drysdale	NNP	PERSON	Drysdale	nn	2	SENT_505	[p28l1208t936r1414b992],
2	CM	NN	O	cm	_	0	SENT_505	[p28l1427t940r1522b990],
3	,	,	O	,	_	0	SENT_505	[p28l1427t940r1522b990],
4	McGraw	NNP	PERSON	McGraw	nn	5	SENT_505	[p28l1537t940r1742b981],
5	DW	NNP	O	DW	appos	2	SENT_505	[p28l1752t940r1849b990],
6	,	,	O	,	_	0	SENT_505	[p28l1752t940r1849b990],
7	Stack	NNP	O	Stack	nn	8	SENT_505	[p28l1867t936r1994b981],
8	CB	NNP	O	CB	appos	2	SENT_505	[p28l2005t940r2086b990],
9	,	,	O	,	_	0	SENT_505	[p28l2005t940r2086b990],
10	et	FW	O	et	nn	11	SENT_505	[p28l2102t946r2145b980],
11	al.	FW	O	al.	appos	2	SENT_505	[p28l1112t1008r1165b1052],
12	.	.	O	.	_	0	SENT_505	[p28l1112t1008r1165b1052],

1	Complex	NN	O	complex	nn	2	SENT_506	[p28l1196t1008r1409b1064],
2	promoter	NN	O	promoter	dep	12	SENT_506	[p28l1435t1017r1660b1064],
3	and	CC	O	and	_	0	SENT_506	[p28l1686t1007r1773b1052],
4	coding	VBG	O	code	amod	6	SENT_506	[p28l1802t1007r1965b1064],
5	region	NN	O	region	nn	6	SENT_506	[p28l1991t1008r2143b1064],
6	beta	NN	O	beta	conj_and	2	SENT_506	[p28l1113t1079r1212b1123],
7	2	CD	NUMBER	2	number	8	SENT_506	[p28l1232t1078r1531b1135],
8	—	CD	NUMBER	—	num	11	SENT_506	[p28l1232t1078r1531b1135],
9	adrenergic	JJ	O	adrenergic	amod	11	SENT_506	[p28l1232t1078r1531b1135],
10	receptor	NN	O	receptor	nn	11	SENT_506	[p28l1551t1088r1747b1135],
11	haplotypes	NNS	O	haplotype	nsubj	12	SENT_506	[p28l1765t1078r2019b1135],
12	alter	VBP	O	alter	_	0	SENT_506	[p28l2040t1078r2145b1122],
13	receptor	NN	O	receptor	nn	14	SENT_506	[p28l1113t1159r1313b1206],
14	expression	NN	O	expression	dobj	12	SENT_506	[p28l1347t1150r1606b1206],
15	and	CC	O	and	_	0	SENT_506	[p28l1641t1149r1730b1194],
16	predict	VB	O	predict	conj_and	12	SENT_506	[p28l1764t1149r1935b1206],
17	in	FW	O	in	nn	18	SENT_506	[p28l1968t1150r2014b1193],
18	vivo	FW	O	vivo	advmod	16	SENT_506	[p28l2047t1150r2142b1194],
19	responsiveness	NN	O	responsiveness	dobj	16	SENT_506	[p28l1113t1221r1492b1277],
20	.	.	O	.	_	0	SENT_506	[p28l1113t1221r1492b1277],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_507	[p28l1518t1224r1623b1265],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_507	[p28l1645t1220r1745b1265],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_507	[p28l1767t1220r1884b1265],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_507	[p28l1909t1221r1976b1265],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_507	[p28l1998t1225r2037b1265],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_507	[p28l2061t1224r2084b1265],
7	A	NNP	O	A	_	0	SENT_507	[p28l2108t1225r2145b1264],
8	2000	CD	DATE	2000	num	7	SENT_507	[p28l1113t1295r1530b1345],
9	;	:	O	;	_	0	SENT_507	[p28l1113t1295r1530b1345],
10	97:10483	CD	NUMBER	97:10483	number	11	SENT_507	[p28l1113t1295r1530b1345],
11	—	CD	NUMBER	—	dep	7	SENT_507	[p28l1113t1295r1530b1345],
12	8	CD	NUMBER	8	dep	11	SENT_507	[p28l1113t1295r1530b1345],
13	.	.	O	.	_	0	SENT_507	[p28l1113t1295r1530b1345],

1	47	CD	NUMBER	47	_	0	SENT_508	[p28l1112t1368r1179b1406],
2	.	.	O	.	_	0	SENT_508	[p28l1112t1368r1179b1406],

1	Israel	NNP	LOCATION	Israel	nn	2	SENT_509	[p28l1208t1362r1337b1406],
2	E	NNP	O	E	_	0	SENT_509	[p28l1362t1366r1405b1416],
3	,	,	O	,	_	0	SENT_509	[p28l1362t1366r1405b1416],
4	Drazen	NNP	PERSON	Drazen	nn	5	SENT_509	[p28l1432t1366r1602b1406],
5	JM	NN	PERSON	jm	appos	2	SENT_509	[p28l1622t1366r1703b1416],
6	,	,	O	,	_	0	SENT_509	[p28l1622t1366r1703b1416],
7	Liggett	NNP	ORGANIZATION	Liggett	nn	8	SENT_509	[p28l1731t1363r1898b1419],
8	SB	NN	O	sb	appos	2	SENT_509	[p28l1921t1366r1994b1416],
9	,	,	O	,	_	0	SENT_509	[p28l1921t1366r1994b1416],
10	et	FW	O	et	nn	11	SENT_509	[p28l2022t1371r2066b1406],
11	al.	FW	O	al.	appos	2	SENT_509	[p28l2087t1362r2140b1406],
12	.	.	O	.	_	0	SENT_509	[p28l2087t1362r2140b1406],

1	Effect	NN	O	effect	_	0	SENT_510	[p28l1112t1433r1250b1478],
2	of	IN	O	of	_	0	SENT_510	[p28l1262t1433r1318b1478],
3	polymorphism	NN	O	polymorphism	prep_of	1	SENT_510	[p28l1321t1434r1672b1490],
4	of	IN	O	of	_	0	SENT_510	[p28l1687t1433r1743b1478],
5	the	DT	O	the	det	9	SENT_510	[p28l1747t1434r1820b1477],
6	beta	NN	O	beta	nn	9	SENT_510	[p28l1834t1433r2142b1484],
7	(	NN	O	(	nn	9	SENT_510	[p28l1834t1433r2142b1484],
8	2	CD	NUMBER	2	num	9	SENT_510	[p28l1834t1433r2142b1484],
9	)	NN	O	)	prep_of	1	SENT_510	[p28l1834t1433r2142b1484],
10	.	.	O	.	_	0	SENT_510	[p28l1834t1433r2142b1484],

1	—	NN	O	—	_	0	SENT_511	[p28l1834t1433r2142b1484],
2	.	.	O	.	_	0	SENT_511	[p28l1834t1433r2142b1484],

1	adre	NN	O	adre	nn	3	SENT_512	[p28l1834t1433r2142b1484],
2	nergic	JJ	O	nergic	amod	3	SENT_512	[p28l1113t1505r1260b1561],
3	receptor	NN	O	receptor	_	0	SENT_512	[p28l1281t1514r1477b1561],
4	on	IN	O	on	_	0	SENT_512	[p28l1497t1519r1556b1549],
5	response	NN	O	response	prep_on	3	SENT_512	[p28l1577t1519r1789b1561],
6	to	TO	O	to	_	0	SENT_512	[p28l1811t1514r1855b1549],
7	regular	JJ	O	regular	amod	8	SENT_512	[p28l1876t1505r2046b1561],
8	use	NN	O	use	prep_to	3	SENT_512	[p28l2065t1519r2143b1549],
9	of	IN	O	of	_	0	SENT_512	[p28l1113t1575r1169b1620],
10	albuterol	NN	O	albuterol	prep_of	3	SENT_512	[p28l1192t1575r1403b1620],
11	in	IN	O	in	_	0	SENT_512	[p28l1435t1576r1481b1619],
12	asthma	NN	O	asthma	prep_in	10	SENT_512	[p28l1513t1576r1699b1620],
13	.	.	O	.	_	0	SENT_512	[p28l1513t1576r1699b1620],

1	Int	NNP	O	Int	nn	4	SENT_513	[p28l1735t1580r1804b1619],
2	Arch	NNP	O	Arch	nn	4	SENT_513	[p28l1832t1576r1945b1619],
3	Allergy	NNP	O	Allergy	nn	4	SENT_513	[p28l1976t1576r2146b1632],
4	Immunol	NNP	O	Immunol	_	0	SENT_513	[p28l1112t1647r1335b1691],
5	2001	CD	DATE	2001	num	4	SENT_513	[p28l1349t1650r1736b1700],
6	;	:	O	;	_	0	SENT_513	[p28l1349t1650r1736b1700],
7	124:183	CD	NUMBER	124:183	number	8	SENT_513	[p28l1349t1650r1736b1700],
8	—	CD	NUMBER	—	dep	4	SENT_513	[p28l1349t1650r1736b1700],
9	6	CD	NUMBER	6	dep	8	SENT_513	[p28l1349t1650r1736b1700],
10	.	.	O	.	_	0	SENT_513	[p28l1349t1650r1736b1700],

1	48	CD	NUMBER	48	_	0	SENT_514	[p28l1112t1722r1179b1762],
2	.	.	O	.	_	0	SENT_514	[p28l1112t1722r1179b1762],

1	Lima	NNP	LOCATION	Lima	nn	2	SENT_515	[p28l1208t1718r1327b1761],
2	J	NNP	O	J	_	0	SENT_515	[p28l1337t1721r1387b1771],
3	]	NN	O	]	dep	2	SENT_515	[p28l1337t1721r1387b1771],
4	,	,	O	,	_	0	SENT_515	[p28l1337t1721r1387b1771],
5	Thomason	NNP	PERSON	Thomason	nn	6	SENT_515	[p28l1404t1717r1661b1761],
6	DB	NNP	O	DB	appos	3	SENT_515	[p28l1676t1721r1762b1771],
7	,	,	O	,	_	0	SENT_515	[p28l1676t1721r1762b1771],
8	Mohamed	NNP	PERSON	Mohamed	nn	9	SENT_515	[p28l1780t1717r2022b1762],
9	MH	NNP	PERSON	MH	appos	3	SENT_515	[p28l2036t1721r2140b1771],
10	,	,	O	,	_	0	SENT_515	[p28l2036t1721r2140b1771],
11	Eberle	NNP	ORGANIZATION	Eberle	nn	12	SENT_515	[p28l1112t1788r1261b1833],
12	LV	NNP	ORGANIZATION	LV	appos	3	SENT_515	[p28l1284t1793r1348b1842],
13	,	,	O	,	_	0	SENT_515	[p28l1284t1793r1348b1842],
14	Self	NN	O	self	nn	15	SENT_515	[p28l1376t1788r1471b1833],
15	TH	NN	O	th	appos	3	SENT_515	[p28l1483t1792r1572b1842],
16	,	,	O	,	_	0	SENT_515	[p28l1483t1792r1572b1842],
17	Johnson	NNP	PERSON	Johnson	nn	18	SENT_515	[p28l1593t1789r1795b1839],
18	JA	NNP	O	JA	appos	3	SENT_515	[p28l1813t1793r1881b1839],
19	.	.	O	.	_	0	SENT_515	[p28l1813t1793r1881b1839],

1	Impact	NN	O	impact	_	0	SENT_516	[p28l1908t1793r2076b1845],
2	of	IN	O	of	_	0	SENT_516	[p28l2097t1788r2153b1833],
3	genetic	JJ	O	genetic	amod	4	SENT_516	[p28l1113t1860r1282b1916],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_516	[p28l1305t1860r1680b1916],
5	of	IN	O	of	_	0	SENT_516	[p28l1705t1859r1761b1904],
6	the	DT	O	the	det	10	SENT_516	[p28l1776t1860r1848b1904],
7	beta2	NN	O	beta2	nn	10	SENT_516	[p28l1873t1859r2142b1904],
8	—	CD	NUMBER	—	num	10	SENT_516	[p28l1873t1859r2142b1904],
9	adre	NN	O	adre	nn	10	SENT_516	[p28l1873t1859r2142b1904],
10	—	NN	O	—	nn	12	SENT_516	[p28l1873t1859r2142b1904],
11	nergic	JJ	O	nergic	amod	12	SENT_516	[p28l1113t1931r1260b1987],
12	receptor	NN	O	receptor	prep_of	1	SENT_516	[p28l1275t1940r1471b1987],
13	on	IN	O	on	_	0	SENT_516	[p28l1486t1945r1545b1975],
14	albuterol	NN	O	albuterol	nn	16	SENT_516	[p28l1560t1930r1772b1975],
15	bronchodilator	NN	O	bronchodilator	nn	16	SENT_516	[p28l1787t1930r2145b1975],
16	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	12	SENT_516	[p28l1112t2001r1591b2058],
17	.	.	O	.	_	0	SENT_516	[p28l1112t2001r1591b2058],

1	Clin	NNP	O	Clin	nn	3	SENT_517	[p28l1624t2001r1721b2046],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_517	[p28l1750t2001r2004b2046],
3	Ther	NNP	O	Ther	_	0	SENT_517	[p28l2032t2001r2145b2046],
4	1999	CD	DATE	1999	num	3	SENT_517	[p28l1115t2076r1500b2126],
5	;	:	O	;	_	0	SENT_517	[p28l1115t2076r1500b2126],
6	65:519	CD	NUMBER	65:519	number	7	SENT_517	[p28l1115t2076r1500b2126],
7	—	CD	NUMBER	—	dep	3	SENT_517	[p28l1115t2076r1500b2126],
8	25	CD	NUMBER	25	dep	7	SENT_517	[p28l1115t2076r1500b2126],
9	.	.	O	.	_	0	SENT_517	[p28l1115t2076r1500b2126],

1	49	CD	NUMBER	49	_	0	SENT_518	[p28l1112t2149r1179b2188],
2	.	.	O	.	_	0	SENT_518	[p28l1112t2149r1179b2188],

1	Martinez	NNP	PERSON	Martinez	nn	2	SENT_519	[p28l1207t2145r1419b2188],
2	FD	NNP	O	FD	_	0	SENT_519	[p28l1433t2148r1512b2198],
3	,	,	O	,	_	0	SENT_519	[p28l1433t2148r1512b2198],
4	Graves	NNP	ORGANIZATION	Graves	nn	5	SENT_519	[p28l1529t2148r1688b2189],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_519	[p28l1703t2148r1776b2198],
6	,	,	O	,	_	0	SENT_519	[p28l1703t2148r1776b2198],
7	Baldini	NNP	PERSON	Baldini	nn	8	SENT_519	[p28l1793t2144r1961b2188],
8	M	NNP	O	M	appos	2	SENT_519	[p28l1973t2148r2034b2198],
9	,	,	O	,	_	0	SENT_519	[p28l1973t2148r2034b2198],
10	Solomon	NNP	ORGANIZATION	Solomon	nn	11	SENT_519	[p28l2052t2144r2142b2188, p28l1113t2229r1252b2259],
11	S	NNP	ORGANIZATION	S	appos	2	SENT_519	[p28l1277t2218r1316b2268],
12	,	,	O	,	_	0	SENT_519	[p28l1277t2218r1316b2268],
13	Erickson	NNP	ORGANIZATION	Erickson	nn	15	SENT_519	[p28l1342t2215r1550b2259],
14	R.	NNP	ORGANIZATION	R.	nn	15	SENT_519	[p28l1574t2218r1621b2261],
15	Association	NNP	ORGANIZATION	Association	appos	2	SENT_519	[p28l1647t2215r1923b2259],
16	between	IN	O	between	_	0	SENT_519	[p28l1948t2214r2143b2259],
17	genetic	JJ	O	genetic	amod	18	SENT_519	[p28l1113t2286r1279b2342],
18	polymorphisms	NNS	O	polymorphism	prep_between	15	SENT_519	[p28l1291t2285r1658b2342],
19	of	IN	O	of	_	0	SENT_519	[p28l1674t2285r1729b2330],
20	the	DT	O	the	det	25	SENT_519	[p28l1733t2285r1804b2330],
21	beta2	NN	O	beta2	nn	25	SENT_519	[p28l1818t2285r2142b2330],
22	—	NN	O	—	nn	25	SENT_519	[p28l1818t2285r2142b2330],
23	adreno	NN	O	adreno	nn	25	SENT_519	[p28l1818t2285r2142b2330],
24	—	NN	O	—	nn	25	SENT_519	[p28l1818t2285r2142b2330],
25	ceptor	NN	O	ceptor	prep_of	18	SENT_519	[p28l1113t2366r1267b2413],
26	and	CC	O	and	_	0	SENT_519	[p28l1289t2356r1378b2401],
27	response	NN	O	response	conj_and	18	SENT_519	[p28l1402t2371r1622b2413],
28	to	TO	O	to	_	0	SENT_519	[p28l1647t2366r1692b2401],
29	albuterol	NN	O	albuterol	prep_to	27	SENT_519	[p28l1717t2356r1938b2401],
30	in	IN	O	in	_	0	SENT_519	[p28l1962t2357r2008b2400],
31	children	NNS	O	child	prep_in	29	SENT_519	[p28l2033t2357r2141b2400, p28l1113t2427r1220b2472],
32	with	IN	O	with	prep	31	SENT_519	[p28l1229t2427r1334b2472],
33	and	CC	O	and	_	0	SENT_519	[p28l1346t2427r1433b2472],
34	without	IN	O	without	conj_and	32	SENT_519	[p28l1442t2427r1628b2472],
35	a	DT	O	a	det	36	SENT_519	[p28l1636t2442r1661b2471],
36	history	NN	O	history	pobj	34	SENT_519	[p28l1673t2428r1835b2484],
37	of	IN	O	of	_	0	SENT_519	[p28l1846t2427r1901b2472],
38	wheezing	VBG	O	wheeze	prepc_of	36	SENT_519	[p28l1901t2428r2140b2484],
39	.	.	O	.	_	0	SENT_519	[p28l1901t2428r2140b2484],

1	JClin	NNP	O	JClin	nn	2	SENT_520	[p28l1107t2498r1236b2549],
2	Invest	NNP	O	Invest	_	0	SENT_520	[p28l1248t2503r1396b2543],
3	1997	CD	DATE	1997	num	2	SENT_520	[p28l1411t2502r1826b2552],
4	;	:	O	;	_	0	SENT_520	[p28l1411t2502r1826b2552],
5	100:3184	CD	NUMBER	100:3184	number	6	SENT_520	[p28l1411t2502r1826b2552],
6	—	CD	NUMBER	—	dep	2	SENT_520	[p28l1411t2502r1826b2552],
7	8	CD	NUMBER	8	dep	6	SENT_520	[p28l1411t2502r1826b2552],
8	.	.	O	.	_	0	SENT_520	[p28l1411t2502r1826b2552],

1	50	CD	NUMBER	50	_	0	SENT_521	[p28l1113t2574r1179b2613],
2	.	.	O	.	_	0	SENT_521	[p28l1113t2574r1179b2613],

1	Tan	NNP	MISC	Tan	nn	2	SENT_522	[p28l1207t2573r1294b2613],
2	S	NNP	O	S	_	0	SENT_522	[p28l1308t2573r1346b2623],
3	,	,	O	,	_	0	SENT_522	[p28l1308t2573r1346b2623],
4	Hall	NNP	O	Hall	nn	5	SENT_522	[p28l1362t2569r1460b2613],
5	IP	NNP	O	IP	appos	2	SENT_522	[p28l1471t2573r1525b2623],
6	,	,	O	,	_	0	SENT_522	[p28l1471t2573r1525b2623],
7	Dewar	NNP	PERSON	Dewar	nn	8	SENT_522	[p28l1540t2573r1732b2623],
8	]	NNP	O	]	appos	2	SENT_522	[p28l1540t2573r1732b2623],
9	,	,	O	,	_	0	SENT_522	[p28l1540t2573r1732b2623],
10	Dow	NNP	ORGANIZATION	Dow	nn	11	SENT_522	[p28l1747t2573r1859b2614],
11	E	NNP	ORGANIZATION	E	appos	2	SENT_522	[p28l1869t2573r1912b2623],
12	,	,	O	,	_	0	SENT_522	[p28l1869t2573r1912b2623],
13	Lipworth	NNP	ORGANIZATION	Lipworth	nn	15	SENT_522	[p28l1927t2569r2143b2625],
14	B.	NNP	ORGANIZATION	B.	nn	15	SENT_522	[p28l1112t2644r1157b2685],
15	Association	NNP	ORGANIZATION	Association	appos	2	SENT_522	[p28l1171t2641r1448b2685],
16	between	IN	O	between	_	0	SENT_522	[p28l1461t2640r1656b2685],
17	beta	NN	O	beta	nn	20	SENT_522	[p28l1669t2641r1768b2685],
18	2	CD	NUMBER	2	num	20	SENT_522	[p28l1779t2640r2144b2697],
19	—	NN	O	—	nn	20	SENT_522	[p28l1779t2640r2144b2697],
20	adrenoceptor	NN	O	adrenoceptor	prep_between	15	SENT_522	[p28l1779t2640r2144b2697],
21	polymorphism	NN	O	polymorphism	dep	2	SENT_522	[p28l1112t2711r1463b2768],
22	and	CC	O	and	_	0	SENT_522	[p28l1489t2711r1577b2756],
23	susceptibility	NN	O	susceptibility	conj_and	21	SENT_522	[p28l1604t2712r1916b2768],
24	to	TO	O	to	_	0	SENT_522	[p28l1941t2721r1985b2756],
25	bronchodilator	NN	O	bronchodilator	nn	26	SENT_522	[p28l2013t2712r2142b2756, p28l1113t2782r1362b2827],
26	desensitization	NN	O	desensitization	prep_to	21	SENT_522	[p28l1395t2782r1760b2827],
27	in	IN	O	in	_	0	SENT_522	[p28l1794t2783r1840b2826],
28	moderately	RB	O	moderately	advmod	29	SENT_522	[p28l1874t2782r2145b2839],
29	severe	JJ	O	severe	amod	31	SENT_522	[p28l1114t2868r1258b2898],
30	stable	JJ	O	stable	amod	31	SENT_522	[p28l1281t2853r1420b2898],
31	asthmatics	NNS	O	asthmatic	prep_in	26	SENT_522	[p28l1440t2853r1708b2898],
32	.	.	O	.	_	0	SENT_522	[p28l1440t2853r1708b2898],

1	Lancet	NNP	O	Lancet	_	0	SENT_523	[p28l1731t2858r1888b2898],
2	1997	CD	DATE	1997	num	1	SENT_523	[p28l1908t2857r2141b2907],
3	;	:	O	;	_	0	SENT_523	[p28l1908t2857r2141b2907],
4	350	CD	NUMBER	350	num	6	SENT_523	[p28l1908t2857r2141b2907],
5	:	:	O	:	_	0	SENT_523	[p28l1908t2857r2141b2907],
6	995	CD	NUMBER	995	dep	1	SENT_523	[p28l1113t2928r1261b2969],
7	—	CD	NUMBER	—	number	8	SENT_523	[p28l1113t2928r1261b2969],
8	9	CD	NUMBER	9	dep	6	SENT_523	[p28l1113t2928r1261b2969],
9	.	.	O	.	_	0	SENT_523	[p28l1113t2928r1261b2969],

1	51	CD	NUMBER	51	_	0	SENT_524	[p28l1113t3001r1179b3039],
2	.	.	O	.	_	0	SENT_524	[p28l1113t3001r1179b3039],

1	Mukae	FW	O	mukae	_	0	SENT_525	[p28l1207t2995r1367b3040],
2	S	NN	O	s	dep	22	SENT_525	[p28l1388t2999r1426b3049],
3	,	,	O	,	_	0	SENT_525	[p28l1388t2999r1426b3049],
4	Aoki	NNP	PERSON	Aoki	nn	5	SENT_525	[p28l1446t2995r1558b3040],
5	S	NNP	O	S	appos	2	SENT_525	[p28l1577t2999r1616b3049],
6	,	,	O	,	_	0	SENT_525	[p28l1577t2999r1616b3049],
7	Itoh	NNP	PERSON	Itoh	nn	8	SENT_525	[p28l1637t2995r1734b3039],
8	S	NNP	O	S	appos	2	SENT_525	[p28l1754t2999r1792b3049],
9	,	,	O	,	_	0	SENT_525	[p28l1754t2999r1792b3049],
10	Iwata	NNP	ORGANIZATION	Iwata	nn	11	SENT_525	[p28l1813t2999r1943b3040],
11	T	NN	ORGANIZATION	t	appos	2	SENT_525	[p28l1959t2999r2000b3049],
12	,	,	O	,	_	0	SENT_525	[p28l1959t2999r2000b3049],
13	Ueda	NNP	PERSON	Ueda	nn	14	SENT_525	[p28l2022t2995r2143b3040],
14	H	NNP	O	H	appos	2	SENT_525	[p28l1112t3071r1166b3120],
15	,	,	O	,	_	0	SENT_525	[p28l1112t3071r1166b3120],
16	Katagiri	NNP	PERSON	Katagiri	nn	19	SENT_525	[p28l1182t3067r1372b3123],
17	T.	NNP	PERSON	T.	nn	19	SENT_525	[p28l1383t3070r1424b3111],
18	Bradykinin	NNP	PERSON	Bradykinin	nn	19	SENT_525	[p28l1439t3066r1698b3123],
19	B	NNP	PERSON	B	appos	2	SENT_525	[p28l1711t3070r1808b3117],
20	(	NN	O	(	dep	22	SENT_525	[p28l1711t3070r1808b3117],
21	2	CD	NUMBER	2	num	20	SENT_525	[p28l1711t3070r1808b3117],
22	)	NN	O	)	dep	27	SENT_525	[p28l1711t3070r1808b3117],
23	receptor	NN	O	receptor	dep	22	SENT_525	[p28l1824t3076r2021b3123],
24	gene	NN	O	gene	nn	25	SENT_525	[p28l2032t3081r2143b3123],
25	polymorphism	NN	O	polymorphism	nsubjpass	27	SENT_525	[p28l1112t3137r1463b3194],
26	is	VBZ	O	be	auxpass	27	SENT_525	[p28l1480t3138r1517b3181],
27	associated	VBN	O	associate	dep	1	SENT_525	[p28l1535t3137r1779b3182],
28	with	IN	O	with	_	0	SENT_525	[p28l1794t3138r1899b3182],
29	angiotensin-converting	JJ	O	angiotensin-converting	amod	32	SENT_525	[p28l1916t3138r2142b3194, p28l1114t3209r1456b3265],
30	enzyme	NN	O	enzyme	nn	32	SENT_525	[p28l1514t3223r1694b3265],
31	inhibitor	NN	O	inhibitor	nn	32	SENT_525	[p28l1753t3208r2143b3253],
32	—	NN	O	—	prep_with	27	SENT_525	[p28l1753t3208r2143b3253],
33	related	JJ	O	related	dep	34	SENT_525	[p28l1753t3208r2143b3253],
34	cough	NN	O	cough	amod	32	SENT_525	[p28l1113t3279r1272b3336],
35	.	.	O	.	_	0	SENT_525	[p28l1113t3279r1272b3336],

1	Hypertension	NN	O	hypertension	_	0	SENT_526	[p28l1288t3280r1609b3336],
2	2000	CD	DATE	2000	num	1	SENT_526	[p28l1623t3283r2010b3333],
3	;	:	O	;	_	0	SENT_526	[p28l1623t3283r2010b3333],
4	36:127	CD	NUMBER	36:127	number	5	SENT_526	[p28l1623t3283r2010b3333],
5	—	CD	NUMBER	—	dep	1	SENT_526	[p28l1623t3283r2010b3333],
6	31	CD	NUMBER	31	dep	5	SENT_526	[p28l1623t3283r2010b3333],
7	.	.	O	.	_	0	SENT_526	[p28l1623t3283r2010b3333],

1	52	CD	NUMBER	52	_	0	SENT_527	[p28l1113t3356r1179b3394],
2	.	.	O	.	_	0	SENT_527	[p28l1113t3356r1179b3394],

1	Arranz	NNP	PERSON	Arranz	nn	2	SENT_528	[p28l1207t3354r1369b3394],
2	MJ	NNP	PERSON	MJ	_	0	SENT_528	[p28l1379t3354r1456b3404],
3	,	,	O	,	_	0	SENT_528	[p28l1379t3354r1456b3404],
4	Munro	NNP	PERSON	Munro	nn	5	SENT_528	[p28l1470t3354r1631b3395],
5	J	NNP	PERSON	J	appos	2	SENT_528	[p28l1638t3354r1670b3404],
6	,	,	O	,	_	0	SENT_528	[p28l1638t3354r1670b3404],
7	BirkettJ	NNP	O	BirkettJ	appos	2	SENT_528	[p28l1685t3350r1883b3404],
8	,	,	O	,	_	0	SENT_528	[p28l1685t3350r1883b3404],
9	et	FW	O	et	nn	10	SENT_528	[p28l1898t3359r1941b3394],
10	al.	FW	O	al.	appos	2	SENT_528	[p28l1950t3350r2002b3394],
11	.	.	O	.	_	0	SENT_528	[p28l1950t3350r2002b3394],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_529	[p28l2017t3350r2142b3394, p28l1113t3422r1413b3478],
2	prediction	NN	O	prediction	_	0	SENT_529	[p28l1450t3421r1693b3478],
3	of	IN	O	of	_	0	SENT_529	[p28l1731t3421r1788b3466],
4	clozapine	NN	O	clozapine	nn	5	SENT_529	[p28l1816t3422r2042b3478],
5	response	NN	O	response	prep_of	2	SENT_529	[p28l2080t3436r2142b3466, p28l1114t3507r1291b3549],
6	.	.	O	.	_	0	SENT_529	[p28l2080t3436r2142b3466, p28l1114t3507r1291b3549],

1	Lancet	NNP	O	Lancet	_	0	SENT_530	[p28l1308t3497r1465b3536],
2	2000	CD	DATE	2000	num	1	SENT_530	[p28l1476t3496r1893b3546],
3	;	:	O	;	_	0	SENT_530	[p28l1476t3496r1893b3546],
4	355:1615	CD	NUMBER	355:1615	number	5	SENT_530	[p28l1476t3496r1893b3546],
5	—	CD	NUMBER	—	dep	1	SENT_530	[p28l1476t3496r1893b3546],
6	6	CD	NUMBER	6	dep	5	SENT_530	[p28l1476t3496r1893b3546],
7	.	.	O	.	_	0	SENT_530	[p28l1476t3496r1893b3546],

1	53	CD	NUMBER	53	_	0	SENT_531	[p28l1113t3569r1179b3607],
2	.	.	O	.	_	0	SENT_531	[p28l1113t3569r1179b3607],

1	Basile	NNP	PERSON	Basile	nn	2	SENT_532	[p28l1208t3563r1348b3607],
2	VS	NNP	O	VS	_	0	SENT_532	[p28l1375t3567r1450b3617],
3	,	,	O	,	_	0	SENT_532	[p28l1375t3567r1450b3617],
4	Masellis	NNP	O	Masellis	nn	5	SENT_532	[p28l1481t3563r1675b3607],
5	M	NNP	O	M	appos	2	SENT_532	[p28l1703t3567r1764b3617],
6	,	,	O	,	_	0	SENT_532	[p28l1703t3567r1764b3617],
7	Badri	NNP	PERSON	Badri	nn	8	SENT_532	[p28l1796t3563r1922b3607],
8	F	NN	O	f	appos	2	SENT_532	[p28l1950t3567r1985b3617],
9	,	,	O	,	_	0	SENT_532	[p28l1950t3567r1985b3617],
10	et	FW	O	et	nn	11	SENT_532	[p28l2018t3572r2061b3607],
11	al.	FW	O	al.	appos	2	SENT_532	[p28l2087t3563r2139b3607],
12	.	.	O	.	_	0	SENT_532	[p28l2087t3563r2139b3607],

1	Association	NNP	O	Association	_	0	SENT_533	[p28l1111t3635r1387b3679],
2	of	IN	O	of	_	0	SENT_533	[p28l1413t3634r1469b3679],
3	the	DT	O	the	det	5	SENT_533	[p28l1485t3635r1557b3679],
4	MscI	NN	MISC	mscus	nn	5	SENT_533	[p28l1581t3639r1696b3678],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_533	[p28l1720t3634r2072b3691],
6	of	IN	O	of	_	0	SENT_533	[p28l2097t3634r2153b3679],
7	the	DT	O	the	det	11	SENT_533	[p28l1113t3705r1185b3749],
8	dopamine	NN	O	dopamine	nn	11	SENT_533	[p28l1199t3705r1437b3762],
9	D3	NN	O	d3	nn	11	SENT_533	[p28l1451t3709r1517b3750],
10	receptor	NN	O	receptor	nn	11	SENT_533	[p28l1533t3715r1729b3762],
11	gene	NN	O	gene	prep_of	1	SENT_533	[p28l1741t3720r1852b3762],
12	with	IN	O	with	_	0	SENT_533	[p28l1864t3705r1970b3750],
13	tardive	JJ	O	tardive	amod	14	SENT_533	[p28l1984t3705r2142b3750],
14	dyskinesia	NN	O	dyskinesium	prep_with	11	SENT_533	[p28l1113t3776r1359b3833],
15	in	IN	O	in	_	0	SENT_533	[p28l1405t3777r1451b3820],
16	schizophrenia	NN	O	schizophrenia	prep_in	1	SENT_533	[p28l1499t3777r1847b3833],
17	.	.	O	.	_	0	SENT_533	[p28l1499t3777r1847b3833],

1	Neuropsy	JJ	O	neuropsy	amod	2	SENT_534	[p28l1896t3781r2142b3833],
2	—	NN	O	—	_	0	SENT_534	[p28l1896t3781r2142b3833],

1	pertensive	JJ	O	pertensive	amod	2	SENT_535	[p29l8t21r248b77],
2	treatment	NN	O	treatment	_	0	SENT_535	[p29l283t30r514b64],
3	with	IN	O	with	_	0	SENT_535	[p29l544t20r649b65],
4	fosinopril	NN	O	fosinopril	prep_with	2	SENT_535	[p29l684t20r930b77],
5	:	:	O	:	_	0	SENT_535	[p29l684t20r930b77],
6	the	DT	O	the	det	7	SENT_535	[p29l967t20r1039b65],
7	role	NN	O	role	dep	2	SENT_535	[p29l9t92r98b136],
8	of	IN	O	of	_	0	SENT_535	[p29l111t91r168b136],
9	angiotensin-converting	JJ	O	angiotensin-converting	amod	12	SENT_535	[p29l170t92r724b148],
10	enzyme	NN	O	enzyme	nn	12	SENT_535	[p29l735t106r915b148],
11	gene	NN	O	gene	nn	12	SENT_535	[p29l928t106r1039b148],
12	polymorphism	NN	O	polymorphism	prep_of	7	SENT_535	[p29l8t162r372b219],
13	.	.	O	.	_	0	SENT_535	[p29l8t162r372b219],

1	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_536	[p29l426t162r684b207],
2	Drugs	NNPS	O	Drugs	nn	3	SENT_536	[p29l734t166r877b219],
3	Ther	NNP	O	Ther	_	0	SENT_536	[p29l928t162r1040b206],
4	2000	CD	DATE	2000	dep	3	SENT_536	[p29l9t237r396b287],
5	;	:	O	;	_	0	SENT_536	[p29l9t237r396b287],
6	14:427	CD	NUMBER	14:427	number	7	SENT_536	[p29l9t237r396b287],
7	—	CD	NUMBER	—	dep	3	SENT_536	[p29l9t237r396b287],
8	32	CD	NUMBER	32	dep	7	SENT_536	[p29l9t237r396b287],
9	.	.	O	.	_	0	SENT_536	[p29l9t237r396b287],

1	41	CD	NUMBER	41	_	0	SENT_537	[p29l7t310r74b348],
2	.	.	O	.	_	0	SENT_537	[p29l7t310r74b348],

1	Marian	NNP	PERSON	Marian	nn	2	SENT_538	[p29l103t305r272b348],
2	A	NNP	O	A	_	0	SENT_538	[p29l291t308r357b358],
3	]	NN	O	]	dep	2	SENT_538	[p29l291t308r357b358],
4	,	,	O	,	_	0	SENT_538	[p29l291t308r357b358],
5	Safavi	NNP	PERSON	Safavi	nn	6	SENT_538	[p29l383t304r519b349],
6	F	NN	O	f	appos	3	SENT_538	[p29l540t308r575b358],
7	,	,	O	,	_	0	SENT_538	[p29l540t308r575b358],
8	Ferlic	JJ	ORGANIZATION	ferlic	amod	9	SENT_538	[p29l599t304r730b348],
9	L	NN	ORGANIZATION	l	appos	3	SENT_538	[p29l750t308r791b358],
10	,	,	O	,	_	0	SENT_538	[p29l750t308r791b358],
11	Dunn	NNP	ORGANIZATION	Dunn	nn	12	SENT_538	[p29l815t308r949b349],
12	JK	NNP	ORGANIZATION	JK	appos	3	SENT_538	[p29l965t308r1035b358],
13	,	,	O	,	_	0	SENT_538	[p29l965t308r1035b358],
14	Gotto	NNP	ORGANIZATION	Gotto	nn	15	SENT_538	[p29l9t379r143b420],
15	AM	NNP	ORGANIZATION	AM	appos	3	SENT_538	[p29l184t380r281b429],
16	,	,	O	,	_	0	SENT_538	[p29l184t380r281b429],
17	Ballantyne	NNP	PERSON	Ballantyne	nn	18	SENT_538	[p29l326t375r573b432],
18	CM	NN	O	cm	appos	3	SENT_538	[p29l615t379r711b420],
19	.	.	O	.	_	0	SENT_538	[p29l615t379r711b420],

1	Interactions	NNS	O	interaction	_	0	SENT_539	[p29l755t376r1038b420],
2	between	IN	O	between	_	0	SENT_539	[p29l9t447r204b491],
3	angiotensin-I	NN	O	angiotensin-i	prep_between	1	SENT_539	[p29l233t447r550b503],
4	converting	VBG	O	convert	partmod	1	SENT_539	[p29l579t447r831b503],
5	enzyme	NN	O	enzyme	nn	7	SENT_539	[p29l859t461r1038b503],
6	insertion/deletion	NN	O	insertion/deletion	nn	7	SENT_539	[p29l8t517r430b568],
7	polymorphism	NN	O	polymorphism	dobj	4	SENT_539	[p29l465t517r817b574],
8	and	CC	O	and	_	0	SENT_539	[p29l853t517r940b562],
9	response	NN	O	response	dobj	4	SENT_539	[p29l976t532r1038b562, p29l9t603r174b645],
10	of	IN	O	of	_	0	SENT_539	[p29l196t588r253b633],
11	plasma	NN	O	plasma	nn	12	SENT_539	[p29l263t589r435b645],
12	lipids	NNS	O	lipid	prep_of	9	SENT_539	[p29l455t588r585b645],
13	and	CC	O	and	_	0	SENT_539	[p29l608t588r695b633],
14	coronary	JJ	O	coronary	amod	15	SENT_539	[p29l717t603r927b645],
15	atherosclerosis	NN	O	atherosclerosis	conj_and	12	SENT_539	[p29l946t589r1038b632, p29l9t660r288b704],
16	to	TO	O	to	_	0	SENT_539	[p29l317t668r361b704],
17	treatment	NN	O	treatment	prep_to	4	SENT_539	[p29l389t669r621b704],
18	with	IN	O	with	_	0	SENT_539	[p29l643t659r749b704],
19	ﬂuvastatin	NN	O	ﬂuvastatin	prep_with	1	SENT_539	[p29l776t659r1036b704],
20	:	:	O	:	_	0	SENT_539	[p29l776t659r1036b704],
21	the	DT	O	the	det	22	SENT_539	[p29l9t730r81b775],
22	Lipoprotein	NN	O	lipoprotein	dep	1	SENT_539	[p29l94t731r372b787],
23	and	CC	O	and	_	0	SENT_539	[p29l385t730r473b775],
24	Coronary	JJ	O	coronary	amod	26	SENT_539	[p29l486t734r707b787],
25	Atherosclerosis	NNP	O	Atherosclerosis	nn	26	SENT_539	[p29l716t730r1038b775, p29l9t802r69b845],
26	Study	NNP	O	Study	conj_and	22	SENT_539	[p29l85t801r222b858],
27	.	.	O	.	_	0	SENT_539	[p29l85t801r222b858],

1	J	NNP	O	J	nn	4	SENT_540	[p29l233t806r254b852],
2	Am	NNP	O	Am	nn	4	SENT_540	[p29l265t806r349b845],
3	Coll	NNP	O	Coll	nn	4	SENT_540	[p29l363t801r458b846],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_540	[p29l472t801r645b846],
5	2000	CD	DATE	2000	num	4	SENT_540	[p29l659t805r1017b855],
6	;	:	O	;	_	0	SENT_540	[p29l659t805r1017b855],
7	35:89	CD	NUMBER	35:89	number	8	SENT_540	[p29l659t805r1017b855],
8	-95	CD	NUMBER	-95	dep	4	SENT_540	[p29l659t805r1017b855],
9	.	.	O	.	_	0	SENT_540	[p29l659t805r1017b855],

1	42	CD	NUMBER	42	_	0	SENT_541	[p29l7t879r74b917],
2	.	.	O	.	_	0	SENT_541	[p29l7t879r74b917],

1	Drazen	NNP	PERSON	Drazen	nn	2	SENT_542	[p29l104t877r274b917],
2	JM	NN	PERSON	jm	_	0	SENT_542	[p29l288t877r370b927],
3	,	,	O	,	_	0	SENT_542	[p29l288t877r370b927],
4	Yandava	NNP	O	Yandava	nn	5	SENT_542	[p29l391t873r584b917],
5	CN	NN	O	cn	appos	2	SENT_542	[p29l604t877r691b927],
6	,	,	O	,	_	0	SENT_542	[p29l604t877r691b927],
7	Dube	NN	PERSON	dube	nn	8	SENT_542	[p29l713t873r839b918],
8	L	NN	O	l	appos	2	SENT_542	[p29l859t877r899b927],
9	,	,	O	,	_	0	SENT_542	[p29l859t877r899b927],
10	et	FW	O	et	nn	11	SENT_542	[p29l923t882r966b917],
11	al.	FW	O	al.	appos	2	SENT_542	[p29l982t873r1035b917],
12	.	.	O	.	_	0	SENT_542	[p29l982t873r1035b917],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_543	[p29l8t943r405b1000],
2	association	NN	O	association	_	0	SENT_543	[p29l414t944r669b988],
3	between	IN	O	between	_	0	SENT_543	[p29l679t944r868b988],
4	ALOX5	NN	O	alox5	nn	6	SENT_543	[p29l876t947r1037b988],
5	promoter	NN	O	promoter	nn	6	SENT_543	[p29l8t1024r226b1071],
6	genotype	NN	O	genotype	prep_between	2	SENT_543	[p29l255t1024r462b1071],
7	and	CC	O	and	_	0	SENT_543	[p29l497t1014r584b1059],
8	the	DT	O	the	det	11	SENT_543	[p29l619t1015r692b1059],
9	re	NN	O	re	nn	11	SENT_543	[p29l727t1029r958b1071],
10	—	NN	O	—	nn	11	SENT_543	[p29l727t1029r958b1071],
11	sponse	NN	O	sponse	prep_between	2	SENT_543	[p29l727t1029r958b1071],
12	to	TO	O	to	_	0	SENT_543	[p29l994t1024r1038b1059],
13	anti-asthma	JJ	O	anti-asthma	amod	14	SENT_543	[p29l8t1085r292b1129],
14	treatment	NN	O	treatment	prep_to	2	SENT_543	[p29l309t1095r551b1130],
15	.	.	O	.	_	0	SENT_543	[p29l309t1095r551b1130],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_544	[p29l571t1090r658b1130],
2	Genet	NNP	PERSON	Genet	_	0	SENT_544	[p29l673t1089r817b1130],
3	1999	CD	DATE	1999	num	2	SENT_544	[p29l833t1089r1037b1139],
4	;	:	O	;	_	0	SENT_544	[p29l833t1089r1037b1139],
5	22	CD	NUMBER	22	num	7	SENT_544	[p29l833t1089r1037b1139],
6	:	:	O	:	_	0	SENT_544	[p29l833t1089r1037b1139],
7	168-70	CD	NUMBER	168-70	dep	2	SENT_544	[p29l11t1160r186b1201],
8	.	.	O	.	_	0	SENT_544	[p29l11t1160r186b1201],

1	43	CD	NUMBER	43	_	0	SENT_545	[p29l7t1233r74b1271],
2	.	.	O	.	_	0	SENT_545	[p29l7t1233r74b1271],

1	Liggett	NNP	ORGANIZATION	Liggett	_	0	SENT_546	[p29l104t1228r271b1284],
2	SB	NN	O	sb	dep	1	SENT_546	[p29l288t1231r361b1271],
3	.	.	O	.	_	0	SENT_546	[p29l288t1231r361b1271],

1	Beta	NN	O	beta	nsubj	2	SENT_547	[p29l382t1227r825b1284],
2	(	NN	O	(	_	0	SENT_547	[p29l382t1227r825b1284],
3	2	CD	NUMBER	2	dep	2	SENT_547	[p29l382t1227r825b1284],
4	)	SYM	O	)	dep	2	SENT_547	[p29l382t1227r825b1284],
5	-	:	O	-	_	0	SENT_547	[p29l382t1227r825b1284],
6	adrenergic	JJ	O	adrenergic	amod	7	SENT_547	[p29l382t1227r825b1284],
7	receptor	NN	O	receptor	dep	8	SENT_547	[p29l844t1236r1040b1283],
8	pharmacogenetics	NNS	O	pharmacogenetic	parataxis	2	SENT_547	[p29l8t1298r456b1355],
9	.	.	O	.	_	0	SENT_547	[p29l8t1298r456b1355],

1	Am	NNP	O	Am	nn	5	SENT_548	[p29l485t1303r569b1342],
2	J	NNP	O	J	nn	5	SENT_548	[p29l591t1303r612b1349],
3	Respir	NNP	O	Respir	nn	5	SENT_548	[p29l638t1299r791b1355],
4	Crit	NNP	O	Crit	nn	5	SENT_548	[p29l817t1299r908b1343],
5	Care	NNP	O	Care	nsubj	6	SENT_548	[p29l932t1302r1039b1343],
6	Med	VBD	O	med	_	0	SENT_548	[p29l7t1369r111b1414],
7	2000	CD	DATE	2000	dobj	6	SENT_548	[p29l125t1373r630b1423],
8	;	:	O	;	_	0	SENT_548	[p29l125t1373r630b1423],
9	161:8197	CD	DURATION	161:8197	num	10	SENT_548	[p29l125t1373r630b1423],
10	-8201	CD	DURATION	-8201	dep	7	SENT_548	[p29l125t1373r630b1423],
11	.	.	O	.	_	0	SENT_548	[p29l125t1373r630b1423],

1	chopharmacology	NN	O	chopharmacology	_	0	SENT_549	[p29l1113t20r1541b77],
2	1999	CD	DATE	1999	num	1	SENT_549	[p29l1555t24r1911b74],
3	;	:	O	;	_	0	SENT_549	[p29l1555t24r1911b74],
4	21:17	CD	TIME	21:17	number	5	SENT_549	[p29l1555t24r1911b74],
5	—	CD	NUMBER	—	dep	1	SENT_549	[p29l1555t24r1911b74],
6	27	CD	NUMBER	27	dep	5	SENT_549	[p29l1555t24r1911b74],
7	.	.	O	.	_	0	SENT_549	[p29l1555t24r1911b74],

1	54	CD	NUMBER	54	_	0	SENT_550	[p29l1113t97r1179b135],
2	.	.	O	.	_	0	SENT_550	[p29l1113t97r1179b135],

1	Eichhammer	NN	O	eichhammer	nn	2	SENT_551	[p29l1208t91r1515b135],
2	P	NN	O	p	_	0	SENT_551	[p29l1546t95r1581b145],
3	,	,	O	,	_	0	SENT_551	[p29l1546t95r1581b145],
4	Albus	NNP	PERSON	Albus	nn	5	SENT_551	[p29l1615t91r1751b136],
5	M	NNP	PERSON	M	appos	2	SENT_551	[p29l1784t95r1844b145],
6	,	,	O	,	_	0	SENT_551	[p29l1784t95r1844b145],
7	BorrmannHassenbach	NNP	O	BorrmannHassenbach	nn	8	SENT_551	[p29l1880t95r2142b135, p29l1112t162r1400b207],
8	M	NNP	O	M	appos	2	SENT_551	[p29l1420t167r1481b216],
9	,	,	O	,	_	0	SENT_551	[p29l1420t167r1481b216],
10	et	FW	O	et	nn	11	SENT_551	[p29l1506t172r1549b207],
11	al.	FW	O	al.	appos	2	SENT_551	[p29l1567t162r1619b207],
12	.	.	O	.	_	0	SENT_551	[p29l1567t162r1619b207],

1	Association	NNP	O	Association	nsubj	9	SENT_552	[p29l1642t163r1919b207],
2	of	IN	O	of	_	0	SENT_552	[p29l1941t162r1997b207],
3	dopamine	NN	O	dopamine	nn	6	SENT_552	[p29l2008t162r2142b219, p29l1113t234r1232b278],
4	D3-receptor	NN	O	d3-receptor	nn	6	SENT_552	[p29l1246t237r1532b290],
5	gene	NN	O	gene	nn	6	SENT_552	[p29l1545t248r1656b290],
6	variants	NNS	O	variant	prep_of	1	SENT_552	[p29l1668t234r1853b278],
7	with	IN	O	with	_	0	SENT_552	[p29l1867t234r1972b278],
8	neuroleptic	NN	O	neuroleptic	prep_with	6	SENT_552	[p29l1987t248r2142b278, p29l1112t304r1241b361],
9	induced	VBD	O	induce	_	0	SENT_552	[p29l1271t304r1460b349],
10	akathisia	NN	O	akathisium	dobj	9	SENT_552	[p29l1490t304r1703b349],
11	in	IN	O	in	_	0	SENT_552	[p29l1732t305r1778b348],
12	schizophrenic	JJ	O	schizophrenic	amod	13	SENT_552	[p29l1810t304r2144b361],
13	patients	NNS	O	patient	prep_in	9	SENT_552	[p29l1112t376r1314b432],
14	:	:	O	:	_	0	SENT_552	[p29l1112t376r1314b432],
15	a	DT	O	a	det	16	SENT_552	[p29l1341t390r1366b419],
16	generalization	NN	O	generalization	dep	13	SENT_552	[p29l1391t376r1729b432],
17	of	IN	O	of	_	0	SENT_552	[p29l1754t375r1811b420],
18	Steen	NNP	PERSON	Steen	poss	20	SENT_552	[p29l1827t379r1992b420],
19	’s	POS	O	’s	_	0	SENT_552	[p29l1827t379r1992b420],
20	study	NN	O	study	prep_of	16	SENT_552	[p29l2019t375r2146b432],
21	on	IN	O	on	_	0	SENT_552	[p29l1113t461r1173b491],
22	DRD3	NN	O	drd3	prep_on	9	SENT_552	[p29l1189t450r1332b493],
23	and	CC	O	and	_	0	SENT_552	[p29l1351t446r1438b491],
24	tardive	JJ	O	tardive	amod	25	SENT_552	[p29l1455t446r1614b491],
25	dyskinesia	NN	O	dyskinesium	conj_and	22	SENT_552	[p29l1631t446r1890b503],
26	.	.	O	.	_	0	SENT_552	[p29l1631t446r1890b503],

1	Am	VBP	O	be	dep	4	SENT_553	[p29l1908t451r2025b497],
2	]	CD	NUMBER	]	num	4	SENT_553	[p29l1908t451r2025b497],
3	Med	NNP	O	Med	nn	4	SENT_553	[p29l2039t446r2143b491],
4	Genet	NNP	O	Genet	_	0	SENT_553	[p29l1113t521r1256b562],
5	2000	CD	DATE	2000	num	4	SENT_553	[p29l1267t521r1655b571],
6	;	:	O	;	_	0	SENT_553	[p29l1267t521r1655b571],
7	96:187	CD	NUMBER	96:187	dep	4	SENT_553	[p29l1267t521r1655b571],
8	—	CD	NUMBER	—	num	9	SENT_553	[p29l1267t521r1655b571],
9	91	CD	NUMBER	91	dep	7	SENT_553	[p29l1267t521r1655b571],
10	.	.	O	.	_	0	SENT_553	[p29l1267t521r1655b571],

1	55	CD	NUMBER	55	_	0	SENT_554	[p29l1113t594r1179b632],
2	.	.	O	.	_	0	SENT_554	[p29l1113t594r1179b632],

1	Hwu	NNP	PERSON	Hwu	nn	2	SENT_555	[p29l1208t592r1321b633],
2	HG	NNP	O	HG	_	0	SENT_555	[p29l1337t592r1434b642],
3	,	,	O	,	_	0	SENT_555	[p29l1337t592r1434b642],
4	Hong	NNP	O	Hong	nn	6	SENT_555	[p29l1454t592r1589b645],
5	C	NNP	O	C	nn	6	SENT_555	[p29l1604t592r1668b642],
6	]	NN	O	]	appos	2	SENT_555	[p29l1604t592r1668b642],
7	,	,	O	,	_	0	SENT_555	[p29l1604t592r1668b642],
8	Lee	NNP	PERSON	Lee	nn	9	SENT_555	[p29l1687t592r1766b632],
9	YL	NNP	PERSON	YL	appos	2	SENT_555	[p29l1781t592r1853b642],
10	,	,	O	,	_	0	SENT_555	[p29l1781t592r1853b642],
11	Lee	NNP	PERSON	Lee	nn	12	SENT_555	[p29l1872t592r1951b632],
12	PC	NNP	O	PC	appos	2	SENT_555	[p29l1967t592r2045b642],
13	,	,	O	,	_	0	SENT_555	[p29l1967t592r2045b642],
14	Lee	NNP	PERSON	Lee	nn	15	SENT_555	[p29l2064t592r2143b632],
15	SF	NNP	O	SF	appos	2	SENT_555	[p29l1114t663r1177b704],
16	.	.	O	.	_	0	SENT_555	[p29l1114t663r1177b704],

1	Dopamine	NN	O	dopamine	nn	3	SENT_556	[p29l1204t660r1452b716],
2	D4	NN	O	d4	nn	3	SENT_556	[p29l1477t663r1545b704],
3	receptor	NN	O	receptor	_	0	SENT_556	[p29l1570t669r1766b716],
4	gene	NN	O	gene	nn	5	SENT_556	[p29l1789t674r1901b716],
5	polymorphisms	NNS	O	polymorphism	dep	3	SENT_556	[p29l1924t660r2142b716, p29l1112t731r1285b787],
6	and	CC	O	and	_	0	SENT_556	[p29l1301t730r1388b775],
7	neuroleptic	JJ	O	neuroleptic	amod	8	SENT_556	[p29l1403t731r1671b787],
8	response	NN	O	response	dep	3	SENT_556	[p29l1685t745r1897b787],
9	in	IN	O	in	_	0	SENT_556	[p29l1912t731r1957b774],
10	schizophrenia	NN	O	schizophrenia	prep_in	3	SENT_556	[p29l1973t730r2142b775, p29l1112t801r1307b858],
11	.	.	O	.	_	0	SENT_556	[p29l1973t730r2142b775, p29l1112t801r1307b858],

1	Biol	NNP	O	Biol	nn	2	SENT_557	[p29l1323t802r1418b846],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_557	[p29l1430t801r1670b858],
3	1998	CD	DATE	1998	num	2	SENT_557	[p29l1683t805r2040b855],
4	;	:	O	;	_	0	SENT_557	[p29l1683t805r2040b855],
5	44:483	CD	NUMBER	44:483	num	6	SENT_557	[p29l1683t805r2040b855],
6	—	NN	O	—	dep	2	SENT_557	[p29l1683t805r2040b855],
7	7	CD	NUMBER	7	dep	6	SENT_557	[p29l1683t805r2040b855],
8	.	.	O	.	_	0	SENT_557	[p29l1683t805r2040b855],

1	56	CD	NUMBER	56	_	0	SENT_558	[p29l1113t878r1179b917],
2	.	.	O	.	_	0	SENT_558	[p29l1113t878r1179b917],

1	Kaiser	NNP	PERSON	Kaiser	nn	2	SENT_559	[p29l1208t874r1358b918],
2	R	NNP	PERSON	R	_	0	SENT_559	[p29l1372t877r1420b927],
3	,	,	O	,	_	0	SENT_559	[p29l1372t877r1420b927],
4	Konneker	NNP	O	Konneker	nn	5	SENT_559	[p29l1438t873r1672b918],
5	M	NN	O	m	appos	2	SENT_559	[p29l1684t877r1745b927],
6	,	,	O	,	_	0	SENT_559	[p29l1684t877r1745b927],
7	Henneken	NN	O	henneken	nn	8	SENT_559	[p29l1764t873r2008b918],
8	M	NN	O	m	appos	2	SENT_559	[p29l2023t877r2084b927],
9	,	,	O	,	_	0	SENT_559	[p29l2023t877r2084b927],
10	et	FW	O	et	nn	11	SENT_559	[p29l2103t882r2146b917],
11	al.	FW	O	al.	appos	2	SENT_559	[p29l1112t944r1165b988],
12	.	.	O	.	_	0	SENT_559	[p29l1112t944r1165b988],

1	Dopamine	NN	O	dopamine	nn	3	SENT_560	[p29l1204t944r1452b1000],
2	D4	NN	O	d4	nn	3	SENT_560	[p29l1488t947r1557b988],
3	receptor	NN	O	receptor	_	0	SENT_560	[p29l1593t953r1789b1000],
4	48	CD	NUMBER	48	number	5	SENT_560	[p29l1823t943r1961b1000],
5	—	CD	NUMBER	—	dep	3	SENT_560	[p29l1823t943r1961b1000],
6	bp	NN	O	bp	nn	8	SENT_560	[p29l1823t943r1961b1000],
7	repeat	NN	O	repeat	nn	8	SENT_560	[p29l1998t953r2146b1000],
8	polymorphism	NN	O	polymorphism	dep	5	SENT_560	[p29l1112t1014r1484b1071],
9	:	:	O	:	_	0	SENT_560	[p29l1112t1014r1484b1071],
10	no	DT	O	no	det	11	SENT_560	[p29l1525t1029r1585b1059],
11	association	NN	O	association	dep	3	SENT_560	[p29l1624t1015r1896b1059],
12	with	IN	O	with	_	0	SENT_560	[p29l1932t1015r2040b1059],
13	response	NN	O	response	prep_with	11	SENT_560	[p29l2078t1029r2142b1059, p29l1114t1100r1281b1142],
14	to	TO	O	to	_	0	SENT_560	[p29l1294t1095r1338b1130],
15	antipsychotic	JJ	O	antipsychotic	amod	16	SENT_560	[p29l1350t1085r1665b1142],
16	treatment	NN	O	treatment	prep_to	13	SENT_560	[p29l1677t1095r1918b1139],
17	,	,	O	,	_	0	SENT_560	[p29l1677t1095r1918b1139],
18	but	CC	O	but	prep	3	SENT_560	[p29l1934t1086r2012b1130],
19	association	NN	O	association	dep	18	SENT_560	[p29l2021t1100r2142b1130, p29l1113t1157r1273b1201],
20	with	IN	O	with	_	0	SENT_560	[p29l1297t1156r1403b1201],
21	catatonic	JJ	O	catatonic	amod	22	SENT_560	[p29l1431t1157r1645b1201],
22	schizophrenia	NN	O	schizophrenia	prep_with	19	SENT_560	[p29l1673t1156r2021b1213],
23	.	.	O	.	_	0	SENT_560	[p29l1673t1156r2021b1213],

1	Mol	NNP	O	Mol	nn	2	SENT_561	[p29l2049t1157r2143b1201],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_561	[p29l1112t1228r1352b1284],
3	2000	CD	DATE	2000	num	2	SENT_561	[p29l1363t1231r1721b1281],
4	;	:	O	;	_	0	SENT_561	[p29l1363t1231r1721b1281],
5	5:418	CD	NUMBER	5:418	number	6	SENT_561	[p29l1363t1231r1721b1281],
6	-24	CD	NUMBER	-24	dep	2	SENT_561	[p29l1363t1231r1721b1281],
7	.	.	O	.	_	0	SENT_561	[p29l1363t1231r1721b1281],

1	57	CD	NUMBER	57	_	0	SENT_562	[p29l1113t1304r1179b1342],
2	.	.	O	.	_	0	SENT_562	[p29l1113t1304r1179b1342],

1	Ongphiphadhanakul	NN	O	ongphiphadhanakul	nn	2	SENT_563	[p29l1209t1298r1703b1355],
2	B	NN	O	b	_	0	SENT_563	[p29l1752t1302r1797b1352],
3	,	,	O	,	_	0	SENT_563	[p29l1752t1302r1797b1352],
4	Chanprasertyothin	NNP	O	Chanprasertyothin	nn	5	SENT_563	[p29l1850t1298r2142b1354, p29l1113t1369r1279b1426],
5	S	NNP	O	S	appos	2	SENT_563	[p29l1315t1373r1354b1423],
6	,	,	O	,	_	0	SENT_563	[p29l1315t1373r1354b1423],
7	Payatikul	NNP	O	Payatikul	nn	8	SENT_563	[p29l1391t1369r1605b1426],
8	P	NN	O	p	appos	2	SENT_563	[p29l1639t1373r1674b1423],
9	,	,	O	,	_	0	SENT_563	[p29l1639t1373r1674b1423],
10	et	FW	O	et	nn	11	SENT_563	[p29l1713t1379r1756b1414],
11	al.	FW	O	al.	appos	2	SENT_563	[p29l1787t1369r1840b1414],
12	.	.	O	.	_	0	SENT_563	[p29l1787t1369r1840b1414],

1	Oestrogen54s	NNS	O	oestrogen54	_	0	SENT_564	[p29l1878t1373r2142b1426, p29l149t1505r204b1528],

1	N	NN	O	n	nn	3	SENT_565	[p29l884t1507r898b1523],
2	ENGLJ	NN	O	englj	nn	3	SENT_565	[p29l913t1507r997b1529],
3	MED	NN	O	med	_	0	SENT_565	[p29l1012t1507r1065b1522],
4	348	CD	NUMBER	348	dep	3	SENT_565	[p29l1077t1501r1148b1529],
5	;	:	O	;	_	0	SENT_565	[p29l1077t1501r1148b1529],
6	6	CD	NUMBER	6	num	7	SENT_565	[p29l1077t1501r1148b1529],
7	WWW	NN	O	www	dep	3	SENT_565	[p29l1183t1507r1303b1529],
8	.	.	O	.	_	0	SENT_565	[p29l1183t1507r1303b1529],

1	NEj	NN	O	nej	nn	3	SENT_566	[p29l1183t1507r1303b1529],
2	M.ORG	NN	O	m.org	nn	3	SENT_566	[p29l1311t1507r1394b1523],
3	FEBRUARY	NN	DATE	february	_	0	SENT_566	[p29l1434t1507r1561b1523],
4	6	CD	DATE	6	dep	3	SENT_566	[p29l1574t1501r1595b1527],
5	,	,	DATE	,	_	0	SENT_566	[p29l1574t1501r1595b1527],
6	2003	CD	DATE	2003	appos	4	SENT_566	[p29l1608t1507r1672b1529],

1	The	DT	O	the	det	4	SENT_567	[p29l935t1540r986b1564],
2	New	NNP	O	New	nn	4	SENT_567	[p29l995t1541r1057b1564],
3	England	NNP	O	England	nn	4	SENT_567	[p29l1066t1540r1177b1571],
4	Journal	NNP	O	Journal	_	0	SENT_567	[p29l1186t1540r1283b1564],
5	of	IN	O	of	_	0	SENT_567	[p29l1293t1540r1322b1564],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_567	[p29l1329t1540r1454b1564],

1	Downloaded	VBN	O	download	_	0	SENT_568	[p29l377t1581r547b1604],
2	from	IN	O	from	_	0	SENT_568	[p29l556t1581r620b1604],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_568	[p29l629t1581r747b1611],
4	at	IN	O	at	_	0	SENT_568	[p29l758t1585r781b1604],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_568	[p29l789t1581r972b1604],
6	on	IN	O	on	_	0	SENT_568	[p29l981t1588r1014b1604],
7	January	NNP	DATE	January	prep_on	1	SENT_568	[p29l1022t1581r1125b1611],
8	5	CD	DATE	5	num	7	SENT_568	[p29l1135t1581r1158b1608],
9	,	,	DATE	,	_	0	SENT_568	[p29l1135t1581r1158b1608],
10	2014	CD	DATE	2014	num	7	SENT_568	[p29l1168t1581r1241b1604],
11	.	.	O	.	_	0	SENT_568	[p29l1168t1581r1241b1604],

1	For	IN	O	for	_	0	SENT_569	[p29l1251t1581r1298b1604],
2	personal	JJ	O	personal	amod	3	SENT_569	[p29l1306t1581r1418b1611],
3	use	NN	O	use	pobj	1	SENT_569	[p29l1427t1588r1471b1604],
4	only	RB	O	only	advmod	3	SENT_569	[p29l1481t1581r1545b1611],
5	.	.	O	.	_	0	SENT_569	[p29l1481t1581r1545b1611],

1	No	DT	O	no	det	3	SENT_570	[p29l1556t1581r1596b1604],
2	other	JJ	O	other	amod	3	SENT_570	[p29l1606t1581r1674b1604],
3	uses	NNS	O	use	_	0	SENT_570	[p29l1682t1588r1738b1604],
4	without	IN	O	without	_	0	SENT_570	[p29l1748t1581r1849b1604],
5	permission	NN	O	permission	prep_without	3	SENT_570	[p29l1858t1581r2010b1611],
6	.	.	O	.	_	0	SENT_570	[p29l1858t1581r2010b1611],

1	Copyright	NN	O	copyright	_	0	SENT_571	[p29l727t1622r862b1653],
2	©	CD	NUMBER	©	num	6	SENT_571	[p29l871t1622r895b1646],
3	2003	CD	DATE	2003	num	6	SENT_571	[p29l905t1622r969b1646],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_571	[p29l979t1622r1170b1646],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_571	[p29l1180t1622r1288b1646],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_571	[p29l1299t1622r1404b1653],
7	.	.	O	.	_	0	SENT_571	[p29l1299t1622r1404b1653],

1	All	DT	O	all	det	2	SENT_572	[p29l1415t1622r1456b1646],
2	rights	NNS	O	rights	nsubj	3	SENT_572	[p29l1465t1622r1540b1653],
3	reserved	VBN	O	reserve	_	0	SENT_572	[p29l1550t1622r1669b1646],
4	.	.	O	.	_	0	SENT_572	[p29l1550t1622r1669b1646],

1	receptor-alpha	NN	O	receptor-alpha	nn	3	SENT_573	[p29l9t1977r355b2033],
2	gene	NN	O	gene	nn	3	SENT_573	[p29l377t1991r489b2034],
3	polymorphism	NN	O	polymorphism	nsubj	4	SENT_573	[p29l511t1977r863b2033],
4	affects	VBZ	O	affect	_	0	SENT_573	[p29l886t1977r1038b2021],
5	response	NN	O	response	dobj	4	SENT_573	[p29l9t2063r221b2105],
6	in	IN	O	in	_	0	SENT_573	[p29l236t2049r282b2092],
7	bone	NN	O	bone	nn	9	SENT_573	[p29l299t2049r414b2093],
8	mineral	NN	O	mineral	nn	9	SENT_573	[p29l431t2048r613b2093],
9	density	NN	O	density	prep_in	5	SENT_573	[p29l629t2048r799b2105],
10	to	TO	O	to	_	0	SENT_573	[p29l812t2058r857b2093],
11	oestrogen	NN	O	oestrogen	prep_to	4	SENT_573	[p29l874t2058r1038b2093, p29l9t2134r94b2176],
12	in	IN	O	in	_	0	SENT_573	[p29l106t2120r151b2163],
13	post-menopausal	JJ	O	post-menopausal	amod	14	SENT_573	[p29l161t2120r574b2176],
14	women	NNS	O	woman	prep_in	11	SENT_573	[p29l583t2134r774b2164],
15	.	.	O	.	_	0	SENT_573	[p29l583t2134r774b2164],

1	Clin	NNP	PERSON	Clin	nn	4	SENT_574	[p29l788t2119r886b2164],
2	Endocrinol	NNP	PERSON	Endocrinol	nn	4	SENT_574	[p29l896t2119r1038b2164, p29l9t2192r146b2236],
3	(	NN	O	(	nn	4	SENT_574	[p29l162t2191r287b2242],
4	Oxf	NN	O	oxf	_	0	SENT_574	[p29l162t2191r287b2242],
5	)	CD	NUMBER	)	num	6	SENT_574	[p29l162t2191r287b2242],
6	2000	CD	DATE	2000	dep	4	SENT_574	[p29l304t2195r662b2245],
7	;	:	O	;	_	0	SENT_574	[p29l304t2195r662b2245],
8	52:581	CD	NUMBER	52:581	number	9	SENT_574	[p29l304t2195r662b2245],
9	—	CD	NUMBER	—	dep	4	SENT_574	[p29l304t2195r662b2245],
10	5	CD	NUMBER	5	dep	9	SENT_574	[p29l304t2195r662b2245],
11	.	.	O	.	_	0	SENT_574	[p29l304t2195r662b2245],

1	58	CD	NUMBER	58	_	0	SENT_575	[p29l9t2266r75b2306],
2	.	.	O	.	_	0	SENT_575	[p29l9t2266r75b2306],

1	Herrington	NNP	PERSON	Herrington	nn	2	SENT_576	[p29l105t2262r371b2318],
2	DM	NN	O	dm	_	0	SENT_576	[p29l390t2265r490b2315],
3	,	,	O	,	_	0	SENT_576	[p29l390t2265r490b2315],
4	Howard	NNP	ORGANIZATION	Howard	nn	5	SENT_576	[p29l514t2261r704b2306],
5	TD	NNP	ORGANIZATION	TD	appos	2	SENT_576	[p29l722t2265r806b2315],
6	,	,	O	,	_	0	SENT_576	[p29l722t2265r806b2315],
7	Hawkins	NNP	ORGANIZATION	Hawkins	nn	8	SENT_576	[p29l829t2261r1037b2306],
8	GA	NNP	ORGANIZATION	GA	appos	2	SENT_576	[p29l9t2336r96b2386],
9	,	,	O	,	_	0	SENT_576	[p29l9t2336r96b2386],
10	et	FW	O	et	nn	11	SENT_576	[p29l115t2342r158b2377],
11	al.	FW	O	al.	appos	2	SENT_576	[p29l170t2332r221b2377],
12	.	.	O	.	_	0	SENT_576	[p29l170t2332r221b2377],

1	Estrogen-receptor	NN	O	estrogen-receptor	nn	2	SENT_577	[p29l239t2337r659b2389],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_577	[p29l671t2333r1039b2389],
3	and	CC	O	and	_	0	SENT_577	[p29l8t2403r95b2448],
4	effects	NNS	O	effect	conj_and	2	SENT_577	[p29l107t2403r256b2448],
5	of	IN	O	of	_	0	SENT_577	[p29l270t2403r326b2448],
6	estrogen	NN	O	estrogen	nn	7	SENT_577	[p29l328t2413r530b2460],
7	replacement	NN	O	replacement	prep_of	2	SENT_577	[p29l542t2404r833b2460],
8	on	IN	O	on	_	0	SENT_577	[p29l843t2418r902b2448],
9	highdensity	NN	O	highdensity	nn	11	SENT_577	[p29l914t2403r1039b2460, p29l9t2474r178b2531],
10	lipoprotein	NN	O	lipoprotein	nn	11	SENT_577	[p29l205t2475r469b2531],
11	cholesterol	NN	O	cholesterol	prep_on	2	SENT_577	[p29l499t2474r760b2519],
12	in	IN	O	in	_	0	SENT_577	[p29l789t2475r834b2518],
13	women	NNS	O	woman	prep_in	11	SENT_577	[p29l862t2489r1039b2519],
14	with	IN	O	with	_	0	SENT_577	[p29l6t2546r112b2590],
15	coronary	JJ	O	coronary	amod	16	SENT_577	[p29l132t2560r341b2602],
16	disease	NN	O	disease	prep_with	13	SENT_577	[p29l359t2545r542b2590],
17	.	.	O	.	_	0	SENT_577	[p29l359t2545r542b2590],

1	N	NN	O	n	nn	3	SENT_578	[p29l563t2550r605b2590],
2	Engll	NNP	O	Engll	nn	3	SENT_578	[p29l623t2545r767b2602],
3	Med	NNP	O	Med	_	0	SENT_578	[p29l783t2545r888b2590],
4	2002	CD	DATE	2002	num	3	SENT_578	[p29l907t2549r1037b2599],
5	;	:	O	;	_	0	SENT_578	[p29l907t2549r1037b2599],
6	346:967	CD	NUMBER	346:967	number	7	SENT_578	[p29l9t2621r291b2662],
7	—	CD	NUMBER	—	dep	3	SENT_578	[p29l9t2621r291b2662],
8	74	CD	NUMBER	74	dep	7	SENT_578	[p29l9t2621r291b2662],
9	.	.	O	.	_	0	SENT_578	[p29l9t2621r291b2662],

1	59	CD	NUMBER	59	_	0	SENT_579	[p29l10t2693r75b2732],
2	.	.	O	.	_	0	SENT_579	[p29l10t2693r75b2732],

1	Michelson	NNP	PERSON	Michelson	nn	2	SENT_580	[p29l103t2688r352b2732],
2	AD	NN	O	ad	_	0	SENT_580	[p29l399t2692r486b2742],
3	,	,	O	,	_	0	SENT_580	[p29l399t2692r486b2742],
4	Furman	NNP	ORGANIZATION	Furman	nn	5	SENT_580	[p29l537t2692r724b2733],
5	MI	NNP	ORGANIZATION	MI	appos	2	SENT_580	[p29l771t2692r850b2742],
6	,	,	O	,	_	0	SENT_580	[p29l771t2692r850b2742],
7	Goldschmidt-Clermont	NNP	O	Goldschmidt-Clermont	nn	8	SENT_580	[p29l903t2688r1038b2732, p29l10t2758r449b2803],
8	P	NN	O	p	appos	2	SENT_580	[p29l469t2762r504b2812],
9	,	,	O	,	_	0	SENT_580	[p29l469t2762r504b2812],
10	et	FW	O	et	nn	11	SENT_580	[p29l531t2768r574b2803],
11	al.	FW	O	al.	appos	2	SENT_580	[p29l594t2759r646b2803],
12	.	.	O	.	_	0	SENT_580	[p29l594t2759r646b2803],

1	Platelet	NN	O	platelet	nn	6	SENT_581	[p29l672t2758r846b2803],
2	GP	NN	O	gp	nn	6	SENT_581	[p29l867t2762r938b2803],
3	IIIa	NN	O	iium	nn	6	SENT_581	[p29l959t2763r1040b2802],
4	PI	NN	O	pi	nn	6	SENT_581	[p29l8t2833r126b2880],
5	(	NN	O	(	nn	6	SENT_581	[p29l8t2833r126b2880],
6	A	NN	O	a	nsubj	9	SENT_581	[p29l8t2833r126b2880],
7	)	CD	NUMBER	)	num	8	SENT_581	[p29l8t2833r126b2880],
8	polymorphisms	NNS	O	polymorphism	dep	6	SENT_581	[p29l146t2829r520b2886],
9	display	VBP	O	display	_	0	SENT_581	[p29l539t2829r706b2886],
10	different	JJ	O	different	amod	11	SENT_581	[p29l721t2829r926b2874],
11	sensitivities	NNS	O	sensitivity	dobj	9	SENT_581	[p29l941t2844r1038b2874, p29l10t2901r200b2945],
12	to	TO	O	to	_	0	SENT_581	[p29l221t2910r265b2945],
13	agonists	NNS	O	agonist	prep_to	9	SENT_581	[p29l285t2901r497b2957],
14	.	.	O	.	_	0	SENT_581	[p29l285t2901r497b2957],

1	Circulation	NN	O	circulation	_	0	SENT_582	[p29l520t2900r783b2945],
2	2000	CD	DATE	2000	num	1	SENT_582	[p29l802t2904r1037b2954],
3	;	:	O	;	_	0	SENT_582	[p29l802t2904r1037b2954],
4	101	CD	NUMBER	101	num	6	SENT_582	[p29l802t2904r1037b2954],
5	:	:	O	:	_	0	SENT_582	[p29l802t2904r1037b2954],
6	1013-8	CD	NUMBER	1013-8	dep	1	SENT_582	[p29l11t2975r187b3016],
7	.	.	O	.	_	0	SENT_582	[p29l11t2975r187b3016],

1	60	CD	NUMBER	60	_	0	SENT_583	[p29l9t3048r75b3087],
2	.	.	O	.	_	0	SENT_583	[p29l9t3048r75b3087],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_584	[p29l105t3044r204b3088],
2	DK	NNP	PERSON	DK	_	0	SENT_584	[p29l218t3047r307b3097],
3	,	,	O	,	_	0	SENT_584	[p29l218t3047r307b3097],
4	Lim	NNP	PERSON	Lim	nn	5	SENT_584	[p29l324t3044r416b3087],
5	SW	NNP	O	SW	appos	2	SENT_584	[p29l431t3047r516b3097],
6	,	,	O	,	_	0	SENT_584	[p29l431t3047r516b3097],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_584	[p29l532t3047r611b3087],
8	S	NNP	O	S	appos	2	SENT_584	[p29l627t3047r666b3097],
9	,	,	O	,	_	0	SENT_584	[p29l627t3047r666b3097],
10	et	FW	O	et	nn	11	SENT_584	[p29l683t3053r726b3087],
11	al.	FW	O	al.	appos	2	SENT_584	[p29l738t3043r790b3087],
12	.	.	O	.	_	0	SENT_584	[p29l738t3043r790b3087],

1	Serotonin	NN	MISC	serotonin	nn	2	SENT_585	[p29l809t3044r1039b3087],
2	transporter	NN	O	transporter	_	0	SENT_585	[p29l9t3123r275b3170],
3	gene	NN	O	gene	nn	4	SENT_585	[p29l287t3128r398b3170],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_585	[p29l410t3114r762b3170],
5	and	CC	O	and	_	0	SENT_585	[p29l774t3113r862b3158],
6	antidepressant	JJ	O	antidepressant	amod	7	SENT_585	[p29l874t3113r1038b3158, p29l8t3193r211b3241],
7	response	NN	O	response	dep	2	SENT_585	[p29l242t3199r467b3241],
8	.	.	O	.	_	0	SENT_585	[p29l242t3199r467b3241],

1	Neuroreport	NNP	LOCATION	Neuroreport	_	0	SENT_586	[p29l503t3189r801b3241],
2	2000	CD	DATE	2000	num	1	SENT_586	[p29l832t3188r1037b3238],
3	;	:	O	;	_	0	SENT_586	[p29l832t3188r1037b3238],
4	11	CD	NUMBER	11	num	6	SENT_586	[p29l832t3188r1037b3238],
5	:	:	O	:	_	0	SENT_586	[p29l832t3188r1037b3238],
6	215-9	CD	NUMBER	215-9	dep	1	SENT_586	[p29l9t3259r157b3300],
7	.	.	O	.	_	0	SENT_586	[p29l9t3259r157b3300],

1	61	CD	NUMBER	61	_	0	SENT_587	[p29l9t3332r75b3371],
2	.	.	O	.	_	0	SENT_587	[p29l9t3332r75b3371],

1	Smeraldi	NNP	PERSON	Smeraldi	nn	2	SENT_588	[p29l106t3327r315b3371],
2	E	NNP	O	E	dep	19	SENT_588	[p29l336t3331r380b3381],
3	,	,	O	,	_	0	SENT_588	[p29l336t3331r380b3381],
4	Zanardi	NNP	PERSON	Zanardi	nn	5	SENT_588	[p29l404t3327r587b3371],
5	R	NNP	PERSON	R	appos	2	SENT_588	[p29l608t3331r656b3381],
6	,	,	O	,	_	0	SENT_588	[p29l608t3331r656b3381],
7	Benedetti	NNP	PERSON	Benedetti	nn	8	SENT_588	[p29l681t3327r904b3371],
8	F	NN	PERSON	f	appos	2	SENT_588	[p29l925t3331r960b3381],
9	,	,	O	,	_	0	SENT_588	[p29l925t3331r960b3381],
10	Di	NNP	PERSON	Di	nn	12	SENT_588	[p29l984t3328r1039b3371],
11	Bella	NNP	PERSON	Bella	nn	12	SENT_588	[p29l8t3397r124b3442],
12	D	NNP	PERSON	D	appos	2	SENT_588	[p29l137t3401r187b3451],
13	,	,	O	,	_	0	SENT_588	[p29l137t3401r187b3451],
14	Perez	NNP	PERSON	Perez	nn	15	SENT_588	[p29l204t3401r331b3442],
15	J	NNP	PERSON	J	appos	2	SENT_588	[p29l339t3402r372b3451],
16	,	,	O	,	_	0	SENT_588	[p29l339t3402r372b3451],
17	Catalano	NNP	PERSON	Catalano	nn	18	SENT_588	[p29l390t3397r598b3442],
18	M.	NNP	O	M.	appos	2	SENT_588	[p29l612t3402r672b3442],
19	Polymorphism	NN	O	polymorphism	_	0	SENT_588	[p29l689t3398r1039b3454],
20	within	IN	O	within	_	0	SENT_588	[p29l6t3469r160b3513],
21	the	DT	O	the	det	22	SENT_588	[p29l177t3468r249b3513],
22	promoter	NN	O	promoter	prep_within	19	SENT_588	[p29l265t3478r491b3525],
23	of	IN	O	of	_	0	SENT_588	[p29l506t3468r563b3513],
24	the	DT	O	the	det	27	SENT_588	[p29l569t3469r642b3513],
25	serotonin	NN	O	serotonin	nn	27	SENT_588	[p29l660t3469r885b3513],
26	transporter	NN	O	transporter	nn	27	SENT_588	[p29l902t3478r1038b3512, p29l8t3549r154b3596],
27	gene	NN	O	gene	prep_of	22	SENT_588	[p29l176t3554r287b3596],
28	and	CC	O	and	_	0	SENT_588	[p29l311t3539r398b3584],
29	antidepressant	JJ	O	antidepressant	amod	30	SENT_588	[p29l422t3539r772b3596],
30	efficacy	NN	O	efficacy	conj_and	19	SENT_588	[p29l794t3539r971b3596],
31	of	IN	O	of	_	0	SENT_588	[p29l993t3539r1050b3584],
32	ﬂuvoxamine	NN	O	ﬂuvoxamine	prep_of	30	SENT_588	[p29l9t3610r306b3655],
33	.	.	O	.	_	0	SENT_588	[p29l9t3610r306b3655],

1	Mol	NNP	O	Mol	nn	2	SENT_589	[p29l321t3610r413b3655],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_589	[p29l425t3610r659b3667],
3	1998	CD	DATE	1998	num	2	SENT_589	[p29l671t3614r1020b3664],
4	;	:	O	;	_	0	SENT_589	[p29l671t3614r1020b3664],
5	3:508	CD	NUMBER	3:508	number	6	SENT_589	[p29l671t3614r1020b3664],
6	-11	CD	NUMBER	-11	dep	2	SENT_589	[p29l671t3614r1020b3664],
7	.	.	O	.	_	0	SENT_589	[p29l671t3614r1020b3664],

1	62	CD	NUMBER	62	_	0	SENT_590	[p29l9t3686r75b3725],
2	.	.	O	.	_	0	SENT_590	[p29l9t3686r75b3725],

1	Whale	NN	O	whale	nn	2	SENT_591	[p29l103t3681r255b3725],
2	R	NN	O	r	_	0	SENT_591	[p29l268t3685r315b3735],
3	,	,	O	,	_	0	SENT_591	[p29l268t3685r315b3735],
4	Quested	NNP	O	Quested	nn	5	SENT_591	[p29l332t3681r526b3736],
5	DJ	NNP	O	DJ	appos	2	SENT_591	[p29l539t3685r607b3735],
6	,	,	O	,	_	0	SENT_591	[p29l539t3685r607b3735],
7	Laver	NNP	PERSON	Laver	nn	8	SENT_591	[p29l624t3685r750b3726],
8	D	NNP	PERSON	D	appos	2	SENT_591	[p29l761t3685r811b3735],
9	,	,	O	,	_	0	SENT_591	[p29l761t3685r811b3735],
10	Harrison	NNP	PERSON	Harrison	nn	12	SENT_591	[p29l827t3682r1039b3726],
11	P	NN	O	p	nn	12	SENT_591	[p29l8t3756r65b3806],
12	]	NN	O	]	appos	2	SENT_591	[p29l8t3756r65b3806],
13	,	,	O	,	_	0	SENT_591	[p29l8t3756r65b3806],
14	Cowen	NNP	ORGANIZATION	Cowen	nn	16	SENT_591	[p29l83t3756r243b3797],
15	P	NN	ORGANIZATION	p	nn	16	SENT_591	[p29l258t3756r315b3803],
16	]	NN	O	]	appos	2	SENT_591	[p29l258t3756r315b3803],
17	.	.	O	.	_	0	SENT_591	[p29l258t3756r315b3803],

1	Serotonin	NN	O	serotonin	nn	2	SENT_592	[p29l334t3753r560b3797],
2	transporter	NN	O	transporter	_	0	SENT_592	[p29l575t3761r835b3809],
3	(	CD	NUMBER	(	num	5	SENT_592	[p29l851t3756r1036b3803],
4	5-HIT	NN	O	5-hit	nn	5	SENT_592	[p29l851t3756r1036b3803],
5	)	NN	O	)	dep	2	SENT_592	[p29l851t3756r1036b3803],

1	DRUG	NN	O	drug	nn	2	SENT_593	[p29l1378t1797r1561b1833],
2	THERAPY	NN	O	therapy	_	0	SENT_593	[p29l1584t1797r1877b1833],

1	tion	NN	O	tion	_	0	SENT_594	[p29l1113t1978r1219b2031],
2	,	,	O	,	_	0	SENT_594	[p29l1113t1978r1219b2031],
3	and	CC	O	and	dep	1	SENT_594	[p29l1234t1977r1322b2022],
4	the	DT	O	the	det	5	SENT_594	[p29l1334t1977r1406b2022],
5	risk	NN	O	risk	dep	1	SENT_594	[p29l1419t1978r1509b2022],
6	of	IN	O	of	_	0	SENT_594	[p29l1519t1977r1576b2022],
7	myocardial	JJ	O	myocardial	amod	8	SENT_594	[p29l1578t1977r1839b2034],
8	infarction	NN	O	infarction	prep_of	5	SENT_594	[p29l1851t1977r2083b2022],
9	or	CC	O	or	_	0	SENT_594	[p29l2095t1992r2145b2022],
10	stroke	NN	O	stroke	prep_of	5	SENT_594	[p29l1114t2048r1259b2093],
11	in	IN	O	in	dep	5	SENT_594	[p29l1271t2049r1317b2092],
12	persons	NNS	O	person	pobj	11	SENT_594	[p29l1329t2063r1515b2105],
13	with	IN	O	with	dep	5	SENT_594	[p29l1526t2049r1632b2093],
14	treated	JJ	O	treated	amod	15	SENT_594	[p29l1645t2048r1806b2093],
15	hypertension	NN	O	hypertension	pobj	13	SENT_594	[p29l1819t2049r2141b2105],
16	.	.	O	.	_	0	SENT_594	[p29l1819t2049r2141b2105],

1	JAMA	NNP	O	JAMA	_	0	SENT_595	[p29l1107t2124r1249b2170],
2	2002	CD	DATE	2002	num	1	SENT_595	[p29l1262t2123r1679b2173],
3	;	:	O	;	_	0	SENT_595	[p29l1262t2123r1679b2173],
4	287:1680	CD	NUMBER	287:1680	number	5	SENT_595	[p29l1262t2123r1679b2173],
5	-9	CD	NUMBER	-9	dep	1	SENT_595	[p29l1262t2123r1679b2173],
6	.	.	O	.	_	0	SENT_595	[p29l1262t2123r1679b2173],

1	70	CD	NUMBER	70	_	0	SENT_596	[p29l1114t2196r1179b2235],
2	.	.	O	.	_	0	SENT_596	[p29l1114t2196r1179b2235],

1	Gerdes	NNP	PERSON	Gerdes	nn	2	SENT_597	[p29l1209t2191r1375b2235],
2	LU	NNP	PERSON	LU	_	0	SENT_597	[p29l1391t2195r1470b2245],
3	,	,	O	,	_	0	SENT_597	[p29l1391t2195r1470b2245],
4	Gerdes	NNP	PERSON	Gerdes	nn	5	SENT_597	[p29l1489t2191r1655b2235],
5	C	NNP	PERSON	C	appos	2	SENT_597	[p29l1672t2195r1718b2245],
6	,	,	O	,	_	0	SENT_597	[p29l1672t2195r1718b2245],
7	Kervinen	NNP	PERSON	Kervinen	nn	8	SENT_597	[p29l1737t2192r1949b2236],
8	K	NNP	PERSON	K	appos	2	SENT_597	[p29l1964t2195r2012b2245],
9	,	,	O	,	_	0	SENT_597	[p29l1964t2195r2012b2245],
10	et	FW	O	et	nn	11	SENT_597	[p29l2032t2200r2075b2235],
11	al.	FW	O	al.	appos	2	SENT_597	[p29l2088t2191r2140b2235],
12	.	.	O	.	_	0	SENT_597	[p29l2088t2191r2140b2235],

1	The	DT	O	the	det	4	SENT_598	[p29l1111t2261r1201b2306],
2	apolipoprotein	NN	O	apolipoprotein	nn	4	SENT_598	[p29l1234t2261r1586b2318],
3	epsilon4	NN	O	epsilon4	nn	4	SENT_598	[p29l1618t2261r1820b2318],
4	allele	NN	O	allele	nsubj	5	SENT_598	[p29l1852t2261r1974b2306],
5	determines	VBZ	O	determine	_	0	SENT_598	[p29l2007t2261r2143b2306, p29l1113t2333r1255b2377],
6	prognosis	NN	O	prognosis	dobj	5	SENT_598	[p29l1274t2333r1511b2389],
7	and	CC	O	and	_	0	SENT_598	[p29l1530t2332r1617b2377],
8	the	DT	O	the	det	9	SENT_598	[p29l1636t2333r1708b2376],
9	effect	NN	O	effect	dobj	5	SENT_598	[p29l1727t2332r1858b2377],
10	on	IN	O	on	_	0	SENT_598	[p29l1874t2347r1933b2377],
11	prognosis	NN	O	prognosis	prep_on	9	SENT_598	[p29l1951t2347r2143b2389, p29l1114t2404r1173b2447],
12	of	IN	O	of	_	0	SENT_598	[p29l1190t2403r1246b2448],
13	simvastatin	NN	O	simvastatin	prep_of	11	SENT_598	[p29l1251t2404r1520b2448],
14	in	IN	O	in	_	0	SENT_598	[p29l1535t2404r1580b2447],
15	survivors	NNS	O	survivor	prep_in	13	SENT_598	[p29l1596t2404r1806b2448],
16	of	IN	O	of	_	0	SENT_598	[p29l1822t2403r1878b2448],
17	myocardial	JJ	O	myocardial	amod	18	SENT_598	[p29l1882t2403r2144b2460],
18	infarction	NN	O	infarction	prep_of	15	SENT_598	[p29l1113t2474r1358b2519],
19	:	:	O	:	_	0	SENT_598	[p29l1113t2474r1358b2519],
20	a	DT	O	a	det	21	SENT_598	[p29l1384t2489r1408b2518],
21	substudy	NN	O	substudy	dep	9	SENT_598	[p29l1432t2474r1644b2531],
22	of	IN	O	of	_	0	SENT_598	[p29l1665t2474r1721b2519],
23	the	DT	O	the	det	27	SENT_598	[p29l1735t2474r1807b2519],
24	Scandinavian	JJ	O	scandinavian	amod	27	SENT_598	[p29l1832t2474r2144b2519],
25	Simvastatin	NNP	O	Simvastatin	nn	27	SENT_598	[p29l1114t2546r1389b2590],
26	Survival	NNP	O	Survival	nn	27	SENT_598	[p29l1445t2545r1628b2590],
27	Study	NNP	O	Study	prep_of	21	SENT_598	[p29l1684t2545r1821b2602],
28	.	.	O	.	_	0	SENT_598	[p29l1684t2545r1821b2602],

1	Circulation	NN	O	circulation	_	0	SENT_599	[p29l1880t2546r2143b2590],
2	2000	CD	DATE	2000	num	1	SENT_599	[p29l1113t2621r1560b2671],
3	;	:	O	;	_	0	SENT_599	[p29l1113t2621r1560b2671],
4	101:1366	CD	NUMBER	101:1366	number	5	SENT_599	[p29l1113t2621r1560b2671],
5	-71	CD	NUMBER	-71	dep	1	SENT_599	[p29l1113t2621r1560b2671],
6	.	.	O	.	_	0	SENT_599	[p29l1113t2621r1560b2671],

1	71	CD	NUMBER	71	_	0	SENT_600	[p29l1114t2694r1179b2732],
2	.	.	O	.	_	0	SENT_600	[p29l1114t2694r1179b2732],

1	Ordovas	NNP	O	Ordovas	nn	2	SENT_601	[p29l1209t2688r1403b2733],
2	JM	NN	O	jm	_	0	SENT_601	[p29l1430t2692r1511b2742],
3	,	,	O	,	_	0	SENT_601	[p29l1430t2692r1511b2742],
4	Lopez-Miranda	NNP	O	Lopez-Miranda	nn	5	SENT_601	[p29l1544t2688r1907b2744],
5	J	NNP	O	J	appos	2	SENT_601	[p29l1931t2692r1964b2742],
6	,	,	O	,	_	0	SENT_601	[p29l1931t2692r1964b2742],
7	PerezJimenez	NNP	O	PerezJimenez	nn	8	SENT_601	[p29l1997t2692r2143b2732, p29l1107t2759r1302b2809],
8	F	NN	O	f	appos	2	SENT_601	[p29l1322t2763r1357b2812],
9	,	,	O	,	_	0	SENT_601	[p29l1322t2763r1357b2812],
10	et	FW	O	et	nn	11	SENT_601	[p29l1382t2768r1424b2802],
11	al.	FW	O	al.	appos	2	SENT_601	[p29l1442t2758r1495b2803],
12	.	.	O	.	_	0	SENT_601	[p29l1442t2758r1495b2803],

1	Effect	NN	O	effect	_	0	SENT_602	[p29l1518t2758r1656b2803],
2	of	IN	O	of	_	0	SENT_602	[p29l1675t2758r1731b2803],
3	apolipoprotein	NN	O	apolipoprotein	nn	4	SENT_602	[p29l1741t2758r2093b2815],
4	E	NN	O	e	prep_of	1	SENT_602	[p29l2113t2763r2142b2802],
5	and	CC	O	and	_	0	SENT_602	[p29l1113t2829r1200b2874],
6	A-IV	NN	O	a-iv	nn	7	SENT_602	[p29l1228t2834r1336b2873],
7	phenotypes	NNS	O	phenotype	prep_of	1	SENT_602	[p29l1364t2829r1635b2886],
8	on	IN	O	on	_	0	SENT_602	[p29l1667t2844r1727b2874],
9	the	DT	O	the	det	13	SENT_602	[p29l1758t2829r1830b2874],
10	low	JJ	O	low	amod	13	SENT_602	[p29l1861t2829r1948b2874],
11	density	NN	O	density	nn	13	SENT_602	[p29l1977t2829r2146b2886],
12	lipoprotein	NN	O	lipoprotein	nn	13	SENT_602	[p29l1112t2900r1377b2957],
13	response	NN	O	response	prep_on	1	SENT_602	[p29l1402t2915r1614b2957],
14	to	TO	O	to	dep	13	SENT_602	[p29l1640t2910r1684b2945],
15	HMG	NN	O	hmg	nn	19	SENT_602	[p29l1710t2904r1842b2945],
16	CoA	NN	O	coa	nn	19	SENT_602	[p29l1868t2904r1970b2945],
17	reductase	NN	O	reductase	nn	19	SENT_602	[p29l1994t2900r2143b2945, p29l1113t2981r1204b3016],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_602	[p29l1219t2971r1426b3016],
19	therapy	NN	O	therapy	dep	13	SENT_602	[p29l1439t2972r1620b3028],
20	.	.	O	.	_	0	SENT_602	[p29l1439t2972r1620b3028],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_603	[p29l1635t2971r1997b3016],
2	1995	CD	DATE	1995	num	1	SENT_603	[p29l2015t2975r2141b3025],
3	;	:	O	;	_	0	SENT_603	[p29l2015t2975r2141b3025],
4	113:157	CD	NUMBER	113:157	number	5	SENT_603	[p29l1115t3047r1396b3088],
5	-66	CD	NUMBER	-66	dep	1	SENT_603	[p29l1115t3047r1396b3088],
6	.	.	O	.	_	0	SENT_603	[p29l1115t3047r1396b3088],

1	72	CD	NUMBER	72	_	0	SENT_604	[p29l1114t3119r1179b3157],
2	.	.	O	.	_	0	SENT_604	[p29l1114t3119r1179b3157],

1	Poirier	NNP	PERSON	Poirier	nn	2	SENT_605	[p29l1208t3114r1367b3157],
2	J	NNP	PERSON	J	_	0	SENT_605	[p29l1383t3117r1415b3167],
3	,	,	O	,	_	0	SENT_605	[p29l1383t3117r1415b3167],
4	Delisle	NNP	PERSON	Delisle	nn	5	SENT_605	[p29l1440t3113r1601b3157],
5	MC	NNP	O	MC	appos	2	SENT_605	[p29l1622t3117r1719b3167],
6	,	,	O	,	_	0	SENT_605	[p29l1622t3117r1719b3167],
7	Quirion	NNP	O	Quirion	nn	8	SENT_605	[p29l1745t3114r1929b3168],
8	R	NNP	O	R	appos	2	SENT_605	[p29l1951t3117r1999b3167],
9	,	,	O	,	_	0	SENT_605	[p29l1951t3117r1999b3167],
10	et	FW	O	et	nn	11	SENT_605	[p29l2025t3122r2068b3157],
11	al.	FW	O	al.	appos	2	SENT_605	[p29l2088t3113r2140b3157],
12	.	.	O	.	_	0	SENT_605	[p29l2088t3113r2140b3157],

1	Apolipoprotein	NN	O	apolipoprotein	nn	3	SENT_606	[p29l1111t3185r1474b3241],
2	E4	NN	O	e4	nn	3	SENT_606	[p29l1499t3188r1559b3229],
3	allele	NN	O	allele	_	0	SENT_606	[p29l1585t3184r1707b3229],
4	as	IN	O	as	_	0	SENT_606	[p29l1732t3199r1779b3228],
5	a	DT	O	a	det	6	SENT_606	[p29l1806t3199r1831b3228],
6	predictor	NN	O	predictor	prep_as	3	SENT_606	[p29l1855t3184r2073b3241],
7	of	IN	O	of	_	0	SENT_606	[p29l2098t3184r2154b3229],
8	cholinergic	JJ	O	cholinergic	amod	9	SENT_606	[p29l1113t3256r1379b3312],
9	deficits	NNS	O	deficit	prep_of	6	SENT_606	[p29l1397t3255r1566b3300],
10	and	CC	O	and	_	0	SENT_606	[p29l1585t3255r1672b3300],
11	treatment	NN	O	treatment	nn	12	SENT_606	[p29l1691t3264r1922b3300],
12	outcome	NN	O	outcome	conj_and	9	SENT_606	[p29l1938t3265r2143b3300],
13	in	IN	O	in	_	0	SENT_606	[p29l1113t3328r1158b3371],
14	Alzheimer	NN	O	alzheimer	nn	15	SENT_606	[p29l1184t3327r1432b3371],
15	disease	NN	O	disease	prep_in	3	SENT_606	[p29l1459t3327r1642b3372],
16	.	.	O	.	_	0	SENT_606	[p29l1459t3327r1642b3372],

1	Proc	NNP	O	Proc	nn	4	SENT_607	[p29l1672t3331r1777b3372],
2	Natl	NNP	O	Natl	nn	4	SENT_607	[p29l1804t3328r1905b3372],
3	Acad	NNP	O	Acad	nn	4	SENT_607	[p29l1930t3327r2048b3372],
4	Sci	NNP	O	Sci	_	0	SENT_607	[p29l2078t3328r2144b3372],

1	U	NNP	O	U	nn	3	SENT_608	[p29l1113t3402r1151b3442],
2	S	NNP	O	S	nn	3	SENT_608	[p29l1166t3401r1190b3442],
3	A	NNP	O	A	_	0	SENT_608	[p29l1204t3402r1241b3441],
4	1995	CD	DATE	1995	num	3	SENT_608	[p29l1255t3401r1670b3451],
5	;	:	O	;	_	0	SENT_608	[p29l1255t3401r1670b3451],
6	92:12260	CD	NUMBER	92:12260	number	7	SENT_608	[p29l1255t3401r1670b3451],
7	-4	CD	NUMBER	-4	dep	3	SENT_608	[p29l1255t3401r1670b3451],
8	.	.	O	.	_	0	SENT_608	[p29l1255t3401r1670b3451],

1	73	CD	NUMBER	73	_	0	SENT_609	[p29l1114t3474r1179b3512],
2	.	.	O	.	_	0	SENT_609	[p29l1114t3474r1179b3512],

1	Mallal	JJ	O	mallal	amod	2	SENT_610	[p29l1207t3468r1355b3512],
2	S	NN	O	s	_	0	SENT_610	[p29l1369t3472r1407b3522],
3	,	,	O	,	_	0	SENT_610	[p29l1369t3472r1407b3522],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_610	[p29l1422t3468r1568b3513],
5	D	NNP	PERSON	D	appos	2	SENT_610	[p29l1580t3472r1630b3522],
6	,	,	O	,	_	0	SENT_610	[p29l1580t3472r1630b3522],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_610	[p29l1644t3469r1749b3512],
8	C	NNP	O	C	appos	2	SENT_610	[p29l1759t3472r1806b3522],
9	,	,	O	,	_	0	SENT_610	[p29l1759t3472r1806b3522],
10	et	FW	O	et	nn	11	SENT_610	[p29l1823t3477r1866b3512],
11	al.	FW	O	al.	appos	2	SENT_610	[p29l1876t3468r1928b3512],
12	.	.	O	.	_	0	SENT_610	[p29l1876t3468r1928b3512],

1	Association	NNP	O	Association	_	0	SENT_611	[p29l1943t3469r2143b3513, p29l1113t3540r1206b3584],
2	between	IN	O	between	_	0	SENT_611	[p29l1248t3539r1443b3584],
3	presence	NN	O	presence	prep_between	1	SENT_611	[p29l1484t3554r1693b3596],
4	of	IN	O	of	_	0	SENT_611	[p29l1735t3539r1791b3584],
5	HLA-B	NN	O	hla-b	prep_of	1	SENT_611	[p29l1822t3540r2140b3593],
6	*	CD	NUMBER	*	num	5	SENT_611	[p29l1822t3540r2140b3593],
7	5701	CD	NUMBER	5701	dep	5	SENT_611	[p29l1822t3540r2140b3593],
8	,	,	O	,	_	0	SENT_611	[p29l1822t3540r2140b3593],
9	HLA-DR7	NN	O	hla-dr7	dep	5	SENT_611	[p29l1113t3614r1357b3664],
10	,	,	O	,	_	0	SENT_611	[p29l1113t3614r1357b3664],
11	and	CC	O	and	_	0	SENT_611	[p29l1385t3610r1472b3655],
12	HLA-DQ3	NN	O	hla-dq3	dep	5	SENT_611	[p29l1497t3614r1731b3665],
13	and	CC	O	and	_	0	SENT_611	[p29l1758t3610r1845b3655],
14	hypersensitivity	NN	O	hypersensitivity	conj_and	5	SENT_611	[p29l1871t3611r2143b3667, p29l1113t3682r1227b3738],
15	to	TO	O	to	_	0	SENT_611	[p29l1246t3691r1290b3726],
16	HIV-1	NN	O	hiv-1	nn	19	SENT_611	[p29l1312t3685r1450b3725],
17	reverse-transcriptase	NN	O	reverse-transcriptase	nn	19	SENT_611	[p29l1471t3682r1963b3738],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_611	[p29l1984t3682r2142b3726, p29l1113t3762r1181b3797],
19	abacavir	NN	O	abacavir	prep_to	14	SENT_611	[p29l1193t3753r1396b3797],
20	.	.	O	.	_	0	SENT_611	[p29l1193t3753r1396b3797],

1	Lancet	NNP	O	Lancet	_	0	SENT_612	[p29l1412t3757r1569b3797],
2	2002	CD	DATE	2002	num	1	SENT_612	[p29l1581t3756r1998b3806],
3	;	:	O	;	_	0	SENT_612	[p29l1581t3756r1998b3806],
4	359:727	CD	NUMBER	359:727	number	5	SENT_612	[p29l1581t3756r1998b3806],
5	-32	CD	NUMBER	-32	dep	1	SENT_612	[p29l1581t3756r1998b3806],
6	.	.	O	.	_	0	SENT_612	[p29l1581t3756r1998b3806],

1	promoter	NN	O	promoter	nn	2	SENT_613	[p30l8t24r234b71],
2	genotype	NN	O	genotype	nsubj	4	SENT_613	[p30l253t24r467b71],
3	may	MD	O	may	aux	4	SENT_613	[p30l489t29r587b71],
4	inﬂuence	VB	O	inﬂuence	_	0	SENT_613	[p30l606t14r824b59],
5	the	DT	O	the	det	7	SENT_613	[p30l846t15r918b59],
6	prolactin	NN	O	prolactin	nn	7	SENT_613	[p30l939t29r1038b71, p30l8t86r138b129],
7	response	NN	O	response	dobj	4	SENT_613	[p30l166t100r378b142],
8	to	TO	O	to	_	0	SENT_613	[p30l407t95r451b130],
9	clomipramine	NN	O	clomipramine	prep_to	4	SENT_613	[p30l480t86r826b142],
10	.	.	O	.	_	0	SENT_613	[p30l480t86r826b142],

1	Psychopharmacology	NNP	O	Psychopharmacology	nn	4	SENT_614	[p30l856t85r1038b142, p30l8t156r350b213],
2	(	NNP	O	(	nn	4	SENT_614	[p30l364t156r490b207],
3	Berl	NNP	PERSON	Berl	nn	4	SENT_614	[p30l364t156r490b207],
4	)	NNP	O	)	_	0	SENT_614	[p30l364t156r490b207],
5	2000	CD	DATE	2000	num	4	SENT_614	[p30l507t160r895b210],
6	;	:	O	;	_	0	SENT_614	[p30l507t160r895b210],
7	150:120	CD	NUMBER	150:120	num	8	SENT_614	[p30l507t160r895b210],
8	—	NN	O	—	dep	4	SENT_614	[p30l507t160r895b210],
9	2	CD	NUMBER	2	dep	8	SENT_614	[p30l507t160r895b210],
10	.	.	O	.	_	0	SENT_614	[p30l507t160r895b210],

1	63	CD	NUMBER	63	_	0	SENT_615	[p30l9t233r75b272],
2	.	.	O	.	_	0	SENT_615	[p30l9t233r75b272],

1	Esteller	NNP	PERSON	Esteller	nn	2	SENT_616	[p30l104t228r281b272],
2	M	NNP	O	M	_	0	SENT_616	[p30l290t232r351b282],
3	,	,	O	,	_	0	SENT_616	[p30l290t232r351b282],
4	Garcia	NNP	PERSON	Garcia	appos	2	SENT_616	[p30l365t228r792b282],
5	.	.	O	.	_	0	SENT_616	[p30l365t228r792b282],

1	—	NN	O	—	_	0	SENT_617	[p30l365t228r792b282],
2	.	.	O	.	_	0	SENT_617	[p30l365t228r792b282],

1	FoncillasJ	NNP	O	FoncillasJ	_	0	SENT_618	[p30l365t228r792b282],
2	,	,	O	,	_	0	SENT_618	[p30l365t228r792b282],
3	Andion	NNP	O	Andion	nn	4	SENT_618	[p30l805t228r982b272],
4	E	NNP	O	E	appos	1	SENT_618	[p30l993t232r1036b282],
5	,	,	O	,	_	0	SENT_618	[p30l993t232r1036b282],
6	et	FW	O	et	nn	7	SENT_618	[p30l9t308r52b343],
7	al.	FW	O	al.	appos	4	SENT_618	[p30l74t298r127b343],
8	.	.	O	.	_	0	SENT_618	[p30l74t298r127b343],

1	Inactivation	NN	O	inactivation	_	0	SENT_619	[p30l155t299r433b343],
2	of	IN	O	of	_	0	SENT_619	[p30l459t298r515b343],
3	the	DT	O	the	det	8	SENT_619	[p30l530t299r603b343],
4	DNA	NN	MISC	dna	nn	8	SENT_619	[p30l627t299r904b355],
5	—	NN	O	—	nn	8	SENT_619	[p30l627t299r904b355],
6	repair	NN	O	repair	nn	8	SENT_619	[p30l627t299r904b355],
7	gene	NN	O	gene	nn	8	SENT_619	[p30l927t313r1038b355],
8	MGMT	NN	ORGANIZATION	mgmt	prep_of	1	SENT_619	[p30l8t373r166b414],
9	and	CC	O	and	_	0	SENT_619	[p30l180t369r267b414],
10	the	DT	O	the	det	12	SENT_619	[p30l284t369r356b414],
11	clinical	JJ	O	clinical	amod	12	SENT_619	[p30l374t369r542b413],
12	response	NN	O	response	prep_of	1	SENT_619	[p30l559t384r770b426],
13	of	IN	O	of	_	0	SENT_619	[p30l788t369r844b414],
14	gliomas	NNS	O	glioma	prep_of	1	SENT_619	[p30l851t370r1038b426],
15	to	TO	O	to	_	0	SENT_619	[p30l9t450r53b485],
16	alkylating	JJ	O	alkylating	amod	17	SENT_619	[p30l66t440r298b497],
17	agents	NNS	O	agent	prep_to	14	SENT_619	[p30l308t450r475b497],
18	.	.	O	.	_	0	SENT_619	[p30l308t450r475b497],

1	N	NN	O	n	nn	2	SENT_620	[p30l489t445r531b485],
2	EnglJ	NN	O	englj	nsubj	3	SENT_620	[p30l541t441r677b497],
3	Med	VBD	O	med	_	0	SENT_620	[p30l686t440r790b485],
4	2000	CD	DATE	2000	dobj	3	SENT_620	[p30l802t444r1037b494],
5	;	:	O	;	_	0	SENT_620	[p30l802t444r1037b494],
6	343	CD	NUMBER	343	num	8	SENT_620	[p30l802t444r1037b494],
7	:	:	O	:	_	0	SENT_620	[p30l802t444r1037b494],
8	1350-4	CD	NUMBER	1350-4	dep	4	SENT_620	[p30l11t515r187b556],
9	.	.	O	.	_	0	SENT_620	[p30l11t515r187b556],

1	[	NN	O	[	nn	2	SENT_621	[p30l214t515r437b565],
2	Erratum	NN	O	erratum	_	0	SENT_621	[p30l214t515r437b565],
3	,	,	O	,	_	0	SENT_621	[p30l214t515r437b565],
4	N	NN	O	n	appos	2	SENT_621	[p30l459t516r501b556],
5	EnglJ	NNP	O	EnglJ	nn	6	SENT_621	[p30l519t512r662b568],
6	Med	NNP	O	Med	dep	2	SENT_621	[p30l679t511r783b556],
7	2000	CD	DATE	2000	rcmod	6	SENT_621	[p30l802t515r1037b565],
8	;	:	O	;	_	0	SENT_621	[p30l802t515r1037b565],
9	343	CD	NUMBER	343	dep	7	SENT_621	[p30l802t515r1037b565],
10	:	:	O	:	_	0	SENT_621	[p30l802t515r1037b565],
11	1740	CD	DATE	1740	dep	9	SENT_621	[p30l11t586r156b633],
12	.	.	O	.	_	0	SENT_621	[p30l11t586r156b633],
13	]	SYM	O	]	dep	7	SENT_621	[p30l11t586r156b633],

1	64	CD	NUMBER	64	_	0	SENT_622	[p30l9t658r75b697],
2	.	.	O	.	_	0	SENT_622	[p30l9t658r75b697],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_623	[p30l104t657r240b698],
2	WE	NNP	O	WE	_	0	SENT_623	[p30l260t657r357b707],
3	,	,	O	,	_	0	SENT_623	[p30l260t657r357b707],
4	Hon	NNP	O	Hon	nn	5	SENT_623	[p30l381t657r485b697],
5	YY	NNP	O	YY	appos	2	SENT_623	[p30l504t657r573b707],
6	,	,	O	,	_	0	SENT_623	[p30l504t657r573b707],
7	Bomgaars	NNP	O	Bomgaars	nn	8	SENT_623	[p30l596t657r834b710],
8	L	NNP	O	L	appos	2	SENT_623	[p30l856t657r897b707],
9	,	,	O	,	_	0	SENT_623	[p30l856t657r897b707],
10	et	FW	O	et	nn	11	SENT_623	[p30l922t662r965b697],
11	al.	FW	O	al.	appos	2	SENT_623	[p30l983t653r1036b697],
12	.	.	O	.	_	0	SENT_623	[p30l983t653r1036b697],

1	Preponderance	NN	O	preponderance	nn	3	SENT_624	[p30l8t724r358b781],
2	ofthiopurine	NN	O	ofthiopurine	nn	3	SENT_624	[p30l374t724r680b781],
3	S	NN	O	s	_	0	SENT_624	[p30l698t724r1039b781],
4	—	CD	NUMBER	—	num	5	SENT_624	[p30l698t724r1039b781],
5	methyltrans	NNS	O	methyltran	dep	3	SENT_624	[p30l698t724r1039b781],
6	—	CD	NUMBER	—	num	7	SENT_624	[p30l698t724r1039b781],
7	ferase	NN	O	ferase	dep	5	SENT_624	[p30l9t795r145b840],
8	deﬁciency	NN	O	deﬁciency	dep	3	SENT_624	[p30l161t795r398b852],
9	and	CC	O	and	_	0	SENT_624	[p30l412t795r499b840],
10	heterozygosity	NN	O	heterozygosity	dep	3	SENT_624	[p30l515t796r860b852],
11	among	IN	O	among	_	0	SENT_624	[p30l874t810r1041b852],
12	patients	NNS	O	patient	prep_among	8	SENT_624	[p30l8t867r192b923],
13	intolerant	JJ	O	intolerant	amod	12	SENT_624	[p30l205t867r434b911],
14	to	TO	O	to	_	0	SENT_624	[p30l444t876r487b911],
15	mercaptopurine	NN	O	mercaptopurine	prep_to	13	SENT_624	[p30l500t867r873b923],
16	or	CC	O	or	_	0	SENT_624	[p30l886t881r935b911],
17	azathioprine	NN	O	azathioprine	conj_or	15	SENT_624	[p30l945t881r1039b910, p30l9t937r236b994],
18	.	.	O	.	_	0	SENT_624	[p30l945t881r1039b910, p30l9t937r236b994],

1	J	NNP	O	J	nn	3	SENT_625	[p30l247t942r268b989],
2	Clin	NNP	O	Clin	nn	3	SENT_625	[p30l279t937r377b982],
3	Oncol	NNP	O	Oncol	_	0	SENT_625	[p30l390t937r532b982],
4	2001	CD	DATE	2001	num	3	SENT_625	[p30l546t941r993b991],
5	;	:	O	;	_	0	SENT_625	[p30l546t941r993b991],
6	19:2293	CD	NUMBER	19:2293	num	7	SENT_625	[p30l546t941r993b991],
7	—	NN	O	—	dep	3	SENT_625	[p30l546t941r993b991],
8	301	CD	NUMBER	301	dep	7	SENT_625	[p30l546t941r993b991],
9	.	.	O	.	_	0	SENT_625	[p30l546t941r993b991],

1	65	CD	NUMBER	65	_	0	SENT_626	[p30l9t1014r75b1052],
2	.	.	O	.	_	0	SENT_626	[p30l9t1014r75b1052],

1	Black	NNP	O	Black	nn	3	SENT_627	[p30l104t1008r236b1053],
2	A	NNP	O	A	nn	3	SENT_627	[p30l250t1012r315b1062],
3	]	NN	O	]	_	0	SENT_627	[p30l250t1012r315b1062],
4	,	,	O	,	_	0	SENT_627	[p30l250t1012r315b1062],
5	McLeod	NNP	PERSON	McLeod	nn	6	SENT_627	[p30l335t1008r524b1053],
6	HL	NNS	O	hl	appos	3	SENT_627	[p30l542t1012r626b1062],
7	,	,	O	,	_	0	SENT_627	[p30l542t1012r626b1062],
8	Capell	NNP	ORGANIZATION	Capell	nn	9	SENT_627	[p30l647t1008r796b1064],
9	HA	NNP	ORGANIZATION	HA	appos	3	SENT_627	[p30l813t1012r903b1062],
10	,	,	O	,	_	0	SENT_627	[p30l813t1012r903b1062],
11	et	FW	O	et	nn	12	SENT_627	[p30l925t1018r968b1052],
12	al.	FW	O	al.	appos	3	SENT_627	[p30l983t1008r1036b1052],
13	.	.	O	.	_	0	SENT_627	[p30l983t1008r1036b1052],

1	Thiopurine	NNP	O	Thiopurine	nn	3	SENT_628	[p30l7t1079r274b1136],
2	methyltransferase	NN	O	methyltransferase	nn	3	SENT_628	[p30l338t1079r761b1136],
3	genotype	NN	O	genotype	nsubj	4	SENT_628	[p30l825t1089r1039b1136],
4	predicts	VBZ	O	predict	_	0	SENT_628	[p30l8t1150r196b1207],
5	therapy	NN	O	therapy	dobj	4	SENT_628	[p30l246t1150r632b1207],
6	—	CD	NUMBER	—	num	5	SENT_628	[p30l246t1150r632b1207],
7	limiting	VBG	O	limit	partmod	5	SENT_628	[p30l246t1150r632b1207],
8	severe	JJ	O	severe	amod	9	SENT_628	[p30l679t1165r822b1195],
9	toxicity	NN	O	toxicity	dobj	7	SENT_628	[p30l871t1151r1042b1207],
10	from	IN	O	from	_	0	SENT_628	[p30l9t1221r125b1266],
11	azathioprine	NN	O	azathioprine	prep_from	7	SENT_628	[p30l149t1222r460b1278],
12	.	.	O	.	_	0	SENT_628	[p30l149t1222r460b1278],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_629	[p30l486t1226r586b1265],
2	Intern	NNP	O	Intern	nn	3	SENT_629	[p30l610t1226r755b1266],
3	Med	NNP	O	Med	_	0	SENT_629	[p30l778t1221r882b1266],
4	1998	CD	DATE	1998	num	3	SENT_629	[p30l909t1225r1037b1275],
5	;	:	O	;	_	0	SENT_629	[p30l909t1225r1037b1275],
6	129:716	CD	NUMBER	129:716	number	7	SENT_629	[p30l11t1297r262b1337],
7	—	CD	NUMBER	—	dep	3	SENT_629	[p30l11t1297r262b1337],
8	8	CD	NUMBER	8	dep	7	SENT_629	[p30l11t1297r262b1337],
9	.	.	O	.	_	0	SENT_629	[p30l11t1297r262b1337],

1	66	CD	NUMBER	66	_	0	SENT_630	[p30l9t1368r75b1407],
2	.	.	O	.	_	0	SENT_630	[p30l9t1368r75b1407],

1	Relling	VBG	ORGANIZATION	rell	_	0	SENT_631	[p30l104t1363r276b1420],
2	MV	NN	ORGANIZATION	mv	dobj	1	SENT_631	[p30l288t1367r375b1417],
3	,	,	O	,	_	0	SENT_631	[p30l288t1367r375b1417],
4	Hancock	NNP	PERSON	Hancock	nn	5	SENT_631	[p30l394t1363r606b1408],
5	ML	NNP	O	ML	appos	2	SENT_631	[p30l618t1367r708b1417],
6	,	,	O	,	_	0	SENT_631	[p30l618t1367r708b1417],
7	Rivera	NNP	PERSON	Rivera	nn	8	SENT_631	[p30l726t1364r874b1410],
8	GK	NNP	PERSON	GK	appos	2	SENT_631	[p30l889t1367r980b1417],
9	,	,	O	,	_	0	SENT_631	[p30l889t1367r980b1417],
10	et	FW	O	et	nn	11	SENT_631	[p30l999t1372r1042b1407],
11	al.	FW	O	al.	appos	2	SENT_631	[p30l9t1434r61b1479],
12	.	.	O	.	_	0	SENT_631	[p30l9t1434r61b1479],

1	Mercaptopurine	JJ	O	mercaptopurine	amod	2	SENT_632	[p30l80t1435r461b1491],
2	therapy	NN	O	therapy	_	0	SENT_632	[p30l479t1434r656b1491],
3	intolerance	NN	O	intolerance	dep	2	SENT_632	[p30l670t1434r935b1479],
4	and	CC	O	and	_	0	SENT_632	[p30l952t1434r1039b1479],
5	heterozygosity	NN	O	heterozygosity	dep	2	SENT_632	[p30l9t1506r353b1562],
6	at	IN	O	at	_	0	SENT_632	[p30l375t1515r419b1549],
7	the	DT	O	the	det	9	SENT_632	[p30l441t1505r513b1549],
8	thiopurine	NN	O	thiopurine	nn	9	SENT_632	[p30l538t1505r786b1562],
9	S	NN	O	s	prep_at	3	SENT_632	[p30l812t1505r1038b1562],
10	—	CD	NUMBER	—	num	11	SENT_632	[p30l812t1505r1038b1562],
11	methyl	NN	O	methyl	dep	2	SENT_632	[p30l812t1505r1038b1562],
12	—	CD	NUMBER	—	num	15	SENT_632	[p30l812t1505r1038b1562],
13	transferase	NN	O	transferase	nn	15	SENT_632	[p30l9t1576r268b1621],
14	gene	NN	O	gene	nn	15	SENT_632	[p30l294t1591r405b1633],
15	locus	NN	O	locus	dep	11	SENT_632	[p30l430t1576r567b1621],
16	.	.	O	.	_	0	SENT_632	[p30l430t1576r567b1621],

1	J	NNP	O	J	nn	4	SENT_633	[p30l590t1581r611b1627],
2	Natl	NNP	O	Natl	nn	4	SENT_633	[p30l635t1576r735b1621],
3	Cancer	NNP	O	Cancer	nn	4	SENT_633	[p30l760t1580r926b1621],
4	Inst	NNP	O	Inst	_	0	SENT_633	[p30l949t1581r1042b1620],
5	1999	CD	DATE	1999	num	4	SENT_633	[p30l11t1651r397b1701],
6	;	:	O	;	_	0	SENT_633	[p30l11t1651r397b1701],
7	91:2001	CD	NUMBER	91:2001	number	8	SENT_633	[p30l11t1651r397b1701],
8	—	CD	NUMBER	—	dep	4	SENT_633	[p30l11t1651r397b1701],
9	8	CD	NUMBER	8	dep	8	SENT_633	[p30l11t1651r397b1701],
10	.	.	O	.	_	0	SENT_633	[p30l11t1651r397b1701],

1	67	CD	NUMBER	67	_	0	SENT_634	[p30l9t1724r75b1762],
2	.	.	O	.	_	0	SENT_634	[p30l9t1724r75b1762],

1	Relling	VBG	ORGANIZATION	rell	_	0	SENT_635	[p30l104t1718r275b1775],
2	MV	NN	ORGANIZATION	mv	dobj	1	SENT_635	[p30l285t1722r372b1772],
3	,	,	O	,	_	0	SENT_635	[p30l285t1722r372b1772],
4	Rubnitz	NNP	PERSON	Rubnitz	nn	5	SENT_635	[p30l388t1718r576b1765],
5	JE	NNP	O	JE	appos	2	SENT_635	[p30l583t1722r648b1772],
6	,	,	O	,	_	0	SENT_635	[p30l583t1722r648b1772],
7	Rivera	NNP	PERSON	Rivera	nn	8	SENT_635	[p30l664t1719r812b1765],
8	GK	NNP	PERSON	GK	appos	2	SENT_635	[p30l823t1722r914b1772],
9	,	,	O	,	_	0	SENT_635	[p30l823t1722r914b1772],
10	et	FW	O	et	nn	11	SENT_635	[p30l931t1727r973b1762],
11	al.	FW	O	al.	appos	2	SENT_635	[p30l983t1718r1036b1762],
12	.	.	O	.	_	0	SENT_635	[p30l983t1718r1036b1762],

1	High	JJ	O	high	amod	2	SENT_636	[p30l8t1789r127b1846],
2	incidence	NN	O	incidence	_	0	SENT_636	[p30l143t1789r368b1834],
3	of	IN	O	of	_	0	SENT_636	[p30l385t1789r441b1834],
4	secondary	JJ	O	secondary	amod	6	SENT_636	[p30l448t1789r686b1846],
5	brain	NN	O	brain	nn	6	SENT_636	[p30l700t1789r823b1834],
6	tumours	NNS	O	tumour	prep_of	2	SENT_636	[p30l839t1799r1038b1834],
7	after	IN	O	after	_	0	SENT_636	[p30l9t1860r117b1905],
8	radiotherapy	NN	O	radiotherapy	prep_after	2	SENT_636	[p30l127t1860r429b1917],
9	and	CC	O	and	_	0	SENT_636	[p30l438t1860r525b1905],
10	antimetabolites	NNS	O	antimetabolite	prep_after	2	SENT_636	[p30l538t1860r918b1905],
11	.	.	O	.	_	0	SENT_636	[p30l538t1860r918b1905],

1	Lancet	NNP	O	Lancet	_	0	SENT_637	[p30l933t1865r1038b1904, p30l9t1941r77b1975],
2	1999	CD	DATE	1999	num	1	SENT_637	[p30l90t1935r446b1985],
3	;	:	O	;	_	0	SENT_637	[p30l90t1935r446b1985],
4	354:34	CD	NUMBER	354:34	number	5	SENT_637	[p30l90t1935r446b1985],
5	—	CD	NUMBER	—	dep	1	SENT_637	[p30l90t1935r446b1985],
6	9	CD	NUMBER	9	dep	5	SENT_637	[p30l90t1935r446b1985],
7	.	.	O	.	_	0	SENT_637	[p30l90t1935r446b1985],

1	68	CD	NUMBER	68	_	0	SENT_638	[p30l9t2007r75b2047],
2	.	.	O	.	_	0	SENT_638	[p30l9t2007r75b2047],

1	McDonald	NNP	ORGANIZATION	McDonald	nn	2	SENT_639	[p30l103t2002r352b2047],
2	OG	NNP	ORGANIZATION	OG	_	0	SENT_639	[p30l364t2006r458b2056],
3	,	,	O	,	_	0	SENT_639	[p30l364t2006r458b2056],
4	Krynetski	NNP	PERSON	Krynetski	nn	5	SENT_639	[p30l473t2002r698b2058],
5	EY	NNP	PERSON	EY	appos	2	SENT_639	[p30l709t2006r777b2056],
6	,	,	O	,	_	0	SENT_639	[p30l709t2006r777b2056],
7	Evans	NNP	PERSON	Evans	nn	8	SENT_639	[p30l791t2006r927b2047],
8	WE	NNP	O	WE	appos	5	SENT_639	[p30l938t2006r1036b2046],
9	.	.	O	.	_	0	SENT_639	[p30l938t2006r1036b2046],

1	Molecular	JJ	O	molecular	amod	2	SENT_640	[p30l7t2073r247b2118],
2	haplotyping	NN	O	haplotyping	nsubj	12	SENT_640	[p30l260t2073r546b2130],
3	of	IN	O	of	_	0	SENT_640	[p30l559t2073r616b2118],
4	genomic	JJ	O	genomic	amod	5	SENT_640	[p30l620t2074r826b2130],
5	DNA	NN	O	dna	prep_of	2	SENT_640	[p30l840t2077r959b2118],
6	for	IN	O	for	_	0	SENT_640	[p30l972t2073r1041b2118],
7	multiple	JJ	O	multiple	amod	11	SENT_640	[p30l9t2144r210b2201],
8	single	JJ	O	single	amod	11	SENT_640	[p30l225t2144r643b2201],
9	—	NN	O	—	nn	11	SENT_640	[p30l225t2144r643b2201],
10	nucleotide	NN	O	nucleotide	nn	11	SENT_640	[p30l225t2144r643b2201],
11	polymorphisms	NNS	O	polymorphism	prep_for	5	SENT_640	[p30l656t2144r1037b2201],
12	located	JJ	O	located	_	0	SENT_640	[p30l8t2215r181b2260],
13	kilobases	NNS	O	kilobase	dobj	12	SENT_640	[p30l209t2215r433b2260],
14	apart	RB	O	apart	advmod	15	SENT_640	[p30l462t2225r587b2272],
15	using	VBG	O	use	partmod	13	SENT_640	[p30l612t2216r747b2272],
16	long	JJ	O	long	amod	21	SENT_640	[p30l772t2215r1038b2272],
17	—	NN	O	—	nn	21	SENT_640	[p30l772t2215r1038b2272],
18	range	NN	O	range	nn	21	SENT_640	[p30l772t2215r1038b2272],
19	polymerase	NN	O	polymerase	nn	21	SENT_640	[p30l8t2287r274b2343],
20	chain	NN	O	chain	nn	21	SENT_640	[p30l292t2287r418b2330],
21	reaction	NN	O	reaction	dobj	15	SENT_640	[p30l435t2287r622b2331],
22	and	CC	O	and	_	0	SENT_640	[p30l639t2286r724b2331],
23	intramolecu	JJ	O	intramolecu	amod	26	SENT_640	[p30l741t2286r1039b2331],
24	—	NN	O	—	nn	26	SENT_640	[p30l741t2286r1039b2331],
25	lar	NN	O	lar	nn	26	SENT_640	[p30l8t2358r69b2401],
26	ligation	NN	O	ligation	conj_and	21	SENT_640	[p30l78t2358r267b2414],
27	.	.	O	.	_	0	SENT_640	[p30l78t2358r267b2414],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_641	[p30l281t2357r704b2414],
2	2002	CD	DATE	2002	num	1	SENT_641	[p30l716t2361r1037b2411],
3	;	:	O	;	_	0	SENT_641	[p30l716t2361r1037b2411],
4	12:93	CD	NUMBER	12:93	number	5	SENT_641	[p30l716t2361r1037b2411],
5	—	CD	NUMBER	—	dep	1	SENT_641	[p30l716t2361r1037b2411],
6	9	CD	NUMBER	9	dep	5	SENT_641	[p30l716t2361r1037b2411],
7	.	.	O	.	_	0	SENT_641	[p30l716t2361r1037b2411],

1	69	CD	NUMBER	69	_	0	SENT_642	[p30l9t2434r75b2473],
2	.	.	O	.	_	0	SENT_642	[p30l9t2434r75b2473],

1	Psaty	NNP	PERSON	Psaty	nn	2	SENT_643	[p30l104t2433r227b2485],
2	BM	NN	O	bm	_	0	SENT_643	[p30l238t2433r332b2483],
3	,	,	O	,	_	0	SENT_643	[p30l238t2433r332b2483],
4	Smith	NNP	ORGANIZATION	Smith	nn	6	SENT_643	[p30l351t2429r490b2473],
5	N	NNP	ORGANIZATION	N	nn	6	SENT_643	[p30l503t2433r545b2474],
6	L	NNP	ORGANIZATION	L	appos	2	SENT_643	[p30l546t2433r587b2483],
7	,	,	O	,	_	0	SENT_643	[p30l546t2433r587b2483],
8	Heckbert	NNP	O	Heckbert	nn	9	SENT_643	[p30l604t2429r823b2474],
9	SR	NN	O	sr	appos	2	SENT_643	[p30l836t2433r911b2483],
10	,	,	O	,	_	0	SENT_643	[p30l836t2433r911b2483],
11	et	FW	O	et	nn	12	SENT_643	[p30l929t2438r972b2473],
12	al.	FW	O	al.	appos	2	SENT_643	[p30l983t2429r1036b2473],
13	.	.	O	.	_	0	SENT_643	[p30l983t2429r1036b2473],

1	Diuretic	JJ	MISC	diuretic	amod	2	SENT_644	[p30l8t2500r198b2544],
2	therapy	NN	O	therapy	_	0	SENT_644	[p30l217t2499r400b2556],
3	,	,	O	,	_	0	SENT_644	[p30l217t2499r400b2556],
4	the	DT	O	the	det	9	SENT_644	[p30l423t2500r495b2543],
5	oz	NN	O	oz	nn	9	SENT_644	[p30l514t2499r759b2544],
6	—	NN	O	—	nn	9	SENT_644	[p30l514t2499r759b2544],
7	adducin	NN	O	adducin	nn	9	SENT_644	[p30l514t2499r759b2544],
8	gene	NN	O	gene	nn	9	SENT_644	[p30l779t2514r890b2556],
9	varia74	NN	O	varia74	appos	2	SENT_644	[p30l907t2500r1038b2544, p30l1114t20r1179b58],
10	.	.	O	.	_	0	SENT_644	[p30l907t2500r1038b2544, p30l1114t20r1179b58],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_645	[p30l1209t14r1529b71],
2	S	NNP	O	S	_	0	SENT_645	[p30l1551t18r1589b68],
3	,	,	O	,	_	0	SENT_645	[p30l1551t18r1589b68],
4	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_645	[p30l1612t14r1795b71],
5	AR	NNS	ORGANIZATION	ar	appos	2	SENT_645	[p30l1814t18r1899b68],
6	,	,	O	,	_	0	SENT_645	[p30l1814t18r1899b68],
7	Mosteller	NNP	PERSON	Mosteller	nn	8	SENT_645	[p30l1920t14r2145b58],
8	M	NNP	O	M	appos	2	SENT_645	[p30l1111t90r1172b139],
9	,	,	O	,	_	0	SENT_645	[p30l1111t90r1172b139],
10	et	FW	O	et	nn	11	SENT_645	[p30l1191t95r1234b129],
11	al.	FW	O	al.	appos	2	SENT_645	[p30l1245t85r1298b130],
12	.	.	O	.	_	0	SENT_645	[p30l1245t85r1298b130],

1	Genetic	JJ	O	genetic	amod	2	SENT_646	[p30l1316t86r1498b130],
2	variations	NNS	O	variation	_	0	SENT_646	[p30l1510t86r1742b130],
3	in	IN	O	in	_	0	SENT_646	[p30l1757t86r1803b129],
4	HLA	NN	O	hlum	prep_in	2	SENT_646	[p30l1818t89r1974b129],
5	.	.	O	.	_	0	SENT_646	[p30l1818t89r1974b129],

1	—	NN	O	—	_	0	SENT_647	[p30l1818t89r1974b129],
2	.	.	O	.	_	0	SENT_647	[p30l1818t89r1974b129],

1	B	NN	O	b	nn	2	SENT_648	[p30l1818t89r1974b129],
2	region	NN	O	region	_	0	SENT_648	[p30l1991t86r2143b142],
3	and	CC	O	and	_	0	SENT_648	[p30l1113t156r1200b201],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_648	[p30l1233t157r1603b213],
5	reaction	NN	O	reaction	conj_and	2	SENT_648	[p30l1634t157r1825b201],
6	to	TO	O	to	_	0	SENT_648	[p30l1859t165r1903b201],
7	abacavir	NN	O	abacavir	prep_to	2	SENT_648	[p30l1937t157r2140b201],
8	.	.	O	.	_	0	SENT_648	[p30l1937t157r2140b201],

1	Lancet	NNP	O	Lancet	_	0	SENT_649	[p30l1112t233r1270b272],
2	2002	CD	DATE	2002	num	1	SENT_649	[p30l1281t232r1698b282],
3	;	:	O	;	_	0	SENT_649	[p30l1281t232r1698b282],
4	359:1121	CD	NUMBER	359:1121	num	5	SENT_649	[p30l1281t232r1698b282],
5	—	NN	O	—	dep	1	SENT_649	[p30l1281t232r1698b282],
6	2	CD	NUMBER	2	dep	5	SENT_649	[p30l1281t232r1698b282],
7	.	.	O	.	_	0	SENT_649	[p30l1281t232r1698b282],

1	75	CD	NUMBER	75	_	0	SENT_650	[p30l1114t304r1179b342],
2	.	.	O	.	_	0	SENT_650	[p30l1114t304r1179b342],

1	Kuivenhoven	NNP	O	Kuivenhoven	nn	2	SENT_651	[p30l1209t298r1516b344],
2	JA	NNP	O	JA	_	0	SENT_651	[p30l1534t302r1603b352],
3	,	,	O	,	_	0	SENT_651	[p30l1534t302r1603b352],
4	Jukema	NNP	O	Jukema	nn	5	SENT_651	[p30l1625t298r1806b349],
5	JW	NNP	O	JW	appos	2	SENT_651	[p30l1824t302r1902b352],
6	,	,	O	,	_	0	SENT_651	[p30l1824t302r1902b352],
7	Zwinder	NNP	O	Zwinder	appos	2	SENT_651	[p30l1928t298r2142b343],
8	—	CD	NUMBER	—	num	10	SENT_651	[p30l1928t298r2142b343],
9	man	NN	O	man	nn	10	SENT_651	[p30l1113t384r1218b413],
10	AH	NNP	O	AH	dep	7	SENT_651	[p30l1228t374r1320b423],
11	,	,	O	,	_	0	SENT_651	[p30l1228t374r1320b423],
12	et	FW	O	et	nn	13	SENT_651	[p30l1337t379r1379b414],
13	al.	FW	O	al.	appos	2	SENT_651	[p30l1389t370r1442b414],
14	.	.	O	.	_	0	SENT_651	[p30l1389t370r1442b414],

1	The	DT	O	the	det	2	SENT_652	[p30l1456t369r1546b414],
2	role	NN	O	role	_	0	SENT_652	[p30l1559t369r1649b414],
3	of	IN	O	of	_	0	SENT_652	[p30l1663t369r1719b414],
4	a	DT	O	a	det	6	SENT_652	[p30l1721t384r1746b413],
5	common	JJ	O	common	amod	6	SENT_652	[p30l1758t384r1971b414],
6	variant	NN	O	variant	prep_of	2	SENT_652	[p30l1981t370r2146b414],
7	of	IN	O	of	_	0	SENT_652	[p30l1113t440r1170b485],
8	the	DT	O	the	det	13	SENT_652	[p30l1173t441r1245b485],
9	cholesteryl	NN	O	cholesteryl	nn	13	SENT_652	[p30l1259t440r1513b497],
10	ester	NN	O	ester	nn	13	SENT_652	[p30l1527t450r1639b485],
11	transfer	NN	O	transfer	nn	13	SENT_652	[p30l1652t440r1836b484],
12	protein	NN	O	protein	nn	13	SENT_652	[p30l1847t441r2019b497],
13	gene	NN	O	gene	prep_of	6	SENT_652	[p30l2032t455r2143b497],
14	in	IN	O	in	_	0	SENT_652	[p30l1113t512r1158b555],
15	the	DT	O	the	det	16	SENT_652	[p30l1171t512r1244b555],
16	progression	NN	O	progression	prep_in	2	SENT_652	[p30l1256t512r1540b568],
17	of	IN	O	of	_	0	SENT_652	[p30l1553t511r1610b556],
18	coronary	JJ	O	coronary	amod	19	SENT_652	[p30l1612t526r1822b568],
19	atherosclerosis	NN	O	atherosclerosis	prep_of	16	SENT_652	[p30l1832t511r2143b556, p30l1114t583r1187b627],
20	.	.	O	.	_	0	SENT_652	[p30l1832t511r2143b556, p30l1114t583r1187b627],

1	N	NN	O	n	nn	2	SENT_653	[p30l1203t587r1245b627],
2	EnglJ	NN	O	englj	nsubj	3	SENT_653	[p30l1257t582r1395b639],
3	Med	VBD	O	med	_	0	SENT_653	[p30l1406t582r1510b627],
4	1998	CD	DATE	1998	dobj	3	SENT_653	[p30l1526t586r1912b636],
5	;	:	O	;	_	0	SENT_653	[p30l1526t586r1912b636],
6	338:86	CD	NUMBER	338:86	number	7	SENT_653	[p30l1526t586r1912b636],
7	—	CD	NUMBER	—	dep	4	SENT_653	[p30l1526t586r1912b636],
8	93	CD	NUMBER	93	dep	7	SENT_653	[p30l1526t586r1912b636],
9	.	.	O	.	_	0	SENT_653	[p30l1526t586r1912b636],

1	76	CD	NUMBER	76	_	0	SENT_654	[p30l1114t658r1179b697],
2	.	.	O	.	_	0	SENT_654	[p30l1114t658r1179b697],

1	Abbott	NNP	PERSON	Abbott	nn	2	SENT_655	[p30l1207t653r1372b698],
2	GVV	NNP	O	GVV	_	0	SENT_655	[p30l1396t657r1495b707],
3	,	,	O	,	_	0	SENT_655	[p30l1396t657r1495b707],
4	Sesti	NNP	O	Sesti	nn	5	SENT_655	[p30l1526t654r1635b697],
5	F	NN	O	f	appos	2	SENT_655	[p30l1660t657r1695b707],
6	,	,	O	,	_	0	SENT_655	[p30l1660t657r1695b707],
7	Splawski	NNP	O	Splawski	appos	2	SENT_655	[p30l1726t653r1936b709],
8	I	PRP	O	I	dep	7	SENT_655	[p30l1961t657r1991b707],
9	,	,	O	,	_	0	SENT_655	[p30l1961t657r1991b707],
10	et	FW	O	et	nn	11	SENT_655	[p30l2021t662r2064b697],
11	al.	FW	O	al.	appos	2	SENT_655	[p30l2087t653r2140b697],
12	.	.	O	.	_	0	SENT_655	[p30l2087t653r2140b697],

1	MiRP1	NN	O	mirp1	nn	2	SENT_656	[p30l1111t725r1271b771],
2	forms	NNS	O	form	nsubj	5	SENT_656	[p30l1290t724r1429b769],
3	IKr	JJ	O	ikr	amod	5	SENT_656	[p30l1449t729r1525b770],
4	potassium	NN	O	potassium	nn	5	SENT_656	[p30l1542t725r1790b781],
5	channels	NNS	O	channel	_	0	SENT_656	[p30l1810t724r2019b769],
6	with	IN	O	with	_	0	SENT_656	[p30l2037t725r2143b769],
7	HERG	NN	ORGANIZATION	herg	prep_with	5	SENT_656	[p30l1113t799r1262b842],
8	and	CC	O	and	_	0	SENT_656	[p30l1311t795r1398b840],
9	is	VBZ	O	be	auxpass	10	SENT_656	[p30l1446t796r1482b839],
10	associated	VBN	O	associate	conj_and	5	SENT_656	[p30l1532t795r1776b840],
11	with	IN	O	with	_	0	SENT_656	[p30l1822t795r1927b840],
12	cardiac	JJ	O	cardiac	amod	13	SENT_656	[p30l1976t795r2144b840],
13	arrhythmia	NN	O	arrhythmium	prep_with	10	SENT_656	[p30l1113t866r1388b923],
14	.	.	O	.	_	0	SENT_656	[p30l1113t866r1388b923],

1	Cell	NN	O	cell	_	0	SENT_657	[p30l1405t867r1495b911],
2	1999	CD	DATE	1999	num	1	SENT_657	[p30l1511t870r1897b920],
3	;	:	O	;	_	0	SENT_657	[p30l1511t870r1897b920],
4	97:175	CD	NUMBER	97:175	number	5	SENT_657	[p30l1511t870r1897b920],
5	—	CD	NUMBER	—	dep	1	SENT_657	[p30l1511t870r1897b920],
6	87	CD	NUMBER	87	dep	5	SENT_657	[p30l1511t870r1897b920],
7	.	.	O	.	_	0	SENT_657	[p30l1511t870r1897b920],

1	77	CD	NUMBER	77	_	0	SENT_658	[p30l1114t943r1179b981],
2	.	.	O	.	_	0	SENT_658	[p30l1114t943r1179b981],

1	Sesti	FW	O	sesti	_	0	SENT_659	[p30l1210t938r1319b981],
2	F	NN	O	f	dep	1	SENT_659	[p30l1335t941r1370b991],
3	,	,	O	,	_	0	SENT_659	[p30l1335t941r1370b991],
4	Abbott	NNP	PERSON	Abbott	nn	5	SENT_659	[p30l1389t937r1554b982],
5	GVV	NNP	O	GVV	appos	2	SENT_659	[p30l1568t941r1667b991],
6	,	,	O	,	_	0	SENT_659	[p30l1568t941r1667b991],
7	Wei	NNP	PERSON	Wei	nn	8	SENT_659	[p30l1686t938r1777b981],
8	J	NNP	PERSON	J	appos	2	SENT_659	[p30l1788t941r1821b991],
9	,	,	O	,	_	0	SENT_659	[p30l1788t941r1821b991],
10	et	FW	O	et	nn	11	SENT_659	[p30l1842t947r1884b981],
11	al.	FW	O	al.	appos	2	SENT_659	[p30l1898t937r1951b981],
12	.	.	O	.	_	0	SENT_659	[p30l1898t937r1951b981],

1	A	DT	O	a	det	3	SENT_660	[p30l1970t941r2006b981],
2	common	JJ	O	common	amod	3	SENT_660	[p30l2022t951r2142b982, p30l1113t1023r1222b1053],
3	polymorphism	NN	O	polymorphism	nsubj	8	SENT_660	[p30l1238t1008r1590b1065],
4	associated	VBN	O	associate	partmod	3	SENT_660	[p30l1607t1008r1851b1053],
5	with	IN	O	with	_	0	SENT_660	[p30l1866t1008r1972b1053],
6	antibiotic	JJ	O	antibiotic	amod	7	SENT_660	[p30l1989t1009r2143b1053, p30l1113t1079r1409b1124],
7	—	NN	O	—	prep_with	4	SENT_660	[p30l1989t1009r2143b1053, p30l1113t1079r1409b1124],
8	induced	VBD	O	induce	_	0	SENT_660	[p30l1989t1009r2143b1053, p30l1113t1079r1409b1124],
9	cardiac	JJ	O	cardiac	amod	10	SENT_660	[p30l1431t1079r1598b1124],
10	arrhythmia	NN	O	arrhythmium	dobj	8	SENT_660	[p30l1619t1079r1894b1136],
11	.	.	O	.	_	0	SENT_660	[p30l1619t1079r1894b1136],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_661	[p30l1918t1083r2023b1124],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_661	[p30l2043t1080r2144b1124],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_661	[p30l1111t1150r1229b1195],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_661	[p30l1244t1151r1310b1195],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_661	[p30l1323t1155r1362b1195],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_661	[p30l1376t1154r1400b1195],
7	A	NNP	O	A	_	0	SENT_661	[p30l1413t1155r1450b1194],
8	2000	CD	DATE	2000	num	7	SENT_661	[p30l1462t1154r1880b1204],
9	;	:	O	;	_	0	SENT_661	[p30l1462t1154r1880b1204],
10	97:10613	CD	NUMBER	97:10613	number	11	SENT_661	[p30l1462t1154r1880b1204],
11	—	CD	NUMBER	—	dep	7	SENT_661	[p30l1462t1154r1880b1204],
12	8	CD	NUMBER	8	dep	11	SENT_661	[p30l1462t1154r1880b1204],
13	.	.	O	.	_	0	SENT_661	[p30l1462t1154r1880b1204],

1	78	CD	NUMBER	78	_	0	SENT_662	[p30l1114t1226r1179b1266],
2	.	.	O	.	_	0	SENT_662	[p30l1114t1226r1179b1266],

1	Napolitano	NNP	PERSON	Napolitano	nn	2	SENT_663	[p30l1208t1221r1475b1277],
2	C	NNP	O	C	_	0	SENT_663	[p30l1493t1225r1540b1275],
3	,	,	O	,	_	0	SENT_663	[p30l1493t1225r1540b1275],
4	Schwartz	NNP	PERSON	Schwartz	nn	6	SENT_663	[p30l1562t1221r1776b1266],
5	P	NN	O	p	nn	6	SENT_663	[p30l1793t1225r1851b1275],
6	]	NN	O	]	appos	2	SENT_663	[p30l1793t1225r1851b1275],
7	,	,	O	,	_	0	SENT_663	[p30l1793t1225r1851b1275],
8	Brown	NNP	PERSON	Brown	nn	9	SENT_663	[p30l1871t1225r2028b1266],
9	AM	NNP	O	AM	appos	2	SENT_663	[p30l2043t1225r2140b1275],
10	,	,	O	,	_	0	SENT_663	[p30l2043t1225r2140b1275],
11	et	FW	O	et	nn	12	SENT_663	[p30l1113t1303r1156b1337],
12	al.	FW	O	al.	appos	2	SENT_663	[p30l1182t1293r1235b1337],
13	.	.	O	.	_	0	SENT_663	[p30l1182t1293r1235b1337],

1	Evidence	NN	O	evidence	nsubj	11	SENT_664	[p30l1267t1293r1476b1337],
2	for	IN	O	for	_	0	SENT_664	[p30l1506t1293r1574b1337],
3	a	DT	O	a	det	10	SENT_664	[p30l1602t1308r1627b1337],
4	cardiac	JJ	O	cardiac	amod	10	SENT_664	[p30l1656t1293r1823b1337],
5	ion	NN	O	ion	nn	10	SENT_664	[p30l1852t1294r1928b1337],
6	channel	NN	O	channel	nn	10	SENT_664	[p30l1957t1293r2144b1337],
7	mutation	NN	O	mutation	nn	10	SENT_664	[p30l1113t1364r1330b1408],
8	underlying	VBG	O	underlie	amod	10	SENT_664	[p30l1347t1363r1604b1420],
9	drug	NN	O	drug	nn	10	SENT_664	[p30l1619t1363r1939b1420],
10	—	NN	O	—	prep_for	1	SENT_664	[p30l1619t1363r1939b1420],
11	induced	VBD	O	induce	_	0	SENT_664	[p30l1619t1363r1939b1420],
12	QT	NNP	O	QT	nn	13	SENT_664	[p30l1956t1367r2029b1418],
13	prolongation	NN	O	prolongation	dobj	11	SENT_664	[p30l2043t1378r2143b1420, p30l1112t1434r1341b1491],
14	and	CC	O	and	_	0	SENT_664	[p30l1356t1434r1443b1479],
15	life	NN	O	life	conj_and	13	SENT_664	[p30l1458t1434r1828b1491],
16	—	CD	NUMBER	—	num	18	SENT_664	[p30l1458t1434r1828b1491],
17	threatening	JJ	O	threatening	amod	18	SENT_664	[p30l1458t1434r1828b1491],
18	arrhythmias	NNS	O	arrhythmia	dep	13	SENT_664	[p30l1841t1434r2140b1491],
19	.	.	O	.	_	0	SENT_664	[p30l1841t1434r2140b1491],

1	J	NNP	O	J	nn	3	SENT_665	[p30l1107t1510r1129b1556],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_665	[p30l1141t1505r1399b1550],
3	Electrophysiol	NNP	O	Electrophysiol	_	0	SENT_665	[p30l1411t1505r1750b1562],
4	2000	CD	DATE	2000	num	3	SENT_665	[p30l1764t1509r2122b1559],
5	;	:	O	;	_	0	SENT_665	[p30l1764t1509r2122b1559],
6	11:691	CD	NUMBER	11:691	number	7	SENT_665	[p30l1764t1509r2122b1559],
7	—	CD	NUMBER	—	dep	3	SENT_665	[p30l1764t1509r2122b1559],
8	6	CD	NUMBER	6	dep	7	SENT_665	[p30l1764t1509r2122b1559],
9	.	.	O	.	_	0	SENT_665	[p30l1764t1509r2122b1559],

1	79	CD	NUMBER	79	_	0	SENT_666	[p30l1114t1581r1179b1620],
2	.	.	O	.	_	0	SENT_666	[p30l1114t1581r1179b1620],

1	Liicking	VBG	O	liick	_	0	SENT_667	[p30l1208t1576r1402b1633],
2	CB	NN	O	cb	dobj	1	SENT_667	[p30l1425t1580r1506b1630],
3	,	,	O	,	_	0	SENT_667	[p30l1425t1580r1506b1630],
4	Dﬁrr	NN	O	dﬁrr	nn	5	SENT_667	[p30l1533t1580r1646b1621],
5	A	NN	O	a	appos	2	SENT_667	[p30l1667t1580r1716b1630],
6	,	,	O	,	_	0	SENT_667	[p30l1667t1580r1716b1630],
7	Bonifati	NNP	O	Bonifati	nn	8	SENT_667	[p30l1743t1576r1932b1620],
8	V	NNP	O	V	appos	2	SENT_667	[p30l1954t1580r1993b1630],
9	,	,	O	,	_	0	SENT_667	[p30l1954t1580r1993b1630],
10	et	FW	O	et	nn	11	SENT_667	[p30l2022t1585r2065b1620],
11	al.	FW	O	al.	appos	2	SENT_667	[p30l2087t1576r2140b1621],
12	.	.	O	.	_	0	SENT_667	[p30l2087t1576r2140b1621],

1	Association	NNP	O	Association	_	0	SENT_668	[p30l1111t1648r1388b1692],
2	between	IN	O	between	_	0	SENT_668	[p30l1431t1648r1627b1692],
3	early	JJ	O	early	amod	5	SENT_668	[p30l1671t1648r1931b1704],
4	—	NN	O	—	nn	5	SENT_668	[p30l1671t1648r1931b1704],
5	onset	NN	O	onset	prep_between	1	SENT_668	[p30l1671t1648r1931b1704],
6	Parkinson	NNP	O	Parkinson	poss	8	SENT_668	[p30l1971t1647r2143b1692, p30l1114t1722r1236b1763],
7	’s	POS	O	’s	_	0	SENT_668	[p30l1971t1647r2143b1692, p30l1114t1722r1236b1763],
8	disease	NN	O	disease	dep	1	SENT_668	[p30l1263t1718r1433b1763],
9	and	CC	O	and	_	0	SENT_668	[p30l1459t1718r1546b1763],
10	mutations	NNS	O	mutation	conj_and	8	SENT_668	[p30l1572t1719r1812b1763],
11	in	IN	O	in	_	0	SENT_668	[p30l1839t1719r1884b1762],
12	the	DT	O	the	det	14	SENT_668	[p30l1910t1719r1982b1763],
13	parkin	NN	O	parkin	nn	14	SENT_668	[p30l2007t1718r2142b1775],
14	gene	NN	O	gene	prep_in	10	SENT_668	[p30l1113t1804r1237b1846],
15	.	.	O	.	_	0	SENT_668	[p30l1113t1804r1237b1846],

1	N	NN	O	n	nn	3	SENT_669	[p30l1253t1794r1295b1834],
2	Englj	NNP	O	Englj	nn	3	SENT_669	[p30l1307t1790r1445b1846],
3	Med	NNP	O	Med	_	0	SENT_669	[p30l1456t1789r1560b1834],
4	2000	CD	DATE	2000	num	3	SENT_669	[p30l1574t1793r1991b1843],
5	;	:	O	;	_	0	SENT_669	[p30l1574t1793r1991b1843],
6	342:1560	CD	NUMBER	342:1560	num	7	SENT_669	[p30l1574t1793r1991b1843],
7	—	NN	O	—	dep	3	SENT_669	[p30l1574t1793r1991b1843],
8	7	CD	NUMBER	7	dep	7	SENT_669	[p30l1574t1793r1991b1843],
9	.	.	O	.	_	0	SENT_669	[p30l1574t1793r1991b1843],

1	80	CD	NUMBER	80	_	0	SENT_670	[p30l1112t1865r1179b1905],
2	.	.	O	.	_	0	SENT_670	[p30l1112t1865r1179b1905],

1	Martinelli	NNP	PERSON	Martinelli	nn	2	SENT_671	[p30l1207t1860r1440b1904],
2	I	NNP	O	I	_	0	SENT_671	[p30l1455t1864r1485b1914],
3	,	,	O	,	_	0	SENT_671	[p30l1455t1864r1485b1914],
4	Sacchi	NNP	PERSON	Sacchi	nn	5	SENT_671	[p30l1505t1860r1655b1905],
5	E	NNP	O	E	appos	2	SENT_671	[p30l1669t1864r1713b1914],
6	,	,	O	,	_	0	SENT_671	[p30l1669t1864r1713b1914],
7	Landi	NNP	PERSON	Landi	nn	8	SENT_671	[p30l1731t1860r1864b1904],
8	G	NNP	PERSON	G	appos	5	SENT_671	[p30l1879t1864r1932b1914],
9	,	,	O	,	_	0	SENT_671	[p30l1879t1864r1932b1914],
10	Taioli	NNP	O	Taioli	nn	11	SENT_671	[p30l1949t1860r2082b1904],
11	E	NNP	O	E	appos	5	SENT_671	[p30l2096t1864r2140b1914],
12	,	,	O	,	_	0	SENT_671	[p30l2096t1864r2140b1914],
13	Duca	NNP	O	Duca	nn	14	SENT_671	[p30l1112t1935r1234b1976],
14	F	NN	O	f	appos	5	SENT_671	[p30l1245t1936r1280b1985],
15	,	,	O	,	_	0	SENT_671	[p30l1245t1936r1280b1985],
16	Mannucci	NNP	PERSON	Mannucci	nn	17	SENT_671	[p30l1294t1932r1529b1976],
17	PM	NNP	O	PM	appos	5	SENT_671	[p30l1540t1935r1630b1976],
18	.	.	O	.	_	0	SENT_671	[p30l1540t1935r1630b1976],

1	High	JJ	O	high	amod	2	SENT_672	[p30l1645t1931r1764b1988],
2	risk	NN	O	risk	_	0	SENT_672	[p30l1777t1931r1867b1976],
3	of	IN	O	of	_	0	SENT_672	[p30l1877t1931r1934b1976],
4	cerebralvein	NN	O	cerebralvein	nn	5	SENT_672	[p30l1936t1931r2143b1976, p30l1110t2003r1208b2047],
5	thrombosis	NN	O	thrombosis	prep_of	2	SENT_672	[p30l1228t2002r1499b2047],
6	in	IN	O	in	_	0	SENT_672	[p30l1520t2003r1566b2046],
7	carriers	NNS	O	carrier	prep_in	2	SENT_672	[p30l1587t2003r1762b2046],
8	of	IN	O	of	_	0	SENT_672	[p30l1784t2002r1840b2047],
9	a	DT	O	a	det	15	SENT_672	[p30l1850t2017r1875b2046],
10	prothrom	NN	O	prothrom	nn	15	SENT_672	[p30l1894t2002r2143b2059],
11	—	NN	O	—	nn	15	SENT_672	[p30l1894t2002r2143b2059],
12	bin	NN	O	bin	nn	15	SENT_672	[p30l1113t2074r1322b2130],
13	—	NN	O	—	nn	15	SENT_672	[p30l1113t2074r1322b2130],
14	gene	NN	O	gene	nn	15	SENT_672	[p30l1113t2074r1322b2130],
15	mutation	NN	O	mutation	prep_of	7	SENT_672	[p30l1338t2074r1555b2118],
16	and	CC	O	and	_	0	SENT_672	[p30l1570t2073r1657b2118],
17	in	IN	O	in	_	0	SENT_672	[p30l1672t2074r1717b2117],
18	users	NNS	O	user	conj_and	7	SENT_672	[p30l1733t2088r1855b2118],
19	of	IN	O	of	_	0	SENT_672	[p30l1872t2073r1928b2118],
20	oral	JJ	O	oral	amod	21	SENT_672	[p30l1933t2074r2024b2118],
21	contraceptives	NNS	O	contraceptive	prep_of	18	SENT_672	[p30l2040t2088r2143b2118, p30l1113t2145r1377b2201],
22	.	.	O	.	_	0	SENT_672	[p30l2040t2088r2143b2118, p30l1113t2145r1377b2201],

1	N	NN	O	n	nsubj	2	SENT_673	[p30l1393t2149r1435b2189],
2	EnglJMed	VBD	O	engljm	_	0	SENT_673	[p30l1447t2144r1700b2201],
3	1998	CD	DATE	1998	dobj	2	SENT_673	[p30l1715t2148r2131b2198],
4	;	:	O	;	_	0	SENT_673	[p30l1715t2148r2131b2198],
5	338:1793	CD	NUMBER	338:1793	num	6	SENT_673	[p30l1715t2148r2131b2198],
6	—	NN	O	—	dep	3	SENT_673	[p30l1715t2148r2131b2198],
7	7	CD	NUMBER	7	dep	6	SENT_673	[p30l1715t2148r2131b2198],
8	.	.	O	.	_	0	SENT_673	[p30l1715t2148r2131b2198],

1	81	CD	NUMBER	81	_	0	SENT_674	[p30l1112t2220r1179b2260],
2	.	.	O	.	_	0	SENT_674	[p30l1112t2220r1179b2260],

1	de	IN	O	de	dep	6	SENT_675	[p30l1209t2215r1263b2260],
2	Maat	NNP	O	Maat	nn	3	SENT_675	[p30l1291t2219r1412b2259],
3	MP	NNP	O	MP	pobj	1	SENT_675	[p30l1437t2219r1522b2269],
4	,	,	O	,	_	0	SENT_675	[p30l1437t2219r1522b2269],
5	Jukema	NNP	O	Jukema	nn	6	SENT_675	[p30l1549t2215r1731b2266],
6	JW	NNP	O	JW	_	0	SENT_675	[p30l1754t2219r1833b2269],
7	,	,	O	,	_	0	SENT_675	[p30l1754t2219r1833b2269],
8	Ye	NNP	O	Ye	nn	9	SENT_675	[p30l1864t2219r1915b2259],
9	S	NNP	O	S	appos	6	SENT_675	[p30l1946t2219r1984b2269],
10	,	,	O	,	_	0	SENT_675	[p30l1946t2219r1984b2269],
11	et	FW	O	et	nn	12	SENT_675	[p30l2018t2224r2061b2259],
12	al.	FW	O	al.	appos	6	SENT_675	[p30l2087t2215r2140b2259],
13	.	.	O	.	_	0	SENT_675	[p30l2087t2215r2140b2259],

1	Effect	NN	O	effect	_	0	SENT_676	[p30l1112t2286r1251b2331],
2	of	IN	O	of	_	0	SENT_676	[p30l1261t2286r1317b2331],
3	the	DT	O	the	det	7	SENT_676	[p30l1319t2287r1391b2331],
4	stromelysin	NN	O	stromelysin	nn	7	SENT_676	[p30l1405t2286r1728b2343],
5	—	NN	O	—	nn	7	SENT_676	[p30l1405t2286r1728b2343],
6	1	CD	NUMBER	1	num	7	SENT_676	[p30l1405t2286r1728b2343],
7	promoter	NN	O	promoter	prep_of	1	SENT_676	[p30l1740t2296r1966b2343],
8	on	IN	O	on	_	0	SENT_676	[p30l1977t2301r2036b2331],
9	efficacy	NN	O	efficacy	prep_on	1	SENT_676	[p30l2049t2286r2143b2331, p30l1113t2372r1213b2414],
10	of	IN	O	of	_	0	SENT_676	[p30l1223t2357r1280b2402],
11	pravastatin	NN	O	pravastatin	prep_of	1	SENT_676	[p30l1281t2358r1542b2414],
12	in	IN	O	in	_	0	SENT_676	[p30l1554t2358r1600b2401],
13	coronary	JJ	O	coronary	amod	14	SENT_676	[p30l1612t2372r1822b2414],
14	atherosclerosis	NN	O	atherosclerosis	prep_in	11	SENT_676	[p30l1832t2358r2142b2402, p30l1114t2430r1173b2473],
15	and	CC	O	and	_	0	SENT_676	[p30l1199t2429r1286b2474],
16	restenosis	NN	O	restenosis	conj_and	14	SENT_676	[p30l1312t2430r1563b2474],
17	.	.	O	.	_	0	SENT_676	[p30l1312t2430r1563b2474],

1	Am	VBP	O	be	dep	3	SENT_677	[p30l1589t2434r1673b2473],
2	J	NN	O	j	nn	3	SENT_677	[p30l1693t2434r1714b2480],
3	Cardiol	NN	O	cardiol	_	0	SENT_677	[p30l1738t2429r1911b2474],
4	1999	CD	DATE	1999	dep	3	SENT_677	[p30l1938t2433r2141b2483],
5	;	:	O	;	_	0	SENT_677	[p30l1938t2433r2141b2483],
6	83	CD	NUMBER	83	dep	4	SENT_677	[p30l1938t2433r2141b2483],
7	:	:	O	:	_	0	SENT_677	[p30l1938t2433r2141b2483],
8	852-6	CD	NUMBER	852-6	dep	6	SENT_677	[p30l1113t2503r1261b2544],
9	.	.	O	.	_	0	SENT_677	[p30l1113t2503r1261b2544],

1	82	CD	NUMBER	82	_	0	SENT_678	[p30l8t2864r146b2946],
2	.	.	O	.	_	0	SENT_678	[p30l8t2864r146b2946],

1	Issa	NNP	PERSON	Issa	nn	2	SENT_679	[p30l207t2862r399b2946],
2	AM	NNP	O	AM	_	0	SENT_679	[p30l438t2864r638b2966],
3	,	,	O	,	_	0	SENT_679	[p30l438t2864r638b2966],
4	Keyserlingk	NNP	PERSON	Keyserlingk	appos	2	SENT_679	[p30l689t2854r1273b2972],
5	`	``	O	`	_	0	SENT_679	[p30l1310t2862r1494b2946],
6	6wM	NN	O	6wm	dep	2	SENT_679	[p30l1310t2862r1494b2946],
7	+	CC	O	+	_	0	SENT_679	[p30l1310t2862r1494b2946],
8	Apolipopro	NN	O	apolipopro	nn	9	SENT_679	[p30l1541t2854r2145b2970],
9	—	NN	O	—	dep	2	SENT_679	[p30l1541t2854r2145b2970],

1	tein	NN	O	tein	_	0	SENT_680	[p30l10t3006r193b3096],
2	E	NN	O	e	nn	3	SENT_680	[p30l219t3014r279b3094],
3	genotyping	NN	O	genotyping	dep	1	SENT_680	[p30l311t3006r868b3122],
4	for	IN	O	for	_	0	SENT_680	[p30l892t3004r1036b3096],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_680	[p30l1059t3006r1912b3122],
6	purposes	NNS	O	purpose	prep_for	3	SENT_680	[p30l1940t3034r2145b3122, p30l8t3184r283b3272],

1	in	IN	O	in	_	0	SENT_681	[p30l312t3156r407b3244],
2	Alzheimer	NN	O	alzheimer	poss	4	SENT_681	[p30l428t3154r1018b3246],
3	’s	POS	O	’s	_	0	SENT_681	[p30l428t3154r1018b3246],
4	disease	NN	O	disease	pobj	1	SENT_681	[p30l1049t3154r1430b3246],
5	:	:	O	:	_	0	SENT_681	[p30l1049t3154r1430b3246],
6	emerging	VBG	O	emerge	dep	4	SENT_681	[p30l1462t3156r1934b3272],
7	ethical	JJ	O	ethical	tmod	6	SENT_681	[p30l1958t3156r2145b3246, p30l10t3304r176b3396],

1	issues	NNS	O	issue	_	0	SENT_682	[p30l199t3306r522b3396],
2	.	.	O	.	_	0	SENT_682	[p30l199t3306r522b3396],

1	CanJ	NN	O	canj	_	0	SENT_683	[p30l552t3312r801b3410],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_683	[p30l820t3306r1317b3420],
3	2000	CD	DATE	2000	num	2	SENT_683	[p30l1336t3312r1729b3416],
4	;	:	O	;	_	0	SENT_683	[p30l1336t3312r1729b3416],
5	45	CD	NUMBER	45	number	6	SENT_683	[p30l1336t3312r1729b3416],
6	:917	CD	NUMBER	:917	dep	1	SENT_683	[p30l1745t3312r2141b3396],
7	—	NN	O	—	dep	6	SENT_683	[p30l1745t3312r2141b3396],
8	22	CD	NUMBER	22	num	7	SENT_683	[p30l1745t3312r2141b3396],
9	.	.	O	.	_	0	SENT_683	[p30l1745t3312r2141b3396],

1	83	CD	NUMBER	83	_	0	SENT_684	[p30l8t3464r146b3546],
2	.	.	O	.	_	0	SENT_684	[p30l8t3464r146b3546],

1	Siest	NNP	O	Siest	nn	2	SENT_685	[p30l211t3456r442b3546],
2	G	NNP	O	G	_	0	SENT_685	[p30l488t3462r598b3566],
3	,	,	O	,	_	0	SENT_685	[p30l488t3462r598b3566],
4	Bertrand	NNP	PERSON	Bertrand	nn	5	SENT_685	[p30l655t3454r1093b3546],
5	P	NN	PERSON	p	appos	2	SENT_685	[p30l1143t3462r1217b3566],
6	,	,	O	,	_	0	SENT_685	[p30l1143t3462r1217b3566],
7	Herbeth	NN	O	herbeth	nn	8	SENT_685	[p30l1276t3454r1685b3546],
8	B	NN	O	b	appos	2	SENT_685	[p30l1736t3462r1831b3566],
9	,	,	O	,	_	0	SENT_685	[p30l1736t3462r1831b3566],
10	et	FW	O	et	nn	11	SENT_685	[p30l1892t3474r1982b3546],
11	al.	FW	O	al.	appos	2	SENT_685	[p30l2027t3454r2139b3546],
12	.	.	O	.	_	0	SENT_685	[p30l2027t3454r2139b3546],

1	Apolipoprotein	NN	O	apolipoprotein	nn	3	SENT_686	[p30l6t3606r775b3722],
2	E	NN	O	e	nn	3	SENT_686	[p30l802t3614r863b3694],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_686	[p30l892t3606r1683b3722],
4	and	CC	O	and	_	0	SENT_686	[p30l1715t3606r1898b3696],
5	concentration	NN	O	concentration	conj_and	3	SENT_686	[p30l1928t3634r2145b3696, p31l10t25r520b115],

1	in	IN	O	in	_	0	SENT_687	[p31l584t25r680b113],
2	chronic	JJ	O	chronic	amod	3	SENT_687	[p31l747t23r1124b115],
3	diseases	NNS	O	disease	pobj	1	SENT_687	[p31l1189t23r1598b115],
4	and	CC	O	and	_	0	SENT_687	[p31l1665t23r1848b115],
5	drug	NN	O	drug	nn	6	SENT_687	[p31l1914t25r2149b141],
6	responses	NNS	O	response	conj_and	3	SENT_687	[p31l10t203r538b291],
7	.	.	O	.	_	0	SENT_687	[p31l10t203r538b291],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_688	[p31l606t175r807b265],
2	Chem	NNP	ORGANIZATION	Chem	nn	3	SENT_688	[p31l864t175r1155b265],
3	Lab	NNP	ORGANIZATION	Lab	_	0	SENT_688	[p31l1211t175r1386b265],
4	Med	NNP	ORGANIZATION	Med	dep	3	SENT_688	[p31l1442t173r1659b265],
5	2000	CD	DATE	2000	num	4	SENT_688	[p31l1717t181r2141b283],
6	,	,	O	,	_	0	SENT_688	[p31l1717t181r2141b283],
7	-.38	CD	NUMBER	-.38	num	4	SENT_688	[p31l1717t181r2141b283],
8	:	:	O	:	_	0	SENT_688	[p31l1717t181r2141b283],
9	841-52	CD	NUMBER	841-52	dep	3	SENT_688	[p31l10t331r379b415],
10	.	.	O	.	_	0	SENT_688	[p31l10t331r379b415],

1	84	CD	NUMBER	84	_	0	SENT_689	[p31l8t483r146b565],
2	.	.	O	.	_	0	SENT_689	[p31l8t483r146b565],

1	Earlow	NNP	O	Earlow	nn	2	SENT_690	[p31l207t473r548b565],
2	MR	NN	O	mr	_	0	SENT_690	[p31l586t481r789b585],
3	,	,	O	,	_	0	SENT_690	[p31l586t481r789b585],
4	Lahiri	NNP	ORGANIZATION	Lahiri	nn	5	SENT_690	[p31l840t473r1127b565],
5	DK	NNP	ORGANIZATION	DK	appos	2	SENT_690	[p31l1173t481r1358b583],
6	,	,	O	,	_	0	SENT_690	[p31l1173t481r1358b583],
7	l	NN	O	l	appos	2	SENT_690	[p31l1410t475r1739b565],
8	>	JJR	O	>	amod	10	SENT_690	[p31l1410t475r1739b565],
9	oirier	NN	O	oirier	nn	10	SENT_690	[p31l1410t475r1739b565],
10	J	NN	O	j	dep	7	SENT_690	[p31l1771t483r1839b585],
11	,	,	O	,	_	0	SENT_690	[p31l1771t483r1839b585],
12	Davignon	NNP	PERSON	Davignon	nn	13	SENT_690	[p31l1892t475r2145b565, p31l10t653r263b741],
13	J	NNP	PERSON	J	appos	2	SENT_690	[p31l283t633r351b735],
14	,	,	O	,	_	0	SENT_690	[p31l283t633r351b735],
15	Schneider	NNP	PERSON	Schneider	nn	16	SENT_690	[p31l390t623r877b715],
16	L	NNP	O	L	appos	2	SENT_690	[p31l902t633r988b735],
17	,	,	O	,	_	0	SENT_690	[p31l902t633r988b735],
18	Hui	NNP	PERSON	Hui	nn	19	SENT_690	[p31l1024t625r1205b715],
19	SL	NNP	O	SL	appos	2	SENT_690	[p31l1239t631r1378b715],
20	.	.	O	.	_	0	SENT_690	[p31l1239t631r1378b715],

1	Treatment	NN	O	treatment	nn	2	SENT_691	[p31l1412t631r1924b715],
2	outcome	NN	O	outcome	nsubj	6	SENT_691	[p31l1950t643r2145b715, p31l10t803r273b865],
3	of	IN	O	of	_	0	SENT_691	[p31l329t773r446b865],
4	tacrine	NN	O	tacrine	nn	5	SENT_691	[p31l480t775r813b865],
5	therapy	NN	O	therapy	prep_of	2	SENT_691	[p31l868t775r1237b891],
6	depends	VBZ	O	depend	_	0	SENT_691	[p31l1286t773r1693b891],
7	on	IN	O	on	_	0	SENT_691	[p31l1752t803r1876b865],
8	apolipoprotein	NN	O	apolipoprotein	nn	9	SENT_691	[p31l1930t803r2145b891, p31l8t925r556b1041],
9	genotype	NN	O	genotype	prep_on	6	SENT_691	[p31l633t943r1077b1041],
10	and	CC	O	and	_	0	SENT_691	[p31l1153t923r1334b1015],
11	gender	NN	O	gender	conj_and	9	SENT_691	[p31l1410t923r1751b1041],
12	of	IN	O	of	_	0	SENT_691	[p31l1824t923r1942b1015],
13	the	DT	O	the	det	14	SENT_691	[p31l1997t925r2147b1015],
14	subjects	NNS	O	subject	prep_of	9	SENT_691	[p31l12t1075r399b1189],
15	with	IN	O	with	_	0	SENT_691	[p31l442t1073r661b1165],
16	Alzheimer	NN	O	alzheimer	poss	18	SENT_691	[p31l701t1073r1291b1165],
17	’s	POS	O	’s	_	0	SENT_691	[p31l701t1073r1291b1165],
18	disease	NN	O	disease	prep_with	14	SENT_691	[p31l1340t1073r1719b1165],
19	.	.	O	.	_	0	SENT_691	[p31l1340t1073r1719b1165],

1	Neurology	NN	O	neurology	_	0	SENT_692	[p31l1766t1075r2145b1165, p31l10t1251r185b1339],
2	1998	CD	DATE	1998	num	1	SENT_692	[p31l213t1229r1012b1331],
3	;	:	O	;	_	0	SENT_692	[p31l213t1229r1012b1331],
4	50:669	CD	NUMBER	50:669	number	5	SENT_692	[p31l213t1229r1012b1331],
5	—	CD	NUMBER	—	dep	1	SENT_692	[p31l213t1229r1012b1331],
6	77	CD	NUMBER	77	dep	5	SENT_692	[p31l213t1229r1012b1331],
7	.	.	O	.	_	0	SENT_692	[p31l213t1229r1012b1331],

1	85	CD	NUMBER	85	_	0	SENT_693	[p31l8t1383r146b1465],
2	.	.	O	.	_	0	SENT_693	[p31l8t1383r146b1465],

1	Richard	NNP	PERSON	Richard	nn	2	SENT_694	[p31l207t1373r592b1471],
2	F	NN	PERSON	f	dep	19	SENT_694	[p31l657t1383r729b1485],
3	,	,	O	,	_	0	SENT_694	[p31l657t1383r729b1485],
4	Helbecque	JJ	ORGANIZATION	helbecque	amod	5	SENT_694	[p31l801t1373r1321b1489],
5	N	NN	ORGANIZATION	n	appos	2	SENT_694	[p31l1384t1383r1492b1485],
6	,	,	O	,	_	0	SENT_694	[p31l1384t1383r1492b1485],
7	Neuman	NNP	PERSON	Neuman	nn	8	SENT_694	[p31l1561t1381r1986b1465],
8	E	NNP	O	E	appos	2	SENT_694	[p31l2049t1383r2139b1485],
9	,	,	O	,	_	0	SENT_694	[p31l2049t1383r2139b1485],
10	Guez	NNP	PERSON	Guez	nn	11	SENT_694	[p31l10t1531r265b1615],
11	D	NNP	O	D	appos	2	SENT_694	[p31l297t1531r400b1635],
12	,	,	O	,	_	0	SENT_694	[p31l297t1531r400b1635],
13	Levy	NNP	ORGANIZATION	Levy	nn	14	SENT_694	[p31l438t1533r654b1639],
14	R	NNP	ORGANIZATION	R	appos	2	SENT_694	[p31l681t1531r781b1635],
15	,	,	O	,	_	0	SENT_694	[p31l681t1531r781b1635],
16	Amouyel	NNP	ORGANIZATION	Amouyel	nn	18	SENT_694	[p31l816t1525r1253b1639],
17	P.	NNP	ORGANIZATION	P.	nn	18	SENT_694	[p31l1284t1531r1358b1615],
18	APOE	NNP	ORGANIZATION	APOE	appos	2	SENT_694	[p31l1394t1531r1679b1615],
19	genotyping	NN	O	genotyping	_	0	SENT_694	[p31l1715t1543r2145b1641, p31l8t1675r170b1791],
20	and	CC	O	and	_	0	SENT_694	[p31l205t1675r385b1765],
21	response	NN	O	response	conj_and	19	SENT_694	[p31l424t1703r864b1791],
22	to	TO	O	to	_	0	SENT_694	[p31l904t1693r996b1765],
23	drug	NN	O	drug	nn	24	SENT_694	[p31l1037t1675r1269b1791],
24	treatment	NN	O	treatment	prep_to	19	SENT_694	[p31l1304t1693r1785b1765],
25	in	IN	O	in	_	0	SENT_694	[p31l1817t1675r1912b1763],
26	Alzheimer	NN	O	alzheimer	poss	28	SENT_694	[p31l1946t1675r2145b1763, p31l10t1825r434b1915],
27	’s	POS	O	’s	_	0	SENT_694	[p31l1946t1675r2145b1763, p31l10t1825r434b1915],
28	disease	NN	O	disease	prep_in	24	SENT_694	[p31l466t1823r845b1915],
29	.	.	O	.	_	0	SENT_694	[p31l466t1823r845b1915],

1	Lancet	NNP	O	Lancet	_	0	SENT_695	[p31l878t1833r1205b1915],
2	1997	CD	DATE	1997	num	1	SENT_695	[p31l1231t1831r1930b1935],
3	;	:	O	;	_	0	SENT_695	[p31l1231t1831r1930b1935],
4	349:539	CD	NUMBER	349:539	dep	1	SENT_695	[p31l1231t1831r1930b1935],
5	.	.	O	.	_	0	SENT_695	[p31l1231t1831r1930b1935],

1	86	CD	NUMBER	86	_	0	SENT_696	[p31l8t1983r146b2065],
2	.	.	O	.	_	0	SENT_696	[p31l8t1983r146b2065],

1	Nestruck	NNP	O	Nestruck	nn	2	SENT_697	[p31l207t1973r657b2065],
2	AC	NN	O	ac	nsubj	7	SENT_697	[p31l711t1981r885b2085],
3	,	,	O	,	_	0	SENT_697	[p31l711t1981r885b2085],
4	Bouthillier	JJ	PERSON	bouthillier	amod	5	SENT_697	[p31l954t1973r1480b2065],
5	D	NN	O	d	appos	2	SENT_697	[p31l1539t1981r1641b2085],
6	,	,	O	,	_	0	SENT_697	[p31l1539t1981r1641b2085],
7	Sing	VB	O	sing	_	0	SENT_697	[p31l1715t1975r1932b2091],
8	CF	NN	O	cf	dobj	7	SENT_697	[p31l1992t1981r2139b2085],
9	,	,	O	,	_	0	SENT_697	[p31l1992t1981r2139b2085],
10	Davignon	NNP	PERSON	Davignon	nn	14	SENT_697	[p31l8t2125r484b2241],
11	J.	NNP	PERSON	J.	nn	14	SENT_697	[p31l556t2133r625b2229],
12	Apolipoprotein	NNP	PERSON	Apolipoprotein	nn	14	SENT_697	[p31l711t2125r1466b2241],
13	E	NNP	O	E	nn	14	SENT_697	[p31l1547t2133r1608b2213],
14	polymorphism	NN	O	polymorphism	dobj	7	SENT_697	[p31l1695t2123r2145b2241, p31l8t2275r319b2391],
15	and	CC	O	and	_	0	SENT_697	[p31l363t2273r544b2365],
16	plasma	NN	O	plasma	nn	18	SENT_697	[p31l586t2275r942b2391],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_697	[p31l986t2273r1526b2365],
18	response	NN	O	response	dobj	7	SENT_697	[p31l1569t2303r2008b2391],
19	to	TO	O	to	_	0	SENT_697	[p31l2054t2293r2145b2365],
20	probucol	NN	O	probucol	prep_to	7	SENT_697	[p31l8t2425r478b2541],
21	.	.	O	.	_	0	SENT_697	[p31l8t2425r478b2541],

1	Metabolism	NN	O	metabolism	_	0	SENT_698	[p31l510t2423r1098b2515],
2	1987	CD	DATE	1987	num	1	SENT_698	[p31l1131t2431r1870b2533],
3	;	:	O	;	_	0	SENT_698	[p31l1131t2431r1870b2533],
4	36:743	CD	NUMBER	36:743	num	5	SENT_698	[p31l1131t2431r1870b2533],
5	—	NN	O	—	dep	1	SENT_698	[p31l1131t2431r1870b2533],
6	7	CD	NUMBER	7	dep	5	SENT_698	[p31l1131t2431r1870b2533],
7	.	.	O	.	_	0	SENT_698	[p31l1131t2431r1870b2533],

1	87	CD	NUMBER	87	_	0	SENT_699	[p31l8t2583r146b2665],
2	.	.	O	.	_	0	SENT_699	[p31l8t2583r146b2665],

1	Pedro	NNP	PERSON	Pedro	_	0	SENT_700	[p31l207t2573r820b2665],
2	.	.	O	.	_	0	SENT_700	[p31l207t2573r820b2665],

1	—	NN	O	—	_	0	SENT_701	[p31l207t2573r820b2665],
2	.	.	O	.	_	0	SENT_701	[p31l207t2573r820b2665],

1	Botet	NNP	PERSON	Botet	nn	2	SENT_702	[p31l207t2573r820b2665],
2	J	NNP	PERSON	J	_	0	SENT_702	[p31l878t2583r948b2685],
3	,	,	O	,	_	0	SENT_702	[p31l878t2583r948b2685],
4	Schaefer	NNP	PERSON	Schaefer	nn	6	SENT_702	[p31l1032t2573r1468b2665],
5	E	NNP	O	E	nn	6	SENT_702	[p31l1537t2583r1667b2685],
6	]	NN	O	]	appos	2	SENT_702	[p31l1537t2583r1667b2685],
7	,	,	O	,	_	0	SENT_702	[p31l1537t2583r1667b2685],
8	Bakl	NN	O	bakl	appos	2	SENT_702	[p31l1748t2573r2143b2665],
9	<	JJR	O	<	dep	8	SENT_702	[p31l1748t2573r2143b2665],
10	er	CD	NUMBER	er	num	13	SENT_702	[p31l1748t2573r2143b2665],
11	—	NN	O	—	nn	13	SENT_702	[p31l1748t2573r2143b2665],
12	Arkema	NN	ORGANIZATION	arkema	nn	13	SENT_702	[p31l6t2725r391b2817],
13	RG	NN	O	rg	dep	2	SENT_702	[p31l412t2731r592b2835],
14	,	,	O	,	_	0	SENT_702	[p31l412t2731r592b2835],
15	et	FW	O	et	nn	16	SENT_702	[p31l623t2743r711b2815],
16	al.	FW	O	al.	appos	13	SENT_702	[p31l729t2723r837b2815],
17	.	.	O	.	_	0	SENT_702	[p31l729t2723r837b2815],

1	Apolipoprotein	NN	O	apolipoprotein	nn	3	SENT_703	[p31l862t2725r1602b2841],
2	E	NN	O	e	nn	3	SENT_703	[p31l1625t2733r1685b2813],
3	genotype	NN	O	genotype	nsubj	4	SENT_703	[p31l1711t2743r2147b2841],
4	affects	VBZ	O	affect	_	0	SENT_703	[p31l10t2873r319b2965],
5	plasma	NN	O	plasma	nn	7	SENT_703	[p31l347t2875r699b2991],
6	lipid	NN	O	lipid	nn	7	SENT_703	[p31l727t2875r948b2991],
7	response	NN	O	response	dobj	4	SENT_703	[p31l978t2903r1418b2991],
8	to	TO	O	to	_	0	SENT_703	[p31l1450t2893r1540b2965],
9	atorvastatin	NN	O	atorvastatin	prep_to	7	SENT_703	[p31l1571t2875r2145b2965],
10	in	IN	O	in	_	0	SENT_703	[p31l8t3025r104b3113],
11	a	DT	O	a	det	14	SENT_703	[p31l127t3055r178b3115],
12	gender	NN	O	gender	nn	14	SENT_703	[p31l201t3025r542b3141],
13	specific	JJ	O	specific	amod	14	SENT_703	[p31l564t3023r932b3141],
14	manner	NN	O	manner	prep_in	9	SENT_703	[p31l956t3053r1357b3115],
15	.	.	O	.	_	0	SENT_703	[p31l956t3053r1357b3115],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_704	[p31l1384t3023r2143b3115],
2	2001	CD	DATE	2001	num	1	SENT_704	[p31l10t3181r875b3285],
3	;	:	O	;	_	0	SENT_704	[p31l10t3181r875b3285],
4	158:183	CD	NUMBER	158:183	number	5	SENT_704	[p31l10t3181r875b3285],
5	—	CD	NUMBER	—	dep	1	SENT_704	[p31l10t3181r875b3285],
6	93	CD	NUMBER	93	dep	5	SENT_704	[p31l10t3181r875b3285],
7	.	.	O	.	_	0	SENT_704	[p31l10t3181r875b3285],

1	88	CD	NUMBER	88	_	0	SENT_705	[p31l8t3333r146b3415],
2	.	.	O	.	_	0	SENT_705	[p31l8t3333r146b3415],

1	Watanabe	NNP	PERSON	Watanabe	nn	2	SENT_706	[p31l205t3323r693b3415],
2	J	NNP	PERSON	J	_	0	SENT_706	[p31l725t3333r793b3435],
3	,	,	O	,	_	0	SENT_706	[p31l725t3333r793b3435],
4	Kobayashi	NNP	LOCATION	Kobayashi	nn	5	SENT_706	[p31l844t3323r1353b3439],
5	K	NNP	LOCATION	K	appos	2	SENT_706	[p31l1396t3333r1496b3435],
6	,	,	O	,	_	0	SENT_706	[p31l1396t3333r1496b3435],
7	Umeda	NNP	PERSON	Umeda	nn	8	SENT_706	[p31l1545t3323r1898b3415],
8	E	NNP	O	E	appos	2	SENT_706	[p31l1938t3333r2012b3433],
9	,	,	O	,	_	0	SENT_706	[p31l1938t3333r2012b3433],
10	et	FW	O	et	nn	11	SENT_706	[p31l2063t3343r2151b3415],
11	al.	FW	O	al.	appos	2	SENT_706	[p31l10t3473r118b3565],
12	.	.	O	.	_	0	SENT_706	[p31l10t3473r118b3565],

1	Apolipoprotein	NN	O	apolipoprotein	nn	3	SENT_707	[p31l163t3475r916b3591],
2	E	NN	O	e	nn	3	SENT_707	[p31l956t3483r1016b3563],
3	polymorphism	NN	O	polymorphism	nsubj	4	SENT_707	[p31l1059t3475r1788b3591],
4	affects	VBZ	O	affect	_	0	SENT_707	[p31l1828t3473r2145b3565],
5	the	DT	O	the	det	6	SENT_707	[p31l10t3623r160b3715],
6	response	NN	O	response	dobj	4	SENT_707	[p31l197t3653r636b3741],
7	to	TO	O	to	_	0	SENT_707	[p31l673t3643r765b3715],
8	pravastatin	NN	O	pravastatin	prep_to	4	SENT_707	[p31l802t3625r1343b3741],
9	on	IN	O	on	_	0	SENT_707	[p31l1380t3653r1504b3715],
10	plasma	NN	O	plasma	nn	11	SENT_707	[p31l1539t3625r1894b3741],
11	apolipoproteins	NNS	O	apolipoprotein	prep_on	8	SENT_707	[p31l1928t3653r2145b3741, p32l8t25r604b141],

1	in	IN	O	in	_	0	SENT_708	[p32l661t25r755b113],
2	diabetic	JJ	O	diabetic	amod	3	SENT_708	[p32l811t23r1193b115],
3	patients	NNS	O	patient	pobj	1	SENT_708	[p32l1246t25r1663b141],
4	.	.	O	.	_	0	SENT_708	[p32l1246t25r1663b141],

1	Diabetes	NNP	O	Diabetes	nn	4	SENT_709	[p32l1723t25r2145b115],
2	Res	NNP	O	Res	nn	4	SENT_709	[p32l8t181r181b271],
3	Clin	NNP	O	Clin	nn	4	SENT_709	[p32l213t175r414b265],
4	Pract	NNP	O	Pract	_	0	SENT_709	[p32l440t181r691b265],
5	1993	CD	DATE	1993	num	4	SENT_709	[p32l719t181r1396b285],
6	;	:	O	;	_	0	SENT_709	[p32l719t181r1396b285],
7	20:21	CD	TIME	20:21	num	8	SENT_709	[p32l719t181r1396b285],
8	—	NN	O	—	dep	4	SENT_709	[p32l719t181r1396b285],
9	7	CD	NUMBER	7	dep	8	SENT_709	[p32l719t181r1396b285],
10	.	.	O	.	_	0	SENT_709	[p32l719t181r1396b285],

1	89	CD	NUMBER	89	_	0	SENT_710	[p32l8t333r146b415],
2	.	.	O	.	_	0	SENT_710	[p32l8t333r146b415],

1	Ballantyne	NNP	PERSON	Ballantyne	nn	2	SENT_711	[p32l207t323r719b439],
2	CM	NN	O	cm	_	0	SENT_711	[p32l753t331r950b435],
3	,	,	O	,	_	0	SENT_711	[p32l753t331r950b435],
4	Herd	NN	O	herd	nn	5	SENT_711	[p32l990t323r1235b415],
5	JA	NN	O	ja	appos	2	SENT_711	[p32l1257t333r1398b435],
6	,	,	O	,	_	0	SENT_711	[p32l1257t333r1398b435],
7	Stein	NNP	PERSON	Stein	nn	8	SENT_711	[p32l1440t325r1681b415],
8	EA	NN	PERSON	ea	appos	2	SENT_711	[p32l1713t333r1876b435],
9	,	,	O	,	_	0	SENT_711	[p32l1713t333r1876b435],
10	et	FW	O	et	nn	11	SENT_711	[p32l1916t343r2006b415],
11	al.	FW	O	al.	appos	2	SENT_711	[p32l2031t323r2141b415],
12	.	.	O	.	_	0	SENT_711	[p32l2031t323r2141b415],

1	Apolipoprotein	NN	O	apolipoprotein	nn	3	SENT_712	[p32l6t475r759b591],
2	E	NN	O	e	nn	3	SENT_712	[p32l810t483r871b563],
3	genotypes	NNS	O	genotype	nsubj	12	SENT_712	[p32l926t493r1418b591],
4	and	CC	O	and	_	0	SENT_712	[p32l1474t475r1655b565],
5	response	NN	O	response	conj_and	3	SENT_712	[p32l1707t503r2147b591],
6	of	IN	O	of	_	0	SENT_712	[p32l10t623r128b715],
7	plasma	NN	O	plasma	nn	8	SENT_712	[p32l171t625r526b741],
8	lipids	NNS	O	lipid	prep_of	3	SENT_712	[p32l589t623r859b741],
9	and	CC	O	and	_	0	SENT_712	[p32l926t623r1108b715],
10	progression	NN	O	progression	nn	11	SENT_712	[p32l1171t625r2145b741],
11	—	NN	O	—	prep_of	3	SENT_712	[p32l1171t625r2145b741],
12	regres	VBZ	O	regre	_	0	SENT_712	[p32l1171t625r2145b741],
13	—	CD	NUMBER	—	num	14	SENT_712	[p32l1171t625r2145b741],
14	sion	NN	O	sion	dobj	12	SENT_712	[p32l12t775r217b865],
15	of	IN	O	of	_	0	SENT_712	[p32l279t773r397b865],
16	coronary	JJ	O	coronary	amod	17	SENT_712	[p32l438t803r873b891],
17	atherosclerosis	NN	O	atherosclerosis	prep_of	14	SENT_712	[p32l930t773r1665b865],
18	to	TO	O	to	_	0	SENT_712	[p32l1731t793r1823b865],
19	lipidlowering	VBG	O	lipidlower	amod	21	SENT_712	[p32l1886t775r2145b891, p32l8t925r446b1041],
20	drug	NN	O	drug	nn	21	SENT_712	[p32l500t925r731b1041],
21	therapy	NN	O	therapy	prep_to	12	SENT_712	[p32l783t925r1163b1041],
22	.	.	O	.	_	0	SENT_712	[p32l783t925r1163b1041],

1	J	NNP	O	J	nn	4	SENT_713	[p32l1213t933r1257b1029],
2	Am	NNP	O	Am	nn	4	SENT_713	[p32l1304t933r1478b1013],
3	Coll	NNP	O	Coll	nn	4	SENT_713	[p32l1534t925r1733b1015],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_713	[p32l1787t923r2147b1015],
5	2000	CD	DATE	2000	num	4	SENT_713	[p32l10t1081r815b1185],
6	;	:	O	;	_	0	SENT_713	[p32l10t1081r815b1185],
7	36:1572	CD	NUMBER	36:1572	number	8	SENT_713	[p32l10t1081r815b1185],
8	-8	CD	NUMBER	-8	dep	4	SENT_713	[p32l10t1081r815b1185],
9	.	.	O	.	_	0	SENT_713	[p32l10t1081r815b1185],

1	90	CD	NUMBER	90	_	0	SENT_714	[p32l10t1233r146b1315],
2	.	.	O	.	_	0	SENT_714	[p32l10t1233r146b1315],

1	Cargill	NNP	ORGANIZATION	Cargill	nn	2	SENT_715	[p32l209t1223r536b1341],
2	M	NNP	O	M	_	0	SENT_715	[p32l571t1233r697b1335],
3	,	,	O	,	_	0	SENT_715	[p32l571t1233r697b1335],
4	Daley	NNP	PERSON	Daley	nn	5	SENT_715	[p32l741t1223r1016b1339],
5	GQ	NNP	O	GQ	appos	2	SENT_715	[p32l1049t1231r1239b1337],
6	.	.	O	.	_	0	SENT_715	[p32l1049t1231r1239b1337],

1	Mining	NN	O	mining	_	0	SENT_716	[p32l1281t1225r1645b1341],
2	for	IN	O	for	_	0	SENT_716	[p32l1679t1223r1822b1315],
3	SNPS	NNS	O	snp	prep_for	1	SENT_716	[p32l1860t1231r2141b1315],
4	:	:	O	:	_	0	SENT_716	[p32l1860t1231r2141b1315],
5	putting	VBG	O	put	dep	3	SENT_716	[p32l8t1375r371b1491],
6	the	DT	O	the	det	8	SENT_716	[p32l396t1373r546b1465],
7	common	JJ	O	common	amod	8	SENT_716	[p32l577t1403r1018b1465],
8	variants	NNS	O	variant	nsubj	12	SENT_716	[p32l1042t1375r1936b1465],
9	—	CD	NUMBER	—	num	12	SENT_716	[p32l1042t1375r1936b1465],
10	common	JJ	O	common	amod	12	SENT_716	[p32l1042t1375r1936b1465],
11	disease	NN	O	disease	nn	12	SENT_716	[p32l1968t1373r2145b1465, p32l10t1555r215b1615],
12	hypothesis	NN	O	hypothesis	xcomp	5	SENT_716	[p32l277t1525r803b1641],
13	to	TO	O	to	_	0	SENT_716	[p32l866t1543r958b1615],
14	the	DT	O	the	det	15	SENT_716	[p32l1022t1523r1171b1615],
15	test	NN	O	test	prep_to	12	SENT_716	[p32l1235t1543r1430b1615],
16	.	.	O	.	_	0	SENT_716	[p32l1235t1543r1430b1615],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_717	[p32l1497t1525r2145b1641, p32l10t1675r367b1765],
2	2000	CD	DATE	2000	num	1	SENT_717	[p32l398t1681r1080b1785],
3	;	:	O	;	_	0	SENT_717	[p32l398t1681r1080b1785],
4	1:27	CD	TIME	1:27	number	5	SENT_717	[p32l398t1681r1080b1785],
5	—	CD	NUMBER	—	dep	1	SENT_717	[p32l398t1681r1080b1785],
6	37	CD	NUMBER	37	dep	5	SENT_717	[p32l398t1681r1080b1785],
7	.	.	O	.	_	0	SENT_717	[p32l398t1681r1080b1785],

1	91	CD	NUMBER	91	_	0	SENT_718	[p32l10t1833r146b1915],
2	.	.	O	.	_	0	SENT_718	[p32l10t1833r146b1915],

1	Sham	NNP	O	Sham	nn	2	SENT_719	[p32l211t1823r486b1915],
2	P.	NNP	O	P.	_	0	SENT_719	[p32l546t1831r620b1915],
3	Shifting	VBG	O	shift	partmod	2	SENT_719	[p32l691t1823r1082b1941],
4	paradigms	NNS	O	paradigm	dobj	3	SENT_719	[p32l1137t1823r1657b1941],
5	in	IN	O	in	_	0	SENT_719	[p32l1721t1825r1815b1913],
6	genemapping	VBG	O	genemapp	prepc_in	3	SENT_719	[p32l1876t1853r2145b1941, p32l10t1975r456b2091],
7	methodology	NN	O	methodology	dobj	6	SENT_719	[p32l504t1973r1159b2091],
8	for	IN	O	for	_	0	SENT_719	[p32l1207t1973r1349b2065],
9	complex	JJ	O	complex	amod	10	SENT_719	[p32l1398t1975r1817b2091],
10	traits	NNS	O	trait	prep_for	6	SENT_719	[p32l1866t1975r2141b2065],
11	.	.	O	.	_	0	SENT_719	[p32l1866t1975r2141b2065],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_720	[p32l8t2125r980b2241],
2	2001	CD	DATE	2001	num	1	SENT_720	[p32l1012t2131r1816b2235],
3	;	:	O	;	_	0	SENT_720	[p32l1012t2131r1816b2235],
4	2:195	CD	NUMBER	2:195	num	5	SENT_720	[p32l1012t2131r1816b2235],
5	—	NN	O	—	dep	1	SENT_720	[p32l1012t2131r1816b2235],
6	202	CD	NUMBER	202	dep	5	SENT_720	[p32l1012t2131r1816b2235],
7	.	.	O	.	_	0	SENT_720	[p32l1012t2131r1816b2235],

1	92	CD	NUMBER	92	_	0	SENT_721	[p32l10t2283r146b2365],
2	.	.	O	.	_	0	SENT_721	[p32l10t2283r146b2365],

1	Staunton	NNP	O	Staunton	nn	2	SENT_722	[p32l211t2281r654b2365],
2	JE	NNP	O	JE	_	0	SENT_722	[p32l685t2283r819b2385],
3	,	,	O	,	_	0	SENT_722	[p32l685t2283r819b2385],
4	Slonim	NNP	ORGANIZATION	Slonim	nn	5	SENT_722	[p32l870t2273r1219b2365],
5	DK	NNP	ORGANIZATION	DK	appos	2	SENT_722	[p32l1259t2281r1444b2385],
6	,	,	O	,	_	0	SENT_722	[p32l1259t2281r1444b2385],
7	Coller	NNP	ORGANIZATION	Coller	nn	8	SENT_722	[p32l1492t2273r1791b2365],
8	HA	NNP	ORGANIZATION	HA	appos	2	SENT_722	[p32l1828t2283r2014b2385],
9	,	,	O	,	_	0	SENT_722	[p32l1828t2283r2014b2385],
10	et	FW	O	et	nn	11	SENT_722	[p32l2063t2293r2153b2365],
11	al.	FW	O	al.	appos	2	SENT_722	[p32l10t2423r118b2515],
12	.	.	O	.	_	0	SENT_722	[p32l10t2423r118b2515],

1	Chemosensitivity	NNP	O	Chemosensitivity	nn	2	SENT_723	[p32l209t2425r1056b2539],
2	prediction	NN	O	prediction	_	0	SENT_723	[p32l1133t2423r1637b2541],
3	by	IN	O	by	_	0	SENT_723	[p32l1721t2425r1834b2539],
4	transcriptional	JJ	O	transcriptional	amod	5	SENT_723	[p32l1912t2443r2145b2515, p32l12t2575r532b2691],
5	profiling	NN	O	profiling	prep_by	2	SENT_723	[p32l601t2573r1060b2691],
6	.	.	O	.	_	0	SENT_723	[p32l601t2573r1060b2691],

1	Proc	NNP	O	Proc	nn	7	SENT_724	[p32l1135t2581r1353b2665],
2	Natl	NNP	O	Natl	nn	7	SENT_724	[p32l1420t2575r1628b2665],
3	Acad	NNP	O	Acad	nn	7	SENT_724	[p32l1693t2573r1938b2665],
4	Sci	NNP	O	Sci	nn	7	SENT_724	[p32l2010t2575r2149b2665],
5	U	NNP	O	U	nn	7	SENT_724	[p32l10t2733r90b2815],
6	S	NNP	O	S	nn	7	SENT_724	[p32l119t2731r169b2815],
7	A	NNP	O	A	_	0	SENT_724	[p32l199t2733r275b2813],
8	2001	CD	DATE	2001	num	7	SENT_724	[p32l300t2731r1227b2835],
9	;	:	O	;	_	0	SENT_724	[p32l300t2731r1227b2835],
10	98:10787	CD	NUMBER	98:10787	number	11	SENT_724	[p32l300t2731r1227b2835],
11	—	CD	NUMBER	—	dep	7	SENT_724	[p32l300t2731r1227b2835],
12	92	CD	NUMBER	92	dep	11	SENT_724	[p32l300t2731r1227b2835],
13	.	.	O	.	_	0	SENT_724	[p32l300t2731r1227b2835],

1	93	CD	NUMBER	93	_	0	SENT_725	[p32l10t2883r146b2965],
2	.	.	O	.	_	0	SENT_725	[p32l10t2883r146b2965],

1	Yeoh	NNP	PERSON	Yeoh	nn	3	SENT_726	[p32l205t2873r442b2965],
2	E	NNP	O	E	nn	3	SENT_726	[p32l490t2883r616b2985],
3	]	NN	O	]	_	0	SENT_726	[p32l490t2883r616b2985],
4	,	,	O	,	_	0	SENT_726	[p32l490t2883r616b2985],
5	Ross	NNP	PERSON	Ross	nn	6	SENT_726	[p32l671t2881r904b2971],
6	ME	NNP	O	ME	appos	3	SENT_726	[p32l954t2883r1147b2985],
7	,	,	O	,	_	0	SENT_726	[p32l954t2883r1147b2985],
8	Shurtleff	NNP	PERSON	Shurtleff	nn	9	SENT_726	[p32l1207t2873r1653b2965],
9	SA	NNP	O	SA	appos	3	SENT_726	[p32l1685t2881r1840b2983],
10	,	,	O	,	_	0	SENT_726	[p32l1685t2881r1840b2983],
11	et	FW	O	et	nn	12	SENT_726	[p32l1898t2893r1988b2965],
12	al.	FW	O	al.	appos	3	SENT_726	[p32l2031t2873r2141b2965],
13	.	.	O	.	_	0	SENT_726	[p32l2031t2873r2141b2965],

1	Classiﬁcation	NNP	MISC	Classiﬁcation	_	0	SENT_727	[p32l10t3023r701b3135],
2	,	,	O	,	_	0	SENT_727	[p32l10t3023r701b3135],
3	subtype	NN	O	subtype	nn	4	SENT_727	[p32l763t3023r1137b3141],
4	discovery	NN	O	discovery	conj_and	1	SENT_727	[p32l1191t3025r1659b3139],
5	,	,	O	,	_	0	SENT_727	[p32l1191t3025r1659b3139],
6	and	CC	O	and	_	0	SENT_727	[p32l1717t3023r1898b3115],
7	prediction	NN	O	prediction	conj_and	1	SENT_727	[p32l1948t3053r2143b3141, p32l10t3173r351b3265],
8	of	IN	O	of	_	0	SENT_727	[p32l398t3173r516b3265],
9	outcome	NN	O	outcome	prep_of	7	SENT_727	[p32l542t3193r968b3265],
10	in	IN	O	in	_	0	SENT_727	[p32l1014t3175r1108b3263],
11	pediatric	JJ	O	pediatric	amod	14	SENT_727	[p32l1153t3175r1583b3291],
12	acute	JJ	O	acute	amod	14	SENT_727	[p32l1629t3193r1882b3265],
13	lymphoblastic	JJ	O	lymphoblastic	amod	14	SENT_727	[p32l1928t3175r2145b3289, p32l8t3325r522b3441],
14	leukemia	NN	O	leukemia	prep_in	9	SENT_727	[p32l597t3323r1048b3417],
15	by	IN	O	by	_	0	SENT_727	[p32l1125t3325r1237b3439],
16	gene	NN	O	gene	nn	18	SENT_727	[p32l1311t3353r1542b3441],
17	expression	NN	O	expression	nn	18	SENT_727	[p32l1621t3325r2147b3441],
18	profiling	NN	O	profiling	prep_by	14	SENT_727	[p32l8t3473r466b3591],
19	.	.	O	.	_	0	SENT_727	[p32l8t3473r466b3591],

1	Cancer	NN	O	cancer	nn	2	SENT_728	[p32l502t3481r845b3565],
2	Cell	NN	O	cell	_	0	SENT_728	[p32l870t3475r1059b3565],
3	2002	CD	DATE	2002	dep	2	SENT_728	[p32l1087t3481r1830b3585],
4	;	:	O	;	_	0	SENT_728	[p32l1087t3481r1830b3585],
5	1:133	CD	NUMBER	1:133	num	6	SENT_728	[p32l1087t3481r1830b3585],
6	-43	CD	NUMBER	-43	dep	2	SENT_728	[p32l1087t3481r1830b3585],
7	.	.	O	.	_	0	SENT_728	[p32l1087t3481r1830b3585],

1	94	CD	NUMBER	94	_	0	SENT_729	[p32l10t3633r146b3715],
2	.	.	O	.	_	0	SENT_729	[p32l10t3633r146b3715],

1	Liotta	NNP	ORGANIZATION	Liotta	nn	2	SENT_730	[p32l207t3625r492b3715],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_730	[p32l522t3633r681b3735],
3	,	,	O	,	_	0	SENT_730	[p32l522t3633r681b3735],
4	Kohn	NNP	ORGANIZATION	Kohn	nn	5	SENT_730	[p32l721t3623r990b3717],
5	EC	NNP	ORGANIZATION	EC	appos	2	SENT_730	[p32l1022t3631r1187b3735],
6	,	,	O	,	_	0	SENT_730	[p32l1022t3631r1187b3735],
7	Petricoin	NNP	O	Petricoin	nn	8	SENT_730	[p32l1225t3625r1663b3715],
8	EF	NNP	O	EF	appos	5	SENT_730	[p32l1693t3631r1833b3715],
9	.	.	O	.	_	0	SENT_730	[p32l1693t3631r1833b3715],

1	Clinical	JJ	O	clinical	_	0	SENT_731	[p32l1872t3623r2143b3715, p33l10t28r144b118],

1	proteomics	NNS	O	proteomic	_	0	SENT_732	[p33l241t28r825b144],
2	:	:	O	:	_	0	SENT_732	[p33l241t28r825b144],
3	personalized	VBN	O	personalize	amod	5	SENT_732	[p33l928t26r1558b144],
4	molecular	JJ	O	molecular	amod	5	SENT_732	[p33l1657t26r2151b118],
5	medicine	NN	O	medicine	dep	1	SENT_732	[p33l10t176r486b268],
6	.	.	O	.	_	0	SENT_732	[p33l10t176r486b268],

1	JAMA	NNP	O	JAMA	_	0	SENT_733	[p33l510t186r805b282],
2	2001	CD	DATE	2001	num	1	SENT_733	[p33l829t184r1695b286],
3	;	:	O	;	_	0	SENT_733	[p33l829t184r1695b286],
4	286:2211	CD	NUMBER	286:2211	number	5	SENT_733	[p33l829t184r1695b286],
5	—	CD	NUMBER	—	dep	1	SENT_733	[p33l829t184r1695b286],
6	4	CD	NUMBER	4	dep	5	SENT_733	[p33l829t184r1695b286],
7	.	.	O	.	_	0	SENT_733	[p33l829t184r1695b286],

1	Copyright	NN	O	copyright	nn	2	SENT_734	[p33l12t322r382b420],
2	t	NN	O	t	_	0	SENT_734	[p33l414t330r498b412],
3	2003	CD	DATE	2003	dep	2	SENT_734	[p33l534t326r725b396],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_734	[p33l759t322r1319b396],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_734	[p33l1350t322r1657b396],
6	Society	NNP	ORGANIZATION	Society	dep	3	SENT_734	[p33l1683t324r1966b418],
7	.	.	O	.	_	0	SENT_734	[p33l1683t324r1966b418],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_735	[p33l522t501r606b523],
2	MED	NNP	O	MED	_	0	SENT_735	[p33l621t501r673b516],
3	;	:	O	;	_	0	SENT_735	[p33l734t502r738b521],
4	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	5	SENT_735	[p33l791t501r1003b523],
5	FEBRUARY	NNP	DATE	FEBRUARY	dep	2	SENT_735	[p33l1042t501r1169b517],
6	6	CD	DATE	6	num	5	SENT_735	[p33l1182t495r1203b521],
7	,	,	O	,	_	0	SENT_735	[p33l1182t495r1203b521],
8	2oo3	CD	NUMBER	2oo3	num	5	SENT_735	[p33l1217t501r1280b523],
9	549	CD	NUMBER	549	dep	5	SENT_735	[p33l1960t499r2016b522],

1	e	LS	O	e	dep	4	SENT_736	[p33l739t542r753b558],
2	New	NNP	O	New	nn	4	SENT_736	[p33l762t535r824b558],
3	England	NNP	O	England	nn	4	SENT_736	[p33l833t534r944b565],
4	Journal	NNP	O	Journal	_	0	SENT_736	[p33l953t534r1050b558],
5	of	IN	O	of	prep	4	SENT_736	[p33l1060t534r1089b558],
6	Medicine	NNP	O	Medicine	dep	4	SENT_736	[p33l1095t534r1220b558],

1	Downloaded	VBN	O	download	_	0	SENT_737	[p33l144t575r314b598],
2	from	IN	O	from	_	0	SENT_737	[p33l323t575r387b598],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_737	[p33l396t575r514b605],
4	at	IN	O	at	_	0	SENT_737	[p33l524t579r548b598],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_737	[p33l556t575r739b598],
6	on	IN	O	on	_	0	SENT_737	[p33l748t582r780b598],
7	January	NNP	DATE	January	prep_on	1	SENT_737	[p33l789t575r892b605],
8	5	CD	DATE	5	num	7	SENT_737	[p33l902t575r924b603],
9	,	,	DATE	,	_	0	SENT_737	[p33l902t575r924b603],
10	2014	CD	DATE	2014	num	7	SENT_737	[p33l935t575r1007b598],
11	.	.	O	.	_	0	SENT_737	[p33l935t575r1007b598],

1	or	CC	O	or	dep	4	SENT_738	[p33l1037t582r1064b598],
2	ersonal	JJ	O	ersonal	amod	3	SENT_738	[p33l1090t575r1185b598],
3	use	NN	O	use	npadvmod	4	SENT_738	[p33l1194t582r1237b598],
4	only	RB	O	only	_	0	SENT_738	[p33l1247t575r1312b605],
5	.	.	O	.	_	0	SENT_738	[p33l1247t575r1312b605],

1	No	DT	O	no	det	3	SENT_739	[p33l1322t575r1362b598],
2	other	JJ	O	other	amod	3	SENT_739	[p33l1372t575r1440b598],
3	uses	NNS	O	use	_	0	SENT_739	[p33l1449t582r1504b598],
4	without	IN	O	without	_	0	SENT_739	[p33l1515t575r1616b598],
5	permission	NN	O	permission	prep_without	3	SENT_739	[p33l1624t575r1777b605],
6	.	.	O	.	_	0	SENT_739	[p33l1624t575r1777b605],

1	Copyright	NN	O	copyright	nn	5	SENT_740	[p33l494t616r629b647],
2	©	CD	NUMBER	©	num	5	SENT_740	[p33l638t616r661b640],
3	2003	CD	DATE	2003	num	5	SENT_740	[p33l672t616r735b640],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_740	[p33l746t616r937b640],
5	Medica	NNP	ORGANIZATION	Medica	_	0	SENT_740	[p33l947t616r1047b640],
6	ociety	NN	O	ociety	dep	5	SENT_740	[p33l1084t616r1170b647],
7	.	.	O	.	_	0	SENT_740	[p33l1084t616r1170b647],

1	All	DT	O	all	det	2	SENT_741	[p33l1181t616r1223b640],
2	rights	NNS	O	rights	nsubj	3	SENT_741	[p33l1232t616r1307b647],
3	reserved	VBN	O	reserve	_	0	SENT_741	[p33l1316t616r1435b640],
4	.	.	O	.	_	0	SENT_741	[p33l1316t616r1435b640],

